Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,rRNA processing (GO:0006364),0.6333814569152393,2.8982041819851463,0.0,0.0,0.0,126/167,26.76%,DKC1;DDX47;NOB1;DCAF13;WDR43;WDR12;EXOSC5;WDR3;EMG1;UTP18;IMP4;MRTO4;EBNA1BP2;BYSL;FBL;LYAR;RRP9;PES1;BOP1;EXOSC4;UTP14A;RPL36;NOLC1;RRP1;RPL8;NAT10;RRP12;RPS2;RCL1;EXOSC8;PRKDC;TFB1M;RPL37;DDX27;RSL1D1;RRP1B;EXOSC7;NOL11;EIF6;RPL18;WDR74;WDR46;WDR18;PIH1D2;RPLP0;DDX10;RPL39;SRFBP1;DDX54;EXOSC1;EXOSC3;DHX37;NOC4L;PDCD11;RPS14;RPLP2;UTP15;HEATR1;DIS3;DDX52;RPL12;RPL28;RPL27A;RRP7A;NHP2;IMP3;RPL29;RPS9;NOP14;RPL35;RPL37A;DDX49;EXOSC2;RPL7A;LSM6;UTP3;UBA52;NOP56;RPL27;RPL32;NOP58;UTP20;RPS19;POP5;POP4;RPL31;MRPL1;RPL35A;TBL3;RPS24;RPL18A;WDR36;NOL6;FCF1;XRN2;RPS16;UTP6;PIH1D1;RPS28;PWP2;RIOK1;ERI1;RPL11;RPL41;RPS15;RPL23;RPF1;MAK16;BMS1;ESF1;RPS7;MPHOSPH6;RPL24;RPL23A;RRP36;RPL4;RIOK2;RPL30;RPLP1;RPL7;RPL13;RPL13A;WDR75;RPL14;RPL15;RPL19
prerank,DNA-dependent DNA replication (GO:0006261),0.6569393104110002,2.8808858653211584,0.0,0.0,0.0,81/128,21.69%,RFC3;PSMD14;MCM4;GINS4;RPA3;GINS1;HMGA1;PSMB2;RFC5;MCM3;DBF4;PRIM2;SSBP1;ORC6;PSMB9;PSMA5;GINS2;POLE2;RFC2;PSMB3;POLD2;PSME3;PSMA3;POLB;MCM5;BLM;PRIM1;PSMA7;MGME1;PSMD13;DDX21;MCMDC2;PSME2;PSMC2;RECQL4;PSMC4;PSMD10;TOPBP1;PSMD12;POLE3;WRNIP1;MCM7;DNA2;PSMB5;CDK2AP1;MCM6;WDHD1;ORC5;POLA1;MCM2;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;MCM10;PSME1;PSMF1;CDT1;PSMD11;UBA52;PSMD1;RPA2;POLD1;LRWD1;TEFM;ORC2;GMNN;CDC6;PSMD6;CDC7;NOC3L;CDC45;MCMBP;RFC4;ORC1;PSMD5;ORC3;BAZ1A;CDK2;PSMC1
prerank,ribosome biogenesis (GO:0042254),0.6123478664754213,2.86911410759889,0.0,0.0,0.0,137/184,26.18%,DKC1;DDX47;NIP7;NOB1;DCAF13;RAN;WDR43;WDR12;EXOSC5;WDR3;EMG1;UTP18;IMP4;MRTO4;EBNA1BP2;BYSL;NOP16;FBL;ABCE1;LYAR;RRP9;RPL26L1;URB2;PES1;BOP1;RRS1;EXOSC4;PAK1IP1;UTP14A;RPL36;NOLC1;RRP1;RPL8;RRP12;RPS2;RCL1;EXOSC8;GTF3A;RPL37;DDX27;DDX31;RRP1B;EXOSC7;NOL11;NAF1;ZNF622;MRPL22;EIF6;NOC2L;RPL18;WDR74;WDR46;WDR18;PIH1D2;RPLP0;DDX10;RPL39;MRPL36;DDX54;EXOSC1;EXOSC3;DHX37;NOC4L;RPF2;PDCD11;RPS14;RPLP2;UTP15;HEATR1;HEATR3;DIS3;DDX52;RPL12;RPL28;RPL27A;RRP7A;IMP3;RPL29;RPS9;NOP14;RPL35;RPL37A;DDX49;EXOSC2;RPL7A;MALSU1;NPM1;UTP3;UBA52;NOP56;RPL27;RPL32;NOP58;UTP20;RPS19;POP5;POP4;RPL31;CUL4A;RPL35A;TBL3;RPS24;RPL18A;WDR36;NOL6;FCF1;XRN2;RPS16;UTP6;PIH1D1;RPS28;PWP2;RIOK1;LSG1;RPL11;RPL41;RPS15;RPL23;RPF1;SURF6;BMS1;ESF1;RPS7;MPHOSPH6;RPL24;RPL23A;RRP36;RPL4;RIOK2;RPL30;RPLP1;RPL7;RPL13;NOM1;RPL13A;WDR75;RPL14
prerank,rRNA metabolic process (GO:0016072),0.6152899699165236,2.8177335067449434,0.0,0.0,0.0,115/154,26.76%,DKC1;DDX47;NOB1;DCAF13;WDR43;WDR12;EXOSC5;WDR3;EMG1;UTP18;IMP4;MRTO4;EBNA1BP2;BYSL;FBL;NIFK;LYAR;RRP9;PES1;BOP1;EXOSC4;UTP14A;RPL36;NOLC1;RRP1;RPL8;RRP12;RPS2;RCL1;EXOSC8;RPL37;DDX27;RRP1B;EXOSC7;NOL11;RPL18;WDR74;WDR46;WDR18;PIH1D2;RPLP0;DDX10;RPL39;DDX54;EXOSC1;EXOSC3;DHX37;NOC4L;PDCD11;RPS14;RPLP2;UTP15;HEATR1;DIS3;DDX52;RPL12;RPL28;RPL27A;RRP7A;IMP3;RPL29;RPS9;NOP14;RPL35;RPL37A;DDX49;EXOSC2;RPL7A;UTP3;UBA52;NOP56;RPL27;RPL32;NOP58;UTP20;RPS19;POP5;POP4;RPL31;DEDD2;RPL35A;TBL3;RPS24;RPL18A;WDR36;NOL6;FCF1;XRN2;RPS16;UTP6;PIH1D1;RPS28;PWP2;RPL11;RPL41;RPS15;RPL23;RPF1;BMS1;ESF1;RPS7;MPHOSPH6;RPL24;RPL23A;RRP36;RPL4;RPL30;RPLP1;RPL7;RPL13;RPL13A;WDR75;RPL14;RPL15;RPL19
prerank,cotranslational protein targeting to membrane (GO:0006613),0.6164102966292058,2.6910834801152217,0.0,0.0,0.0,68/93,28.50%,RPS21;SSR1;ARL6IP1;RPL36;RPL8;SRP72;RPS2;RPS18;SEC61A1;RPS3;TRAM1;RPL37;RPS4X;RPL18;RPLP0;RPL39;SRP9;RPS14;RPLP2;RPL12;RPL28;RPL27A;RPL29;RPS9;RPL35;RPL37A;RPL7A;UBA52;RPL27;RPL32;RPS11;RPS19;RPL31;RPL35A;RPS5;RPS24;RPL18A;SIL1;RPS16;RPS29;RPS13;RPS28;SSR2;RPL11;RPL41;RPS15;RPS8;RPS12;SRP54;RPL23;RPS7;RPL24;RPL23A;RPL4;RPL30;RPS26;RPLP1;RPL7;RPL13;RPL13A;RPL14;RPS20;RPL15;RPL19;RPS3A;RPL3;RPL34;RPL10A
prerank,translation (GO:0006412),0.5679970236811916,2.690109331047391,0.0,0.0,0.0,125/195,27.32%,MRPL3;MRPS16;RPS21;YARS2;ABCE1;AIMP2;FARSB;MRPL37;RPL26L1;RPL22L1;MRPL13;DARS2;FARSA;ZC3H15;MRPS12;RPL36;RPL8;FTSJ1;MRPL47;MARS2;MRPL57;FASTKD2;RPS2;LARS2;RPS18;IGF2BP3;RPS3;RPL37;WARS2;MRPL16;MRPL42;MRPS18B;APEH;MRPS33;MRPL52;DRG1;MRPL11;RPS4X;RPL18;TUFM;QRSL1;MRPL9;RPLP0;MRPS34;RPL39;MRPL36;EEF1B2;PPA1;RPS14;TRMT112;RPLP2;RRBP1;MRPL51;GSPT1;PPA2;FARS2;RPL12;RPL28;MRPS18A;SRBD1;RPL27A;COPS5;RPL29;RPS9;MRPL18;RPL35;RPL37A;AIMP1;GFM2;RPL7A;UBA52;RPL27;RPL32;RPS11;RPS19;ABCF1;MRPS18C;RPL31;RPL35A;RPS5;MRPS2;MRPL23;NOA1;IARS2;RPS24;RPL18A;RPS16;RPS29;RPS13;MRPS11;RPS28;MRPL27;MRPL24;RPS6KB2;RARS2;RPL11;RPL41;RPS15;RPS8;RPS12;RPL23;EEF2;MRPS15;MRPS7;MRPS5;RPS7;RPL24;RPL23A;RPL4;RPL30;EEFSEC;RPS26;RPLP1;RPL7;RPL13;MRPL28;RPL13A;RPL14;RPS20;RPL15;RPL19;HBS1L;RPS3A;RPL3;ASMT
prerank,DNA replication initiation (GO:0006270),0.7296347142535844,2.6722825839953837,0.0,0.0,0.0,29/38,21.69%,MCM4;RPA3;MCM3;DBF4;PRIM2;ORC6;POLE2;MCM5;PRIM1;TOPBP1;POLE3;MCM7;MCM6;ORC5;POLA1;MCM2;MCM10;CDT1;RPA2;LRWD1;ORC2;GMNN;CDC6;CDC7;NOC3L;CDC45;ORC1;ORC3;CDK2
prerank,mitochondrial translation (GO:0032543),0.6372579330618996,2.646262189731334,0.0,0.0,0.0,67/103,22.62%,MRPL17;MRPL3;MRPL19;MRPL30;MRPS16;MRPS35;MRPS23;EARS2;MRPL14;MRPL15;MRPL37;MRPL13;MRPS12;MRPL48;MRPL47;MRPL44;MRPL57;DAP3;FASTKD2;LARS2;MRPL50;MTIF2;MRPL16;MRPL42;MRPS18B;MRPS33;MRPL52;MRPL11;CHCHD1;MRPL22;TUFM;QRSL1;MRPL9;MRPS30;MRPS34;MRPL36;MRPL4;MRPL51;GFM1;MRPL45;MRPS31;MRPS18A;MRPS22;ERAL1;MRPL18;MRPS10;MRPL54;MRPL39;GFM2;MRPL49;MRPS18C;MRPL1;MRPS2;MRPL23;NOA1;IARS2;GADD45GIP1;MRPS11;MRPL27;MRPL24;RARS2;MRPS26;MRPS15;MRPS27;MRPS7;MRPL40;MRPS5
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.5205714404668437,2.6320789790315233,0.0,0.0,0.0,184/306,27.32%,POLR2F;RFC3;CHEK1;POLR2D;MCM4;RPA3;FEN1;MRPL3;E2F1;RFC5;MCM3;DBF4;CDK1;ORC6;TIPIN;MRPS16;EXO1;TOP1MT;RPS21;POLE2;RFC2;YARS2;POLD2;TIMELESS;RMI1;FARSB;INHBA;MRPL37;RHNO1;MRPL13;FAM111B;MCM5;SET;RMI2;BLM;MRPS12;RPL36;RPL8;TICRR;PTMA;RPS2;RPS18;GRWD1;RECQL4;TOP1;IGF2BP3;RPS3;RPL37;TOPBP1;RAD9B;POLE3;MRPL42;GCNT1;MRPS18B;MRPS33;MRPL52;MCM7;DRG1;DNA2;MRPL11;RPS4X;MCM6;RPL18;TUFM;MRPL9;ORC5;RPLP0;POLA1;RPL39;MRPL36;MCM2;EEF1B2;RPS14;RPLP2;RRBP1;MRPL51;GSPT1;RBBP8;RPL12;RPL28;MRPS18A;SRBD1;RPL27A;TAF1B;COPS5;POLR2C;RPL29;MCM10;RPS9;MRPL18;POLR2K;RPL35;RPL37A;BRCA1;EXT2;HUS1;RPL7A;POLR2J;RPL27;RPL32;RPS11;RPS19;ABCF1;RPA2;MRPS18C;RPL31;POLR2G;POLD1;RPL35A;RPS5;MRPL23;CLSPN;RPS24;RPL18A;ORC2;RNASEH2A;CDC6;RPS16;RPS29;RPS13;MRPS11;RPS28;MRPL27;MRPL24;RPS6KB2;CDC7;TOP3A;CDC45;RFC4;BRIP1;POLR2H;B4GALT5;ORC1;PAX8;RPL11;ALAS1;ORC3;RPL41;RPS15;RPS8;RPS12;RPL23;EEF2;POLR2I;MED20;NFKBIB;POLR2L;CDK2;MRPS15;PWP1;MRPS7;MRPS5;RPS7;RPL24;RPL23A;POLR3A;GAL3ST2;RPL4;RNPS1;BARD1;RPL30;EEFSEC;RPS26;RPLP1;RAD1;ORC4;TERT;RPL7;NKX2-8;POLR2B;RPL13;MRPL28;RPL13A;EXT1;RPL14;RPS20;ATR;PPP5C;RPL15;RPL19;HBS1L;RPS3A;RPL3;ASMT
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5969134211918405,2.623169385967455,0.0,0.0,0.0,64/90,28.50%,RPS21;RPL36;RPL8;SEC61B;SRP72;RPS2;RPS18;SEC61A1;RPS3;RPL37;RPS4X;RPL18;RPLP0;RPL39;SRP9;RPS14;RPLP2;RPL12;RPL28;RPL27A;RPL29;RPS9;RPL35;RPL37A;RPL7A;UBA52;RPL27;RPL32;RPS11;RPS19;RPL31;RPL35A;RPS5;RPS24;RPL18A;RPS16;RPS29;RPS13;RPS28;RPL11;RPL41;RPS15;RPS8;RPS12;SRP54;RPL23;RPS7;RPL24;RPL23A;RPL4;RPL30;RPS26;RPLP1;RPL7;RPL13;RPL13A;RPL14;RPS20;RPL15;RPL19;RPS3A;RPL3;RPL34;RPL10A
prerank,cytoplasmic translation (GO:0002181),0.5917963569691627,2.6206733235016824,0.0,0.0,0.0,64/93,27.16%,RPS21;RPL26L1;RPL22L1;ZC3H15;RPL36;RPL8;FTSJ1;EIF3I;RPS2;RPS18;EIF3M;RPS3;RPL37;DRG1;RPS4X;RPL18;RPLP0;RPL39;RPS14;GSPT1;RPL12;RPL28;RPL27A;RPL29;RPS9;RPL35;RPL37A;RPL7A;UBA52;RPL27;RPL32;RPS11;RPS19;RPL31;RPL35A;RPS5;RPS24;RPL18A;RPS16;RPS29;RPS13;RPS28;RPL11;RPL41;RPS15;RPS8;RPS12;RPL23;RPS7;RPL24;RPL23A;RPL4;RPL30;RPS26;RPLP1;RPL7;RPL13;RPL13A;RPL14;RPS20;RPL15;RPL19;RPS3A;RPL3
prerank,translational termination (GO:0006415),0.6276309320607251,2.5980441294091507,0.0,0.0,0.0,61/95,22.62%,MRPL17;MRPL3;MRPL19;MRPL30;MRPS16;MRPS35;MRPS23;ABCE1;MRPL14;MRPL15;MRPL37;MRPL13;MRPS12;MRPL48;MRPL47;MRPL44;MRPL57;DAP3;MRPL50;MRPL16;MRPL42;MRPS18B;APEH;MRPS33;MRPL52;MRPL11;CHCHD1;MRPL22;MRPL9;MRPS30;MRPS34;MRPL36;TRMT112;MRPL4;MRPL51;MRPL45;MRPS31;GSPT1;MRPS18A;MRPS22;ERAL1;MRPL18;MRPS10;MRPL54;MRPL39;GFM2;MRPL49;MRPS18C;MRPL1;MRPS2;MRPL23;GADD45GIP1;MRPS11;MRPL27;MRPL24;MRPS26;MRPS15;MRPS27;MRPS7;MRPL40;MRPS5
prerank,mitochondrial translational termination (GO:0070126),0.6334521345426103,2.5661548121681124,0.0,0.0,0.0,57/88,22.62%,MRPL17;MRPL3;MRPL19;MRPL30;MRPS16;MRPS35;MRPS23;MRPL14;MRPL15;MRPL37;MRPL13;MRPS12;MRPL48;MRPL47;MRPL44;MRPL57;DAP3;MRPL50;MRPL16;MRPL42;MRPS18B;MRPS33;MRPL52;MRPL11;CHCHD1;MRPL22;MRPL9;MRPS30;MRPS34;MRPL36;MRPL4;MRPL51;MRPL45;MRPS31;MRPS18A;MRPS22;ERAL1;MRPL18;MRPS10;MRPL54;MRPL39;GFM2;MRPL49;MRPS18C;MRPL1;MRPS2;MRPL23;GADD45GIP1;MRPS11;MRPL27;MRPL24;MRPS26;MRPS15;MRPS27;MRPS7;MRPL40;MRPS5
prerank,pre-replicative complex assembly (GO:0036388),0.6744268556293708,2.5596845321759436,0.0,0.0,0.0,41/64,20.25%,PSMD14;MCM4;PSMB2;MCM3;ORC6;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;MCM5;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;MCM7;PSMB5;MCM6;ORC5;MCM2;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;CDT1;PSMD11;UBA52;PSMD1;ORC2;GMNN;CDC6;PSMD6;ORC1;PSMD5;ORC3
prerank,mitochondrial translational elongation (GO:0070125),0.6368858879387135,2.5536400227990965,0.0,0.0,0.0,59/88,22.62%,MRPL17;MRPL3;MRPL19;MRPL30;MRPS16;MRPS35;MRPS23;MRPL14;MRPL15;MRPL37;MRPL13;MRPS12;MRPL48;MRPL47;MRPL44;MRPL57;DAP3;MRPL50;MRPL16;MRPL42;MRPS18B;MRPS33;MRPL52;MRPL11;CHCHD1;MRPL22;TUFM;MRPL9;MRPS30;MRPS34;MRPL36;MRPL4;MRPL51;GFM1;MRPL45;MRPS31;MRPS18A;MRPS22;ERAL1;MRPL18;MRPS10;MRPL54;MRPL39;GFM2;MRPL49;MRPS18C;MRPL1;MRPS2;MRPL23;GADD45GIP1;MRPS11;MRPL27;MRPL24;MRPS26;MRPS15;MRPS27;MRPS7;MRPL40;MRPS5
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.6198975268926332,2.499252555520815,0.0,0.0,0.0,44/58,26.18%,NIP7;WDR12;EMG1;MRTO4;EBNA1BP2;BYSL;NOP16;RPL26L1;URB2;PES1;BOP1;RRS1;TGS1;PAK1IP1;SHQ1;GTF3A;DDX31;NAF1;ZNF622;NOC2L;WDR74;MRPL36;DHX37;RPF2;HEATR3;NOP14;MALSU1;NPM1;RPS19;CUL4A;RPL35A;RPS24;RPS16;RPS28;RIOK1;RPL11;RPS15;SURF6;RPS7;RRP36;RIOK2;RPL7;NOM1;RPL14
prerank,ncRNA processing (GO:0034470),0.5626429147541959,2.4930713200256607,0.0,0.0,0.0,128/189,26.76%,DKC1;DDX47;NOB1;DCAF13;WDR43;WDR12;EXOSC5;INTS7;WDR3;EMG1;UTP18;IMP4;MRTO4;EBNA1BP2;BYSL;FBL;SMAD1;LYAR;POP1;RRP9;PES1;BOP1;EXOSC4;PUS10;UTP14A;RPL36;NOLC1;RRP1;RPL8;ADAT1;MRPL44;POP7;RRP12;RPS2;RCL1;EXOSC8;RPL37;DDX27;RRP1B;EXOSC7;NOL11;RPL18;WDR74;WDR46;WDR18;PIH1D2;RPLP0;DDX10;RPL39;DDX54;EXOSC1;EXOSC3;DHX37;NOC4L;TARBP2;PDCD11;RPS14;RPLP2;UTP15;HEATR1;DIS3;DDX52;FARS2;RPL12;RPL28;RPL27A;RRP7A;IMP3;RPL29;RPS9;NOP14;RPL35;RPL37A;SSB;DDX49;EXOSC2;RPL7A;UTP3;UBA52;NOP56;RPL27;RPL32;NOP58;UTP20;RPS19;POP5;POP4;RPL31;RPL35A;TBL3;RPS24;RPL18A;WDR36;NOL6;FCF1;XRN2;RPS16;UTP6;PIH1D1;RPS28;PWP2;INTS5;HNRNPA2B1;RPL11;RPL41;RPS15;RPL23;RPF1;BMS1;ESF1;RPS7;MPHOSPH6;RPL24;RPL23A;THG1L;RRP36;RPL4;RPL30;RPLP1;RPL7;INTS2;RPL13;RPL13A;WDR75;RPL14;LIN28A;RPL15;RPL19
prerank,peptide biosynthetic process (GO:0043043),0.5371439463799805,2.486294810326923,0.0,0.0,0.0,94/155,27.32%,MRPL3;RHCE;MRPS16;RPS21;YARS2;FARSB;MRPL37;MRPL13;MRPS12;RPL36;RPL8;RPS2;RPS18;IGF2BP3;RPS3;RPL37;MRPL42;MRPS18B;MRPS33;MRPL52;MRPL11;PCSK1;RPS4X;RPL18;MRPL9;RPLP0;RPL39;MRPL36;GGTLC2;RPS14;RPLP2;RRBP1;MRPL51;GSPT1;RPL12;RPL28;MRPS18A;SRBD1;RPL27A;COPS5;RPL29;RPS9;MRPL18;RPL35;RPL37A;RPL7A;RPL27;RPL32;RPS11;RPS19;ABCF1;MRPS18C;RPL31;RPL35A;RPS5;MRPL23;RPS24;RPL18A;RPS16;RPS29;RPS13;MRPS11;RPS28;MRPL27;MRPL24;RPS6KB2;RPL11;RPL41;RPS15;RPS8;RPS12;RPL23;MRPS15;MRPS7;MRPS5;RPS7;RPL24;RPL23A;RPL4;RPL30;RPS26;RPLP1;RPL7;RPL13;MRPL28;RPL13A;RPL14;RPS20;RPL15;RPL19;HBS1L;RPS3A;RPL3;ASMT
prerank,regulation of cardiac conduction (GO:1903779),-0.6838894500986255,-2.4722978693034188,0.0,0.0,0.0,31/54,13.89%,RYR3;TNNI3K;DMPK;NPR2;ATP1B2;ATP2B4;ANK2;ATP1A2;NPR1;FXYD6;TRPC1;CASQ1;FXYD7;ITPR1;FXYD1;STIM1;FXYD2;SLC8A2;RYR1;NPPA;CASQ2;SLC8A1;PRKACA;ATP1A4;NOS1;ATP1A3;ABCC9;RYR2;ATP2B3;SLC8A3;TRDN
prerank,tRNA transport (GO:0051031),0.7198220316940094,2.4663154687481366,0.0,0.0,0.0,22/35,17.76%,NUP37;RAN;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;TOMM20;NUP43;XPOT;TOMM20L;NUP50;NUP88;NUP107;NUP205;SSB;NUP62;NUP160;NOL6;NDC1
prerank,translational elongation (GO:0006414),0.5884102894387907,2.4323121365032443,0.0,0.0,0.0,61/100,22.62%,MRPL17;MRPL3;MRPL19;MRPL30;MRPS16;MRPS35;MRPS23;MRPL14;MRPL15;MRPL37;MRPL13;MRPS12;MRPL48;MRPL47;MRPL44;MRPL57;DAP3;MRPL50;MRPL16;MRPL42;MRPS18B;MRPS33;MRPL52;MRPL11;CHCHD1;MRPL22;TUFM;MRPL9;MRPS30;MRPS34;MRPL36;EEF1B2;MRPL4;MRPL51;GFM1;MRPL45;MRPS31;MRPS18A;MRPS22;ERAL1;MRPL18;MRPS10;MRPL54;MRPL39;GFM2;MRPL49;MRPS18C;MRPL1;MRPS2;MRPL23;GADD45GIP1;MRPS11;MRPL27;MRPL24;MRPS26;EEF2;MRPS15;MRPS27;MRPS7;MRPL40;MRPS5
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.5893513986191337,2.4237604028569466,0.0,0.0,0.0,47/83,21.69%,PSMD14;MAD2L1;PSMB2;CDK1;FBXO5;PTTG1;PSMB9;PSMA5;SKP2;PSMB3;UBE2S;PSME3;PSMA3;BUB3;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;AURKB;PSMD12;ANAPC1;PSMB5;UBE2C;PSMD8;AURKA;CDC26;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;ANAPC11;PLK1;PSMD11;UBA52;PSMD1;PSMD6;CDC20;BUB1B;UBE2D1;PSMD5;CUL3;CDK2;PSMC1
prerank,protein targeting to ER (GO:0045047),0.5721387037990392,2.409441764688655,0.0,0.0,0.0,65/101,27.16%,SRPRB;RPS21;RPL36;RPL8;SRP72;RPS2;RPS18;SPCS1;SEC61A1;RPS3;RPL37;SEC61G;RPS4X;RPL18;RPLP0;RPL39;SRP9;RPS14;RPLP2;RPL12;RPL28;RPL27A;RPL29;RPS9;RPL35;RPL37A;RPL7A;UBA52;RPL27;RPL32;RPS11;RPS19;RPL31;RPL35A;RPS5;RPS24;RPL18A;RPS16;RPS29;RPS13;SPCS2;RPS28;RPL11;RPL41;RPS15;RPS8;RPS12;SRP54;RPL23;RPS7;RPL24;RPL23A;RPL4;RPL30;RPS26;RPLP1;RPL7;RPL13;RPL13A;RPL14;RPS20;RPL15;RPL19;RPS3A;RPL3
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.5479507606882977,2.407776395403735,0.0,0.0,0.0,74/112,27.16%,RPS21;PABPC1;MAGOH;RPL36;RPL8;MAGOHB;EIF4A3;RPS2;NCBP1;RPS18;RPS3;RPL37;HELZ2;RPS4X;RPL18;RPLP0;RPL39;RPS14;RPLP2;NCBP2;GSPT1;RPL12;RPL28;RPL27A;RPL29;RPS9;RPL35;RPL37A;RPL7A;UBA52;RPL27;RPL32;RPS11;RPS19;RPL31;RPL35A;RPS5;EIF3E;RPS24;RPL18A;RPS16;RPS29;RPS13;RPS28;SMG8;RBM8A;RPL11;RPL41;RPS15;RPS8;RPS12;RPL23;RPS7;RPL24;RPL23A;RPL4;RNPS1;RPL30;RPS26;RPLP1;RPL7;DHX34;PPP2R2A;PPP2CA;RPL13;RPL13A;RPL14;SMG7;RPS20;RPL15;RPL19;RPS3A;PPP2R1A;RPL3
prerank,ribosomal large subunit biogenesis (GO:0042273),0.6251920382477864,2.396993392642703,0.0,0.0,0.0,41/54,29.02%,NIP7;WDR12;MRTO4;EBNA1BP2;NOP16;BRIX1;RPL26L1;NLE1;PES1;BOP1;RRS1;PAK1IP1;GTF3A;RSL1D1;ZNF622;EIF6;NOC2L;WDR74;RPLP0;RPF2;HEATR3;NHP2;RPL7A;MALSU1;NPM1;MRPL1;RPL35A;TRAF7;RPL11;RPF1;SURF6;MAK16;RPL24;RPL23A;RPL7;RPL14;MRPL20;RPL3;SDAD1;RPL10A;RRP15
prerank,muscle contraction (GO:0006936),-0.5945681726259987,-2.3904057123292235,0.0,0.0,0.0,70/128,17.55%,TPCN2;CACNA1H;SMTN;CRYAB;MYH7;SORBS1;TACR2;MYOM1;MYL9;GNAO1;LMOD1;TPM2;TPM1;MYL2;SGCA;HRC;MYH3;TLN1;MYLK;TMOD2;ACTA1;GJC1;VCL;MYH6;DTNA;DMD;CALD1;KLHL41;MYL7;PABPN1;MYOT;ACTA2;TCAP;TNNT3;PXN;FXYD1;GALR2;ACTN2;ACTN3;MYH2;SORBS3;DES;SCN4A;CALM1;KCNIP2;RYR1;P2RX6;CASQ2;TMOD1;SNTA1;SLC8A1;ADRA1A;SSPN;MYL1;NOS1;ARHGEF11;DYSF;LMOD2;ALDOA;MYL6;SMPX;TRDN;MYBPC1;ACTC1;VIM;ROCK1;MYL3;GAMT;MYOM2;ANKRD2
prerank,DNA replication (GO:0006260),0.5613261311773164,2.3812608693583166,0.0,0.0,0.0,59/106,20.25%,RFC3;CHEK1;MCM4;RPA3;FEN1;RFC5;MCM3;DBF4;CDK1;ORC6;TIPIN;EXO1;TOP1MT;POLE2;RFC2;POLD2;TIMELESS;RMI1;RHNO1;FAM111B;POLB;MCM5;SET;RMI2;BLM;TICRR;GRWD1;RECQL4;TOP1;TOPBP1;RAD9B;POLE3;WRNIP1;MCM7;DNA2;CDK2AP1;MCM6;WDHD1;ORC5;POLA1;MCM2;RBBP8;MCM10;BRCA1;HUS1;RPA2;POLD1;CLSPN;ORC2;RNASEH2A;CDC6;CDC7;TOP3A;CDC45;MCMBP;RFC4;BRIP1;ORC1;ORC3
prerank,tRNA export from nucleus (GO:0006409),0.7178765200886963,2.3775947587186703,0.0,0.0,0.0,20/32,17.76%,NUP37;RAN;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;NUP43;XPOT;NUP50;NUP88;NUP107;NUP205;SSB;NUP62;NUP160;NOL6;NDC1
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.7178765200886963,2.3775947587186703,0.0,0.0,0.0,20/32,17.76%,NUP37;RAN;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;NUP43;XPOT;NUP50;NUP88;NUP107;NUP205;SSB;NUP62;NUP160;NOL6;NDC1
prerank,protein-DNA complex assembly (GO:0065004),0.5608803847658386,2.3755629435199097,0.0,0.0,0.0,58/115,20.25%,PSMD14;MCM4;RPA3;CHAF1B;PSMB2;MCM3;ORC6;CHAF1A;PSMB9;PSMA5;CDK7;PSMB3;PSME3;PSMA3;MCM5;GTF2H3;PSMA7;PSMD13;PSME2;GRWD1;PSMC2;PSMC4;PSMD10;PSMD12;SOX9;SPTY2D1;MCM7;HMGB2;ERCC5;PSMB5;MCM6;ORC5;MCM2;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;RAD23B;DDB1;PSME1;PSMF1;NPM1;CDT1;PSMD11;UBA52;PSMD1;RPA2;CUL4A;CENPV;ORC2;GMNN;CDC6;PSMD6;ERCC2;ORC1;PSMD5;ORC3
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.7949546904992787,2.372995480882107,0.0,0.0,0.0,12/18,9.48%,RFC3;MCM4;GINS4;GINS1;MCM3;GINS2;POLD2;MCMDC2;LIG1;POLE3;MCM7;POLA1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.7575785280533839,2.365370934959511,0.0,0.0,0.0,21/29,14.14%,RPN1;RPN2;STT3A;ALG8;STT3B;ALG5;MGAT5;DPM2;DDOST;UGGT1;MAGT1;OSTC;FUT8;MGAT2;DPM1;NUDT14;ST6GAL1;DAD1;ASGR1;OST4;UBE2J1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.6011909162137019,2.362968702575203,0.0,0.0,0.0,36/73,22.28%,PSMD14;CALR;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;PDIA3;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;CYBA;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;VAMP8;PSME1;PSMF1;PSMD11;PSMD1;FCGR1A;TAP1;PSMD6;PSMD5;NCF2;PSMC1;HLA-F;CYBB
prerank,protein N-linked glycosylation (GO:0006487),0.6233102631273733,2.360057874609929,0.0,0.0,0.0,37/66,14.30%,RPN1;RPN2;STT3A;ALG1;ALG8;PMM2;STT3B;ALG5;MGAT5;DPM2;DDOST;UGGT1;MAGT1;OSTC;ALG10;FUT8;SRD5A3;MGAT2;DPM1;ALG3;ALG11;NUDT14;ALG2;GFPT1;ALG14;ST6GAL1;PGM3;SLC39A8;DAD1;DPAGT1;B4GALT7;ASGR1;TMEM165;OST4;TMEM258;UBE2J1;B4GALT1
prerank,regulation of heart contraction (GO:0008016),-0.5963980183821261,-2.357262625090164,0.0,0.0,0.0,49/90,17.44%,RYR3;CACNA1H;TNNI3K;DMPK;NPR2;ATP1B2;ATP2B4;TPM1;ANK2;HRC;ATP1A2;NPR1;FXYD6;TRPC1;MYH6;CASQ1;FXYD7;HSPB7;ITPR1;FXYD1;STIM1;FXYD2;DES;SLC8A2;CALM1;PDE4D;KCNIP2;PLN;RYR1;NPPA;CASQ2;SLC8A1;PRKACA;ATP1A4;NOS1;ATP1A3;ABCC9;RNF207;FOXN4;CELF2;RYR2;ATP2B3;SLC8A3;ADORA3;TRDN;TBX2;CAMK2D;ASB3;NPPC
prerank,muscle organ development (GO:0007517),-0.6532190903992796,-2.356830927690207,0.0,0.0,0.0,29/55,13.29%,POU6F1;CACNA1H;ITGA7;SPEG;FHL1;SMTN;BVES;SGCA;MYH3;MYH6;DMD;MEF2D;LAMA2;CAPN3;SGCG;ITGB1BP2;SGCE;MEF2A;CTF1;CHD2;MEF2B;TCF21;TBX1;FHL3;MSTN;CHODL;MEF2C;EVC;SGCD
prerank,regulation of cellular amine metabolic process (GO:0033238),0.6634867684671327,2.343717711743175,0.0,0.0,0.0,28/51,14.43%,PSMD14;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;ODC1;PSMA3;NQO1;PSMA7;AZIN1;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;OAZ3;PSME1;PSMF1;PSMD11;PSMD1
prerank,regulation of cation channel activity (GO:2001257),-0.5904622346966029,-2.3379320572912854,0.0,0.0,0.0,46/87,17.33%,PRRT1;VAMP2;AHNAK;NLGN2;CACNB2;ANK2;HRC;JPH2;DMD;DLG2;JPH4;PIRT;GRIA4;ACTN2;CAMK2A;ANK3;SLMAP;LRRC7;CALM1;PDE4D;DLG4;GRIA1;NLGN1;CACNB1;GSG1L;PRKACA;GRIA3;DAPK1;NOS1;KCNE2;GRIA2;FGF12;SHISA7;JPH3;STAC;MEF2C;KCNE1;CACNG7;FGF13;RELN;CAMK2B;CNIH2;CAMK2D;NEFL;CRHBP;GRIN2A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.5845377344616587,2.3357807262776404,0.0,0.0,0.0,37/78,22.28%,PSMD14;CALR;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;PDIA3;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;CYBA;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;VAMP8;PSME1;PSMF1;PSMD11;PSMD1;FCGR1A;TAP1;PSMD6;PSMD5;NCF2;PSMC1;HLA-F;MFSD6;CYBB
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.718406220224302,-2.3180010406002594,0.0,0.0,0.0,16/26,14.19%,NLGN2;STX1B;NLGN3;NRXN1;NLGN4X;TMEM25;SLC8A2;CUX2;SHANK3;DLG4;TMEM108;NLGN1;PTEN;LRRK2;SLC8A3;RELN
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.6398305855288374,2.3175282675371474,0.0,0.0,0.0,28/53,14.43%,PSMD14;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;ODC1;PSMA3;NQO1;PSMA7;AZIN1;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;OAZ3;PSME1;PSMF1;PSMD11;PSMD1
prerank,maturation of SSU-rRNA (GO:0030490),0.6912028275316444,2.307645039403554,0.0,0.0,0.0,27/32,23.84%,NOB1;DCAF13;WDR3;NOL10;NAT10;NOL11;WDR46;SRFBP1;DHX37;RPS14;HEATR1;DDX52;NOP14;LSM6;UTP3;RPS19;RPS16;UTP6;MRPS11;RPS28;PWP2;RIOK1;RPS8;TSR1;BMS1;RRP36;RIOK2
prerank,peptidyl-asparagine modification (GO:0018196),0.7318580062404689,2.3023633469617466,0.0,0.0,0.0,21/30,14.14%,RPN1;RPN2;STT3A;ALG8;STT3B;ALG5;MGAT5;DPM2;DDOST;UGGT1;MAGT1;OSTC;FUT8;MGAT2;DPM1;NUDT14;ST6GAL1;DAD1;ASGR1;OST4;UBE2J1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.6637267015618509,2.3003681137490846,0.0,0.0,0.0,23/28,23.73%,DCAF13;RPS21;RPP40;ABT1;RRS1;NOL10;WDR46;DHX37;RPS14;HEATR1;NOP14;UTP3;UTP20;RPS19;TBL3;RPS16;UTP6;MRPS11;PWP2;RPS8;TSR1;BMS1;RRP36
prerank,regulation of potassium ion transport (GO:0043266),-0.6944787365588647,-2.287151980634681,0.0,0.0,0.0,18/31,16.86%,FHL1;DPP6;KCNIP3;ANK2;KCNA5;KCNIP4;ACTN2;ANK3;KCNIP2;KCNH2;CASQ2;NOS1;KCNE2;KCNAB3;VIP;KCNE1;KCNIP1;CD63
prerank,myofibril assembly (GO:0030239),-0.6919736428531892,-2.2870666484566113,0.0,0.0,0.0,27/42,15.01%,CSRP1;CFLAR;LMOD1;MYOZ2;PGM5;TPM1;MYL2;MYH3;TMOD2;MYH6;CASQ1;KLHL41;CAPN3;TCAP;TNNT3;ACTN2;PDGFRA;TMOD1;OBSCN;OBSL1;LMOD2;MYOZ1;CSRP2;CSRP3;FLII;ACTC1;FHOD3
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.7656386734510695,2.276087596417169,0.0,0.0,0.0,11/22,11.82%,ENC1;PSMB2;PSMB9;PSMA5;PSMB3;PSMA3;PSMA7;PSMB5;PSMB4;PSMB1;PSMA4
prerank,mitochondrial gene expression (GO:0140053),0.6439567112508392,2.2731724021011135,0.0,0.0,0.0,26/40,22.48%,MRPS16;TFB2M;MRPS12;TFAM;MRPL47;MRPL57;FASTKD2;LARS2;MRPL16;MRPS18B;QRSL1;MRPS34;MRPL51;MRPS18A;GFM2;SLC25A33;MRPS2;MRPL23;NOA1;IARS2;FASTKD5;TEFM;MRPS11;RARS2;MRPS15;MRPS7
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.7382095273948468,-2.270954252100397,0.0,0.0,0.0,18/23,17.76%,GSTM2;CACNA1C;ANK2;HRC;ATP1A2;AKAP6;CASQ1;DMD;CALM1;PDE4D;CASQ2;SLC8A1;PRKACA;RYR2;TRDN;CLIC2;CAMK2D;DHRS7C
prerank,maturation of LSU-rRNA (GO:0000470),0.6754501966772464,2.2452350425680074,0.0,0.0,0.0,20/25,29.02%,WDR12;NIFK;RPL7L1;PES1;BOP1;DDX18;RSL1D1;EIF6;RPF2;NHP2;RPL35;RPL7A;MRPL1;ZNHIT3;RPF1;MAK16;RPL7;URB1;RPL10A;RRP15
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.8412195176659296,2.240169649147008,0.0,0.0,0.0,14/15,15.57%,RUVBL1;DKC1;CCT6A;CCT2;CCT3;RUVBL2;CCT8;CCT7;SHQ1;NAF1;NOP10;NHP2;CCT4;TCP1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.783071276257735,2.2322296296931823,0.0,0.0,0.0,14/18,15.57%,RUVBL1;DKC1;CCT6A;CCT2;CCT3;RUVBL2;CCT8;CCT7;SHQ1;NAF1;NOP10;NHP2;CCT4;TCP1
prerank,DNA strand elongation (GO:0022616),0.7723288658874333,2.2274709516533844,0.0,0.0,0.0,11/17,9.48%,RFC3;MCM4;GINS4;GINS1;MCM3;GINS2;POLD2;DCLRE1B;MCMDC2;MCM7;POLA1
prerank,regulation of mRNA catabolic process (GO:0061013),0.5228419397538348,2.223401670679833,0.0,0.0,0.0,51/122,14.43%,PSMD14;EXOSC5;PSMB2;PSMB9;PSMA5;PABPC1;PSMB3;PSME3;PSMA3;SET;YWHAB;EXOSC4;SERBP1;IGF2BP1;PSMA7;KHSRP;PSMD13;ANP32A;PNPT1;EXOSC8;PSME2;PSMC2;YTHDF1;PSMC4;PSMD10;IGF2BP3;PSMD12;EXOSC7;PSMB5;IGF2BP2;APEX1;PKP1;EXOSC1;CARHSP1;EXOSC3;PSMD8;MAPKAPK2;DIS3;PSMB4;PSMD3;PSMB1;PSMA4;ELAVL1;EXOSC2;PSME1;PSMF1;YTHDF2;PSMD11;PKP3;UBA52;PSMD1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.5493097187789252,2.2218716064272934,0.0,0.0,0.0,31/60,21.57%,POLR2F;NUP37;POLR2D;NUP155;RAE1;NUP93;NUP35;AJUBA;SEH1L;SEC13;NUP210;NUP43;DHX9;NUP50;NUP88;NUP107;TRIM71;POLR2C;ELAVL1;POLR2K;NUP205;POLR2J;NUP62;POLR2G;PPARG;NUP160;TGFB1;NDC1;POLR2H;POLR2I;POLR2L
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.7322789683481566,2.2134686042776974,0.0,0.0,0.0,20/24,20.15%,NARS2;YARS2;EARS2;AIMP2;FARSB;DARS2;FARSA;MARS2;LARS2;TARS2;WARS2;PARS2;PPA1;PPA2;FARS2;AIMP1;IARS2;AARS2;RARS2;CARS2
prerank,DNA metabolic process (GO:0006259),0.47142050863589535,2.193312476180558,0.0,0.0,0.0,119/266,20.74%,RFC3;CHEK1;MCM4;UBE2T;RPA3;FEN1;RNASEH1;RAN;TSN;XRCC2;RFC5;MCM3;TDP1;DBF4;CDK1;PRIM2;ORC6;RAD51AP1;EXO1;TOP1MT;POLE2;RFC2;POLD2;TIMELESS;NUDT1;POLH;UBE2N;UNG;POLB;MCM5;DCLRE1B;DCTPP1;GLRX2;NUDT15;RMI2;BLM;HMGB3;NTHL1;PRIM1;XRCC5;GTF2H3;SMARCB1;TICRR;RAD18;NABP2;AXIN2;DDX21;ZRANB3;PRKDC;RECQL4;INIP;TOP1;DNMT1;NEIL3;TOPBP1;RAD9B;LIG1;MSH3;POLE3;FANCL;MCM7;HMGB2;ERCC5;DNA2;APEX1;MCM6;PARP4;UHRF1;RAD51B;WDHD1;ORC5;RAD54L;POLA1;PTGES3;MCM2;RBBP8;TOP3B;LONP1;DDB1;MCM10;MPG;BRCA1;HUS1;MSH6;NPM1;CDT1;SMC1A;UBA52;VCP;KPNA2;RPA2;POLD1;DNASE1L1;TOP2A;UBE2A;LRWD1;FANCA;SUMO1;ENDOG;ORC2;FBXO6;RNASEH2A;DNASE2;REXO4;GMNN;LIG3;CDC6;RAG1;CDC7;TOP3A;FANCC;NOC3L;CDC45;RFC4;PDS5A;ORC1;ORC3;TRIM28;SMUG1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.45700637981533404,2.193263532507355,0.0,0.0,0.0,93/163,27.16%,POLR2D;DCPS;EXOSC5;MRTO4;RPS21;PABPC1;MAGOH;EXOSC4;RPL36;RPL8;MAGOHB;EIF4A3;RPS2;NCBP1;RPS18;EXOSC8;CNOT11;RPS3;RPL37;HELZ2;CNOT10;EXOSC7;RPS4X;PDE12;RPL18;RPLP0;RPL39;RPS14;RPLP2;NCBP2;GSPT1;RPL12;RPL28;RPL27A;RPL29;RPS9;RPL35;RPL37A;RPL7A;PATL1;UBA52;RPL27;RPL32;RPS11;RPS19;RPL31;POLR2G;RPL35A;CNOT1;RPS5;EIF3E;RPS24;RPL18A;XRN2;RPS16;RPS29;RPS13;RPS28;SMG8;RBM8A;ERI1;RPL11;RPL41;RPS15;RPS8;RPS12;RPL23;ZC3H12A;MTPAP;RPS7;RPL24;RPL23A;RPL4;RNPS1;RPL30;CNOT6;LSM1;RPS26;RPLP1;RPL7;DHX34;PPP2R2A;PPP2CA;RPL13;RPL13A;RPL14;SMG7;RPS20;RPL15;RPL19;RPS3A;PPP2R1A;RPL3
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.5538018624115308,2.1891715986772358,0.0,0.0,0.0,33/75,14.43%,PSMD14;OSM;PSMB2;TP73;PUS7;PSMB9;PSMA5;CBFB;PSMB3;PSME3;PSMA3;PSMA7;PDCD2;PSMD13;PSME2;PRKDC;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;TCF3;RUNX1;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;YTHDF2;PSMD11;PSMD1
prerank,nucleocytoplasmic transport (GO:0006913),0.6311186699217776,2.187376125892909,0.0,0.00021522921114431684,0.01,27/40,24.24%,SNRPF;NXT2;SNRPD1;SNRPG;SNRPB;ANP32A;NUTF2;RITA1;SNRPD2;NCBP1;SNRPE;RSRC1;NXT1;GEMIN6;NCBP2;NUP205;NPM1;HTATIP2;SMN1;LSG1;SNRPD3;HNRNPA1;RBM15B;GEMIN2;GEMIN5;RGS14;GEMIN4
prerank,double-strand break repair via homologous recombination (GO:0000724),0.5239287377561693,2.1860162525916778,0.0,0.00021109018785308,0.01,41/94,18.93%,RAD54B;PSMD14;RFWD3;MCM4;GINS4;RPA3;FEN1;FANCB;XRCC2;MCM3;RAD51AP1;GINS2;RMI1;UBE2N;MCM5;BLM;MMS22L;NABP2;MCMDC2;RECQL4;SFR1;PALB2;TONSL;MCM7;ERCC5;MCM6;RAD51B;RAD54L;MCM2;RBBP8;BRCA2;BRCA1;HUS1;NSMCE2;RPA2;RAD51AP2;NSMCE1;LIG3;SWSAP1;CDC7;CDC45
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.5605146649427513,2.180359097826378,0.0,0.000207107354120003,0.01,32/71,14.43%,PSMD14;OSM;PSMB2;TP73;PUS7;PSMB9;PSMA5;CBFB;PSMB3;PSME3;PSMA3;PSMA7;PSMD13;PSME2;PRKDC;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;TCF3;RUNX1;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;YTHDF2;PSMD11;PSMD1
prerank,regulation of gene silencing by RNA (GO:0060966),0.5843007802907877,2.1736507601758706,0.0,0.00019957617760654834,0.01,26/49,21.57%,POLR2F;NUP37;POLR2D;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;NUP43;NUP50;NUP88;NUP107;TRIM71;POLR2C;POLR2K;NUP205;POLR2J;NUP62;POLR2G;NUP160;NDC1;POLR2H;POLR2I;POLR2L
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.5843007802907877,2.1736507601758706,0.0,0.00019957617760654834,0.01,26/49,21.57%,POLR2F;NUP37;POLR2D;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;NUP43;NUP50;NUP88;NUP107;TRIM71;POLR2C;POLR2K;NUP205;POLR2J;NUP62;POLR2G;NUP160;NDC1;POLR2H;POLR2I;POLR2L
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5818413158646197,2.1683358469303893,0.0,0.0001960123172921457,0.01,30/51,28.27%,CXCL5;CXCL8;CXCL3;CXCL1;CXCL11;ROMO1;CXCL2;GAPDH;DEFA6;REG1A;PF4;RPL39;CXCL9;CXCL10;CXCL6;SEMG1;RPS19;GNLY;PF4V1;PGLYRP4;ANG;PGLYRP3;HMGN2;CXCL13;RNASE7;RPL30;DEFB4A;REG3A;DEFA1;CXCL14
prerank,regulation of striated muscle contraction (GO:0006942),-0.6958336432980204,-2.167047794555256,0.0,0.0009238314292774727,0.01,18/26,22.97%,TNNI3K;MYL2;ANK2;ATP1A2;DMD;TNNT3;CALM1;PRKACA;NOS1;RNF207;RYR2;SLC8A3;MYL3;ASB3;MYBPC3;SMAD7;CAV3;CALM2
prerank,positive regulation of cation channel activity (GO:2001259),-0.6375352841088571,-2.1618492730967582,0.0,0.0008398467538886115,0.01,21/38,14.19%,GSTM2;ANK2;AKAP6;JPH2;PKD2;CASQ1;NLGN3;HAP1;PIRT;GALR2;ACTN2;ANK3;CALM1;KCNIP2;SHANK3;ADRB2;STAC2;STAC;LRRC55;TRDN;RELN
prerank,ncRNA export from nucleus (GO:0097064),0.6609678352743321,2.1471643957246305,0.0,0.00019257350470807297,0.01,22/36,17.76%,NUP37;RAN;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;NUP43;XPOT;NUP50;NUP88;NUP107;NCBP2;NUP205;SSB;NPM1;NUP62;NUP160;NOL6;NDC1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.5717232626910521,2.140422006064317,0.0,0.00037850654373655727,0.02,20/47,12.36%,TOMM34;RALA;HSPD1;TIMM23;GRPEL1;ROMO1;BCAP31;TOMM40;TIMM10;GRPEL2;TIMM13;TOMM22;TOMM20;TIMM50;TIMM17B;TIMM8B;TOMM20L;AIFM1;TSPO;DNAJC15
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.5936886464424309,-2.1352779155895996,0.0,0.0015397190487957874,0.02,27/56,17.33%,PRRT1;LYNX1;NPTX1;NLGN2;DLG2;GRIA4;ACTN2;CAMK2A;LRRC7;DLG4;DLGAP2;GRIA1;NLGN1;GSG1L;GRIA3;DAPK1;NPTXR;GRIA2;SHISA7;MEF2C;CACNG7;RELN;CAMK2B;CNIH2;NEFL;CRHBP;GRIN2A
prerank,purine-containing compound biosynthetic process (GO:0072522),0.6566145942143534,2.117551341751987,0.0,0.00037209117858848,0.02,11/26,6.40%,PAICS;PPAT;HPRT1;SHMT2;GART;MTHFD1;ADK;DCK;PNP;GMPS;APRT
prerank,regulation of sodium ion transport (GO:0002028),-0.6157116935567613,-2.1144295820753074,0.0,0.0014212791219653425,0.02,14/35,9.83%,PER1;ATP2B4;WNK3;SCN3B;ANK3;SLMAP;SPTBN4;P2RX7;SCN1B;CNKSR3;SNTA1;NOS1;SCN4B;FGF12
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.5687708974312209,2.109394115049276,0.0,0.0003658896589453386,0.02,29/64,14.43%,PSMD14;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;ODC1;PSMA3;NQO1;PSMA7;AZIN1;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;FGFR4;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;OAZ3;PSME1;PSMF1;PSMD11;PSMD1
prerank,actomyosin structure organization (GO:0031032),-0.5544428436335903,-2.108343522405089,0.0,0.001979638777023155,0.03,34/75,17.53%,CSRP1;SORBS1;LMOD1;MYOZ2;PGM5;TPM1;MYH3;TMOD2;MYH6;CASQ1;KLHL41;CAPN3;TCAP;TNNT3;ACTN2;CDC42BPA;TMOD1;OBSCN;EPB41L3;CDC42BPB;LMOD2;TJP1;FRMD6;MYOZ1;CSRP2;CSRP3;FLII;RHOA;ACTC1;FHOD3;PDLIM1;ROCK1;FRMD3;MYOM2
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.6809162972565551,2.0999880747772557,0.0,0.0003540867667212955,0.02,16/26,13.89%,RUVBL1;CENPH;CENPW;CENPN;MIS18A;CENPL;CENPU;CENPA;CENPO;CENPK;HJURP;OIP5;CENPM;CENPQ;MIS18BP1;NPM1
prerank,CENP-A containing chromatin organization (GO:0061641),0.6809162972565551,2.0999880747772557,0.0,0.0003540867667212955,0.02,16/26,13.89%,RUVBL1;CENPH;CENPW;CENPN;MIS18A;CENPL;CENPU;CENPA;CENPO;CENPK;HJURP;OIP5;CENPM;CENPQ;MIS18BP1;NPM1
prerank,regulation of cell cycle phase transition (GO:1901987),0.49317519415817,2.0866967880635987,0.0,0.0010453990255581103,0.06,45/93,20.02%,PSMD14;MAD2L1;PSMB2;TFAP4;DBF4;CDK1;FBXO5;PSMB9;PSMA5;PSMB3;UBE2S;PSME3;PSMA3;GTSE1;BUB3;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;ANAPC1;PSMB5;UBE2C;PSMD8;CDC26;PSMB4;PSMD3;PSMB1;PSMA4;DDB1;PSME1;PSMF1;ANAPC11;PLK1;PSMD11;PSMD1;SIX3;PSMD6;CDC20;ERCC2;BUB1B;UBE2D1;PSMD5
prerank,spliceosomal snRNP assembly (GO:0000387),0.579671422851948,2.084478782855357,0.0,0.001029064665783765,0.06,18/38,16.25%,SNRPF;CLNS1A;SNRPD1;PRPF19;LSM4;SNRPG;WDR77;TGS1;SNRPB;SNRPC;SNRPD2;SNRPE;PRPF6;LSM2;GEMIN6;STRAP;COIL;SMN1
prerank,ribosomal small subunit assembly (GO:0000028),0.7486957062011953,2.08137998141484,0.0,0.001013232901694784,0.06,13/16,22.48%,ABT1;XRCC5;PRKDC;RPS14;RRP7A;ERAL1;RPS19;RPS5;MRPS11;RPS28;PWP2;RPS15;MRPS7
prerank,centromere complex assembly (GO:0034508),0.6181266887381985,2.0813596720495275,0.0,0.0009978808880327418,0.06,20/33,15.66%,RUVBL1;CENPH;CENPW;CENPN;MIS18A;CENPL;CENPU;CENPE;CENPA;CENPO;CENPK;HJURP;DLGAP5;OIP5;CENPM;CENPQ;MIS18BP1;NPM1;CENPF;CENPV
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.6157996091925636,2.080447053389079,0.0,0.0009829871434352381,0.06,18/34,15.92%,RUVBL1;CENPH;CENPW;CENPN;MIS18A;CENPL;CENPU;CENPA;CENPO;CENPK;HJURP;OIP5;CENPM;CENPQ;MIS18BP1;HAT1;NPM1;HIRA
prerank,negative regulation of ion transport (GO:0043271),-0.6615811504196628,-2.079677301801976,0.0,0.0018476628585549452,0.03,15/25,24.37%,GPM6B;WNK3;ACTN2;PXK;PLN;SNCA;CASQ2;SYT11;NOS1;VIP;INPP5K;PACSIN3;CAV3;WNK1;CD33
prerank,chromatin remodeling at centromere (GO:0031055),0.6540372496117711,2.0765181504859274,0.0,0.0009685314501494258,0.06,17/28,15.66%,RUVBL1;CENPH;CENPW;CENPN;MIS18A;CENPL;CENPU;CENPA;CENPO;CENPK;HJURP;OIP5;CENPM;CENPQ;MIS18BP1;NPM1;CENPV
prerank,presynaptic endocytosis (GO:0140238),-0.6414882915662539,-2.0719201841959656,0.0,0.0017321839298952613,0.03,17/27,12.21%,VAMP2;PIP5K1C;STON1;NLGN2;NLGN3;NLGN4X;SYNJ1;AMPH;SNCA;PACSIN1;NLGN1;KIAA1109;SNCB;SYT2;SNCG;OPHN1;SYT5
prerank,DNA replication checkpoint signaling (GO:0000076),0.7124468106099459,2.0708970544581775,0.0,0.0011135772228771175,0.07,13/17,19.97%,TIPIN;TIMELESS;TICRR;TOPBP1;RAD9B;DNA2;NAE1;HUS1;CDT1;CLSPN;CDC6;CDC45;ORC1
prerank,protein targeting to mitochondrion (GO:0006626),0.5619813642312069,2.0636218155700137,0.0,0.001097668976836016,0.07,22/53,12.36%,TOMM34;TIMM8A;HSPD1;TIMM23;MIPEP;GRPEL1;ROMO1;BCAP31;TOMM40;TIMM10;GRPEL2;TIMM13;TOMM22;TOMM20;TIMM50;TIMM17B;TIMM8B;TOMM20L;AIFM1;HSPA4;TSPO;DNAJC15
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.742274267009211,-2.0597778504309368,0.0,0.001630290757548481,0.03,13/17,15.78%,GSTM2;CACNA1C;ANK2;HRC;ATP1A2;DMD;CALM1;CASQ2;SLC8A1;PRKACA;RYR2;CLIC2;CAMK2D
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.5683100087200872,2.0588542098647977,0.0,0.0010822088504017057,0.07,17/35,16.05%,DCPS;EXOSC5;LSM7;LSM5;LSM4;EXOSC4;EXOSC8;EXOSC7;LSM2;EXOSC1;EXOSC3;DIS3;EXOSC2;LSM6;PATL1;POLR2G;LSM3
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.6742997595648967,-2.056816602684428,0.0,0.0015397190487957877,0.03,13/22,15.78%,ANK2;HRC;ATP1A2;CASQ1;CACNA2D1;NPPA;CASQ2;CACNB1;PRNP;NOS1;TRDN;PSEN2;CAMK2D
prerank,tRNA aminoacylation (GO:0043039),0.7148121113655846,2.0556202011355733,0.0,0.0012196321964844622,0.08,15/20,19.80%,YARS2;AIMP2;FARSB;DARS2;FARSA;MARS2;LARS2;WARS2;QRSL1;PPA1;PPA2;FARS2;AIMP1;IARS2;RARS2
prerank,retrograde axonal transport (GO:0008090),-0.722362424069388,-2.0553259592232664,0.0,0.001458681204122325,0.03,15/16,27.35%,DLG2;KIF5A;MAP1A;HAP1;PAFAH1B1;TMEM108;KIF1A;KIF1C;DST;MGARP;NEFL;SOD1;FBXW11;ACTR10;DYNC1H1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.46876573941567107,2.054404512352741,0.0,0.0012029249061216614,0.08,50/116,22.41%,PSMD14;PSMB2;PSMB9;PSMA5;TNFRSF11B;PSMB3;PSME3;PSMA3;EIF5A;TNFSF11;TXNDC17;PSMA7;PSMD13;PSME2;PSMC2;TNFSF9;CARD14;PSMC4;PSMD10;PSMD12;EDAR;PSMB5;TNFSF15;RELA;PSMD8;CD70;PSMB4;STAT1;PSMD3;PSMB1;PSMA4;TNFRSF9;ACTN4;PSME1;PSMF1;PSMD11;TRAF2;TNFRSF12A;PSMD1;TMSB4X;BAG4;TNFRSF1B;PSMD6;NFKBIA;TNFSF4;PSMD5;PSMC1;TNFSF8;TNFSF18;LTB
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.7736437345461982,2.049650945005566,0.0,0.0011866691641470443,0.08,9/15,10.08%,MCM4;HMGA1;SSBP1;BLM;MCMDC2;RECQL4;MCM7;MCM6;MCM2
prerank,sarcomere organization (GO:0045214),-0.7017181123848634,-2.0486565954759475,0.0,0.0018476628585549454,0.04,19/27,20.40%,CSRP1;MYOZ2;TPM1;MYH3;MYH6;CASQ1;CAPN3;TCAP;TNNT3;ACTN2;OBSCN;LMOD2;MYOZ1;CSRP2;CSRP3;FHOD3;MYOM2;ANKRD1;MYLK3
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.6804049262946638,-2.0454962340050984,0.0,0.0017596789129094715,0.04,12/22,16.14%,RAP1A;MAPT;MAGI2;STMN2;NTRK3;TMEM108;KIDINS220;NGF;WASF1;NTRK1;RAPGEF1;NTF3
prerank,tRNA processing (GO:0008033),0.5490363568065897,2.043952452812687,0.0,0.0011708469086250837,0.08,28/56,19.40%,CSTF2;WDR4;RPP40;POP1;METTL1;TRMT10C;FTSJ1;ADAT1;POP7;DTWD2;TRUB1;TRMT6;CLP1;FARS2;TSEN54;SSB;CDKAL1;FAM98B;POP5;NSUN2;TSEN34;ANKRD16;CTU2;AARS2;CPSF4;TRNT1;URM1;RTCB
prerank,histone exchange (GO:0043486),0.6028564202216811,2.0338273094881614,0.0,0.0017331615423726565,0.09,19/34,15.44%,RUVBL1;CENPH;CENPW;CENPN;MIS18A;CENPL;CENPU;CENPA;CENPO;CENPK;HJURP;OIP5;CENPM;SPTY2D1;CENPQ;ZNHIT1;MIS18BP1;NPM1;VPS72
prerank,neurotrophin signaling pathway (GO:0038179),-0.6706898262361106,-2.0314983384513923,0.0,0.0020996168847215286,0.05,12/21,20.23%,RAP1A;HAP1;MAGI2;KIDINS220;NGF;NGFR;NTRK1;RAPGEF1;NTF3;SOS1;CASP3;RAPGEF2
prerank,ribosomal small subunit biogenesis (GO:0042274),0.6287144438387172,2.0314545904077987,0.0,0.0017106529509132715,0.09,26/37,23.84%,NOB1;WDR3;EMG1;NOL11;SRFBP1;RPS14;DDX52;RRP7A;ERAL1;NOP14;NPM1;LSM6;RPS19;RPS5;RPS24;RPS16;MRPS11;RPS28;PWP2;RIOK1;RPS15;SURF6;MRPS7;RPS7;RRP36;RIOK2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.6534104347746298,2.0270202482034425,0.0,0.0018294482947266931,0.1,14/22,20.12%,WDR12;RPS21;RPP40;ABT1;PES1;RRS1;EXOSC8;EXOSC7;EXOSC3;NOP14;EXOSC2;UTP20;ERI1;ERI2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6864837485202477,-2.0267372924039377,0.0,0.0020083291940814624,0.05,10/17,14.19%,NLGN2;STX1B;NLGN3;NRXN1;CUX2;SHANK3;DLG4;NLGN1;PTEN;RELN
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.4550401062444509,-2.024961086306843,0.0,0.0019246488109947342,0.05,112/240,26.60%,MPZ;NOVA1;KCNMB1;NPTX1;NLGN2;CACNB2;PLP1;PTCHD1;DTNA;NLGN3;SLC12A4;MYCBPAP;DLG2;KIF5A;HAP1;KCNK3;PMP22;GRIA4;NRXN1;NLGN4X;ATXN3;CALM1;KCNIP2;PAFAH1B1;DLG4;SYT10;AMPH;SNCA;SCN2B;GRIA1;NLGN1;CACNB1;GRIK2;SYN2;CORT;RPS6KA2;SNCB;PDE7B;RAPSN;CAMK1;PRKACA;CHRM2;GRIA3;CHRNA3;PENK;HTR3A;GRIA2;UNC13C;NTSR1;NRXN2;SNAP25;KCNA1;GLRB;PCDHB4;SLC18A3;SNCG;PRKAR2B;SLC1A2;SYT5;SYNJ2BP;CHRNB4;KCNMB4;MAPK1;NPFF;RIT2;NPY;PCDHB6;APBA1;HTR2B;PCDHB5;BSN;SLC6A1;NLGN4Y;GRIN2A;CACNA1A;HTR4;SST;GABRG1;GABRG2;CACNA1B;SYN1;CAMKK1;CHRM5;CAMKK2;KCNN1;HTR1E;CHRM3;HTR7;PCDHB3;LRP6;SYT1;DRD4;PCDHB2;CPNE6;PCDHB10;CHRNA10;HTR2A;CACNB3;GABARAP;GRIK1;CACNB4;PRKAR1A;CNP;HTR5A;GRM3;GABRA1;GABRA5;KCNC4;PCDHB14;KCNQ3;AKAP9;HTR3B
prerank,regulation of ATP metabolic process (GO:1903578),0.5345611407352486,2.024469858317933,0.0,0.0019452361614815472,0.11,23/52,17.76%,NUP37;SHMT2;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;BEND3;NUP43;UQCC2;EIF6;NUP50;NUP88;NUP107;COX7A2L;NUP205;COX7A2;NUP62;SLC25A33;NUP160;NDC1
prerank,cholesterol biosynthetic process (GO:0006695),0.6573708546197257,2.023358532603209,0.0,0.0019209207094630278,0.11,20/31,22.35%,CYP51A1;SQLE;NSDHL;DHCR7;SC5D;IDI2;FDPS;ACAT2;MSMO1;DHCR24;TM7SF2;ACLY;HMGCS1;G6PD;INSIG1;FDFT1;MVK;EBP;IDI1;HMGCR
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.5708190144495412,-2.022996767718088,0.0,0.001847662858554945,0.05,28/56,17.93%,PKD1;IGSF11;PALLD;PLXNB3;TRO;KIRREL3;ROBO3;CNTN2;DSCAML1;MYOT;PTPRM;NEXN;CADM3;AMIGO1;L1CAM;SDK1;OBSL1;NPTN;CADM1;TENM3;PCDHB6;CDH2;CNTN4;HMCN1;ROBO4;DSCAM;AMIGO2;CNTN6
prerank,membrane depolarization during action potential (GO:0086010),-0.6982123983544888,-2.019565787167764,0.0,0.001776598902456678,0.05,15/26,12.79%,CACNA1H;CACNA1C;ATP1A2;SCN7A;SCN3B;SCN9A;SCN4A;KCNH2;SCN11A;SCN2B;SCN1B;SLC8A1;SCN4B;CACNA1G;SCN3A
prerank,striated muscle contraction (GO:0006941),-0.5690471036486983,-2.0169482923996824,0.0,0.002395118520349003,0.07,25/51,13.69%,MYH7;TPM1;MYH3;ATP1A2;MYH6;DTNA;DMD;KLHL41;TCAP;TNNT3;SCN3B;KCNH2;SCN2B;SCN1B;CASQ2;SLC8A1;NOS1;SCN4B;STAC2;ARHGEF11;RYR2;STAC;ALDOA;SMPX;CSRP3
prerank,synaptic vesicle endocytosis (GO:0048488),-0.6021777835451426,-2.0166088082417866,0.0,0.0023095785731936814,0.07,20/38,12.21%,VAMP2;PIP5K1C;STON1;NLGN2;NLGN3;NLGN4X;SYNJ1;AMPH;SNCA;PACSIN1;ITSN2;NLGN1;ITSN1;KIAA1109;SNCB;SNAP91;SYT2;SNCG;OPHN1;SYT5
prerank,chemical synaptic transmission (GO:0007268),-0.43783691132582203,-2.0152222477108164,0.0,0.0028670630563783633,0.08,143/301,26.60%,VAMP2;MPZ;GRIK5;GRIK3;NOVA1;RIC3;KCNMB1;NPTX1;NLGN2;CACNB2;BRSK1;PLP1;PTCHD1;SLC17A7;DTNA;NLGN3;SLC12A4;MYCBPAP;DLG2;KIF5A;HAP1;KCNK3;PMP22;GRIA4;SLC5A7;NRXN1;NLGN4X;PDLIM4;ATXN3;CALM1;KCNIP2;PAFAH1B1;DLG4;SYT10;DLGAP2;AMPH;SNCA;SCN2B;GRIA1;SNPH;NLGN1;CACNB1;GRIK2;SYN2;CORT;RPS6KA2;SNCB;PDE7B;RAPSN;CAMK1;PRKACA;CHRM2;GRIA3;CHRNA3;PTEN;PENK;HTR3A;GRIA2;UNC13C;NTSR1;NAPB;NRXN2;SNAP25;KCNA1;GLRB;PCDHB4;SLC18A3;SNCG;FCHSD1;PRKAR2B;SLC1A2;CBLN2;KIF1B;SYT5;SYNJ2BP;CHRNB4;KCNMB4;MAPK1;RAB3A;NPFF;RIT2;NPY;ERC1;PCDHB6;APBA1;HTR2B;PCDHB5;BSN;SLC6A1;CRHBP;NLGN4Y;GRIN2A;CACNA1A;HTR4;SST;GABRG1;GRID1;FCHSD2;GABRG2;CACNA1B;SYN1;CAMKK1;CHRM5;CAMKK2;KCNN1;HTR1E;SNAPIN;CHRM3;RIMS1;NSG1;HTR7;CHAT;PCDHB3;SLC17A8;LRP6;CDH8;SYT1;DRD4;ERC2;PCDHB2;CPNE6;GRID2;PCDHB10;TBC1D24;STXBP1;GRIN2C;CHRNA10;HTR2A;CACNB3;GABARAP;GRIK1;CACNB4;PRKAR1A;CNP;HTR5A;GRM3;GABRA1;GABRA5;KCNC4;PCDHB14;KCNQ3;AKAP9;HTR3B
prerank,regulation of focal adhesion assembly (GO:0051893),-0.5566256022273699,-2.0086922070681243,0.0,0.002771494287832418,0.08,27/53,15.69%,FAM107A;TSC1;GPM6B;DUSP22;VCL;FERMT2;MYOC;MACF1;PHLDB2;DUSP3;COL16A1;ARHGAP6;DLC1;CLASP1;APOD;PTEN;CLASP2;PPM1F;CORO1C;DAPK3;RAC1;EFNA5;SFRP1;RHOA;PEAK1;EPHA3;ROCK1
prerank,mitotic metaphase plate congression (GO:0007080),0.5059006157280517,2.005212699075436,0.0,0.0025747790814671977,0.15,27/51,22.34%,KIF18A;CDCA5;NUF2;CEP55;CENPE;RRS1;SPDL1;NDC80;KIF14;SEH1L;KIF22;PSRC1;RAB11A;CHMP4C;ZW10;KIF2C;EML4;KPNB1;CDT1;NUP62;CHAMP1;CHMP5;CHMP2B;CHMP1A;CUL3;CDCA8;KIFC1
prerank,synapse organization (GO:0050808),-0.4990946241154473,-2.004102523850455,0.0,0.002682091246289437,0.08,52/125,17.68%,NLGN2;PDZRN3;CACNB2;KIRREL3;DCTN1;MAPT;CTNND2;CNTN2;NLGN3;PTPRS;MYOT;SLITRK2;NRXN1;NLGN4X;ANK3;DNER;SLC8A2;SHANK3;SNCA;LRFN5;NLGN1;L1CAM;CACNB1;GPM6A;SNCB;LRRC4B;SDK1;ADGRL3;PSEN1;SLITRK3;OBSL1;PTEN;PPFIA4;UNC13C;LRRK2;NRXN2;NTNG1;SEMA3E;PCDHB4;SNCG;LRRC4C;CBLN2;PPFIBP1;SLC8A3;PCDHB6;CDH2;MUSK;PCDHB5;ZC4H2;SLC6A1;DSCAM;APBB2
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5653737713237228,2.000762264373848,0.0,0.0030788276179546784,0.19,16/33,16.05%,DCPS;EXOSC5;LSM7;LSM5;LSM4;EXOSC4;EXOSC8;EXOSC7;LSM2;EXOSC1;EXOSC3;DIS3;EXOSC2;LSM6;PATL1;LSM3
prerank,regulation of microtubule-based process (GO:0032886),-0.5817395901855659,-2.0004029747727707,0.0,0.0028869732164921017,0.09,19/36,16.55%,FAM107A;MAP6;KLHL42;MAPT;PHLDB1;MACF1;PHLDB2;HDAC6;CLASP1;CLASP2;BICD2;PRKAA2;TPPP;MARK4;EFNA5;EPHA3;ROCK1;APC;MAP6D1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.5392418888319931,1.9965785985177122,0.0,0.0031739825836222145,0.2,17/40,17.76%,NUP37;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;NUP43;EIF6;NUP50;NUP88;NUP107;NUP205;NUP62;NUP160;NDC1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.561513414451969,1.9948393582266792,0.0,0.0031361970766743312,0.2,19/37,19.62%,CHEK1;E2F1;INTS7;TIPIN;PRPF19;TIMELESS;RHNO1;CHEK2;RAD9B;DNA2;HUS1;CDT1;CLSPN;FBXO6;TIPRL;CDC6;CDC45;CDC5L;BRIP1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.6241984816927476,-1.9923205039324343,0.0,0.0033593870155544455,0.11,16/29,16.86%,DPP6;ATP2B4;KCNIP3;HRC;KCNIP4;WNK3;SLMAP;KCNIP2;KCNH2;SNTA1;KCNE2;FGF12;KCNAB3;KCNE1;KCNIP1;CD63
prerank,regulation of mRNA stability (GO:0043488),0.4577936580830648,1.9914873288533252,0.0,0.003099300640478163,0.2,55/139,14.43%,PSMD14;E2F1;EXOSC5;PSMB2;PSMB9;PSMA5;PABPC1;PSMB3;PSME3;PSMA3;SET;YWHAB;EXOSC4;SERBP1;IGF2BP1;PSMA7;KHSRP;PSMD13;ANP32A;TBRG4;AXIN2;EXOSC8;PSME2;PSMC2;YTHDF1;PSMC4;PSMD10;IGF2BP3;PSMD12;EXOSC7;PSMB5;IGF2BP2;APEX1;PDE12;EXOSC1;CARHSP1;EXOSC3;PSMD8;MEX3D;MAPKAPK2;DIS3;PSMB4;PSMD3;PSMB1;PSMA4;FUS;ELAVL1;EXOSC2;PSME1;PSMF1;NPM1;YTHDF2;PSMD11;UBA52;PSMD1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.6493355829060793,1.9902044881610936,0.0,0.0031908981884767903,0.2,19/30,22.35%,CYP51A1;SQLE;NSDHL;DHCR7;IDI2;FDPS;ACAT2;MSMO1;DHCR24;TM7SF2;ACLY;HMGCS1;G6PD;INSIG1;FDFT1;MVK;EBP;IDI1;HMGCR
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.609577106265869,1.984039815887924,0.0,0.0032803900457168294,0.21,15/31,13.96%,HSPD1;TIMM23;PEX7;GRPEL1;ROMO1;TOMM40;GRPEL2;TOMM20;TIMM50;TIMM17B;TOMM20L;AIFM1;PEX10;DNAJC15;PEX16
prerank,NIK/NF-kappaB signaling (GO:0038061),0.5146075083259077,1.9834245668004649,0.0,0.0032431128861064107,0.21,36/74,20.34%,PSMD14;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;PSMA7;PSMD13;PSME2;PSMC2;CARD14;PSMC4;PSMD10;PSMD12;PSMB5;TNFSF15;RELA;IRAK1;PSMD8;TNFRSF10B;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;TRAF2;PSMD1;NFKB2;PSMD6;CARD10;CHI3L1;PSMD5;TNFRSF10A
prerank,skeletal muscle tissue development (GO:0007519),-0.5827613460882508,-1.9814614690322694,0.0,0.0038040117676131223,0.13,15/35,13.69%,POPDC2;BVES;CFLAR;MYOZ2;ACTA1;KLHL41;RYR1;TCF21;CAV2;KLHL40;MEF2C;SKI;MYL6;MYOZ1;CSRP3
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.5861606137480231,-1.973315635900641,0.0,0.004487181227919153,0.15,23/35,25.13%,GRIK5;GRIK3;NLGN2;NLGN3;PXK;NLGN4X;NLGN1;GRIK2;NGF;NRG3;LRRC4C;RELN;NTF3;IQSEC2;NLGN4Y;CACNA1A;GRID1;CACNA1B;GRID2;PSMC5;GRIK1;EIF4EBP2;ARC
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.556626446530315,1.9714070957885068,0.0,0.0037000077870876936,0.24,21/45,17.76%,NUP37;NUP155;RAE1;NUP93;NUP35;PNPT1;SEH1L;SEC13;NUP210;NUP43;EIF6;NUP50;NUP88;NUP107;NOS2;KHK;NUP205;NUP62;NUP160;NOA1;NDC1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.5479058222959251,1.9701554540583233,0.0,0.003658896589453386,0.24,17/40,17.76%,NUP37;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;NUP43;EIF6;NUP50;NUP88;NUP107;NUP205;NUP62;NUP160;NDC1
prerank,positive regulation of cell projection organization (GO:0031346),-0.4962072295527561,-1.968610381830012,0.0,0.004875776987853328,0.17,54/111,21.09%,ATP1B2;MAP6;PLXNB3;CAPRIN2;RAP1A;FZD4;PTN;MAGI2;LRRC7;ROR2;CUX2;DVL3;DLG4;STMN2;NTRK3;AMIGO1;SCN1B;NDRG4;KIDINS220;NGF;FES;DPYSL3;NGFR;CAMK1;PRKD1;OBSL1;SLIT2;NPTN;CHODL;NTRK1;ROR1;GRIP1;TOX;DAB2IP;TIAM1;TENM3;RIT2;DVL2;RAPGEF1;FUT9;RELN;CAMK2B;RHOA;EPHA3;IL1RAPL1;SCARF1;PLXNA4;PLXNB1;RET;SETX;INS;RAPGEF2;SLITRK1;FZD1
prerank,interstrand cross-link repair (GO:0036297),0.5345483824068616,1.9685910141609322,0.0,0.003618688934624228,0.24,22/52,18.88%,RFWD3;UBE2T;RPA3;FANCB;EME1;RAD51AP1;FANCF;DCLRE1C;DCLRE1B;FAAP24;NEIL3;FANCL;FANCE;MSH6;UBA52;VCP;USP1;RPA2;RAD51AP2;FANCA;FANCI;FANCC
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.74013524438211,-1.967867563186853,0.0,0.004743999231424859,0.17,11/17,10.67%,CACNA1C;CACNB2;ANK2;ATP1A2;SCN3B;CACNA2D1;SCN2B;SCN1B;SLC8A1;SCN4B;CACNA1G
prerank,heart contraction (GO:0060047),-0.5924477769241498,-1.966740019700049,0.0,0.004619157146387363,0.17,27/40,23.36%,MYH7;TPM1;MYL2;ATP1A2;MYH6;DMD;TCAP;SGCG;SCN3B;KCNH2;SCN2B;SCN1B;CASQ2;SLC8A1;SCN4B;RYR2;SGCD;CSRP3;TRDN;ACTC1;MYL3;SCN5A;MYBPC3;SOD1;TTN;MYLK2;MYL4
prerank,"base-excision repair, gap-filling (GO:0006287)",0.5834605867154614,1.9656529610688511,0.0,0.003937290895172666,0.26,18/34,22.67%,RFC3;RPA3;FEN1;RFC5;RFC2;POLD2;UNG;POLB;NTHL1;LIG1;APEX1;MPG;RPA2;POLD1;LIG3;RFC4;SMUG1;TDG
prerank,action potential (GO:0001508),-0.5724841262356258,-1.9591587395245096,0.0,0.004737597073217808,0.18,29/43,24.88%,CACNA1H;KCNB1;AKAP6;SCN7A;DMD;SCN3B;SCN9A;ANK3;GPER1;SCN4A;KCNH2;SCN11A;KCNA2;KCNE2;KCNA1;CACNA1G;KCNMB2;KCNMB4;SCN3A;KCNE1;GNAQ;SLC4A3;KCNE4;CACNA1I;SCN5A;GNA11;KCNMB3;GNA14;CLN3
prerank,neuronal action potential (GO:0019228),-0.6943962790942116,-1.9587653352453303,0.0,0.005081072861026099,0.19,13/22,12.79%,CACNA1H;SCN7A;SCN9A;ANK3;GPER1;SCN4A;SCN11A;KCNA2;KCNA1;CACNA1G;KCNMB2;KCNMB4;SCN3A
prerank,mitotic sister chromatid segregation (GO:0000070),0.472736489403084,1.9583867211970694,0.0,0.004367070122895977,0.29,51/96,22.34%,NCAPD3;RAN;DSN1;KIF18A;CDK1;CDCA5;SMC2;KNSTRN;CEP55;CENPE;NCAPD2;KIF23;SET;RRS1;NCAPG;SPDL1;ZWINT;NDC80;KIF14;CENPK;SMC4;SEH1L;DLGAP5;KIF22;SPAG5;PSRC1;RAB11A;CHMP4C;CSNK2A1;ZW10;NAA50;KIF2C;EML4;NSL1;NCAPG2;KPNB1;PLK1;SMC1A;TUBG1;NUP62;KIF18B;NCAPH;ESPL1;CHMP5;CHMP2B;PDS5A;WRAP73;CHMP1A;CUL3;CDCA8;KIFC1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.5075353081019912,1.957950756567546,0.0,0.0043206119300992114,0.29,30/61,21.13%,DKC1;RFC3;MYC;DSCC1;CCT6A;RFC5;CCT2;CCT3;RFC2;PDGFRB;XRCC5;CCT8;CCT7;NEK2;AURKB;FBXO4;NAF1;PTGES3;FGFR4;WRAP53;MAPK15;GRHL2;CCT4;TCP1;CHTF18;HSP90AB1;RFC4;HSP90AA1;HNRNPA1;MAPKAPK5
prerank,gene expression (GO:0010467),0.39673949996674646,1.9570406759494812,0.0,0.004390675907344064,0.29,187/349,27.32%,POLR2F;DKC1;NUP37;POLR2D;TESC;MRPL3;CPSF3;E2F1;ALYREF;MRPS16;HSPD1;THOC3;RPS21;HNRNPF;YARS2;NUP155;FARSB;MRPL37;MRPL13;U2AF1;MAGOH;RAE1;PRPF4;SLBP;MRPS12;RPL36;DUOXA2;RPL8;PTMA;NUP93;MRPL44;NUP35;MAGOHB;FASTKD2;EIF4A3;RPS2;NCBP1;RPS18;SEH1L;NUFIP1;DDX39A;SRSF9;SEC13;IGF2BP3;NUP210;RPS3;RPL37;SNRNP40;NUP43;MRPL42;MRPS18B;NXT1;MRPS33;MRPL52;DRG1;MRPL11;HNRNPK;RPS4X;RPL18;GLE1;MRPL9;RPLP0;NUP50;RPL39;MRPL36;DDX54;NUP88;CLP1;NUP107;EIF4E;DUSP11;RPS14;RPLP2;NCBP2;RRBP1;MRPL51;GSPT1;RPL12;RPL28;SORL1;MRPS18A;SRBD1;RPL27A;TAF1B;COPS5;POLR2C;RPL29;RPS9;CPSF2;TSPAN17;MRPL18;DHX8;POLR2K;RPL35;RPL37A;NUP205;THOC6;RPL7A;POLR2J;APOBEC1;RPL27;RPL32;RPS11;RPS19;ABCF1;NUP62;RBM3;MRPS18C;RPL31;POLR2G;DEDD2;RPL35A;NUP160;RPS5;MRPL23;RPS24;RPL18A;SYNCRIP;XRN2;RPS16;RPS29;NDC1;RPS13;MRPS11;RPS28;MRPL27;MRPL24;RPS6KB2;RBM8A;CPSF4;HNRNPA2B1;POLR2H;SRSF3;NXF3;PAX8;RPL11;RPL41;RPS15;TFIP11;RPS8;RPS12;RPL23;RBM15B;POLR2I;MED20;NFKBIB;POLR2L;MRPS15;PWP1;U2AF2;RNGTT;AGFG1;MRPS7;MRPS5;RPS7;RPL24;RPL23A;DNAJB11;POLR3A;RPL4;RNPS1;THOC7;TSPAN33;RPL30;RPS26;RPLP1;HNRNPD;TSPAN15;RPL7;NKX2-8;POLR2B;RPL13;MRPL28;NUP98;RPL13A;NXF2;RPL14;SMG7;RPS20;HNRNPU;PPP5C;RPL15;RPL19;HBS1L;RPS3A;RPL3;ASMT
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.49646404762575586,1.956942061156159,0.0,0.004344939699975897,0.29,30/73,21.57%,POLR2F;RFC3;POLR2D;RPA3;RFC5;PRPF19;CDK7;RFC2;POLD2;GTF2H3;ERCC8;HMGN1;LIG1;ERCC5;COPS5;DDB1;POLR2C;POLR2K;POLR2J;UBA52;RPA2;POLR2G;POLD1;CUL4A;LIG3;RFC4;ERCC2;POLR2H;POLR2I;POLR2L
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.4556628674095494,1.9565410292434708,0.0,0.00430014650719264,0.29,62/122,19.58%,CENPH;RCC2;CENPN;NUP37;MAD2L1;ERCC6L;INCENP;RAN;DSN1;KIF2A;TACC3;CENPL;KIF18A;NUF2;CENPU;SPC24;RCC1;CENPE;SKA1;CENPA;NEK6;STMN1;SPDL1;ZWINT;NDC80;BUB3;CENPO;CENPK;SEH1L;WDR62;DLGAP5;SEC13;AURKB;CENPM;NUP43;GPSM2;KIF3B;CENPQ;RANGAP1;ZW10;NUP107;AURKA;KIF4B;KIF2C;EML4;NSL1;BUB1;CKAP5;KPNB1;PLK1;TUBG1;CENPF;BCCIP;NUP160;DYNLL1;ESPL1;SKA2;BIRC5;KNTC1;MAPRE1;CDC20;BUB1B
prerank,muscle filament sliding (GO:0030049),-0.5955651063936643,-1.9548738599131523,0.0,0.005279036738728414,0.2,21/38,16.46%,MYH7;TPM2;TPM1;MYL2;MYH3;ACTA1;MYH6;DMD;TCAP;TNNT3;ACTN2;ACTN3;MYH2;DES;TMOD1;MYL1;MYL6;MYBPC1;ACTC1;VIM;MYL3
prerank,actin-myosin filament sliding (GO:0033275),-0.5955651063936643,-1.9548738599131523,0.0,0.005279036738728414,0.2,21/38,16.46%,MYH7;TPM2;TPM1;MYL2;MYH3;ACTA1;MYH6;DMD;TCAP;TNNT3;ACTN2;ACTN3;MYH2;DES;TMOD1;MYL1;MYL6;MYBPC1;ACTC1;VIM;MYL3
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.6584823301335251,-1.9514922630468061,0.0,0.005800801997788782,0.22,16/24,15.78%,GSTM2;HRC;AKAP6;JPH2;PKD2;DMD;JPH4;CALM1;PDE4D;CASQ2;PRKACA;NOS1;JPH3;TRDN;CLIC2;CAMK2D
prerank,heart development (GO:0007507),-0.45909524954246955,-1.947920057567742,0.0,0.0058789272772202805,0.22,71/157,21.10%,PKD1;POU6F1;POPDC2;RBM20;MYH7;BVES;LDB3;FOXF1;HAND2;MYL2;CACNA1C;PDLIM7;MYOCD;SMYD4;TBX19;TGFBR3;PKD2;DAND5;MYH6;MEF2D;OSR1;TCAP;KAT2B;SGCG;PDLIM4;CITED2;MEF2A;SRF;WDR11;NTRK3;CRELD1;PDLIM2;TAB2;DLC1;NDRG4;TBX1;ZFPM2;PTEN;HAND1;FGF12;MEGF8;ECE1;GLI2;SOX17;MEF2C;SCUBE1;PLCE1;SGCD;DVL2;CSRP3;HDAC9;CDKN1A;TBX2;HTR2B;PDLIM1;PDGFB;TCF25;KAT2A;PCSK5;IFT122;FLRT2;TSC2;INSR;ERBB4;SOX18;KDM6B;POPDC3;MYBPC3;HEG1;AKAP13;ALPK3
prerank,recombinational repair (GO:0000725),0.49098660181328113,1.9435263872112216,0.0,0.0049283096919168065,0.33,28/76,17.32%,RAD54B;PSMD14;RFWD3;RPA3;FEN1;XRCC2;RAD51AP1;RMI1;RHNO1;UBE2N;BLM;MMS22L;NABP2;RECQL4;SFR1;PALB2;TONSL;ERCC5;RAD51B;RBBP8;BRCA2;BRCA1;HUS1;NSMCE2;RPA2;RAD51AP2;NSMCE1;LIG3
prerank,ribosome assembly (GO:0042255),0.5595643293275899,1.9375207031220003,0.0,0.005100280094389568,0.35,27/47,23.40%,BRIX1;NLE1;BOP1;RRS1;C1QBP;MRPL22;EIF6;RPLP0;DHX37;RPF2;RPS14;RRP7A;ERAL1;NPM1;RPS19;RPS5;MRPS2;TRAF7;MRPS11;RPS28;PWP2;RPL11;RPS15;MTERF3;MRPS7;RPL24;RPL23A
prerank,rRNA modification (GO:0000154),0.6343063465136535,1.9364710195075345,0.0,0.005268811088812876,0.36,10/19,12.39%,DKC1;GAR1;FBL;TFB2M;NSUN3;NAT10;TFB1M;NOP10;TRMT112;NHP2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.5253069521900031,1.9351489070014471,0.0,0.005216644642388986,0.36,29/65,14.43%,PSMD14;CHEK1;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;PSMA7;NABP2;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;AURKB;PSMD12;CHMP4C;PSMB5;PSMD8;AURKA;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;PSMD1
prerank,DNA repair (GO:0006281),0.4190677069120314,1.9337789214637013,0.0,0.005380730278607921,0.37,115/277,20.74%,RFC3;RFWD3;CHEK1;UBE2T;RPA3;FEN1;FANCB;XRCC2;TP73;BRCC3;RFC5;TDP1;EME1;CDK1;CDCA5;RAD51AP1;EXO1;FANCF;POLE2;RFC2;POLD2;TIMELESS;NUDT1;POLH;DCLRE1C;RHNO1;UBE2N;UNG;POLB;TRAIP;DCLRE1B;CHEK2;APEX2;RMI2;BLM;XRCC5;GTF2H3;FAAP24;TICRR;RAD18;NABP2;MGME1;ZRANB3;XRCC4;PRKDC;RECQL4;INIP;ASCC3;ERCC8;NEIL3;TOPBP1;RAD9B;LIG1;MSH3;ACTR8;FANCL;WRNIP1;ERCC5;DNA2;APEX1;PARP4;RAD51B;WDHD1;HMGA2;RAD54L;POLA1;TRIP13;APTX;DTX3L;TEX264;RBBP8;PRMT6;RAD23B;DDB1;BRCA2;FANCE;MPG;PMS2;BRCA1;HUS1;MSH6;CIB1;NPM1;SMC1A;UBA52;SLC30A9;VCP;USP1;KPNA2;RPA2;RAD51AP2;POLD1;COMMD1;EYA1;UBE2A;FANCA;SUMO1;SPRTN;NSMCE1;FBXO6;RNASEH2A;REXO4;LIG3;GTF2H2C;FANCI;FANCC;RFC4;ERCC2;BRIP1;UBE2NL;PDS5A;VCPIP1;ALKBH2;TRIM28;SMUG1
prerank,neuron cell-cell adhesion (GO:0007158),-0.6894582053136336,-1.9321197311111198,0.0,0.007185355561047009,0.27,13/16,19.36%,NLGN2;NLGN3;NRXN1;NLGN4X;NLGN1;NRXN3;NRXN2;ASTN1;ASTN2;NCAM2;CNTN4;NLGN4Y;RET
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.5883886102683363,-1.9299452448111531,0.0,0.007029152179285118,0.27,18/33,20.23%,PDE2A;ADCY2;CAP2;AKAP6;RAPGEF3;MAPK7;PDE9A;PDE4D;NPPA;PDE7B;KSR1;EPHA5;PDE3A;AQP1;HTR2B;NPPB;CD36;RAPGEF2
prerank,dendrite self-avoidance (GO:0070593),-0.7145803660268218,-1.9270626388633163,0.0,0.007076155628508302,0.28,10/16,17.93%,PALLD;ROBO3;CNTN2;DSCAML1;NEXN;NPTN;CNTN4;ROBO4;DSCAM;CNTN6
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.6550636991714208,-1.9258654408849112,0.0,0.006928735719581044,0.28,14/21,19.38%,GPM6B;VCL;MACF1;DUSP3;CLASP1;CORO1C;DAPK3;EFNA5;RHOA;PEAK1;EPHA3;ROCK1;LIMCH1;SLK
prerank,cardiac muscle contraction (GO:0060048),-0.6093992167901989,-1.9227190842291073,0.0,0.006975869976176834,0.29,23/33,23.36%,MYH7;TPM1;ATP1A2;GSN;MYH6;DMD;TCAP;SCN3B;KCNH2;SCN2B;SCN1B;CASQ2;SLC8A1;SCN4B;RYR2;CSRP3;CAMK2D;MYL3;SCN5A;MYBPC3;TTN;MYLK2;MYL4
prerank,"DNA-templated transcription, termination (GO:0006353)",0.48205586928508826,1.9131559177778772,0.0,0.006500758018155046,0.42,32/66,19.63%,POLR2F;CSTF2;POLR3K;CPSF3;SNRPF;POLR1C;CDK7;POLR1B;SNRPG;CSTF1;SLBP;SNRPB;GTF2H3;NCBP1;SNRPE;TAF1A;NUDT21;TTF2;MAZ;CLP1;POLR1A;NCBP2;TAF1B;CPSF2;POLR2K;MED18;ZNF473;SMN1;CPSF4;SNRPD3;ERCC2;POLR2H
prerank,regulation of muscle contraction (GO:0006937),-0.5959753986594256,-1.9121481140715426,0.0,0.008314482863497253,0.34,14/26,16.46%,MYL9;PPP1R12B;TPM1;MYL2;ATP1A2;CNN1;TNNT3;CHRM2;CHRNA3;KCNA1;ANXA6;PLCE1;DAPK3;MYL3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.5040591678318295,-1.9104973236315457,0.0,0.008694884040258566,0.36,33/70,19.29%,YJEFN3;ATP2B4;NPR1;FOXJ2;MECP2;PTPRM;STAB1;PDE3B;ADGRB1;CLDN5;ADAMTS1;SEMA3E;DCN;EMILIN1;ANGPT4;FOXO4;THBS4;SYNJ2BP;PRL;DAB2IP;KRIT1;SEMA6A;HSPG2;ROCK1;ECSCR;SPINK5;COL4A2;SERPINF1;NPPB;HOXA5;COL4A3;AGO1;HHEX
prerank,cAMP-mediated signaling (GO:0019933),-0.6527623762358401,-1.9104782096605926,0.0,0.008527674731792055,0.36,11/24,10.82%,PDE2A;ADCY2;CAP2;AKAP6;RAPGEF3;MAPK7;PDE4D;PDE7B;KSR1;EPHA5;PDE3A
prerank,regulation of neuron projection development (GO:0010975),-0.44878050532331953,-1.9076693372557567,0.0,0.008715390842240307,0.37,69/158,20.23%,CAMK2G;ATP1B2;PLXNB3;BRSK1;NCS1;LPAR1;RAP1A;STX1B;CRMP1;PTPRS;PTN;MAGI2;LRRC7;ROR2;ZDHHC15;SHANK3;STMN2;DENND5A;NTRK3;RUFY3;SCN1B;NDRG4;KIDINS220;FES;DPYSL3;CAMK1;PSEN1;PRKD1;PTEN;KIF1A;LRRK2;NTNG1;NPTN;LRRC4C;NTRK1;ROR1;NDEL1;TOX;DAB2IP;ABI2;EPHA4;EFHC2;TENM3;RIT2;MARK1;RAPGEF1;FUT9;RELN;DISC1;MAG;CAMK2B;CDH2;EPHA3;KANK1;ADCY6;IL1RAPL1;DBN1;CCDC88A;CAMSAP2;SCARF1;SEMA3A;SPOCK1;MYLIP;DCC;SIPA1L1;RET;GSK3A;SETX;RAPGEF2
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.5741212213901619,-1.9041678421337493,0.0,0.00940939418708537,0.38,18/40,13.82%,GABBR1;KCNMB1;FLNA;ANK2;KCNN3;AKAP6;KCNMA1;PIRT;ACTN2;ANK3;KCNH2;AMIGO1;NOS1;GNG2;STAC;KCNMB2;KCNMB4;KCNE1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.6437104272915305,-1.9037219515886623,0.0,0.009238314292774727,0.38,12/24,15.47%,PRRT1;NLGN2;NLGN3;SHANK3;NLGN1;ADRB2;GSG1L;SHISA7;MEF2C;CACNG7;RELN;CNIH2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5284613376685914,1.9023735477497785,0.0,0.0079158820444905,0.49,25/56,14.43%,PSMD14;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;PSMD8;AURKA;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;PSMD1
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.5566671939558466,-1.9002540018247642,0.0,0.009733223987030514,0.38,29/46,23.61%,TTC23;PTCH2;INTU;RAB34;GLI3;IFT81;FGFR2;KIF7;WDR11;RORA;STK36;TULP3;MEGF8;EVC;SFRP1;GLIS2;BTRC;ARMC9;TXNDC15;IFT122;KCTD21;GAS1;SMO;DLG5;SUFU;FUZ;TUBD1;KCTD6;HERC4
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5781686447496822,1.8993792001545518,0.0,0.007945032594241638,0.5,14/23,18.79%,RCC2;CCND1;CDK1;FBXO5;CDC25C;CDK4;RAB11A;RAD51B;ATAD5;NPM1;CDC25A;DYRK3;STOX1;CDC7
prerank,tRNA modification (GO:0006400),0.50019403068278,1.8982616228649574,0.0,0.007870079456560115,0.5,31/60,23.61%,METTL2A;PUS7;WDR4;MOCS3;METTL1;PUS10;FTSJ1;PUS1;DTWD2;METTL6;TRUB1;THUMPD3;TRMT6;TRMT112;SSB;CDKAL1;TPRKB;TYW1;TRMT61B;NSUN2;ANKRD16;DUS2;PUSL1;CTU2;AARS2;METTL2B;URM1;TRMT5;TRMT10A;TRMT12;THG1L
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.6445712402915359,-1.896498296868035,0.0,0.0103728441182032,0.41,12/22,13.89%,GSTM2;ANK2;AKAP6;JPH2;PKD2;CASQ1;HAP1;CALM1;STAC2;RYR2;STAC;TRDN
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.4093189848238919,1.8938575863364147,0.0,0.008001699083477498,0.5,84/185,21.69%,PSMD14;MAD2L1;CEP72;E2F1;PSMB2;TFAP4;CDK1;FBXO5;PSMB9;PSMA5;PSMB3;UBE2S;PSME3;CENPE;PSMA3;NEK6;CEP250;KIF14;BUB3;PSMA7;YWHAE;NEK2;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;TUBB4B;HAUS2;PSMD12;ANAPC1;PSMB5;MAD2L1BP;YWHAG;TUBA4A;UBE2C;HAUS8;ZW10;CEP76;PSMD8;AURKA;TPX2;CDC26;PSMB4;PSMD3;PSMB1;PSMA4;DDB1;CKAP5;ANLN;HAUS1;PSME1;HAUS6;PSMF1;ANAPC11;PLK1;PSMD11;TUBG1;UBA52;PSMD1;CEP78;CENPF;PLK4;TM4SF5;DYNLL1;HAUS7;CDC6;NPM2;PSMD6;KNTC1;MAPRE1;CDC20;ERCC2;BUB1B;SSNA1;UBE2D1;CEP41;PSMD5;HSP90AA1;CUL3;HECW2;TUBB;CDK2;PSMC1
prerank,GPI anchor biosynthetic process (GO:0006506),0.5662718513832691,1.8900485909545741,0.0,0.008130881309896415,0.51,16/30,25.38%,PIGM;PIGU;DPM2;DPM1;PIGW;PIGT;PGAP2;PIGF;PIGO;PIGA;PIGN;PIGX;DPM3;PGAP3;GPAA1;PIGC
prerank,chemokine-mediated signaling pathway (GO:0070098),0.5071124642939361,1.8873925835749914,0.023809523809523808,0.00825769322023425,0.51,23/51,17.57%,CXCL5;CCL24;CXCL8;CXCL3;CXCL1;CXCL11;CXCL2;TFF2;CCL20;CCL22;PF4;RBM15;STK39;CCL4;CCL3;GPR35;CXCL9;CCL26;CIB1;CXCL10;CXCL6;CCL17;PF4V1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.5286385729646812,-1.88554682286664,0.0,0.012105377349153089,0.47,22/46,20.74%,FLCN;NOVA1;ARNTL;ACTN3;TFE3;PLCL1;NR1D1;ATF4;LAMA4;RBPJ;NOVA2;NPR3;NR1H2;ALDH1A1;IP6K1;ZNF423;ADAMTS5;IL18R1;ABHD6;TLE3;LNPEP;MAP2K6
prerank,base-excision repair (GO:0006284),0.5380070783844028,1.884847735925766,0.0,0.008382199459475029,0.52,21/47,17.32%,RFC3;RPA3;FEN1;RFC5;RFC2;POLD2;UNG;POLB;APEX2;NTHL1;NEIL3;LIG1;ERCC5;DNA2;APEX1;HMGA2;PRMT6;MPG;RPA2;POLD1;LIG3
prerank,import into nucleus (GO:0051170),0.48255233123930324,1.8835118053677864,0.0,0.008306684149029308,0.52,28/75,16.25%,RAN;CSE1L;SNRPF;NXT2;SNRPD1;NUP155;SNRPG;SNRPB;E2F3;NUP62CL;NUP93;NUTF2;SNRPD2;SYK;SNRPE;SEC13;NXT1;NUP50;NUP88;NUP107;GEMIN6;TNPO3;HEATR3;KPNB1;HTATIP2;MMP12;NUP62;SMN1
prerank,sister chromatid segregation (GO:0000819),0.5744364025233595,1.8818583333654706,0.0,0.008526535802208338,0.53,22/32,22.34%,RAN;DSN1;KIF18A;KNSTRN;ZWINT;NDC80;CENPK;SMC4;SPAG5;ZW10;NSL1;NCAPG2;PLK1;SMC1A;TUBG1;TOP2A;KIF18B;ESPL1;CHAMP1;WRAP73;CDCA8;KIFC1
prerank,regulation of NMDA receptor activity (GO:2000310),-0.5468518144362791,-1.88048584488151,0.0,0.012526527854609797,0.48,17/32,17.33%,DLG2;GRIA4;ACTN2;CAMK2A;LRRC7;DLG4;GRIA1;NLGN1;GRIA3;DAPK1;GRIA2;MEF2C;RELN;CAMK2B;NEFL;CRHBP;GRIN2A
prerank,lysosome localization (GO:0032418),-0.5641025883892413,-1.8786259196721766,0.0,0.012933640009884615,0.48,19/34,20.41%,FLCN;MAP6;RAB34;HDAC6;PLEKHM2;KIT;VPS33B;KLC2;SYTL4;NDEL1;S100A13;DEF8;RAB3A;TFEB;SPAG9;MRGPRX2;BLOC1S1;NR4A3;SNAPIN
prerank,cellular amide metabolic process (GO:0043603),0.45099558811351154,1.8776607785985016,0.0,0.008742496275685081,0.55,50/100,25.67%,NLN;SHMT2;MTHFD1;MTHFD1L;MIPEP;DHFR;SLC5A6;PDZD11;HLCS;CPZ;CPD;DNPEP;SLC19A1;MME;PCCB;MCCC2;SMPD2;ACSL6;BAAT;THEM5;DBI;ACOT7;MTHFD2;ST6GAL1;CPN1;ACOT13;ORMDL3;AASDHPPT;PLA2G4E;VNN1;FUT7;THOP1;SGPL1;ACOT4;ACOT8;OXSM;ORMDL2;BTD;FPGS;PCCA;CPXM1;PLA2G15;FUT6;ASAH2;VNN3;SHMT1;SLC46A1;ABCA12;PPP2CA;FUT3
prerank,nucleotide-excision repair (GO:0006289),0.43772654821968154,1.876403032706067,0.0,0.00876209446421732,0.55,38/105,19.63%,POLR2F;RFC3;POLR2D;RPA3;RFC5;PRPF19;CDK7;RFC2;POLD2;POLB;GTF2H3;ERCC8;HMGN1;LIG1;ERCC5;POLA1;COPS5;RAD23B;DDB1;POLR2C;BRCA2;POLR2K;HUS1;POLR2J;UBA52;SLC30A9;RPA2;POLR2G;POLD1;CUL4A;COMMD1;LIG3;GTF2H2C;FANCC;RFC4;ERCC2;BRIP1;POLR2H
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.596053327814345,-1.8727141546904897,0.0,0.013630299776225005,0.52,12/27,17.20%,MYOCD;CDON;BOC;MEF2A;RBM4;CAMK1;BNIP2;MEF2C;MAPK11;CDH2;SPAG9;MAPK14
prerank,mitotic spindle organization (GO:0007052),0.4316777496525292,1.8714874005662407,0.0,0.009258599195921178,0.56,77/147,22.71%,CENPH;RCC2;CENPN;NUP37;MAD2L1;ERCC6L;INCENP;RAN;DSN1;KIF2A;MZT1;CENPL;KIF18A;NUF2;CENPU;SPC24;RCC1;CENPE;SKA1;CENPA;KIF23;NEK6;STMN1;CHEK2;SPDL1;ZWINT;NDC80;BUB3;CENPO;CENPK;SEH1L;WDR62;DLGAP5;SEC13;AURKB;RAB11A;CENPM;NUP43;GPSM2;KIF3B;CENPQ;RANGAP1;ZW10;NUP107;AURKA;SPAST;TPX2;KIF4B;KIF2C;EML4;NSL1;BUB1;CKAP5;KPNB1;PLK1;SMC1A;TUBG1;VCP;CENPF;BCCIP;NUP160;DYNLL1;SKA2;BIRC5;KNTC1;MAPRE1;CDC20;BUB1B;WRAP73;KIF4A;MISP;SPC25;TTK;CDCA8;KIFC1;CENPP;ITGB3BP
prerank,regulation of stem cell differentiation (GO:2000736),0.46099059750546545,1.8714068009754958,0.0,0.009178783685611513,0.56,37/90,15.40%,PSMD14;TACSTD2;OSM;PSMB2;TP73;PUS7;PSMB9;PSMA5;CBFB;PSMB3;SLC4A11;PSME3;PSMA3;PSMA7;PSMD13;PSME2;PRKDC;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;NUDT21;TCF3;RUNX1;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;YTHDF2;PSMD11;SMYD5;PSMD1;NSUN2
prerank,regulation of muscle cell differentiation (GO:0051147),-0.5874882068125038,-1.8698376162308206,0.0,0.013857471439162088,0.53,18/34,17.20%,MYOCD;CDON;BOC;MEF2A;SRF;FGFR2;CDK9;RBM4;MEGF10;CAMK1;BNIP2;MEF2C;MAPK11;SUPT6H;HDAC9;CDH2;SPAG9;MAPK14
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.4705817072936164,1.868375570557035,0.0,0.00947560398807159,0.59,30/83,11.69%,COPZ1;KDELR3;KIF2A;KIF18A;TMED2;KIF15;TMED3;RACGAP1;TMED9;KDELR2;CENPE;COPB2;KIF23;KDELR1;ERGIC3;LMAN2;SURF4;KIF22;ARF4;COPA;KIF3B;TMED10;COPG1;ZW10;ARF5;COPG2;GOLPH3L;KIF4B;ATP9A;KIF2C
prerank,neuron projection morphogenesis (GO:0048812),-0.45136736604413275,-1.8667334218259435,0.0,0.014224071212684895,0.57,59/138,18.78%,APBB1;MAP6;S100B;BRSK1;CTNND2;DSCAML1;ZDHHC17;GAS7;MAP1A;SLITRK2;MAP1B;ANK3;NYAP1;MEF2A;SPTBN4;ADGRB1;CNTNAP1;SHANK3;FGFR2;DLG4;PACSIN1;NLGN1;DCLK1;NEFH;FLRT1;PARD3;GPM6A;NGF;DIP2A;EPB41L3;SLITRK3;SRGAP2;PTEN;MAP2;LRRK2;NTNG1;SDC2;NCKAP1L;DICER1;TAOK2;SLITRK5;DAB2IP;ISL2;RAB3A;KLF7;ZNF335;ATL1;CNTN4;ROCK1;DBN1;NTF3;TRIO;BAIAP2;NRK;PLXNB1;MYO16;ALS2;DCC;UBB
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.45993899164106355,1.865763835270764,0.0,0.00986041623259472,0.62,35/93,14.43%,PSMD14;IL1A;PSMB2;PSMB9;PSMA5;PSMB3;RIPK2;PSME3;PSMA3;IL1RN;UBE2N;IRAK2;PSMA7;IL1B;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;MYD88;RELA;IRAK1;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;RPS6KA4;PSME1;PSMF1;PSMD11;UBA52;PSMD1
prerank,embryonic organ morphogenesis (GO:0048562),-0.5463943110963498,-1.864057107235421,0.0,0.014867912064934326,0.59,24/42,22.89%,RBPMS2;FOXF1;DSCAML1;PDGFRA;HOXD3;FGFR2;HOXA4;HOXB4;TCF21;TBX1;MEGF8;RYR2;MFAP5;SOX17;HOXB3;HOXD4;HOXD9;SOX11;EFEMP1;FUZ;OSR2;HOXC4;NIPBL;ID2
prerank,positive regulation of endopeptidase activity (GO:0010950),0.5618072741258494,1.863738826342814,0.0,0.0098697966824751,0.63,13/28,19.38%,GRIN2B;USP50;PSME3;EFNA3;PSME2;APH1A;EFNA1;PRELID1;PSME1;SEMG1;NCSTN;LYN;FYN
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.4685791623345065,1.8626872246302306,0.0,0.010153438035733146,0.65,21/52,16.05%,POLR2D;DCPS;EXOSC5;LSM7;LSM5;LSM4;EXOSC4;EXOSC8;CNOT11;CNOT10;EXOSC7;PDE12;LSM2;EXOSC1;EXOSC3;DIS3;EXOSC2;LSM6;PATL1;CNOT1;LSM3
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.647916268736042,-1.8617296270225727,0.0,0.01478130286843956,0.6,13/21,15.78%,GSTM2;CACNA1C;ANK2;HRC;ATP1A2;DMD;CALM1;CASQ2;SLC8A1;PRKACA;RYR2;CLIC2;CAMK2D
prerank,cellular response to chemokine (GO:1990869),0.5008140560890466,1.8613200065442503,0.0,0.010160241769060642,0.66,21/54,13.89%,SLC12A2;CXCL5;CCL24;CXCL8;CXCL3;CXCL1;CXCL11;CXCL2;TFF2;CCL20;CCL22;PF4;STK39;CCL4;CCL3;GPR35;DUSP1;CXCL9;CCL26;CXCL10;CXCL6
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.5266042925108565,-1.860944277752641,0.0,0.0146973181930507,0.6,24/48,20.43%,BVES;RADIL;TMEFF2;FERMT2;LAMA5;PXN;LAMB2;ATRNL1;PIK3R1;ILK;ITGB3;LAMC1;PARVA;SRGAP2;NTNG1;FER;LAMB1;RAC1;RHOA;PEAK1;LAMB4;MEGF9;NTN4;ITGA8
prerank,response to muscle stretch (GO:0035994),-0.6926318811823793,-1.8607789306891542,0.0,0.014477955234945465,0.6,11/15,22.87%,GSN;DMD;TCAP;NPPA;SLC8A1;RYR2;CSRP3;CDH2;ANKRD1;TTN;CAV3
prerank,cell cycle G1/S phase transition (GO:0044843),0.49323943988554736,1.859555880014603,0.0,0.010166933965776212,0.66,28/63,21.69%,MYC;CCND1;CDKN3;E2F1;DBF4;CDK7;RCC1;INHBA;KHDRBS1;EIF4EBP1;E2F3;CCNE1;CDK4;CDKN2A;USP37;EIF4E;GSPT1;TRIM71;CDC25A;CUL4A;USP26;ACVR1B;CDC7;SPDYA;CRLF3;CDK6;CUL3;CDK2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.43071898668624925,-1.8590070502972327,0.0,0.01453675925480729,0.6,67/139,25.69%,ARHGEF26;INPP5B;FLCN;ARHGAP10;ARHGEF17;TRIP10;ARHGAP33;STARD13;ARHGEF9;SYDE1;PLEKHG2;MYO9A;FAM13B;ARHGAP6;ARHGAP20;ITSN1;ARHGEF6;DLC1;STARD8;OBSCN;RHOQ;RHOJ;MYO9B;RHOB;SRGAP2;SLIT2;ARHGAP21;ARHGAP19;ARHGEF18;ARHGEF11;SYDE2;OPHN1;ARHGAP23;FGD1;ARHGAP24;PLCE1;TIAM1;RAC1;RELN;RHOA;SOS2;ARHGAP29;ARHGEF7;ARHGAP31;MCF2;TRIO;SOS1;RHOT2;CGNL1;FGD2;ARHGAP5;SRGAP1;AKAP13;PIK3R2;ARHGEF3;ARHGDIG;ARHGAP28;RHOU;RHOC;RASGRF2;ARHGAP11B;ARHGAP35;ARHGAP15;ARHGAP1;ARHGAP17;ARAP3;CHN1
prerank,cell junction assembly (GO:0034329),-0.46487789553689024,-1.857917582530167,0.0,0.014459970197386528,0.6,36/102,15.39%,LIMS2;FLCN;NLGN2;FLNA;TLN1;GJC1;FLNC;KIRREL3;CDH19;CTNND2;NLGN3;FERMT2;CDHR3;NRXN1;DNER;SHANK3;ILK;CLDN5;MYO9A;NLGN1;DCHS1;CTNND1;GPM6A;SDK1;ADGRL3;OBSL1;PTEN;NRXN2;CDH10;PCDHB4;OPHN1;TJP1;PCDHB6;CDH2;RHOA;PCDHB5
prerank,positive regulation of potassium ion transport (GO:0043268),-0.5647908719893137,-1.8576689536979787,0.0,0.01425339919456672,0.6,15/38,13.82%,FHL1;GABBR1;KCNMB1;FLNA;ANK2;KCNN3;AKAP6;KCNMA1;ACTN2;KCNH2;AMIGO1;GNG2;KCNMB2;KCNMB4;KCNE1
prerank,peripheral nervous system development (GO:0007422),-0.5972606580197863,-1.853466035261899,0.0,0.014573115504095343,0.62,11/24,22.91%,GDNF;NFASC;PMP22;GFRA3;ADGRB1;NGF;GSTM3;NTF3;GPC1;ADGRB2;SOX8
prerank,negative chemotaxis (GO:0050919),-0.546441293991937,-1.8444572307385139,0.0,0.015653810329423843,0.66,22/32,28.35%,NTN1;SEMA6C;EPHA7;ITGB3;SEMA4C;SLIT2;SEMA3E;SLIT3;SEMA6D;SEMA6A;SEMA3B;RHOA;SEMA3G;SEMA3A;UNC5C;LRTM2;SEMA3C;SLIT1;PDGFA;SEMA4B;SEMA3D;SEMA6B
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.6398605068951516,-1.8431869441124955,0.0,0.015565926822072482,0.67,12/20,23.42%,ADRA2B;ADRB3;PDE4D;ADRB2;ADRA1A;ADCY9;ADRA1D;ADRB1;RAPGEF2;AKAP13;ZDHHC21;ADRA1B
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.4632514761809634,-1.840955764380644,0.0,0.015730102714724532,0.68,60/107,26.51%,GRIK5;GRIK3;NPTX1;NLGN2;LGI1;ATP1A2;STX1B;NLGN3;CPLX3;GRM6;PXK;NLGN4X;CAMK2A;SLC8A2;NPAS4;DLG4;DLGAP2;TMEM108;NLGN1;GRIK2;NGF;NPTXR;PTEN;RIMS3;LRRK2;NRG3;LRRC4C;OPHN1;MEF2C;SLC8A3;CHRNB4;KCNMB4;RELN;CDH2;CNTNAP4;NTF3;IQSEC2;NLGN4Y;CACNA1A;GRID1;CACNA1B;SYN1;RIMS1;BEGAIN;GRM2;SYT1;GRID2;DLGAP4;CLSTN2;PSMC5;DGKI;GRIK1;DLGAP3;EIF4EBP2;CLN3;ARC;GRM3;CPLX2;CLSTN3;AKAP9
prerank,cellular protein metabolic process (GO:0044267),0.37382469394455986,1.835764311419662,0.0,0.01329696565435499,0.73,183/384,27.32%,NOTUM;RPN1;MRPL3;RPN2;PDIA6;ERO1A;EVA1A;HM13;MRPS16;P4HB;RPS21;SERP1;TMEM208;YARS2;UBE2S;FARSB;LOXL2;MRPL37;MRPL13;ATG3;MMP1;CHEK2;MRPS12;RPL36;RPL8;TMEM132A;MSLN;FUCA2;TIMP1;AMELX;RPS2;SPP1;RPS18;PRKDC;SPCS1;IGF2BP3;RPS3;CTSH;RPL37;MRPL42;F5;STOML2;MRPS18B;MRPS33;MRPL52;SERPINA10;APH1A;MRPL11;CKAP4;RPS4X;PARP4;RPL18;SERPIND1;MRPL9;VGF;RPLP0;RPL39;DNAJC3;MRPL36;FN1;FDXR;ABL2;ADAM10;AFP;PCSK9;IGFBP2;RPS14;RPLP2;RRBP1;MRPL51;L2HGDH;MMP2;GSPT1;ADORA2B;PROC;RPL12;RPL28;MRPS18A;SRBD1;RPL27A;COPS5;SEPHS1;CCDC59;RPL29;RPS9;FDX1;B4GALT7;SHISA5;MRPL18;RPL35;LCMT1;RPL37A;PRKCSH;RPL7A;UBL5;BMP4;UBA52;GATA6;C3;RPL27;IGFBP1;RPL32;YME1L1;RPS11;RPS19;ABCF1;MRPS18C;RPL31;MANBA;RPL35A;RPS5;MRPL23;NCSTN;RPS24;RPL18A;RPS16;LGALS1;RPS29;MMP15;IDE;RPS13;RCN1;MRPS11;SPCS2;RPS28;MRPL27;MRPL24;RPS6KB2;IGFBP3;UBE2L6;SLC34A1;SEC11C;RPL11;GOLM1;RPL41;RPS15;RPS8;RPS12;YES1;RPL23;DMBT1;MCRS1;MRPS15;LGMN;LTA4H;MSRB1;MRPS7;UBE2D2;MRPS5;QSOX1;RPS7;RPL24;RPL23A;MEN1;RPL4;WWP2;UBL4A;RPL30;RPS26;CSNK1G3;RPLP1;ICMT;RPL7;SEC11A;CSF2RA;PPP4R2;SERPINA1;RPL13;MRPL28;RPL13A;HTRA2;RPL14;IGFALS;MAGEA2;KNG1;MATN3;RPS20;RPL15;RPL19;HBS1L;RPS3A;RPL3;ASMT
prerank,protein glycosylation (GO:0006486),0.4224524228991451,1.8343165970342186,0.0,0.013366775443728902,0.74,46/126,15.71%,POMK;RPN1;GALNT6;RPN2;STT3A;ALG1;ALG8;PMM2;STT3B;ALG5;C1GALT1C1;MGAT5;B3GNT4;SERP1;DDOST;MAGT1;ALG10;FUT8;POFUT1;MGAT2;FUT1;PLOD3;DPM1;ALG3;ALG11;ALG2;GFPT1;B3GNT2;ALG1L2;B3GALNT2;PGM3;SLC39A8;DAD1;DPAGT1;GALNT1;B4GALT7;TMEM165;ST8SIA6;FUT7;GALNT7;TMEM258;B4GALT1;FUT2;B3GNT3;B3GNT5;FUT10
prerank,sterol biosynthetic process (GO:0016126),0.5636667825736658,1.8301444734140704,0.0,0.013786722349060358,0.75,20/34,22.35%,CYP51A1;SQLE;NSDHL;DHCR7;SC5D;IDI2;FDPS;ACAT2;MSMO1;DHCR24;TM7SF2;ACLY;HMGCS1;G6PD;INSIG1;FDFT1;MVK;EBP;IDI1;HMGCR
prerank,histone mRNA metabolic process (GO:0008334),0.5683599735776476,1.8278642494496926,0.0,0.013851537088644963,0.76,16/24,24.47%,CPSF3;SNRPF;SNRPG;EXOSC4;SLBP;SNRPB;NCBP1;SNRPE;NCBP2;CPSF2;SSB;ZNF473;SNRPD3;ERI1;MTPAP;LSM1
prerank,positive regulation of viral transcription (GO:0050434),0.5493070366868075,1.8276203723026903,0.0,0.01374246986747453,0.76,17/26,27.50%,POLR2F;POLR2D;NELFCD;DHX9;POLR2C;GTF2F2;POLR2K;POLR2J;POLR2G;NELFE;POLR2H;POLR2I;POLR2L;NELFA;POLR2B;NELFB;GTF2F1
prerank,error-free translesion synthesis (GO:0070987),0.6130568670050444,1.8274222455412932,0.0,0.013635106821634886,0.76,12/21,19.41%,RFC3;RPA3;RFC5;RFC2;POLH;POLDIP2;UBA52;VCP;RPA2;POLD1;SPRTN;RFC4
prerank,positive regulation of cytokinesis (GO:0032467),0.5294225617354267,1.8265029833901782,0.0,0.013699589555860356,0.77,20/37,23.30%,KIF20B;RACGAP1;SSTR5;KIF23;KIF14;CXCR5;AURKB;ECT2;OR2A4;SPAST;DRD2;CENPV;CDC6;PKP4;CDC42;RXFP3;CUL3;GIPC1;CDC14C;CSPP1
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.5361661162466037,-1.8218137323513988,0.017857142857142856,0.01970840382458608,0.77,16/30,22.90%,VAMP2;MACF1;RAB34;ANK3;VAMP4;BBS1;GGA3;OPTN;BBS2;KIF13A;GGA2;VAMP5;PREPL;GOLGA7;RAB31;GGA1
prerank,negative regulation of reproductive process (GO:2000242),0.6093649407455556,1.8193961584925538,0.0,0.014776313149715597,0.82,8/20,14.29%,CALR;WDR77;ZP3;TIMP1;HYAL3;DUSP1;ARHGDIB;SEMG1
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.4742412138637996,-1.8193721220727772,0.0,0.020056866556681967,0.79,29/72,14.70%,BVES;RADIL;TMEFF2;FERMT2;LAMA5;PXN;LAMB2;ATRNL1;PIK3R1;ILK;ITGB3;ACTN1;METTL3;ATF4;LAMC1;PARVA;SRGAP2;NTNG1;FER;LAMB1;OPHN1;MEF2C;ABI2;UNK;RAC1;RELN;RILPL1;RHOA;PEAK1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.595745968492129,-1.8181968430010504,0.0,0.01991636587792993,0.79,14/27,10.06%,AHNAK;CACNB2;ANK2;HRC;JPH2;DMD;JPH4;CALM1;PDE4D;PLN;CACNB1;PRKACA;NOS1;JPH3
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.5042665459149545,1.817552160233264,0.0,0.01471874309848294,0.82,30/51,27.61%,NUP37;RAN;CDK1;VRK1;RCC1;NUP155;NUP93;NUP35;SEH1L;SEC13;CHMP4C;NUP43;RANGAP1;NUP107;SPAST;NUP205;KPNB1;BANF1;NUP160;SUMO1;NDC1;CHMP2B;CCNB2;REEP4;PPP2R2A;PPP2CA;CHMP2A;NUP98;PPP2R1A;CCNB1
prerank,mitotic nuclear membrane organization (GO:0101024),0.5042665459149545,1.817552160233264,0.0,0.01471874309848294,0.82,30/51,27.61%,NUP37;RAN;CDK1;VRK1;RCC1;NUP155;NUP93;NUP35;SEH1L;SEC13;CHMP4C;NUP43;RANGAP1;NUP107;SPAST;NUP205;KPNB1;BANF1;NUP160;SUMO1;NDC1;CHMP2B;CCNB2;REEP4;PPP2R2A;PPP2CA;CHMP2A;NUP98;PPP2R1A;CCNB1
prerank,regulation of blood circulation (GO:1903522),-0.5855624070262045,-1.8169308936992232,0.0,0.020490107341667018,0.8,18/34,15.78%,CACNA1H;DMPK;TPM1;MYH6;HSPB7;FXYD1;AGTR1;DES;KCNIP2;PLN;FOXN4;CELF2;ECE1;KCNMB2;KCNMB4;ADORA3;TBX2;CAMK2D
prerank,positive regulation of type I interferon production (GO:0032481),0.47642297639218634,1.8147754976151111,0.0,0.015350859375300672,0.82,35/73,25.07%,POLR2F;POLR3K;POLR1C;HSPD1;RIPK2;G3BP1;GAPDH;XRCC5;POLR3C;PRKDC;DHX9;POLR3B;OAS2;MYD88;RELA;IRAK1;STAT1;POLR2K;NFKB2;ISG15;DDX41;POLR3G;CRCP;OAS3;POLR2H;HSP90AA1;IFI16;POLR2L;POLR3A;TRIM15;XRCC6;ZBP1;CTNNB1;CREBBP;PTPN11
prerank,negative regulation of angiogenesis (GO:0016525),-0.4641308943796293,-1.8137919982402217,0.0,0.02116626439230665,0.8,35/78,19.29%,YJEFN3;ATP2B4;NPR1;EPN2;FOXJ2;MECP2;PTPRM;STAB1;PDE3B;ADGRB1;CLDN5;ADAMTS1;SEMA3E;DCN;EMILIN1;ANGPT4;FOXO4;THBS4;SYNJ2BP;PRL;DAB2IP;KRIT1;SEMA6A;HSPG2;ADAMTS9;ROCK1;ECSCR;SPINK5;COL4A2;SERPINF1;NPPB;HOXA5;COL4A3;AGO1;HHEX
prerank,positive regulation of neuron projection development (GO:0010976),-0.4876284234824688,-1.8124258741209012,0.0,0.020901686087402817,0.8,36/84,15.71%,ATP1B2;PLXNB3;CAPRIN2;RAP1A;PTN;MAGI2;LRRC7;ROR2;CUX2;ZDHHC15;STMN2;NTRK3;PACSIN1;SCN1B;NDRG4;KIDINS220;FES;DPYSL3;CAMK1;PRKD1;ALK;BHLHB9;NPTN;NTRK1;ROR1;TOX;DAB2IP;TENM3;RIT2;RAPGEF1;FUT9;RELN;CAMK2B;EPHA3;VLDLR;DBN1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.46374611790601533,1.8117342970493253,0.0,0.01580970989025008,0.82,38/85,22.43%,MYC;CCND1;CDKN3;E2F1;TFDP1;DBF4;FBXO5;CDK7;CDK5;RCC1;INHBA;DHFR;KHDRBS1;EIF4EBP1;E2F3;CCNE1;CDK4;CDKN2A;USP37;POLA1;EIF4E;GSPT1;TRIM71;CDT1;CDC25A;CUL4A;CDC6;USP26;ACVR1B;CDC7;CDC45;ORC1;SPDYA;CRLF3;CDK6;CUL3;CDK2;CDK16
prerank,striated muscle cell differentiation (GO:0051146),-0.6674944599235199,-1.811685922225619,0.0,0.020757693843024692,0.8,10/18,20.65%,POPDC2;BVES;MYOCD;MYEF2;MEF2C;SKI;KDM6B;CBY1;POPDC3;AKAP13
prerank,cardiac muscle cell contraction (GO:0086003),-0.6618072057789175,-1.8112806164013189,0.0,0.02072987597403109,0.8,12/19,15.78%,CACNA1C;GSN;SCN3B;CACNA2D1;SCN2B;SCN1B;KCNE2;SCN4B;FGF12;CACNA1G;KCNE1;CAMK2D
prerank,regulation of interleukin-4 production (GO:0032673),0.563631208926337,1.8110539199815399,0.0,0.015855218554298008,0.82,10/23,20.11%,CEBPB;FOXP3;ZP3;SLC7A5;SYK;LEF1;ZFPM1;PRKCZ;TNFSF4;CD86
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.6049332832119529,-1.8104854343911096,0.0,0.020702728415133723,0.8,12/23,15.58%,ATP2B4;SNCA;ATF4;PRKACA;GNG2;LRRK2;SIRT2;RYR2;MAPK1;MAPK3;APLP1;ADCY6
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.598266286269213,1.8104594199110051,0.0,0.015819347019107286,0.82,12/24,19.41%,RFC3;RPA3;RFC5;RFC2;POLD2;POLB;LIG1;UBA52;RPA2;POLD1;LIG3;RFC4
prerank,membrane depolarization (GO:0051899),-0.6061585051032057,-1.809962262489544,0.0,0.02067622722668629,0.8,16/29,20.08%,CACNA1H;SCN7A;SCN3B;SCN9A;SCN4A;KCNH2;SCN11A;P2RX7;SCN1B;CACNA1G;SCN3A;CACNA1A;CACNA1B;BEST2;CACNA1I;SCN5A
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.5586117039570279,-1.8098718451565514,0.0,0.020432977494607627,0.8,16/35,19.13%,ATP2B4;FGF2;MECP2;PTPRM;ADGRB1;NR2F2;SLIT2;DCN;ANGPT4;SYNJ2BP;MEF2C;DAB2IP;KRIT1;ADAMTS9;CSNK2B;AGTR2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.5084805538993316,-1.809284117337364,0.0,0.020195384733042422,0.8,25/52,18.78%,SNX1;GAS7;NYAP1;CNTNAP1;PACSIN1;DCLK1;GPM6A;NGF;WASF1;EPB41L3;SRGAP2;LRRK2;NCKAP1L;DICER1;TAOK2;DAB2IP;ZNF335;DBN1;NTF3;TRIO;NRK;PLXNB1;MYO16;ALS2;UBB
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.4026697447009751,1.8058812693700528,0.0,0.016985826502863895,0.84,69/147,22.30%,PSMD14;RCC2;CCND1;CEP72;PSMB2;CDK1;FBXO5;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;CEP250;KIF14;PSMA7;YWHAE;NEK2;PSMD13;CDC25C;PSME2;PSMC2;PSMC4;PSMD10;CDK4;TUBB4B;HAUS2;PSMD12;RAB11A;PSMB5;YWHAG;TUBA4A;RAD51B;HAUS8;CEP76;PSMD8;AURKA;TPX2;PSMB4;PSMD3;PSMB1;PSMA4;CKAP5;HAUS1;PSME1;HAUS6;PSMF1;PLK1;PSMD11;TUBG1;PSMD1;CEP78;CENPF;PLK4;CDC25A;DYNLL1;HAUS7;PSMD6;STOX1;CDC7;MAPRE1;SSNA1;CEP41;PSMD5;HSP90AA1;TUBB;CDK2;PSMC1;DTL;RFPL1
prerank,intracellular protein transmembrane transport (GO:0065002),0.5192576533510062,1.8015855346836853,0.0,0.01781723556603388,0.84,18/43,13.96%,HSPD1;TIMM23;PEX7;GRPEL1;ROMO1;TOMM40;SEC61B;GRPEL2;SEC61A1;TOMM20;TIMM50;SEC61G;TIMM17B;TOMM20L;AIFM1;PEX10;DNAJC15;PEX16
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.5937156958287624,-1.8013298395095818,0.0,0.022405566847993875,0.85,13/27,9.83%,ATP2B4;FXYD6;FXYD7;FXYD1;SCN3B;FXYD2;SLMAP;SCN2B;SCN1B;SNTA1;NOS1;SCN4B;FGF12
prerank,nervous system development (GO:0007399),-0.3772889692083961,-1.8011738206509615,0.0,0.022150958133812126,0.85,153/439,19.66%,PKD1;MAL;MAB21L2;MPZ;RBFOX3;GPM6B;HDAC4;GFRA1;GDNF;NFASC;S100B;ATN1;NR2C2;ROGDI;NPTX1;NLGN2;SZT2;LGI1;NUMBL;TMOD2;TENM1;CYP46A1;LPAR1;PKD2;PRX;GSN;KIRREL3;FGF2;DCTN1;GBA2;NLGN3;DSCAML1;CRMP1;INTU;PTN;TRIM3;HAP1;PMP22;GFRA3;NRXN1;PPP2R5D;GFRA2;WWTR1;LRCH4;DNER;ADGRB1;LY6H;ATXN3;TAGLN3;SHANK3;PHOX2B;PTPRZ1;DLG4;TRAK2;PCDHB15;MTR;MBNL1;NAV2;NLGN1;DCLK1;SCRG1;DCHS1;NRSN1;L1CAM;IRF2BPL;TEAD1;NAB2;HAPLN2;GPM6A;NGF;SNTG2;RBFOX2;SDK1;CHRM2;ADGRL3;EVL;CHRNA3;OBSL1;FAT4;DYRK1A;PTEN;ZBTB16;FGF12;NRXN2;NAV1;MBD5;LSAMP;NRTN;ZNF358;HPCAL4;ADAM23;GLRB;PCDHB4;ADORA2A;LDB2;MOBP;FEZ2;NRSN2;OPHN1;MERTK;MEF2C;ACTL6B;MYT1L;SH3GL3;NAV3;ARNT2;FGF17;SEMA6A;APLP1;DPYSL5;FGF13;RELN;MARK4;NTN5;EFNA5;CNTFR;PCDHB6;CDH2;PCDHA3;APBA1;CNTN4;VLDLR;SDHA;PCDHB5;MOG;GLIS2;SCD5;NOTCH2;APC;NTF3;DPYSL4;ZC4H2;EDNRB;SPINK5;FGF5;AHI1;ZEB2;SMO;DSCAM;SPOCK1;PCDHB12;MYLIP;CNTN6;ERBB4;CHST8;DPF2;DPYSL2;HAPLN4;POU3F3;APAF1;CDK5RAP2;RBM45;ADGRB2
prerank,positive regulation of T cell proliferation (GO:0042102),0.4562604774615912,1.8005272836415496,0.0,0.017925960988616953,0.84,16/64,10.97%,IL23A;SLC7A1;ZP3;CD276;IL1B;SYK;PNP;TNFSF9;RPS3;CD46;IL27RA;IL21;CD80;JAK3;IGFBP2;CD70
prerank,embryonic organ development (GO:0048568),-0.504484756398816,-1.8002622194352933,0.0,0.021902070963769296,0.85,31/64,16.87%,RNF112;TEAD3;GDNF;TPO;PBX3;BMPR1A;GLI3;FGFR2;TAL1;TEAD1;ATF4;NDRG4;RARB;KIT;KMT2A;PBX2;KITLG;RBPJ;HAND1;FLT3LG;GLI2;HEY1;RARRES2;SOX17;ERCC3;TBX2;TEAD2;HEY2;COL13A1;PCSK5;IFT122
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.40323963741320407,1.7991131455397058,0.0,0.018189943044711124,0.84,41/116,20.60%,PSMD14;PSMB2;PSMB9;PSMA5;MUC5AC;PSMB3;PSME3;PSMA3;PSMA7;NRAS;PSMD13;SYK;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;CARD11;PSMB5;CLEC6A;RELA;FFAR2;PSMD8;PAK2;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;PSMD1;PAK1;LYN;MUC20;PSMD6;MUC17;FYN;PSMD5;CLEC4C;MUC16
prerank,histone methylation (GO:0016571),0.5535250083697021,1.7989929309446508,0.0,0.018138785220056148,0.84,11/24,12.30%,SUV39H2;NTMT1;FBL;SUV39H1;SMYD3;SMYD2;TRMT112;PRMT1;SETD6;PRMT6;CARM1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.6356092010268142,-1.7989856220937719,0.01818181818181818,0.02196665842948657,0.85,10/16,18.29%,AKAP6;TGFBR3;BMPR1A;FGF2;FGFR2;ZFPM2;RBPJ;MEF2C;TBX2;ERBB4
prerank,nuclear membrane reassembly (GO:0031468),0.5010237020313715,1.7984513849955412,0.0,0.018320249824657447,0.84,30/54,27.61%,NUP37;RAN;CDK1;VRK1;RCC1;NUP155;NUP93;NUP35;SEH1L;SEC13;CHMP4C;NUP43;RANGAP1;NUP107;SPAST;NUP205;KPNB1;BANF1;NUP160;SUMO1;NDC1;CHMP2B;CCNB2;REEP4;PPP2R2A;PPP2CA;CHMP2A;NUP98;PPP2R1A;CCNB1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.43965969902281643,1.79429258293888,0.0,0.0190364969409323,0.88,27/64,21.69%,SOX4;RFWD3;CCND1;E2F1;TFDP1;CDK1;TRIAP1;CHEK2;GTSE1;ARID3A;CDC25C;PRKDC;CNOT11;PML;CNOT10;CASP2;AURKA;PRMT1;CARM1;E2F8;RPA2;CNOT1;SDE2;BAX;SFN;E2F7;CDK2
prerank,axon guidance (GO:0007411),-0.41248199104731526,-1.793500135654154,0.0,0.022537426076879,0.86,79/201,18.12%,NCAM1;GFRA1;GDNF;NTN1;PALLD;PLXNB3;PDLIM7;SEMA6C;LGI1;EPHA7;ROBO3;CNTN2;GAB1;LAMA2;KIF5A;DSCAML1;LAMA5;PTPRM;NRP2;MAPK7;NEXN;GFRA3;NRXN1;GFRA2;SPTBN4;KIF5C;SHANK3;PIK3R1;RPS6KA5;SCN1B;L1CAM;PRKCA;GAP43;UNC5D;NRXN3;SEMA4C;EVL;SLIT2;EPHA5;SEMA3E;NRTN;NFIB;SLIT3;NPTN;GRB10;TMEFF1;FEZ2;GLI2;RNF165;OPHN1;MAPK1;EPHA4;MAPK3;RANBP9;SEMA6D;SEMA6A;RAC1;KLF7;RELN;NTN5;EFNA5;SEMA3B;EPHA3;CNTN4;VLDLR;SEMA3G;ENAH;EPHA6;NOTCH2;ROBO4;DOK6;SOS1;SMO;DSCAM;SEMA3A;PLXNA4;PLXNB1;CNTN6;GPC1
prerank,RNA modification (GO:0009451),0.474498059988834,1.7931307756121857,0.0,0.01905675307006972,0.88,23/53,19.24%,PUS7;WDR4;HENMT1;METTL1;FTSJ1;NSUN3;NAT10;DTWD2;TRUB1;TFB1M;TRMT6;RBM15;NOP10;APOBEC3F;SSB;CDKAL1;NSUN2;NSUN5;ANKRD16;CTU2;PUS7L;AARS2;URM1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.4172762070225359,-1.7921968614386692,0.0,0.022392870514008303,0.86,67/160,24.53%,PDE2A;GLP2R;ADCY5;GABBR1;PTH1R;GNAO1;CNR1;ADCYAP1R1;ADCY2;LPAR1;ADRB3;ADGRD1;ADCY4;ADGRB3;GNAZ;VIPR2;GALR2;AKAP12;ADGRB1;GPER1;GNAI1;GPR26;ADRB2;ABCA1;PTGER3;CORT;ADCY9;CHRM2;ADGRL3;GRK5;ADRA1D;S1PR1;RAMP1;ADGRL2;GPR161;ADORA2A;VIP;MC1R;GPR12;P2RY12;GNA12;GNAL;S1PR3;ADGRG4;AVPR2;OPRL1;S1PR2;ADCY6;GNAQ;TBXA2R;CRHR1;WASF2;RAMP3;ADGRL1;ADGRB2;LHCGR;GNAI2;HTR1E;PTGFR;CRHR2;ADGRL4;RAMP2;GNA11;ADRA1B;ADCYAP1;GNA14;RGS1
prerank,circulatory system development (GO:0072359),-0.4524865984707199,-1.7909034736028422,0.0,0.022251423672919768,0.86,61/122,23.07%,PKD1;POU6F1;POPDC2;RBM20;BVES;LDB3;FOXF1;HAND2;MYL2;CACNA1C;PDLIM7;SMYD4;PKD2;OSR1;KAT2B;NXN;PDLIM4;CITED2;MEF2A;SRF;WDR11;NTRK3;PDLIM2;TAB2;TCF21;TBX1;ZFPM2;PTEN;HAND1;FGF12;FLT4;ECE1;GLI2;HEY1;SOX17;NOTCH4;MEF2C;PLCE1;DVL2;HDAC9;CDKN1A;HSPG2;PDLIM1;PDGFB;TCF25;HEY2;KAT2A;PCSK5;TSC2;ERBB4;FBXW7;SOX18;KDM6B;POPDC3;HEG1;AKAP13;ALPK3;CDH5;ID2;SH3PXD2B;RAMP2
prerank,regulation of innate immune response (GO:0045088),0.47263316597161953,1.7906952678685644,0.0,0.019076729804322484,0.88,22/61,20.67%,EREG;ABCE1;LYAR;POLR3C;LRP8;TKFC;TNFAIP3;USP18;AKIRIN2;NMI;DHX9;POLR3B;XIAP;GBP5;FPR2;ADAM8;HSP90AB1;POLR3G;PLSCR1;SLC15A4;ERAP1;IFI16
prerank,cardiac muscle cell action potential (GO:0086001),-0.5841700937198998,-1.78905607461326,0.0,0.022407826156942954,0.87,17/30,13.82%,CACNA1C;ANK2;ATP1A2;DMD;SCN3B;CACNA2D1;KCNIP2;KCNH2;SCN2B;SCN1B;SLC8A1;KCNE2;SCN4B;FGF12;CACNA1G;KCND3;KCNE1
prerank,positive regulation of immune response (GO:0050778),0.47134760861028135,1.7889049476690562,0.0,0.019472346917844392,0.88,35/71,30.64%,EREG;IL23A;SKAP1;ZP3;POLR3C;CD46;AKIRIN2;TGFB2;NMI;DHX9;POLR3B;CYBA;CD81;XBP1;GBP5;GRN;FPR2;ADAM8;IL23R;MYB;POLR3G;NOD2;PLSCR1;SLC15A4;TNFSF4;IL12B;IL12RB1;ITGB2;IFNG;IFI35;IL10;NLRP3;IFNL1;TLR8;RSAD2
prerank,axonogenesis (GO:0007409),-0.41117897050040747,-1.7888872996315774,0.0,0.022171954302659343,0.87,92/236,18.12%,NCAM1;APBB1;GFRA1;GDNF;S100B;PALLD;PDLIM7;SEMA6C;BRSK1;LGI1;EPHA7;ULK1;ROBO3;CNTN2;NLGN3;GAB1;LAMA2;KIF5A;DSCAML1;ZDHHC17;LAMA5;MAP1A;NRP2;MAPK7;NEXN;PPP3CB;SLITRK2;GFRA3;NRXN1;MAP1B;GFRA2;ULK2;ANK3;SPTBN4;ADGRB1;KIF5C;SHANK3;PIK3R1;FGFR2;RPS6KA5;SCN1B;L1CAM;NEFH;PRKCA;PARD3;UNC5D;NRXN3;SEMA4C;EVL;SLITRK3;SLIT2;PTEN;EPHA5;NTNG1;SEMA3E;NRTN;SLIT3;NPTN;GRB10;FEZ2;GLI2;TAOK2;OPHN1;SLITRK5;MAPK1;EPHA4;MAPK3;RANBP9;ISL2;RAB3A;SEMA6D;SEMA6A;KLF7;RELN;EFNA5;SEMA3B;ATL1;EPHA3;CNTN4;VLDLR;SEMA3G;ENAH;EPHA6;NOTCH2;ROBO4;DOK6;BAIAP2;SOS1;DSCAM;SEMA3A;CNTN6;GPC1
prerank,intracellular lipid transport (GO:0032365),-0.5859279665285106,-1.7888691640118466,0.03076923076923077,0.02194099644533997,0.87,8/19,24.10%,ACACB;PRKAB2;PRKAG2;PRKAA2;CPT1B;ABCD4;ABCD1;ABCD2
prerank,cellular response to hormone stimulus (GO:0032870),-0.4740062583963636,-1.787340287977239,0.0,0.022191002373366096,0.88,35/75,20.98%,CACNA1H;KLF9;ATP1A2;SOCS2;THRB;GPER1;NCOA1;BRD8;AR;GHR;CYP11B1;SLIT2;ZFP36L1;GAS2L1;GCK;ATP1A3;AKR1C1;RAMP1;SLIT3;NR3C1;WBP2;RDX;CYP11A1;MEF2C;INPP5K;SFRP1;MGARP;AKR1C2;ARID5A;TFPI;CRHBP;RAMP3;NR4A3;LHCGR;BCAS3
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.5351890116099403,-1.784579694438712,0.0,0.022153100600021024,0.88,18/44,13.82%,GABBR1;ATP1B2;KCNMB1;FLNA;ANK2;KCNN3;AKAP6;KCNMA1;WNK3;ACTN2;KCNIP2;KCNH2;NPPA;AMIGO1;GNG2;KCNMB2;KCNMB4;KCNE1
prerank,inner mitochondrial membrane organization (GO:0007007),0.5563315331549106,1.7844056048364176,0.0,0.019937252844572532,0.88,11/28,11.80%,TIMM8A;MTX1;ROMO1;TIMM10;APOO;TIMM13;HSPA9;UQCC3;TIMM8B;CHCHD6;CHCHD3
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.4335331502958728,-1.7829065351675077,0.0,0.022489229743017262,0.9,44/115,20.86%,ADCY5;PTH1R;CNR1;ADRA2B;ADCY2;LPAR1;ADRB3;ADGRD1;ADCY4;ADGRB3;ADGRB1;GPER1;GPR26;ADRB2;ABCA1;ADRA1A;PTGER3;ADCY9;ADGRL3;ADRA1D;GNG2;S1PR1;RAMP1;ADGRL2;GPR161;ADORA2A;VIP;MC1R;GPR12;GNAL;S1PR3;ADGRG4;ADRB1;S1PR2;ADCY6;GNAQ;TBXA2R;CRHR1;RAMP3;ADGRL1;ADGRB2;RAPGEF2;LHCGR;PTGFR
prerank,mRNA splice site selection (GO:0006376),-0.6222670826569597,-1.7821054226796844,0.0,0.022449103731442585,0.9,15/29,14.31%,LUC7L2;SRSF5;LUC7L3;CELF1;LUC7L;SFSWAP;CELF4;CELF6;PRPF39;SF1;CELF2;YTHDC1;ISY1;PSIP1;SRSF12
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.5252887272356684,-1.7820988970877176,0.0,0.022226835377665927,0.9,19/37,18.20%,FAM107A;MAP6;STMN4;MAPT;PHLDB1;PHLDB2;STMN2;CLASP1;CLASP2;BICD2;GAS2L1;PRKAA2;TPPP;MAPRE3;EFNA5;EPHA3;ROCK1;MAP6D1;MAPRE2
prerank,regulation of mitochondrial translation (GO:0070129),0.6277210557820284,1.7820217479031588,0.0,0.020247542613258944,0.89,12/20,15.42%,SHMT2;TRMT10C;NSUN3;TRUB2;FASTKD2;C1QBP;RMND1;UQCC2;COA3;RPUSD4;MALSU1;MTG2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.568640429841751,-1.7788562990760404,0.0,0.0232769291494422,0.9,16/30,13.82%,CACNA1C;ANK2;KCNA5;GJC1;SCN3B;CACNA2D1;KCNH2;SCN2B;SCN1B;SNTA1;KCNE2;SCN4B;FGF12;CACNA1G;RYR2;KCNE1
prerank,synaptic vesicle recycling (GO:0036465),-0.551929125205346,-1.7779316765506616,0.0,0.023320016661373094,0.92,18/34,13.20%,VAMP2;PIP5K1C;STON1;NLGN2;NLGN3;NLGN4X;SYNJ1;AMPH;SNCA;PACSIN1;NLGN1;KIAA1109;SNCB;SYT2;SNCG;OPHN1;SYT5;RAB3A
prerank,regulation of endopeptidase activity (GO:0052548),0.47308410068644374,1.7766708130413758,0.0,0.021585034242480046,0.92,22/57,13.37%,SERPINB5;PSMB9;PSME3;PSMA3;GAPDH;TIMP1;SERPINB1;CRB2;PSME2;SERPINE3;SERPINA10;APH1A;ATP13A2;SERPIND1;HDAC1;SERPINA7;SERPINA4;SERPING1;PRELID1;SERPINB7;AGT;PSME1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.44026579468329363,1.7735965760533925,0.0,0.022172913332087523,0.92,27/73,14.43%,PSMD14;CA9;PSMB2;PSMB9;PSMA5;PSMB3;VHL;PSME3;PSMA3;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;UBA52;PSMD1
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.6316395844881392,-1.773227218051656,0.0,0.025163408454605442,0.93,9/16,11.28%,FAM107A;DUSP22;PHLDB2;ARHGAP6;DLC1;APOD;PTEN;CLASP2;CORO1C
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.6316395844881392,-1.773227218051656,0.0,0.025163408454605442,0.93,9/16,11.28%,FAM107A;DUSP22;PHLDB2;ARHGAP6;DLC1;APOD;PTEN;CLASP2;CORO1C
prerank,cardiac muscle cell development (GO:0055013),-0.5839900812372374,-1.772422005883995,0.0,0.02518747953407449,0.93,14/23,22.84%,MYL2;MYH6;TCAP;SORBS2;PDGFRA;SLC8A1;OBSL1;CSRP3;ACTC1;FHOD3;HEY2;MYLK3;ALPK3;TTN
prerank,double-strand break repair (GO:0006302),0.404195931736236,1.7708624740179526,0.0,0.02282569925341119,0.92,52/150,17.90%,RAD54B;PSMD14;RFWD3;RPA3;FEN1;XRCC2;BRCC3;TDP1;EME1;CDCA5;RAD51AP1;PRPF19;RMI1;DCLRE1C;UBE2N;POLB;DCLRE1B;CHEK2;BLM;XRCC5;MMS22L;NABP2;XRCC4;PRKDC;RECQL4;SFR1;PALB2;TONSL;ACTR8;HMGB2;ERCC5;DNA2;RAD51B;POLA1;TRIP13;APTX;DTX3L;RBBP8;BRCA2;BRCA1;HUS1;CIB1;NSMCE2;VCP;KPNA2;RPA2;RAD51AP2;EYA1;SUMO1;NSMCE1;LIG3;PAXIP1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.6450115209002472,1.7705319521319764,0.0,0.022747745243641117,0.92,12/15,31.51%,TNFSF11;IL23A;IL17A;POU4F1;ATP6AP1;IL23R;IL12B;OCSTAMP;TYROBP;IFNG;TRAF6;TNF
prerank,nucleic acid metabolic process (GO:0090304),0.4494570255216086,1.7702518777328502,0.0,0.02259906717015327,0.92,34/71,21.57%,POLR2F;POLR2D;FEN1;RAN;HNRNPF;LSM8;NCBP1;PTBP1;TOPBP1;DNA2;HNRNPK;PDE12;WDR74;DDX54;DUSP11;NCBP2;HNRNPC;POLR2C;GTF2F2;POLR2K;HNRNPA0;POLR2J;KPNA2;POLR2G;DNASE1L1;DNASE2;XRN2;HNRNPR;HNRNPA2B1;POLR2H;HNRNPA1;POLR2I;DDX1;POLR2L
prerank,positive regulation of translation (GO:0045727),0.41820831035700107,1.767944896902922,0.0,0.02295126042475306,0.92,48/96,26.49%,SOX4;POLR2D;CDC123;KHDRBS1;EIF2S3;TRMT10C;EIF5A;EIF3C;NAT10;TRUB2;FASTKD2;EIF4A3;C1QBP;PRKDC;YTHDF1;RMND1;EIF5AL1;UQCC2;RPS4X;EIF6;DHX9;EIF3D;RPS9;ELAVL1;COA3;RPUSD4;NPM1;YTHDF2;LARP4B;RBM3;POLR2G;NSUN5;EIF3E;JMJD4;RPS6KB2;PKM;PASK;UHMK1;EEF2;MRPS27;LARP1;METTL5;THBS1;LARP4;HNRNPD;FASTKD3;RPUSD3;LIN28A
prerank,DNA recombination (GO:0006310),0.5106761953498214,1.7669148456003707,0.0,0.022944822483539944,0.93,12/37,9.44%,RAD54B;TSN;XRCC2;EXO1;RHNO1;BLM;HMGB3;HDAC10;RECQL4;MSH3;RAD51B;RAD54L
prerank,positive regulation of establishment of protein localization (GO:1904951),0.6350982362389392,1.7661034722211866,0.0,0.023079193871936743,0.93,9/19,15.57%,DKC1;CCT6A;CCT2;CCT3;CCT8;CCT7;WRAP53;CCT4;TCP1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.579583879399091,1.7655669379033718,0.0,0.02307202307999269,0.93,7/18,8.56%,SHMT2;MTHFD1;MTHFD1L;DHFR;GGH;SLC19A1;MTHFD2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.5741772794259355,-1.7621544018190527,0.016129032258064516,0.027283245948755263,0.95,7/23,12.70%,INPP5B;MTMR9;SYNJ1;MTMR10;INPP5F;PTEN;INPP5K
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.6609905170010097,-1.7613526369769084,0.0,0.027201703195392248,0.96,8/17,14.19%,NLGN2;TSHZ3;NLGN3;NRXN1;SHANK3;NLGN1;CACNG7;RELN
prerank,cellular response to lectin (GO:1990858),0.3998575607109213,1.760272052458867,0.0,0.023472166800267008,0.93,40/113,20.60%,PSMD14;PSMB2;PSMB9;PSMA5;MUC5AC;PSMB3;PSME3;PSMA3;PSMA7;NRAS;PSMD13;SYK;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;CARD11;PSMB5;CLEC6A;RELA;PSMD8;PAK2;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;PSMD1;PAK1;LYN;MUC20;PSMD6;MUC17;FYN;PSMD5;CLEC4C;MUC16
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3998575607109213,1.760272052458867,0.0,0.023472166800267008,0.93,40/113,20.60%,PSMD14;PSMB2;PSMB9;PSMA5;MUC5AC;PSMB3;PSME3;PSMA3;PSMA7;NRAS;PSMD13;SYK;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;CARD11;PSMB5;CLEC6A;RELA;PSMD8;PAK2;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;PSMD1;PAK1;LYN;MUC20;PSMD6;MUC17;FYN;PSMD5;CLEC4C;MUC16
prerank,purine nucleotide metabolic process (GO:0006163),0.5856922353671328,1.7601489175896095,0.0,0.02332546575776534,0.93,10/24,13.71%,PPAT;HPRT1;GART;MTHFD1;NUDT15;ITPA;PNP;DNPH1;GPX1;PRPS2
prerank,anterograde axonal transport (GO:0008089),-0.4944120582505873,-1.7594567767763374,0.0,0.02763018770132624,0.96,16/37,16.36%,AP3S2;DLG2;KIF5A;MAP1A;HAP1;KIF5C;TRAK2;MAPK8IP3;KIF1A;KIF1C;KIF1B;HSPB1;AP3B2;MGARP;NEFL;BLOC1S1
prerank,positive regulation by host of viral transcription (GO:0043923),0.650223887845566,1.7586553521365822,0.0,0.023726012667014507,0.93,5/16,7.07%,TFAP4;SMARCB1;LEF1;RRP1B;SMARCA4
prerank,water-soluble vitamin metabolic process (GO:0006767),0.4448461270109484,1.7572227406409995,0.0,0.023782827831447008,0.94,35/73,20.83%,PNPO;SHMT2;MTHFD1;MTHFD1L;MMACHC;DHFR;TCN1;SLC5A6;PDZD11;HLCS;SLC52A2;SLC19A1;PCCB;MCCC2;GSTO2;MTHFD2;PDXK;RFK;SLC52A3;SLC25A19;AASDHPPT;GSTO1;VNN1;FLAD1;CD320;MMAA;ACP5;PRSS3;MMAB;SLC2A1;MMADHC;THTPA;BTD;FPGS;PCCA
prerank,myotube differentiation (GO:0014902),-0.6105000136713143,-1.7571328956219192,0.0,0.028302835606046205,0.96,9/18,16.51%,CACNA1H;ADGRB3;JAM2;NOS1;MYEF2;KLHL40;MEF2C;SKI;ADAMTS5
prerank,cytosolic calcium ion transport (GO:0060401),-0.5934685654391427,-1.7559723559308602,0.0,0.028630451501932483,0.96,12/26,11.88%,CACNA1C;JPH2;JPH4;CACNA2D1;SLC8A2;SLC25A23;MICU3;SLC8A1;ADRA1A;JPH3;RYR2;ATP2B3
prerank,protein import into nucleus (GO:0006606),0.43324706764554494,1.754464662250825,0.0,0.02397362918733875,0.94,23/74,15.21%,RGPD4;RAN;CSE1L;NXT2;NUP155;E2F3;NUP62CL;NUP93;NUP35;NUTF2;SYK;SEC13;NXT1;NUP50;NUP88;NUP107;TNPO3;KPNA7;HEATR3;KPNB1;MMP12;KPNA2;NUP62
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.6315716850257755,-1.7531089702112916,0.0,0.029529611757262066,0.99,13/20,23.61%,PTCH2;GLI3;KIF7;TULP3;MEGF8;GPR161;GLIS2;BTRC;IFT122;KCTD21;SUFU;KCTD6;HERC4
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.5293947355757893,-1.7520414336654544,0.017857142857142856,0.0295135527406343,0.99,16/36,15.25%,TPM1;BMPR1A;FGF2;CNN1;MEF2D;FOXJ2;GPER1;PRKG1;ADAMTS1;MFN2;PTEN;EFEMP2;MEF2C;CDKN1A;IGFBP5;PDGFB
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3724198210476542,1.7478903297000299,0.0,0.025701517506404273,0.96,56/187,14.67%,PSMD14;TDGF1;PSMB2;PSMB9;PSMA5;TNFRSF11B;CCL24;CXCL8;PSMB3;PSME3;PSMA3;EIF5A;TNFSF11;TXNDC17;PSMA7;PSMD13;CCL20;PSME2;PSMC2;TNFSF9;CARD14;PSMC4;PSMD10;RPS3;CCL22;PSMD12;HYAL3;EDAR;PSMB5;DHX9;DCSTAMP;CCL4;CCL3;TNFSF15;RELA;PSMD8;CD70;ADAMTS12;PSMB4;STAT1;PSMD3;PSMB1;PSMA4;TNFRSF9;ACTN4;CCL26;BRCA1;PSME1;PSMF1;CIB1;PSMD11;TRAF2;TNFRSF12A;PSMD1;TMSB4X;GBA
prerank,postsynaptic membrane organization (GO:0001941),-0.5779341974352318,-1.746807731873874,0.018867924528301886,0.031928910801344225,0.99,11/19,17.24%,NLGN2;NLGN3;NRXN1;NLGN4X;SHANK3;DLG4;NLGN1;NRXN2;SHISA7;MUSK;NLGN4Y
prerank,GPI anchor metabolic process (GO:0006505),0.5540571019504371,1.7467758101895867,0.0,0.02587837769631577,0.96,13/26,25.38%,PIGM;PIGU;DPM2;DPM1;PIGW;PGAP2;PIGF;PIGO;PIGA;PIGN;DPM3;PGAP3;PIGC
prerank,positive regulation of cell cycle process (GO:0090068),0.42996804321930326,1.7418993610574278,0.0,0.026780478049312433,0.97,43/99,22.14%,RCC2;MAD2L1;FEN1;IL1A;KIF20B;DBF4;RANBP1;RACGAP1;EREG;SSTR5;RHNO1;PDGFRB;KIF23;NDC80;KIF14;IL1B;CXCR5;AURKB;SPAG5;ECT2;GPSM2;OR2A4;AURKA;SPAST;DRD2;E2F8;NUP62;PLK4;CENPV;DMRT1;CDC6;LRP5;NPM2;PLSCR1;CDC7;PKP4;TGFA;CDC42;RXFP3;E2F7;CUL3;GIPC1;CDC14C
prerank,positive regulation of peptidase activity (GO:0010952),0.5704595103842647,1.741848603470352,0.0,0.026620115905304574,0.97,12/20,21.34%,PRSS22;PSME3;PSME2;CTSH;APH1A;PRELID1;PSME1;GRN;VCP;NCSTN;CLDN4;DDRGK1
prerank,regulation of primary metabolic process (GO:0080090),0.4079273007927038,1.7411582075056746,0.0,0.026723012590829195,0.97,58/125,22.35%,PSMD14;PSMB2;CYP51A1;PSMB9;PSMA5;PSMB3;PSME3;ODC1;PSMA3;ADIPOR1;TGS1;SQLE;NQO1;DHCR7;PSMA7;SC5D;AZIN1;PSMD13;SCD;PSME2;PSMC2;PSMC4;PSMD10;NFYA;HELZ2;PSMD12;PSMB5;FGFR4;PSMD8;CERS2;PSMB4;PSMD3;PSMB1;PSMA4;FDPS;OAZ3;CARM1;PSME1;PSMF1;PSMD11;TM7SF2;PSMD1;HMGCS1;PPARG;MED1;EDF1;FASN;FDFT1;MVK;PSMD6;PRKAB1;PSMD5;HNF4A;IDI1;PSMC1;LDLR;ELOVL6;HMGCR
prerank,synaptic vesicle exocytosis (GO:0016079),-0.532630824144573,-1.7397381105807987,0.0,0.03454326213820115,0.99,15/39,13.20%,PRRT2;VAMP2;PIP5K1C;STX1B;CPLX3;SYT10;SNCA;SNPH;STX2;RIMS3;UNC13C;SNAP25;SYT2;SYT5;RAB3A
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.4216559269421015,1.7387946322148329,0.0,0.02721439652628939,0.97,32/85,15.01%,PSMD14;CELSR1;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;CELSR3;PSMA7;PSMD13;WNT5A;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;PSMD8;AP2S1;ARHGEF19;PSMB4;PSMD3;PSMB1;PSMA4;CLTC;WNT11;PSME1;PSMF1;PSMD11;PSMD1;AP2B1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.5276724349662409,1.7382339886787501,0.0,0.02724801813087051,0.97,20/30,31.79%,THY1;HSPD1;TNFSF11;SKAP1;CD44;MDK;RELA;IRAK1;FUT7;LCK;CD47;PRKCQ;ITGB2;ETS1;HAS2;TRAF6;CCDC88B;SIRPG;TNF;SIRPB1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.6421912211325156,1.7377185337050265,0.0,0.027217055332074313,0.97,10/15,23.06%,CDK1;MTBP;CENPA;SPDL1;BUB3;AURKB;ZW10;CHAMP1;TTK;CTCF
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.5280275023271355,-1.7354906502035055,0.0,0.035041881800179996,0.99,16/31,20.77%,STX1B;CPLX3;CAMK2A;GPER1;SYT11;CHRNA3;RIMS3;LRRK2;MEF2C;CHRNB4;KCNMB4;RIMS4;SYN1;SNAPIN;PREPL;RIMS1
prerank,potassium ion transport (GO:0006813),-0.4381566266217546,-1.734846450768824,0.0,0.034821338488150895,0.99,53/120,24.97%,KCNB1;KCNMB1;KCNQ4;KCNN3;ATP1A2;KCNA5;PKD2;KCNMA1;KCNK3;SLC9A9;ABCC8;KCNIP2;SLC24A4;KCNH2;KCNA2;KCNK4;ATP1A4;KCND1;KCNE2;SLC24A3;ABCC9;KCNA1;KCNAB3;KCNMB2;KCNJ8;AQP1;LRRC55;KCNMB4;KCND3;KCNE1;TMEM175;KCNQ5;KCNA4;KCNC1;KCNJ1;KCNK2;SLC9A5;KCNS2;KCNN1;HCN3;KCNS3;KCNK7;KCNF1;KCNH5;LRRC52;KCNG1;KCNH1;KCNK6;KCNMB3;KCNJ5;KCNN2;HCN2;LRRC38
prerank,synapse assembly (GO:0007416),-0.48671220998474674,-1.7347348079760307,0.0,0.034526242399268256,0.99,40/69,29.25%,NLGN2;KIRREL3;NLGN3;NRXN1;NLGN4X;DNER;SHANK3;NPAS4;NLGN1;GPM6A;SDK1;ADGRL3;OBSL1;PTEN;NRXN2;PCDHB4;FGF13;PCDHB6;CDH2;PCDHB5;NLGN4Y;DSCAM;PLXNB1;LGI2;GABRG2;SLITRK1;FZD1;LRRTM3;PCDHB3;PCDHB2;GRID2;PCDHB10;GABRA1;SDK2;PCDHB14;DNM3;RYK;RAB29;DVL1;GABRB3
prerank,establishment of protein localization to organelle (GO:0072594),0.41953920676645673,1.7341073512756278,0.0,0.02852662980498251,0.98,24/74,15.21%,RAN;RALA;CSE1L;NXT2;NUP155;LAMP3;E2F3;NUP62CL;NUP93;NUTF2;SYK;SEC13;RAB11A;LAMP2;NXT1;NUP50;NUP88;NUP107;TNPO3;HEATR3;TSPAN17;KPNB1;MMP12;NUP62
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.4844905706036035,-1.7333673899645101,0.0,0.03493480194746745,0.99,21/54,16.86%,FHL1;DPP6;GABBR1;KCNMB1;KCNIP3;FLNA;KCNN3;AKAP6;KCNMA1;KCNIP4;KCNIP2;KCNH2;AMIGO1;GNG2;KCNE2;KCNAB3;KCNMB2;KCNMB4;KCNE1;KCNIP1;CD63
prerank,snRNA 3'-end processing (GO:0034472),0.6039441955665258,1.7321112202717313,0.023255813953488372,0.028805879507719727,0.98,10/19,25.49%,EXOSC5;INTS7;EXOSC4;EXOSC8;EXOSC7;EXOSC3;EXOSC2;INTS5;INTS2;SAGE1
prerank,protein import into mitochondrial matrix (GO:0030150),0.6088068774454225,1.729963218156583,0.0,0.029145003867714906,0.98,10/18,12.36%,TIMM23;GRPEL1;ROMO1;TOMM40;GRPEL2;TOMM20;TIMM50;TIMM17B;TOMM20L;DNAJC15
prerank,cellular response to nutrient levels (GO:0031669),-0.4638003756913794,-1.7296095522937585,0.0,0.036029425741821434,1.0,28/60,26.01%,FLCN;FAM107A;TSC1;KCNB1;ULK1;ZFYVE1;WDR45;RRAGC;ATG14;MAP1LC3C;GAS2L1;LRRK2;PRKAA2;RRAGB;SFRP1;CARTPT;TFEB;KLF10;PDK2;RRAGD;SIRT1;RPTOR;MAP1LC3A;MTOR;LPL;RRAGA;PDK4;FNIP1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.5473703331155164,1.7289812665327893,0.0,0.029041184930004307,0.98,11/20,18.79%,RCC2;CCND1;CDK1;FBXO5;CDC25C;CDK4;RAB11A;RAD51B;CDC25A;STOX1;CDC7
prerank,7-methylguanosine mRNA capping (GO:0006370),0.5380853717137064,1.728914550520962,0.02,0.028713035947744367,0.98,17/31,22.56%,POLR2F;POLR2D;CDK7;GTF2H3;NCBP1;NCBP2;POLR2C;GTF2F2;POLR2K;POLR2J;POLR2G;ERCC2;POLR2H;POLR2I;POLR2L;RNGTT;CMTR2
prerank,7-methylguanosine RNA capping (GO:0009452),0.5380853717137064,1.728914550520962,0.02,0.028713035947744367,0.98,17/31,22.56%,POLR2F;POLR2D;CDK7;GTF2H3;NCBP1;NCBP2;POLR2C;GTF2F2;POLR2K;POLR2J;POLR2G;ERCC2;POLR2H;POLR2I;POLR2L;RNGTT;CMTR2
prerank,regulation of DNA binding (GO:0051101),0.4943433845893036,1.7283410814956641,0.0,0.028613393553478167,0.98,25/45,21.39%,E2F1;TFAP4;MDFI;HJURP;LEF1;HMGB2;HMGA2;CEBPG;KDM1A;NME1;CDT1;MMP9;PPARG;PLAUR;EDF1;SUMO1;GZMA;TGFB1;CPNE1;SUMO3;NFKBIA;MMP8;HES1;IFI16;HMGB1
prerank,regulation of calcium ion transport (GO:0051924),-0.48894421871801047,-1.7280795886615778,0.0,0.036342459531907186,1.0,19/56,15.02%,CAMK2G;CACNB2;ANK2;HRC;MYLK;PKD2;CASQ1;WNK3;STIM1;CAMK2A;CACNA2D1;PLN;BCL2;NOS1;TRPC6;INPP5K;HOMER2;CAMK2B;HOMER3
prerank,regulation of establishment of planar polarity (GO:0090175),0.41959921203297884,1.7269960433575875,0.0,0.02888279821730522,0.98,33/88,15.01%,PSMD14;CELSR1;PSMB2;PSMB9;PSMA5;PSMB3;SAPCD2;PSME3;PSMA3;CELSR3;PSMA7;PSMD13;WNT5A;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;PSMD8;AP2S1;ARHGEF19;PSMB4;PSMD3;PSMB1;PSMA4;CLTC;WNT11;PSME1;PSMF1;PSMD11;PSMD1;AP2B1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.5598405499476352,1.7243008816381828,0.025,0.02939313593527553,0.98,9/22,11.25%,WDR43;LYAR;NCL;SMARCB1;SMARCA4;NOL11;IPPK;UTP15;HEATR1
prerank,tRNA metabolic process (GO:0006399),0.5915747575694356,1.722828989987977,0.0,0.02983718986758673,0.99,8/15,15.00%,YARS2;POP1;DARS2;ADAT1;POP7;FARS2;SSB;POP5
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.41436997651641483,1.7196431979621774,0.0,0.030638232979818464,0.99,28/85,14.43%,PSMD14;CHEK1;CA9;PSMB2;PSMB9;PSMA5;PSMB3;VHL;PSME3;PSMA3;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;UBA52;PSMD1
prerank,negative regulation of TOR signaling (GO:0032007),-0.5467247818827131,-1.7194509097818866,0.017543859649122806,0.04043655600280085,1.0,15/33,20.09%,FLCN;EPM2A;TSC1;SZT2;ARNTL;TNFAIP8L1;PRKAA2;UBR2;RNF152;UBR1;TSC2;DEPDC5;KPTN;GSK3A;SIRT1
prerank,vesicle transport along microtubule (GO:0047496),-0.5794880586611235,-1.7184854683232667,0.0196078431372549,0.040633561238952245,1.0,10/21,13.99%,DYNC1I1;FYCO1;KIF5A;HAP1;PAFAH1B1;TRAK2;KIF1A;KIF1C;NDEL1;KIF13A
prerank,cellular response to alkaloid (GO:0071312),-0.5833484228329575,-1.7179402031621942,0.0,0.040603881367437304,1.0,9/18,17.90%,RYR3;GSTM2;TRPV1;RYR1;CASQ2;SLC8A1;RYR2;CRHBP;CASP3
prerank,regulation of dendritic spine development (GO:0060998),-0.6403054290624159,-1.7174960347768582,0.0,0.040500769859524395,1.0,14/21,25.78%,PTPRS;SHANK3;NLGN1;CAMK1;PSEN1;KIF1A;CPEB3;MEF2C;SRGAP2C;CAMK2B;DLG5;PPFIA2;FOXO6;TANC2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.4673311470271115,-1.7170398890746474,0.0,0.04032597508750873,1.0,30/74,15.13%,APBB1;MAP6;S100B;BRSK1;DSCAML1;ZDHHC17;MAP1A;SLITRK2;MAP1B;ANK3;MEF2A;SPTBN4;ADGRB1;FGFR2;NEFH;PARD3;SLITRK3;MAP2;NTNG1;SDC2;TAOK2;OPHN1;MEF2C;SLITRK5;ISL2;RAB3A;UNK;KLF7;ATL1;CNTN4
prerank,neuron projection development (GO:0031175),-0.3986301168777595,-1.7148653264051892,0.0,0.041099587208013544,1.0,62/168,18.83%,GPM6B;GDNF;LGI1;PLP1;STMN4;ULK1;MAPT;CTNND2;GAS7;PTPRM;MYOC;NYAP1;ATCAY;CNTNAP1;MICALL1;SHANK3;DLG4;STMN2;TMEM108;PACSIN1;NLGN1;DCLK1;L1CAM;NEFH;FRY;GPM6A;NGF;DIP2A;EPB41L3;SRGAP2;PTEN;MAP2;MAPK8IP3;LRRK2;NRTN;NCKAP1L;LAMB1;DICER1;TAOK2;OPHN1;PPP1R9A;DAB2IP;EPHA4;NPY;ZNF335;CNTN4;ROCK1;DBN1;NTF3;NCDN;BLOC1S1;TRIO;RAB13;CAMSAP2;NRK;VAPA;PLXNB1;BTG2;MYO16;ALS2;UBB;FRYL
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.6246633505099122,-1.714693132068854,0.0,0.04092284534377555,1.0,10/17,23.42%,ADRA2B;ADRB3;ADRB2;ADRA1A;ADCY9;ADRA1D;ADRB1;RAPGEF2;AKAP13;ADRA1B
prerank,muscle cell differentiation (GO:0042692),-0.5454761440244532,-1.7120446983731532,0.017857142857142856,0.041966295934620076,1.0,13/30,12.28%,SPEG;POPDC2;BVES;MYOCD;DMD;SYNE1;RORA;MEGF10;TBX1;SEMA4C;WNT5B;TMEM204;MEF2C
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.6253164379195516,-1.7113478866280443,0.0,0.041998798054075866,1.0,12/17,26.92%,BOC;RBM24;SMYD1;MEF2C;HIF1AN;RANBP3L;MAPK14;PLCB1;AKIRIN1;MYF6;XKR8;BTG1
prerank,folic acid metabolic process (GO:0046655),0.5414983640337717,1.710850643492039,0.0,0.03334994268419808,0.99,6/18,8.56%,SHMT2;MTHFD1;MTHFD1L;DHFR;SLC19A1;MTHFD2
prerank,Golgi to plasma membrane transport (GO:0006893),-0.4845329785097915,-1.7093985092227455,0.0,0.04308862620523174,1.0,23/46,22.90%,VAMP2;RABEP1;EXOC6B;MACF1;RAB34;ANK3;VAMP4;BBS1;OSBPL5;GGA3;OPTN;BBS2;CCDC93;KIF13A;STEAP2;GGA2;VAMP5;ARL3;PREPL;GOPC;GOLGA7;RAB31;GGA1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.43721274168810714,1.7082037211171013,0.0,0.034421467371433756,1.0,27/73,19.58%,SOX4;E2F1;TFDP1;TFAP4;CDK1;TRIAP1;CHEK2;GTSE1;ARID3A;CDC25C;CNOT11;PML;CNOT10;CASP2;USP10;AURKA;BATF;PRMT1;CARM1;MYO6;FOXM1;ACER2;E2F8;CNOT1;PAXIP1;BAX;SFN
prerank,nucleotide biosynthetic process (GO:0009165),0.5823978410424926,1.7077173783931427,0.0,0.03441340576026428,1.0,5/18,5.81%,PPAT;HPRT1;GART;MTHFD1;PNP
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.49846989642128375,-1.7044950507754464,0.0,0.04535172470998501,1.0,18/33,22.90%,VAMP2;MACF1;RAB34;ANK3;VAMP4;BBS1;GGA3;OPTN;GORASP1;BBS2;KIF13A;RILPL1;GGA2;VAMP5;PREPL;GOLGA7;RAB31;GGA1
prerank,response to nutrient levels (GO:0031667),-0.5848545248711763,-1.7027191806790223,0.0,0.045705344395832855,1.0,10/22,22.81%,FAM107A;KCNB1;ULK1;GH1;ATF4;PRKAA2;PRL;RPS6KB1;RPTOR;MTOR
prerank,negative regulation of metabolic process (GO:0009892),-0.46394383819836676,-1.7025458214681797,0.0,0.045364259736162454,1.0,23/54,20.74%,FLCN;NOVA1;ARNTL;ACTN3;TFE3;PLCL1;NR1D1;ZDHHC7;ATF4;LAMA4;RBPJ;NOVA2;NPR3;NR1H2;ALDH1A1;IP6K1;ZNF423;ADAMTS5;IL18R1;ABHD6;TLE3;LNPEP;MAP2K6
prerank,positive regulation of interleukin-17 production (GO:0032740),0.561464582002194,1.7022264558441005,0.04,0.03652995143341364,1.0,14/23,28.38%,OSM;IL23A;PHB;SLC7A5;IL21;MYD88;IL23R;TGFB1;NOD2;IL12B;PRKCQ;CCL1;SLAMF6;IL18
prerank,regulation of mitotic cell cycle (GO:0007346),0.37627829383070305,1.7021989665711996,0.0,0.03639330297531176,1.0,53/176,14.43%,PSMD14;MAD2L1;CKS2;CKS1B;KIF20B;PSMB2;TP73;TFAP4;CDK1;FBXO5;PSMB9;PSMA5;RCC1;PSMB3;UBE2S;PSME3;PSMA3;MCIDAS;NEK6;EIF4EBP1;BUB3;PSMA7;NEK2;PSMD13;CDC25C;RNF40;PSME2;PSMC2;DLGAP5;PSMC4;PSMD10;PSMD12;ANAPC1;PSMB5;PDXP;UBE2C;TTLL12;EIF4E;PSMD8;CDC26;PSMB4;PSMD3;PSMB1;PSMA4;DDB1;PKMYT1;PTPN3;PSME1;PSMF1;ANAPC11;PLK1;PSMD11;PSMD1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.4024931441128303,1.7013400166446264,0.0,0.03649165481502713,1.0,66/131,23.40%,POLR2D;MCTS1;SNRPF;CLNS1A;SNRPD1;PRPF19;BRIX1;LSM4;SNRPG;WDR77;NLE1;ABT1;EIF2S3;BOP1;RRS1;TGS1;SNRPB;XRCC5;SNRPC;SHQ1;EIF2S2;SNRPD2;NCBP1;SNRPE;PRKDC;SRPK1;SRSF9;DENR;NAF1;EIF6;DHX9;NUDT21;PRPF6;RPLP0;PTGES3;CLP1;RPF2;TARBP2;GEMIN6;RPS14;CRNKL1;RRP7A;ERAL1;RPS19;STRAP;USP39;PUF60;COIL;SMN1;RPS5;TRAF7;HSP90AB1;MRPS11;RPS28;PWP2;SNRPD3;RPL11;RPS15;HSP90AA1;DDX1;TXNL4A;GEMIN2;GEMIN5;MRPS7;RPL24;RPL23A
prerank,response to calcium ion (GO:0051592),-0.40491290861406676,-1.7004477009992836,0.0,0.04646529929477066,1.0,49/103,23.71%,RYR3;ADD1;RASGRP2;ITPKB;KCNMB1;SLC25A12;PKD2;TRPC1;KCNMA1;CAPN3;STIM1;MEF2A;CALM1;CARF;KCNIP2;SYT10;RYR1;NLGN1;CASQ2;SYT11;CLIC4;PRKAA2;SYT2;SYT9;RYR2;KCNMB2;SYT6;SYT5;MEF2C;KCNMB4;MCOLN1;BRAF;CAMK2D;CRHBP;CPNE8;CPNE4;AHCYL1;D2HGDH;SCN5A;ACER1;SYT1;TTN;TRPC3;CPNE6;CALM2;PLCG2;KCNH1;KCNMB3;SYT3
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.4693454896158534,1.6980100475317135,0.0,0.0370535876836708,1.0,15/39,19.55%,RFC3;RPA3;RFC5;RFC2;POLD2;NTHL1;GTF2H3;ERCC5;DDB1;UBA52;RPA2;POLD1;CUL4A;RFC4;ERCC2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.5041696179684274,1.6967030131339,0.0,0.03726297316101212,1.0,17/26,27.61%,FBXO5;CENPE;NEK6;DLGAP5;UBE2C;DUSP1;LCMT1;ANAPC11;PLK1;NSMCE2;ESPL1;CDC6;CUL3;HECW2;RIOK2;CDC23;CCNB1
prerank,positive regulation of interleukin-4 production (GO:0032753),0.5635101839167292,1.6959246114733877,0.0392156862745098,0.03724028780050986,1.0,13/18,34.40%,CEBPB;ZP3;SLC7A5;SYK;PRKCZ;TNFSF4;CD86;PRKCQ;NLRP3;GATA3;CD28;HAVCR2;FCER1G
prerank,regulation of viral transcription (GO:0046782),0.4750244439093049,1.6943253779100775,0.0,0.037217838745846166,1.0,23/41,27.50%,POLR2F;POLR2D;IFITM3;NELFCD;DHX9;TRIM27;TARBP2;TRIM14;POLR2C;GTF2F2;POLR2K;POLR2J;TRIM11;POLR2G;NELFE;POLR2H;POLR2I;POLR2L;TRIM31;NELFA;POLR2B;NELFB;GTF2F1
prerank,regulation of T cell proliferation (GO:0042129),0.4268533752679158,1.693742414170643,0.0,0.03730937040437443,1.0,28/74,22.35%,CEBPB;IL4I1;IL23A;SLC7A1;FOXP3;ZP3;CD276;IL1B;PNP;TNFSF9;CD46;IL21;CD80;JAK3;CD70;IDO1;PLA2G2F;VTCN1;CLC;IL23R;TNFRSF1B;LILRB4;PLA2G2D;TNFSF4;CD86;IL12B;TNFSF8;TNFSF18
prerank,cellular response to type I interferon (GO:0071357),0.4176649070011834,1.6927683123646,0.0,0.037377035929185363,1.0,27/65,30.64%,IFITM3;IFITM1;IFITM2;IFI6;OAS2;MYD88;IRAK1;STAT1;IRF8;BST2;IFIT3;OASL;ISG15;MX1;XAF1;IRF6;EGR1;OAS3;HLA-F;TYK2;STAT2;IFI35;IRF3;IRF7;SAMHD1;IRF9;RSAD2
prerank,type I interferon signaling pathway (GO:0060337),0.4176649070011834,1.6927683123646,0.0,0.037377035929185363,1.0,27/65,30.64%,IFITM3;IFITM1;IFITM2;IFI6;OAS2;MYD88;IRAK1;STAT1;IRF8;BST2;IFIT3;OASL;ISG15;MX1;XAF1;IRF6;EGR1;OAS3;HLA-F;TYK2;STAT2;IFI35;IRF3;IRF7;SAMHD1;IRF9;RSAD2
prerank,termination of RNA polymerase II transcription (GO:0006369),0.49406289826515115,1.689485361719111,0.0,0.038194400112355247,1.0,17/34,14.97%,CSTF2;CPSF3;SNRPF;SNRPG;CSTF1;SLBP;SNRPB;NCBP1;SNRPE;NUDT21;TTF2;MAZ;CLP1;NCBP2;CPSF2;MED18;ZNF473
prerank,microtubule polymerization (GO:0046785),-0.5210087616069367,-1.6882750528456023,0.0,0.05230516180468043,1.0,17/29,22.67%,MAPT;TUBG2;TUBGCP6;CLASP1;MAP7D3;CLASP2;TPPP;CCDC57;NDEL1;RANBP9;FGF13;SLAIN2;TUBGCP5;CSNK1D;TPPP3;GOLGA2;PIN1
prerank,positive regulation of axonogenesis (GO:0050772),-0.47702386536836583,-1.6880826471065535,0.0,0.052058238204540794,1.0,17/43,17.91%,MAP6;NTN1;PLXNB3;MAPT;MACF1;RUFY3;AMIGO1;L1CAM;NGF;NGFR;SLIT2;CHODL;TIAM1;RHOA;DBN1;PLXNA4;PLXNB1
prerank,regulation of viral genome replication (GO:0045069),0.463319795528619,1.687151079002054,0.0,0.03866915075757336,1.0,22/66,15.78%,HACD3;IFITM3;IFITM1;PABPC1;CXCL8;PPIH;IFITM2;SRPK1;PROX1;PDE12;STAU1;SLPI;OAS2;TARBP2;APOBEC3F;DDB1;TMEM39A;BST2;OASL;ISG15;MX1;BANF1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.6038501478480975,-1.6862333730575934,0.0,0.05241739196552616,1.0,12/18,24.51%,GRIK5;GRIK3;SLC17A7;GRIK2;GRIA2;UNC13C;NAPB;GRID1;SLC17A8;CDH8;GRID2;GRIK1
prerank,protein sumoylation (GO:0016925),0.4775279015887797,1.685897997018495,0.0,0.038751041151938136,1.0,24/53,21.60%,NUP37;NUP155;RAE1;NUP93;NUP35;SEH1L;NUP210;NUP43;NUP50;NUP88;RANGAP1;NUP107;RNF212B;UBA2;NUP205;NSMCE2;NUP62;NUP160;EYA1;SUMO1;NDC1;SUMO3;TRIM28;ZBED1
prerank,positive regulation of viral process (GO:0048524),0.4419986872492772,1.685536934946059,0.0,0.03894242701739835,1.0,31/61,27.50%,POLR2F;POLR2D;HACD3;PABPC1;PPIH;NELFCD;SRPK1;DHX9;PDE12;STAU1;TARBP2;DDB1;POLR2C;GTF2F2;POLR2K;TMEM39A;POLR2J;KPNA2;POLR2G;RAB7A;NELFE;POLR2H;POLR2I;POLR2L;PPID;LARP1;NELFA;POLR2B;RAD23A;NELFB;GTF2F1
prerank,myelination (GO:0042552),-0.5004622256127769,-1.6850157036432174,0.0,0.05250552727548225,1.0,24/47,21.56%,LGI4;MAL;MPZ;NFASC;PLP1;MYOC;PMP22;CNTNAP1;AMIGO1;PARD3;MARVELD1;ARHGEF10;EPB41L3;SIRT2;TPPP;FAM126A;SLC8A3;SKI;EIF2B4;SBF2;GPC1;ZNF24;DEGS1;ABCD1
prerank,ameboidal-type cell migration (GO:0001667),-0.483521216334012,-1.6824630242284968,0.0,0.053384259020391095,1.0,25/50,22.91%,GDNF;SEMA6C;AMOTL1;RADIL;NANOS1;TBX1;SEMA4C;SRGAP2;SEMA3E;NRTN;MEGF8;CORO1C;ANXA6;SEMA6D;SEMA6A;SEMA3B;HTR2B;PDLIM1;SEMA3G;AMOTL2;SEMA3A;ERBB4;SEMA3C;PKN1;SOX8
prerank,postreplication repair (GO:0006301),0.4635834094366615,1.6815350966395546,0.0,0.040119801103356376,1.0,24/45,22.28%,RFC3;RPA3;RFC5;RFC2;POLD2;POLH;UBE2N;RAD18;USP10;BRCA1;UBA52;VCP;RPA2;ISG15;POLD1;UBE2A;SPRTN;NSMCE1;UBE2L6;RFC4;UBE2NL;MSH2;DTL;USP43
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.4731714769177355,1.6807641810862413,0.0,0.04013864169027222,1.0,15/37,19.55%,RFC3;RPA3;RFC5;RFC2;POLD2;NTHL1;GTF2H3;ERCC5;DDB1;UBA52;RPA2;POLD1;CUL4A;RFC4;ERCC2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.5148193234227255,-1.6800784012012837,0.0,0.054316046444753525,1.0,14/27,22.89%,PER1;CRY2;FBXL22;PER3;RBM4;USP2;CRTC1;RBM4B;PPP1CB;FBXL8;CRY1;FBXL12;PDE6B;ID2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.45062428704285035,-1.6785697754024884,0.018867924528301886,0.054258831832212126,1.0,18/50,10.06%,GSTM2;ANK2;HRC;AKAP6;JPH2;TRPC1;CASQ1;DMD;CAPN3;JPH4;GPER1;CALM1;PDE4D;SNCA;CASQ2;PRKACA;NOS1;JPH3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5458620739682419,1.67447782379202,0.0,0.04244680526188534,1.0,9/25,8.32%,E2F1;TFDP1;TP73;GZMB;YWHAB;YWHAE;PMAIP1;BBC3;YWHAG
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5458620739682419,1.67447782379202,0.0,0.04244680526188534,1.0,9/25,8.32%,E2F1;TFDP1;TP73;GZMB;YWHAB;YWHAE;PMAIP1;BBC3;YWHAG
prerank,lamellipodium organization (GO:0097581),-0.5200374622949415,-1.6744554271372152,0.0,0.056657354089254784,1.0,12/28,16.20%,SNX1;VCL;WHAMM;ARHGEF6;KIT;WASF1;S1PR1;ABLIM3;P2RY12;RAC1;ARHGEF7;CCDC88A
prerank,inositol phosphate metabolic process (GO:0043647),-0.4555321359031181,-1.6743035303503184,0.0,0.05645636512251222,1.0,15/47,14.15%,INPP5B;IP6K3;PLCD4;ITPKB;INPP5A;INPP4A;INPPL1;FGF2;SYNJ1;CALM1;NUDT10;NUDT11;PTEN;PLCE1;IP6K1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.6184434702182399,1.6724234493366152,0.02127659574468085,0.04277680571493297,1.0,11/18,21.45%,PAICS;PPAT;HPRT1;GART;ATIC;GMPS;IMPDH2;NT5C2;IMPDH1;AMPD2;PFAS
prerank,negative regulation of protein modification process (GO:0031400),-0.4248480639453566,-1.671314918061599,0.0,0.05765982368938708,1.0,25/75,12.78%,ATP2B4;DMD;MAPT;TARDBP;FXYD1;WWTR1;ATG14;BEX4;NTRK3;SNTA1;PRNP;TERF2IP;CRTAP;CADM4;SLIT2;PTEN;LRRK2;PRKAA2;TPPP;CORO1C;FBLN1;PID1;INPP5K;TINF2;DAB2IP
prerank,positive regulation of heart rate (GO:0010460),-0.6292551123793602,-1.6693478810420594,0.017543859649122806,0.05853041589600425,1.0,9/17,14.32%,TPM1;HRC;SCN3B;PDE4D;NPPA;ADRA1A;ADRA1D;RYR2;ADRB1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.5358273053675817,-1.6687152662509663,0.0,0.05863501520516204,1.0,15/28,23.51%,PLEKHH2;LIMA1;SMAD4;SHANK3;CLASP1;SLIT2;KANK3;TJP1;SSH1;KANK1;MYADM;IQCJ-SCHIP1;ARPIN;CAV3;PRKCD
prerank,positive regulation of T cell activation (GO:0050870),0.42612438077794323,1.667789332851027,0.0,0.04433511769854737,1.0,36/73,31.79%,THY1;HSPD1;TNFSF11;IL23A;SLC7A1;ZP3;CD276;IL1B;PNP;CD46;MDK;IL21;CD80;CD81;XBP1;JAK3;CD70;IL23R;IL36B;NOD2;LCK;TNFSF4;CD86;IL12B;CD47;ZAP70;PRKCQ;ANXA1;RHOH;CD3E;CD6;CCDC88B;SIRPG;CCL5;CD274;SIRPB1
prerank,neuron development (GO:0048666),-0.3988002992252672,-1.6641541174136578,0.0,0.06092293749829819,1.0,55/141,21.53%,LGI4;GPM6B;GDNF;LGI1;PLP1;STMN4;TENM1;ULK1;PBX3;GBA2;MAPT;PTPRM;MYOC;ATCAY;MICALL1;SRF;PHOX2B;STMN2;TMEM108;NLGN1;L1CAM;FRY;GPM6A;PBX2;ALK;MAP2;EPHA5;NRTN;LAMB1;ATP8A2;GLI2;OPHN1;MEF2C;ACTL6B;MYT1L;PPP1R9A;ISL2;VSX1;TENM3;UNK;NPY;CNTN4;ROCK1;NCDN;BLOC1S1;RAB13;VAPA;BTG2;FRYL;ARL3;RAPGEF2;SNAPIN;TENM2;DCX;SRRM4
prerank,photoperiodism (GO:0009648),-0.5095037520009094,-1.6613286528124624,0.0,0.06280813676899864,1.0,14/28,22.89%,PER1;CRY2;FBXL22;PER3;RBM4;USP2;CRTC1;RBM4B;PPP1CB;FBXL8;CRY1;FBXL12;PDE6B;ID2
prerank,cytoplasmic microtubule organization (GO:0031122),-0.473560288316695,-1.661326834779531,0.0,0.06238941585720532,1.0,24/54,19.38%,CLIP3;FIGN;CLIP4;CCDC13;DCTN1;MAPT;TUBGCP6;CEP126;NUMA1;KATNAL1;CLIP1;CLASP1;TPPP;DST;KATNAL2;TRDN;SLAIN2;RHOA;PCM1;TUBGCP5;CCDC88A;CAMSAP2;HOOK3;SLK
prerank,regulation of membrane depolarization (GO:0003254),-0.6164106980450619,-1.6612704551994026,0.0,0.062098602696465874,1.0,11/18,22.87%,FHL1;SCN3B;SCN2B;SCN1B;LRRK2;CAMK2D;SCN5A;SMAD7;ABCD1;GPD1L;CAV3
prerank,amino acid import (GO:0043090),0.5423260771082781,1.6585611929143063,0.0,0.04854254552901022,1.0,9/22,12.92%,SLC6A20;SH3BP4;SLC6A14;SLC7A1;SLC7A5;SLC6A6;TSPO2;SFXN2;SFXN1
prerank,ribosomal large subunit assembly (GO:0000027),0.5478995449401874,1.6581057704625777,0.043478260869565216,0.0483610679649491,1.0,14/24,27.16%,BRIX1;NLE1;BOP1;RRS1;DDX28;FASTKD2;RPLP0;RPF2;TRAF7;RPL11;RPL24;RPL23A;MRPL20;RPL3
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.5737313903708828,1.6578928354709321,0.0,0.048339653018355314,1.0,13/24,16.10%,HSD17B12;DGAT2;TECR;ACSL6;THEM5;ACOT7;HACD2;ACSL3;ELOVL1;ACSL5;ELOVL7;FAR2;ACSF3
prerank,extracellular matrix assembly (GO:0085029),-0.5759692952666665,-1.6576587570733772,0.0,0.06399963783086701,1.0,13/24,19.85%,GPM6B;FBLN5;TNXB;LAMB2;MFAP4;LTBP3;NTNG1;EFEMP2;EMILIN1;LAMB1;LAMB4;PXDN;NTN4
prerank,chromosome condensation (GO:0030261),0.4856933151018263,1.6573650664775335,0.025,0.04831844299948013,1.0,16/32,16.98%,NCAPD3;INCENP;CDK1;CDCA5;SMC2;NCAPD2;SET;NCAPG;SMC4;CSNK2A1;AIFM1;NCAPG2;PLK1;BANF1;TOP2A;NCAPH
prerank,oxoacid metabolic process (GO:0043436),0.5108654458051501,1.6567594757819266,0.0,0.048140625126950984,1.0,10/29,17.96%,SULT2B1;LIPT2;SULT1C2;SULT1C3;MINPP1;PPA1;PPA2;BPNT1;SULT1A3;TPST2
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.5338951047177309,-1.6567425974647854,0.0,0.06388324524023307,1.0,19/35,24.09%,TNNI3K;ANK2;RGS2;CALM1;PDE4D;PLN;NPPA;SLC8A1;ADRA1A;PRKACA;NOS1;RNF207;RYR2;ASB3;SCN5A;SMAD7;CAV3;CALM2;ATP2A2
prerank,mitochondrion localization (GO:0051646),-0.6142577681783914,-1.656641443297534,0.01694915254237288,0.06346841897243935,1.0,7/17,13.66%,HAP1;ATCAY;MEF2A;TRAK2;MFN2;LRRK2;MARK1
prerank,regulation of microtubule polymerization (GO:0031113),-0.48245035453258117,-1.655556896322105,0.0,0.06389337368938391,1.0,18/38,14.50%,CLIP3;DCTN1;GBA2;MAPT;TUBB4A;NUMA1;CLIP1;STMN2;SNCA;CLASP1;FES;DYRK1A;MAP2;MAPRE3;NAV3;ARL2;RAC1;SLAIN2
prerank,supramolecular fiber organization (GO:0097435),-0.35350725866514804,-1.654142597411743,0.0,0.0641944403421013,1.0,112/336,19.58%,CORO6;CLIP3;FIGN;DPT;LMOD1;RND2;PGM5;FBLN5;TPM2;TPM1;COL21A1;CLIP4;STMN4;TMOD2;INPPL1;CCDC13;GSN;MYH6;DCTN1;LOXL4;COL6A1;COL28A1;MPRIP;MAPT;KLHL41;DDR2;TUBGCP6;MYO15A;CAPN3;TNXB;CEP126;KATNAL1;COL24A1;MFAP4;WHAMM;CLIP1;DES;COL6A2;LTBP3;STMN2;COL16A1;SNCA;RUFY3;ACTN1;NPPA;TMOD1;RHOB;CRTAP;MAP7D3;EVL;NCKAP5L;TRIOBP;CORO7;EFEMP2;EMILIN1;MYO5A;GGA3;P3H2;MYO1C;TPPP;CORO1C;APH1B;DST;KATNAL2;LMOD2;BMP1;BACE1;PRL;PPP1R9A;TLL1;ALDOA;COL4A5;COL5A3;COL23A1;MYOZ1;GFAP;OPTC;FLII;TRDN;ELMO2;RAC1;FGF13;HSPG2;SLAIN2;RHOA;MFGE8;PCM1;TUBGCP5;ACTC1;PLA2G1B;VIM;DBN1;NEFL;COL13A1;CCDC88A;COL27A1;COL4A6;ELMO1;COL4A2;DNAJB6;CAMSAP2;KRT20;GGA2;COL4A3;HOOK3;UBB;CD36;COL25A1;COLGALT2;CGNL1;SLK;PXDN
prerank,regulation of type I interferon production (GO:0032479),0.4055408114133917,1.6540174745320895,0.019230769230769232,0.04884887058052222,1.0,34/83,25.05%,POLR2F;POLR3K;POLR1C;G3BP1;GAPDH;XRCC5;POLR3C;PRKDC;TNFAIP3;IKBKE;DHX9;POLR3B;POLA1;MYD88;RELA;IRAK1;NLRC5;POLR2K;IRF8;NFKB2;ISG15;DDX41;POLR3G;CRCP;UBE2L6;POLR2H;IFI16;POLR2L;POLR3A;TRIM15;XRCC6;ZBP1;CTNNB1;CREBBP
prerank,calcium ion transport (GO:0006816),-0.4168177935195773,-1.6527572193859952,0.0,0.06490357111420715,1.0,34/112,15.17%,PKD1;RYR3;CACNA1H;ATP2B4;CACNA1C;CACNB2;ANK2;TRPV1;PKD2;TRPC1;ITPR1;STIM1;CAMK2A;CACNA2D1;SLC8A2;SLC24A4;RYR1;P2RX7;ORAI3;SLC8A1;CDH23;PSEN1;TRPC6;TRPC4;SLC24A3;RAMP1;CACNA1G;RYR2;SLC8A3;MCOLN3;CACNG7;TRPV3;MCOLN1;PSEN2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.6165675414479825,-1.6526003644224245,0.02127659574468085,0.06455125936217278,1.0,10/16,22.75%,CCBE1;CADM4;DCN;MYO1C;DAB2IP;SEMA6A;CD63;DLL1;ADAMTS3;IL12A
prerank,regulation of neuron projection arborization (GO:0150011),-0.6574654396039774,-1.6518594319737,0.02040816326530612,0.06466820004942309,1.0,9/15,13.72%,FZD4;MACF1;DVL3;DLG4;MYO9A;NTNG1;GRIP1;DVL2;SPRY3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.3638687493378118,-1.6512821367957822,0.0,0.0645527211207634,1.0,128/261,28.65%,TTLL3;NPHP3;PKD1;NTN1;FLNA;IFT80;WDR19;MYLK;RFX2;VCL;RAP1A;GSN;DZIP1;CNGB1;TTBK2;RABL2B;CEP126;INTU;PMP22;EHD2;ACTN2;WHAMM;IFT81;BBS4;CYS1;BBS5;DYNC2H1;WDR11;P2RX7;HDAC6;DZIP1L;ARHGEF6;STK36;INPP5E;CFAP44;CCDC66;KIT;EXOC7;BBS1;CC2D2A;FBF1;PARVA;SRGAP2;CFAP54;TEKT2;S1PR1;EMP3;NEK1;ABLIM3;RAB23;PTPDC1;CEP164;CEP162;OPHN1;EXOC3;CCDC57;FGD1;INPP5K;P2RY12;BBS2;RAC1;DISC1;TEKT3;RILPL1;CLUAP1;CFAP70;PCM1;GBF1;ARHGEF7;S1PR2;BBS7;RAB11FIP3;EMP1;CEP290;CCDC88A;ARMC9;BBS9;TXNDC15;PCNT;IFT122;AHI1;TMEM138;CDC14A;ARL3;AIF1L;FGD2;RAPGEF6;RPGR;FUZ;CCL21;RAPGEF2;RAB8B;WDR35;CNGA4;CEP89;RFX3;ANO6;UBXN10;RHO;FGD5;IFT46;KIF3A;ARL6;BBIP1;TRAF3IP1;TTC8;PIP5K1A;CDC14B;WDPCP;EXOC1;MTSS1;SPEF1;IFT43;ABCC4;GOLPH3;CDH13;DNM3;SPAG16;ASAP1;FGD6;IFT172;OCRL;IFT140;PTPN23;CEP19;CCDC28B;UNC119B;ATAT1
prerank,T cell receptor signaling pathway (GO:0050852),0.36526805351424085,1.6508110907433227,0.0,0.05032708705116073,1.0,38/153,14.58%,PSMD14;THY1;PSMB2;PSMB9;PSMA5;PSMB3;RIPK2;PSME3;KHDRBS1;PSMA3;UBE2N;SKAP1;PSMA7;CD276;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;STOML2;CARD11;BTN1A1;PSMB5;RELA;PSMD8;PAK2;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;INPP5D;PSMF1;VTCN1;PSMD11;PSMD1;PAK1
prerank,positive regulation of ion transport (GO:0043270),-0.4696978591126192,-1.647095675214401,0.0,0.06661914840938793,1.0,15/50,9.51%,FHL1;GDNF;CACNB2;ANK2;MYLK;WNK3;SCN3B;ACTN2;CAMK2A;ANK3;P2RX7;SCN1B;CNKSR3;TRPC6;SCN4B
prerank,nuclear transport (GO:0051169),0.6062343711362966,1.6466424622193023,0.022727272727272728,0.05143068727147154,1.0,11/16,22.69%,HMGA1;NXT2;ANP32A;NUTF2;RSRC1;NXT1;NUP205;NPM1;BANF1;RBM15B;RGS14
prerank,O-glycan processing (GO:0016266),0.4190249286837673,1.6466226816256515,0.0,0.05119035695711888,1.0,21/59,20.60%,GALNT6;C1GALT1C1;B3GNT4;MUC5AC;CHST4;C1GALT1;POFUT1;B3GNT2;GCNT1;GALNT5;ST6GAL1;GALNT3;GALNT1;GALNT7;B3GNT3;B3GNT5;MUC20;MUC17;B3GNT8;B4GALT5;MUC16
prerank,protein localization to cilium (GO:0061512),-0.5280687503406576,-1.6464431028425717,0.0,0.06649305225540328,1.0,21/34,28.12%,TUB;WDR19;RABEP1;BBS4;TTC21A;BBS1;TULP3;ZNF423;TTC21B;TULP1;BBS9;IFT122;CSNK1D;ARL3;TULP2;WDR35;ARL6;FSIP2;ROPN1;IFT140;RAB29
prerank,protein localization to nucleus (GO:0034504),0.3943330855692813,1.6462809607021671,0.0,0.05110542538664428,1.0,33/102,15.54%,CALR;RAN;CSE1L;COL1A1;NXT2;NUP155;RRS1;E2F3;NUP62CL;NUP93;YWHAE;NUTF2;SYK;SEC13;PML;NXT1;ARL2BP;NUP50;NUP88;NUP107;RPF2;TNPO3;SIX1;HEATR3;TOR1A;TOR1B;BMP7;KPNB1;PLK1;BMP4;MMP12;NUP62;MSX1
prerank,regulation of endocytosis (GO:0030100),-0.45763041044062974,-1.6455642467984817,0.0,0.06642518006829436,1.0,30/60,29.19%,CLIP3;STON1;SNX33;CALY;SNCA;PACSIN1;SYT11;PRKD1;RAB5B;OPHN1;LGALS3;RAB4B;RIT2;PACSIN2;EPHA3;LRSAM1;ROCK1;TSC2;PACSIN3;DLL1;RUFY1;RUFY2;ZFYVE16;SMPD1;HIP1;CDH13;FLOT1;NEDD4L;MCTP1;RAB5C
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.580556139819738,-1.6451810296581513,0.0,0.06635813559078431,1.0,10/19,17.48%,NPR2;ADCY5;ADCY2;NPR1;ADCY4;NPPA;ADCY9;ADCY6;NPPC;NPPB
prerank,DNA duplex unwinding (GO:0032508),0.43578176572747457,1.6450413048404087,0.0,0.05158027830965538,1.0,16/49,15.64%,MCM4;HMGA1;SSBP1;BLM;GTF2H3;MCMDC2;RECQL4;ASCC3;MCM7;DHX9;MCM6;MCM2;RAD23B;DDB1;UBA52;CUL4A
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.37058159712553207,1.6449765938682441,0.0,0.051443748822222496,1.0,71/151,27.05%,RFC3;CHEK1;RPA3;TP73;RFC5;CDK1;EXO1;CDK5;RFC2;RMI1;RHNO1;TP53RK;BOP1;RRS1;CHEK2;RMI2;PAK1IP1;BLM;HDAC2;SMYD2;PML;AURKB;RPL37;SSRP1;TOPBP1;RAD9B;DNA2;NOC2L;CSNK2A1;HDAC1;RPF2;MTA2;AURKA;TPX2;RBBP8;POU4F1;TAF9;MLST8;BRCA1;HUS1;RPA2;RNF34;CHD4;TAF4;PPP1R13L;TOP3A;TTC5;PRDM1;RFC4;BRIP1;PRKAB1;RPL11;RPS15;RPL23;MAPKAPK5;TAF15;CDK2;PRR5;TAF4B;RBBP7;TP53;BARD1;RAD1;SETD9;ING2;TAF5;RPS20;TAF2;ATR;PRMT5;CDK5R1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.4437200117934009,-1.644367743425475,0.016129032258064516,0.06640388334079288,1.0,28/69,18.60%,CLIP3;PLEKHH2;CRYAB;TTBK2;CLU;TUBB4A;LIMA1;SMAD4;CHADL;SHANK3;STMN2;SNCA;CLASP1;DYRK1A;SLIT2;MAP2;CLASP2;KANK3;EMILIN1;NAV3;FGF13;SSH1;KANK1;APC;MYADM;ATXN7;CAMSAP2;PFDN5
prerank,fatty acid transmembrane transport (GO:1902001),-0.5614993612335643,-1.6428470916044107,0.0,0.06711690986196578,1.0,10/18,24.10%,ACACB;PRKAB2;PRKAG2;PRKAA2;SLC27A1;CPT1B;CD36;ABCD4;ABCD1;ABCD2
prerank,positive regulation of signal transduction (GO:0009967),-0.36795472543389224,-1.6423172705847746,0.0,0.06704692768169442,1.0,94/234,22.28%,LIMS2;SLC2A4;TRIM39;SORBS1;TTC23;NLGN2;FLNA;LMO3;AGPAT1;CCBE1;EPN2;SASH1;PKD2;STX1B;NLGN3;GKAP1;HAP1;KAT2B;MACF1;RAB34;NRXN1;CITED2;GPER1;CUX2;ARNT;SHANK3;PIK3R1;FGFR2;ILK;DLG4;GH1;KIF7;NTRK3;TMEM108;ITGB3;NLGN1;RSPO1;PRKCB;PRKCA;STK36;RWDD3;NECAB2;PTGIS;DSTYK;MN1;RBPJ;PTEN;CAV2;LRRK2;MAML1;MBD5;RSPO2;ZMIZ1;NPTN;TSLP;GRB10;MYO1C;WLS;NOTCH4;SKI;EVC;DAB2IP;ASXL1;RELN;DISC1;SFRP1;KANK1;NTF3;ARMC9;TXNDC15;FAS;GPS2;CD63;SPIN1;SMO;FGF1;DLG5;RSPO3;ZRANB1;HHEX;ENHO;DLL1;CRADD;TM2D3;SIRT1;INS;ING5;PHIP;RIMS1;LOXL3;ADAMTS3;KLF2;TRIM44;TUBD1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5478848696963582,1.6410733293149118,0.0,0.053070784476383526,1.0,14/25,28.66%,CBFB;IL4I1;FOXP3;CD46;MDK;SOCS1;RUNX1;FANCA;LILRB4;TNFSF4;IL2RA;IFNG;CTLA4;BCL6
prerank,cellular modified amino acid catabolic process (GO:0042219),0.614803892707433,1.6393180189362104,0.03571428571428571,0.05363040206459072,1.0,7/15,12.43%,DPEP1;GGACT;ABHD12;GOT2;CHAC2;CHAC1;ALDH4A1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.4994164887032759,-1.638636827862821,0.018867924528301886,0.0691773772637536,1.0,15/27,20.48%,STMN4;GBA2;MAPT;MAP1A;MAP1B;STMN2;CLASP1;MAP2;CLASP2;GAS2L1;MAPRE3;ARL2;CAMSAP2;MAPRE2;GAS2L2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.5047769133265375,-1.6382231682131347,0.03125,0.06898670199693316,1.0,16/37,20.61%,FAM107A;KANK2;FHL1;NACC2;PKD2;JADE1;ZNF655;PTEN;CDKN1A;PRMT2;APC;CDKN2C;RBL2;MYO16;DCUN1D3;CCL2
prerank,DNA biosynthetic process (GO:0071897),0.544729820898922,1.637817425536366,0.045454545454545456,0.05413503817577623,1.0,6/16,15.63%,RFC3;POLD2;POLH;WRNIP1;POLA1;POLD1
prerank,in utero embryonic development (GO:0001701),-0.5304737316735262,-1.6377226984936872,0.05172413793103448,0.06868958391804267,1.0,12/24,16.07%,PKD1;FLCN;FOXF1;EGFL8;MYH6;FGFR2;FOXD3;MBNL1;ZNF568;ARNT2;HINFP;LMX1B
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.5351149137574174,-1.6340550265649425,0.0,0.07115122762330009,1.0,13/24,25.31%,PDE2A;OR51E2;PDE3B;RASD2;GNAI1;PDE4D;PDE3A;PRKAR2B;GPR61;PEX5L;RAPGEF2;PRKAR1A;UBE2B
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.48257174230977556,-1.6322790311184001,0.0,0.0718654914170499,1.0,14/40,9.83%,FXYD6;DMD;FXYD7;OSR1;WNK3;FXYD1;SCN3B;ANK3;FXYD2;SLMAP;SCN2B;SCN1B;SCN4B;FGF12
prerank,cell projection organization (GO:0030030),-0.49533479538171515,-1.6318406329678699,0.0,0.07166368659481896,1.0,13/30,14.95%,ATP1B2;GSN;NEFH;RHOQ;RHOJ;PARVA;NCKAP1L;NPHP1;KIF17;QRICH2;P2RY12;RAC1;PACSIN2
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.47191178651851,-1.6317200686147921,0.019230769230769232,0.07141110760794257,1.0,18/40,22.82%,TSC1;CORO2B;FZD4;VIT;GCNT2;ATXN3;FZD7;PPM1F;CORO1C;ARL2;RAC1;RHOA;PDGFB;MYADM;SPOCK1;FBLN2;ECM2;RSU1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.5567233654179938,1.6316353108400605,0.0,0.05751586765502743,1.0,9/21,9.99%,TIMM8A;ROMO1;TIMM10;PMAIP1;TIMM13;TOMM22;COX18;TIMM8B;HSPA4
prerank,neutrophil activation involved in immune response (GO:0002283),0.3275521885331725,1.6291193149143455,0.0,0.05829512268872354,1.0,151/464,20.64%,PSMD14;S100A11;S100P;PRDX4;DSN1;CMTM6;ILF2;CCT2;PSMA5;DDOST;ACTR2;TCN1;CXCL1;GDI2;PLAU;MAGT1;NEU1;HEXB;GGH;GLA;GLB1;XRCC5;DIAPH1;CCT8;CNN2;NRAS;MLEC;CSTB;RAB10;ANXA3;PSMD13;SURF4;FUCA2;RAP2B;SERPINB1;TRPM2;LCN2;SYK;OLR1;CEACAM6;PNP;ERP44;PSMC2;ARPC5;CD44;APRT;CTSH;GCA;TUBB4B;SVIP;MME;CTSC;PSMD12;PAFAH1B2;LAMP2;APEH;ATP11A;OSTF1;JUP;HMOX2;CD55;CKAP4;RAB3D;CLEC5A;IMPDH2;LAMTOR2;COMMD9;SLPI;PKP1;CYBA;DNAJC3;ADGRE3;PA2G4;CPNE3;CANT1;PDXK;SELL;ADAM10;AGPAT2;CHIT1;ABCA13;CYSTM1;PSMD3;ORMDL3;PSMB1;PECAM1;VAMP8;PTGES2;CAPN1;VNN1;GM2A;KPNB1;FCGR3B;PSMD11;MMP9;NIT2;B4GALT1;TMC6;GRN;CXCR2;PSMD1;C3;BST2;COPB1;VCP;FPR2;COTL1;ADAM8;PRSS3;MANBA;DSP;PTPRN2;ACLY;DNASE1L1;PLAUR;HPSE;FTL;DYNLL1;RAB7A;FRK;NCSTN;PGRMC1;AGA;PDAP1;CTSZ;FAF2;NAPRT;HSP90AB1;TMEM63A;GHDC;GPR84;CPNE1;TNFRSF1B;IMPDH1;ATP6AP2;PSMD6;PKM;CTSA;DNAJC5;SLC15A4;TMEM179B;MMP8;CHI3L1;MNDA;ALDOC;OLFM4;RHOF;CLEC4C;DERA;HSP90AA1;PTAFR
prerank,diol biosynthetic process (GO:0034312),0.587442825211731,1.628796393577455,0.0,0.05818137805471618,1.0,10/17,22.52%,SPTLC1;DHFR;SPTLC2;ASAH2B;GCH1;SPR;GBA;ACER2;QDPR;ASAH2
prerank,striated muscle tissue development (GO:0014706),-0.48129616062048264,-1.6278283550220631,0.0,0.07332582030093768,1.0,12/34,15.12%,POPDC2;BVES;CFLAR;MYOZ2;PGM5;SGCG;MEF2C;MYL6;MYOZ1;SGCD;CSRP3;TBX2
prerank,negative regulation of cell communication (GO:0010648),0.5442912848881815,1.626453332910228,0.0,0.059195719822227995,1.0,4/20,4.69%,OSM;IL11;SRMS;IL1B
prerank,signal transduction in response to DNA damage (GO:0042770),0.45232025991431,1.6259269596870656,0.0,0.05917655417342609,1.0,20/50,21.06%,CHEK1;E2F1;INTS7;PRPF19;RHNO1;TRIAP1;CHEK2;USP10;BATF;HUS1;MYO6;ACER2;CLSPN;FBXO6;TIPRL;PAXIP1;CDC5L;BID;BRIP1;E2F7
prerank,amino acid transmembrane transport (GO:0003333),0.4538720636969742,1.6258657339922782,0.02702702702702703,0.05891471101336669,1.0,22/45,26.47%,LRRC8E;SLC6A20;SLC6A14;SLC7A1;SLC7A11;SLC38A5;SLC7A5;MFSD12;SLC6A6;LRRC8D;TSPO2;SLC25A22;SFXN2;SFXN1;SLC3A2;SLC7A7;SLC25A13;SLC7A8;SLC7A6;SLC38A8;SLC38A9;SLC38A7
prerank,myoblast differentiation (GO:0045445),-0.6160232395133056,-1.6257565803859408,0.0,0.074168966452788,1.0,7/15,21.39%,DDX17;SOX15;MBNL1;PLEKHM3;HINFP;EPAS1;MAPK12
prerank,protein methylation (GO:0006479),0.49380841554701366,1.6255987852374165,0.0,0.058751885764570896,1.0,14/32,14.27%,NTMT1;PRMT3;CAMKMT;SNRPB;EEF2KMT;FAM98A;TRMT112;METTL21A;GSPT1;PRMT1;PRMT6;CARM1;LCMT1;FAM98B
prerank,blood vessel diameter maintenance (GO:0097746),-0.5212619391244292,-1.624257426502915,0.018518518518518517,0.07489819779735442,1.0,24/33,32.82%,NPR1;AGTR1;GPER1;SCPEP1;NOS1;ECE1;KCNMB2;KCNMB4;HTR2B;ADCY6;ROCK1;EDNRB;NPPB;AGTR2;INS;KLF2;ITGB1BP1;F2RL1;GCLC;EDN3;BDKRB2;PER2;KEL;NOS3
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.5921030898763496,-1.6236787124716558,0.0,0.07489262654198837,1.0,10/17,20.77%,RAP1A;NLGN1;RIMS3;LRRK2;RIMS4;RAB3GAP1;SYN1;SNAPIN;PREPL;RIMS1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.5015770766136042,-1.6233638180012238,0.0,0.07468067475779346,1.0,16/42,19.49%,CALCOCO1;DDX17;PGR;EGLN2;GPER1;PPARGC1B;RBFOX2;AR;RHOXF1;ZMIZ1;NR3C1;KDM3A;WBP2;ESR1;TRERF1;RNF14
prerank,positive regulation of neurogenesis (GO:0050769),-0.43463847298499503,-1.6229511151625653,0.0,0.07447107799342294,1.0,27/71,17.91%,SMARCD3;MAP6;PLXNB3;CAPRIN2;NUMBL;GPER1;CUX2;SHANK3;AMIGO1;NGF;NGFR;OBSL1;SLIT2;BHLHB9;NPTN;CHODL;NUMB;TIAM1;ZNF335;DISC1;RHOA;IL1RAPL1;SPEN;SERPINF1;PLXNA4;SOX11;PLXNB1
prerank,regulation of hydrolase activity (GO:0051336),-0.4190223877639282,-1.6205048096616603,0.0,0.0754887670663747,1.0,34/69,28.26%,BVES;PLXNB3;RABGAP1;CAMK2A;PAFAH1B1;PRKG1;NOS1;SERPINA5;EPHA5;FGD1;RDX;RASIP1;DAB2IP;EPHA4;EFNA5;EPHA3;RAB3GAP1;PLXNA4;PLXNB1;SIPA1L1;CDK5RAP3;FGD2;RAPGEF6;SOD1;FGD5;ARHGAP15;FBXW11;CHN1;ITGB1BP1;ARHGAP9;PLXNA3;FGD6;OCRL;CRK
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5938580208154515,1.6202029087533483,0.0,0.061334661249521236,1.0,7/15,20.13%,HM13;DERL1;SEC61B;VCP;FAF2;OS9;AUP1
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.5670134705225203,-1.6201859419111972,0.0,0.07532779346416314,1.0,6/20,12.50%,NFATC4;INPP5A;PPP3CB;NFATC1;PPP3CC;PLCE1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.5938274720608875,1.6185051136975912,0.019230769230769232,0.06168995516104596,1.0,9/16,30.93%,IL23A;SYK;CD55;CD81;TGFBR2;TNFSF4;IL12B;IL18;XCL1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5845675333780846,1.6179904885451832,0.022222222222222223,0.06170808639343342,1.0,12/17,34.62%,MYD88;IL17A;GBP5;NOD2;TICAM1;HIF1A;CLEC7A;CD6;IL17D;TNF;CARD9;TLR4
prerank,neutrophil migration (GO:1990266),0.42093229289601636,1.6175935735553963,0.023809523809523808,0.061773578782979253,1.0,26/68,17.57%,CXCL5;CCL24;CXCL8;CXCL3;CXCL1;CXCL11;CXCL2;CCL20;SYK;PPIB;CCL22;PF4;TGFB2;CXADR;CCL4;CCL3;PECAM1;CXCL9;CCL26;UMODL1;CXCL10;CXCL6;CXCR2;CCL17;PIK3CG;PF4V1
prerank,cellular response to interleukin-1 (GO:0071347),0.37136984953551805,1.6175669338024508,0.0,0.06150731335719055,1.0,47/149,15.11%,PSMD14;IL1A;PSMB2;PSMB9;PSMA5;CCL24;CXCL8;PSMB3;RIPK2;PSME3;PSMA3;IL1RN;UBE2N;IRAK2;PSMA7;IL1B;PSMD13;CCL20;PSME2;PSMC2;PSMC4;PSMD10;CCL22;PSMD12;SOX9;HYAL3;PSMB5;USP10;CCL4;CCL3;MYD88;RELA;IRAK1;PSMD8;ADAMTS12;PSMB4;PSMD3;PSMB1;PSMA4;RPS6KA4;CCL26;PSME1;PSMF1;PSMD11;UBA52;PSMD1;MAPK13
prerank,protein localization to cell surface (GO:0034394),-0.5326484979570021,-1.6172193164339,0.019230769230769232,0.07733933058213595,1.0,13/27,19.12%,PRRT1;JAM3;RIC3;FBLN5;FLNA;ANK2;VCL;GPIHBP1;GGA3;FGF7;FGF10;GGA2;ANGPT1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.42961869934387686,1.6167375234966226,0.0,0.06180865654973618,1.0,18/55,15.78%,SOX4;E2F1;TFDP1;CDK1;TRIAP1;CHEK2;GTSE1;ARID3A;CDC25C;CNOT11;PML;CNOT10;CASP2;AURKA;PRMT1;CARM1;E2F8;CNOT1
prerank,neutrophil mediated immunity (GO:0002446),0.3223747556654346,1.6163406655814645,0.0,0.06177906164500141,1.0,150/466,20.64%,PSMD14;S100A11;S100P;PRDX4;DSN1;CMTM6;ILF2;CCT2;PSMA5;DDOST;ACTR2;TCN1;CXCL1;GDI2;PLAU;MAGT1;NEU1;HEXB;GGH;GLA;GLB1;XRCC5;DIAPH1;CCT8;CNN2;NRAS;MLEC;CSTB;RAB10;ANXA3;PSMD13;SURF4;FUCA2;RAP2B;SERPINB1;TRPM2;LCN2;OLR1;CEACAM6;PNP;ERP44;PSMC2;ARPC5;CD44;APRT;CTSH;GCA;TUBB4B;SVIP;MME;CTSC;PSMD12;PAFAH1B2;LAMP2;APEH;ATP11A;OSTF1;JUP;HMOX2;CD55;CKAP4;RAB3D;CLEC5A;IMPDH2;LAMTOR2;COMMD9;SLPI;PKP1;CYBA;DNAJC3;ADGRE3;PA2G4;CPNE3;CANT1;PDXK;SELL;ADAM10;AGPAT2;CHIT1;ABCA13;CYSTM1;PSMD3;ORMDL3;PSMB1;PECAM1;VAMP8;PTGES2;CAPN1;VNN1;GM2A;KPNB1;FCGR3B;PSMD11;MMP9;NIT2;B4GALT1;TMC6;GRN;CXCR2;PSMD1;C3;BST2;COPB1;VCP;FPR2;COTL1;ADAM8;PRSS3;MANBA;DSP;PTPRN2;ACLY;DNASE1L1;PLAUR;HPSE;FTL;DYNLL1;RAB7A;FRK;NCSTN;PGRMC1;AGA;PDAP1;CTSZ;FAF2;NAPRT;HSP90AB1;TMEM63A;GHDC;GPR84;CPNE1;TNFRSF1B;IMPDH1;ATP6AP2;PSMD6;PKM;CTSA;DNAJC5;SLC15A4;TMEM179B;MMP8;CHI3L1;MNDA;ALDOC;OLFM4;RHOF;CLEC4C;DERA;HSP90AA1;PTAFR
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3987504153046276,1.6158860976620246,0.0,0.06188984656628601,1.0,32/88,15.88%,PSMD14;PSMB2;PSMB9;PSMA5;SKP2;FBXL18;PSMB3;PSME3;PSMA3;KIF14;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;FBXO4;PSMB5;CCNF;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;FBXL13;PSMD11;PSMD1;CUL4A;FBXL14
prerank,protein alkylation (GO:0008213),0.577817964129664,1.6154293693494943,0.0196078431372549,0.061674112851040554,1.0,10/18,14.27%,PRMT3;CAMKMT;SNRPB;EEF2KMT;FAM98A;METTL21A;GSPT1;PRMT1;LCMT1;FAM98B
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.471466472733022,1.6150150907746357,0.021739130434782608,0.06183072084709204,1.0,13/33,15.57%,CCT6A;CCT2;CCT3;XRCC5;CCT8;CCT7;NEK2;AURKB;FBXO4;NAF1;MAPK15;CCT4;TCP1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.33015030251004174,1.6143559697001801,0.0,0.062032133354808464,1.0,115/327,20.61%,RFC3;RFWD3;CHEK1;MYC;UBE2T;FEN1;CCND1;E2F1;XRCC2;CBX3;TP73;RFC5;TDP1;DCUN1D5;CDK1;RAD51AP1;EXO1;FANCF;POLE2;RFC2;TIMELESS;NUDT1;POLH;FBXO45;SUV39H1;UNG;POLB;TRAIP;CHEK2;RMI2;BLM;XRCC5;GTF2H3;TICRR;RAD18;MASTL;NABP2;ZRANB3;PRKDC;RECQL4;INIP;ERCC8;CCNK;PML;RPS3;TOPBP1;RBBP5;RAD9B;LIG1;MSH3;POLE3;FANCL;IKBKE;EPHA2;BCL2L1;MCM7;APEX1;PARP4;BCL2A1;CASP2;RAD51B;USP10;WDHD1;XIAP;RAD54L;POLA1;AATF;CHCHD6;NEK4;APTX;DTX3L;MAPKAPK2;MACROD1;BATF;RBBP8;DDB1;TAF9;MCM10;BRCA1;HUS1;MAPK15;MSH6;CIB1;NPM1;SMC1A;PAK1;ACER2;VCP;UBA1;POLD1;CUL4A;TOP2A;UBE2A;OARD1;FANCA;SUMO1;ZDHHC16;SPRTN;FBXO6;REXO4;LYN;TNFRSF1B;VAV3;FANCC;RFC4;BAX;BID;SFN;PDS5A;MNDA;VCPIP1;SPDYA;BAK1;BRAT1;TRIM28
prerank,neutrophil degranulation (GO:0043312),0.3268006229571299,1.614234703109745,0.0,0.061818512251936304,1.0,199/460,28.77%,PSMD14;S100A11;S100P;PRDX4;DSN1;CMTM6;ILF2;CCT2;PSMA5;DDOST;ACTR2;TCN1;CXCL1;GDI2;PLAU;MAGT1;NEU1;HEXB;GGH;GLA;GLB1;XRCC5;DIAPH1;CCT8;CNN2;NRAS;MLEC;CSTB;RAB10;ANXA3;PSMD13;SURF4;FUCA2;RAP2B;SERPINB1;TRPM2;LCN2;OLR1;CEACAM6;PNP;ERP44;PSMC2;ARPC5;CD44;APRT;CTSH;GCA;TUBB4B;SVIP;MME;CTSC;PSMD12;PAFAH1B2;LAMP2;APEH;ATP11A;OSTF1;JUP;HMOX2;CD55;CKAP4;RAB3D;CLEC5A;IMPDH2;LAMTOR2;COMMD9;SLPI;PKP1;CYBA;DNAJC3;ADGRE3;PA2G4;CPNE3;CANT1;PDXK;SELL;ADAM10;AGPAT2;CHIT1;ABCA13;CYSTM1;PSMD3;ORMDL3;PSMB1;PECAM1;VAMP8;PTGES2;CAPN1;VNN1;GM2A;KPNB1;FCGR3B;PSMD11;MMP9;NIT2;B4GALT1;TMC6;GRN;CXCR2;PSMD1;C3;BST2;COPB1;VCP;FPR2;COTL1;ADAM8;PRSS3;MANBA;DSP;PTPRN2;ACLY;DNASE1L1;PLAUR;HPSE;FTL;DYNLL1;RAB7A;FRK;NCSTN;PGRMC1;AGA;PDAP1;CTSZ;FAF2;NAPRT;HSP90AB1;TMEM63A;GHDC;GPR84;CPNE1;TNFRSF1B;IMPDH1;ATP6AP2;PSMD6;PKM;CTSA;DNAJC5;SLC15A4;TMEM179B;MMP8;CHI3L1;MNDA;ALDOC;OLFM4;RHOF;CLEC4C;DERA;HSP90AA1;PTAFR;EEF2;HMGB1;TUBB;ALDH3B1;LTA4H;CXCR1;CYBB;CYFIP1;CTSB;CD47;PFKL;ADGRE5;QSOX1;OSCAR;CD58;CDA;NFAM1;TYROBP;XRCC6;DYNLT1;CD300A;PGAM1;PTPRJ;SERPINA1;GSTP1;PIGR;FUCA1;SCAMP1;ITGAX;IQGAP1;BRI3;VAMP7;ITGB2;FCGR2A;CEACAM8;ATP11B;MCEMP1;DEFA1;GPI;PSMD2;AMPD3;DSG1;CREG1;CRACR2A;FCAR;FABP5;MMP25;CPPED1;ADGRG3
prerank,dicarboxylic acid metabolic process (GO:0043648),0.4015541725418942,1.6116922518896606,0.0,0.0624299230575484,1.0,19/54,15.64%,SHMT2;MTHFD1;MTHFD1L;GPT2;DHFR;ASS1;GOT2;ALDH18A1;SLC19A1;SDHAF3;ALDH5A1;MTHFD2;MDH2;L2HGDH;GCLM;NIT2;ACOT4;ACOT8;ACLY
prerank,response to endoplasmic reticulum stress (GO:0034976),0.38551881811495486,1.6115771732658908,0.0,0.06221642416423227,1.0,40/104,21.34%,TRIB3;CEBPB;PDIA4;TMEM33;ERO1A;P4HB;CXCL8;PDIA3;RNF183;BCAP31;GORASP2;DERL1;HYOU1;ERP44;BBC3;ERP27;TMCO1;CHAC1;AIFM1;TMX1;TNFRSF10B;GSK3B;TRAF2;VCP;HSPA5;UFC1;UBQLN1;OS9;ERLEC1;AGR2;CREB3L1;MBTPS2;CCDC47;CFTR;BAX;EIF2S1;BAK1;DNAJC10;UFM1;DDRGK1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.599600338996759,-1.6113023860322695,0.017857142857142856,0.08108629121103905,1.0,10/18,22.06%,DMD;PDE4D;CNKSR3;NCK1;PTEN;PPM1F;INPP5K;RASSF2;SMAD7;GPD1L
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.43902348208512165,1.6089573125958143,0.025,0.06322936172352918,1.0,19/41,22.28%,RFC3;RPA3;RFC5;RFC2;POLD2;POLH;WRNIP1;USP10;POLA1;UBA52;VCP;RPA2;ISG15;POLD1;SPRTN;UBE2L6;RFC4;DTL;USP43
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3446360060569922,1.6088902097254782,0.0,0.0630143301516972,1.0,110/269,22.05%,POLR2F;POLR2D;CSTF2;DCPS;CPSF3;ALYREF;SNRPF;CLNS1A;SNRPD1;PRPF19;LSM7;LSM5;PABPC1;HNRNPF;PPIH;LSM4;SNRPG;SF3B3;WDR77;U2AF1;CSTF1;MAGOH;PRPF4;TGS1;PPIL1;SNRPB;RNF113A;SNRPC;EFTUD2;MAGOHB;LSM8;EIF4A3;PHF5A;SNRPD2;NCBP1;SNRPE;DDX39A;SRPK1;SRSF9;SF3B6;PTBP1;NONO;RALY;RSRC1;SNRNP40;BUD31;SNRPB2;RBM15;HNRNPK;DHX9;NUDT21;SF3B5;PRPF40A;PRPF6;LSM2;CLP1;SNRPA1;GEMIN6;NCBP2;PSPC1;HNRNPC;FUS;CRNKL1;POLR2C;CPSF2;GTF2F2;ELAVL1;DHX8;POLR2K;HNRNPA0;RBM22;POLR2J;UBL5;LSM6;CTNNBL1;STRAP;POLR2G;USP39;PUF60;DDX41;LSM3;COIL;SMN1;ELAVL2;SYNCRIP;TRA2B;SF3A3;HNRNPR;PPIL3;RBM8A;CPSF4;HNRNPA2B1;SNRPD3;CDC5L;POLR2H;SRSF3;DBR1;WDR83;TFIP11;HNRNPA1;RBM15B;POLR2I;DDX1;POLR2L;RBMX2;TXNL4A;GEMIN2;CSTF3;U2AF2;GPKOW
prerank,regulation of metal ion transport (GO:0010959),-0.5950985572979112,-1.6083470272406513,0.020833333333333332,0.08259552346080755,1.0,7/17,14.63%,CAMK2G;ANK2;STIM1;CACNA2D1;PLN;BCL2;CAMK2B
prerank,maturation of 5.8S rRNA (GO:0000460),0.5700793127339799,1.606295084609908,0.0425531914893617,0.06388073553717798,1.0,10/16,29.02%,WDR12;PES1;EXOSC4;PRKDC;EIF6;RPF1;MAK16;MPHOSPH6;URB1;RRP15
prerank,ncRNA catabolic process (GO:0034661),0.49626642621780626,1.605328849312014,0.047619047619047616,0.06397842036415635,1.0,11/25,18.28%,SND1;EXOSC5;POP1;EXOSC4;EXOSC8;EXOSC7;EXOSC3;DIS3;EXOSC2;DEDD2;NUDT16L1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.36672375718902095,1.605062016237399,0.0,0.06385220755497312,1.0,56/113,30.03%,IL1A;CXCL5;CXCL8;CXCL3;CXCL1;CXCL11;CXCL2;IL1B;WNT5A;DEFA6;PF4;TNFAIP3;CARD17;HMGB2;PLAA;CD80;CCL3;XBP1;MYD88;RELA;IRAK1;CXCL9;CXCL10;CXCL6;TNIP3;TGFB1;PF4V1;LYN;IL36B;TNFRSF1B;CHMP5;NOD2;CTR9;ADAM9;SERPINE1;TNFSF4;CD86;CXCL13;GIT1;NFKBIB;HMGB1;ZC3H12A;MTDH;IL36RN;TICAM1;CARD16;GSTP1;IL36G;IL37;DEFA1;IL10;IL18;TRAF6;HCK;NLRP3;CD6
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.4603050070163093,-1.60432764799327,0.016129032258064516,0.08537990467354706,1.0,19/54,15.28%,DDX17;RBFOX3;RBM5;NOVA1;RBM24;ZC3H10;CELF1;RBM25;MBNL1;RBM4;CELF4;FXR2;CELF6;RBFOX2;NOVA2;CELF2;YTHDC1;SRSF12;NSRP1
prerank,regulation of stress fiber assembly (GO:0051492),-0.4301022785032723,-1.604020227075058,0.01818181818181818,0.08517034139435094,1.0,41/71,27.14%,TSC1;TPM1;RAPGEF3;LPAR1;ASAP3;TMEFF2;FERMT2;MYOC;PXN;PHLDB2;SORBS3;PIK3R1;ARHGAP6;DLC1;CLASP1;ARHGEF10;EVL;CLASP2;PPM1F;ARHGEF15;ARHGEF18;INPP5K;TJP1;RAC1;SFRP1;RHOA;ROCK1;CCDC88A;WASF2;CGNL1;LIMCH1;TESK1;ARHGAP28;RHOC;TGFB3;FHOD1;SYNPO2L;RGCC;ALMS1;ITGB1BP1;PPM1E
prerank,glycogen metabolic process (GO:0005977),-0.5268298783408972,-1.6028883600743002,0.0,0.08555268714745105,1.0,9/26,14.53%,PYGM;GYG1;PPP1R3C;CALM1;NR1D1;GYS2;PRKAG2;AGL;UGP2
prerank,T cell migration (GO:0072678),0.5267260121800879,1.601727008535781,0.0,0.06514909797739268,1.0,12/18,28.62%,SLC12A2;CXCL11;CCL20;CCL3;CXCL16;CCL26;CXCL10;PIK3CG;MSN;ZAP70;DEFA1;PIK3CD
prerank,protein autoprocessing (GO:0016540),0.5289711638132587,1.6016723836230649,0.0,0.06488640000167739,1.0,9/16,26.15%,KLK6;F12;PCSK9;MYRF;SPRTN;FXN;MYRFL;CASP4;HTRA2
prerank,positive regulation of dendritic spine development (GO:0060999),-0.5660728622280543,-1.6010348099853298,0.016666666666666666,0.08622426673256411,1.0,12/22,17.84%,CAPRIN2;CUX2;SHANK3;NLGN1;CAMK1;PSEN1;BHLHB9;CPEB3;RELN;CAMK2B;DBN1;DLG5
prerank,neutrophil chemotaxis (GO:0030593),0.4174459271730375,1.6003766093440432,0.022222222222222223,0.06537522460432978,1.0,24/63,17.57%,CXCL5;CCL24;CXCL8;CXCL3;CXCL1;CXCL11;CXCL2;CCL20;SYK;PPIB;CCL22;PF4;TGFB2;CXADR;CCL4;CCL3;CXCL9;CCL26;CXCL10;CXCL6;CXCR2;CCL17;PIK3CG;PF4V1
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.42487215460924616,-1.6001351941397863,0.0,0.08654841811125796,1.0,33/85,16.71%,FLCN;KANK2;DENND3;SYNGAP1;RAF1;LZTR1;STARD13;DENND4B;DLC1;STARD8;NGF;MYO9B;MFN2;CADM4;SPRY1;ARHGEF18;NTRK1;OPHN1;RDX;PLCE1;DAB2IP;OGT;SPRY3;RAPGEF1;MMD2;EPOR;MADD;KANK1;DENND4A;MAPKAP1;NOTCH2;SGSM3;FGF10
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.4098032033232316,1.5997341256002449,0.0,0.06555279129664687,1.0,26/63,21.57%,POLR2F;POLR2D;EAF1;CDK7;NELFCD;GTF2H3;NCBP1;CCNK;SSRP1;NCBP2;ADRM1;POLR2C;GTF2F2;POLR2K;MLLT3;POLR2J;LEO1;POLR2G;CDK12;NELFE;CTR9;ERCC2;POLR2H;ELP4;POLR2I;POLR2L
prerank,positive regulation of protein polymerization (GO:0032273),-0.41102111143301956,-1.5996544798275587,0.0,0.08643386199575095,1.0,31/65,24.33%,LMOD1;TENM1;DCTN1;MAPT;NUMA1;CLIP1;CDC42EP3;CLASP1;FES;EVL;NCK1;FER;NCKAP1L;TPPP;FCHSD1;LMOD2;NAV3;ARL2;CDC42EP4;RAC1;SLAIN2;BAIAP2;CCL11;FCHSD2;CDK5RAP2;CCL21;TPPP3;CAV3;CDC42EP2;PINK1;OCLN
prerank,positive regulation of T cell differentiation (GO:0045582),0.44964341502169863,1.5995513169184339,0.025,0.06529162479745704,1.0,21/42,24.88%,SOX4;IL4I1;IL23A;PNP;SHH;TNFSF9;LEF1;CD46;MDK;XBP1;SOCS1;VNN1;ADAM8;IL23R;IL36B;LILRB4;IHH;TNFSF4;IL12B;ZAP70;IL12RB1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.46568489693341836,-1.5994764894445115,0.0,0.08612803429201436,1.0,15/39,15.36%,IP6K3;ITPKB;SOCS2;TTC7B;PI4KB;PIK3R1;PI4KA;PIP4K2B;FAM126A;PIK3C3;TMEM150A;PIK3R3;IP6K1;PI4K2A;PIP4K2A
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.5038815953862905,-1.5991988625547862,0.016129032258064516,0.08582537578728022,1.0,16/35,20.61%,FAM107A;KANK2;FHL1;PKD2;JADE1;ZNF655;PTEN;CDKN1A;PRMT2;APC;CDKN2C;RBL2;MYO16;DCUN1D3;SUSD2;CCL2
prerank,regulation of protein localization (GO:0032880),-0.4171028574694232,-1.5966196503602468,0.0,0.08714492348339045,1.0,32/64,27.10%,CSNK1E;ATCAY;TRIM6;DVL3;ITGB3;DZIP1L;PLEKHM2;ZDHHC7;CAMK1;MAP2;PPM1F;VIP;MMD2;MAPK8;TRIM34;CEP290;DNAJB6;VPS4A;TRIM67;FBXW7;INS;TRIM46;TESK1;SLC26A4;TRIM38;ADCYAP1;NKX3-1;USP8;MMD;WDPCP;TPR;AAK1
prerank,DNA damage checkpoint signaling (GO:0000077),0.48015231186449314,1.5965309478712095,0.0,0.06668774617206112,1.0,12/30,19.62%,CHEK1;E2F1;INTS7;PRPF19;RHNO1;CHEK2;HUS1;CLSPN;FBXO6;TIPRL;CDC5L;BRIP1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.5913670659612784,-1.5964707247614982,0.03636363636363636,0.08684015435208242,1.0,6/15,17.90%,HAP1;NGF;NGFR;NTRK1;SOS1;CASP3
prerank,rRNA methylation (GO:0031167),0.497259180749057,1.5954940341855726,0.02702702702702703,0.06694479174932698,1.0,8/19,15.56%,EMG1;FBL;TFB2M;NSUN3;TFB1M;TRMT112;MRM1;NSUN5
prerank,regulation of ion transport (GO:0043269),-0.415742875931272,-1.5951081339620763,0.016666666666666666,0.08766971726816832,1.0,20/74,12.33%,PER1;VAMP2;GDNF;KCNA5;PXK;ANK3;SPTBN4;SYT10;SNCA;P2RX7;ITGB3;KCNA2;SYT11;CHRNA3;NOS1;SYT2;SYT9;SYT6;SYT5;KCNJ8
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.4689194830097,-1.594254714211193,0.0,0.08778743327956491,1.0,22/44,25.62%,GRIK3;NLGN2;TSHZ3;ATP1A2;NLGN3;GRM6;NRXN1;SHANK3;NLGN1;LRRK2;OPHN1;MEF2C;CACNG7;RELN;CDH2;CCL2;GRM2;SYT1;DGKI;GRIK1;CLN3;GRM3
prerank,negative regulation of cellular protein localization (GO:1903828),-0.5010112724949102,-1.593432368005141,0.020833333333333332,0.08799727654632895,1.0,16/33,23.11%,FLCN;GPM6B;MAPT;TTBK2;MAP1A;ACTN2;SNX33;OTUD7B;ANKRD13A;LATS2;LEPROT;SIN3A;TAX1BP3;GOPC;CAV3;LATS1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.46174443759711825,-1.5932621824159532,0.0,0.08774077393640317,1.0,13/39,9.83%,FHL1;ANK2;FXYD6;FXYD7;WNK3;FXYD1;SCN3B;FXYD2;SCN2B;SCN1B;TRPC6;SCN4B;FGF12
prerank,positive regulation of innate immune response (GO:0045089),0.4848100866117549,1.5925881313898753,0.022222222222222223,0.06849627276712934,1.0,16/33,19.04%,EREG;POLR3C;WNT5A;AKIRIN2;NMI;DHX9;POLR3B;GBP5;NLRC5;RPS19;FPR2;ADAM8;UBE2K;POLR3G;PLSCR1;SLC15A4
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4511640190203795,1.5924902372640994,0.0,0.06822765993274844,1.0,16/40,18.72%,ENTPD7;RNASEH1;SND1;NUDT1;NUDT15;NUDT5;PNPT1;NCBP1;EXOSC7;ENTPD2;DNASE1L1;PPP1R8;RNASEH2A;XRN2;ENTPD6;RNASEH2B
prerank,regulation of myoblast differentiation (GO:0045661),-0.5069730535268476,-1.5921844237664697,0.0,0.08790256049575151,1.0,20/33,28.22%,EID2B;BOC;KLHL41;RBM24;SMYD1;ZFP36L1;MSTN;MEF2C;HIF1AN;RANBP3L;MAPK14;ANKRD2;PLCB1;DLL1;SOX8;AKIRIN1;MYF6;XKR8;BTG1;TRIP4
prerank,mitotic chromosome condensation (GO:0007076),0.5067342182699899,1.5902569168096026,0.0,0.06899021030191992,1.0,11/24,13.76%,NCAPD3;CDK1;CDCA5;SMC2;NCAPD2;SET;NCAPG;SMC4;CSNK2A1;NCAPG2;PLK1
prerank,epithelial structure maintenance (GO:0010669),0.5672057675335397,1.5886568639254133,0.0196078431372549,0.06957598300645408,1.0,9/16,24.21%,TFF2;TFF1;CXADR;VSIG1;STRAP;TFF3;NOD2;RBP4;MUC13
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.4026544167837076,1.5879589756594825,0.0,0.06998703360059094,1.0,39/86,29.26%,COX20;SDHAF4;UQCC2;SDHAF3;UQCC3;COX18;AIFM1;COA1;NDUFS6;SCO2;COA3;FOXRED1;NDUFB3;NDUFB11;NDUFA12;SLC25A33;NDUFAB1;NDUFA3;NDUFAF2;COX19;NUBPL;SAMM50;NDUFAF3;NDUFA1;NDUFB9;TMEM126A;NDUFB6;NDUFB5;NDUFB4;COX17;NDUFS3;FASTKD3;PET117;NDUFAF6;SMIM20;NDUFAF4;NDUFS1;TTC19;NDUFB7
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.5714385064538903,1.5868258984044283,0.07272727272727272,0.07035252901728906,1.0,10/18,20.50%,VPS35;CTSC;CD81;RNF128;PCSK9;EZR;GBA;VGLL4;MSN;HSP90AA1
prerank,granulocyte chemotaxis (GO:0071621),0.4122426794130859,1.5853857756172107,0.02127659574468085,0.07096852115620549,1.0,25/66,17.57%,CXCL5;CCL24;CXCL8;CXCL3;CXCL1;CXCL11;CXCL2;CCL20;SYK;PPIB;CCL22;PF4;TGFB2;CXADR;CCL4;CCL3;CXCL9;CCL26;ADGRE2;CXCL10;CXCL6;CXCR2;CCL17;PIK3CG;PF4V1
prerank,activation of adenylate cyclase activity (GO:0007190),-0.5048783911161439,-1.584659352608025,0.01818181818181818,0.09353218699401276,1.0,16/35,20.24%,ADCY5;RAF1;ADCY2;CAP2;ADRB3;ADCY4;ADRB2;ADCY9;ACR;ADORA3;AVPR2;ADRB1;ADCY6;CRHR1;P2RY11;LHCGR
prerank,actin filament organization (GO:0007015),-0.3734442913211647,-1.5840835779735758,0.0,0.09352649865705107,1.0,43/147,16.98%,CORO6;EFS;LMOD1;RND2;TPM2;FLNA;TPM1;TMOD2;ACTA1;INPPL1;GSN;MPRIP;MYO15A;TCAP;DSTN;WHAMM;RUFY3;ACTN1;TMOD1;DPYSL3;RHOB;EVL;TRIOBP;CORO7;GAS2L1;MYO5A;MYO1C;CORO1C;LMOD2;PPP1R9A;ALDOA;ABI2;FLII;ELMO2;RAC1;RHOA;ACTC1;FHOD3;PLA2G1B;ENAH;DBN1;ELMO1;BAIAP2
prerank,amino acid transport (GO:0006865),0.4404519914164509,1.58334596599658,0.0,0.07183213074467107,1.0,25/49,29.71%,SLC6A20;SLC1A5;SH3BP4;SLC1A4;SLC6A14;SLC7A1;SLC7A11;SLC38A5;SLC7A5;SLC6A6;SLC7A4;SLC3A2;SLC16A10;SLC43A2;SLC25A48;SLC7A7;SLC7A8;SLC6A18;SLC7A6;SLC38A8;SLC38A9;SLC38A7;SLC6A12;SLC38A10;SLC38A3
prerank,positive regulation of interferon-gamma production (GO:0032729),0.4015389161369066,1.58285110545186,0.02,0.0717674411190876,1.0,28/56,30.16%,HSPD1;IL23A;ZP3;CD276;IL1B;SLC7A5;IL21;TRIM27;ZFPM1;CEBPG;ISG15;IL23R;TNFSF4;IL12B;CRTAM;CD2;IL12RB2;SCRIB;IL12RB1;CLEC7A;CD244;SLAMF6;IL18;TLR7;RASGRP1;BTN3A2;IFNL1;TLR8
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.4599913675285587,-1.5823953119821854,0.014705882352941176,0.09484062554750014,1.0,19/36,27.00%,CDH19;CDHR3;NLGN1;DCHS1;CDH23;CDH10;PCDHB4;PCDHB6;PCDHB5;PCDHGC3;PCDHB3;CDH5;CDH8;PCDHB2;PCDHB10;CDH20;SELP;PCDHB14;CDH13
prerank,mRNA modification (GO:0016556),0.5515008051326988,1.582262277275618,0.02127659574468085,0.07178671635581549,1.0,10/21,15.40%,DKC1;PUS7;TRMT10C;PUS1;TRUB2;TRUB1;TRMT6;RPUSD2;TRMT61B;NSUN2
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.5567439688683432,-1.5809682512219467,0.05555555555555555,0.09546258102533883,1.0,9/17,22.89%,HAND2;AKAP6;PDE9A;MEF2A;PRKCA;ROCK1;CAMK2D;NR4A3;TRPC3
prerank,determination of heart left/right asymmetry (GO:0061371),-0.44975689622779996,-1.5804735835642956,0.0,0.09558275421939118,1.0,20/46,19.83%,NPHP3;PKD2;DAND5;SRF;BBS4;BBS5;CCDC39;NDRG4;CCDC40;HAND1;MEGF8;FOXN4;SOX17;MEF2C;TBX2;BBS7;AHI1;SMO;SOX18;DLL1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.4786290849667315,-1.5793205154340233,0.01818181818181818,0.096195068728164,1.0,13/33,15.39%,PTPRM;ADGRB1;NR2F2;EVL;SLIT2;PTEN;DCN;CORO1C;MCC;SYNJ2BP;DAB2IP;KRIT1;ADAMTS9
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5605854385093163,1.5791047722669296,0.0,0.07313635341873302,1.0,10/19,28.38%,IL23A;TNFSF9;RPS3;IL27RA;IGFBP2;IL23R;HMGB1;IL12B;IL12RB1;IL18
prerank,negative regulation of autophagy (GO:0010507),-0.4335754367028395,-1.5774244050358834,0.02,0.0969799853053115,1.0,23/55,24.80%,NRBP2;TSC1;SNRNP70;MTMR9;SNCA;WDR6;TAB2;ZKSCAN3;BCL2;KLHL22;LRRK2;SIRT2;RASIP1;LEPR;HTR2B;NUPR1;EIF4G3;GOLGA2;SMG1;MTOR;HGF;PINK1;RRAGA
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.5008912811673379,-1.5771851568073614,0.016666666666666666,0.0969578851015732,1.0,12/33,11.05%,MYH7;TPM1;MYL2;TGFBR3;BMPR1A;MYH6;SMAD4;FGFR2;ZFPM2;RBPJ;HAND1;RYR2
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5761627310289855,-1.5762009740380363,0.02040816326530612,0.09715700868669305,1.0,6/18,15.24%,DDX17;EGLN2;PPARGC1B;RBFOX2;AR;ESR1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.5786189422344251,-1.5758325969023557,0.058823529411764705,0.09704629204695736,1.0,7/15,10.76%,ST8SIA1;ST6GALNAC3;A4GALT;ST8SIA3;ST3GAL5;B4GALNT1;ST8SIA5
prerank,polyol metabolic process (GO:0019751),-0.4335274048533234,-1.57563831960512,0.0,0.09680527441386218,1.0,14/47,14.15%,INPP5B;IP6K3;PLCD4;ITPKB;INPP5A;INPP4A;INPPL1;SYNJ1;CALM1;NUDT10;NUDT11;PTEN;PLCE1;IP6K1
prerank,phospholipid dephosphorylation (GO:0046839),-0.5049553131955972,-1.5748945488980108,0.03636363636363636,0.09713303093676823,1.0,7/26,12.70%,INPP5B;MTMR9;SYNJ1;MTMR10;INPP5F;PTEN;INPP5K
prerank,protein localization to cell junction (GO:1902414),-0.515023554713798,-1.572552528107781,0.017543859649122806,0.09862876385807384,1.0,10/21,20.57%,JAM3;NLGN2;FERMT2;DLG4;NLGN1;ARHGEF18;TJP1;BSN;CGNL1;HEG1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.4737812171792413,-1.5720620537359737,0.0,0.09864274840649648,1.0,11/33,6.26%,GSTM2;AKAP6;JPH2;PKD2;TRPC1;CASQ1;CAPN3;HAP1;GPER1;CALM1;SNCA
prerank,axon development (GO:0061564),-0.41723352497850485,-1.5714017735736718,0.0,0.09857066505872196,1.0,34/78,18.60%,APBB1;S100B;BRSK1;PLP1;MAPT;DSCAML1;ZDHHC17;MAP1A;SLITRK2;MAP1B;ANK3;SPTBN4;ADGRB1;FGFR2;MTR;AMIGO1;L1CAM;NEFH;PARD3;GAP43;SLITRK3;MAPK8IP3;NTNG1;TAOK2;SLITRK5;ISL2;RAB3A;KLF7;ATL1;CNTN4;BAIAP2;CAMSAP2;RTN4;DCC
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.5283610854127073,1.571360175635881,0.021739130434782608,0.07691967132016911,1.0,13/20,28.28%,HPRT1;ADK;POLD2;DCK;PNP;APRT;DGUOK;POLD1;AMPD2;CDA;TERT;AMPD3;POLD3
prerank,neuron migration (GO:0001764),-0.44802528916779394,-1.570980312600553,0.0,0.09858478909650807,1.0,27/49,25.12%,FGFR1;MAP1B;DNER;PAFAH1B1;PHOX2B;CEP85L;GPM6A;MDGA1;ADGRL3;NAV1;ASTN1;MEF2C;ASTN2;MARK1;RAC1;FGF13;RELN;DISC1;SEMA3A;SPOCK1;RAPGEF2;TUBB2A;DCX;CDKL5;CCK;TUBB2B;POMGNT2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.5365118188867458,-1.5706448304250373,0.0,0.09868392871268118,1.0,12/28,16.20%,CAMK2G;BRSK1;NCS1;PSEN1;PTEN;NTNG1;NDEL1;EFHC2;MARK1;DISC1;IL1RAPL1;CCDC88A
prerank,cellular calcium ion homeostasis (GO:0006874),-0.38940502799916576,-1.5699906765268998,0.018518518518518517,0.09878215879109122,1.0,39/128,15.78%,TPCN2;DMPK;PTH1R;ATP2B4;ANK2;HRC;TRPC1;CCL14;SCGN;STIM1;SLC8A2;GPER1;PLN;SLC24A4;MICU3;RYR1;TMEM178A;SLC8A1;CDH23;ELANE;PRKACA;BCL2;PSEN1;TRPC6;TRPC4;CAV2;SLC24A3;NPTN;CTRC;RYR2;ANXA6;ATP2B3;SLC8A3;PACS2;CSRP3;TRDN;RGN;HTR2B;CAMK2D
prerank,regulation of telomerase activity (GO:0051972),0.4312052108322557,1.5683191488399737,0.0,0.07840492691685827,1.0,22/46,25.30%,DKC1;MYC;CCT2;XRCC5;NABP2;NEK2;AURKB;NAF1;PARP4;PTGES3;WRAP53;MAPK15;GRHL2;CCT4;TCP1;HSP90AB1;HSP90AA1;MAPKAPK5;MEN1;TP53;CTNNB1;PRKCQ
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.4135399076914553,1.5682156702244672,0.0,0.07811127550518465,1.0,16/50,15.57%,GNL3L;CCT6A;CCT2;CCT3;XRCC5;CCT8;CCT7;NAT10;NEK2;AURKB;FBXO4;NAF1;HNRNPC;MAPK15;CCT4;TCP1
prerank,synaptic vesicle membrane organization (GO:0048499),-0.5576864372098262,-1.567894527184352,0.0196078431372549,0.09989190979584726,1.0,6/17,10.32%,PRRT2;SYNGR1;STX1B;STX2;SYP;SNAP25
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3400592285830987,1.5669861427110836,0.0,0.07855705587953278,1.0,100/246,22.05%,POLR2F;POLR2D;CSTF2;CPSF3;ALYREF;SNRPF;SNRPD1;PRPF19;LSM7;LSM5;PABPC1;HNRNPF;PPIH;LSM4;SNRPG;SF3B3;U2AF1;CSTF1;MAGOH;PRPF4;PPIL1;SNRPB;RNF113A;SNRPC;EFTUD2;MAGOHB;LSM8;EIF4A3;PHF5A;SNRPD2;NCBP1;SNRPE;DDX39A;SRSF9;SF3B6;PTBP1;NONO;RALY;RSRC1;SNRNP40;BUD31;SNRPB2;RBM15;HNRNPK;DHX9;NUDT21;SF3B5;PRPF40A;PRPF6;LSM2;CLP1;SNRPA1;GEMIN6;NCBP2;PSPC1;HNRNPC;FUS;CRNKL1;POLR2C;CPSF2;GTF2F2;ELAVL1;DHX8;POLR2K;HNRNPA0;RBM22;POLR2J;UBL5;LSM6;CTNNBL1;POLR2G;USP39;PUF60;DDX41;LSM3;ELAVL2;SYNCRIP;TRA2B;SF3A3;HNRNPR;PPIL3;RBM8A;CPSF4;HNRNPA2B1;SNRPD3;CDC5L;POLR2H;SRSF3;DBR1;WDR83;TFIP11;HNRNPA1;RBM15B;POLR2I;POLR2L;RBMX2;TXNL4A;CSTF3;U2AF2;GPKOW
prerank,inorganic cation transmembrane transport (GO:0098662),-0.34985937057408617,-1.5666988714100492,0.0,0.09994176371274477,1.0,94/268,23.42%,PKD1;RYR3;CACNA1H;SCNN1D;KCNB1;ATP2B4;KCNQ4;SLC25A27;CACNA1C;UCP3;KCNN3;ASIC3;ATP1A2;SLC6A16;KCNA5;TRPV1;PKD2;SCN7A;TRPC1;KCNK3;SCN3B;SLC9A9;SCARA5;SCN9A;ABCC8;SLC8A2;SCN4A;SLC39A13;SLC24A4;KCNH2;SCN11A;SCN2B;P2RX7;SCN1B;KCNA2;SLC8A1;KCNK4;ATP1A4;KCND1;TRPC6;KCNE2;SCN4B;TRPC4;SLC24A3;ATP1A3;ABCC9;KCNA1;CACNA1G;KCNAB3;SLC30A8;SLC8A3;KCNJ8;LRRC55;SCN3A;SCNN1B;RHAG;SLC41A1;KCND3;KCNE1;MCOLN3;TRPV3;TMEM175;KCNQ5;SLC30A4;MCOLN1;KCNA4;SCNN1G;KCNC1;KCNJ1;SLC6A1;SLC6A17;CACNA1A;ATP6V1B1;ATP4A;KCNK2;OTOP2;SLC9A5;KCNS2;SCN5A;KCNN1;HCN3;KCNS3;KCNK7;KCNF1;SLC6A15;KCNH5;LRRC52;TRPC3;ANO6;ASIC4;TRPM7;KCNG1;KCNH1;KCNK6
prerank,placenta development (GO:0001890),0.5716737849246838,1.5639094271224856,0.02,0.080754160043066,1.0,8/15,21.06%,ASCL2;PHLDA2;PLAC1;E2F8;PPARG;TEX19;ANG;E2F7
prerank,calcium ion import into cytosol (GO:1902656),-0.575154689389917,-1.5635432290462088,0.019230769230769232,0.10229029445438803,1.0,7/15,14.21%,ATP2B4;TRPV1;CACNA2D1;SLC8A2;SLC8A1;SLC8A3;TRPV3
prerank,cilium organization (GO:0044782),-0.35632554450640963,-1.5630557827216134,0.0,0.10212082556067198,1.0,102/210,28.89%,TTLL3;NPHP3;PKD1;FLNA;IFT80;WDR19;RFX2;PKD2;GSN;DZIP1;CNGB1;TTBK2;RABL2B;CEP126;INTU;EHD2;IFT81;BBS4;CYS1;BBS5;DYNC2H1;WDR11;HDAC6;DZIP1L;STK36;INPP5E;CFAP44;CCDC66;EXOC7;BBS1;CC2D2A;FBF1;PARVA;CFAP54;TEKT2;NEK1;ABLIM3;RAB23;PTPDC1;CEP164;CEP162;EXOC3;CCDC57;BBS2;MARK4;DISC1;TEKT3;RILPL1;CLUAP1;CFAP70;PCM1;GBF1;BBS7;RAB11FIP3;CEP290;ARMC9;BBS9;TXNDC15;PCNT;IFT122;AHI1;TMEM138;CDC14A;ARL3;RTTN;RPGR;FUZ;FAM161B;RAB8B;WDR35;CNGA4;CEP89;RFX3;UBXN10;RHO;IFT46;KIF3A;ARL6;BBIP1;TRAF3IP1;TTC8;CDC14B;WDPCP;EXOC1;KIFAP3;IFT43;ABCC4;IQCG;SPAG16;CCP110;CFAP61;ROPN1;ASAP1;IFT172;OCRL;IFT140;PTPN23;CEP19;CCDC28B;UNC119B;ATAT1;NME8
prerank,neural crest cell development (GO:0014032),-0.45542715293163966,-1.5623871717374016,0.03508771929824561,0.10245000558758699,1.0,23/44,24.27%,GDNF;SEMA6C;RADIL;TAPT1;TBX1;SEMA4C;SEMA3E;NRTN;CORO1C;ANXA6;SEMA6D;SEMA6A;SEMA3B;CDH2;HTR2B;SEMA3G;SEMA3A;SOX11;ERBB4;SEMA3C;SOX8;FAM172A;SNAI2
prerank,mitotic nuclear division (GO:0140014),0.4093390380512699,1.5623586897389707,0.0,0.08147143072516207,1.0,29/68,17.37%,RAN;DSN1;KIF2A;MZT1;KIF18A;KNSTRN;UBE2S;CHEK2;ZWINT;NDC80;CENPK;SMC4;SPAG5;RAB11A;KIF3B;UBE2C;ZW10;SPAST;TPX2;NSL1;NCAPG2;KPNB1;PLK1;SMC1A;TUBG1;NUP62;BCCIP;KIF18B;ESPL1
prerank,protein import (GO:0017038),0.39092804044797114,1.5620732377754931,0.0,0.08137332009090611,1.0,26/87,15.21%,RAN;CSE1L;NXT2;NUP155;E2F3;NUP62CL;NUP93;NUTF2;SYK;PEX13;SEC13;ACBD5;TOMM22;LAMP2;NXT1;NUP50;NUP88;HSPA4;NUP107;TNPO3;HEATR3;KPNB1;SLC25A17;PEX16;MMP12;NUP62
prerank,regulation of exit from mitosis (GO:0007096),0.45636111860194045,1.5619140308748984,0.0,0.08115486442710397,1.0,18/39,19.74%,MAD2L1;CDCA5;UBE2S;BUB3;NEK2;ANAPC1;MAD2L1BP;UBE2C;ZW10;CDC26;ANLN;ANAPC11;UBA52;NPM2;KNTC1;CDC20;BUB1B;UBE2D1
prerank,cellular response to cAMP (GO:0071320),-0.4871345130311298,-1.561669540629342,0.0,0.10265251908355488,1.0,14/30,20.49%,PDE2A;AKAP6;RAPGEF3;PKD2;RAP1A;ZFP36L1;AQP1;INPP5K;RAPGEF1;KCNE1;IGFBP5;CRHBP;RAPGEF2;HCN3
prerank,translesion synthesis (GO:0019985),0.4518519563077177,1.5611630224820008,0.0,0.08150091633870346,1.0,19/40,22.28%,RFC3;RPA3;RFC5;POLE2;RFC2;POLD2;POLH;USP10;POLDIP2;UBA52;VCP;RPA2;ISG15;POLD1;SPRTN;UBE2L6;RFC4;DTL;USP43
prerank,skeletal system morphogenesis (GO:0048705),-0.4536868597662426,-1.5610535976364908,0.0,0.10264793658638584,1.0,20/39,22.94%,FGFR1;DSCAML1;PDGFRA;HOXD3;FGFR2;HOXA4;HOXB4;MEGF8;HOXB3;SKI;CYP26B1;HOXD4;HOXD9;ANKRD11;SOX11;FUZ;OSR2;LRP6;HOXC4;SPEF2
prerank,long-term memory (GO:0007616),-0.5641719588686668,-1.5606292076475932,0.047619047619047616,0.10276602713290116,1.0,7/18,15.89%,NFATC4;SLC2A4;NPAS4;PJA2;PRNP;CPEB3;KAT2A
prerank,mitochondrial transport (GO:0006839),0.43967747024889625,1.5604008692292988,0.0,0.08164413776612411,1.0,24/53,22.19%,TOMM34;TIMM23;BCAP31;TOMM40;TIMM10;PMAIP1;TIMM13;TOMM22;TOMM20;BCL2L1;COX18;TIMM17B;TIMM8B;PPIF;TSPO;SLC25A24;SLC25A5;MTX2;TMEM14A;BAK1;HSP90AA1;SLC25A13;SLC25A6;TIMM17A
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.48739376644596627,1.5603110248600291,0.0,0.08142708046347172,1.0,14/27,24.32%,ALG8;ALG11;ALG2;GCNT1;TPI1;TKT;GK;ST8SIA6;B3GNT5;G6PD;ALG6;B4GALT5;GAL3ST2;RRM2
prerank,cell junction organization (GO:0034330),-0.41542113797262464,-1.5586458449580662,0.0,0.10406330240803954,1.0,26/72,13.03%,LIMS2;NLGN2;FLNA;FLNC;MAPT;CTNND2;NLGN3;FERMT2;MYOT;NLGN4X;SLC8A2;ILK;SNCA;MYO9A;L1CAM;SNCB;SDK1;PSEN1;PPFIA4;SEMA3E;SNCG;CBLN2;OPHN1;PPFIBP1;SLC8A3;TJP1
prerank,positive regulation of telomerase activity (GO:0051973),0.4715349938684558,1.5585128262851236,0.0,0.08220586141739293,1.0,16/34,21.13%,DKC1;MYC;CCT2;XRCC5;NEK2;AURKB;NAF1;PTGES3;WRAP53;MAPK15;GRHL2;CCT4;TCP1;HSP90AB1;HSP90AA1;MAPKAPK5
prerank,basement membrane organization (GO:0071711),-0.5936541079556091,-1.5582668903595485,0.0,0.10380947902670547,1.0,11/16,27.34%,LAMB2;NID1;NTNG1;LAMB1;LAMB4;FLRT2;PXDN;NTN4;RAMP2;CTSS;CMA1
prerank,positive regulation of viral genome replication (GO:0045070),0.48481334308330026,1.5582088183251241,0.02127659574468085,0.082107224548889,1.0,10/29,16.13%,HACD3;PABPC1;PPIH;SRPK1;PDE12;STAU1;TARBP2;DDB1;TMEM39A;TOP2A
prerank,glutamate receptor signaling pathway (GO:0007215),-0.4452278236651006,-1.5579183132930436,0.017241379310344827,0.10355787244346167,1.0,19/36,25.62%,GRIK3;KCNB1;GRM6;GRIA4;GRIK2;GRIA3;GRIA2;HOMER2;HOMER3;GNAQ;GRIN2A;PLCB1;GRM2;CPEB4;GRID2;GRIN2C;GRIK1;CLN3;GRM3
prerank,cell-matrix adhesion (GO:0007160),-0.4011705755545391,-1.557854382202641,0.0,0.1031477874080239,1.0,35/95,17.13%,PKD1;ITGA7;TSC1;ITGA10;SORBS1;FBLN5;VCL;FERMT2;LYVE1;ACTN2;SGCE;ACTN3;WHAMM;THBS3;HOXD3;ILK;ITGB3;ACTN1;CD34;L1CAM;DLC1;SIGLEC1;EMILIN1;TAOK2;TIAM1;RAC1;ADAMTS13;TMEM8B;PEAK1;ARHGEF7;ADAMTS9;THSD1;COL13A1;CD63;BCAM
prerank,potassium ion transmembrane transport (GO:0071805),-0.37721075495880396,-1.5575466156690256,0.0,0.10298120910777021,1.0,55/136,24.97%,KCNB1;ATP1B2;KCNQ4;KCNN3;ATP1A2;KCNA5;PKD2;SLC12A4;KCNK3;SLC9A9;ABCC8;FXYD2;KCNIP2;SLC24A4;KCNH2;KCNA2;KCNK4;ATP1A4;KCNT2;KCND1;KCNE2;SLC24A3;ATP1A3;ABCC9;KCNA1;KCNAB3;KCNJ8;LRRC55;KCND3;KCNE1;TMEM175;KCNQ5;KCNA4;KCNC1;KCNJ1;ATP4A;KCNK2;SLC9A5;KCNS2;KCNE4;KCNJ9;KCNN1;HCN3;KCNS3;KCNK7;KCNF1;KCNH5;LRRC52;KCNG1;KCNH1;KCNK6;KCNJ5;KCNN2;HCN2;LRRC38
prerank,error-prone translesion synthesis (GO:0042276),0.5153784652230686,1.5564041510523705,0.02631578947368421,0.08295692519181545,1.0,6/21,2.67%,RFC3;RPA3;RFC5;POLE2;RFC2;POLH
prerank,cytoskeleton organization (GO:0007010),-0.40272301467838495,-1.5562035877867333,0.0,0.10361247323189585,1.0,59/113,25.31%,ZNF135;MICAL3;ARHGAP10;RND2;ZMYM6;PALLD;TPM1;LRCH3;SYNE3;CNTNAP1;DES;WTIP;PACSIN1;RHOB;EPB41L3;CDC42BPB;OBSL1;WASF3;KLHL20;MAST2;MAST4;PPP2R3C;DST;FGD1;MAST1;KRT25;PLCE1;ABI2;RANBP9;MARK1;SEMA6A;RAC1;RHOA;PACSIN2;ZMYM3;RANBP10;SIPA1;PACSIN3;CAPZB;CCL11;DPYSL2;PLD2;ZRANB1;FGD2;CECR2;PHIP;CCL2;RHOBTB1;STRIP1;BRWD1;FMNL3;FMNL2;RHOU;LIMD1;FGD5;RHOC;ARC;WDPCP;ARAP3
prerank,sphingosine metabolic process (GO:0006670),0.5522513760616625,1.5561020326803694,0.044444444444444446,0.08281696043870299,1.0,6/16,14.82%,SPTLC1;SGPP2;SPTLC2;ASAH2B;GBA;ACER2
prerank,negative regulation of cell cycle process (GO:0010948),0.3848266145281071,1.5530015175661254,0.0,0.08503014324133282,1.0,30/61,27.58%,NME6;CHEK1;E2F1;TFDP1;CBX3;FBXO5;TOM1L1;NEK2;AURKB;CHMP4C;RNF2;UXT;RBBP8;BMP7;BRCA1;BMP4;E2F8;DMRT1;ESPL1;CDC7;E2F7;SUZ12;EZH2;RBBP7;AURKAIP1;RRM2;CHMP2A;EED;FBXO43;CBX5
prerank,cellular response to metal ion (GO:0071248),-0.3712303098321128,-1.5527793586009968,0.0,0.10606219198786433,1.0,52/126,23.71%,RYR3;CACNA1H;ADD1;RASGRP2;ITPKB;PKD2;DLG2;CAPN3;ANK3;MEF2A;CARF;DLG4;SYT10;RYR1;SNCA;NLGN1;PRNP;SYT11;CLIC4;CYP11B1;LRRK2;PRKAA2;KCNA1;SYT2;SYT9;SYT6;SYT5;MEF2C;AQP1;MAPK1;MAPK3;SLC41A1;MT1X;MCOLN1;BRAF;MAPK8;CAMK2D;ZNF658;CRHBP;CPNE8;EGFR;CPNE4;SCN5A;BNIP3;MT1M;B2M;ACER1;SYT1;CPNE6;PLCG2;KCNH1;SYT3
prerank,DNA geometric change (GO:0032392),0.5033707315825522,1.5524943132543356,0.02857142857142857,0.08504004849010699,1.0,8/25,8.44%,BLM;HMGB3;ZRANB3;RECQL4;ASCC3;HMGB2;DNA2;DHX9
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.5043099842196239,1.552183562781991,0.023255813953488372,0.0850109590570872,1.0,11/28,14.82%,SPTLC1;CYB5B;NQO1;SPTLC2;GCHFR;ASAH2B;NOS2;GCH1;SPR;GBA;ACER2
prerank,lymphocyte chemotaxis (GO:0048247),0.43912021531740086,1.5518567979163953,0.0,0.08505964898238103,1.0,15/39,17.07%,SLC12A2;CCL24;CXCL11;CCL20;CCL22;CCL4;CCL3;CXCL16;CYP7B1;CCL26;CXCL10;HSD3B7;ADAM8;CCL17;PIK3CG
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.4541782849514161,-1.5516627262197178,0.020833333333333332,0.10675385404984128,1.0,15/39,16.81%,PER1;TRIM39;MAPKBP1;ZMYND11;RORA;NR1D1;CARD8;OTUD7A;OTUD7B;DAB2IP;PPM1A;PPM1B;ESR1;TLE1;NLRX1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.45995997588169335,1.5502684422073556,0.02040816326530612,0.08564910044607785,1.0,17/44,16.85%,MIA2;PDIA4;CANX;RAB15;CTAGE9;RAB10;RAB8A;MTTP;RAB3D;COPG1;COPG2;CTAGE8;CTAGE4;CTAGE6;CTAGE15;STEAP3;PREB
prerank,regulation of RNA splicing (GO:0043484),-0.40905383299621934,-1.5487734642985043,0.01818181818181818,0.10928729248473931,1.0,24/74,11.64%,RBM20;CLK4;PTBP2;AHNAK;SNRNP70;CLK1;PRX;PIK3R1;CLK3;CELF1;CLK2;MBNL1;HNRNPH3;AKAP17A;QKI;AHNAK2;RBM38;DYRK1A;SF1;SON;TIA1;JMJD6;HABP4;YTHDC1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.47734204686414416,-1.5486731913629306,0.01818181818181818,0.10894164693555958,1.0,14/32,15.05%,TPM1;CNN1;GPER1;PRKG1;NDRG4;MFN2;APOD;PTEN;EFEMP2;OGN;VIP;MEF2C;CDKN1A;IGFBP5
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.5143490530334787,1.5470729450959977,0.0,0.08789054754876449,1.0,8/20,12.31%,CCT2;HSPD1;PSMG1;PSMG3;PFDN6;PTGES3;HSPA4;LONP1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.5043487926487235,1.546598658782868,0.0,0.08789027821519148,1.0,12/26,21.57%,POLR2F;POLR1C;CDK7;POLR1B;GTF2H3;TAF1A;POLR1A;TAF1B;POLR2K;ERCC2;POLR2H;POLR2L
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5668830415969716,1.5453893513664578,0.023809523809523808,0.0885019516515171,1.0,9/15,24.21%,TFF2;TFF1;SOX9;VSIG1;STRAP;TFF3;NOD2;RBP4;MUC13
prerank,regulation of blood coagulation (GO:0030193),0.5012382417572758,1.5431452919539042,0.0,0.09002410150300935,1.0,13/23,26.64%,FAP;F12;EPHB2;THBD;FOXA2;PROC;HPSE;F2R;SERPINE1;CAV1;THBS1;KNG1;SERPINE2
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.34903932436138824,-1.542340263024493,0.0,0.11452391304713985,1.0,59/191,17.85%,PER1;PDE2A;FLCN;BCL2L2;EPM2A;TSC1;TRIM39;ATP2B4;MAPKBP1;SFRP5;ARNTL;PPP2R5B;HDAC7;MAGI2;ITPR1;PDE3B;DUSP3;GPER1;WTIP;PDE4D;ZMYND11;RORA;P2RX7;NR1D1;BCL2;TNFAIP8L1;SLIT2;PPEF2;PTEN;CARD8;PHLDA3;OTUD7A;MSTN;PRKAA2;OTUD3;PDE3A;DGKG;PRDM15;OTUD7B;C1QTNF3;WWC2;UBR2;INPP5K;DAB2IP;PPM1A;SPRY3;PPM1B;UBR1;ESR1;WWC3;TLE1;PHLPP2;MYADM;NLRX1;TSC2;MAPK14;DEPDC5;DLG5;MARK3
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.5053254536489331,1.5420163846675152,0.07547169811320754,0.09051021355710125,1.0,13/22,21.98%,MAD2L1;FBXO5;ZWINT;BUB3;TRIP13;ZW10;BUB1;PLK1;CENPF;KNTC1;CDC20;BUB1B;TTK
prerank,regulation of protein kinase A signaling (GO:0010738),-0.5613737900597693,-1.5418731696801575,0.0,0.11439206815465176,1.0,7/19,11.62%,AKAP6;AKAP12;ADRB2;PJA2;LRRK2;PRKAR2B;MC1R
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.46191216755764436,1.5409395075540488,0.0,0.09087942115114737,1.0,11/40,7.17%,RFWD3;ALYREF;EME1;TIPIN;TIMELESS;TRAIP;BLM;MMS22L;ZRANB3;MSH3;TONSL
prerank,positive regulation of macroautophagy (GO:0016239),-0.44384088270536354,-1.5409238161734864,0.01694915254237288,0.11495709919126375,1.0,22/50,21.13%,EPM2A;HSPB8;SLC25A4;FYCO1;GPSM1;VPS13D;CALCOCO2;ADRB2;PIP4K2B;PRKAA2;DCN;OPTN;UVRAG;WAC;BAG3;PIP4K2A;LRSAM1;TSC2;RAB3GAP1;SIRT1;BNIP3;MAP3K7
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.5777160684823476,-1.5394558690269968,0.02040816326530612,0.11590235139810291,1.0,8/16,14.34%,TPM1;CNN1;GPER1;PRKG1;PTEN;EFEMP2;MEF2C;CDKN1A
prerank,protein polymerization (GO:0051258),-0.42521639629758046,-1.5386378252051036,0.01639344262295082,0.1163030936277117,1.0,16/52,14.17%,FAM107A;GSN;CASQ1;MAPT;GAS7;TRIM6;CHMP3;ARHGAP6;CASQ2;WASF1;MAP7D3;WASF3;CORO7;TPPP;RAC1;FGF13
prerank,sodium ion transmembrane transport (GO:0035725),-0.4012809456055487,-1.5380893380424778,0.0,0.11650964967582009,1.0,32/87,20.49%,SCNN1D;ATP1B2;ASIC3;ATP1A2;SLC6A16;PKD2;SCN7A;SCN3B;SLC9A9;SCN9A;FXYD2;SLC8A2;SCN4A;SLC24A4;SCN11A;SCN2B;SCN1B;SLC8A1;ATP1A4;SCN4B;SLC24A3;ATP1A3;SLC8A3;SCN3A;SCNN1B;SCNN1G;SLC6A1;SLC6A17;ATP4A;SLC9A5;SCN5A;HCN3
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.43613814347691937,-1.5371996812685635,0.0,0.11705666546277112,1.0,16/44,20.16%,LMOD1;TENM1;GSN;WHAMM;CDC42EP3;EVL;NCK1;FER;NCKAP1L;FCHSD1;LMOD2;CDC42EP4;BAIAP2;CCL11;FCHSD2;CCL21
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.5702574989115734,1.53671772708222,0.06666666666666667,0.09388653207370597,1.0,12/17,23.73%,ALG1;ALG8;SRD5A3;ALG3;ALG2;ALG14;DOLK;DPAGT1;MPDU1;ALG6;NUS1;DOLPP1
prerank,lamellipodium assembly (GO:0030032),-0.49699363679203024,-1.536417126948391,0.0,0.11729630196318075,1.0,11/25,16.20%,VCL;WHAMM;ARHGEF6;KIT;SRGAP2;S1PR1;ABLIM3;P2RY12;RAC1;ARHGEF7;CCDC88A
prerank,regulation of translation (GO:0006417),0.3372706361617298,1.5354314554595563,0.0,0.0942040567106526,1.0,53/168,16.82%,SOX4;ENC1;CALR;CAPRIN1;SHMT2;PUS7;GZMB;DHFR;MRPL13;EIF3C;GAPDH;NOLC1;IGF2BP1;NCL;NSUN3;NAT10;EIF4A3;NCBP1;PRKDC;YTHDF1;NANOS3;IGF2BP3;RPS3;CNOT10;MTIF2;GRB7;IGF2BP2;RPS4X;EIF6;DHX9;GLE1;TRAP1;EIF4E;EIF4E2;NCBP2;GSPT1;EIF3D;TRIM71;ELAVL1;OGFOD1;METAP1;EIF3B;EIF3H;MALSU1;NPM1;PKP3;LARP4B;RBM3;MTG2;NSUN5;CNOT1;EIF3E;SYNCRIP
prerank,rRNA catabolic process (GO:0016075),0.5387033232025035,1.5312738483754316,0.06976744186046512,0.0972916837147827,1.0,8/16,15.74%,EXOSC5;EXOSC4;EXOSC8;EXOSC7;EXOSC3;DIS3;EXOSC2;DEDD2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.36810496832991224,1.529752470473462,0.02127659574468085,0.09796882296658863,1.0,49/130,20.05%,CDH3;SOX4;RUVBL1;PSMD14;COL1A1;PSMB2;PSMB9;PSMA5;LGR5;PSMB3;PSME3;PSMA3;PTK7;PSMA7;PSMD13;AXIN2;LGR6;GID8;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;JUP;PSMB5;BAMBI;XIAP;PSMD8;NRARP;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;SEMA5A;PSMF1;PSMD11;PSMD1;GSKIP;VCP;TMEM9;SCEL;TGFB1;SFRP4;ATP6AP2;PSMD6;AXIN1;PSMD5;CAV1
prerank,cellular response to hypoxia (GO:0071456),0.3552672456400718,1.5288269772606975,0.022222222222222223,0.09815765291164101,1.0,37/127,14.43%,PSMD14;MYC;SUV39H2;CA9;PSMB2;TBL2;PSMB9;PSMA5;P4HB;PSMB3;VHL;PSME3;SUV39H1;PSMA3;HYOU1;PSMA7;PMAIP1;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;PSMB5;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;BMP7;PSME1;PSMF1;AQP3;PSMD11;UBA52;GATA6;PSMD1
prerank,synaptic vesicle cycle (GO:0099504),-0.4688839379986303,-1.5274169319060933,0.04,0.12477380406037374,1.0,14/30,21.86%,VAMP2;PIP5K1C;BRSK1;SLC17A7;CPLX3;SYT10;SNCA;NLGN1;SNAP25;RAB3A;PLD2;SNAPIN;RIMS1;SLC17A8
prerank,ceramide catabolic process (GO:0046514),0.5464025183773221,1.5264053359266532,0.05263157894736842,0.10008812731352726,1.0,6/16,14.82%,NEU1;HEXB;GLA;ASAH2B;GM2A;ACER2
prerank,microtubule depolymerization (GO:0007019),0.5220860326921796,1.5263550431398947,0.022222222222222223,0.09978808880327418,1.0,9/18,16.26%,KIF24;KIF2A;KIF18A;STMN1;KIF14;KATNB1;KIF2C;CKAP5;KIF18B
prerank,microtubule nucleation (GO:0007020),-0.5435194411385491,-1.5240659882039742,0.0,0.1273835856954954,1.0,11/20,18.43%,TUBG2;TUBGCP6;CLASP1;CLASP2;TPPP;CCDC57;NDEL1;RANBP9;SLAIN2;TUBGCP5;CSNK1D
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.3681292935238086,-1.5228343716086403,0.0,0.12780291473040986,1.0,70/161,24.76%,PKD1;MPZ;IGSF11;PALLD;PLXNB3;TRO;TENM1;KIRREL3;CDH19;ROBO3;CNTN2;DSCAML1;CDHR3;PTPRS;MYOT;PTPRM;NEXN;SLITRK2;CADM3;CLDN11;CLDN5;LRFN5;NLGN1;AMIGO1;DCHS1;L1CAM;CDH23;UNC5D;LRRC4B;SDK1;ADGRL3;SLITRK3;OBSL1;FAT4;NTNG1;CDH10;NPTN;PCDHB4;LRRC4C;CADM1;CRB1;TENM3;MAG;PCDHB6;CDH2;CNTN4;PCDHB5;IL1RAPL1;HMCN1;ROBO4;DSCAM;AMIGO2;PCDHGC3;CNTN6;ADGRL1;TENM2;SLITRK1;PCDHB3;CDH5;PTPRT;GPC6;CDH8;PCDHB2;GRID2;PCDHB10;CDH26;CELSR2;CDH4;CDH20;FAT2
prerank,positive regulation of immune effector process (GO:0002699),0.4519398594857044,1.522707556924094,0.05128205128205128,0.10166330121031557,1.0,15/31,28.33%,IL23A;PHB;IL1B;CD46;CD81;XBP1;RPS19;IL23R;MYB;TNFSF4;IL12B;IL12RB1;PTPRJ;IFNG;IL10
prerank,regulation of immune response (GO:0050776),0.33734908045461354,1.522262296790577,0.0,0.10165369220263973,1.0,70/168,30.64%,ULBP3;COL1A1;IFITM1;IL4I1;COL1A2;CD1A;FOXP3;CD276;LRP8;LAIR2;SYK;TKFC;TREM1;TGFB2;CXADR;ULBP1;XIAP;CD81;ICAM1;SELL;CD1B;COL3A1;NCR3LG1;FCGR3B;TREML2;C3;FCGR1A;MICB;CD8B;FCGR3A;LYN;CD300LD;PLSCR1;ZMPSTE24;ADCY7;ERAP1;TNFSF4;CD3D;CXCL13;CD300LF;HLA-F;RAET1E;CRTAM;OSCAR;TYROBP;ICAM2;ELMOD2;CD3G;CD300A;SH2D1A;TREML4;HCST;ITGB2;FCGR2A;COL17A1;PDCD1;CASP8;FCRLB;SLAMF6;SLA2;CD3E;BCL6;NCR3;SIGLEC7;AHR;IRF7;IFNL1;SAMHD1;CD300LB;RSAD2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.43821860403324225,-1.5221226268327332,0.03571428571428571,0.128032605743011,1.0,26/48,27.14%,TPM1;RAPGEF3;LPAR1;SYNPO2;FERMT2;MYOC;PXN;SORBS3;ARHGEF10;EVL;PPM1F;SYNPO;ARHGEF15;RAC1;SFRP1;RHOA;CCDC88A;LIMCH1;TESK1;RHOC;TGFB3;FHOD1;SYNPO2L;RGCC;ITGB1BP1;PPM1E
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.4959235773355105,-1.5197923902335748,0.034482758620689655,0.12996712838389504,1.0,12/28,17.18%,SYNGR1;CAMK2A;SLC8A2;DLG4;GRIK2;SYP;SHISA7;RAB3A;CAMK2B;DBN1;NCDN;RAB3GAP1
prerank,negative regulation of signaling (GO:0023057),0.47620643647911903,1.518925384179163,0.022727272727272728,0.10391266314047617,1.0,6/24,11.65%,OSM;IL11;SRMS;IL1B;PCSK9;AP1AR
prerank,myeloid leukocyte differentiation (GO:0002573),0.3847016691912051,1.5186692035594436,0.0,0.10367684056959446,1.0,33/70,27.66%,E2F1;DHRS2;CSF2;TNFSF11;GLO1;SNX10;LEF1;PML;CDK4;CEBPA;EPHA2;DCSTAMP;RUNX1;BATF;EFNA2;MMP9;BMP4;PPARG;DEK;TGFBR2;CDC42;IFI16;SRP54;BATF2;CDK2;OSCAR;TYROBP;SPI1;TNFRSF11A;CEBPE;IFNG;FARP2;CASP8
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.50446261292993,1.5185043615065197,0.047619047619047616,0.10362431301190335,1.0,9/23,21.43%,SULT2B1;SULT1C2;SLC35B2;SULT1C3;BPNT1;PAPSS1;SULT1A3;TPST2;ABHD14B
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.5720531648971565,1.5173491557522356,0.023809523809523808,0.10407930595544136,1.0,11/16,26.90%,TACC3;PTTG1;CENPE;NEK6;ANAPC1;UBE2C;PLK1;CDC6;HECW2;RIOK2;CDC23
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.4881321618279368,1.5166834312485629,0.02564102564102564,0.10413412267089045,1.0,7/22,12.60%,CHEK1;ZWINT;NABP2;AURKB;CHMP4C;ZW10;BUB1
prerank,response to lipopolysaccharide (GO:0032496),0.33393158673625367,1.5164891803274705,0.0,0.10397264505177868,1.0,67/148,28.43%,IL1A;CXCL5;CXCL8;CXCL3;CXCL1;CXCL11;CXCL2;SCARB1;IL1B;WNT5A;CYP27B1;DEFA6;PF4;TNFAIP3;CARD17;HMGB2;PLAA;SLPI;MAPKAPK3;CD80;XBP1;MYD88;RELA;IRAK1;NOS2;MAPKAPK2;CXCL9;HNRNPA0;GCH1;CXCL10;CXCL6;TNIP3;TRIB1;NOCT;F2R;IL23R;PALM3;PF4V1;IL36B;TNFRSF1B;CHMP5;NOD2;CTR9;ADAM9;SERPINE1;TNFSF4;CD86;CXCL13;GIT1;NFKBIB;HMGB1;ZC3H12A;PRDX3;SRR;S100A14;IL36RN;RPS6KA3;TICAM1;CARD16;GSTP1;IL36G;TNFRSF11A;IL37;IRAK3;DEFA1;IL10;TRAF6
prerank,negative regulation of protein depolymerization (GO:1901880),-0.5073638942117246,-1.516321269109699,0.06896551724137931,0.13317953884464045,1.0,15/23,26.63%,PLEKHH2;TTBK2;LIMA1;STMN2;CLASP1;CLASP2;NAV3;FGF13;APC;ATXN7;CAMSAP2;APC2;SPEF1;TAOK1;CAMSAP1
prerank,positive regulation of synaptic transmission (GO:0050806),-0.4171442437669175,-1.5162047795294173,0.0,0.13279616720450682,1.0,23/71,14.19%,VAMP2;NFATC4;MPP2;NLGN2;LGI1;TSHZ3;STX1B;NLGN3;HAP1;NRXN1;SLC8A2;GPER1;SHANK3;DLG4;NLGN1;GRIK2;ADRA1A;RIMS3;SHISA7;NPTN;SLC8A3;CACNG7;RELN
prerank,cellular glucuronidation (GO:0052695),0.5660095739384031,1.5142910719378462,0.027777777777777776,0.10513946964399877,1.0,8/16,30.23%,ABHD10;UGT1A3;UGT1A6;UGT1A5;UGT2B7;UGT1A7;UGT1A9;UGT1A10
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.4329388539126267,1.5139289013605408,0.020833333333333332,0.10519029738930159,1.0,12/39,12.44%,CHEK1;FANCB;PARPBP;RAD51AP1;TIMELESS;ACTR2;RMI2;PPP4C;FIGNL1;WRAP53;FUS;KDM1A
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.4425907306495358,1.5138018993825284,0.023809523809523808,0.10499132486230203,1.0,13/34,21.81%,AZGP1;HSPD1;IL23A;CD1A;ZP3;IL1B;CD55;CD1B;TRAF2;IL23R;TNFSF4;HLA-F;IL12B
prerank,actin polymerization or depolymerization (GO:0008154),-0.4489194616235629,-1.513466983141642,0.017857142857142856,0.13520199647521108,1.0,15/48,15.59%,FAM107A;MICAL3;CFL2;GSN;GAS7;DSTN;ARHGAP6;WASF1;EVL;WASF3;CORO7;ABI2;FLII;RAC1;ENAH
prerank,negative regulation of protein polymerization (GO:0032272),-0.4907100398769828,-1.5134223441352577,0.01818181818181818,0.1347406313847381,1.0,11/26,16.33%,CLIP3;TUBB4A;STMN2;SNCA;DYRK1A;SLIT2;MAP2;KANK3;SSH1;KANK1;MYADM
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4685466852690062,1.5123449102382247,0.0,0.10568172187984295,1.0,21/33,29.82%,E2F1;TFDP1;TP73;GZMB;YWHAB;YWHAE;PMAIP1;BBC3;YWHAG;GSK3B;ZNF205;BAX;BID;SFN;BAK1;TP53;CASP8;YWHAQ;HIP1R;PPP3R1;CHCHD10
prerank,alpha-amino acid catabolic process (GO:1901606),0.4807787462468342,1.5121770006041184,0.022222222222222223,0.10551785648294604,1.0,9/27,13.73%,IL4I1;HSD17B10;GOT2;KMO;IDO1;ACMSD;ALDH4A1;KYNU;TDO2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.4678692241421865,1.5121046379199536,0.02,0.10521386559318853,1.0,13/28,23.80%,POLR2F;POLR1C;CDK7;POLR1B;GTF2H3;TAF1A;POLR1A;TAF1B;POLR2K;ERCC2;POLR2H;POLR2L;RRN3
prerank,regulation of protein polymerization (GO:0032271),-0.4598013233074255,-1.5112751462324574,0.03773584905660377,0.1361378362120307,1.0,18/33,26.63%,GBA2;MAPT;PLEKHG2;MAP2;TPPP;FCHSD1;MAPRE3;ARL2;DBN1;CAMSAP2;FCHSD2;ESAM;TPPP3;PAK3;ARHGAP28;LATS1;HCLS1;CAMSAP1
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.4558411261487899,-1.5107302966911837,0.018867924528301886,0.13636476469805517,1.0,24/41,27.14%,TPM1;RAPGEF3;LPAR1;FERMT2;MYOC;PXN;SORBS3;ARHGEF10;EVL;PPM1F;ARHGEF15;RAC1;SFRP1;RHOA;CCDC88A;LIMCH1;TESK1;RHOC;TGFB3;FHOD1;SYNPO2L;RGCC;ITGB1BP1;PPM1E
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.5251695725142478,-1.509883180403584,0.0392156862745098,0.13658992030528258,1.0,8/17,12.42%,DLG2;LRRC7;MTCL1;PARD3B;PARD3;CLIC4;SYNJ2BP;CRB1
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.34217059075514766,-1.5091472360916216,0.0,0.13688521722523797,1.0,75/168,27.75%,LCAT;PITPNM2;PIP5K1C;CSNK2A2;AGPAT1;INPP4A;INPPL1;FGF2;PLA2G5;PLA2G4B;MTMR9;ABHD8;SYNJ1;PI4KB;PIK3R1;PI4KA;PCYT1B;DGKE;INPP5F;INPP5E;CHKB;PLD6;PIP4K2B;AGPAT4;PTEN;ABHD4;LIPI;SLC27A1;DDHD2;DGKG;PIK3C3;INPP5K;PITPNM3;DDHD1;PLA2G4C;PIK3R3;LPIN1;BMX;PI4K2A;ETNK2;PLA2G1B;PIP4K2A;PCYT1A;CDS2;CDIPT;PISD;CSNK2B;PLD2;DGKB;PIKFYVE;PLEKHA3;RUFY1;PLEKHA4;CHAT;PIK3R2;GPD1L;CPNE6;CHKA;PLCG2;SBF1;MTMR12;DGKD;LPIN3;PIP5K1A;PIK3R6;CLN3;MTMR7;PLA2G4A;PIK3C2A;DGKA;PIK3R5;TPTE2;SLC44A2;FIG4;OCRL
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.4749687002751697,-1.5091097504116733,0.08,0.1363546543677758,1.0,17/33,23.93%,WDR91;FGF2;PDGFRA;ATG14;PIK3R1;KIT;PRKD1;TNFAIP8L3;DAB2IP;P2RY12;PIK3R3;PDGFB;PIK3IP1;CCL21;PIK3R2;WDR81;FLT1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.545070519995287,-1.5087528902576246,0.018867924528301886,0.13622054935948524,1.0,10/21,9.51%,FLNA;ANK2;KCNA5;CACNA2D1;KCNH2;NPPA;SCN1B;SNTA1;KCNE2;SCN4B
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.38781366013519597,1.5086126109936278,0.023255813953488372,0.10765599580507078,1.0,26/65,21.57%,POLR2F;POLR2D;EAF1;CDK7;NELFCD;GTF2H3;NCBP1;CCNK;SSRP1;NCBP2;ADRM1;POLR2C;GTF2F2;POLR2K;MLLT3;POLR2J;LEO1;POLR2G;CDK12;NELFE;CTR9;ERCC2;POLR2H;ELP4;POLR2I;POLR2L
prerank,positive regulation of kinase activity (GO:0033674),-0.36443727930717684,-1.5084610215458016,0.0,0.1360519439501324,1.0,44/110,20.23%,FGFR1;EPHA7;RAP1A;MAPT;DDR2;PDGFRA;ROR2;FGFR2;NTRK3;TAB2;KIT;DSTYK;PRKAG2;ALK;EPHA5;FLT4;NTRK1;ROR1;MERTK;MAPRE3;EPHA4;RELN;CDKN1A;MMD2;MUSK;EPHA3;EPHA6;INSRR;PIFO;RAD50;TIE1;DUSP19;AZU1;INSR;EGFR;ERBB4;ALS2;EEF1A2;RASSF2;LMO4;RET;CAMKK1;CCL21;RAPGEF2
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.46699492227045897,1.508394252274672,0.0,0.10745232412222214,1.0,11/22,22.84%,TMED9;DERL1;SEC61B;SURF4;SEC13;VCP;PREB;FAF2;OS9;AUP1;LMAN1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.35680027046345253,-1.5078931061666652,0.0,0.13634477645888218,1.0,47/138,19.43%,NPR2;EFS;LIFR;FGFR1;PILRB;EPHA7;NPR1;DDR2;ANGPTL1;SHC4;PTN;GFRA2;PDGFRA;ROR2;FGFR2;NTRK3;NPPA;NGF;SHC2;FES;KIT;ALK;EPHA5;FLT4;FER;NTRK1;ROR1;MERTK;EPHA4;RAPGEF1;MUSK;EPHA3;EPHA6;INSRR;NTF3;TIE1;TRIO;AHI1;TNK2;NPPC;NPPB;ACVR2A;INSR;EGFR;ERBB4;RET;SH2D6
prerank,RNA catabolic process (GO:0006401),0.4244561772247105,1.5068469886225266,0.02564102564102564,0.10843850847596564,1.0,18/46,18.72%,FEN1;RNASEH1;SND1;LSM5;PNPT1;NCBP1;CNOT10;EXOSC7;ZPR1;DNA2;LSM2;YTHDF2;LSM6;PPP1R8;RNASEH2A;XRN2;NUDT16L1;RNASEH2B
prerank,negative regulation of DNA recombination (GO:0045910),0.4466916632369434,1.50588006944467,0.0,0.10906996499989619,1.0,17/40,21.57%,POLR2F;POLR2D;FANCB;PARPBP;RMI2;BLM;ZRANB3;MSH3;POLR2C;POLR2K;MSH6;POLR2J;POLR2G;POLR2H;POLR2I;MSH2;POLR2L
prerank,amino acid import across plasma membrane (GO:0089718),0.5010469685039238,1.5051794070623228,0.0,0.10910690684309893,1.0,8/24,8.85%,SLC6A20;SLC1A5;SLC1A4;SLC6A14;SLC7A1;SLC7A5;SLC6A6;TSPO2
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.5730619137202282,-1.5051745922784494,0.09259259259259259,0.13843367142531898,1.0,8/17,17.76%,CLU;HAP1;PRNP;RTN1;GGA3;ROCK1;RTN2;RTN4
prerank,positive regulation of cytokine production (GO:0001819),0.31015069922463995,1.5044330932772914,0.0,0.10938600308596134,1.0,140/321,30.93%,POLR2F;POLR3K;CEBPB;OSM;IL1A;POLR1C;HSPD1;EREG;RIPK2;CSF2;G3BP1;IL23A;PHB;GAPDH;XRCC5;ZP3;CD276;POLR3C;IL1B;WNT5A;SLC7A5;SYK;PNP;PRKDC;RPS3;CD46;STOML2;CARD11;TMED10;MDK;DHX9;IL21;POLR3B;CYBA;CD80;XBP1;TRIM27;CLEC6A;NOX1;MYD88;RELA;FFAR2;IRAK1;RUNX1;IL17A;NOS2;ZFPM1;CEBPG;BATF;AGPAT2;SORL1;GBP5;LAMTOR5;DRD2;POLR2K;IL17F;BRCA1;AGT;PRKCZ;TRAF2;C3;MAPK13;NFKB2;ISG15;RAB1A;DDX41;HPSE;F2R;IL23R;PIK3CG;TGFB1;POLR3G;CRCP;EGR1;NOD2;SERPINE1;POLR2H;TNFSF4;MMP8;CHI3L1;SULF2;CD86;IFI16;HMGB1;POLR2L;IL12B;HYAL2;LTB;ITK;CRTAM;CD2;IL12RB2;POLR3A;CD58;SCRIB;NFAM1;TYROBP;TRIM15;XRCC6;TICAM1;ZBP1;IL12RB1;CTNNB1;CREBBP;PTPN11;PRKCQ;CCL1;HIF1A;ANXA1;TIGIT;IFNG;CLEC7A;CD244;PARK7;SLAMF6;IL10;IL18;TLR7;GLMN;TRAF6;HILPDA;PIK3CD;PIBF1;IRF3;NOD1;RASGRP1;EIF2AK2;BTN3A2;NLRP3;ADAM17;IRF7;CD6;IFNL1;CCDC88B;AIRE;TLR8;SCIMP;IL26;LACC1;XCL1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.5575546997800893,1.5036831340440484,0.06976744186046512,0.10962882611418825,1.0,9/17,19.58%,ETV4;SULT2B1;CYP27B1;ZBED2;BMP4;MED1;SFRP4;KDF1;SFN
prerank,regulation of RNA metabolic process (GO:0051252),-0.41700600738147015,-1.5035737493162764,0.0,0.13948800781980394,1.0,20/63,10.01%,RBM20;CLK4;PTBP2;NOVA1;AHNAK;SNRNP70;CLK1;PRX;MITF;CLK3;PCBP3;CELF1;CLK2;MBNL1;HNRNPH3;AKAP17A;AHNAK2;RBM38;NOVA2;SON
prerank,neural crest cell migration (GO:0001755),-0.46070947774663523,-1.5016487088876385,0.04,0.14098927380905063,1.0,17/36,18.29%,GDNF;SEMA6C;RADIL;PHOX2B;TBX1;SEMA4C;SEMA3E;NRTN;CORO1C;ANXA6;SEMA6D;SEMA6A;SEMA3B;HTR2B;SEMA3G;SEMA3A;ERBB4
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4931758331322089,-1.5007238326117425,0.018518518518518517,0.141144771751265,1.0,5/23,7.96%,FLCN;TGFB1I1;SMAD4;CITED2;CDKN1C
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4931758331322089,-1.5007238326117425,0.018518518518518517,0.141144771751265,1.0,5/23,7.96%,FLCN;TGFB1I1;SMAD4;CITED2;CDKN1C
prerank,tRNA methylation (GO:0030488),0.46855062395865754,1.5003130314564432,0.03508771929824561,0.11220998537499209,1.0,15/32,22.47%,METTL2A;METTL1;TRMT10C;FTSJ1;HSD17B10;METTL6;THUMPD3;TRMT112;TRMT61B;NSUN2;DALRD3;METTL2B;TRMT5;TRMT10A;TRMT12
prerank,organelle assembly (GO:0070925),-0.3178880488988595,-1.50016861631872,0.0,0.1413081482085842,1.0,126/404,18.91%,STARD9;TTLL3;NPHP3;PKD1;CIRBP;POGZ;LMOD1;PGM5;FLNA;IFT80;WDR19;GABARAPL1;RFX2;TMOD2;ULK1;EIF4ENIF1;ATG2B;GSN;MYH6;DZIP1;MAPT;CNGB1;KLHL41;ZFYVE1;TUBGCP6;ATG9A;CAPN3;TTBK2;RABL2B;CENPT;CEP126;WDR45;INTU;EHD2;ULK2;IFT81;ATG14;CHMP3;BBS4;CYS1;BBS5;GOLGA8A;DYNC2H1;WDR11;MAP1LC3C;HDAC6;DZIP1L;CD34;TMOD1;STK36;INPP5E;CFAP44;CCDC66;EXOC7;BBS1;CC2D2A;TP53INP2;FBF1;PARVA;CFAP54;TEKT2;ATG16L2;BSCL2;NEK1;ABLIM3;GOLGA8B;ATXN2;SYNPO;CSDE1;RAB23;PTPDC1;CEP164;GOLGA8N;CEP162;EXOC3;CCDC57;LMOD2;MAPRE3;PIK3C3;MYOZ1;BBS2;PACS2;PLA2G4C;CENPC;FLII;TSG101;VPS37A;DISC1;TEKT3;RILPL1;HAUS4;CLUAP1;CFAP70;PCM1;TUBGCP5;ATXN2L;GBF1;TP53INP1;CEP63;EMC6;BBS7;RAB11FIP3;CEP290;DHX29;CDS2;ARMC9;BBS9;TXNDC15;PCNT;STX12;IFT122;NEK7;VPS4A;HAUS3;AHI1;ABCA3;GABARAPL2;TMEM138;CDC14A;ATG12;MAPRE2;CHMP4A;CSNK1D;FITM1;GOLGA8R;ARL3
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.4612682171968034,-1.5000689532908649,0.017543859649122806,0.1409532356087905,1.0,21/36,25.44%,FLCN;ARNTL;FERMT2;RUNX1T1;WWTR1;GPER1;RORA;ZADH2;ZFPM2;SIRT2;ASXL1;GATA2;TRIB2;GPS2;TRIO;SIRT1;ANKRD26;WNT10B;ZFP36L2;BBS12;SMAD3
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.3725957488546145,-1.4993166997424978,0.0,0.1414595411596249,1.0,50/107,27.75%,INPP5B;IP6K3;PITPNM2;PIP5K1C;INPP4A;INPPL1;FGF2;PLA2G5;MTMR9;SYNJ1;PI4KB;PIK3R1;PI4KA;MTMR10;INPP5F;INPP5E;PIP4K2B;PTEN;SLC27A1;PIK3C3;INPP5K;PITPNM3;PLA2G4C;PIK3R3;BMX;PI4K2A;PLA2G1B;PIP4K2A;CDIPT;PLCD1;PLCB1;PIKFYVE;PLEKHA3;RUFY1;PLEKHA4;PIK3R2;PLCB2;PLCG1;PLCG2;SBF1;MTMR12;PIP5K1A;PIK3R6;MTMR7;PLA2G4A;PIK3C2A;PIK3R5;TPTE2;FIG4;OCRL
prerank,negative regulation of synaptic transmission (GO:0050805),-0.5117186461057581,-1.4991328163653026,0.07575757575757576,0.14107248084855628,1.0,7/24,9.79%,PRRT1;GRIK3;NLGN4X;TMEM25;SYT11;PTEN;LRRK2
prerank,dendritic cell differentiation (GO:0097028),0.519587423265888,1.4986477057430714,0.0,0.11323141539174027,1.0,9/23,20.74%,DHRS2;CSF2;TRPM2;DCSTAMP;BATF;IRF8;LYN;TGFBR2;BATF2
prerank,maintenance of protein location in nucleus (GO:0051457),-0.5150900783052961,-1.4986406015421034,0.02040816326530612,0.1410632639981617,1.0,9/20,16.01%,SUPT7L;SYNE1;SUN1;BBS4;SUN2;SKP1;ARL2;MORC3;TAF3
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.4826819151803589,-1.4974232972934496,0.057692307692307696,0.14200511786062914,1.0,17/35,22.69%,TNRC6A;GNAO1;FZD4;PPP3CB;AGO4;CAMK2A;CALM1;TNRC6C;NFATC1;GNG2;AGO3;TNRC6B;AGO1;PLCB1;MAP3K7;PDE6B;PLCB2
prerank,RNA export from nucleus (GO:0006405),0.36334800885792135,1.495921316023557,0.0,0.11499877785356766,1.0,43/104,20.85%,NUP37;RAN;CPSF3;ALYREF;THOC3;NUP155;U2AF1;XPO5;MAGOH;RAE1;SLBP;NUP62CL;NUP93;NUP35;MAGOHB;EIF4A3;NCBP1;SEH1L;DDX39A;SRSF9;SEC13;NUP210;NUP43;NXT1;GLE1;NUP50;NUP88;NUP107;EIF4E;NCBP2;CPSF2;NUP205;THOC6;NUP62;NUP160;NDC1;RBM8A;CPSF4;HNRNPA2B1;SRSF3;NXF3;HNRNPA1;RBM15B
prerank,regulation of interferon-gamma production (GO:0032649),0.35249757357455574,1.4956727493806075,0.02631578947368421,0.11484617338386763,1.0,38/84,31.68%,HSPD1;INHBA;IL23A;FOXP3;ZP3;CD276;IL1B;SLC7A5;C1QBP;IL21;TRIM27;ZFPM1;CEBPG;ISG15;IL23R;LILRB4;TNFSF4;HMGB1;ZC3H12A;IL12B;CD47;CRTAM;CD2;IL12RB2;IL36RN;SCRIB;IL12RB1;CLEC7A;CD244;SLAMF6;IL18;TLR7;RASGRP1;BTN3A2;IFNL1;TLR8;XCL1;CD274
prerank,metal ion export (GO:0070839),-0.49167908685411155,-1.4948189501745506,0.01818181818181818,0.14459823067042638,1.0,13/31,13.82%,ATP1B2;ATP2B4;ATP1A2;KCNA5;FXYD2;KCNIP2;KCNH2;ATP1A4;KCNT2;KCNE2;ATP1A3;KCND3;KCNE1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.3990949412957752,1.4946968736512576,0.0,0.11513630010899138,1.0,19/41,30.93%,AZGP1;IL23A;CD1A;IL21;NOS2;CD1B;IL23R;HLA-F;RAET1E;IL12B;CRTAM;TYROBP;SPI1;IL12RB1;CD1E;SLAMF6;NCR3;RASGRP1;XCL1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.386387544656046,-1.4939230722094672,0.0,0.145318009495836,1.0,40/94,26.51%,ATP2B4;RAF1;CAPRIN2;HRC;TENM1;RAPGEF3;DMD;SPTBN4;TRIM6;PDE4D;NTRK3;SNCA;HDAC6;CNKSR3;NGF;CAMK1;TERF2IP;NCK1;PRKD1;NOS1;PTEN;PPM1F;MTCP1;INPP5K;BRAF;NTF3;EGFR;RAMP3;RASSF2;SMAD7;RPTOR;SH2D3C;GPD1L;BCAR3;LATS1;PINK1;HCLS1;FNIP1;DOCK7;AKAP9
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.5348275306590583,-1.493483375409111,0.018518518518518517,0.14519270681226315,1.0,9/21,12.78%,EPN2;ARNT;ITGB3;PRKCB;CADM4;TMEM204;EMILIN1;GRB10;DAB2IP
prerank,response to interferon-gamma (GO:0034341),0.389348564537379,1.4930933056436306,0.022222222222222223,0.11623772405939416,1.0,24/71,16.94%,TDGF1;IFITM3;IFITM1;CCL24;IFITM2;GAPDH;WNT5A;CCL20;CYP27B1;CCL22;PDE12;CCL4;CCL3;STAT1;CXCL16;GBP5;CCL26;GCH1;KYNU;IRF8;BST2;CCL17;SYNCRIP;IL23R
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.5789991574588219,1.4929568736751597,0.05128205128205128,0.11601516724405275,1.0,5/16,5.35%,CLDN1;CLDN2;CLDN16;CLDN12;CLDN14
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.3438009627382452,1.4920328469029016,0.0,0.11643372153064241,1.0,39/107,21.40%,IL1A;CXCL5;CXCL8;CXCL3;CXCL1;CXCL11;CXCL2;IL1B;WNT5A;DEFA6;PF4;TNFAIP3;CARD17;HMGB2;PLAA;CD80;XBP1;MYD88;RELA;IRAK1;CXCL9;CXCL10;CXCL6;TNIP3;PF4V1;IL36B;TNFRSF1B;CHMP5;NOD2;CTR9;ADAM9;SERPINE1;TNFSF4;CD86;CXCL13;GIT1;NFKBIB;HMGB1;ZC3H12A
prerank,regulation of neuron differentiation (GO:0045664),-0.39197188363363056,-1.4919506077471394,0.0,0.14680886408735488,1.0,34/74,25.07%,FGFR1;ADRA2B;HOXD3;NLGN1;CASZ1;NGF;ALK;LRRK2;HEY1;MEF2C;TIAM1;MMD2;RHOA;ZFHX3;CNTN4;ROCK1;TCF4;GPRC5B;NTF3;ZC4H2;SIN3A;SOX11;PCP4;BEND6;CDK5RAP3;CDK5RAP2;DLL1;SOX2;ID2;NREP;ZFHX2;VWC2;MMD;NBL1
prerank,cellular response to calcium ion (GO:0071277),-0.382199632766712,-1.4916135140260567,0.01818181818181818,0.14657903002434988,1.0,32/68,23.71%,RYR3;ADD1;RASGRP2;ITPKB;PKD2;CAPN3;MEF2A;CARF;SYT10;RYR1;NLGN1;SYT11;CLIC4;PRKAA2;SYT2;SYT9;SYT6;SYT5;MEF2C;MCOLN1;BRAF;CAMK2D;CRHBP;CPNE8;CPNE4;SCN5A;ACER1;SYT1;CPNE6;PLCG2;KCNH1;SYT3
prerank,response to interferon-beta (GO:0035456),0.47604021196341373,1.4903134995927045,0.038461538461538464,0.11765534445902862,1.0,12/25,20.67%,IFITM3;IFITM1;IFITM2;PNPT1;IKBKE;STAT1;BST2;XAF1;UBE2K;PLSCR1;MNDA;IFI16
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.534174366704609,1.4899830489645878,0.06818181818181818,0.11783208742193939,1.0,9/22,12.38%,RPIA;TALDO1;PGD;RPE;HKDC1;TKT;PGLS;G6PC3;RPEL1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.40023037547907214,1.4884384113136762,0.0,0.11884185092674432,1.0,18/53,18.73%,CCND1;CDKN3;CDK7;GTPBP4;BLM;CCNO;CCNE1;CCNI2;CDC25C;CCNK;CCNF;CCNJ;PKMYT1;CDC25A;BCCIP;HSP90AB1;CDC6;STOX1
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.43012935506924654,-1.4880932001397058,0.0,0.14950782734961685,1.0,20/46,19.83%,NPHP3;PKD2;SRF;BBS4;BBS5;CCDC39;NDRG4;CCDC40;HAND1;MEGF8;FOXN4;RYR2;SOX17;MEF2C;TBX2;BBS7;AHI1;SMO;SOX18;DLL1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.4328820652970622,-1.4880897247921538,0.07692307692307693,0.14897195700069352,1.0,17/48,13.93%,FLCN;LMO3;SMAD4;DUSP3;GPER1;DUSP26;CNKSR3;PTEN;EMILIN1;SPRY1;FBLN1;SYNJ2BP;TIMP3;DAB2IP;RANBP9;SPRY3;SEMA6A
prerank,RNA methylation (GO:0001510),0.39312481404714,1.4878415191655636,0.0,0.11884761376469953,1.0,24/56,23.71%,METTL2A;FBL;HENMT1;METTL1;TRMT10C;TFB2M;TGS1;FTSJ1;NSUN3;METTL6;TFB1M;THUMPD3;TRMT6;RBM15;TRMT112;TRMT61B;NSUN2;NSUN5;METTL2B;TRMT5;RBM15B;TRMT10A;TRMT12;METTL5
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.5527494081986672,-1.4872905492362587,0.017241379310344827,0.14916578184869478,1.0,8/17,22.97%,CALM1;PARD3;CADM4;PPEF2;SIRT2;INPP5K;SMAD7;CALM2
prerank,negative regulation of histone modification (GO:0031057),0.500337226445111,1.4862038012099277,0.044444444444444446,0.12001401894772029,1.0,6/15,13.13%,SET;FOXP3;SDR16C5;NOC2L;PRMT6;BRCA1
prerank,positive regulation of nervous system development (GO:0051962),-0.4161811863307958,-1.4857840086633498,0.03636363636363636,0.15004863499012047,1.0,17/44,17.84%,NLGN2;NUMBL;NLGN3;SLITRK2;NRXN1;GPER1;CUX2;NLGN1;LRRC4B;BHLHB9;NUMB;ZNF335;IL1RAPL1;SPEN;SERPINF1;SOX11;DLG5
prerank,negative regulation of cell migration (GO:0030336),-0.3679351835301855,-1.4856360067568612,0.0,0.14981138744985398,1.0,45/135,15.69%,FLCN;ADARB1;ATP1B2;DUSP22;TPM1;PLXNB3;VCL;BMPR1A;FGF2;CHRD;TMEFF2;MAGI2;RECK;MITF;PHLDB2;CITED2;DUSP3;PODN;CLDN5;DLC1;CLASP1;NDRG4;DPYSL3;NGFR;RHOB;CLIC4;EVL;SRGAP2;SLIT2;PTEN;CLASP2;CORO1C;MCC;DAB2IP;EPHA4;NAV3;ADORA3;SCAI;SRGAP2C;RAC1;SFRP1;IGFBP5;KANK1;TP53INP1;PIP5KL1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.5376304398170438,-1.4854404195034474,0.06,0.14944523969018622,1.0,10/21,20.65%,GBA2;MAPT;MAP1A;MAP1B;MAP2;EFEMP2;MAPRE3;ARL2;CAMSAP2;AKAP13
prerank,actin cytoskeleton reorganization (GO:0031532),-0.39071135908676613,-1.4852896955362638,0.03389830508474576,0.1490491411601894,1.0,22/63,18.65%,EFS;FLNA;GSN;GAB1;SYDE1;PDLIM4;WHAMM;CDC42BPA;KIT;CDC42BPB;PARVA;S1PR1;FER;RICTOR;RHOA;S1PR2;FGF7;INSRR;FGF10;THSD7A;NRK;SIPA1L1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3989202962395944,-1.4850856371507475,0.0,0.1487206525447384,1.0,38/80,24.45%,ZER1;CLU;CSNK1E;ATXN3;RNF185;RNF19A;RNF180;CSNK1A1;RNF217;DET1;BAG2;KCNE2;LRRK2;SIRT2;ZYG11B;KLHL40;DAB2IP;TRIB2;ECSCR;BBS7;ARIH2;RNF144B;NUPR1;HECTD1;CSNK1D;TMEM259;FBXW7;DNAJB2;ARIH1;RNF14;GSK3A;PRICKLE1;SMAD7;PIAS1;OSBPL7;PSMC5;RNF144A;GABARAP
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3842150945365262,-1.4849003626910886,0.0,0.14862057364005773,1.0,37/77,24.84%,PALM;TENM1;TAPT1;BBS4;PIK3R1;CDC42EP3;P2RX7;NLGN1;CROCC;GPM6A;RHOQ;DPYSL3;MSTN;PLCE1;NDEL1;ABI2;P2RY12;DEF8;ARPC2;CDC42EP4;RAC1;MARK4;APC;CCDC88A;DOCK11;WASF2;FUZ;CCL21;TENM2;BCAS3;CDC42EP2;CEP120;BRK1;OCLN;ARHGAP35;AKIRIN1;TGFB3
prerank,negative regulation of developmental growth (GO:0048640),-0.4650370378395763,-1.4842659083096976,0.058823529411764705,0.14858557064616074,1.0,18/32,20.41%,ULK1;PTPRS;ULK2;PTEN;MAP2;MSTN;WWC2;MYOZ1;BBS2;FGF13;CDKN1A;MAG;SEMA3G;WWC3;OSTN;RTN4;DCC;TRIM46
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.435444493473511,1.483615199936555,0.021739130434782608,0.1215370830978673,1.0,20/45,23.26%,RALA;P4HB;TALDO1;HNRNPF;CNN2;CAPZA1;PSME2;HSPA9;RPLP0;SNRPA1;PAK2;GSTO1;TCP1;CFL1;HNRNPA2B1;MSN;CDC42;IL12B;TYK2;IL12RB2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.4774579409232198,-1.4828831848948762,0.0,0.14973767749539035,1.0,14/26,23.51%,PLXNB3;EVL;EVI5L;SLIT2;ARHGAP24;TCHP;SRGAP2C;KANK1;CAPZB;CCL21;ODF2L;TESK1;CEP97;PRKCD
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.5088399270152945,-1.4828805239731406,0.07692307692307693,0.1492195540438492,1.0,9/18,23.65%,FLCN;TFE3;SOX13;FNDC5;FTO;VSTM2A;SIRT1;INS;PIM1
prerank,central nervous system neuron differentiation (GO:0021953),-0.43447537429181293,-1.4822372564204342,0.024390243902439025,0.14915099144403884,1.0,17/34,23.03%,CEND1;GBA2;MAPT;CHD5;PHOX2B;MDGA1;MAP2;FOXN4;OPHN1;TOX;NPY;ZC4H2;SIN3A;SPOCK1;MDGA2;LRP6;GRID2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5022926397495611,-1.4810954824440674,0.0,0.1500670503846946,1.0,9/25,11.11%,ATP1B2;ANK2;DMD;WNK3;PIRT;ACTN2;ANK3;TRPC6;STAC
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.4170784484150152,-1.4809723062595306,0.0,0.14974295050583142,1.0,21/59,20.60%,PDE2A;ADCY5;GABBR1;FLNA;ADCY2;LPAR1;ADCY4;AKAP12;GNAI1;CORT;ADCY9;CHRM2;P2RY12;GNAL;OPRL1;ADCY6;HTR4;CHRM5;GNAI2;HTR1E;CHRM3
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.44697217699148284,-1.4806996575497664,0.0,0.14992554423939872,1.0,14/35,17.91%,FLNA;PLXNB3;SEMA6C;NRP2;SEMA4C;SEMA3E;SEMA6D;SEMA6A;RAC1;SEMA3B;SEMA3G;SEMA3A;PLXNA4;PLXNB1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.48516878298389604,-1.479810053806386,0.017857142857142856,0.1504211242160293,1.0,13/26,24.67%,SKP1;TAOK2;KAT7;MAPK1;MAPK3;MAPK11;MAP2K7;MAPK8;BTRC;UBB;MAP3K7;MAP3K8;FBXW11
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.3772302120021239,-1.4792011993307834,0.0,0.1506314974516828,1.0,40/100,20.44%,VAMP2;SLC2A4;ADCY5;SORBS1;ADCY2;ADCY4;KAT2B;PDE3B;GPER1;PIK3R1;CPEB1;RAB12;CPEB2;RHOQ;ADCY9;PRKACA;CYP11B1;ZFP36L1;GCK;FER;MYO5A;PRKAR2B;CYP11A1;HDAC5;INPP5K;LPIN1;HDAC9;MGARP;PLA2G1B;ADCY6;CRHBP;RAB13;AKT2;INSR;CRHR1;RPS6KB1;GSK3A;NR4A3;LHCGR;RAB8B
prerank,regulation of DNA metabolic process (GO:0051052),0.41844691769653014,1.4788169333680767,0.023255813953488372,0.12516063378517575,1.0,18/44,18.73%,MYC;ALYREF;POLH;UBE2N;TOM1L1;KDM1B;XRCC5;TICRR;WRNIP1;WDR18;SUB1;CDT1;GRHL2;USP1;KPNA2;IL7R;MPV17;STOX1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3538931155496742,1.4781807354068717,0.0,0.12537745947992218,1.0,47/153,14.98%,CDH3;SOX4;RUVBL1;PSMD14;COL1A1;PSMB2;PSMB9;PSMA5;LGR5;PSMB3;ATP6V1C2;PSME3;PSMA3;PTK7;PSMA7;DEPDC1B;PSMD13;AXIN2;LGR6;GID8;PSME2;PSMC2;PSMC4;PSMD10;TNFAIP3;PSMD12;SMARCA4;JUP;PSMB5;CSNK2A1;BAMBI;XIAP;LBX2;PSMD8;NRARP;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;SEMA5A;PSMF1;PSMD11;PSMD1;GSKIP;VCP;TMEM9
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.3973206248573375,-1.4775569683895977,0.03508771929824561,0.15158950175677988,1.0,28/89,15.28%,DDX17;CIRBP;RBFOX3;RBM5;NOVA1;SRSF4;RBM24;ZC3H10;CELF1;RBM25;MBNL1;RBM4;SFSWAP;CELF4;FXR2;CELF6;RBFOX2;QKI;SF1;NOVA2;SON;CELF2;TIA1;JMJD6;YTHDC1;PCBP4;SRSF12;NSRP1
prerank,negative regulation of telomere maintenance (GO:0032205),-0.5417572937514895,-1.4771478636894955,0.07272727272727272,0.15148347005324214,1.0,9/16,29.43%,TERF2IP;RTEL1;RAD50;SMG6;TNKS;ERCC1;SLX4;TNKS2;ERCC4
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.4512527427193953,-1.4766300580702658,0.04,0.1515331552452445,1.0,21/38,27.80%,IFT80;WDR19;IFT81;DYNC2H1;KIF17;CLUAP1;PCM1;TTC21B;IFT122;DYNLRB2;KIF3C;WDR35;IFT46;KIF3A;TRAF3IP1;KIFAP3;IFT43;TRIP11;IFT172;IFT27;IFT140
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.4973524285157754,-1.475908452764488,0.10526315789473684,0.15204596867807502,1.0,10/23,20.36%,HDAC4;ACTN3;CLK2;GCK;SOGA1;C1QTNF3;NUPR1;GSK3A;INS;CRY1
prerank,neutral amino acid transport (GO:0015804),0.46186075657421893,1.4750947933623013,0.03333333333333333,0.1275917312178939,1.0,7/28,6.59%,SLC6A20;SLC1A5;SLC1A4;SLC6A14;SLC38A5;SLC7A5;SLC6A6
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.5078930383851408,-1.4746674369497366,0.018867924528301886,0.15292489592639763,1.0,9/17,19.48%,VAMP2;AKAP6;ANK3;NPPA;KCNE2;RNF207;KCNE1;KCNS2;KCNE4
prerank,regulation of peptidase activity (GO:0052547),0.51853621752658,1.47367295970967,0.046511627906976744,0.12842073654590414,1.0,6/19,9.92%,PRSS22;PSMA3;CSTB;CTSH;ATP13A2;HDAC1
prerank,detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),0.40840962065120073,1.473502738759907,0.02040816326530612,0.12816995322996208,1.0,5/36,5.24%,CST1;AZGP1;CST4;CST2;LPO
prerank,regulation of neurotransmitter transport (GO:0051588),-0.5556503334134127,-1.4733955280842732,0.01694915254237288,0.1537059069043715,1.0,10/16,29.01%,CPLX3;CAMK2A;MEF2C;CHRNB4;KCNMB4;SYN1;RIMS1;CPLX2;FLOT1;MCTP1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.532857250886287,1.4725779571880113,0.04878048780487805,0.12853768669576776,1.0,10/19,21.81%,IL23A;SYK;PNP;SHH;CD55;HSPH1;IL23R;IHH;TNFSF4;IL12B
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.4865780918497616,-1.4722336417745123,0.06779661016949153,0.1550017831837402,1.0,16/29,21.91%,DSCAML1;OSR1;PDGFRA;HOXD3;FGFR2;HOXA4;HOXB4;TBX1;MEGF8;HOXB3;HOXD4;HOXD9;SOX11;FUZ;OSR2;HOXC4
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.5495940045580174,-1.4720762108580365,0.07272727272727272,0.15464267357410366,1.0,8/19,17.76%,CLU;HAP1;PRNP;RTN1;GGA3;ROCK1;RTN2;RTN4
prerank,regulation of actin filament polymerization (GO:0030833),-0.38702255427629045,-1.4716816697536004,0.0,0.1545290400617088,1.0,28/67,23.51%,LMOD1;TENM1;GBA2;PLEKHG2;CDC42EP3;EVL;NCK1;SLIT2;KANK3;FER;NCKAP1L;FCHSD1;LMOD2;CDC42EP4;SSH1;KANK1;DBN1;MYADM;BAIAP2;CCL11;FCHSD2;ESAM;CCL21;PAK3;ARHGAP28;CDC42EP2;LATS1;PRKCD
prerank,cellular response to interleukin-12 (GO:0071349),0.43630130749332735,1.4714990456428023,0.022727272727272728,0.12919466718512398,1.0,21/47,23.26%,RALA;P4HB;TALDO1;HNRNPF;CNN2;CAPZA1;PSME2;HSPA9;RPLP0;SNRPA1;PAK2;GSTO1;TCP1;CFL1;HNRNPA2B1;MSN;CDC42;IL12B;CD47;TYK2;IL12RB2
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.362367268550694,-1.471316207807561,0.0,0.15456759946239157,1.0,41/123,20.41%,GPM6B;GDNF;ATP1B2;TPM1;LGI1;PLP1;STMN4;ULK1;PKD2;MAPT;PTPRM;MYOC;LIMA1;ATCAY;MICALL1;STMN2;TMEM108;NLGN1;L1CAM;FRY;GPM6A;MAP2;NRTN;LAMB1;OPHN1;PPP1R9A;NPY;RAC1;MARK4;CNTN4;ROCK1;NCDN;BLOC1S1;RAB13;VAPA;BTG2;FRYL;CCL21;RAPGEF2;FAM161B;SNAPIN
prerank,sulfation (GO:0051923),0.4780881512599747,1.4712671889321103,0.08333333333333333,0.12900838915990354,1.0,4/16,7.10%,SULT2B1;CHST4;SULT1C2;SULT1C3
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.5365550234653683,-1.4709449402837298,0.0392156862745098,0.15460590684084763,1.0,10/16,25.11%,CRMP1;DPYSL3;DPYD;NT5M;DPYSL5;NT5E;DPYSL4;DPYSL2;UPB1;TET2
prerank,regulation of cellular response to heat (GO:1900034),0.37824220298963646,1.4707152299444666,0.0425531914893617,0.12911291102901054,1.0,30/76,17.81%,NUP37;RPA3;NUP155;RAE1;NUP93;YWHAE;NUP35;SEH1L;SEC13;NUP210;NUP43;HSBP1;NUP50;PTGES3;NUP88;DNAJC2;NUP107;FKBP4;MAPKAPK2;GSK3B;DNAJC7;MLST8;NUP205;RPA2;NUP62;HSPH1;NUP160;HSP90AB1;NDC1;BAG4
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.4620419525642975,-1.4705821830114925,0.02,0.15443331905706806,1.0,12/31,16.03%,MAP3K3;FGF2;STARD13;HDAC7;RHOJ;HDAC5;HDAC9;MEOX2;MAP2K5;RHOA;GATA2;TBXA2R
prerank,embryonic digestive tract development (GO:0048566),-0.521964901693935,-1.4698430023663305,0.10909090909090909,0.15465178082320288,1.0,14/20,23.96%,RBPMS2;FOXF1;GLI3;PDGFRA;FGFR2;TCF21;RARB;GLI2;RARRES2;PCSK5;SOX11;NIPBL;ID2;PKDCC
prerank,purine ribonucleotide metabolic process (GO:0009150),0.38612515078839377,1.468581596903718,0.0,0.13072531411266353,1.0,23/67,17.96%,SULT2B1;ENTPD7;RAN;HPRT1;SULT1C2;SULT1C3;EPHA2;ACSL6;BAAT;THEM5;DBI;ACOT7;GNAI3;ACOT13;BPNT1;ACOT4;ACOT8;SULT1A3;ACLY;OXSM;HINT1;NT5C2;TPST2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.4041451724418743,1.46802172976353,0.037037037037037035,0.13111223901157892,1.0,22/47,24.07%,PNPO;PSAT1;SQLE;DHCR7;SC5D;HSD17B10;AKR1C4;OSBPL3;BAAT;CYP39A1;CYP7B1;MSMO1;HSD3B7;TM7SF2;ACOT8;INSIG1;SLC27A5;HSD17B4;EBP;HMGCR;OSBPL2;OSBP
prerank,embryonic limb morphogenesis (GO:0030326),-0.4621330424366505,-1.4679603901548186,0.07272727272727272,0.1562740090884579,1.0,14/35,15.12%,AFF3;CACNA1C;MYH3;FBXW4;OSR1;INTU;GLI3;MBNL1;ZNF358;MEGF8;ECE1;SKI;CYP26B1;TBX2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.4787608823227811,1.4672966484039058,0.1,0.1312416424920504,1.0,10/23,14.67%,PSMD14;PSME3;NUDT15;PSME2;CTSC;EFNA1;UCHL5;GPX1;PSME1;GBA
prerank,neurotransmitter transport (GO:0006836),-0.39018021948894327,-1.4670065911005048,0.03333333333333333,0.15717054703256095,1.0,28/71,22.73%,VAMP2;BRSK1;ATP1A2;SLC6A16;SLC17A7;SLC5A7;NRXN1;SYNJ1;SNPH;SYN2;PPFIA4;NRXN2;SNAP25;SLC18A3;SLC1A2;RAB3A;APBA1;SLC38A2;GLUL;SLC29A1;SYN1;SNAPIN;RIMS1;CHAT;SLC6A15;SLC17A8;SYT1;PPFIA2
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.4902531404153478,-1.4666918156569588,0.03636363636363636,0.15705134297717036,1.0,6/20,12.29%,SOCS2;PXN;PIK3R1;GH1;GHR;PRL
prerank,negative regulation of cell projection organization (GO:0031345),-0.41343826603926054,-1.4665256121908512,0.015873015873015872,0.15681446312350944,1.0,20/46,20.23%,LPAR1;STX1B;CRMP1;PTPRS;STMN2;DENND5A;PRNP;DPYSL3;PTEN;EPHA4;GORASP1;SPRY3;MAG;KANK1;ADCY6;SEMA3A;SPOCK1;MYLIP;DCC;RAPGEF2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.37179775816856403,-1.466477284703768,0.0,0.15640200459237466,1.0,33/86,20.40%,LMOD1;CFL2;TENM1;DCTN1;SYNPO2;MAPT;CLU;NUMA1;CLIP1;STMN2;CDC42EP3;CLASP1;FES;EVL;NCK1;PSEN1;EFEMP2;FER;NCKAP1L;SYNPO;FCHSD1;LMOD2;NAV3;ARL2;CDC42EP4;RAC1;SLAIN2;BAIAP2;CCL11;FCHSD2;CDK5RAP2;CCL21;MYLK3
prerank,aorta morphogenesis (GO:0035909),-0.5528723519456075,-1.466204257536485,0.0392156862745098,0.15613928010113207,1.0,9/17,15.80%,MYLK;BMPR1A;TBX1;RBPJ;EFEMP2;HEY1;TBX2;ADAMTS9;HEY2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.47851830877367657,-1.4659918097052096,0.05263157894736842,0.15576091177437007,1.0,12/26,13.03%,TMEFF2;MYOC;PHLDB2;SHANK3;PIK3R1;ARHGAP6;DLC1;CLASP1;CLASP2;ARHGEF18;INPP5K;TJP1
prerank,histone H4-K16 acetylation (GO:0043984),-0.5197090222985548,-1.4655811143279396,0.015384615384615385,0.1555895843865414,1.0,10/19,24.44%,KANSL3;JADE1;MSL1;ING4;KMT2A;KAT7;OGT;KANSL1;KAT8;JADE2
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.5197816621096265,-1.464968081114295,0.09433962264150944,0.1557690532961543,1.0,13/24,20.40%,SORBS1;PPP1R3E;PPP1R3C;PPP1R3F;EPM2AIP1;GCK;INPP5K;AKT2;INSR;PPP1R3B;GSK3A;INS;PPP1R3G
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4415633554873344,1.4646605148968441,0.02564102564102564,0.1327702214590346,1.0,16/36,21.13%,CCT6A;CCT2;CCT3;XRCC5;CCT8;CCT7;NEK2;AURKB;FBXO4;NAF1;MAPK15;CCT4;TCP1;HNRNPA2B1;HNRNPA1;MAPKAPK5
prerank,cellular response to organic cyclic compound (GO:0071407),-0.3397839921207202,-1.464549965423026,0.0,0.15586023956206416,1.0,53/147,22.12%,PDE2A;RYR3;ADCY5;ADCY2;ATP1A2;AKAP6;TRPV1;RAPGEF3;PKD2;RAP1A;GPER1;GNAI1;P2RY1;RORA;P2RX7;FES;AR;GNG2;ZFP36L1;LRRK2;ATP1A3;NR3C1;PDE3A;EPG5;MEF2C;AQP1;INPP5K;P2RY12;RAPGEF1;KCNE1;SSH1;SFRP1;MGARP;CYP1A1;IGFBP5;ESR1;PDGFB;TFPI;ADCY6;CRHBP;CASP3;EGFR;GABRG2;RAMP3;P2RY11;GPBAR1;NR4A3;RAPGEF2;HCN3;CCL2;KAT5;SSTR2;ACTB
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.4492723036955608,1.4644262633068343,0.043478260869565216,0.13273546240121073,1.0,10/28,13.23%,MYC;E2F1;WNT2;EREG;WNT5A;CDK4;S100A6;DHX9;FN1;AGT
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.537770851701093,-1.4636620071450452,0.0625,0.15658797925088697,1.0,8/17,11.05%,ATP1B2;CACNA1C;ATP1A2;GJC1;SLC8A1;PRKACA;ATP1A3;RYR2
prerank,cytoplasmic translational initiation (GO:0002183),0.533540730354233,1.4623750906578425,0.019230769230769232,0.13444072482861866,1.0,7/18,11.65%,MCTS1;EIF2S3;EIF2S2;EIF3I;EIF3M;DENR;EIF3D
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5129425954250557,1.4620623645624522,0.043478260869565216,0.13424365417856565,1.0,7/17,21.43%,SULT2B1;SULT1C2;SULT1C3;BPNT1;SULT1A3;TPST2;ABHD14B
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.5412307428163877,-1.4614711821626507,0.09259259259259259,0.15849482958541639,1.0,7/15,20.11%,HAND2;PDE9A;MEF2A;PRKCA;ROCK1;CAMK2D;NR4A3
prerank,negative regulation of endocytosis (GO:0045806),-0.4882463793839751,-1.4609328248377096,0.03389830508474576,0.15863423171892302,1.0,9/23,17.58%,SNX33;SYT11;PRKD1;LGALS3;NR1H2;RAC1;EPHA3;LRSAM1;PACSIN3
prerank,tight junction assembly (GO:0120192),0.40410878647964804,1.459436266950935,0.041666666666666664,0.136154985694072,1.0,19/50,19.87%,CLDN1;CLDN2;CLDN16;CLDN12;CLDN14;PARD6B;ACTG1;ECT2;LSR;PAK2;POF1B;PECAM1;MARVELD2;PRKCI;GRHL2;CRB3;CLDN4;STRN;F11R
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.3536561670066438,-1.458499250159129,0.0,0.16049419302416712,1.0,55/120,26.63%,ZNF135;GDNF;ZMYM6;BRSK1;FGF2;MAPT;FERMT2;ADGRB3;PHLDB1;PHLDB2;WTIP;ZDHHC15;SHANK3;FGFR2;RUFY3;CLASP1;TBX1;CHRNA3;CLASP2;EGLN1;KIF1A;LRRK2;FLT4;SDC2;LRRC4C;PID1;MEF2C;ABI2;EPHA4;EFNA5;SFRP1;CDH2;ZMYM3;CAPZB;SIPA1L1;ZRANB1;DLL1;PHIP;RC3H1;KRT1;STRIP1;ADGRA2;SARM1;PAK3;FMNL2;PPFIA2;HMOX1;ARHGAP35;GPNMB;ARC;CHN1;TANC2;BMPER;CEACAM1;CAMSAP1
prerank,cell-cell junction assembly (GO:0007043),-0.39176872479872343,-1.457060187526132,0.015384615384615385,0.16177060569638962,1.0,21/64,14.70%,FLCN;JAM3;PIP5K1C;TLN1;GJC1;VCL;CDH19;CTNND2;CDHR3;CNTNAP1;CLDN11;CLDN5;DCHS1;PRKCA;CTNND1;EPB41L3;FBF1;CDH10;TJP1;CDH2;RHOA
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.4645126590714543,-1.455779641815827,0.02,0.16275400612085847,1.0,8/26,14.77%,ADCY5;PPP3CB;NR1D1;EPHA5;PLA2G6;KLF7;EFNA5;STXBP4
prerank,negative regulation of macroautophagy (GO:0016242),-0.4952547728630078,-1.454937373997295,0.0392156862745098,0.16282173621234963,1.0,10/24,23.85%,NRBP2;TSC1;LRRK2;FEZ2;TSC2;NUPR1;CHMP4A;SMG1;MTOR;PINK1
prerank,chromosome organization (GO:0051276),0.3440145741928679,1.4546919979787793,0.0,0.14028209523964286,1.0,33/100,17.04%,CENPH;RFWD3;CENPW;MYC;NUF2;NUP155;SUV39H1;RAE1;HDAC2;NDC80;HMGN4;AXIN2;HDAC10;PADI3;HMGN1;MSH3;SMARCA4;PADI1;POLE3;HMGB2;HMGA2;HDAC1;COPS5;RAD23B;DDB1;MSH6;CDT1;UBA52;CUL4A;CENPV;TOP2A;LRWD1;SOX1
prerank,regulation of mitotic nuclear division (GO:0007088),0.38237678069029196,1.4544912195393405,0.021739130434782608,0.14007006687317708,1.0,22/56,17.54%,NME6;CHEK1;IL1A;KIF20B;FBXO5;RCC1;EREG;PDGFRB;TOM1L1;IL1B;NEK2;CDC25C;PDXP;AURKA;DUSP1;PKMYT1;BMP7;LCMT1;BMP4;NUP62;DMRT1;LRP5
prerank,autophagosome maturation (GO:0097352),-0.43339282925382927,-1.4544382180360547,0.03571428571428571,0.16314409626841747,1.0,20/33,25.92%,GABARAPL1;CALM1;LIX1L;ATG14;CHMP3;MAP1LC3C;UVRAG;LIX1;EPG5;VTI1B;VPS33B;VIPAS39;TSG101;GABARAPL2;MAP1LC3A;ATP2A2;TECPR1;GABARAP;CLN3;VPS33A
prerank,positive regulation of cilium assembly (GO:0045724),-0.5178441696356222,-1.454319290063018,0.0,0.16272993983603184,1.0,10/16,27.22%,TAPT1;HAP1;BBS4;CROCC;MARK4;CCDC88A;FUZ;CEP120;ARHGAP35;CCP110
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3152593830040273,1.4540952093925474,0.0,0.14010871343534717,1.0,39/179,14.58%,PSMD14;THY1;PSMB2;PSMB9;PSMA5;PSMB3;RIPK2;PSME3;KHDRBS1;PSMA3;UBE2N;SKAP1;PSMA7;CD276;PSMD13;SYK;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;STOML2;CARD11;BTN1A1;PSMB5;RELA;PSMD8;PAK2;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;INPP5D;PSMF1;VTCN1;PSMD11;PSMD1;PAK1
prerank,regulation of axonogenesis (GO:0050770),-0.41305316444736273,-1.4537510102650626,0.029411764705882353,0.16299428296429067,1.0,22/51,18.65%,MAP6;PLXNB3;BRSK1;RUFY3;AMIGO1;NGF;NGFR;GDI1;SLIT2;PTEN;CHODL;LRRC4C;EPHA4;TIAM1;MAG;CDH2;RHOA;MCF2;PLXNA4;RTN4;PLXNB1;SIPA1L1
prerank,skeletal muscle organ development (GO:0060538),-0.46245682737840954,-1.4536259234965303,0.017857142857142856,0.1626954194903853,1.0,10/30,13.69%,POPDC2;BVES;CFLAR;MYOZ2;TCF21;DISP1;MEF2C;MYL6;MYOZ1;CSRP3
prerank,regulation of synapse assembly (GO:0051963),-0.39802286770553463,-1.4534983635723058,0.0,0.1623423775266686,1.0,22/47,23.91%,NLGN2;NLGN3;SLITRK2;NRXN1;CUX2;SNCA;LRFN5;NLGN1;SETD5;MDGA1;LRRC4B;SLITRK3;BHLHB9;MEF2C;MUSK;IL1RAPL1;DLG5;SLITRK1;SLIT1;GPC6;GRID2;CLSTN2
prerank,nuclear membrane organization (GO:0071763),-0.5013054637073622,-1.4530171675651864,0.05555555555555555,0.1624938544185331,1.0,6/19,8.07%,DCTN1;TARDBP;AKAP8L;GPER1;TOR1AIP1;TMEM43
prerank,regulation of cytoskeleton organization (GO:0051493),-0.3546570335828064,-1.4524769061359917,0.017241379310344827,0.1625609400553914,1.0,52/110,26.70%,FAM107A;GPM6B;MAP6;RND2;CORO2B;MAPT;PHLDB1;NEXN;SYDE1;PHLDB2;SORBS3;P2RX7;DLC1;CLASP1;RHOQ;RHOB;SPATA4;CLIC4;BICD2;EPHA5;PRKAA2;TPPP;TAOK2;MAPK1;MAPK3;TJP1;RICTOR;RAC1;EFNA5;RHOA;EPHA3;ROCK1;CCDC88A;MAP6D1;IQCJ-SCHIP1;BAIAP2;PLXNB1;TESK1;RHOBTB1;PAK3;MTOR;PRKCD;RHOC;ARHGAP35;PDGFA;TRAF3IP1;CLN3;ARHGAP17;SPEF1;TAOK1;KATNBL1;CAPN2
prerank,regulation of kinase activity (GO:0043549),-0.3582330078116334,-1.451185892159252,0.018867924528301886,0.16351538871355628,1.0,41/93,23.93%,TSPYL2;FGFR1;EPHA7;MAPT;DDR2;PDGFRA;ROR2;FGFR2;NTRK3;CDKN1C;KIT;DSTYK;ALK;EPHA5;FLT4;LDB2;NTRK1;ROR1;MERTK;PLCE1;EPHA4;MUSK;EPHA3;EPHA6;INSRR;PIFO;RAD50;TIE1;RBL2;INSR;EGFR;ERBB4;ANKRD54;LMO4;RET;CAMKK2;SOD1;DRD4;TTN;EPHB6;FLT1
prerank,regulation of cellular localization (GO:0060341),-0.41573773141317905,-1.4511757618898813,0.020833333333333332,0.16308114092874187,1.0,18/47,15.78%,ADCY5;BRSK1;KIAA1614;GSN;NUMA1;CSNK1E;DVL3;NR1D1;PARD6G;FES;MAP2;LRRK2;EPHA5;PPM1F;FER;EFNA5;STXBP4;CAMK2D
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.48234049800781,-1.4509424539021847,0.05357142857142857,0.16298041035910038,1.0,14/27,22.97%,GSTM2;ATP1A2;PKD2;CALM1;PLN;CASQ2;TLR9;GNB5;TRDN;CLIC2;CRHR1;SLN;DRD4;CALM2
prerank,embryonic skeletal system development (GO:0048706),-0.45196804191796996,-1.450917231071415,0.01818181818181818,0.16255033958001244,1.0,17/34,21.91%,WNT9A;DSCAML1;OSR1;PDGFRA;HOXD3;HOXA4;HOXB4;MEGF8;HOXB3;XYLT1;HOXD4;HOXD9;PCSK5;SOX11;FUZ;OSR2;HOXC4
prerank,negative regulation of transport (GO:0051051),-0.4255347833291343,-1.4507598632225718,0.0,0.16220506133634435,1.0,15/44,17.58%,CRYAB;PXK;SNX33;SNCA;ITGB3;SYT11;PRKD1;PTEN;PPM1F;DYSF;LGALS3;NR1H2;EPHA3;LRSAM1;PACSIN3
prerank,regulation of nervous system process (GO:0031644),-0.5117925438079627,-1.4505675154679996,0.07547169811320754,0.16188915845001392,1.0,10/19,26.51%,NPTX1;SLC8A2;DLGAP2;TMEM108;NPTXR;SLC8A3;BEGAIN;DLGAP4;DLGAP3;AKAP9
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.4775721332419035,1.4484195275845304,0.09259259259259259,0.14507782645956582,1.0,12/21,21.98%,MAD2L1;ZWINT;BUB3;TRIP13;ZW10;BUB1;PLK1;CENPF;KNTC1;CDC20;BUB1B;TTK
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.4775721332419035,1.4484195275845304,0.09259259259259259,0.14507782645956582,1.0,12/21,21.98%,MAD2L1;ZWINT;BUB3;TRIP13;ZW10;BUB1;PLK1;CENPF;KNTC1;CDC20;BUB1B;TTK
prerank,spindle assembly checkpoint signaling (GO:0071173),0.4775721332419035,1.4484195275845304,0.09259259259259259,0.14507782645956582,1.0,12/21,21.98%,MAD2L1;ZWINT;BUB3;TRIP13;ZW10;BUB1;PLK1;CENPF;KNTC1;CDC20;BUB1B;TTK
prerank,positive regulation of DNA recombination (GO:0045911),0.45688053532138656,1.4477848112162173,0.04,0.1453486392360949,1.0,12/24,29.87%,FANCB;RAD51AP1;TIMELESS;ACTR2;WRAP53;FUS;PAXIP1;ERCC2;HMCES;OOEP;PARP1;MAD2L2
prerank,telomere organization (GO:0032200),0.4067115362966826,1.4473854509680202,0.024390243902439025,0.14540270564306776,1.0,13/41,15.63%,RPA3;POLD2;DCLRE1B;BLM;XRCC5;PRKDC;RECQL4;DNA2;APEX1;PTGES3;HUS1;RPA2;POLD1
prerank,adherens junction organization (GO:0034332),-0.420481551786041,-1.4470241432000372,0.017543859649122806,0.16560836565543366,1.0,21/43,24.63%,JAM3;PIP5K1C;VCL;CDH19;CADM2;FERMT2;CDHR3;CADM3;DCHS1;CTNND1;CDH10;CADM1;TJP1;CDH2;SMAD7;CDH5;ACTB;CDH8;RAMP2;CDH4;CDH20
prerank,negative regulation of axonogenesis (GO:0050771),-0.45577253378449395,-1.4469690545609286,0.03125,0.16520279676491273,1.0,16/28,20.41%,ULK1;PTPRS;ULK2;RUFY3;NGFR;GDI1;PTEN;MAP2;FGF13;MAG;RHOA;SEMA3G;MCF2;RTN4;DCC;TRIM46
prerank,regulation of activated T cell proliferation (GO:0046006),0.44168634840944265,1.4469493064882368,0.021739130434782608,0.14518051970163506,1.0,15/33,24.88%,IL23A;FOXP3;TNFSF9;RPS3;IL27RA;IGFBP2;IDO1;CLC;IL23R;LILRB4;HMGB1;IL12B;CRTAM;SCRIB;IL12RB1
prerank,calcium ion import (GO:0070509),-0.48530355590141405,-1.446793623282832,0.015873015873015872,0.16490797390064443,1.0,11/26,19.85%,CACNA1H;CACNA1C;CACNB2;SLC25A23;MICU3;SLC8A1;TRPC4;CACNA1G;CACNA1A;CACNA1B;CACNA1I
prerank,regulation of DNA biosynthetic process (GO:2000278),0.43040332207466003,1.4465191034929814,0.0,0.14523475320253693,1.0,7/28,10.13%,MYC;DACH1;PDGFRB;TOM1L1;NABP2;PARP4;FGFR4
prerank,epithelial cell differentiation (GO:0030855),0.3572689111268391,1.4462338241360986,0.04878048780487805,0.1451667221865631,1.0,41/99,22.68%,ANXA4;CDK1;VDAC1;MCIDAS;HDAC2;CCNO;ACTL8;RAB10;TAGLN2;UPK3A;DNPH1;PTER;PROX1;CASP6;EHF;HDAC1;SETSIP;SIX1;UPK2;ZNF703;GRHL2;KDR;BMP4;GATA6;E2F8;OVOL3;PPARG;SIX3;EDF1;IRF6;DLX3;OVOL1;PIH1D1;PAX2;ALDOC;VIL1;OVOL2;E2F7;DMBT1;PCK2;CTSB
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.4466279510499364,-1.4452939951871484,0.02040816326530612,0.16599251850614238,1.0,7/26,9.36%,VAMP2;FHL1;ATP1B2;ANK2;ACTN2;CASQ2;KCNE2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.37507646226812696,1.4443026626421545,0.04878048780487805,0.14677141693040024,1.0,27/53,24.79%,DPEP1;BCL2L12;TRIAP1;ARL6IP1;LAMP3;IFI6;YWHAE;CD44;CSNK2A1;XIAP;GPX1;PAK2;CAAP1;LAMTOR5;DHCR24;MMP9;RNF34;PLAUR;PIH1D1;SFN;PAX2;RPS6KA1;SH3RF1;RPS6KA3;NAIP;THBS1;CARD16
prerank,protein phosphorylation (GO:0006468),-0.30286884534073116,-1.4442161386386856,0.0,0.16688220221000644,1.0,181/479,24.11%,PRRT1;PKD1;NRBP2;MKNK1;TNNI3K;DMPK;IP6K3;NIM1K;SIK3;MAP3K3;FGFR1;CSNK2A2;BRSK1;ULK1;TGFBR3;BMPR1A;PNCK;DDR2;TTBK2;MAP3K6;WNK3;PPP3CB;HIPK4;STRADA;CSNK1E;PXK;SNRK;CAMK2A;ULK2;PDGFRA;EEF2K;FGFR2;ILK;RPS6KA5;CLK3;CLK2;CDK9;MAPK10;DCLK1;CDC42BPA;PRKCB;CDK20;PRPF4B;PRKCA;STK36;PRKG1;TLR9;RPS6KA2;CDK3;CSNK1A1;FES;KIT;CAMK1;AURKC;PRKACA;DAPK1;GRK5;PRKD1;HIPK3;CDC42BPB;GDF7;DYRK1A;PRKAG2;ALK;LRRK2;PRKAA2;MAML1;MAST2;FLT4;NEK1;FER;MAP4K5;TLR3;GRK4;CDK17;FAM20B;TSSK3;MAST4;STK32B;NTRK1;PRKG2;TAOK2;MERTK;FAM20C;LATS2;MAST1;MEX3B;DAB2IP;ABI2;MAPK1;EPHA4;MAPK3;DAPK3;RICTOR;MARK1;RELN;MARK4;STK33;NEK10;BMX;PPP4R1;ERC1;MORC3;CDK15;BRD2;CAMK2B;PEAK1;MUSK;EPHA3;TRIB2;PDGFB;GDF6;BRAF;ROCK1;MAPK8;CAMK2D;SGK3;INSRR;MAP4K2;AATK;NEK7;MAPK14;ERG;AKT2;NRK;ACVR2A;MARK3;INSR;EGFR;CDK14;STK32A;ERBB4;SMAD2;CSNK1D;CCL11;USP15;CSNK2B;TESK2;RET;MAP3K10;SLK;PDK2;BMPR1B;MAP3K12;RPS6KB1;EFEMP1;GSK3A;STK19;CAMKK2;CRY1;MYLK3;CCL2;MAP2K6;MKNK2;GTF2H4;MAP3K7;SMAD7;TBCK;MAPK12;RNASEL;PAK3;PKN1;CDKL2;SMG1;TNKS;MTOR;NUAK1;LATS1;HIPK1;MYLK2;WNK1;PRKCD;CDK11B;RIPK1;PIM1;CDKL5;PINK1;FLT1;PKDCC;NRBP1;PRKCH
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.5047796999109564,-1.444070814827362,0.018867924528301886,0.1666119240476,1.0,12/23,18.20%,TSC1;FERMT2;MYOC;DUSP3;PIK3R1;COL16A1;PPM1F;RAC1;SFRP1;ROCK1;IQSEC1;MAPRE2
prerank,Golgi to endosome transport (GO:0006895),-0.5264442799774656,-1.4438040420282279,0.0851063829787234,0.16650387905064706,1.0,6/15,17.92%,MON2;CORO7;KLHL20;VPS13A;GBF1;EPS15
prerank,positive regulation of developmental process (GO:0051094),-0.3332761317908522,-1.443708138492113,0.0,0.16612945528798942,1.0,58/165,20.75%,GDNF;NR2C2;FGFR1;RAPGEF3;FZD4;BMPR1A;TAPT1;PHLDB1;PTN;NUMA1;SYDE1;NRXN1;PHLDB2;SRF;DVL3;ZDHHC15;SHANK3;DLG4;PACSIN1;NLGN1;CLASP1;KRT2;SOX5;AR;CAMK1;RBM19;PLD6;PSEN1;ALK;ZBTB16;CLASP2;DCN;CORO1C;CPEB3;BMP1;PRL;GRIP1;DAB2IP;DDHD1;DVL2;RELN;FST;CAMK2B;ENPP2;ARHGEF7;VLDLR;PDGFB;RTN4;TP53BP1;DLG5;INSR;PLCB1;ADGRL1;BMPR1B;SIRT1;INS;BNIP3;SOX6
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.43822588674768775,-1.4436332256238484,0.04,0.16570394281910633,1.0,14/31,17.46%,CLIP3;TTBK2;TUBB4A;STMN2;SNCA;CLASP1;DYRK1A;MAP2;CLASP2;NAV3;FGF13;APC;ATXN7;CAMSAP2
prerank,regulation of cellular response to stress (GO:0080135),0.3507190960663184,1.4420039966967506,0.0425531914893617,0.14851885769455264,1.0,43/114,18.57%,NUP37;RPA3;CEBPB;NUP155;NEK6;RAE1;NUP93;YWHAE;NUP35;AJUBA;CHCHD2;PNPT1;SEH1L;SEC13;NUP210;RSL1D1;NUP43;MANF;HSBP1;NUP50;PTGES3;NUP88;DNAJC2;NUP107;NEK4;FKBP4;MAPKAPK2;GSK3B;ARMT1;DNAJC7;MLST8;NUP205;NPM1;IER3;RPA2;NUP62;HSPH1;NUP160;HSP90AB1;DYRK3;NDC1;BAG4;MBTPS2
prerank,negative regulation of programmed cell death (GO:0043069),0.2935778370297945,1.441851444348216,0.0,0.14823067009504545,1.0,125/372,21.53%,MYC;MAD2L1;DCPS;DPEP1;ANXA4;TDGF1;CDK1;VDAC1;HSPD1;DHRS2;CBX4;VHL;RIPK2;TRIAP1;ARL6IP1;MET;GLO1;HDAC2;IFI6;KIF14;MYDGF;PTMA;FIGNL1;WNT5A;PRDX5;SHH;PRKDC;CARD14;LEF1;PSMD10;CDSN;CD44;CTSH;ARF4;CIAPIN1;SOX9;TMBIM6;ATAD3A;BCL2L1;BFAR;ERCC5;HSPA9;CLEC5A;HNRNPK;BCL2A1;CASP2;PPIF;HMGA2;XIAP;XBP1;AATF;DNAJC3;PRAME;PA2G4;HDAC1;MYD88;RELA;NAA15;ADAM10;IRAK1;CEACAM5;PAK2;IGF1R;PRELID1;SEMA4D;GSK3B;PROC;WDR73;ARHGDIA;TM7SF3;COPS5;PRDX2;POU4F1;PRLR;TAF9;NAA35;WNT11;THOC6;CIB1;DNAJA1;PLK1;DHCR24;PRKCI;VTCN1;NPM1;MMP9;KDR;BMP4;MIEN1;HTATIP2;UBA52;GATA6;PDCD10;YME1L1;NUP62;IFIT3;MED1;PLAUR;NUAK2;RAB7A;HSPA5;PPT1;ANXA5;CFL1;BAG4;API5;FHL2;BNIP1;BIRC5;TPT1;FXN;NFKBIA;PROK2;COMP;BID;TMEM14A;BIRC7;PAX2;UFM1;DDRGK1;RPS6KA1;UBE2Z;MCL1;OPN3;PRDX3
prerank,cardiac muscle cell differentiation (GO:0055007),-0.4813711835497463,-1.4407188358917646,0.0,0.16849304832253215,1.0,10/24,22.84%,MYOCD;MYH6;TCAP;SLC8A1;MEF2C;KDM6B;CBY1;AKAP13;ALPK3;TTN
prerank,heart looping (GO:0001947),-0.4244693907129616,-1.4406946725418408,0.0,0.16803673103304861,1.0,18/42,19.83%,NPHP3;PKD2;SRF;BBS4;BBS5;CCDC39;NDRG4;CCDC40;HAND1;FOXN4;SOX17;MEF2C;TBX2;BBS7;AHI1;SMO;SOX18;DLL1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.31289690942874154,1.4406946327159051,0.0,0.14884873817754324,1.0,57/182,18.05%,SPTBN2;MIA2;COPZ1;KDELR3;TMED2;TMED3;TMED9;KDELR2;COPB2;KDELR1;AREG;ERGIC3;BCAP31;FOLR1;LMAN2;STX17;CTAGE9;HYOU1;CAPZA1;SEC13;ARF4;COG6;CTSC;GOLT1A;F5;COG5;YKT6;COPA;CD55;YIF1A;TMED10;COPG1;F7;ZW10;TRAPPC6A;COPG2;YIF1B;SPAST;RAB2A;CTAGE8;PROC;CTAGE4;CTAGE6;COPB1;ARCN1;DCTN5;RAB1A;CTAGE15;TFG;VTI1A;DYNLL1;NSF;PREB;CTSZ;TMED4;CNIH1;CNIH4
prerank,cilium assembly (GO:0060271),-0.3125599657411977,-1.440260181656818,0.0,0.1681901104958873,1.0,132/292,28.65%,TTLL3;NPHP3;PKD1;FLNA;IFT80;WDR19;RFX2;CCDC13;GSN;DZIP1;DCTN1;CNGB1;TTBK2;RABL2B;CEP126;INTU;TUBB4A;EHD2;CSNK1E;IFT81;ACTR1A;SPATA6;BBS4;PAFAH1B1;CYS1;BBS5;DYNC2H1;WDR11;HDAC6;DZIP1L;CCDC39;STK36;INPP5E;CFAP44;CCDC66;CLASP1;CCDC40;EXOC7;BBS1;CC2D2A;PRKACA;FBF1;PARVA;CFAP54;TEKT2;TMEM80;NEK1;ABLIM3;TUBA1A;RAB23;PTPDC1;PRKAR2B;CEP164;CEP162;NPHP1;EXOC3;CCDC57;KIF17;BBS2;NINL;MARK4;DCTN2;DISC1;TEKT3;RILPL1;HAUS4;CLUAP1;CFAP70;PCM1;GBF1;CEP63;BBS7;RAB11FIP3;CEP290;TTC21B;ARMC9;BBS9;TXNDC15;PCNT;IFT122;HAUS3;AHI1;TMEM138;CDC14A;DYNLRB2;CSNK1D;ARL3;CDK5RAP2;RPGR;FUZ;CEP192;RAB8B;KIF3C;WDR35;CNGA4;DCX;CEP97;CEP89;RFX3;RSPH4A;UBXN10;RHO;IFT46;KIF3A;ARL6;BBIP1;TRAF3IP1;TTC8;C2CD3;CDC14B;WDPCP;EXOC1;KIFAP3;IFT43;ALMS1;ABCC4;AKAP9;CNTRL;TRIP11;SPAG16;CCP110;ASAP1;DYNC1H1;IFT172;IFT27;OCRL;IFT140;PTPN23;CEP19;CCDC28B;UNC119B;ATAT1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.4228910410111082,1.4401805832193098,0.022727272727272728,0.14889203025520864,1.0,16/33,31.81%,CALR;PDIA3;CANX;BCAP31;SEC13;TAP1;IDE;ERAP1;HLA-F;MFSD6;SEC24A;TAPBPL;TAPBP;SEC24D;ERAP2;SEC24C
prerank,regulation of DNA replication (GO:0006275),0.3868064243725848,1.4399988824987802,0.058823529411764705,0.14869515811893352,1.0,19/50,20.25%,S100A11;DSCC1;FBXO5;EREG;GTPBP4;MCIDAS;BLM;ESCO2;DNA2;DHX9;USP37;ORC5;ATAD5;CDT1;GMNN;CDC6;NPM2;PDS5A;ORC3
prerank,regulation of osteoblast proliferation (GO:0033688),-0.531985958199158,-1.43956437883739,0.05555555555555555,0.1685531758715936,1.0,8/16,24.67%,FGFR2;MN1;NPR3;SFRP1;RHOA;PLXNB1;SOX8;TNN
prerank,regulation of DNA recombination at telomere (GO:0072695),0.5103879188400671,1.4393557128616106,0.06521739130434782,0.14878187109940347,1.0,9/20,21.57%,POLR2F;POLR2D;POLR2C;POLR2K;POLR2J;POLR2G;POLR2H;POLR2I;POLR2L
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.5103879188400671,1.4393557128616106,0.06521739130434782,0.14878187109940347,1.0,9/20,21.57%,POLR2F;POLR2D;POLR2C;POLR2K;POLR2J;POLR2G;POLR2H;POLR2I;POLR2L
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.5273745372524161,-1.4393152986173223,0.09803921568627451,0.16852050020996168,1.0,8/16,22.65%,MAGI2;FSTL3;SKI;FST;ACVR2A;CSNK2B;SMAD7;IGSF1
prerank,positive regulation of collagen metabolic process (GO:0010714),0.5081299338844593,1.4387447052193278,0.07272727272727272,0.14857097935120994,1.0,8/15,17.46%,HDAC2;AMELX;RUNX1;SUCO;BMP4;F2R;TGFB1;CREB3L1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.5081299338844593,1.4387447052193278,0.07272727272727272,0.14857097935120994,1.0,8/15,17.46%,HDAC2;AMELX;RUNX1;SUCO;BMP4;F2R;TGFB1;CREB3L1
prerank,mismatch repair (GO:0006298),0.42476013112107447,1.438499134885448,0.044444444444444446,0.14849597290404215,1.0,11/29,17.11%,RPA3;TP73;EXO1;POLD2;LIG1;MSH3;PMS2;MSH6;RPA2;POLD1;RNASEH2A
prerank,positive regulation of calcium ion transport (GO:0051928),-0.43254856905536954,-1.4379755184717398,0.06557377049180328,0.16958718588436325,1.0,16/37,22.89%,CACNB2;ANK2;MYLK;WNK3;GRM6;CAMK2A;P2RX7;P2RX2;TRPC6;LGALS3;PDGFB;PLA2G1B;FFAR1;CCL2;WFS1;TRPC3
prerank,regulation of smooth muscle contraction (GO:0006940),-0.506534502251319,-1.4377035705655528,0.06521739130434782,0.1692647076354149,1.0,9/20,13.79%,MYOCD;CNN1;SRF;ADRB2;CHRM2;CHRNA3;PLCE1;DAPK3;SETD3
prerank,innate immune response (GO:0045087),0.30688419075294954,1.4376297188969729,0.0,0.1491295432507856,1.0,80/270,22.40%,CLPB;SIGLEC15;SHMT2;IFITM3;RNF39;IFITM1;SKP2;F12;SRMS;RIPK2;IFITM2;PPP1R14B;PHB;IFI6;CAPZA1;SERINC5;CYP27B1;LCN2;SYK;DEFA6;SRPK1;TKFC;TREM1;PML;ATAD3A;CLEC5A;COLEC10;SLPI;CYBA;RPL39;TRIM27;CLEC6A;MYD88;RELA;IRAK1;WFDC10A;TRIM14;NOS2;TRIM26;APOBEC3F;CXCL16;NLRC5;VNN1;GCH1;KYNU;PI3;TIFA;CXCL10;C3;BST2;TRIM11;ISG15;MX1;PPARG;RNF187;FRK;ADAM15;TRIM59;IL23R;PIK3CG;OTULIN;LYN;PGLYRP4;NOD2;FYN;LCK;ANG;CORO1A;PGLYRP3;NCF2;TRIM28;YES1;DMBT1;RNASE7;HMGB1;SERINC3;TRIM31;TRIM22;CYBB;MSRB1
prerank,response to interferon-alpha (GO:0035455),0.516610685770587,1.4375831640479608,0.0625,0.1487885883882814,1.0,6/17,14.63%,IFITM3;IFITM1;IFITM2;LAMP3;PDE12;BST2
prerank,blood circulation (GO:0008015),-0.41561516656825964,-1.436496485122732,0.018518518518518517,0.17008907666922707,1.0,21/48,21.23%,MYL2;NPR1;SGCG;HOXB2;AGTR1;PLN;SCPEP1;ADORA2A;SGCD;TRDN;MEOX2;ACTC1;CYB5R3;ADCY6;ROCK1;ELN;NPPB;COL4A3;AVPR1A;SOD1;HTR7
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.44760018664897916,-1.4363050971659266,0.04,0.1699746028586361,1.0,14/33,21.28%,ATP2B4;FGF2;STARD13;MECP2;ANGPT4;MEF2C;HDAC5;MEOX2;MAP2K5;RHOA;TBXA2R;CSNK2B;AGTR2;MMRN2
prerank,cellular response to glucagon stimulus (GO:0071377),-0.5283545760367618,-1.4362213480066472,0.05555555555555555,0.16952436115396982,1.0,7/17,15.58%,ADCY5;ADCY2;ADCY4;ADCY9;PRKACA;PRKAR2B;ADCY6
prerank,cellular response to chemical stress (GO:0062197),0.3342225378060337,1.4361893512192074,0.0,0.15006367589739436,1.0,38/100,22.28%,LRRC8E;ERO1A;DHRS2;SLC4A11;VRK2;CHCHD2;PRDX5;PNPT1;ERMP1;VKORC1L1;LRRC8D;ATP13A2;CYBA;PRDX1;NOX1;GPX1;GPX2;BRF2;LONP1;PRDX2;GSR;CYCS;SLC25A24;G6PD;TRPV4;ZFAND1;STOX1;PYCR1;FANCC;CAV1;TMEM161A;EIF2S1;NCF2;KEAP1;ZC3H12A;PRDX3;ALDH3B1;CYBB
prerank,negative regulation of cellular component organization (GO:0051129),-0.39227682780496853,-1.4361586253197807,0.017241379310344827,0.16910244011327594,1.0,21/68,19.06%,CRYAB;RAF1;ULK1;RAPGEF3;TMEFF2;CLU;SNX33;HSPA2;HDAC6;SYT11;AR;PRKD1;RTEL1;RDX;LGALS3;SACS;EPHA3;LRSAM1;DNAJB6;PACSIN3;DNAJB2
prerank,transcription by RNA polymerase I (GO:0006360),0.44141175867765464,1.4354117387316816,0.06521739130434782,0.15045382775832325,1.0,9/30,12.88%,POLR2F;POLR1C;CDK7;POLR1B;GTF2H3;TAF1A;POLR1A;TAF1B;POLR2K
prerank,regulation of protein phosphorylation (GO:0001932),-0.3224463491823194,-1.4348272368625956,0.0,0.1703298114314092,1.0,85/252,21.16%,TSPYL2;FLCN;CLIP3;HRC;EPHA7;FGF2;TARDBP;PPP2R5B;AKAP8L;PPP2R5D;WWTR1;WDFY2;SPTBN4;GPER1;ATG14;DVL3;ILK;P2RY1;FAXDC2;NTRK3;FGF22;ITGB3;RSPO1;FXR2;ATF4;PRNP;TBX1;TERF2IP;CADM4;SLIT2;PTEN;LRRK2;VEGFB;FLT4;FER;NPTN;CORO1C;PELI2;NTRK1;RARRES2;FBLN1;PID1;AKTIP;HSPB1;THPO;PLCE1;INPP5K;DAB2IP;MAPK3;FGF17;DVL2;LEPR;RAC1;PIK3R3;EFNA5;MUSK;FGF7;AKAP8;PIP5KL1;CCDC88A;MYADM;FGF5;FGF10;PDE8A;FAS;AKT2;FGF1;ACVR2A;INSR;FGF16;EGFR;ERBB4;CSNK1D;CDK5RAP3;ANGPT1;ANKRD54;LIMCH1;FKBP8;SIRT1;CAMKK2;PHIP;VEGFC;TESK1;FGF9;SOD1
prerank,regulation of fat cell differentiation (GO:0045598),-0.36951735629981985,-1.4345968057880925,0.03125,0.17019027886022772,1.0,37/79,25.44%,LMO3;ARNTL;FERMT2;RUNX1T1;WWTR1;WDFY2;GPER1;PPARD;RORA;NR1D1;ZADH2;GNB3;ZFPM2;ZBTB16;ZFP36L1;SIRT2;RARRES2;ASXL1;SFRP1;GATA2;PTPRQ;TRIB2;GPS2;TRIO;ZFP36;FTO;MEDAG;SIRT1;ZNF385A;ANKRD26;ID2;TMEM64;LPL;WNT10B;ZFP36L2;BBS12;SMAD3
prerank,protein monoubiquitination (GO:0006513),0.42596299651688097,1.433830033967342,0.05405405405405406,0.15157173743969668,1.0,14/36,21.83%,UBE2T;RAD18;RNF40;FANCL;UHRF1;UBE3D;DTX3L;LEO1;KBTBD8;RAG1;CTR9;KLHL12;CUL3;DTL
prerank,cation transport (GO:0006812),-0.3317288668729563,-1.4330734261181046,0.0,0.17138224603521424,1.0,74/168,28.86%,SCNN1D;KCNMB1;KCNQ4;ATP1A2;KCNA5;SCN7A;CNGB1;KCNMA1;KCNK3;SCN3B;SCN9A;ABCC8;SLC8A2;SCN4A;KCNIP2;SCN11A;KCNA2;SLC8A1;KCNK4;PIEZO2;ATP1A4;TRPC6;SCN4B;ABCC9;KCNA1;ATP10D;KCNAB3;KCNMB2;SLC8A3;KCNJ8;AQP1;KCNMB4;SCN3A;SCNN1B;RHAG;SLC41A1;KCND3;SLC47A1;FGF13;MCOLN1;KCNA4;SCNN1G;KCNC1;KCNJ1;SLC6A17;PIEZO1;KCNS2;SLC36A4;SCN5A;KCNN1;KCNS3;KCNK7;KCNF1;ANO6;TRPM7;KCNG1;KCNH1;KCNK6;KCNMB3;KCNJ5;KCNN2;CLN3;SLC9B2;KCNC4;SCN1A;NEDD4L;SLC39A1;SGK1;SLC6A9;KCNB2;SLC4A4;SLC6A3;SLC17A4;CALHM1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.4505874200645905,-1.4327191166903157,0.05357142857142857,0.17134265790521963,1.0,12/31,13.01%,FAM107A;DUSP22;MYOC;PHLDB2;ARHGAP6;DLC1;APOD;PTEN;CLASP2;SEMA3E;CORO1C;AJAP1
prerank,plasma membrane organization (GO:0007009),-0.3962146565492167,-1.4322766190944296,0.017241379310344827,0.1713796375965427,1.0,34/60,29.63%,ANK2;EHD2;PLSCR4;ANK3;WHAMM;MICALL1;SNX33;P2RX7;PACSIN1;STX2;A4GALT;SYT11;EPB41L3;AHNAK2;ANXA6;DYSF;SYTL4;RAB3A;PACSIN2;PACSIN3;CHMP4A;DEGS1;ABCD1;CAV3;ANO6;ABCD2;SMPD1;CLN3;PLSCR5;OTOF;UGCG;MYOF;SNX9;ARL8B
prerank,positive regulation of phospholipase activity (GO:0010518),-0.47172867006603014,-1.432113698990025,0.07142857142857142,0.1710610943222573,1.0,8/24,8.13%,FGFR1;FGF2;PLA2G5;AGTR1;PDGFRA;FGFR2;NTRK3;KIT
prerank,negative regulation of neuron projection development (GO:0010977),-0.40815184627850787,-1.4318818406190625,0.03225806451612903,0.17092146964139104,1.0,23/55,18.60%,LPAR1;STX1B;CRMP1;PTPRS;STMN2;DENND5A;NLGN1;RUFY3;DPYSL3;NGFR;GDI1;PTEN;EPHA4;MAG;RHOA;KANK1;ADCY6;MCF2;SEMA3A;RTN4;SPOCK1;MYLIP;DCC
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.45405019161064447,-1.4303935998534902,0.03225806451612903,0.17227184439395493,1.0,16/31,23.32%,MYH7;TPM1;MYL2;TGFBR3;MYH6;TCAP;FGFR2;S1PR1;HAND1;ACTC1;MYL3;ANKRD1;MYBPC3;SMAD7;TTN;MYLK2
prerank,digestive tract development (GO:0048565),-0.44463073360738675,-1.4302893700611679,0.02,0.1719031288974349,1.0,17/38,17.54%,PKD1;FOXF1;CLMP;GLI3;FGFR2;CCDC39;CCDC40;RARB;KIT;MEGF8;GLI2;RARRES2;NPY;BBS7;EDNRB;PCSK5;SMO
prerank,positive regulation of cell junction assembly (GO:1901890),-0.3886114786154287,-1.4297831187121701,0.03225806451612903,0.17221422839248537,1.0,19/56,15.69%,TSC1;NLGN2;NLGN3;FERMT2;MYOC;SLITRK2;NRXN1;CUX2;CLDN5;COL16A1;NLGN1;LRRC4B;PPM1F;BHLHB9;NPHP1;RAC1;SFRP1;IL1RAPL1;ROCK1
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.49734833174527243,-1.429058184524865,0.08163265306122448,0.17242349738303395,1.0,9/20,17.44%,ATP1A2;OR51E2;GPER1;AR;ATP1A3;NR3C1;MGARP;TFPI;TRERF1
prerank,mRNA processing (GO:0006397),0.3059601855162522,1.4286111635848047,0.0,0.15600292779542102,1.0,111/292,22.56%,POLR2F;POLR2D;CSTF2;CPSF3;ALYREF;SNRPF;SNRPD1;PRPF19;THOC3;LSM7;CDK7;LSM5;PABPC1;HNRNPF;PPIH;LSM4;SNRPG;SF3B3;U2AF1;CSTF1;MAGOH;PRPF4;PPIL1;SNRPB;RNF113A;GTF2H3;SNRPC;EFTUD2;MAGOHB;LSM8;TBRG4;EIF4A3;PHF5A;SNRPD2;NCBP1;SNRPE;DDX39A;SRSF9;SF3B6;PTBP1;NONO;RALY;RSRC1;SNRNP40;BUD31;SNRPB2;RBM15;HNRNPK;DHX9;NUDT21;SF3B5;PRPF40A;PRPF6;LSM2;CLP1;SNRPA1;GEMIN6;NCBP2;PSPC1;HNRNPC;FUS;CRNKL1;POLR2C;CPSF2;GTF2F2;ELAVL1;DHX8;POLR2K;HNRNPA0;THOC6;RBM22;POLR2J;UBL5;LSM6;CTNNBL1;POLR2G;USP39;PUF60;DDX41;LSM3;ELAVL2;SYNCRIP;TRA2B;SF3A3;HNRNPR;PPIL3;RBM8A;CPSF4;RPRD1B;HNRNPA2B1;SNRPD3;CDC5L;ERCC2;POLR2H;SRSF3;DBR1;WDR83;TFIP11;HNRNPA1;RBM15B;POLR2I;POLR2L;RBMX2;TXNL4A;GEMIN2;CSTF3;U2AF2;GPKOW;RNGTT;GEMIN5;CMTR2
prerank,negative regulation of protein ubiquitination (GO:0031397),0.3913698074433733,1.4277041489017357,0.02,0.15666465952461125,1.0,9/49,6.98%,GNL3L;SOX4;PRR7;FBXO5;PRMT3;GTPBP4;LIMK1;RPS3;TNFAIP3
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.49080289768708424,-1.4276085920616288,0.05357142857142857,0.17395496129124732,1.0,20/30,32.45%,CSNK2A2;ABLIM3;NPEPPS;HSPA1L;LEPROT;ARIH2;VPS11;RNF31;FBXW7;GSK3A;RHOU;BAP1;PINK1;UBL4B;MICALL2;SH3GLB1;SAE1;HPS4;TOMM7;ATG13
prerank,sensory perception of bitter taste (GO:0050913),0.3999010815752333,1.4270733097102049,0.043478260869565216,0.15694639011805725,1.0,5/37,5.24%,CST1;AZGP1;CST4;CST2;LPO
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4077186536289182,1.4268058811926794,0.041666666666666664,0.15667780343048818,1.0,9/29,15.64%,RPA3;CDK7;GTF2H3;ERCC5;RAD23B;DDB1;UBA52;RPA2;CUL4A
prerank,positive regulation of translational initiation (GO:0045948),0.45958643456492604,1.4267086960715782,0.06818181818181818,0.15635300622805925,1.0,8/22,19.62%,POLR2D;CDC123;KHDRBS1;YTHDF1;YTHDF2;POLR2G;RPS6KB2;UHMK1
prerank,axonal transport (GO:0098930),-0.4229018498193687,-1.4259285112775675,0.02040816326530612,0.17532876262918287,1.0,17/36,24.67%,AP3S2;DCTN1;MAPT;HAP1;PAFAH1B1;TMEM108;KIF1A;DST;KIF1B;AP3B2;MGARP;NEFL;BLOC1S1;SNAPIN;SOD1;KIF3A;FBXW11
prerank,neuron projection extension (GO:1990138),-0.44351523854409,-1.4258603407244972,0.04081632653061224,0.1749071171075602,1.0,8/32,7.04%,ULK1;NLGN3;NRP2;PPP3CB;MAP1B;ULK2;TMEM108;FLRT1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.4720677966447795,-1.4258594965047204,0.05172413793103448,0.17443819722255335,1.0,17/28,27.99%,CACNA1H;KCNB1;SYT10;SYT11;CACNA1G;SYT2;SYT9;SYT6;SYT5;RAB3GAP1;CACNA1I;SYT1;SYT3;STXBP1;DOC2B;SYT15;STX1A
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5278031438317624,1.425358705344369,0.058823529411764705,0.1574666490330201,1.0,9/18,16.10%,HSD17B12;TECR;ACSL6;HACD2;ACSL3;ELOVL1;ACSL5;ELOVL7;ACSF3
prerank,insulin receptor signaling pathway (GO:0008286),-0.3682242235318684,-1.4252614457535886,0.01694915254237288,0.17476222893417429,1.0,29/72,22.45%,ATP6V1G2;SORBS1;GAB1;PIK3R1;ZNF106;RHOQ;CAV2;FER;SOGA1;GRB10;FOXO4;RARRES2;GRB14;PIK3R3;APC;BAIAP2;SOS1;AKT2;INSR;ATP6V0A1;ATP6V1B1;PDK2;ATP6V1E1;TCIRG1;GSK3A;INS;PHIP;PIK3R2;BCAR3
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.34081622303447073,1.4250404507715448,0.0,0.15751406518774785,1.0,37/99,21.49%,TRIB3;CEBPB;E2F1;TP73;ERO1A;CHEK2;IFI6;PMAIP1;C1QBP;PRKDC;PML;BBC3;IKBKE;EPHA2;BCL2L1;ZNF622;BCL2A1;CASP2;CHAC1;AIFM1;STK24;TNFRSF10B;POU4F1;BRCA1;MSH6;TRAF2;GSKIP;CUL4A;HINT1;TNFRSF1B;BAX;SFN;BAK1;IFI16;DNAJC10;CUL3;MCL1
prerank,response to ionizing radiation (GO:0010212),0.379168170927981,1.4249544805932308,0.0,0.15730396821689052,1.0,15/67,7.04%,RFWD3;MYC;INTS7;BRCC3;RAD51AP1;RHNO1;BLM;TICRR;FIGNL1;NABP2;XRCC4;INIP;TOPBP1;RAD9B;ECT2
prerank,rRNA transcription (GO:0009303),0.5208997339206309,1.424361834277055,0.11363636363636363,0.15740858236653618,1.0,12/15,33.24%,NIFK;GTF3A;TAF1B;GTF3C4;GTF3C3;ANG;GTF3C2;SIRT7;GTF3C6;TCOF1;GTF3C5;GTF3C1
prerank,positive regulation of cell differentiation (GO:0045597),-0.3107938969691904,-1.424221322242413,0.0,0.1755279715627198,1.0,97/247,25.70%,TGFB1I1;GDNF;TMEM100;FGFR1;LMO3;ADRA2B;ARNTL;CDON;RAP1A;IL6R;BMPR1A;PLA2G5;BOC;ZHX3;GLIPR2;DDR2;FERMT2;GCNT2;PTN;RBM24;AGTR1;SMAD4;WWTR1;WDFY2;MEF2A;HOXD3;SRF;SMYD1;PPARD;RBM4;CD34;HOXB4;NGF;FES;SOX5;AR;CAMK1;OLFM1;BNIP2;PRKD1;KITLG;ZBTB16;ZFP36L1;RRAS;RARRES2;MEF2C;HIF1AN;TIAM1;MAPK11;SFRP1;MMD2;CDH2;RHOA;RANBP3L;TCF15;GDF5;GDF6;SPAG9;TCF4;GPRC5B;ZC4H2;SIN3A;ZFP36;MAPK14;HOXA5;SOX11;ACVR2A;MEDAG;PCP4;GPC1;SMAD2;BEND6;CD36;PLCB1;BMPR1B;INS;RAPGEF2;SOX6;ZNF385A;MAPK12;DLX1;MTOR;ID2;HGF;VWC2;PKDCC;PRKCH;TMEM64;LPL;MMD;AKIRIN1;TGFB3;NBL1;HOXA11;SMAD3;MYF6;RUNX2
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.4452311376326298,-1.4235841194519565,0.03636363636363636,0.17597023128950157,1.0,15/26,25.23%,NKX3-2;WNT9A;CHADL;SOX5;ZBTB16;TRPS1;GDF5;GDF6;BMPR1B;EFEMP1;SOX6;ADAMTS7;PKDCC;SNAI2;HOXA11
prerank,cellular defense response (GO:0006968),0.3829450940191159,1.422721937835226,0.06521739130434782,0.15879232037959362,1.0,17/47,25.76%,CLEC5A;LGALS3BP;DCDC2;RELA;ADORA2B;CXCL9;CXCR2;CCR3;PRF1;GNLY;IL1RL2;MNDA;NCF2;ITK;TYROBP;FOSL1;BECN1
prerank,protein localization to membrane (GO:0072657),-0.341220304565232,-1.42191821991909,0.01818181818181818,0.1773168228714003,1.0,66/191,20.63%,DPP6;KCNB1;KCNIP3;NLGN2;FLNA;CACNB2;ANK2;WDR19;CYP46A1;RAP1A;DLG2;FERMT2;CAPN3;KCNIP4;RABEP1;WNK3;PTN;MAGI2;EHD2;SCN3B;RAB34;ACTN2;NRXN1;ANK3;SYNE3;TTC7B;SLMAP;LRRC7;SPTBN4;TMEM88;ZDHHC15;SHANK3;P2RY1;DLG4;RAB12;PACSIN1;NLGN1;EPB41L3;CLASP2;NRXN2;RAMP1;MYO5A;FAM126A;RDX;SYNJ2BP;INPP5K;RAB3A;TMEM150A;PACS2;FGF13;BRAF;ROCK1;MYADM;RAB13;RAB3C;PLEKHF1;RAMP3;ARL3;EFR3B;SAV1;RAPGEF6;RAB40A;RAPGEF2;RAB8B;TM9SF1;MADCAM1
prerank,negative regulation of signal transduction (GO:0009968),-0.31221463593880383,-1.4215747984763634,0.0,0.17711657058131863,1.0,83/251,19.92%,TNS2;KANK2;NTN1;CSNK2A2;DACT3;SFRP5;PALM;EPN2;FGF2;PTCH2;RGS2;GLI3;NXN;NLGN4X;TMEM25;TRABD2B;PLIN5;KIF7;SNCA;PRKCB;METTL3;TLR9;NDRG4;CILP;BCL2;NCK1;PIP4K2B;APOD;NFATC1;FSTL3;CADM4;PTEN;CARD8;LRRK2;DCN;TULP3;MEGF8;EMILIN1;SPRY1;GRB10;HEY1;PID1;HIF1AN;INPP5K;DAB2IP;EGFL7;CYP26B1;GRB14;SPRY3;ASXL1;SEMA6A;SFRP1;TMBIM1;GATA2;IGFBP5;PIP4K2A;GLIS2;KANK1;LEPROT;BTRC;TLE1;CRHBP;GPS2;IFT122;TSC2;KCTD21;HIC1;EGFR;GPC1;SUFU;BEND6;DCC;LRRC14;DKK3;TAX1BP3;FBXW7;AGTR2;HHEX;RPS6KB1;DLL1;CBY1;GSK3A;ZNF653
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.38563936018971073,1.4215049395731423,0.0425531914893617,0.1595449094238395,1.0,24/49,26.45%,P4HB;BCAP31;PMAIP1;BBC3;STYXL1;BCL2L1;RTKN2;NOC2L;PPIF;PTPMT1;MMP9;PLAUR;UBQLN1;SLC9A3R1;LCK;BAX;BID;URI1;CAV1;MCL1;TP53;NDUFS3;BECN1;BCL2L10
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.31064462691186806,-1.421426029172189,0.0,0.17674674653538136,1.0,135/356,25.01%,RBPMS;FLCN;CLIP3;ATP2B4;RAF1;CSPG4;CAPRIN2;TENM1;RAPGEF3;RAP1A;IL6R;BMPR1A;FGF2;DDR2;WNK3;SMAD4;WDFY2;GPER1;CALM1;TRIM6;ATG14;DVL3;ILK;P2RY1;FAXDC2;RPS6KA5;GH1;NTRK3;SNCA;CDK9;FGF22;ITGB3;HDAC6;RSPO1;TAB2;FXR2;PRNP;NGF;BMP3;TBX1;CAMK1;TERF2IP;GHR;PRKD1;GDF7;NOS1;PRKAG2;MSTN;LRRK2;VEGFB;FLT4;NPTN;ANGPT4;MTCP1;PELI2;NTRK1;TAOK2;RARRES2;AKTIP;MAPRE3;THBS4;THPO;MAPK1;MAPK3;FGF17;DVL2;LEPR;RAC1;PIK3R3;RELN;EFNA5;NEK10;CDKN1A;MMD2;ENPP2;MUSK;PDGFB;S1PR2;GDF5;FGF7;GDF6;BRAF;NTF3;RAD50;FGF5;DUSP19;FGF10;PDE8A;AZU1;FAS;TNK2;AKT2;FGF1;ACVR2A;INSR;FGF16;EGFR;ERBB4;CSNK1D;ALS2;CSNK2B;RAMP3;RASSF2;ANGPT1;LIMCH1;CAMKK1;SIRT1;INS;CCL21;RAPGEF2;CAMKK2;VEGFC;TESK1;FGF9;PDGFD;TNFRSF14;RPTOR;SH2D3C;BCAR3;PIN1;INHA;CALM2;LATS1;HGF;PLCG2;RIPK1;ADCYAP1;PINK1;NKX3-1;GDF11;TWSG1;PDGFA;MMD;TGFB3;GPNMB
prerank,negative regulation of peptidase activity (GO:0010466),0.35888905350811706,1.420999287882015,0.0,0.15961464864197944,1.0,24/52,27.92%,SERPINB5;GAPDH;CSTB;TIMP1;SERPINB1;CRB2;SERPINE3;SERPINA10;SERPIND1;SERPINA7;SERPINA4;SERPING1;SERPINB7;AGT;SERPINE1;CST7;SERPINB8;CSTA;SERPINA1;KNG1;SERPINE2;SERPINH1;SERPINB9;PARK7
prerank,hemopoiesis (GO:0030097),-0.35889003753578164,-1.420376440707676,0.016666666666666666,0.17769168201550123,1.0,30/94,15.95%,YJEFN3;FLCN;MEIS1;TGFBR3;TPO;KIRREL3;SNRK;L3MBTL1;ZNF160;FGFR2;TAL1;CD34;ATF4;KIT;KMT2A;KITLG;FSTL3;ZBTB16;FLT3LG;FLT4;RRAS;MFAP5;NOTCH4;WNT2B;TOX;FST;SFRP1;PDGFB;ARIH2;NOTCH2
prerank,regulation of signal transduction (GO:0009966),-0.32494759029019643,-1.420157279180309,0.015151515151515152,0.1776375078972904,1.0,63/192,20.87%,TSPYL2;NCAM1;TCF7L1;YJEFN3;GDNF;LIFR;IGFBP6;RGS11;GNG7;SOCS2;ZDHHC17;CLU;INTU;RGS2;PXN;WWTR1;USP20;IFT81;SLC8A2;GIT2;FGFR2;ILK;WDR11;RORA;TMEM108;FRRS1L;RIC8B;ZDHHC7;PRNP;KCTD8;GRK5;NCK1;PRKD1;TMEM204;LRRK2;TULP3;GRK4;RGS5;SYNJ2BP;SLC8A3;PLCE1;IGFBP4;OGT;RGS8;IGFBP5;LRIT3;ESR1;GDF5;CD63;TSC2;GAS1;RSPO3;CD36;PLCB1;ANKRD54;RGS6;MDFIC;DLL1;SIRT1;RGS12;FUZ;RFNG;ZFAND2B
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.36642482631277473,-1.419375207845613,0.0,0.1778496421703281,1.0,23/65,18.32%,NRP2;PXN;PIK3R1;ITGB3;SHC2;NCK1;PRKD1;VEGFB;FLT4;DOCK1;NCKAP1L;HSPB1;DAB2IP;MAPK11;ELMO2;RAC1;CLEC14A;RHOA;ROCK1;ELMO1;BAIAP2;MAPK14;WASF2
prerank,axon extension (GO:0048675),-0.4674709638148938,-1.4184576723801348,0.1509433962264151,0.17873605459389222,1.0,8/23,10.63%,ULK1;NLGN3;NRP2;PPP3CB;MAP1B;ULK2;SLIT2;SLIT3
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.5148194400401703,-1.4182501391907456,0.11320754716981132,0.1785592934400365,1.0,13/21,26.55%,AHNAK;CACNB2;DMD;NPPA;CACNB1;GNB5;STAC2;STAC;CRHR1;DRD4;CACNB3;CACNB4;NOS1AP
prerank,cellular response to insulin stimulus (GO:0032869),-0.3414232939060648,-1.4176579780631953,0.0,0.17871938922749653,1.0,47/124,20.55%,VAMP2;SLC2A4;ATP6V1G2;SORBS1;GAB1;KAT2B;PDE3B;PIK3R1;ZNF106;CPEB1;RAB12;ZDHHC7;CPEB2;RHOQ;CAV2;ZFP36L1;GCK;FER;MYO5A;SLC27A1;SOGA1;GRB10;FOXO4;RARRES2;HDAC5;INPP5K;GRB14;PIK3R3;LPIN1;HDAC9;PLA2G1B;APC;BAIAP2;SOS1;RAB13;AKT2;INSR;ATP6V0A1;ATP6V1B1;PDK2;ATP6V1E1;TCIRG1;RPS6KB1;GSK3A;INS;RAB8B;PHIP
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.37105653749881595,-1.4173742769825557,0.057692307692307696,0.17851965365234893,1.0,36/80,27.43%,GPR17;PTH1R;LPAR1;GALR2;AGTR1;ACTN2;P2RY1;ADRA1A;PTGER3;CHRM2;ADRA1D;VIP;PLCE1;TACR1;P2RY12;GPR20;HTR2B;OPRL1;ESR1;P2RY11;C5AR2;LHCGR;LPAR6;CCKAR;GNA11;ADRA1B;LPAR4;HTR2A;GNA14;NMBR;F2RL3;GPR4;P2RY4;F2RL1;CCKBR;NMUR1
prerank,negative regulation of cell junction assembly (GO:1901889),-0.4634745202494205,-1.416236926400172,0.03636363636363636,0.1799203483840907,1.0,9/25,11.28%,FAM107A;DUSP22;PHLDB2;ARHGAP6;DLC1;APOD;PTEN;CLASP2;CORO1C
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.5065755642018853,1.4161058241933473,0.11538461538461539,0.16431173398756094,1.0,9/22,11.10%,DUSP4;DUSP18;PPM1G;DUSP16;PPP1CA;DUSP9;DUSP6;PDP1;DUSP1
prerank,regulation of phospholipase C activity (GO:1900274),-0.5217797903439884,-1.415608152754429,0.0784313725490196,0.1803614195045581,1.0,9/15,23.93%,FGFR1;FGF2;PDGFRA;NTRK3;KIT;ESR1;NTF3;PLCG1;FLT1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.329425252685101,1.4147046144163045,0.0,0.16532583512653226,1.0,30/110,14.58%,PSMD14;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;PSMA7;PSMD13;SYK;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;CARD11;PSMB5;RELA;PSMD8;PAK2;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;FOS;PSMF1;PSMD11;PSMD1;PAK1
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.4921743407421444,-1.414673083024428,0.08163265306122448,0.18122770274592268,1.0,6/22,8.04%,RBPMS;SH2B1;BMPR1A;SMAD4;WWTR1;CILP
prerank,positive regulation of bone mineralization (GO:0030501),-0.4264830712858615,-1.4140463483675563,0.019230769230769232,0.18140259193350985,1.0,14/35,24.84%,GPM6B;BMPR1A;OSR1;PTN;P2RX7;SLC8A1;KL;MEF2C;ACVR2A;BMPR1B;OSR2;ANO6;PKDCC;TGFB3
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.3742690533580989,-1.4140101371429767,0.015873015873015872,0.1809622740878814,1.0,35/69,27.72%,PLCD4;PITPNM2;FGFR1;PIRT;NYAP1;PDGFRA;PI4KB;PIK3R1;PLCL1;PI4KA;INPP5F;NGF;PTEN;ZFP36L1;SIRT2;NTRK1;PIK3C3;PLCE1;OGT;RHOA;HTR2B;MYO16;PLCD1;PLCB1;RPS6KB1;PIK3R2;PLCB2;KCNH1;HTR2A;EXOC1;PIK3C2A;PLCL2;PIK3R5;TPTE2;LTK
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.4983609210774924,-1.4139403790575216,0.08,0.18064203840336293,1.0,10/21,21.04%,BMPR1A;FGF2;MEF2D;FOXJ2;ADAMTS1;MFN2;IGFBP5;PDGFB;NR4A3;FGF9
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.5094385216234166,-1.4135876748718292,0.0847457627118644,0.1806760398327393,1.0,6/15,13.20%,CACNA1H;KCNB1;SYT10;NLGN1;CACNA1G;RAB3A
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.4391712419498562,-1.413348978436888,0.04411764705882353,0.1806160786732074,1.0,16/38,15.78%,CACNA1C;CACNB2;ANK2;KCNA5;SCN3B;CACNA2D1;CTNNA3;KCNH2;SCN2B;SCN1B;KCNE2;SCN4B;CACNA1G;KCND3;KCNE1;CAMK2D
prerank,negative regulation of viral genome replication (GO:0045071),0.38064226162240755,1.4125680702915022,0.018867924528301886,0.16748575743743405,1.0,18/51,21.67%,IFITM3;IFITM1;IFITM2;SRPK1;PROX1;SLPI;OAS2;HMGA2;APOBEC3F;BST2;OASL;ISG15;MX1;BANF1;PLSCR1;OAS3;IFI16;APOBEC3B
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.34579366060676214,1.41244336730404,0.0,0.16717050489058713,1.0,38/97,19.89%,NUP37;CPSF3;ALYREF;THOC3;NUP155;U2AF1;MAGOH;RAE1;SLBP;NUP93;NUP35;MAGOHB;EIF4A3;NCBP1;SEH1L;DDX39A;SRSF9;SEC13;NUP210;NUP43;NXT1;GLE1;NUP50;NUP88;NUP107;EIF4E;NCBP2;CPSF2;NUP205;THOC6;NUP62;NUP160;NDC1;RBM8A;CPSF4;HNRNPA2B1;SRSF3;NXF3
prerank,regulation of receptor internalization (GO:0002090),-0.45456714061791387,-1.412137538595639,0.05660377358490566,0.18163227543718613,1.0,12/35,19.12%,MAGI2;DLG4;GH1;RSPO1;RIN3;ATXN2;ANKRD13A;NTF3;CD63;AHI1;INSR;ANGPT1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.4508294094115886,-1.4108794587135733,0.09259259259259259,0.18278331435325754,1.0,11/23,25.99%,GSN;GPER1;PLA2G1B;ECSCR;PIAS4;PLA2R1;CCL2;PLCG1;ANO6;PDCD4;RGCC
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.33032628157184357,-1.4104447182533968,0.029850746268656716,0.18288139049601151,1.0,57/143,27.04%,ADCY5;ATP2B4;CACNA1C;HRC;ATP1A2;LPAR1;TRPC1;SCGN;AGTR1;PDGFRA;SLC8A2;GPER1;PLN;P2RY1;DLG4;RYR1;TMEM178A;SLC8A1;CDH23;ADRA1A;PTGER3;PRKACA;CCR10;ADRA1D;TRPC6;TRPC4;CAV2;NPTN;RYR2;ATP2B3;PLCE1;TACR1;S1PR3;ACKR3;ESR1;TBXA2R;CACNA1A;ACKR2;FFAR1;CD36;C5AR2;PTGFR;CALB2;CAV3;TRPC3;ADRA1B;ADCYAP1;CHRNA10;C1QTNF1;CLN3;SMAD3;BDKRB1;P2RY4;TAC1;F2RL1;CCKBR;AVPR1B
prerank,regulation of cell killing (GO:0031341),0.49583574531926866,1.4099426823438799,0.08695652173913043,0.16959404649741192,1.0,7/16,9.88%,IL11;WNT5A;TGFB2;CD55;CYBA;ICAM1;NOX1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.3211415908106536,-1.4096411147150034,0.016666666666666666,0.18369854098748536,1.0,68/220,20.61%,FLCN;HAND2;LMO3;EPHA7;TGFBR3;RAP1A;FGF2;PLA2G5;GLIPR2;MTURN;FERMT2;GCNT2;ZDHHC17;CCL14;SMAD4;PDGFRA;DUSP3;ROR2;GPER1;FGFR2;P2RY1;DUSP26;NTRK3;CNKSR3;PRKCA;ADRA1A;NDRG4;NECAB2;DSTYK;TNFAIP8L3;PTEN;FLT4;EMILIN1;SPRY1;RRAS;NTRK1;ROR1;FBLN1;SYNJ2BP;THPO;TIMP3;DAB2IP;MAPK3;RANBP9;SPRY3;SEMA6A;MAP2K7;ACKR3;NEK10;FAM83D;HTR2B;PDGFB;BRAF;NOTCH2;FGF10;PDE8A;EGFR;CCL23;ERBB4;CCL11;RAMP3;CD36;FBXW7;ANGPT1;MAP3K12;CCL21;RAPGEF2;CCL2
prerank,regulation of cell differentiation (GO:0045595),-0.32793912577684575,-1.4094439016037437,0.0,0.18346968034071912,1.0,44/150,16.84%,DDX17;GDNF;FGFR1;RAF1;KLHL41;PHLDB1;PHLDB2;SRF;LTBP4;FGFR2;CDK9;NLGN1;CASZ1;PRKCB;MEGF10;NR1D1;ATF4;GNB3;KIAA1109;CLASP1;NGF;TBX1;FES;AR;CAMK1;PRKACA;ALK;ZFP36L1;CLASP2;CEBPD;TRPS1;HEY1;NOTCH4;LGALS3;TIAM1;SUPT6H;ZFHX3;PTPRQ;EPHA3;ROCK1;HEY2;APC;NTF3;GPS2
prerank,negative regulation of organelle assembly (GO:1902116),-0.4378147979164031,-1.408909369140265,0.08333333333333333,0.1836345923546296,1.0,16/34,23.85%,MDM1;KAT2B;SMAD4;EVI5L;LRRK2;FEZ2;TCHP;KAT2A;NUPR1;CHMP4A;CDK5RAP2;ODF2L;TESK1;CEP97;CAV3;PINK1
prerank,regulation of cytoplasmic translation (GO:2000765),-0.534202888195396,-1.4089085465942268,0.12727272727272726,0.1831766507278101,1.0,8/15,22.57%,RBM24;CPEB1;CPEB2;CPEB3;YBX3;UNK;ZNF385A;CPEB4
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.49034010185446164,-1.408800513320232,0.07017543859649122,0.18281291094284313,1.0,9/23,15.78%,HAND2;RGS2;PDE9A;SMAD4;MEF2A;PRKCA;MLIP;ROCK1;CAMK2D
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.4562896382480037,-1.408075865246844,0.06779661016949153,0.18311576816547023,1.0,11/24,13.03%,TMEFF2;MYOC;PHLDB2;PIK3R1;ARHGAP6;DLC1;CLASP1;CLASP2;ARHGEF18;INPP5K;TJP1
prerank,neuromuscular synaptic transmission (GO:0007274),-0.5060286653933553,-1.4077426777331647,0.10714285714285714,0.18300551803236667,1.0,11/19,23.68%,DTNA;SLC5A7;CHRNA3;FCHSD1;KIF1B;CHRNB4;ERC1;FCHSD2;CHAT;ERC2;TBC1D24
prerank,negative regulation of viral process (GO:0048525),0.3658708614367746,1.406141395185653,0.04,0.17261819747400903,1.0,24/67,21.70%,IFITM3;IFITM1;IFITM2;SRPK1;PML;PROX1;SLPI;OAS2;TRIM27;TRIM14;TRIM26;STAT1;APOBEC3F;BST2;TRIM11;OASL;ISG15;MX1;BANF1;PLSCR1;OAS3;TRIM28;IFI16;TRIM31
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.4573282670738976,-1.406061614819926,0.05454545454545454,0.18465223259262073,1.0,22/36,31.07%,CSNK2A2;LRRK2;ABLIM3;NPEPPS;HSPA1L;LEPROT;ARIH2;VPS11;RNF31;FBXW7;PARL;GSK3A;RHOU;BAP1;PINK1;UBL4B;MICALL2;SIAH3;SH3GLB1;SAE1;HPS4;TOMM7
prerank,dendrite morphogenesis (GO:0048813),-0.4428955717357725,-1.4060212824752802,0.04,0.18424293307536196,1.0,12/35,14.07%,MAP6;CTNND2;PTN;MEF2A;SHANK3;DLG4;DIP2A;PTEN;MAP2;SDC2;TAOK2;KLF7
prerank,positive regulation of phosphorylation (GO:0042327),-0.31613848664736144,-1.405645507597467,0.0,0.18426691751534452,1.0,84/243,21.04%,FLCN;CLIP3;FGFR1;EPHA7;FGF2;DDR2;WDFY2;PDGFRA;ROR2;GPER1;ARNT;ATG14;DVL3;FGFR2;ILK;P2RY1;FAXDC2;NTRK3;P2RX7;FGF22;ITGB3;RSPO1;FXR2;TBX1;KIT;AR;DSTYK;PSEN1;FZD7;ALK;LRRK2;EPHA5;PRKAA2;VEGFB;FLT4;NCKAP1L;NPTN;PELI2;NTRK1;ROR1;RARRES2;MERTK;AKTIP;THPO;EPHA4;MAPK3;FGF17;DVL2;LEPR;RAC1;PIK3R3;EFNA5;BCL10;MUSK;EPHA3;FGF7;EPHA6;INSRR;PIFO;RAD50;TIE1;FGF5;FGF10;PDE8A;FAS;DSCAM;AKT2;FGF1;ACVR2A;INSR;FGF16;EGFR;ERBB4;CSNK1D;ANGPT1;LMO4;RET;LIMCH1;SIRT1;INS;CAMKK2;VEGFC;TESK1;FGF9
prerank,positive regulation of interleukin-2 production (GO:0032743),0.474286195018508,1.4048395971098029,0.045454545454545456,0.1732927528999847,1.0,9/26,14.13%,IL1A;IL1B;PNP;RPS3;STOML2;CARD11;CD80;RUNX1;TRAF2
prerank,mesonephric tubule development (GO:0072164),-0.5136902120717003,-1.404369911977179,0.05357142857142857,0.18560407416145694,1.0,6/17,9.34%,PKD1;PKD2;OSR1;FGFR2;TCF21;SLIT2
prerank,mRNA export from nucleus (GO:0006406),0.3392834471848657,1.403047831351218,0.02564102564102564,0.17496178236840737,1.0,31/103,13.22%,NUP37;POLR2D;CPSF3;ALYREF;THOC3;NUP155;U2AF1;MAGOH;RAE1;SLBP;NUP93;NUP35;MAGOHB;EIF4A3;NCBP1;SEH1L;DDX39A;SRSF9;SEC13;NUP210;NUP43;NXT1;GLE1;NUP50;NUP88;NUP107;EIF4E;NCBP2;CPSF2;NUP205;THOC6
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.49393431368234975,-1.4024700792762865,0.09259259259259259,0.18758973154399536,1.0,11/20,23.25%,TNRC6A;AGO4;WTIP;CELF1;TNRC6C;MOV10L1;AGO3;TNRC6B;AGO1;HELZ;LIMD1
prerank,phosphorylation (GO:0016310),-0.3004655620144971,-1.4023801734611514,0.0,0.18728992293059396,1.0,143/384,24.98%,PRRT1;NRBP2;MKNK1;TNNI3K;DMPK;IP6K3;NIM1K;SIK3;FGFR1;BRSK1;EPHA7;ULK1;BMPR1A;MAP3K6;WNK3;PPP3CB;STRADA;CSNK1E;PXK;SNRK;CAMK2A;ILK;PI4KA;RPS6KA5;CLK3;CLK2;CDK9;MAPK10;DCLK1;CDC42BPA;PRKCB;CDK20;PRPF4B;PRKCA;DGKE;STK36;PRKG1;GK5;CDK3;CSNK1A1;CAMK1;AURKC;PRKACA;DAPK1;GRK5;PRKD1;HIPK3;CDC42BPB;DYRK1A;PRKAG2;ALK;LRRK2;PRKAA2;MAML1;MAST2;NEK1;FER;MAP4K5;DGKG;GRK4;CDK17;FAM20B;TSSK3;NTRK1;PRKG2;TAOK2;MERTK;FAM20C;LATS2;MAST1;MEX3B;MAPK1;MAPK3;DAPK3;MARK1;MARK4;NEK10;BMX;PPP4R1;MORC3;CDK15;BRD2;CAMK2B;PEAK1;TRIB2;HTR2B;PDGFB;BRAF;ROCK1;MAPK8;CAMK2D;SGK3;MAP4K2;AATK;NEK7;ERG;TNK2;NRK;ACVR2A;MARK3;INSR;SHPK;CDK14;CSNK1D;CCL11;DGKB;TESK2;RET;PDK2;BMPR1B;MAP3K12;GSK3A;STK19;CAMKK2;MYLK3;CCL2;MKNK2;TBCK;RNASEL;CERKL;PAK3;PKN1;CDKL2;MTOR;NUAK1;LATS1;HIPK1;LIMD1;WNK1;PRKCD;CDK11B;PIM1;CDKL5;PINK1;NRBP1;PRKCH;DGKI;SIK2;CDK11A;DGKD;TLK1;MAP4K3;PDK4
prerank,androgen metabolic process (GO:0008209),0.48063751149612,1.4019607042851845,0.04,0.17598647449776425,1.0,10/18,23.02%,SRD5A1;SRD5A3;HSD17B10;AKR1C4;SPP1;SHH;MED1;HSD17B4;UGT2B7;HSD3B1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.45725757066728706,-1.4009467261524762,0.08333333333333333,0.1886549193655919,1.0,9/25,20.40%,MYOCD;AKAP6;RBM24;SMYD1;MAML1;MEF2C;MAPK14;PIEZO1;MYLK3
prerank,mitotic cell cycle phase transition (GO:0044772),0.31786648593500355,1.4001338173536426,0.0,0.1773921321359109,1.0,74/206,21.69%,MYC;CCND1;CEP72;CDKN3;E2F1;TACC3;DBF4;CDK1;CDK7;SKP2;RCC1;UBE2S;INHBA;KHDRBS1;CEP250;CHEK2;EIF4EBP1;PHLDA1;CCNO;E2F3;CCNE1;YWHAE;MASTL;AJUBA;NEK2;CCNI2;CDC25C;CDK4;TUBB4B;HAUS2;CDKN2A;ANAPC1;YWHAG;USP37;TUBA4A;UBE2C;CCNF;HAUS8;EIF4E;CEP76;CCNJ;AURKA;SPAST;GSPT1;PPME1;TRIM71;PKMYT1;CKAP5;LCMT1;HAUS1;HAUS6;PLK1;TUBG1;FOXM1;USH1C;CEP78;PLK4;CDC25A;CUL4A;DYNLL1;HAUS7;USP26;ACVR1B;CDC7;MAPRE1;SSNA1;CEP41;SPDYA;HSP90AA1;CRLF3;CDK6;CUL3;TUBB;CDK2
prerank,cellular response to ATP (GO:0071318),-0.5335372601469223,-1.3997513326602793,0.08333333333333333,0.18960967393131814,1.0,7/15,18.83%,RYR3;TRPV1;P2RY1;P2RX7;P2RY12;SSH1;P2RY11
prerank,cellular response to growth factor stimulus (GO:0071363),-0.3377802233815517,-1.3991724101367644,0.015873015873015872,0.1899782161950018,1.0,65/153,25.70%,PDE2A;TMEM100;DUSP22;RAP1A;BMPR1A;MAPT;MAPK7;MAGI2;SMAD4;DUSP3;PHOX2B;STMN2;NTRK3;KIDINS220;TBX1;CILP;SOX5;DSTYK;PRKD1;NOS1;ZFP36L1;SIRT2;FLT4;NR3C1;PDE3A;NTRK1;HSPB1;MEF2C;INPP5K;DAB2IP;RAPGEF1;SEMA6A;MAP2K5;SFRP1;PDGFB;SMAD9;PDE8A;ZFP36;MAPK14;CLEC3B;GAS1;ACVR2A;EGFR;VSTM2A;ANKRD1;BMPR1B;RPS6KB1;SETX;RAPGEF2;CCL2;SOX6;SMAD7;PTPN12;DLX1;PLCG1;RAMP2;HGF;NR4A1;ADAMTS7;FLT1;SNAI2;ZFP36L2;AMHR2;SMAD3;RUNX2
prerank,positive regulation of intracellular transport (GO:0032388),-0.3983718760636835,-1.3979466491494417,0.06,0.19132682788949396,1.0,11/36,16.55%,VAMP2;TENM1;TBC1D20;EHD2;NUMA1;ACTN2;RUFY3;OAZ2;PCM1;CEP290;PCNT
prerank,regulation of stem cell population maintenance (GO:2000036),0.47350656621488724,1.3974652095765776,0.06,0.1803863529101192,1.0,7/19,16.31%,MYC;WDR43;LOXL2;HMGA2;ELAVL1;CNOT1;ZNF706
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3671066955778284,1.3967194256982496,0.05,0.1807860804848918,1.0,27/67,26.02%,POLR2F;POLR2D;INTS7;CDK7;NABP2;NCBP1;CCNK;NCBP2;POLR2C;TAF9;GTF2F2;POLR2K;GTF2E1;POLR2J;POLR2G;INTS5;RPRD1B;POLR2H;POLR2I;POLR2L;GTF2A1;GTF2E2;GTF2B;GTF2A2;INTS2;POLR2B;TAF5
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.533740935991599,-1.3966978228220557,0.038461538461538464,0.19244633026756025,1.0,13/17,26.55%,ANK2;CACNA2D1;KCNH2;SCN1B;SNTA1;KCNE2;SCN4B;KCNE1;KCNE4;SCN5A;CAV3;AKAP9;NOS1AP
prerank,modified amino acid transport (GO:0072337),0.4965897602432524,1.396420923292613,0.09375,0.1809922013675745,1.0,5/17,6.85%,SLC6A20;SLC1A4;SLC5A6;FOLR1;SLC19A1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.36092974584972154,-1.396185746495755,0.06060606060606061,0.19262773599886532,1.0,42/104,27.41%,RBPMS2;TGFB1I1;BMPR1A;DAND5;CHRD;MAGI2;WFIKKN2;SMAD4;SKOR1;CILP;FSTL3;EMILIN1;SPRY1;SKI;PPM1A;FST;SMAD9;IL17RD;ACVR2A;SMAD2;UBB;TRIM33;BMPR1B;SIRT1;PRDM16;VASN;SMAD7;DLX1;IGSF1;PIN1;CD109;VWC2;PEG10;NBL1;SMAD3;SNX25;ZNF451;BMPER;CRIM1;NOG;SMURF1;LDLRAD4
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.39883075994346207,1.3957395212577055,0.05128205128205128,0.18127921236851516,1.0,12/44,12.88%,POLR2F;CHEK1;ATAD2;CDCA4;HMGA1;POLR1C;POLR1B;DDX21;TAF1A;POLR1A;TAF1B;POLR2K
prerank,regulation of MAPK cascade (GO:0043408),-0.32868431113901037,-1.3956941229126067,0.04285714285714286,0.1928082716787013,1.0,48/161,18.06%,FGFR1;ADRA2B;EPHA7;TGFBR3;LPAR1;FGF2;ADRB3;ZDHHC17;PRDM11;MYOC;DUSP3;ROR2;GPER1;FGFR2;NTRK3;P2RX7;ADRB2;ADRA1A;TLR9;TBX1;KIT;KSR1;ADRA1D;PPEF2;CAV2;FLT4;RRAS;PRDM15;PELI2;NTRK1;ROR1;TAOK2;THPO;DAB2IP;MAPK1;MAPK3;RIT2;SPRY3;NEK10;FAM83D;PDGFB;ROCK1;DUSP19;FGF10;FAS;NRK;INSR;EGFR
prerank,activation of protein kinase A activity (GO:0034199),-0.5084181012316432,-1.3954751017939733,0.06779661016949153,0.19259012140487788,1.0,7/17,15.58%,ADCY5;ADCY2;ADCY4;ADCY9;PRKACA;PRKAR2B;ADCY6
prerank,focal adhesion assembly (GO:0048041),-0.48779909525675336,-1.395192292257394,0.09090909090909091,0.19248325483513928,1.0,12/21,19.02%,SORBS1;FERMT2;ACTN2;ACTN3;WHAMM;ACTN1;DLC1;TAOK2;PEAK1;ARHGEF7;THSD1;TESK2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.5109374979622546,-1.3946019248876749,0.15,0.19299278477334628,1.0,12/17,22.87%,ANK2;SCN3B;KCNH2;SNTA1;KCNE2;RYR2;KCNJ8;KCNE1;KCNE4;SCN5A;GPD1L;CAV3
prerank,smoothened signaling pathway (GO:0007224),-0.4326101816947776,-1.39397887954178,0.08,0.19341211918412454,1.0,8/32,11.54%,EVC2;PTCHD1;TTBK2;PTCH2;GLI3;STK36;CC2D2A;GLI2
prerank,zinc ion transmembrane transport (GO:0071577),0.4447554845846895,1.3923571459438169,0.09302325581395349,0.18491500455929807,1.0,10/22,18.44%,SLC39A11;SLC30A2;SLC39A10;TRPM2;SLC30A6;SLC39A8;SLC30A5;SLC39A2;SLC39A7;SLC30A1
prerank,negative regulation of cell motility (GO:2000146),-0.36792256754359626,-1.3922750894740032,0.0,0.1949021614895104,1.0,35/107,15.69%,FLCN;ADARB1;DUSP22;TPM1;PLXNB3;VCL;CHRD;TMEFF2;MAGI2;RECK;MITF;CITED2;DUSP3;PODN;CLDN5;DLC1;DPYSL3;NGFR;RHOB;CLIC4;SRGAP2;SLIT2;PTEN;FBLN1;EPHA4;NAV3;ADORA3;SCAI;SRGAP2C;SPOCK3;SFRP1;IGFBP5;KANK1;TP53INP1;PIP5KL1
prerank,positive regulation of cell division (GO:0051781),0.400188576015141,1.3920610200215018,0.05128205128205128,0.18481050446630146,1.0,21/44,23.30%,KIF20B;RACGAP1;SSTR5;KIF23;KIF14;SHH;CXCR5;AURKB;ECT2;OR2A4;SPAST;DRD2;CENPV;CDC6;PKP4;CDC42;RXFP3;CUL3;GIPC1;CDC14C;CSPP1
prerank,central nervous system neuron development (GO:0021954),-0.5083800445796678,-1.3914187838033525,0.08695652173913043,0.19542419927127244,1.0,6/15,13.76%,GBA2;MAPT;PTEN;MAP2;LHX6;NPY
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.4148137453467706,-1.3890632892147707,0.06349206349206349,0.19749075648516537,1.0,25/51,29.05%,RBPMS2;BMPR1A;DAND5;CHRD;SMAD4;GREM2;SKOR1;CHRDL1;FSTL3;SKI;FSTL1;SMAD9;ACVR2A;TRIM33;BMPR1B;SMAD7;DLX1;VWC2;NBL1;BMPER;CRIM1;NOG;SMURF1;BMPR2;LEMD2
prerank,Fc receptor signaling pathway (GO:0038093),0.32313586443343917,1.388667925594446,0.02564102564102564,0.18869065226499612,1.0,30/111,14.58%,PSMD14;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;PSMA7;PSMD13;SYK;PSME2;PSMC2;PSMC4;PSMD10;PSMD12;CARD11;PSMB5;RELA;PSMD8;PAK2;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;FOS;PSMF1;PSMD11;PSMD1;PAK1
prerank,positive regulation of MAPK cascade (GO:0043410),-0.3123471044812343,-1.3883123868531229,0.0,0.19815640727749267,1.0,77/255,20.61%,HAND2;FGFR1;ADRA2B;TENM1;LPAR1;RAP1A;FGF2;PLA2G5;GLIPR2;MTURN;ADRB3;FERMT2;GCNT2;CCL14;PDGFRA;ROR2;GPER1;FGFR2;P2RY1;GH1;NTRK3;ADRB2;PRKCA;ADRA1A;TLR9;NDRG4;ELANE;TBX1;SEMA4C;NECAB2;KIT;DSTYK;KSR1;ADRA1D;TNFAIP8L3;CAV2;LRRK2;FLT4;DIRAS2;PELI2;NTRK1;ROR1;TAOK2;THPO;DAB2IP;MAPK3;RIT2;MAP2K7;MID1;ACKR3;NEK10;HTR2B;PDGFB;BRAF;ROCK1;NOTCH2;DUSP19;FGF10;PDE8A;DIRAS1;FGF1;INSR;EGFR;CCL23;ERBB4;CCL11;RAMP3;CD36;FBXW7;ANGPT1;RET;MAP3K12;INS;CCL21;SOX2;RAPGEF2;CCL2
prerank,response to insulin (GO:0032868),-0.3597539734930889,-1.388180462931283,0.03571428571428571,0.19779968231079406,1.0,31/79,20.44%,VAMP2;SLC2A4;TSC1;SORBS1;KAT2B;PDE3B;PIK3R1;CPEB1;RAB12;EPM2AIP1;CPEB2;RHOQ;ZFP36L1;GCK;FER;MYO5A;SLC27A1;HDAC5;INPP5K;CELA2A;OGT;LPIN1;HDAC9;PLA2G1B;RAB13;AKT2;INSR;RPS6KB1;GSK3A;SIRT1;RAB8B
prerank,receptor clustering (GO:0043113),-0.44278962330943666,-1.3873376406535056,0.11764705882352941,0.19887256435406392,1.0,11/28,15.07%,FLNA;DLG2;PTN;MAGI2;NRXN1;LRRC7;DLG4;NLGN1;NRXN2;SYNJ2BP;MUSK
prerank,nucleotide catabolic process (GO:0009166),0.5165919916508084,1.3869915886398694,0.07142857142857142,0.1901725020459245,1.0,8/16,20.42%,NUDT15;ITPA;PNP;DNPH1;GPX1;VCP;NT5C2;DERA
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5462920307329342,-1.3866921401194707,0.0847457627118644,0.19912020876366085,1.0,8/15,18.43%,NPHP3;DAAM2;CSNK1E;WNT5B;TIAM1;SFRP1;RSPO3;CSNK1D
prerank,positive regulation of GTPase activity (GO:0043547),-0.3192314694841088,-1.3861318587513676,0.0,0.19938823318601676,1.0,80/199,24.85%,ARHGEF26;FLCN;TSC1;TBC1D1;RASGRP2;SGSM2;TBC1D17;RAPGEF3;RAP1A;ASAP3;RABGAP1;FERMT2;CCL14;TBC1D10A;USP6;TBC1D20;TBC1D26;SYDE1;DVL3;NTRK3;ARHGEF10;EVI5L;GARNL3;RGS10;SRGAP2;TBC1D2B;GNB5;CAV2;RIC1;SIPA1L2;SGSM1;RAB11FIP2;ARHGEF15;SYDE2;CORO1C;NTRK1;ARHGAP24;NDEL1;TBC1D13;TIAM1;RGS8;RAPGEF1;ADRB1;SFRP1;ARHGAP29;ARHGEF7;SNX18;TBC1D25;NTF3;RALGAPA1;SIPA1;SGSM3;RAB3GAP1;DOCK11;PLXNB1;CCL23;MAPRE2;ALS2;CCL11;SIPA1L1;TAX1BP3;ADPRH;RGS6;RAPGEF6;TBC1D12;CCL21;RAPGEF2;CCL2;BCAS3;TBCK;PRTN3;BCAR3;PIN1;RSU1;ADCYAP1;CDKL5;ARHGAP11B;RGS1;PIP5K1A;APC2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5105768260791755,1.385192964734385,0.0625,0.19207858606943748,1.0,5/15,5.07%,RNASEH1;RPP40;POP1;LACTB2;POP7
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.4538330388347523,1.382670829055018,0.125,0.19454030322306937,1.0,9/20,29.44%,PHB;CD46;CD55;CD70;MSH2;IL12B;SLA2;IL18;BTN3A2
prerank,nucleic acid-templated transcription (GO:0097659),0.40557739064264653,1.381897635482788,0.05,0.19500398009023207,1.0,23/42,26.58%,POLR2F;POLR2D;E2F1;PTMA;DRG1;TAF1B;POLR2C;POLR2K;POLR2J;POLR2G;POLR2H;PAX8;POLR2I;MED20;NFKBIB;POLR2L;PWP1;POLR3A;RNPS1;TERT;NKX2-8;POLR2B;PPP5C
prerank,cellular protein localization (GO:0034613),-0.3039795973260157,-1.3806956265219745,0.0,0.20622925324731298,1.0,95/304,20.05%,PRRT1;SEC31B;JAM3;SNX1;DNAJC27;TBC1D1;SGSM2;RIC3;FBLN5;FLNA;ANK2;TBC1D17;VCL;ARL4D;STX1B;DMD;RABGAP1;CNTN2;FERMT2;ATG9A;CAPN3;RABL2B;WDR45;TBC1D10A;USP6;RRAGC;TBC1D26;RABL2A;CNTNAP1;VPS45;BBS4;ZDHHC15;RAB6B;STX16;SNX15;REEP1;WDR11;PACSIN1;TRIM23;HDAC6;CROCC;SNX27;ITSN1;STX2;COPZ2;RAB28;NGFR;MFN2;EVI5L;EPB41L3;RAB5B;TBC1D2B;GPIHBP1;RIC1;BICD2;LRRK2;NAPB;SGSM1;GGA3;RAB23;WLS;VPS33B;NPHP1;CEP68;HERC2;TBC1D13;CNTLN;BBS2;VIPAS39;PACS2;RRAGB;CSRP3;KIF13A;TICAM2;FGF7;TBC1D25;HEY2;RTP5;SGSM3;STX12;FGF10;CD63;AHI1;GGA2;EGFR;TRAPPC8;RAB24;ANGPT1;ADPRH;SNX31;HHEX;RRAGD;ESAM;TBC1D12;RPGR
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.3321085657729468,-1.3804011192771255,0.0,0.20609371676340832,1.0,52/121,27.75%,IP6K3;PITPNM2;PIP5K1C;ITPKB;INPP4A;INPPL1;FGF2;SOCS2;MTMR9;SYNJ1;TTC7B;PI4KB;PIK3R1;PI4KA;INPP5F;INPP5E;PIP4K2B;PTEN;SLC27A1;FAM126A;PIK3C3;INPP5K;PITPNM3;TMEM150A;PIK3R3;IP6K1;BMX;PI4K2A;PIP4K2A;CDIPT;EFR3B;PIKFYVE;PLEKHA3;RUFY1;PLEKHA4;PIK3R2;SMG1;PLCG2;SBF1;FAM126B;PIGQ;MTMR12;PIP5K1A;PIK3R6;PIGG;MTMR7;PIK3C2A;TTC7A;PIK3R5;TPTE2;FIG4;OCRL
prerank,snRNA transcription (GO:0009301),0.36253685987254525,1.3798757117364462,0.05,0.19755364341641368,1.0,27/68,26.02%,POLR2F;POLR2D;INTS7;CDK7;NABP2;NCBP1;CCNK;NCBP2;POLR2C;TAF9;GTF2F2;POLR2K;GTF2E1;POLR2J;POLR2G;INTS5;RPRD1B;POLR2H;POLR2I;POLR2L;GTF2A1;GTF2E2;GTF2B;GTF2A2;INTS2;POLR2B;TAF5
prerank,protein-DNA complex disassembly (GO:0032986),0.49690463235124904,1.3795864854447368,0.09803921568627451,0.1974735867329806,1.0,8/18,12.57%,MYC;HMGA1;SET;SMARCB1;GRWD1;SMARCA4;SMARCD2;SMARCC1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.38426532488874005,1.379312609994115,0.02857142857142857,0.19723406396885984,1.0,18/37,28.41%,CEBPB;IL4I1;FOXP3;CD80;PLA2G2F;VTCN1;LST1;LYN;LILRB4;PLA2G2D;MNDA;CD86;TYROBP;CD300A;SDC4;CTLA4;IL10;GLMN
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.4666883728833263,-1.3792464432991778,0.10204081632653061,0.20696390214230045,1.0,15/24,26.75%,VAMP2;PPP3CB;SYT10;SYT11;RIMS3;SYT2;SYT9;SYT6;SYT5;RIMS1;SYT1;SYT3;ARHGAP17;DOC2B;SYT15
prerank,long-chain fatty acid transport (GO:0015909),-0.45447082478381634,-1.377454184839839,0.03636363636363636,0.20872616333998878,1.0,14/31,24.10%,ACACB;PRKAB2;PRKAG2;PRKAA2;SLC27A1;CPT1B;SPX;SLC27A6;CD36;RPS6KB1;ABCD4;ABCD1;FABP4;ABCD2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3495540244782838,1.376386453601732,0.024390243902439025,0.20061030114184622,1.0,29/92,14.43%,PSMD14;PSMB2;FBXO5;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;RBL1;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;CDK4;PSMD12;CDKN2A;PSMB5;PSMD8;AURKA;PSMB4;PSMD3;PSMB1;PSMA4;PSME1;PSMF1;PSMD11;PSMD1
prerank,autophagy of nucleus (GO:0044804),-0.5111529396136755,-1.3762984234778217,0.1016949152542373,0.20965013241829095,1.0,5/16,4.89%,ULK1;ATG2B;ATG9A;WDR45;ULK2
prerank,natural killer cell mediated immunity (GO:0002228),0.4694769442265002,1.3759187918858091,0.10416666666666667,0.20078857878210501,1.0,6/20,11.12%,ULBP3;GZMB;ULBP2;TUBB4B;ULBP1;CEBPG
prerank,positive regulation of leukocyte activation (GO:0002696),0.5091392012230347,1.3752087631261198,0.15555555555555556,0.2012040459467849,1.0,8/16,27.35%,HSPD1;WNT5A;CEBPA;SPACA3;HAVCR1;CD2;THBS1;CLEC7A
prerank,regulation of microtubule depolymerization (GO:0031114),-0.4655524500157138,-1.3745922557488888,0.09433962264150944,0.21146182853599527,1.0,15/24,26.63%,TTBK2;MAP1A;MAP1B;STMN2;CLASP1;CLASP2;NAV3;FGF13;APC;ATXN7;CAMSAP2;APC2;SPEF1;TAOK1;CAMSAP1
prerank,negative regulation of viral life cycle (GO:1903901),0.47401782777917395,1.3742666830586778,0.10526315789473684,0.20172306076709956,1.0,7/19,15.15%,IFITM3;LY6E;IFITM1;IFITM2;TRIM26;BST2;TRIM11
prerank,regulation of programmed cell death (GO:0043067),0.3057581780529689,1.374244630427914,0.02631578947368421,0.20123931241993623,1.0,57/185,21.07%,CALR;DCPS;PERP;TP73;SKP2;CDK5;TRIAP1;PHB;TRIM24;LRP8;PMAIP1;ANP32A;STK26;TNFSF9;RTKN;RPS3;RSL1D1;GLS2;BRMS1;SOX9;NAE1;APEX1;CASP6;CASP2;DNAJA3;JAK3;TOX3;TNFRSF10B;PRELID1;STAT1;TM7SF3;PRDX2;POU4F1;NME1;ACTN4;LCMT1;AGT;CXCL10;TRAF2;HTATIP2;ACER2;VCP;NUP62;STEAP3;LGALS1;BIRC5;TPT1;IGFBP3;BAX;BID;PAX8;PAX2;OLFM4;TNFRSF10A;HSP90AA1;BCL2L14;ANP32B
prerank,regulation of interleukin-17 production (GO:0032660),0.44417101867420744,1.3736505195468622,0.075,0.2011780390320746,1.0,18/32,28.38%,OSM;IL23A;PHB;FOXP3;SLC7A5;IL21;MYD88;IL23R;TGFB1;NOD2;TNFSF4;IL12B;IL36RN;PRKCQ;CCL1;IFNG;SLAMF6;IL18
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.3892892604388748,1.3730555709810783,0.08333333333333333,0.20145762367229025,1.0,19/37,30.93%,EPHB2;PHB;WNT5A;SLC7A5;IL21;XBP1;FFAR2;NOD2;TNFSF4;CD86;RBP4;TNFRSF4;CD244;GPI;IL10;PHB2;SCIMP;LACC1;XCL1
prerank,anion transport (GO:0006820),0.3848163945726035,1.3730075107340933,0.04081632653061224,0.2010040976391857,1.0,9/37,13.21%,LRRC8E;VDAC1;SLC22A11;ABCC11;SLC19A1;LRRC8D;SLCO1B3;TSPO;LRRC8B
prerank,platelet aggregation (GO:0070527),-0.4234784806369696,-1.372858563493375,0.11627906976744186,0.21404919950828044,1.0,11/32,13.04%,CSRP1;MYL9;FLNA;TLN1;VCL;PDGFRA;ILK;ITGB3;ACTN1;HSPB1;P2RY12
prerank,regulation of axon extension (GO:0030516),-0.4027388076154919,-1.3728275685268083,0.06896551724137931,0.21358052471373698,1.0,14/38,17.76%,NTN1;MAPT;PTPRS;MACF1;RUFY3;L1CAM;OLFM1;MAP2;MAG;SEMA3G;DBN1;SIN3A;SEMA3A;RTN4
prerank,epidermal cell differentiation (GO:0009913),0.36952333063551407,1.372532675394997,0.027777777777777776,0.20125669435147758,1.0,22/44,26.41%,EREG;HDAC2;WNT5A;CDSN;EPHA2;HDAC1;EVPL;GATA6;DSP;OVOL3;MED1;SCEL;PITX2;ST14;OVOL1;ADAM9;ERCC2;OVOL2;OPN3;CSTA;CTNNB1;ANXA1
prerank,regulation of T cell cytokine production (GO:0002724),0.46284802088482196,1.3725045932462354,0.07692307692307693,0.20083180497987863,1.0,8/19,21.72%,FOXP3;CD55;TRAF2;CLC;TNFRSF1B;LILRB4;TNFSF4;HLA-F
prerank,peptidyl-lysine methylation (GO:0018022),0.43314444428820303,1.3720039378540063,0.08333333333333333,0.20087601772311106,1.0,8/19,11.59%,SUV39H2;SUV39H1;SMYD3;SMYD2;EEF2KMT;TRMT112;METTL21A;SETD6
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.3464085538603788,-1.3712832212808925,0.03773584905660377,0.21526537824670972,1.0,49/102,27.53%,PIP5K1C;FGFR1;FGF2;GAB1;PPP2R5B;MYOC;PDGFRA;ROR2;GPER1;PIK3R1;GH1;NTRK3;KIT;PIP4K2B;PTEN;DCN;NTRK1;ROR1;FBXL2;DAB2IP;MAPK1;MAPK3;EPOR;PDGFB;PIP4K2A;NTF3;CBL;TSC2;WNT16;INSR;PLXNB1;EGFR;PIK3IP1;SIRT1;INS;PDGFD;HGF;FLT1;NKX3-1;PDGFA;PIP5K1A;EPO;HCLS1;SELP;CEACAM1;F2RL1;PIK3R5;NLRC3;FSHR
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.4566439537851824,1.371277535002316,0.08,0.20169667449361792,1.0,9/22,17.32%,IFNGR2;SOCS1;STAT1;NLRC5;SOCS3;PPARG;SUMO1;PTPN2;HSP90AB1
prerank,negative regulation of phosphorylation (GO:0042326),-0.35611276434250094,-1.3711166606446572,0.02040816326530612,0.21488024429048458,1.0,32/81,22.71%,HDAC4;MAPT;TARDBP;WWTR1;ACTN3;ATG14;NTRK3;PRKRIP1;PRNP;CDKN1C;TERF2IP;CADM4;SLIT2;PTEN;LRRK2;CORO1C;FBLN1;PID1;INPP5K;DAB2IP;CDKN1A;ROCK1;PIP5KL1;MYADM;CDKN2C;NUPR1;CDK5RAP3;FKBP8;SIRT1;TESK1;LRP6;INHA
prerank,regulation of cellular senescence (GO:2000772),0.4143600700343581,1.3708559971563017,0.1,0.20189360922181498,1.0,9/30,10.39%,HMGA1;FBXO5;RBL1;NEK6;PNPT1;RSL1D1;CDKN2A;HMGA2;NEK4
prerank,negative regulation of execution phase of apoptosis (GO:1900118),0.5225811862831349,1.3707951340609934,0.06,0.2014454474390604,1.0,7/15,24.17%,BCL2L1;PAK2;RNF34;MTRNR2L3;MTRNR2L1;MTRNR2L9;DFFA
prerank,sphingolipid catabolic process (GO:0030149),0.46690586838448955,1.3702831964825473,0.05128205128205128,0.20169346117694098,1.0,8/16,22.52%,GLA;SMPD2;ASAH2B;SGPL1;ACER2;PPT1;PDXDC1;ASAH2
prerank,response to ethanol (GO:0045471),0.48206517714373354,1.3696705137026373,0.15555555555555556,0.20204290185780688,1.0,6/15,18.95%,GRIN2B;GOT2;CHRNB2;TH;GLRA2;ADCY7
prerank,actin filament polymerization (GO:0030041),-0.4636769909835604,-1.3692319047027113,0.1,0.2169534126982756,1.0,8/27,14.02%,FAM107A;GSN;GAS7;ARHGAP6;WASF1;WASF3;CORO7;RAC1
prerank,positive regulation of protein modification process (GO:0031401),-0.3200451634751986,-1.3681859896791868,0.0,0.21799069961590428,1.0,75/205,24.16%,FLCN;CLIP3;ARNTL;RAPGEF3;FGF2;TRABD2B;WDFY2;GPER1;CALM1;ATG14;DVL3;ILK;P2RY1;FAXDC2;NTRK3;FGF22;ITGB3;RSPO1;FXR2;DLC1;TBX1;CAMK1;TERF2IP;DYRK1A;LRRK2;VEGFB;FLT4;RAMP1;NPTN;PELI2;NTRK1;RARRES2;AKTIP;THPO;MAPK3;FGF17;DVL2;LEPR;RAC1;PIK3R3;EFNA5;MUSK;FGF7;FGF5;FGF10;PDE8A;FAS;RAB3GAP1;AKT2;FGF1;ACVR2A;INSR;FGF16;EGFR;ERBB4;CSNK1D;ANGPT1;LIMCH1;SIRT1;CAMKK2;VEGFC;TESK1;FGF9;KAT5;CDH5;GOLGA2;PIN1;CALM2;NNMT;HGF;PRKCD;RIPK1;PINK1;NKX3-1;CAMTA1
prerank,cytosolic transport (GO:0016482),-0.33371090247168933,-1.367423940472049,0.0,0.21839625802082152,1.0,41/108,28.12%,SNX1;WDR91;TBC1D17;RAB9B;DCTN1;TBC1D10A;RBSN;ANKFY1;MON2;RAB6B;STX16;DENND5A;DENND2A;CORO7;RIC1;KLHL20;VTI1B;AKTIP;PIK3C3;VPS13A;ERC1;GBF1;SPAG9;EPS15;HEATR5A;HOOK3;HEATR5B;PIKFYVE;PREPL;CCDC91;CLTCL1;WDR81;GGA1;CLN3;VPS13C;MAGEL2;VPS26B;VPS54;VPS52;PTPN23;RAB29
prerank,regulation of DNA recombination (GO:0000018),0.4336080071171646,1.3670291899367473,0.0425531914893617,0.2050005557671366,1.0,13/31,17.20%,CHEK1;ALYREF;RAD51AP1;BLM;PPP4C;FIGNL1;ZRANB3;MSH3;KDM1A;MSH6;KPNA2;RPA2;IL7R
prerank,regulated exocytosis (GO:0045055),-0.3147200836417079,-1.3656421267488197,0.01694915254237288,0.22055172000087017,1.0,78/157,28.00%,VAMP2;PIP5K1C;FLNA;SYNGR1;TLN1;VCL;CPLX3;CLU;PPP3CB;ACTN2;ITIH4;CALM1;SYT10;F8;SNCA;ITGB3;ACTN1;CFD;PCDH7;SYT11;CYB5R1;RIMS3;VEGFB;SNAP25;RAB11FIP2;SYT2;SYT9;MMRN1;HABP4;VTI1B;SYT6;RARRES2;SYT5;ALDOA;SYTL4;TIMP3;RAB3A;CDC37L1;NHLRC2;PDGFB;TMX3;CRHBP;CD63;STEAP2;CLEC3B;SCG3;CD36;F13A1;ITGA2B;SNAPIN;RIMS1;VEGFC;A1BG;SOD1;TPH1;RAB11FIP5;ENDOD1;SYT1;RAB31;SYNGR3;TTN;HGF;CD109;SYT3;STXBP1;PDGFA;TGFB3;ARHGAP17;CPLX2;SELP;ABCC4;SYT15;ISLR;LHFPL2;BRPF3;BLK;STX1A;OTOF
prerank,visual system development (GO:0150063),-0.4038026534581418,-1.3653270806825224,0.11320754716981132,0.22045031516204555,1.0,10/41,11.67%,MEIS1;MAB21L2;MAB21L1;SALL2;MEIS2;PBX3;CPAMD8;CHRDL1;PBX2;MEIS3
prerank,regulation of TORC1 signaling (GO:1903432),-0.465557797587553,-1.3653025016832214,0.11320754716981132,0.22003796222274005,1.0,10/28,19.43%,FLCN;SIK3;SZT2;RRAGC;KLHL22;RRAGB;RNF152;DEPDC5;KPTN;RRAGD
prerank,proteasomal protein catabolic process (GO:0010498),0.2883926559794822,1.3650237430247436,0.0,0.20751049099302266,1.0,51/202,16.22%,PSMD14;ENC1;PSMB2;PSMB9;PSMA5;PRPF19;SKP2;PSMB3;FBXO45;PSME3;PSMA3;KIF14;DERL1;PSMA7;PMAIP1;PSMD13;GID8;PSME2;PSMC2;PSMC4;PSMD10;TRIM72;ERCC8;PML;PSMD12;BFAR;PSMB5;KCTD5;PLAA;UBE3D;TRIM2;PRAME;PSMD8;PSMB4;PSMD3;PSMB1;PSMA4;TRIM71;RAD23B;DDB1;SPSB2;PSME1;PSMF1;PSMD11;NHLRC1;PSMD1;VCP;CUL4A;RNF34;RNF187;UBE2A
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.45416142316679065,-1.3648617775077079,0.08064516129032258,0.2200624462924634,1.0,11/23,18.59%,MAP6;DYNC1I1;KIF5A;KIF5C;KIF1A;TUBA1A;KIF1C;KIF1B;CCDC88A;MAP6D1;HOOK3
prerank,modulation by host of symbiont process (GO:0051851),0.43197465775541877,1.3642697313948178,0.0625,0.2080222784871596,1.0,9/32,9.92%,TFAP4;SMARCB1;LEF1;RRP1B;SMARCA4;HMGA2;CCL4;CCL3;HDAC1
prerank,pyroptosis (GO:0070269),0.4785609569965093,1.3639308582661311,0.13333333333333333,0.20789647149241397,1.0,12/18,30.39%,GZMB;GSDMA;DHX9;GZMA;GSDMC;GSDMB;NAIP;CASP4;ZBP1;APIP;CASP8;AIM2
prerank,positive regulation of immunoglobulin production (GO:0002639),0.4043897811359891,1.3637683945991017,0.045454545454545456,0.20759379333279754,1.0,15/29,30.93%,EPHB2;PHB;IL21;XBP1;PAXIP1;TNFSF4;CD86;RBP4;HMCES;TNFRSF4;GPI;IL10;PHB2;MAD2L2;XCL1
prerank,respiratory chain complex IV assembly (GO:0008535),0.4578835197749226,1.3636866835345964,0.09090909090909091,0.20714075853195785,1.0,11/22,27.06%,COX20;COA6;COX18;COA1;SCO2;COA3;COX19;COX17;FASTKD3;PET117;SMIM20
prerank,protein localization to plasma membrane (GO:0072659),-0.34076743609980487,-1.362940021227506,0.015873015873015872,0.2224222335991982,1.0,55/130,24.78%,DPP6;KCNB1;KCNIP3;FLNA;CACNB2;ANK2;RAP1A;KCNIP4;WNK3;EHD2;SCN3B;RAB34;ACTN2;ANK3;TTC7B;SLMAP;SPTBN4;TMEM88;P2RY1;RAB12;PACSIN1;EPB41L3;CLASP2;RAMP1;MYO5A;FAM126A;RDX;INPP5K;GORASP1;RAB3A;TMEM150A;PACS2;FGF13;ROCK1;CCDC88A;MYADM;RAB13;ASB3;RAB3C;PLEKHF1;RAMP3;EFR3B;RAPGEF6;RAB40A;RAPGEF2;RAB8B;PACS1;LRP6;CAV3;RAMP2;STXBP1;FAM126B;CACNB3;PIP5K1A;TNFRSF1A
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.4612394732014702,-1.362798388082667,0.1509433962264151,0.22213196777180655,1.0,13/20,26.63%,TTBK2;STMN2;CLASP1;CLASP2;NAV3;FGF13;APC;ATXN7;CAMSAP2;APC2;SPEF1;TAOK1;CAMSAP1
prerank,heart morphogenesis (GO:0003007),-0.3774011087429649,-1.3623581267690863,0.05,0.22217219985162917,1.0,23/52,23.32%,TBX19;TGFBR3;BMPR1A;TCAP;DLC1;TBX1;OLFM1;MDM4;MEGF8;RYR2;HEY1;SOX17;ACTC1;TBX2;HTR2B;HEY2;FLRT2;INSR;ANKRD1;MYBPC3;NIPBL;TTN;MYLK2
prerank,response to ATP (GO:0033198),-0.4893828114212324,-1.3619913289272345,0.1,0.22204801642366986,1.0,11/19,27.77%,RYR3;TRPV1;P2RY1;P2RX7;ABCC9;P2RY12;SSH1;P2RY11;TRPC3;P2RY4;HSP90B1
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.4152132496719927,-1.3619528546807096,0.047619047619047616,0.22159663862358533,1.0,19/42,21.18%,MYH7;FOXF1;TPM1;MYL2;TGFBR3;BMPR1A;MYH6;FGFR2;RBPJ;HAND1;HEY1;MEF2C;HEY2;MYL3;NPY2R;SOX11;GSK3A;MYBPC3;SMAD7
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.4495763053991782,-1.3616628703437028,0.0625,0.22167866552972276,1.0,15/34,15.87%,FLCN;SYNGAP1;LZTR1;MYOC;DLC1;MFN2;KCTD10;SPRY1;ARHGAP24;RASIP1;DAB2IP;SPRY3;SCAI;KANK1;MAPKAP1
prerank,iron-sulfur cluster assembly (GO:0016226),0.46314810451768557,1.3615436921099036,0.12727272727272726,0.20981879407796486,1.0,8/21,19.64%,CIAO1;GLRX3;CIAPIN1;HSPA9;ISCA2;FXN;LYRM4;NUBPL
prerank,cellular metal ion homeostasis (GO:0006875),-0.34569312506860755,-1.3595826991227284,0.0847457627118644,0.22428914037955064,1.0,26/101,14.00%,TPCN2;DMPK;PTH1R;ATP1B2;ATP2B4;ANK2;ATP1A2;KCNMA1;CCL14;STIM1;SLC8A2;SLC24A4;SLC8A1;ELANE;ATP1A4;SLC24A3;ATP1A3;NPTN;CTRC;RYR2;ATP2B3;SLC8A3;SLC41A1;CSRP3;TRDN;RGN
prerank,cellular component disassembly (GO:0022411),0.36069512709736995,1.3592584490785653,0.02631578947368421,0.21248454505724712,1.0,21/60,17.69%,MMP7;MMP13;CAPG;CTSV;KIF9;KLK7;MMP11;MMP1;TIMP1;CD44;MMP10;ADAM10;MMP2;MMP3;CAPN1;MMP9;MMP12;ADAM8;ADAM15;DYRK3;MMP15
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.47021158708301997,-1.3592179363552455,0.13043478260869565,0.2244259214427587,1.0,7/18,14.19%,CRTC3;RPS6KA5;PRKD1;EPHA5;CRTC1;CRTC2;RELN
prerank,glucose transmembrane transport (GO:1904659),-0.5082765825053621,-1.3585873636687793,0.10416666666666667,0.22482605310746054,1.0,4/18,5.73%,SLC2A4;SLC45A1;SLC2A11;PPARD
prerank,zinc ion transport (GO:0006829),0.4589418498900672,1.357949632365792,0.1282051282051282,0.21343005254406472,1.0,10/21,18.44%,SLC39A11;SLC30A2;TRPM2;SLC30A6;SLC39A8;SLC30A5;SLC39A2;SLC30A9;SLC39A7;SLC30A1
prerank,positive regulation of neuron differentiation (GO:0045666),-0.39762908378750694,-1.3579245912654003,0.03571428571428571,0.2254472838815727,1.0,21/42,28.87%,FGFR1;ADRA2B;HOXD3;NGF;MEF2C;MMD2;RHOA;TCF4;GPRC5B;ZC4H2;SIN3A;SOX11;PCP4;BEND6;DLX1;VWC2;MMD;NBL1;ASCL1;BRINP2;KCTD11
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.48344464973774154,-1.357532746836677,0.0392156862745098,0.22549977228862597,1.0,10/17,24.78%,ADD1;VCL;PPP1R12A;CLDN5;S1PR3;S1PR2;ROCK1;CDH5;ZDHHC21;TNFRSF1A
prerank,"transcription, DNA-templated (GO:0006351)",0.3029312292599955,1.357483231523316,0.0,0.21384496299866948,1.0,90/215,27.50%,NFE2L3;POLR2F;POLR2D;POLR3K;E2F1;TFDP1;POLR1C;EAF1;CDK7;CBFB;EREG;ETV7;ABT1;TFB2M;TRIM24;NELFCD;GTF2H3;TFAM;PTMA;DDX21;NCBP1;CCNK;GTF3A;NFYA;SSRP1;DRG1;TAF1A;TTF2;XBP1;TRIP13;NCBP2;TAF1B;BRF2;POLR2C;TAF9;GTF2F2;POLR2K;MLLT3;GTF2E1;POLR2J;HSF2BP;LEO1;POLR2G;SLC25A33;GTF3C4;NOCT;SMN1;TEFM;TAF4;POLR3G;CRCP;DEK;BTF3;NELFE;CTR9;GTF3C3;ERCC2;POLR2H;PAX8;GTF3C2;POLR2I;MED20;NFKBIB;TAF15;POLR2L;PWP1;RNGTT;GTF2A1;TAF4B;POLR3A;TP53;RNPS1;NELFA;GTF2E2;GTF2B;IVNS1ABP;TCFL5;GTF2A2;NKX2-8;POLR2B;TAF5;LHX1;NELFB;FOXE3;TAF2;PPP5C;PRMT5;TBPL1;WDR61;GTF2F1
prerank,non-motile cilium assembly (GO:1905515),-0.420739116998375,-1.3571723360035426,0.09090909090909091,0.22545117652913343,1.0,14/29,25.05%,CCDC13;DCTN1;BBS4;BBS1;TMEM80;DISC1;PCM1;CEP290;IFT122;CSNK1D;FUZ;CEP89;TTC8;C2CD3
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.494019019869751,-1.3560432525580164,0.08771929824561403,0.2265299071136809,1.0,8/19,20.85%,NXF1;PABPN1;DDX25;DDX19A;POLDIP3;HHEX;NXF5;MCM3AP
prerank,positive regulation of catalytic activity (GO:0043085),0.3913014716694491,1.355917922533799,0.06976744186046512,0.21550817565716676,1.0,15/38,21.53%,SSBP1;YWHAB;XRCC5;XRCC4;MSH3;APH1A;ABL2;FGFR4;MSH6;CIB1;NCSTN;NOD2;FXN;CAV1;MSH2
prerank,embryonic heart tube development (GO:0035050),-0.48300220032872715,-1.355825777802061,0.10344827586206896,0.22629853358909915,1.0,9/18,19.58%,CITED2;NDRG4;HAND1;MEGF8;RYR2;SOX17;TBX2;IFT122;SOX18
prerank,positive regulation of ossification (GO:0045778),-0.38130128563719085,-1.3556942911758019,0.07272727272727272,0.22592788576299835,1.0,16/39,24.84%,GPM6B;BMPR1A;OSR1;PTN;P2RX7;SLC8A1;ZBTB16;KL;MEF2C;SOX11;ACVR2A;BMPR1B;OSR2;ANO6;PKDCC;TGFB3
prerank,diol metabolic process (GO:0034311),0.4581152536895135,1.354886202340641,0.09615384615384616,0.21611605332569103,1.0,8/16,22.52%,SGPP2;PTS;GCHFR;DEGS2;GCH1;SPR;HSP90AA1;ASAH2
prerank,regulation of cell motility (GO:2000145),-0.3173418098723216,-1.354756486209098,0.03636363636363636,0.2268586053063404,1.0,43/128,19.38%,NTN1;RAF1;FLNA;PLXNB3;NRG2;FGF2;AMOTL1;TTBK2;BTC;NEXN;MACF1;BEX4;FGF22;INPP5F;FES;RHOB;CADM4;HACE1;LDB2;FBLN1;DAPK3;FGF17;RAC1;SPOCK3;RHOA;ENPP2;FGF7;ROCK1;SGK3;FGF5;AMOTL2;ROBO4;FGF10;AKT2;FGF1;PLXNA4;SST;PLXNB1;FGF16;EGFR;ERBB4;LMO4;SLK
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.3493754649689703,1.3544268724844657,0.044444444444444446,0.21637270783753937,1.0,20/87,8.12%,ENC1;CALR;CAPRIN1;PUS7;CST4;CDK5;GZMB;DHFR;MRPL13;GAPDH;IGF2BP1;NCL;CSTB;EIF4A3;NANOS3;IGF2BP3;RPS3;CNOT10;GRB7;IGF2BP2
prerank,cardiac muscle tissue development (GO:0048738),-0.39609306553817913,-1.3542216407510776,0.06779661016949153,0.22684750581977506,1.0,27/51,26.51%,MYOCD;BMPR1A;TCAP;SGCG;SMAD4;NPPA;MAML1;CACNA1G;HEY1;SGCD;CSRP3;ACTC1;TBX2;ADAMTS9;HEY2;NOTCH2;NPPB;ANKRD1;KDM6B;CBY1;SCN5A;AKAP13;TTN;MYLK2;SGCZ;BMP5;NDUFV2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.2872076936948149,-1.3540969133838796,0.0,0.22649798145389066,1.0,136/399,21.05%,NFATC4;ATP6V1G2;SORBS1;EFS;FGFR1;PILRB;EPHA7;FGF2;GAB1;DDR2;SOCS2;ANGPTL1;SHC4;NRP2;HAP1;PXN;ANKS1A;GFRA2;PDGFRA;ROR2;PIK3R1;FGFR2;ZNF106;TIAL1;GH1;NTRK3;FGF22;ITGB3;FRS3;ADRB2;ITSN1;FLRT1;RHOQ;NGF;RBFOX2;SHC2;FES;GIGYF1;KIT;NGFR;GHR;NCK1;PSEN1;PRKD1;CHRNA3;ALK;CAV2;EPHA5;VEGFB;SIRT2;FLT4;KL;DOCK1;SDC2;FER;NCKAP1L;SOGA1;TIA1;GRB10;NTRK1;ROR1;FOXO4;APH1B;RARRES2;MERTK;MAPK1;EPHA4;TIAM1;MAPK3;ARPC2;FGF17;GRB14;MAPK11;AP2A2;RAPGEF1;ELMO2;RAC1;PIK3R3;EFNA5;RHOA;MUSK;EPHA3;ARHGEF7;PSEN2;PDGFB;FGF7;ROCK1;HNRNPH1;EPHA6;APC;INSRR;NTF3;TIE1;COL4A6;FGF5;ELMO1;FGF10;COL4A2;BAIAP2;FLRT2;SOS1;CBL;TSC2;MAPK14;AHI1;TNK2;AKT2;FGF1;INSR;CASP3;FGF16;EGFR;ATP6V0A1;ERBB4;WASF2;ATP6V1B1;SIPA1L1;PLCB1;PLAT;ANGPT1;RET;PDK2;SH2D6;ATP6V1E1;TCIRG1;DNM1;GSK3A;SETX;AP2M1;INS;NR4A3;RAPGEF2;PHIP;VEGFC;FGF9;PDGFD
prerank,regulation of fatty acid oxidation (GO:0046320),-0.4923496652579106,-1.353826349733295,0.06779661016949153,0.2263088991591331,1.0,9/16,25.72%,PRKAG2;SIRT4;ACADVL;ACADL;NR4A3;MLYCD;ABCD1;PDK4;ABCB11
prerank,skin development (GO:0043588),0.33504772467716926,1.3538073263566115,0.02702702702702703,0.2167275375757446,1.0,32/70,26.90%,CLDN1;COL1A1;EREG;COL1A2;STMN1;MET;WNT5A;CDSN;EPHA2;LSR;COL3A1;EVPL;DHCR24;GATA6;DSP;MED1;SCEL;ST14;CLDN4;ADAM9;KDF1;FA2H;SFN;OPN3;ALOXE3;ITGA6;ABCB6;CSTA;ABCA12;ALOX12;ANXA1;ALOX12B
prerank,small GTPase mediated signal transduction (GO:0007264),-0.3354249446664777,-1.3534332470524237,0.014705882352941176,0.226318875464198,1.0,42/104,24.98%,RASGRP2;NTN1;ARHGAP33;FGF2;RERG;RRAGC;SHC2;RGL2;ERAS;RALGDS;KSR1;PRKD1;DIRAS3;RGL1;ARHGEF18;RRAS;PLCE1;KRIT1;TIAM1;MAPK11;RIT2;RAC1;CDKN1A;RRAD;ARHGAP31;CCDC88A;RUNDC3A;SOS1;MAPK14;TNK2;PLD2;ARL3;RAPGEF6;RAPGEF2;SETDB1;SHC3;RASSF1;USP28;RIT1;RAB18;USP8;ARHGAP1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.42927716508614966,-1.3532997905761093,0.14583333333333334,0.226111204210739,1.0,8/26,6.26%,CACNB2;ANK2;AKAP6;TRPC1;CASQ1;CAPN3;GPER1;SNCA
prerank,respiratory tube development (GO:0030323),-0.4196474745453316,-1.352701291433164,0.08,0.2264966200754214,1.0,15/29,21.13%,NPHP3;FOXF1;FGF2;FGFR2;CCDC39;TCF21;CCDC40;GLI2;FGF7;PCSK5;ABCA3;FGF1;HECA;FGF9;LOXL3
prerank,limb morphogenesis (GO:0035108),-0.47095789503308916,-1.352521147741535,0.10344827586206896,0.2263485491221202,1.0,12/22,25.23%,MYH3;FBXW4;GLI3;MBNL1;MEGF8;SKI;CYP26B1;PCSK5;BMPR1B;LRP6;NIPBL;HOXA11
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3245084816136027,1.3520166705744605,0.08333333333333333,0.21787740299224792,1.0,26/96,16.52%,SPTBN2;AP1S3;AP1S1;KIF2A;KIF18A;KIF15;RACGAP1;CTSV;CENPE;CANX;KIF23;CAPZA1;SEC13;KIF22;KIF3B;CLTA;CTSE;AP2S1;KIF4B;KIF2C;CLTC;AP2B1;DCTN5;AP1M2;DYNLL1;RAB7A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3245084816136027,1.3520166705744605,0.08333333333333333,0.21787740299224792,1.0,26/96,16.52%,SPTBN2;AP1S3;AP1S1;KIF2A;KIF18A;KIF15;RACGAP1;CTSV;CENPE;CANX;KIF23;CAPZA1;SEC13;KIF22;KIF3B;CLTA;CTSE;AP2S1;KIF4B;KIF2C;CLTC;AP2B1;DCTN5;AP1M2;DYNLL1;RAB7A
prerank,energy reserve metabolic process (GO:0006112),-0.46517195980334847,-1.3515094124929974,0.10344827586206896,0.22702665974797467,1.0,8/19,14.53%,PYGM;ADRB3;PPP1R3C;PRKAG2;PID1;GFPT2;LEPR;UGP2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.4608232904496018,-1.3511150117878645,0.057692307692307696,0.227015391984235,1.0,15/24,29.92%,SEMA6C;SEMA4C;SEMA3E;MEGF8;SEMA6D;SEMA6A;SEMA3B;SEMA3G;DSCAM;SEMA3A;SEMA3C;SEMA4B;SEMA3D;SEMA6B;SEMA5B
prerank,regulation of small molecule metabolic process (GO:0062012),-0.4432753983939498,-1.3510108072114428,0.09803921568627451,0.22678887226775585,1.0,12/27,27.73%,RORA;GNB3;ACADVL;ACADL;FMO5;PDK2;SIRT1;MLYCD;PDK4;ABCB11;NR1H4;NCOR2
prerank,regulation of mRNA processing (GO:0050684),-0.40774413400912585,-1.3507632930971105,0.1016949152542373,0.2266804982704936,1.0,20/35,25.96%,PABPN1;SAFB2;QKI;SF1;SLTM;ZFP36L1;SON;TIA1;JMJD6;SRPK3;YTHDC1;SUPT6H;AHCYL1;LARP7;KHDRBS2;CDK11B;RBM39;CDK11A;METTL16;PTCD2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.4877760998837346,1.3503015570579562,0.14583333333333334,0.21987912942733137,1.0,10/20,20.79%,PTDSS1;MGST2;GSS;CHAC2;CHAC1;GGCT;GCLM;CNDP2;PLSCR1;FPGS
prerank,acylglycerol catabolic process (GO:0046464),0.4019313750135285,1.3499450390823973,0.046511627906976744,0.21977990948756998,1.0,12/29,24.59%,FABP6;ABHD12;PNPLA4;LIPG;PNPLA1;PNPLA3;LYPLA2;ABHD2;ABHD12B;LIPE;FAAH;DAGLA
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.501278574748596,-1.3485641889785633,0.12,0.22953507895782266,1.0,5/16,10.39%,DDR2;CLASP1;CLASP2;EFEMP2;EMILIN1
prerank,membrane assembly (GO:0071709),-0.4152335251986038,-1.3477611776692682,0.12727272727272726,0.23047163025132736,1.0,12/36,17.24%,NLGN2;NLGN3;NRXN1;NLGN4X;ANK3;NLGN1;STX2;PTEN;NRXN2;IL1RAPL1;VPS4A;NLGN4Y
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.40844150651038563,-1.3477014335313768,0.1,0.23014271194059394,1.0,12/37,17.16%,FLCN;SFRP5;PPP2R5B;MAGI2;GPER1;PTEN;PHLDA3;MSTN;OTUD3;INPP5K;PHLPP2;TSC2
prerank,histone H4-K5 acetylation (GO:0043981),-0.5096452928202425,-1.3467306050360692,0.1016949152542373,0.23047468188564563,1.0,8/15,24.44%,KANSL3;JADE1;ING4;KAT7;OGT;KANSL1;KAT8;JADE2
prerank,histone H4-K8 acetylation (GO:0043982),-0.5096452928202425,-1.3467306050360692,0.1016949152542373,0.23047468188564563,1.0,8/15,24.44%,KANSL3;JADE1;ING4;KAT7;OGT;KANSL1;KAT8;JADE2
prerank,regulation of double-strand break repair (GO:2000779),0.4184723841695583,1.3467177589070325,0.0425531914893617,0.22451873501592157,1.0,18/38,25.51%,CHEK1;OTUB2;RAD51AP1;TIMELESS;ACTR2;PPP4C;FIGNL1;PML;WRAP53;KDM1A;FOXM1;RPA2;DEK;SPIRE2;SIRT6;MGMT;OTUB1;PPP4R2
prerank,histone H2A acetylation (GO:0043968),0.4299331436640327,1.3466069392614692,0.027777777777777776,0.2241400848235686,1.0,4/16,3.13%,RUVBL1;ACTL6A;YEATS4;RUVBL2
prerank,positive regulation of lymphocyte activation (GO:0051251),0.392067752052362,1.3464343825893736,0.05405405405405406,0.22388535612169785,1.0,19/33,31.79%,THY1;HSPD1;TNFSF11;IL23A;PRKDC;SH3KBP1;NOD2;LCK;TNFSF4;IL12B;CD47;TYROBP;XRCC6;TICAM1;PRKCQ;CLEC7A;CCDC88B;SIRPG;SIRPB1
prerank,positive regulation of double-strand break repair (GO:2000781),0.40517269955061364,1.3458498837883377,0.06779661016949153,0.22411961242598474,1.0,9/32,14.60%,FANCB;RAD51AP1;TIMELESS;ACTR2;PRKDC;DTX3L;WRAP53;FUS;FOXM1
prerank,regulation of acute inflammatory response (GO:0002673),0.47617176590058446,1.3456412216364309,0.1875,0.2239390744094941,1.0,7/18,21.34%,C2CD4A;OSM;F12;FFAR2;ADAM8;PLA2G2D;C2CD4B
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.37523355900261035,1.3445495757787262,0.046511627906976744,0.22511927909889087,1.0,5/40,5.24%,CST1;AZGP1;CST4;CST2;LPO
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.36642288008032897,1.3444286639551712,0.09302325581395349,0.2247192514608656,1.0,14/39,16.91%,RFWD3;MYC;FBXO5;POLH;UBE2N;SMYD2;WRNIP1;HMGA2;NEK4;ARMT1;IER3;USP1;RPA2;NSMCE1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.38651803731412404,1.3442352433688955,0.07547169811320754,0.22453858563603699,1.0,18/36,28.43%,TESC;TNFSF11;IL23A;LEF1;PF4;DCSTAMP;RUNX1;IL17A;CTNNBIP1;POU4F1;IL23R;IL12B;LIF;OCSTAMP;IFNG;CASP8;HAX1;TRAF6
prerank,negative regulation of cell growth (GO:0030308),-0.32948842734779243,-1.3441744942748117,0.0,0.2339472909631679,1.0,42/121,20.41%,TSPYL2;FLCN;FHL1;APBB1;MYL2;CAPRIN2;DACT3;NPR1;ULK1;RERG;JADE1;PTPRS;PRDM11;SMAD4;ULK2;WFDC1;SLIT2;MAP2;SLIT3;CGRRF1;SOX17;TCHP;FGF13;CDKN1A;MAG;SFRP1;SEMA3G;SIPA1;CDKN2C;OSTN;NPPB;APBB2;RTN4;SMARCA2;DCC;DCUN1D3;DNAJB2;AGTR2;TP53TG5;GSK3A;SIRT1;TRIM46
prerank,polyol biosynthetic process (GO:0046173),-0.44930008966269697,-1.3429733387883112,0.0784313725490196,0.23536530309654607,1.0,3/16,2.91%,IP6K3;ITPKB;FGF2
prerank,protein deacetylation (GO:0006476),-0.40000730292850845,-1.342107613714565,0.07407407407407407,0.2359899536701103,1.0,19/44,21.07%,SIN3B;HDAC4;FLNA;RCOR3;HDAC7;HDAC6;MORF4L1;SIRT2;SIRT4;HDAC5;MTA3;PRDM5;HDAC9;SIN3A;TRERF1;BAZ2A;BRMS1L;SIRT1;SIRT3
prerank,regulation of protein autophosphorylation (GO:0031952),-0.4286634094789285,-1.342038754438109,0.1111111111111111,0.23561534772008236,1.0,17/36,25.28%,EPHA7;PPP2R5B;PPP2R5D;CALM1;TAOK2;NEK10;PDGFB;RAD50;RASSF2;INS;TESK1;PDGFD;ERRFI1;CALM2;PDGFA;GPNMB;MOB1B
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.3909900087374725,1.3419256833887216,0.047619047619047616,0.22730191428019655,1.0,17/35,26.90%,IL1A;EREG;PDGFRB;IL1B;DLGAP5;AURKA;ANAPC11;NSMCE2;NUP62;DMRT1;ESPL1;LRP5;TGFA;CUL3;EGF;EPGN;CDC23
prerank,negative regulation of cell differentiation (GO:0045596),-0.3103479485520268,-1.3411626336012479,0.014285714285714285,0.23661943295220733,1.0,74/182,26.72%,NPHP3;MEIS1;NKX3-2;WNT9A;MYOCD;ARNTL;MEIS2;EID2B;TWIST2;CHRD;FERMT2;OSR1;HDAC7;RUNX1T1;WWTR1;GPER1;CHADL;RORA;ITGB3;ABCA1;ZADH2;TBX1;ZFPM2;PTEN;ZBTB16;MSTN;SIRT2;SPRY1;HEY1;NOTCH4;SKI;NR1H2;DAB2IP;ASXL1;SFRP1;RANBP3L;GATA2;CNTN4;TRIB2;GDF5;ABCA5;RORB;GPS2;TRIO;IL17RD;ANKRD2;EGFR;SUFU;DLL1;EFEMP1;SIRT1;SOX2;VASN;SMAD7;ANKRD26;ID2;SOX8;LIMD1;ADAMTS7;SDHAF2;ESRRB;PDCD4;SNAI2;TMEM64;TNN;WNT10B;ZFP36L2;BBS12;SMAD3;CRIM1;METTL14;BMP5;ASCL1;NOG
prerank,osteoclast differentiation (GO:0030316),0.44131185654332716,1.3411044961349907,0.06976744186046512,0.22819960307906648,1.0,11/22,27.62%,TNFSF11;GLO1;SNX10;EPHA2;DCSTAMP;EFNA2;OSCAR;OCSTAMP;TYROBP;TNFRSF11A;FARP2
prerank,membrane protein proteolysis (GO:0033619),0.36285683829607923,1.3407795498348418,0.02631578947368421,0.22815662168414255,1.0,13/39,19.27%,MMP7;HM13;BACE2;CTSH;APH1A;RELA;ADAM10;CLPP;NCSTN;TGFB1;MBTPS2;ADAM9;ERAP1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.35379537688025203,1.3401845801487076,0.02702702702702703,0.22854522626873905,1.0,14/50,13.23%,SERPINB5;GAPDH;TIMP1;SERPINB1;CRB2;SERPINE3;SERPINA10;SERPIND1;SERPINA7;SERPINA4;SERPING1;SORL1;SERPINB7;AGT
prerank,receptor-mediated endocytosis (GO:0006898),-0.3141233199255804,-1.3400577577948065,0.047619047619047616,0.23779115590782546,1.0,48/133,23.07%,TPCN2;SNX1;PIP5K1C;PDLIM7;LMBR1L;NLGN3;ADRB3;MASP1;STAB1;CUBN;MICALL1;PI4KB;SNCA;TMEM108;ADRB2;INPP5F;STAB2;DNAJC13;SNAP91;WASF1;LRP1B;CAV2;RAMP1;GRK4;SFTPD;AP4E1;COLEC12;AP2A2;ACKR3;HSPG2;VLDLR;SCARF1;INSR;EPS15;FCHSD2;RAMP3;CD36;COLEC11;DNM1;HBB;DLL1;AP2M1;PIKFYVE;LRP6;CLTCL1;RAB31;SGIP1;RAMP2
prerank,protein localization to cell periphery (GO:1990778),-0.33355393603281447,-1.3398963525759078,0.047619047619047616,0.23766277820814485,1.0,55/136,24.78%,DPP6;KCNB1;KCNIP3;FLNA;CACNB2;ANK2;WDR19;RAP1A;KCNIP4;RABEP1;WNK3;EHD2;SCN3B;RAB34;ACTN2;ANK3;TTC7B;SLMAP;SPTBN4;TMEM88;P2RY1;RAB12;PACSIN1;EPB41L3;CLASP2;RAMP1;MYO5A;FAM126A;RDX;INPP5K;RAB3A;TMEM150A;PACS2;FGF13;ROCK1;MYADM;RAB13;RAB3C;PLEKHF1;RAMP3;ARL3;EFR3B;RAPGEF6;RAB40A;RAPGEF2;RAB8B;PACS1;LRP6;CAV3;RAMP2;STXBP1;FAM126B;CACNB3;PIP5K1A;TNFRSF1A
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.4753732859256954,-1.3394036252373989,0.13559322033898305,0.237744026460357,1.0,12/24,22.89%,MYH7;TPM1;MYL2;TGFBR3;MYH6;FGFR2;HAND1;ADAMTS9;MYL3;MYBPC3;SMAD7;ID2
prerank,response to glucagon (GO:0033762),-0.48629285947493706,-1.3392333350035563,0.09433962264150944,0.23752142353148323,1.0,7/19,15.58%,ADCY5;ADCY2;ADCY4;ADCY9;PRKACA;PRKAR2B;ADCY6
prerank,protein O-linked glycosylation (GO:0006493),0.3274644548962522,1.3390369694425914,0.09302325581395349,0.22950608215022317,1.0,32/93,20.60%,POMK;GALNT6;C1GALT1C1;B3GNT4;MUC5AC;DPM2;TMTC4;CHST4;C1GALT1;POFUT1;PLOD3;DPM1;B3GNT2;GCNT1;GALNT5;B3GALNT2;ST6GAL1;GALNT3;PGM3;SLC35C1;GALNT1;SDF2L1;ST8SIA6;GALNT7;B3GNT3;B3GNT5;MUC20;MUC17;B3GNT8;B4GALT5;TET3;MUC16
prerank,regulation of biomineral tissue development (GO:0070167),0.4296792213858039,1.338906539754259,0.14634146341463414,0.2292219172062341,1.0,6/24,7.26%,NOTUM;CEBPB;FBXO5;CYP27B1;ANKH;SOX9
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.4123730940490509,1.3377660215365408,0.08888888888888889,0.23036762149432655,1.0,15/32,24.32%,E2F1;TFDP1;FBXO5;CDK5;DHFR;CCNE1;ZPR1;POLA1;CDT1;CDC6;CDC45;ORC1;E2F7;CDK16;RRM2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3724643392128928,-1.3356378442030128,0.0847457627118644,0.24254361212915942,1.0,14/42,15.17%,RYR3;ATP2B4;TRPV1;PKD2;FGF2;ITPR1;CACNA2D1;SLC8A2;RYR1;SLC8A1;RYR2;SLC8A3;TRPV3;HTR2B
prerank,mRNA transport (GO:0051028),0.3218784647515156,1.3353782343430445,0.02631578947368421,0.2328388738743064,1.0,30/102,13.22%,NUP37;CPSF3;ALYREF;THOC3;NUP155;U2AF1;MAGOH;RAE1;SLBP;NUP93;NUP35;MAGOHB;EIF4A3;NCBP1;SEH1L;DDX39A;SRSF9;SEC13;NUP210;NUP43;NXT1;GLE1;NUP50;NUP88;NUP107;EIF4E;NCBP2;CPSF2;NUP205;THOC6
prerank,brain development (GO:0007420),-0.3190906409974897,-1.335029798352209,0.015625,0.24304890261052522,1.0,57/145,24.18%,POU6F1;MEIS1;EML1;ROGDI;EPHA7;MEIS2;NNAT;PBX3;DSCAML1;HAP1;SYNJ1;BBS4;SHANK3;PAFAH1B1;CIC;AMIGO1;NDRG4;MDGA1;SMARCA1;ADGRL3;APOD;PBX2;PTEN;ADGRL2;NFIB;MEIS3;MAST1;ARNT2;BBS2;RELN;HSPG2;ZNF335;UGP2;CDH2;ZFHX3;CNTN4;CA10;AATK;SLC6A17;RAB3GAP1;GRIN2A;AMIGO2;KLHL17;CDK5RAP3;AGTR2;CDK5RAP2;RAPGEF2;SOX6;BPTF;SETD1A;PCDH18;NIPBL;SPEF2;CHD8;ZFHX2;GRIN2C;RAB18
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.37607387249781926,-1.3349921334846013,0.017241379310344827,0.24255288444193235,1.0,25/64,23.18%,MTMR9;PLIN5;WDR6;TAB2;ZKSCAN3;BCL2;KLHL22;TIMP4;RIC1;SIRT2;TIMP2;RASIP1;TIMP3;DAB2IP;LEPR;HTR2B;ROCK1;NUPR1;EIF4G3;CDK5RAP3;GSK3A;INS;GOLGA2;MTOR;HGF
prerank,presynapse assembly (GO:0099054),-0.44243901038177713,-1.3348034537351683,0.13333333333333333,0.24232230097076515,1.0,10/18,21.44%,NLGN2;NLGN3;NLGN4X;NLGN1;PTEN;IL1RAPL1;BSN;NLGN4Y;FZD1;LRRTM3
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.4197242144835233,1.334739906326484,0.13157894736842105,0.23314204574957623,1.0,8/23,19.27%,MMP7;HM13;BACE2;APH1A;ADAM10;NCSTN;ADAM9;ERAP1
prerank,lung development (GO:0030324),-0.40581977526642976,-1.3346248049921239,0.10526315789473684,0.242186540138635,1.0,17/34,22.86%,NPHP3;PKD1;FOXF1;FGF2;FGFR2;CCDC39;TCF21;CCDC40;GLI2;FGF7;FGF10;ABCA3;FGF1;SOX11;FGF9;LOXL3;ERRFI1
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.4870663455515339,-1.3344965815830683,0.09090909090909091,0.24188267929236545,1.0,8/18,15.69%,TSC1;FERMT2;MYOC;COL16A1;PPM1F;RAC1;SFRP1;ROCK1
prerank,positive regulation of acute inflammatory response (GO:0002675),0.472142957891096,1.3338606707630298,0.06976744186046512,0.23391704402919236,1.0,5/15,15.38%,C2CD4A;OSM;IL1B;FFAR2;ADAM8
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3928599298662471,1.3335927803437695,0.10869565217391304,0.2338625065271916,1.0,15/42,19.04%,EREG;POLR3C;AKIRIN2;NMI;DHX9;POLR3B;CYBA;GBP5;GRN;FPR2;ADAM8;OASL;POLR3G;PLSCR1;SLC15A4
prerank,dendritic cell chemotaxis (GO:0002407),0.4861283735383083,1.332854629549982,0.16666666666666666,0.23479751847857094,1.0,6/16,22.26%,TRPM2;CXCR4;CXCR2;PIK3CG;HMGB1;CXCR1
prerank,negative regulation of chemotaxis (GO:0050922),-0.3987945889303345,-1.3324327595537675,0.09259259259259259,0.24460961730666686,1.0,11/31,17.57%,SEMA6C;DUSP3;ELANE;SEMA4C;SLIT2;SEMA3E;SEMA6D;SEMA6A;SEMA3B;SEMA3G;SEMA3A
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.4798014347766509,1.3321188359144798,0.13725490196078433,0.23542296513896221,1.0,11/15,34.60%,IL23A;IL1B;CD80;IL17F;IL23R;IL12B;IL18;RASGRP1;IL17D;CARD9;CD84
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.4038048795623095,-1.331435773147491,0.1,0.2457391601878077,1.0,15/33,25.99%,PTPRM;NGFR;NR2F2;ATOH8;CAV2;SYNJ2BP;MEF2C;PRL;KRIT1;COL4A3;CCL2;IL12A;SCG2;FLT1;RGCC
prerank,regulation of GTPase activity (GO:0043087),-0.30208482426271216,-1.3313801208084366,0.0,0.24539272340182866,1.0,72/181,24.53%,FLCN;BVES;RASGRP2;SGSM2;PLXNB3;RAPGEF3;RAP1A;ASAP3;RABGAP1;FERMT2;CCL14;TBC1D20;GPSM1;DVL3;PRKG1;CPEB2;EVI5L;RGS10;SRGAP2;GNB5;CAV2;RIC1;LRRK2;EPHA5;RAB11FIP2;NTRK1;FGD1;RDX;RASIP1;NDEL1;DAB2IP;EPHA4;RGS8;RAPGEF1;ARL2;EFNA5;ADRB1;SFRP1;EPHA3;ARHGEF7;SNX18;SGSM3;RAB3GAP1;DOCK11;PLXNA4;PLXNB1;CCL23;MAPRE2;ALS2;CCL11;SIPA1L1;RGS6;KLRK1;FGD2;RAPGEF6;CCL21;RAPGEF2;CCL2;BCAS3;SOD1;PRTN3;BCAR3;PIN1;RSU1;FICD;WNK1;FGD5;ADCYAP1;CDKL5;ARHGAP11B;ARHGAP15;RGS1
prerank,respiratory system development (GO:0060541),-0.4071612650321811,-1.3312332245421072,0.10909090909090909,0.24506626888519512,1.0,16/34,21.13%,NPHP3;FOXF1;FGF2;PHOX2B;FGFR2;CCDC39;TCF21;DISP1;CCDC40;GLI2;SMCHD1;FGF7;ABCA3;FGF1;FGF9;LOXL3
prerank,regulation of T cell differentiation (GO:0045580),0.37709613213094906,1.3311354351465066,0.11904761904761904,0.23637410146481555,1.0,18/39,27.97%,CBFB;TCF7;FOXP3;MDK;XBP1;RUNX1;PRELID1;ZNF683;FANCA;IL36B;PRDM1;CRTAM;CD2;ZAP70;IL2RA;IFNG;CTLA4;RHOH
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.4297443267253078,1.3309677905954018,0.1111111111111111,0.23612755452662185,1.0,6/21,6.23%,THY1;IL1RN;SKAP1;IL1B;CEACAM6;CD44
prerank,negative regulation of ATPase activity (GO:0032780),-0.516520639847741,-1.3302333690683446,0.06896551724137931,0.24655910695837124,1.0,8/16,21.91%,TSC1;PXK;PLN;TLR9;VCPKMT;PAM16;SIRT1;SLN
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.43125516016174137,-1.330211403602926,0.11538461538461539,0.246120541499293,1.0,8/25,15.69%,TSC1;ASAP3;SYNPO2;SHANK3;SYNPO;RDX;RAC1;ROCK1
prerank,vitamin transport (GO:0051180),0.4160785897692481,1.3301219289479929,0.09090909090909091,0.23679288842851845,1.0,8/26,14.04%,TCN1;SLC5A6;FOLR1;SLC52A2;SLC19A1;TTPA;SLC52A3;CD320
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.31952171652951533,1.3299780656924052,0.0,0.23647658403301597,1.0,37/111,20.77%,GNL3L;RPA3;CAPG;USP50;CSF2;FERMT1;MMP1;GTF2H3;SKAP1;AJUBA;SYK;PSMC2;PSMC4;RPS3;ERCC5;MYD88;BIK;GSK3B;MMP3;GBP5;DDB1;CDT1;VCP;RPA2;ISG15;CUL4A;SUMO1;TGFB1;PLEK;PIH1D1;BAX;BID;ERCC2;FSCN1;BAK1;HSP90AA1;CXCL13
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.4628060502860266,-1.329773544829502,0.08333333333333333,0.24618259927386088,1.0,13/20,29.92%,SEMA6C;SEMA4C;SEMA3E;SEMA6D;SEMA6A;SEMA3B;SEMA3G;SEMA3A;SEMA3C;SEMA4B;SEMA3D;SEMA6B;SEMA5B
prerank,autophagosome assembly (GO:0000045),-0.3670964663276411,-1.3295818999464764,0.038461538461538464,0.2460784515710154,1.0,20/56,18.47%,GABARAPL1;ULK1;ATG2B;ATG9A;WDR45;ULK2;ATG14;MAP1LC3C;MFN2;TP53INP2;ATG16L2;RAB23;PIK3C3;PACS2;TP53INP1;EMC6;STX12;GABARAPL2;ATG12;TRAPPC8
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4001077456082937,1.3293986347600841,0.12,0.23730114914480313,1.0,10/30,18.67%,ETV4;CBFB;CTSV;CYP27B1;ZBED2;RUNX1;AQP3;GRHL2;MED1;HOXA7
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.43361038827193676,-1.32934892527874,0.05660377358490566,0.2458643007001401,1.0,14/32,15.71%,CAPRIN2;CUX2;ZDHHC15;SHANK3;NLGN1;PTEN;KIF1A;LRRK2;BHLHB9;ABI2;EPHA4;RELN;CAMK2B;DBN1
prerank,response to cAMP (GO:0051591),-0.4029382157299701,-1.3291288784243407,0.11666666666666667,0.24568773418379228,1.0,14/37,20.49%,PDE2A;AKAP6;RAPGEF3;PKD2;RAP1A;ZFP36L1;AQP1;INPP5K;RAPGEF1;KCNE1;IGFBP5;CRHBP;RAPGEF2;HCN3
prerank,calcium ion homeostasis (GO:0055074),-0.34871053642339295,-1.3284905080124292,0.05357142857142857,0.2464283677620306,1.0,24/94,15.17%,TPCN2;DMPK;PTH1R;ATP2B4;ANK2;JPH2;CCL14;STIM1;SLC8A2;SLC24A4;SNCA;SLC8A1;ELANE;TMTC2;SLC24A3;NPTN;CTRC;RYR2;ATP2B3;SLC8A3;CSRP3;TRDN;RGN;HTR2B
prerank,microtubule bundle formation (GO:0001578),-0.3769899312361957,-1.3267901202929016,0.1111111111111111,0.24870273823816316,1.0,18/41,23.43%,TTLL3;NUMA1;CLIP1;MTCL1;CCDC66;CLASP1;CCDC40;NCKAP5L;GAS2L1;NAV1;TPPP;MARK4;CDK5RAP2;GAS2L2;DCX;TPPP3;RSPH4A;AAAS
prerank,positive regulation of wound healing (GO:0090303),0.38151439533548387,1.3266636935090106,0.09523809523809523,0.24079097893552856,1.0,16/36,28.22%,CLDN1;F12;FERMT1;ACTG1;DUOX2;XBP1;HPSE;F2R;CLDN4;SERPINE1;THBS1;ARFGEF1;REG3A;ANXA1;CLEC7A;INSL3
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.4866117166369759,-1.3263301882959224,0.07017543859649122,0.2490145625279733,1.0,10/18,23.11%,FLCN;APOD;RAB23;OTUD7B;LATS2;SIN3A;SUFU;CABP1;MDFIC;LATS1
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.40610439440512375,-1.3260911074802122,0.07272727272727272,0.24876028939834427,1.0,20/43,24.27%,FGFR1;LPAR1;FGF2;PDGFRA;NTRK3;ARHGAP6;ADRA1A;KIT;P2RY12;HTR2B;ESR1;GNAQ;NTF3;EGFR;AVPR1A;PLCB2;PLCG1;FLT1;RASGRP4;HTR2A
prerank,activation of GTPase activity (GO:0090630),-0.3438196171933508,-1.3249854097793414,0.03225806451612903,0.24996186998856026,1.0,36/98,21.35%,ARHGEF26;TSC1;TBC1D1;SGSM2;TBC1D17;RABGAP1;TBC1D10A;USP6;TBC1D26;SYDE1;NTRK3;ARHGEF10;EVI5L;GARNL3;TBC1D2B;SIPA1L2;SGSM1;ARHGEF15;SYDE2;CORO1C;ARHGAP24;TBC1D13;TIAM1;ARHGAP29;TBC1D25;NTF3;RALGAPA1;SIPA1;SGSM3;SIPA1L1;TAX1BP3;ADPRH;TBC1D12;CCL21;BCAS3;TBCK
prerank,negative regulation of apoptotic process (GO:0043066),0.26686469407215596,1.3247785418770124,0.0,0.24327030805194827,1.0,150/466,21.84%,FOXQ1;MYC;MAD2L1;DPEP1;ANXA4;TDGF1;CDK1;VDAC1;HSPD1;DHRS2;CBX4;VHL;RIPK2;TRIAP1;ARL6IP1;SET;LAMP3;GLO1;HDAC2;IFI6;KIF14;MYDGF;PTRH2;PTMA;FIGNL1;YWHAE;WNT5A;PRDX5;CEACAM6;SHH;PRKDC;CARD14;LEF1;PSMD10;CD44;CTSH;ARF4;CIAPIN1;SOX9;TMBIM6;ATAD3A;BCL2L1;BFAR;ERCC5;HSPA9;CLEC5A;HNRNPK;MDK;CSNK2A1;MAZ;BCL2A1;CASP2;PPIF;HMGA2;XIAP;XBP1;AATF;DNAJC3;TRIM27;PRAME;PA2G4;HDAC1;MYD88;RELA;NAA15;ADAM10;IRAK1;GPX1;TOX3;CEACAM5;PAK2;IGF1R;SIX1;PRELID1;SEMA4D;FGF20;GSK3B;PROC;WDR73;ARHGDIA;COPS5;PLA2G3;PRDX2;POU4F1;ITGA5;PRLR;TAF9;NAA35;LAMTOR5;WNT11;THOC6;CIB1;DNAJA1;PLK1;DHCR24;PRKCI;VTCN1;NPM1;MMP9;KDR;BMP4;MIEN1;HTATIP2;UBA52;GATA6;GRN;PDCD10;YME1L1;NUP62;IFIT3;ADAM8;MED1;PLAUR;F2R;PRKCG;NUAK2;HSPA5;PPT1;ANXA5;CFL1;BAG4;API5;MTRNR2L3;FHL2;BNIP1;MTRNR2L1;BIRC5;TPT1;FXN;NFKBIA;PROK2;COMP;BID;SFN;TMEM14A;BIRC7;CAV1;PAX2;UFM1;DDRGK1;RPS6KA1;ZC3H12A;UBE2Z;MCL1;OPN3;MSH2;PRDX3;FOXB1;NOTCH1;LGMN
prerank,protein export from nucleus (GO:0006611),0.40131693886021924,1.3227950840377514,0.061224489795918366,0.24578541552900768,1.0,6/26,5.50%,CALR;RAN;CSE1L;XPO5;NUTF2;DUSP16
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.34625345210212344,1.3227244012906283,0.02564102564102564,0.2453382404318986,1.0,28/67,22.77%,DKC1;RAN;CCT6A;CDK1;CCT2;CCT3;GTSE1;CCT8;CCT7;ECT2;ZPR1;JUP;DTX3L;NMD3;ORMDL3;LAMTOR5;RBM22;PLK1;CCT4;TCP1;TGFB1;CARD10;TRIM28;ZC3H12A;MCRS1;IPO5;HYAL2;LIF
prerank,chordate embryonic development (GO:0043009),-0.3711370296887146,-1.3218325912467705,0.11320754716981132,0.254316817034105,1.0,18/57,16.72%,PKD1;FLCN;FOXF1;FGFR1;EGFL8;PKD2;MYH6;FGFR2;FOXD3;MBNL1;ZNF568;TBX1;ZNF358;ARNT2;XYLT1;HINFP;LMX1B;PCSK5
prerank,DNA packaging (GO:0006323),0.4659400402882227,1.3213542217620653,0.15,0.2468029303263369,1.0,6/15,15.78%,CHAF1B;CHAF1A;NOC2L;AIFM1;HAT1;BANF1
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.4689017690343087,-1.321310975333807,0.1111111111111111,0.2551586178980878,1.0,5/18,13.02%,JAM3;MSTN;RARRES2;MAPK1;MAPK3
prerank,extracellular matrix disassembly (GO:0022617),0.34791679626772287,1.320114842656704,0.05263157894736842,0.24798592637765976,1.0,20/60,17.69%,MMP7;MMP13;CAPG;CTSV;KIF9;KLK7;MMP11;MMP1;TIMP1;CD44;MMP10;ADAM10;MMP2;MMP3;CAPN1;MMP9;MMP12;ADAM8;ADAM15;MMP15
prerank,positive regulation of inflammatory response (GO:0050729),0.34315167496022536,1.3200058607588212,0.0,0.24755987383631484,1.0,40/86,28.40%,C2CD4A;OSM;IL23A;ZP3;IL1B;WNT5A;MGST2;CEBPA;NMI;MDK;DHX9;IL21;CD81;CCL3;PLA2G7;VAMP8;PLA2G3;AGT;GRN;RPS19;MAPK13;ADAM8;FEM1A;NFKBIA;SNX4;SERPINE1;TNFSF4;MMP8;C2CD4B;IL12B;HYAL2;CD47;ZBP1;CCL1;VAMP7;ETS1;IFNG;IFI35;IL18;TLR7
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.41423079176298955,1.3199795390016662,0.0975609756097561,0.24655333941239743,1.0,10/26,17.38%,ACSL6;BAAT;THEM5;DBI;ACOT7;ACOT13;ACOT4;ACOT8;ACLY;OXSM
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.41423079176298955,1.3199795390016662,0.0975609756097561,0.24655333941239743,1.0,10/26,17.38%,ACSL6;BAAT;THEM5;DBI;ACOT7;ACOT13;ACOT4;ACOT8;ACLY;OXSM
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.43640669052461556,1.3196111590528334,0.0,0.24656560191293658,1.0,9/22,18.87%,MMP7;HM13;APH1A;RELA;ADAM10;NCSTN;TGFB1;MBTPS2;ADAM9
prerank,cortical cytoskeleton organization (GO:0030865),-0.3921930049310551,-1.3186891811994872,0.08620689655172414,0.25966713930943913,1.0,19/41,25.82%,RND2;NLGN1;RHOQ;RHOB;EPB41L3;NCKAP1L;PPP2R3C;RAC1;RHOA;FHOD3;ROCK1;RAB13;RHOBTB1;STRIP1;FMNL3;FMNL2;RHOC;FHOD1;NCKAP1
prerank,negative regulation of viral entry into host cell (GO:0046597),0.4817683138463482,1.3182868231636846,0.125,0.24850952922778125,1.0,6/16,15.15%,IFITM3;LY6E;IFITM1;IFITM2;TRIM26;TRIM11
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3512292116797493,-1.317909085302799,0.08571428571428572,0.26053128920580915,1.0,33/77,27.38%,RBPMS2;ATP2B4;EPN2;BMPR1A;DAND5;FGF2;CHRD;SMAD4;SKOR1;FSTL3;CADM4;SLIT2;EMILIN1;SPRY1;SKI;DAB2IP;SPRY3;SMAD9;ACVR2A;GPC1;AGTR2;HHEX;TRIM33;BMPR1B;SMAD7;MMRN2;DLX1;VWC2;NBL1;BMPER;CRIM1;NOG;SMURF1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.3994897841170334,1.3177405830062179,0.13725490196078433,0.24890324423089408,1.0,9/29,11.16%,RUVBL1;MYC;TCF7;AXIN2;LEF1;RBBP5;SMARCA4;HDAC1;BCL9L
prerank,regulation of collagen biosynthetic process (GO:0032965),0.43727653095404995,1.3171261047523901,0.08771929824561403,0.24918217391679454,1.0,8/18,17.46%,HDAC2;AMELX;RUNX1;SUCO;BMP4;F2R;TGFB1;CREB3L1
prerank,cellular response to UV (GO:0034644),0.316935765348724,1.317077224042071,0.0,0.24873721073858113,1.0,32/74,25.05%,CHEK1;MYC;RHNO1;TRIAP1;RUVBL2;MMP1;TIMP1;AURKB;MME;HYAL3;NOC2L;MMP2;MMP3;DDB1;KDM1A;PTPRK;NPM1;MMP9;MAPK13;CDC25A;POLD1;SDE2;TMEM161A;EIF2S1;BAK1;OPN3;HYAL2;ACTR5;PPID;TP53;CARD16;CREBBP
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.42700980879580497,-1.3168564288662694,0.13793103448275862,0.2616441878357193,1.0,8/27,15.02%,ATP2B4;MYOZ2;AKAP6;ACTN3;PRNP;MYOZ1;HOMER2;HOMER3
prerank,positive regulation of heart contraction (GO:0045823),-0.47835500398196207,-1.3167484187480338,0.11538461538461539,0.261296912817819,1.0,7/20,11.05%,HRC;ATP1A2;RGS2;SCN3B;NPPA;ADRA1A;RYR2
prerank,DNA conformation change (GO:0071103),0.4469381418391086,1.3165079959035753,0.06,0.2491280328740962,1.0,9/18,21.39%,TOP1MT;HMGB3;TOP1;HMGB2;TOP3B;HAT1;TOP2A;TOP3A;HMGB1
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.4105994438670713,-1.316314852405663,0.12280701754385964,0.26163264846625117,1.0,10/30,18.06%,PTH1R;ILK;SNCA;AR;PSEN1;FZD7;NCKAP1L;BCL10;DSCAM;EGFR
prerank,replication fork processing (GO:0031297),0.40478236391862304,1.3162747036693536,0.10869565217391304,0.24906738894477878,1.0,9/35,7.94%,RFWD3;ALYREF;EME1;TRAIP;BLM;MMS22L;ZRANB3;TONSL;DNA2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.4919828406100333,-1.3154789981687205,0.19230769230769232,0.2621640236222874,1.0,6/17,15.00%,MAP3K3;FGF2;HDAC7;RHOJ;HDAC9;GATA2
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.4346522512688878,-1.3150289777090283,0.04,0.26256825960934593,1.0,6/22,10.00%,PDE3B;GPER1;ASXL3;APOD;ALK;BSCL2
prerank,regulation of insulin secretion (GO:0050796),-0.32144541309443425,-1.314906776383455,0.07142857142857142,0.262186213162319,1.0,24/97,14.77%,ADCY5;KCNB1;NLGN2;CACNA1C;ARNTL;NNAT;KCNA5;RAPGEF3;RAP1A;PPP3CB;ITPR1;ABCC8;GPER1;PRKCA;NR1D1;EPHA5;GCK;SNAP25;SIRT4;SLC30A8;CELA2A;EFNA5;SFRP1;STXBP4
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.49234090378067824,-1.3139407449885965,0.14545454545454545,0.26308725481158085,1.0,9/16,17.86%,ANK2;TAPT1;BCAP29;LRRK2;RYR2;SEC16B;GBF1;GABARAPL2;VAPA
prerank,defense response to virus (GO:0051607),0.31321590615737194,1.3138932260198575,0.05,0.2522618397072218,1.0,32/127,15.93%,CLPB;EXOSC5;IFITM3;IFITM1;SKP2;ABCE1;IFITM2;G3BP1;EXOSC4;PHB;IFI6;PMAIP1;SERINC5;ATAD3A;BCL2L1;NT5C3A;PDE12;IFI44L;IL21;OAS2;MYD88;RELA;STAT1;APOBEC3F;NLRC5;CXCL10;BST2;IFIT3;OASL;ISG15;MX1;PRF1
prerank,homotypic cell-cell adhesion (GO:0034109),-0.384165118379234,-1.3135307483014664,0.10869565217391304,0.26318536140993226,1.0,10/39,7.02%,CSRP1;MYL9;FLNA;TLN1;VCL;PDGFRA;ILK;ITGB3;ACTN1;MEGF10
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.355946689638816,1.3127377826080637,0.06521739130434782,0.2536511392798818,1.0,19/54,16.58%,RFWD3;CHEK1;CCND1;BRCC3;EME1;CDK1;TIPIN;CHEK2;BLM;TICRR;PRKDC;TOPBP1;RAD9B;HMGA2;BRCA1;HUS1;PLK1;RPA2;CLSPN
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.366315809577575,-1.3125716058026522,0.046153846153846156,0.2644888598676158,1.0,16/52,18.80%,CLIP3;SORBS1;ATP2B4;WNK3;NUMA1;GPER1;GNAI1;PIK3R1;CNPY4;STAC2;STAC;LGALS3;EPHA3;EFCAB7;EGFR;RAMP3
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.45306284445530787,1.3122786871191445,0.15555555555555556,0.25378285590717825,1.0,10/19,27.06%,COX20;COX18;COA1;SCO2;COA3;COX19;COX17;FASTKD3;PET117;SMIM20
prerank,regulation of myotube differentiation (GO:0010830),-0.4420590712679381,-1.3118172196507631,0.11764705882352941,0.2651679368747964,1.0,9/24,17.49%,DMPK;HDAC4;RBM24;SMYD1;MAML1;HDAC5;HDAC9;MAPK14;PIEZO1
prerank,regulation of glucose import (GO:0046324),-0.40175004773174633,-1.310821305824246,0.10909090909090909,0.2666746288298662,1.0,15/34,24.33%,SORBS1;PIK3R1;RHOQ;PRKAG2;GRB10;PID1;PLA2G1B;PEA15;RTN2;AKT2;INSR;GSK3A;INS;CLTCL1;OCLN
prerank,positive regulation of synapse assembly (GO:0051965),-0.38692301540742463,-1.3104579529248,0.1568627450980392,0.2668180315016273,1.0,8/28,10.14%,NLGN2;NLGN3;SLITRK2;NRXN1;CUX2;NLGN1;LRRC4B;BHLHB9
prerank,motor neuron axon guidance (GO:0008045),-0.485053485104559,-1.3101447732345368,0.08888888888888889,0.2668729039318504,1.0,9/16,21.84%,NTN1;SLIT2;TMEFF1;RNF165;EPHA4;RAC1;NTN5;SEMA3A;SLIT1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4138294149214036,1.3101412651919422,0.125,0.25670283023323576,1.0,11/31,14.16%,GLYATL1;DDAH1;GOT2;ALDH18A1;GLS2;ALDH5A1;SLC39A8;CAD;ALDH4A1;GCLM;NIT2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.4142170309042321,-1.309549281734213,0.061224489795918366,0.26717345441385765,1.0,11/26,32.46%,TLR9;TLR3;GPS2;LRRC14;CD36;NFKBIL1;OTUD4;FLOT1;CACTIN;BIRC2;TLR2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.34208252647661286,1.3092845944362792,0.07894736842105263,0.25729538937762675,1.0,35/70,35.01%,COA6;UQCC3;COX6B1;NDUFS6;COX7A2L;UQCRQ;UQCRH;CYCS;NDUFB3;NDUFB11;NDUFA12;NDUFAB1;NDUFA3;COX4I1;CYC1;COX5B;COX7B;UQCRC1;NDUFA1;NDUFB9;NDUFB6;NDUFB5;COX5A;NDUFB4;NDUFS3;NDUFA4;NDUFS1;NDUFB7;UQCRHL;NDUFA2;NDUFC1;NDUFS5;NDUFB2;NDUFA6;NDUFS8
prerank,regulation of water loss via skin (GO:0033561),0.5121461775004189,1.3084025766503076,0.21739130434782608,0.25763067015920876,1.0,12/17,26.90%,CLDN1;STMN1;MET;LSR;CLDN4;KDF1;FA2H;SFN;ALOXE3;ABCA12;ALOX12;ALOX12B
prerank,establishment of skin barrier (GO:0061436),0.5121461775004189,1.3084025766503076,0.21739130434782608,0.25763067015920876,1.0,12/17,26.90%,CLDN1;STMN1;MET;LSR;CLDN4;KDF1;FA2H;SFN;ALOXE3;ABCA12;ALOX12;ALOX12B
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.3381042064624919,-1.3073315283706457,0.10714285714285714,0.2700848355005317,1.0,24/68,21.13%,FGFR1;TENM1;SASH1;FGF2;DVL3;GH1;TLR9;ELANE;KIT;MAP3K4;LRRK2;DIRAS2;DAB2IP;DVL2;NEK10;HTR2B;PDGFB;DUSP19;DIRAS1;FGF1;EGFR;MAP3K10;PDGFD;MAP3K7
prerank,central nervous system development (GO:0007417),-0.2896501047066055,-1.3070526712071833,0.0,0.2700457249899339,1.0,86/260,21.69%,PKD1;POU6F1;MEIS1;MAL;S100B;ATN1;EML1;ROGDI;NPTX1;SZT2;EPHA7;MEIS2;NNAT;PBX3;PKD2;GSN;VIT;GBA2;DSCAML1;HAP1;SYNJ1;DNER;TAGLN3;PTPRZ1;DCLK1;CIC;AMIGO1;HAPLN2;NDRG4;MDGA1;SNTG2;SMARCA1;ADGRL3;APOD;PBX2;PTEN;ZBTB16;ADGRL2;HPCAL4;NFIB;ADAM23;ADORA2A;TPPP;MEIS3;SLC8A3;MAST1;SH3GL3;ARNT2;RELN;HSPG2;ZNF335;UGP2;CDH2;ZFHX3;CNTN4;CA10;MOG;GLIS2;AATK;SPINK5;SLC6A17;RAB3GAP1;AHI1;GRIN2A;SMO;AMIGO2;SOX11;SPOCK1;CNTN6;KLHL17;CHST8;HAPLN4;CDK5RAP3;POU3F3;AGTR2;CDK5RAP2;DLL1;SOX6;BPTF;SETD1A;DCX;LOXL3;NCAN;ADGRA2;PCDH18;LIG4
prerank,histone H4 acetylation (GO:0043967),-0.36442265238627536,-1.3064005598276551,0.06944444444444445,0.2705656017730791,1.0,15/48,13.69%,PER1;KANSL3;APBB1;JADE1;CHD5;DMAP1;MSL1;ING4;BRD8;KMT2A;MORF4L1;EPC1;ACTL6B;KAT7;OGT
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.3225958812076572,-1.3063963004640744,0.1111111111111111,0.2700551006376582,1.0,47/113,25.48%,PDE2A;DUSP22;TGFBR3;BMPR1A;FERMT2;GCNT2;MAPK7;PXN;WFIKKN2;SMAD4;CLDN5;PARD3;CILP;SOX5;ZFP36L1;ZMIZ1;NR3C1;ARHGEF18;PDE3A;MEF2C;SKI;SFRP1;RHOA;USP9Y;GDF5;SMAD9;CBL;CLEC3B;ZFYVE9;SMAD2;USP15;LRRC32;HPGD;UBB;ANKRD1;SIRT1;SOX6;MAP3K7;SMAD7;CDH5;DLX1;TWSG1;TGFB3;ZFP36L2;AMHR2;SMAD3;FNTA
prerank,regulation of epithelial cell migration (GO:0010632),-0.3764868114591811,-1.3062016134546655,0.1,0.2698770834454266,1.0,19/51,17.76%,SASH1;GLIPR2;PTN;MACF1;HDAC6;CLASP1;RHOJ;EVL;CLASP2;PPM1F;DOCK1;CORO1C;MCC;DAB2IP;CAPN7;ENPP2;FGF10;GLUL;RTN4
prerank,neuron projection organization (GO:0106027),-0.5023678385725104,-1.3054649732110108,0.17391304347826086,0.2705159023549712,1.0,9/16,24.10%,DCTN1;MAP1A;PRNP;PSEN1;ATP1A3;INSR;INS;ABCD1;ABCD2
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.43124651692061694,1.3051511691661877,0.09523809523809523,0.2621791203341992,1.0,5/19,10.16%,GNPNAT1;PMM2;GFPT1;GNPDA1;PGM3
prerank,renal water homeostasis (GO:0003091),-0.4068259395423739,-1.3050023019968482,0.05454545454545454,0.2707363400621786,1.0,10/30,15.58%,ADCY5;ADCY2;ADCY4;ADCY9;PRKACA;RAB11FIP2;PRKAR2B;AQP1;AVPR2;ADCY6
prerank,sodium ion transport (GO:0006814),-0.3438548541571106,-1.3043277180615582,0.06,0.27126735601256124,1.0,41/88,28.66%,SCNN1D;ASIC3;ATP1A2;SLC6A16;PKD2;SCN7A;SCN3B;SCN9A;SLC8A2;SCN4A;SLC24A4;SCN11A;SCN2B;SCN1B;SLC8A1;ATP1A4;SCN4B;SLC24A3;SLC8A3;SCN3A;SCNN1B;FGF13;SCNN1G;SLC6A1;SLC6A17;SCN5A;HCN3;SLC6A15;ANO6;ASIC4;HCN2;SLC9B2;SCN1A;NEDD4L;SGK1;SLC6A9;SLC6A8;SLC4A4;SLC6A3;SLC17A4;SLC6A7
prerank,positive regulation of programmed cell death (GO:0043068),-0.28831570358829584,-1.3043137652939292,0.03333333333333333,0.2708293857343529,1.0,90/274,23.16%,ARHGEF26;FLCN;CLIP3;APBB1;RBM5;ADAMTSL4;ARHGEF17;MLLT11;KCNMA1;CLU;ARHGEF9;PNMA1;GPER1;MOAP1;JMY;PLEKHG2;SNCA;HDAC6;ITSN1;ARHGEF6;ATF4;OBSCN;NGF;RPS6KA2;ING4;NGFR;RHOB;OLFM1;DAPK1;PSEN1;SLIT2;PHLDA3;LRRK2;QRICH1;ARHGEF18;ARHGEF11;CALHM2;NTRK1;APH1B;FGD1;LATS2;PNMA3;TNFSF10;DAB2IP;ERCC3;TIAM1;DAPK3;KLF11;GADD45B;MARK4;PRMT2;SFRP1;CSRNP3;SOS2;BCL10;ARHGEF7;PSEN2;PIDD1;PIP5KL1;MAPK8;RNF122;APC;MCF2;FAS;TRIO;SOS1;HOXA5;CASP3;ING3;CASP9;DCUN1D3;UBB;RASSF2;MAP3K10;APAF1;FGD2;ANKRD1;CRADD;SIRT1;BNIP3;ING5;AKAP13;SOD1;BOK;ARHGEF3;BCL2L11;BAD;GADD45G;LATS1;ANO6
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2659921108510675,1.3039145387526827,0.027777777777777776,0.2634184685457377,1.0,97/312,21.69%,PSMD14;MAD2L1;DCAF12;PSMB2;CDK1;FBXO5;PTTG1;STT3B;PSMB9;PSMA5;SKP2;FBXL18;PSMB3;UBE2S;FBXO45;PSME3;PSMA3;KIF14;BUB3;DERL1;PSMA7;SEC61B;PSMD13;GID8;PSME2;PSMC2;PSMC4;PSMD10;TRIM72;ERCC8;PML;AURKB;PSMD12;ANAPC1;FBXO4;BFAR;PSMB5;KCTD5;PLAA;ERLIN1;UBE2C;UBE3D;CCNF;TRIM2;PRAME;PSMD8;AURKA;CDC26;FOXRED2;PSMB4;PSMD3;PSMB1;PSMA4;TRIM71;RAD23B;DDB1;SPSB2;PSME1;PSMF1;ANAPC11;PLK1;FBXL13;PSMD11;UBE2J1;UBA52;NHLRC1;PSMD1;VCP;CUL4A;RNF34;RNF187;FBXL14;UBE2A;ERLIN2;HSPA5;MAN1B1;FBXO6;FAF2;UBQLN1;FEM1A;OS9;UBE2K;PSMD6;CDC20;BUB1B;UBE2D1;PSMD5;AUP1;RBCK1;DNAJC10;KBTBD7;HECW1;UBXN8;CUL3;HECW2;CDK2;PSMC1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5059619207287764,1.303888810467724,0.18867924528301888,0.26293359888909307,1.0,5/16,7.72%,SRPRB;RAB10;SPCS1;SEC61A1;SEC61G
prerank,triglyceride catabolic process (GO:0019433),0.4566066002626301,1.303849270567067,0.044444444444444446,0.2624286752235204,1.0,5/19,11.13%,FABP6;PNPLA4;LIPG;PNPLA1;PNPLA3
prerank,signal release from synapse (GO:0099643),-0.3922626354038105,-1.3036039777627821,0.07547169811320754,0.2709389418936856,1.0,22/43,28.55%,VAMP2;PIP5K1C;BRSK1;CPLX3;NRXN1;SYT10;SNCA;SNPH;SYN2;NRXN2;SNAP25;RAB3A;SYN1;SNAPIN;RIMS1;SYT1;STXBP1;CPLX2;LIN7A;STX1A;OTOF;DVL1
prerank,neurotransmitter secretion (GO:0007269),-0.3922626354038105,-1.3036039777627821,0.07547169811320754,0.2709389418936856,1.0,22/43,28.55%,VAMP2;PIP5K1C;BRSK1;CPLX3;NRXN1;SYT10;SNCA;SNPH;SYN2;NRXN2;SNAP25;RAB3A;SYN1;SNAPIN;RIMS1;SYT1;STXBP1;CPLX2;LIN7A;STX1A;OTOF;DVL1
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.4141959086618331,-1.303429681792396,0.10204081632653061,0.2707272549068519,1.0,9/31,14.04%,HSPB8;DNAJC18;ATXN3;HSPA2;HDAC6;OPTN;DAB2IP;BAG3;HSPA1L
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5099447234210944,1.3025510355368124,0.18518518518518517,0.26420892272442903,1.0,7/16,20.02%,PIGM;DPM2;PIGW;PIGF;PIGA;PIGN;PIGX
prerank,spliceosomal complex assembly (GO:0000245),-0.39949788358049526,-1.3021794829400215,0.05454545454545454,0.2721103482599101,1.0,14/45,11.64%,LUC7L2;SRSF5;RBM5;LUC7L3;DDX39B;SF3B1;CELF1;LUC7L;CELF4;CELF6;SF1;CELF2;SRPK3;YTHDC1
prerank,T cell activation (GO:0042110),0.32931134729867084,1.3016256365925563,0.022222222222222223,0.2651056810322513,1.0,38/90,29.63%,SOX4;HSPD1;DDOST;FOXP3;CD276;LFNG;CD44;CXADR;MDK;GPR89A;TREML2;CHD7;MICB;GPR89B;PIK3CG;PTPN2;CD8B;LCK;MSN;TNFSF4;JAG2;ITK;CRTAM;CD2;ZAP70;SCRIB;CD3G;TNFRSF4;CLEC7A;CASP8;RHOH;SLA2;CD3E;PPP3CA;IFNE;PIK3CD;RASGRP1;LCP1
prerank,DNA modification (GO:0006304),0.4260900077705914,1.3016033056577574,0.1276595744680851,0.2646431798136713,1.0,7/24,12.71%,EXOSC5;UNG;EXOSC4;NTHL1;NEIL3;EXOSC3;MPG
prerank,regulation of T cell activation (GO:0050863),0.3465104201684437,1.3012480806882631,0.03225806451612903,0.264466209349417,1.0,18/45,26.53%,THY1;HSPD1;IL4I1;TNFSF11;TNFSF9;JAK3;PRELID1;VTCN1;TNFRSF1B;LCK;SIT1;TNFSF8;TNFSF18;CD47;CRTAM;CD2;PRKCQ;TIGIT
prerank,regulation of cellular respiration (GO:0043457),0.4791428618739048,1.300771470014875,0.1111111111111111,0.26474730322259143,1.0,8/16,17.71%,SHMT2;PNPT1;TRAP1;NOS2;PRELID1;VCP;NOA1;IDE
prerank,calcium ion transmembrane transport (GO:0070588),-0.3454603041182831,-1.3005569823564989,0.07407407407407407,0.27429239454825405,1.0,23/85,14.81%,PKD1;RYR3;ATP2B4;CACNA1C;TRPV1;PKD2;TRPC1;CACNA2D1;SLC8A2;SLC25A23;SLC24A4;MICU3;P2RX7;SLC8A1;TRPC6;TRPC4;SLC24A3;CACNA1G;ATP2B3;SLC8A3;MCOLN3;TRPV3;MCOLN1
prerank,eye photoreceptor cell development (GO:0042462),0.4715509034747636,1.300028914678037,0.15217391304347827,0.2652881160848232,1.0,7/15,14.62%,THY1;CRB2;RP1;TH;NRL;RPGRIP1L;USH1C
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.31438663329179867,1.2997383255978414,0.08108108108108109,0.26511092027495947,1.0,26/101,16.52%,SPTBN2;AP1S3;AP1S1;KIF2A;KIF18A;KIF15;RACGAP1;CTSV;CENPE;CANX;KIF23;CAPZA1;SEC13;KIF22;KIF3B;CLTA;CTSE;AP2S1;KIF4B;KIF2C;CLTC;AP2B1;DCTN5;AP1M2;DYNLL1;RAB7A
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.3279969504115578,1.29962559380164,0.11363636363636363,0.26473957098127815,1.0,23/72,18.84%,FAP;HM13;PRPF19;GZMB;CTSV;PMAIP1;CTSH;TNFAIP3;CTSC;CHMP4C;ADAMTS12;LONP1;DDB1;CLPP;UBA52;YME1L1;VCP;ISG15;CTSZ;GZMA;IDE;RSPRY1;NGLY1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.36267310865869173,1.2992702619005057,0.0975609756097561,0.26478022917615235,1.0,18/52,17.90%,PSMD14;BRCC3;PRPF19;DCLRE1C;UBE2N;POLB;DCLRE1B;XRCC5;XRCC4;PRKDC;ERCC8;HMGB2;POLA1;BRCA1;NSMCE2;SUMO1;LIG3;PAXIP1
prerank,negative regulation of axon extension (GO:0030517),-0.3891952154907818,-1.2990450301110053,0.09615384615384616,0.2759711594926661,1.0,18/31,28.35%,SEMA6C;PTPRS;SEMA4C;MAP2;SEMA3E;SEMA6D;SEMA6A;SEMA3B;MAG;SEMA3G;SEMA3A;RTN4;TRIM46;SEMA3C;SEMA4B;SEMA3D;MT3;SEMA6B
prerank,regulation of presynapse organization (GO:0099174),-0.4453782236699598,-1.2989869782380379,0.11666666666666667,0.2750567719544917,1.0,9/18,21.88%,SLITRK2;SNCA;LRFN5;MDGA1;LRRC4B;SLITRK3;IL1RAPL1;SLITRK1;GPC6
prerank,regulation of presynapse assembly (GO:1905606),-0.4453782236699598,-1.2989869782380379,0.11666666666666667,0.2750567719544917,1.0,9/18,21.88%,SLITRK2;SNCA;LRFN5;MDGA1;LRRC4B;SLITRK3;IL1RAPL1;SLITRK1;GPC6
prerank,telomere maintenance (GO:0000723),0.36723100093215033,1.2985551213232824,0.058823529411764705,0.2653814229655012,1.0,15/51,15.63%,RPA3;POLD2;DCLRE1B;BLM;XRCC5;PRKDC;RECQL4;DNA2;APEX1;PTGES3;HUS1;NSMCE2;TPRKB;RPA2;POLD1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.4041924291453072,1.2980556278251991,0.08695652173913043,0.2657865528421169,1.0,9/24,28.01%,AZGP1;IL23A;CD1A;CD1B;IL23R;HLA-F;IL12B;IL12RB1;CD1E
prerank,regulation of amyloid-beta formation (GO:1902003),-0.40682631950238135,-1.2969632104764435,0.09836065573770492,0.2778117344034958,1.0,15/34,22.67%,CLU;HAP1;PRNP;RTN1;GGA3;EPHA4;GSAP;ROCK1;RTN2;RTN4;CASP3;GSK3A;LRRTM3;IFNGR1;PIN1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.4807473274878996,1.2965105207062446,0.09523809523809523,0.26754338760259444,1.0,12/18,29.82%,GSK3B;ZNF205;SLC35F6;SLC25A5;BAX;BID;TMEM102;TMEM14A;BAK1;FZD9;HIP1R;CHCHD10
prerank,regulation of wound healing (GO:0061041),0.36729003538454946,1.2964508028765518,0.06382978723404255,0.2671923527013138,1.0,15/43,20.26%,CLDN1;CASK;EPHB2;PLAU;EPPK1;ACTG1;TNFAIP3;DUOX2;FOXA2;TNFRSF12A;F2R;CLDN4;SERPINE1;CAV1;VIL1
prerank,nuclear export (GO:0051168),0.32676827599253544,1.296083725015622,0.0975609756097561,0.26705665691793984,1.0,18/82,6.05%,CALR;RAN;ALYREF;CSE1L;THOC3;NUP155;U2AF1;XPO5;MAGOH;RAE1;NUP62CL;MAGOHB;EIF4A3;NUTF2;RITA1;NCBP1;DDX39A;SRSF9
prerank,regulation of angiogenesis (GO:0045765),-0.2973773963832623,-1.2946528943452573,0.0,0.28096341174814876,1.0,69/189,23.93%,YJEFN3;ATP2B4;NPR1;RAPGEF3;SASH1;FGF2;FOXJ2;GAB1;MECP2;PTPRM;STAB1;STIM1;PDE3B;ADGRB1;CLDN5;CD34;PRKCB;PRKCA;ADAMTS1;HSPB6;RHOJ;PTGIS;RHOB;PRKD1;EGLN1;VEGFB;SEMA3E;DCN;EMILIN1;RRAS;ANGPT4;FOXO4;HSPB1;THBS4;SYNJ2BP;PRL;AQP1;DAB2IP;KRIT1;SEMA6A;HSPG2;SFRP1;GATA2;ROCK1;ECSCR;SPINK5;TIE1;GLUL;COL4A2;SERPINF1;NPPB;HOXA5;FGF1;COL4A3;FGF16;AGO1;HHEX;ANGPTL4;SIRT1;VEGFC;KRT1;ADGRA2;CDH5;PLCG1;RAMP2;HIPK1;ATF2;HMOX1;FLT1
prerank,negative regulation of catalytic activity (GO:0043086),-0.4135408288799961,-1.294339018908255,0.09523809523809523,0.28097334642091043,1.0,13/24,28.77%,PPP1R12A;CAMK2A;PLN;HDAC6;NOS1;SERPINA5;TMBIM1;SIRT1;SLN;CLN3;MT3;NES;OXA1L
prerank,mitochondrion organization (GO:0007005),0.29813972002002626,1.2938627100556177,0.0,0.26969769471716043,1.0,43/163,15.65%,TOMM34;MTFR2;SSBP1;MTX1;HSPD1;MTFR1;TIMM23;TFB2M;PHB;BCAP31;TOMM40;TIMM10;TFAM;HSD17B10;MGME1;CHCHD2;PNPT1;TIMM13;TFB1M;TOMM22;TOMM20;TIMM50;STOML2;ATAD3A;CXADR;BCL2L1;TIMM17B;TIMM8B;AIFM1;DNAJA3;BIK;TSPO;CHCHD3;COX7A2L;LONP1;CYCS;GBA;COX7A2;YME1L1;SLIRP;MYH14;MX1;SLC25A33
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.42631803336099905,1.2936160366637808,0.12195121951219512,0.2695789751266394,1.0,6/16,18.89%,VPS25;VTA1;CHMP4C;CHMP5;LEPROTL1;STAM
prerank,RNA splicing (GO:0008380),0.31588296909341523,1.291595311389825,0.044444444444444446,0.2723963420229687,1.0,32/97,17.02%,DDX47;SNRPF;SNRPD1;LSM4;SNRPG;SF3B3;U2AF1;MAGOH;PRPF4;SNRPB;RNF113A;KHSRP;MAGOHB;SNRPD2;NCBP1;SRPK1;PTBP1;NONO;RSRC1;SNRNP40;PRPF6;SNRPA1;NCBP2;HNRNPC;FUS;DHX8;LSM6;USP39;CDK12;SYNCRIP;TRA2B;SF3A3
prerank,endothelial cell development (GO:0001885),-0.41572509618210957,-1.2910942514874804,0.1276595744680851,0.2858304041881526,1.0,15/25,27.06%,PDE2A;RAPGEF3;RAP1A;PDE4D;GSTM3;RDX;RAPGEF1;MYADM;ROBO4;SOX18;RAPGEF2;COL22A1;COL18A1;F2RL1;COL15A1
prerank,proteolysis (GO:0006508),0.2749161273468444,1.2908705410976726,0.0,0.27327074276317914,1.0,82/272,19.39%,MMP7;FAP;PRSS33;NLN;PRSS22;CAPN12;HM13;TMPRSS3;ACAN;GZMB;F12;CTSV;MIPEP;VHL;BACE2;PLAU;MMP1;MMEL1;LRP8;CPZ;KLK12;OLR1;CPD;PSMC4;ERMP1;SPCS1;CTSH;MME;CTSC;APEH;PSMB5;APH1A;PCSK1;REN;DPP3;CASP6;CASP2;CPN1;F7;CTSE;ADAM10;ADAMTS12;MMP2;PROC;XPNPEP1;MMP3;LONP1;CAPN1;CLPP;PRSS48;LAP3;MMP24;THOP1;MMP9;YME1L1;MMP12;CNDP2;TMPRSS7;PRSS3;NCSTN;SPRTN;LCN1;FBXO6;CTSZ;GZMA;PCSK7;ST14;MMP15;PRSS54;IDE;CPNE1;DESI1;PRSS21;PSMD6;RSPRY1;PCSK6;ZMPSTE24;SDE2;CTSA;TMPRSS4;ERAP1;TYSND1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.363908253273717,-1.2908419702220049,0.05263157894736842,0.28581456299215824,1.0,7/48,6.57%,PRRT2;JAM3;CRYAB;RAF1;ULK1;CLU;HDAC6
prerank,positive regulation of endocytosis (GO:0045807),-0.370419295853793,-1.2906675347889045,0.140625,0.2855968491383837,1.0,20/45,27.23%,CLIP3;CLU;ANKFY1;CALY;SNCA;NLGN1;NCKAP1L;CBL;DLL1;CCL21;B2M;RAB31;SGIP1;ANO6;SMPD1;CLN3;HIP1;F2RL1;FLOT1;NEDD4L
prerank,protein maturation (GO:0051604),0.308146011983961,1.2904916082943487,0.047619047619047616,0.273357718169587,1.0,29/94,19.39%,CIAO1;TESC;LIPT2;HSPD1;F12;DUOXA2;MMEL1;CPZ;GLRX3;CPD;MME;APH1A;PCSK1;CASP2;CPN1;F7;NAA15;NAA50;ADAM10;SORL1;NAA35;TSPAN17;NDUFAB1;NCSTN;PCSK7;PCSK6;SDE2;TMPRSS4;TYSND1
prerank,ion homeostasis (GO:0050801),-0.41901897206083344,-1.2903186243898526,0.09433962264150944,0.28569906873782785,1.0,17/30,29.33%,FHL1;WNK3;UNC80;SLC4A7;SLC30A8;RHAG;SLC30A4;CAMK2D;SLC4A3;KLHL3;WNK1;SLC4A5;SLC4A1;NEDD4L;SLC4A4;SLC12A5;SLC4A10
prerank,regulation of glycolytic process (GO:0006110),0.32830982361297484,1.2902746327851011,0.02564102564102564,0.2731694124241615,1.0,29/67,27.18%,NUP37;PFKFB3;NUP155;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;NUP43;EIF6;NUP50;NUP88;NUP107;GAPDHS;PFKFB4;NUP205;NUP62;NUP160;NDC1;MLXIPL;GIT1;FBP1;PGAM1;ZBTB20;NUP98;HIF1A;TIGAR;IFNG
prerank,drug catabolic process (GO:0042737),0.47442708718563453,1.2901705505111647,0.16326530612244897,0.27283406780010583,1.0,4/17,7.14%,CYP2S1;CYP2W1;NUDT15;CYP2F1
prerank,cellular component assembly (GO:0022607),-0.27743162154672274,-1.290153224001406,0.015625,0.28554942054491167,1.0,64/252,17.76%,LIMS2;TTLL3;VAMP2;FAM107A;SH3BGR;ADD1;GPM6B;NLGN2;FLNA;WDR19;FLNC;GSN;CALD1;NLGN3;FERMT2;CAPN3;TCAP;NLGN4X;LIMA1;MITF;ANK3;TRAF1;ILK;DLG4;MYO9A;SYCE1;NLGN1;NEFH;PARD3;TEAD1;RHOQ;CCDC40;RHOJ;LAMC1;DPYSL3;KMT2A;DET1;WASF1;PARVA;WASF3;MDM4;NCKAP1L;TSPAN4;MAGI1;OPHN1;TINF2;QRICH2;RANBP9;CDAN1;RAC1;ADD2;RHOA;TEAD2;APC;REC8;CEP290;BSN;FAS;BAIAP2;NLGN4Y;ABCA3;WIPF1;FSCN3;RTN4
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.37836390791709634,-1.290054477038301,0.1320754716981132,0.28518274555956763,1.0,15/45,20.09%,MAP3K3;FGFR1;FGF2;HDAC7;PRKCA;RHOJ;PRKD1;ANGPT4;HSPB1;HDAC9;GATA2;PDGFB;MAPK14;ANGPT1;SIRT1
prerank,cell-substrate junction assembly (GO:0007044),-0.38206060602835146,-1.2888456652326659,0.1016949152542373,0.2870392697621254,1.0,13/32,16.00%,SORBS1;FERMT2;ACTN2;ACTN3;WHAMM;ACTN1;DLC1;LAMC1;DST;TAOK2;PEAK1;ARHGEF7;THSD1
prerank,bicellular tight junction assembly (GO:0070830),0.3622467440820296,1.2883770072657752,0.08333333333333333,0.2751546417942105,1.0,19/47,24.37%,CLDN1;CLDN2;CLDN16;CLDN14;PARD6B;ECT2;PAK2;POF1B;PECAM1;MARVELD2;PRKCI;GRHL2;CRB3;CLDN4;STRN;F11R;CLDN9;FRMPD2;CLDN10
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.2957265438359359,-1.288065581540326,0.029850746268656716,0.28757171476335763,1.0,52/190,19.25%,FLCN;TNRC6A;ATP2B4;HAND2;PGR;RBMS3;BMPR1A;FGF2;MAPT;TARDBP;MECP2;AGO4;TCEAL1;CITED2;GPER1;TRIM6;DLG4;CLDN5;CELF1;CD34;TNRC6C;CILP;DIP2A;OLFM1;PSEN1;ATOH8;RIN3;PRKAA2;SLC24A3;EMILIN1;ATXN2;OPTN;DICER1;ANKRD13A;MEF2C;AGO3;SFRP1;SFMBT2;HINFP;GATA2;ESR1;PDGFB;HEY2;NOTCH2;MYADM;RBL2;SMO;SOX11;TNRC6B;AGO1;FBXW7;PARP15
prerank,positive regulation of organelle organization (GO:0010638),-0.4023914868086996,-1.2875381339334226,0.14516129032258066,0.28793578493048144,1.0,12/31,17.62%,PLA2G5;FYCO1;SYNJ1;SORBS3;P2RX7;CALCOCO2;ADRB2;UVRAG;ATL3;MGARP;RAB3GAP1;AKT2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.493984143949158,-1.287324667988068,0.14814814814814814,0.28781669097022267,1.0,4/15,8.32%,RAPGEF3;EHD2;ADGRB1;CAMK1
prerank,protein processing (GO:0016485),0.3014380103050139,1.2867230698463532,0.02857142857142857,0.2769826774498851,1.0,40/96,25.26%,KLK6;HM13;F12;TMEM208;MMEL1;CPZ;CPD;SPCS1;CTSH;MME;STOML2;APH1A;PCSK1;CASP2;CPN1;F7;ADAM10;PCSK9;YME1L1;PRSS3;MYRF;NCSTN;SPRTN;PCSK7;SPCS2;PCSK6;FXN;ZMPSTE24;SDE2;TMPRSS4;TYSND1;SEC11C;CPXM1;SRGN;LGMN;MYRFL;RCE1;CASP4;SEC11A;METAP2
prerank,regulation of myelination (GO:0031641),-0.4372310144006882,-1.2865880033188792,0.12962962962962962,0.2885604884482849,1.0,9/25,11.72%,LGI4;JAM2;PTN;PTPRZ1;PARD3;SIRT2;RNF10;TPPP;DICER1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.4261806175656284,-1.2861524143896816,0.16363636363636364,0.28877182418382935,1.0,7/25,14.02%,DLG4;ITGB3;PSEN1;RIN3;ATXN2;ANKRD13A;RAC1
prerank,regulation of cellular catabolic process (GO:0031329),-0.3557053384072594,-1.285769178120959,0.08333333333333333,0.2889162977930014,1.0,28/61,25.74%,TPCN2;WDR91;MAPT;RRAGC;ITPR1;HDAC6;DAPK1;PIP4K2B;LRRK2;SOGA1;HSPB1;FBXL2;DAPK3;RRAGB;PIP4K2A;ROCK1;DEPDC5;NUPR1;RRAGD;ABCD1;BOK;RPTOR;PIK3R2;OSBPL7;KAT8;RRAGA;ABCB11;RAB39B
prerank,hippo signaling (GO:0035329),-0.4139649891747243,-1.2855465846586789,0.14285714285714285,0.28877980659825286,1.0,13/26,19.18%,TEAD3;AMOTL1;WWTR1;DCHS1;TEAD1;FAT4;LATS2;TJP1;DVL2;TEAD2;AMOTL2;CASP3;SAV1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.49688239765150577,1.2853618254655745,0.14285714285714285,0.2788037225294385,1.0,8/15,21.40%,GSTO2;PPIF;GSTO1;VCP;MAPK13;ZFAND1;HNRNPA1;ZC3H12A
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.35516440904562646,-1.2852037559177891,0.07936507936507936,0.2888084778372248,1.0,32/73,24.45%,ZER1;CLU;CSNK1E;RNF19A;RNF180;CSNK1A1;RNF217;DET1;BAG2;PTEN;LRRK2;SIRT2;ZYG11B;KLHL40;TRIB2;BBS7;ARIH2;RNF144B;HECTD1;CSNK1D;CDK5RAP3;FBXW7;DNAJB2;ARIH1;RNF14;GSK3A;PRICKLE1;SMAD7;CAV3;PIAS1;RNF144A;GABARAP
prerank,positive regulation of autophagy (GO:0010508),-0.3377126733182548,-1.2847492208621711,0.06666666666666667,0.2891658126765128,1.0,28/86,21.56%,FLCN;EPM2A;ULK1;GPSM1;TRIM6;DAPK1;PRKD1;LRRK2;PRKAA2;DCN;OPTN;WAC;RNF152;TPCN1;TFEB;TP53INP1;ROCK1;TRIM34;TSC2;PLEKHF1;GSK3A;SIRT1;CAMKK2;BNIP3;TRIM8;MAP3K7;KAT5;TRIM38
prerank,response to light stimulus (GO:0009416),-0.3310754868931203,-1.2847474857029029,0.0392156862745098,0.2886521966682064,1.0,16/58,16.85%,CIRBP;CRY2;BRSK1;MAPK10;REV1;OPN4;ELANE;GPR88;CPT1B;ERCC3;UBE4B;MAP2K7;MAPK8;OPN1SW;PRIMPOL;FECH
prerank,cellular response to interleukin-7 (GO:0098761),0.44327001977878594,1.2837528421760052,0.1276595744680851,0.28012512288855124,1.0,8/17,20.75%,IRS1;SMARCA4;SOCS1;JAK3;IL7R;CISH;STAT5A;STAT5B
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.44327001977878594,1.2837528421760052,0.1276595744680851,0.28012512288855124,1.0,8/17,20.75%,IRS1;SMARCA4;SOCS1;JAK3;IL7R;CISH;STAT5A;STAT5B
prerank,cell projection assembly (GO:0030031),-0.4257171464020873,-1.2835622548180152,0.18867924528301888,0.2903517006271716,1.0,8/22,14.02%,GSN;NEFH;RHOQ;RHOJ;PARVA;NCKAP1L;QRICH2;RAC1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.4199041469718268,1.283124732681715,0.0784313725490196,0.28048989957514997,1.0,8/21,17.05%,YWHAB;YWHAE;MASTL;STYXL1;PPP1R1B;GSK3B;PPP1R8;TIPRL
prerank,metallo-sulfur cluster assembly (GO:0031163),0.4422975428261006,1.2829216099990222,0.1896551724137931,0.280207604276564,1.0,7/19,19.64%,CIAO1;CIAPIN1;HSPA9;ISCA2;FXN;LYRM4;NUBPL
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.37421369850609465,1.2825087044688364,0.08888888888888889,0.2804045295372004,1.0,15/29,26.15%,INHBA;PMAIP1;PPP2R1B;PML;PAK2;AGT;TRAF2;TNFRSF12A;DEDD2;BID;CAV1;HYAL2;THBS1;G0S2;HTRA2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.48247676405582895,1.2814880448028674,0.08,0.2816174546997809,1.0,6/15,15.62%,CANX;IL27RA;OAS2;STAT1;OASL;MX1
prerank,fluid transport (GO:0042044),0.4289397286182954,1.2811815925578034,0.14285714285714285,0.28164529086779205,1.0,5/17,13.86%,SLC4A11;UPK3A;AQP5;AQP9;AQP3
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.41749560030295285,1.2799557292184491,0.2,0.28314071517368944,1.0,17/29,24.39%,HSD17B12;SCD;TECR;ACSL6;HACD2;ACSL3;ELOVL1;ACSL5;ELOVL7;ACLY;ACSF3;PPT1;FASN;ELOVL6;SLC25A1;GCDH;HSD17B8
prerank,regulation of adaptive immune response (GO:0002819),0.44727983484000444,1.2797092818342675,0.12195121951219512,0.2832274820493983,1.0,10/18,37.15%,IL4I1;SKAP1;TRIM27;ADCY7;TNFSF4;AHR;IRF7;EIF2AK4;SAMSN1;SASH3
prerank,inositol lipid-mediated signaling (GO:0048017),-0.37903418288888735,-1.2795400630930711,0.12280701754385964,0.2968360312761635,1.0,26/49,26.49%,PLCD4;PITPNM2;FGFR1;PIRT;PDGFRA;PI4KB;PIK3R1;PLCL1;PI4KA;INPP5F;NGF;TNFAIP8L3;NTRK1;PIK3C3;PLCE1;OGT;RHOA;PLCD1;PLCB1;RPS6KB1;PIK3R2;PLCB2;KCNH1;EXOC1;PIK3C2A;PLCL2
prerank,maintenance of protein localization in organelle (GO:0072595),-0.4459982483326275,-1.2789325406815488,0.14583333333333334,0.297405167365103,1.0,7/19,16.01%,SUPT7L;TAPT1;BBS4;SKP1;ARL2;MORC3;TAF3
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.4304600782047595,-1.2781802605000836,0.15,0.2982004024450847,1.0,9/22,21.72%,CACNA1C;CAP2;PALM;STIM1;LTB4R2;EDNRB;CRHR1;GNAI2;GRM2
prerank,muscle tissue morphogenesis (GO:0060415),-0.4555972383642255,-1.2776505582628452,0.1320754716981132,0.2985048982663636,1.0,10/17,23.32%,MYLK;TGFBR3;TCAP;TBX1;EFEMP2;ACTC1;HEY2;ANKRD1;TTN;MYLK2
prerank,regulation of JNK cascade (GO:0046328),-0.3218216413611485,-1.277563246693923,0.1076923076923077,0.2981751177272545,1.0,33/102,23.85%,PER1;DUSP22;TGFBR3;MTURN;DUSP3;TRAF1;ZMYND11;PJA2;TLR9;ANKRD6;FZD7;MAPK8IP3;FLT4;TAOK2;DAB2IP;GADD45B;MAP4K2;SH3RF3;DUSP19;GPS2;SEMA3A;WNT16;EGFR;MAPK8IP1;PLCB1;RASSF2;EDA2R;MAP3K10;CCL21;TIRAP;GADD45G;RIPK1;PINK1
prerank,nucleosome disassembly (GO:0006337),0.46922803611938474,1.2772156748021481,0.14583333333333334,0.28613393553478167,1.0,7/16,12.57%,HMGA1;SET;SMARCB1;GRWD1;SMARCA4;SMARCD2;SMARCC1
prerank,chromatin disassembly (GO:0031498),0.46922803611938474,1.2772156748021481,0.14583333333333334,0.28613393553478167,1.0,7/16,12.57%,HMGA1;SET;SMARCB1;GRWD1;SMARCA4;SMARCD2;SMARCC1
prerank,eye development (GO:0001654),-0.36372314511386095,-1.277177504639072,0.058823529411764705,0.2983975516566237,1.0,22/57,24.18%,MEIS1;MAB21L2;CACNA1C;MAB21L1;SALL2;MEIS2;PBX3;CPAMD8;CHRDL1;PBX2;MEIS3;SKI;CEP290;ABCB5;RAB3GAP1;BMPR1B;EFEMP1;SOX2;NIPBL;SH3PXD2B;HIPK1;RAB18
prerank,nucleotide metabolic process (GO:0009117),0.41087644389559486,1.2769510258902383,0.14,0.28607100082288917,1.0,15/23,31.91%,NUDT5;DCK;PNP;DCTD;CMPK1;CTPS2;CMPK2;RNASEH2B;ME1;ENPP3;FHIT;GUK1;PARK7;NMNAT1;AK7
prerank,autophagy of mitochondrion (GO:0000422),-0.37201479885473626,-1.2768918770496445,0.13114754098360656,0.298603027298512,1.0,8/39,6.17%,GABARAPL1;ULK1;ATG2B;ATG9A;WDR45;ULK2;ATG14;MAP1LC3C
prerank,ion transport (GO:0006811),-0.3081198780626865,-1.2768428200478352,0.06451612903225806,0.29814559763045706,1.0,49/111,31.41%,KCNN3;SLC17A7;CNGB1;SLC12A4;P2RX1;SLC26A11;SLC9A9;SLC8A2;SLC24A4;SLC8A1;PIEZO2;ATP1A4;CHRNA3;TRPC6;SLC24A3;GLRB;ATP10D;SLC1A2;SLC8A3;CHRNB4;MCOLN1;PIEZO1;SLC26A7;SLC9A5;KCNN1;SLC26A4;SLC17A8;SLC15A2;ANO6;WNK1;KCNN2;SLC4A1;SLC15A3;VDAC2;SLC39A1;CTNS;SLC17A4;SLC26A2;CALHM1;SLC12A5;LRRC8A;SLC36A1;SLC1A6;PDZD3;HCN4;TRPM3;SLC20A2;GRIN1;SLC1A3
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.2959790218236835,-1.2764949447529501,0.015625,0.2982863049400091,1.0,59/140,27.41%,DMD;TARDBP;WWTR1;CALM1;ATG14;PDE4D;NTRK3;SNCA;CNKSR3;PARD3;PRKRIP1;DBNDD2;PRNP;TERF2IP;NCK1;CADM4;SLIT2;PPEF2;PTEN;PRKAG2;LRRK2;PPM1F;SIRT2;EMILIN1;CORO1C;FBLN1;PID1;HSPB1;INPP5K;DAB2IP;TAB1;SFRP1;TRIB2;GNAQ;PIP5KL1;NTF3;MYADM;DUSP19;TSC2;CDK5RAP3;RASSF2;FKBP8;TESK1;SMAD7;LRP6;GPD1L;ERRFI1;CAV3;CALM2;PRKCD;OCLN;TRAF3IP1;SNX25;CEACAM1;NOG;DEPTOR;ITGB1BP1;PPM1E;LDLRAD4
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.3272736276268795,-1.2760655288340856,0.06557377049180328,0.29845871122859674,1.0,24/77,20.04%,ATP1B2;ATP2B4;ATP1A2;TRPV1;SLC12A4;SLC9A9;FXYD2;CACNA2D1;SLC8A2;KCNH2;SLC8A1;ATP1A4;KCNE2;ATP1A3;ABCC9;SLC8A3;KCNJ8;TRPV3;SLC39A12;KCNJ1;SLC6A1;ATP4A;SLC9A5;KCNJ9
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4138698817808453,-1.2760607976643437,0.15254237288135594,0.2979557192339257,1.0,13/26,19.91%,TNS2;PRKCB;NCK1;PIP4K2B;GRB10;PID1;INPP5K;GRB14;PIP4K2A;KANK1;TSC2;RPS6KB1;GSK3A
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.44179006414837174,1.2760445622162244,0.13636363636363635,0.2869298513889817,1.0,6/20,10.24%,SLC39A10;RPS3;KCNN4;CARD11;CD81;RELA
prerank,cellular response to organic substance (GO:0071310),-0.30745638422122973,-1.2755033296884537,0.07462686567164178,0.29843283688482525,1.0,36/120,20.61%,CACNA1H;AKAP6;BMPR1A;SOCS2;MAPK7;NCOA1;CDK9;HDAC6;DPYSL3;GHR;CYP11B1;NOS1;PTPN14;SLIT2;LRRK2;RAMP1;SLIT3;PID1;PTPN5;CERS1;INPP5K;MAP2K5;SFRP1;RHOA;CYP1A1;IGFBP5;PDGFB;IL1RAPL1;MAPK8;CLEC3B;ACVR2A;IL18R1;RAMP3;BMPR1B;RPS6KB1;CCL2
prerank,potassium ion homeostasis (GO:0055075),-0.4281409465721572,-1.2748893775215864,0.1346153846153846,0.2989403226350033,1.0,7/24,9.98%,ATP1B2;ATP1A2;KCNMA1;SLC12A4;KCNH2;ATP1A4;ATP1A3
prerank,positive regulation of hydrolase activity (GO:0051345),-0.3029531751875032,-1.2745187420624262,0.0847457627118644,0.29909442103926204,1.0,57/140,24.53%,FLCN;RASGRP2;SGSM2;RAPGEF3;RAP1A;ASAP3;FERMT2;CCL14;TBC1D20;MTMR9;MTCL1;PLIN5;CALM1;DVL3;EVI5L;RGS10;SRGAP2;GNB5;CAV2;RIC1;RAB11FIP2;NTRK1;NDEL1;RGS8;RAPGEF1;ADRB1;SFRP1;RHOA;ARHGEF7;SNX18;MAPK8;SGSM3;RAB3GAP1;DOCK11;PLXNB1;CCL23;MAPRE2;ALS2;CCL11;RGS6;RAPGEF6;CCL21;RAPGEF2;CCL2;BCAS3;MAPK12;PRTN3;BCAR3;PIN1;RSU1;CALM2;ADCYAP1;CDKL5;PINK1;RHOC;ARHGAP11B;RGS1
prerank,regulation of protein targeting to membrane (GO:0090313),-0.393172612818479,-1.274254026865674,0.12698412698412698,0.2989448300335531,1.0,9/29,17.62%,KCNB1;ANK3;MTCL1;PRNP;GDI1;MYO1C;INPP5K;KCNE1;AKT2
prerank,digestive tract morphogenesis (GO:0048546),-0.5105105019002936,-1.2734633396035016,0.19230769230769232,0.29989479569717675,1.0,10/15,22.89%,RBPMS2;FOXF1;PDGFRA;FGFR2;TCF21;SOX17;BBS7;SOX11;NIPBL;ID2
prerank,response to axon injury (GO:0048678),-0.4575645882488797,-1.2731996694450547,0.16,0.2996966399143168,1.0,10/18,23.05%,MTR;GAP43;DPYSL3;APOD;MAPK8IP3;P2RY12;MORN4;SOD1;SARM1;NREP
prerank,cellular response to ketone (GO:1901655),-0.3744853494637225,-1.2725118142103904,0.13114754098360656,0.3002610879074342,1.0,12/38,17.44%,ADCY5;KLF9;ADCY2;GNAI1;AR;GNG2;NR3C1;AQP1;SFRP1;AKR1C2;ADCY6;TRERF1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.30312080452677315,-1.2718545151880596,0.047619047619047616,0.30093452269997395,1.0,47/157,21.05%,HAND2;RAP1A;FGF2;PLA2G5;GLIPR2;MTURN;FERMT2;GCNT2;CCL14;PDGFRA;ROR2;GPER1;FGFR2;P2RY1;NTRK3;PRKCA;ADRA1A;NDRG4;NECAB2;DSTYK;TNFAIP8L3;FLT4;NTRK1;ROR1;THPO;MAPK3;MAP2K7;ACKR3;HTR2B;PDGFB;BRAF;NOTCH2;FGF10;PDE8A;EGFR;CCL23;ERBB4;CCL11;RAMP3;CD36;FBXW7;ANGPT1;MAP3K12;CCL21;RAPGEF2;CCL2;PDGFD
prerank,skeletal muscle contraction (GO:0003009),-0.45172090647210916,-1.2713843055121303,0.14285714285714285,0.30130508961383595,1.0,6/19,11.11%,MYH7;MYH3;TCAP;TNNT3;STAC2;STAC
prerank,exogenous drug catabolic process (GO:0042738),0.48508790896795995,1.2708785249188028,0.12244897959183673,0.29504197414620215,1.0,4/16,7.14%,CYP2S1;CYP2W1;NUDT15;CYP2F1
prerank,amide transport (GO:0042886),0.38200291180848694,1.2708614097091204,0.13157894736842105,0.2945139717588827,1.0,9/27,18.60%,SLC5A6;FOLR1;UPK3A;SLC38A5;SLC19A1;ABCA13;GLTPD2;TAP1;SLC14A2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.477134034848312,-1.2708284618213037,0.17647058823529413,0.3017059736127541,1.0,10/18,17.84%,TTC23;RAB34;KIF7;STK36;EVC;SFRP1;ARMC9;TXNDC15;SMO;DLG5
prerank,regulation of vasoconstriction (GO:0019229),-0.4326578832003142,-1.2703427381728674,0.17307692307692307,0.30191630890943477,1.0,15/27,28.14%,AGTR1;ADRA1A;ADRA1D;ECE1;KCNMB2;KCNMB4;AVPR2;TBXA2R;CHRM3;AVPR1A;ZDHHC21;ADRA1B;ADM;AVPR1B;BMPR2
prerank,glutamate metabolic process (GO:0006536),0.45670630625007447,1.270154439722075,0.14285714285714285,0.29523018844511545,1.0,6/19,12.44%,GAD1;GOT2;ALDH18A1;GLS2;ALDH5A1;GCLM
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.4043499830075288,-1.270095304158806,0.10526315789473684,0.30192133116284553,1.0,12/27,25.73%,GBA2;PLEKHG2;FCHSD1;DBN1;FCHSD2;ESAM;PAK3;ARHGAP28;LATS1;BRK1;ARHGAP35;HCLS1
prerank,protein lipidation (GO:0006497),0.3380379493250265,1.2699904325717652,0.06818181818181818,0.2949883739230419,1.0,21/57,22.59%,PIGM;PIGU;ZDHHC9;DPM2;ZDHHC5;DPM1;PIGW;ZDHHC12;ZDHHC3;ZDHHC13;PGAP2;PIGF;ZDHHC6;PIGO;ZDHHC16;PIGA;WDR45B;ATG5;PIGN;DPM3;PGAP3
prerank,autophagosome organization (GO:1905037),-0.358637515600495,-1.269555200462903,0.14,0.30241339031858494,1.0,18/53,18.17%,GABARAPL1;ULK1;ATG2B;ATG9A;WDR45;ULK2;ATG14;MAP1LC3C;TP53INP2;ATG16L2;RAB23;PIK3C3;PACS2;TP53INP1;EMC6;STX12;GABARAPL2;ATG12
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.27919009437550657,1.269196949088796,0.05714285714285714,0.29576193484914237,1.0,48/184,14.56%,NOTUM;PSMD14;PSMB2;DKK4;PSMB9;PSMA5;SHISA2;PSMB3;UBAC2;PSME3;PSMA3;MDFI;RUVBL2;PSMA7;KREMEN2;PSMD13;WNT5A;AXIN2;PSME2;PSMC2;PSMC4;PSMD10;PTPRO;PSMD12;SOX9;LRP4;RNF43;PSMB5;MDK;STK4;ZNRF3;HDAC1;PSMD8;IGFBP2;CTNNBIP1;PSMB4;GSK3B;PSMD3;PSMB1;PSMA4;MLLT3;WNT11;PSME1;PSMF1;PSMD11;PSMD1;SOX30;IGFBP1
prerank,positive regulation of signaling (GO:0023056),-0.39899085363099734,-1.2689451933948828,0.14545454545454545,0.30304494134244564,1.0,19/37,28.12%,BVES;LGI1;ILK;DLG4;SNCA;INPP5F;GRIK2;RIMS3;ECE1;WLS;CARTPT;SOX11;RAMP3;RIMS1;SYT1;CLSTN2;CLSTN3;PTPN23;RAB29
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.43400416128561825,1.2678959328804627,0.11764705882352941,0.2975249988689651,1.0,13/20,24.39%,DGAT2;SCD;THEM5;ACSL3;FAR2;ACLY;FITM2;PPT1;FASN;HSD17B4;SLC25A1;GCDH;HSD17B8
prerank,regulation of complement activation (GO:0030449),0.3680653156068825,1.2678375908336956,0.06818181818181818,0.29709836008395807,1.0,13/37,19.14%,PHB;IL1B;C1QBP;CD46;CD55;C4BPA;CD81;CPN1;SERPING1;C4BPB;C3;C2;C8G
prerank,regulation of cell migration (GO:0030334),-0.2704039758288225,-1.2678269864678098,0.029411764705882353,0.3046451574241103,1.0,114/387,19.38%,FLCN;FAM107A;ADARB1;DUSP22;FLNA;TPM1;PLXNB3;SEMA6C;MYLK;SASH1;VCL;FGF2;AMOTL1;TWIST2;CHRD;TMEFF2;FERMT2;TTBK2;GCNT2;MYOC;NEXN;MAGI2;MACF1;RECK;MITF;CAMK2A;CITED2;PDGFRA;DUSP3;ROR2;GPER1;PODN;CLDN5;BEX4;NTRK3;SUN2;FGF22;RUFY3;PRKCA;DLC1;SEMA4C;KIT;DPYSL3;NGFR;RHOB;WNT5B;CLIC4;SRGAP2;SLIT2;PTEN;HACE1;NTNG1;PPM1F;SEMA3E;FER;LAMB1;LDB2;MYO1C;NUMB;CORO1C;RDX;EPHA4;TIAM1;TJP1;NAV3;GNA12;ADORA3;FGF17;SEMA6D;SCAI;SEMA6A;SRGAP2C;RAC1;PIK3R3;SEMA3B;SFRP1;CAMK2B;RHOA;ENPP2;IGFBP5;PDGFB;SEMA3G;FGF7;SPAG9;KANK1;TP53INP1;ROCK1;PIP5KL1;SGK3;APC;NTF3;MYADM;FGF5;AMOTL2;ROBO4;FGF10;IGSF10;SMO;SEMA3A;AKT2;FGF1;PLXNA4;SST;DLG5;INSR;PLXNB1;FGF16;EGFR;ERBB4;CCL11;LMO4;RET;LIMCH1;SLK
prerank,post-translational protein modification (GO:0043687),0.25985213584523137,1.2677413067500072,0.0,0.2967741785166199,1.0,91/324,17.60%,NOTUM;PSMD14;DCAF13;DSCC1;STT3A;PDIA6;PSMB2;EVA1A;STT3B;PSMB9;PSMA5;P4HB;SKP2;FBXL18;ASB9;PSMB3;VHL;PSME3;PSMA3;PSMA7;ESCO2;TMEM132A;MSLN;PSMD13;FUCA2;TIMP1;AMELX;DCAF7;SPP1;PSME2;PSMC2;PSMC4;PSMD10;RAB8A;ERCC8;RBBP5;PSMD12;RAB11A;F5;FBXO4;SERPINA10;PSMB5;NAE1;CKAP4;FBXW9;LMO7;SERPIND1;VGF;CCNF;DNAJC3;FN1;LRR1;ADAM10;AFP;PCSK9;PSMD8;RAB2A;FBXO41;PSMB4;PSMD3;PSMB1;PROC;PSMA4;COPS5;SUMF2;DDB1;SHISA5;SPSB2;PRKCSH;PSME1;PSMF1;FBXL13;PSMD11;BMP4;KLHL11;PSMD1;C3;IGFBP1;SOCS3;KBTBD8;CUL4A;WDR5;RAB1A;COMMD1;FBXL14;SUMF1;FBXO6;FEM1A;WSB2;TULP4;LGALS1
prerank,histone deacetylation (GO:0016575),-0.3680600022039172,-1.2669410739912195,0.14035087719298245,0.3054583749494263,1.0,23/46,28.58%,PER1;SIN3B;HDAC4;RCOR3;HDAC6;MORF4L1;SIRT2;HDAC5;MTA3;PRDM5;HDAC9;SIN3A;TRERF1;BAZ2A;BRMS1L;SIRT1;TBL1X;MIER2;ELK4;ZNF541;MTA1;MSL3;MIER1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.4468095471186386,1.2666126256318897,0.13043478260869565,0.29818328811114153,1.0,9/16,31.51%,MDK;RELA;IRAK1;FUT7;FUT4;ITGB2;ETS1;TRAF6;TNF
prerank,substantia nigra development (GO:0021762),-0.37486858047290883,-1.2662601320429414,0.14814814814814814,0.3061440030332003,1.0,18/40,26.36%,SYPL2;NDRG2;PLP1;CALM1;MAOB;INA;SIRT2;RHOA;MAPKAP1;CCDC14;POTEE;FGF9;ACTB;SYNGR3;CALM2;CNP;GNB4;CKB
prerank,positive regulation of lyase activity (GO:0051349),-0.4680780285547849,-1.2657782065027001,0.18867924528301888,0.3064378450908581,1.0,4/15,9.17%,CACNA1C;ISCU;STIM1;NOS1
prerank,protein K63-linked deubiquitination (GO:0070536),0.37835507798962564,1.2652771451149196,0.1956521739130435,0.3001300394722506,1.0,8/29,11.80%,PSMD14;OTUB2;SHMT2;BRCC3;USP50;TNFAIP3;SPATA2;STAMBP
prerank,steroid biosynthetic process (GO:0006694),0.333451120092886,1.265260842628009,0.1276595744680851,0.2996214898197176,1.0,26/62,24.07%,CYP51A1;SRD5A1;SQLE;DHCR7;SC5D;HSD17B10;AKR1C4;OSBPL3;BAAT;FDXR;CYP39A1;PRLR;CYP7B1;MSMO1;HSD3B7;TM7SF2;ACOT8;INSIG1;SLC27A5;FDFT1;HSD17B4;EBP;HMGCR;OSBPL2;HSD3B1;OSBP
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.34330607229039034,1.2651911066387458,0.125,0.29911479618781434,1.0,18/58,18.79%,RCC2;CCND1;TFDP1;CDK1;FBXO5;CDCA5;CDC25C;DLGAP5;CDK4;RAB11A;UBE2C;RAD51B;ANAPC11;NSMCE2;CDC25A;ESPL1;STOX1;CDC7
prerank,regulation of endothelial cell migration (GO:0010594),-0.33699946925472674,-1.2647950241605954,0.1111111111111111,0.30758609725287167,1.0,26/85,17.63%,SASH1;FGF2;PTPRM;NRP2;PTN;ADGRB1;ZNF580;ITGB3;PRKCA;RHOJ;RHOB;NR2F2;PRKD1;SLIT2;ATOH8;FLT4;DCN;RRAS;ANGPT4;SYNJ2BP;DAB2IP;KRIT1;RAC1;ADAMTS9;GLUL;FGF1
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.42627562611581754,-1.2643797754203985,0.1346153846153846,0.3079541608115864,1.0,10/19,23.22%,LY6H;CHRM2;CHRNA3;RGS10;RGS8;GNAQ;PLCB1;CHRM5;CHRM3;GNA11
prerank,positive regulation of defense response (GO:0031349),0.32173874192847274,1.2640200460478912,0.06976744186046512,0.30072930930037367,1.0,31/95,19.77%,OSM;EREG;IL23A;ZP3;POLR3C;IL1B;WNT5A;MGST2;AKIRIN2;CEBPA;NMI;MDK;DHX9;IL21;POLR3B;CYBA;CCL3;PLA2G7;GBP5;AGT;GRN;MAPK13;FPR2;ADAM8;FEM1A;POLR3G;PLSCR1;NFKBIA;SLC15A4;SERPINE1;TNFSF4
prerank,aerobic electron transport chain (GO:0019646),0.330008650947841,1.264010924505303,0.07692307692307693,0.30020248635577,1.0,34/69,35.01%,UQCC3;COX6B1;NDUFS6;COX7A2L;UQCRQ;UQCRH;CYCS;NDUFB3;NDUFB11;NDUFA12;NDUFAB1;NDUFA3;COX4I1;CYC1;COX5B;COX7B;UQCRC1;NDUFA1;NDUFB9;NDUFB6;NDUFB5;COX5A;NDUFB4;NDUFS3;NDUFA4;NDUFS1;NDUFB7;UQCRHL;NDUFA2;NDUFC1;NDUFS5;NDUFB2;NDUFA6;NDUFS8
prerank,regulation of dopamine secretion (GO:0014059),-0.4350989935522397,-1.263966952362836,0.17857142857142858,0.30811948240230874,1.0,9/22,12.21%,GDNF;SYT10;SNCA;KCNA2;SYT11;SYT2;SYT9;SYT6;SYT5
prerank,diterpenoid metabolic process (GO:0016101),-0.3544778833407969,-1.2638822784879926,0.11290322580645161,0.30774264043619926,1.0,18/57,18.12%,RDH5;BCO2;LRAT;ADH1B;GPIHBP1;AKR1C1;SDC3;SDC2;PNLIP;RARRES2;CLPS;ALDH1A1;HSPG2;CYP4V2;OPN1SW;AKR1B1;RLBP1;GPC1
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.4179190880122888,-1.2629267669954476,0.16363636363636364,0.3090973116552454,1.0,11/27,14.50%,DCTN1;MAPT;MECP2;NUMA1;CLIP1;CLASP1;FES;NAV3;ARL2;RAC1;SLAIN2
prerank,regulation of fibroblast migration (GO:0010762),-0.44822772581449566,-1.262343683064807,0.14,0.30969173789468535,1.0,6/20,15.16%,FGF2;DDR2;CORO1C;GNA12;RAC1;ARHGEF7
prerank,Ras protein signal transduction (GO:0007265),-0.3086440760240654,-1.259572732625003,0.09259259259259259,0.3143798353831239,1.0,56/137,24.98%,RASGRP2;NTN1;RAPGEF3;RAP1A;FGF2;RERG;AGTR1;CDC42EP3;ARHGAP6;SHC2;MYO9B;NGFR;RGL2;RHOB;ERAS;WASF1;RALGDS;KSR1;PRKD1;GDI1;HACE1;RRAS;ARHGEF11;PLCE1;ABI2;TIAM1;GNA12;MAPK11;RIT2;RAPGEF1;CDC42EP4;RAC1;CDKN1A;RHOA;ARHGAP29;ROCK1;SGSM3;ELMO1;SOS1;MAPK14;TAX1BP3;RAPGEF6;ARHGAP5;RAPGEF2;CTNNAL1;SETDB1;SHC3;RASSF1;USP28;ARHGEF3;ARHGDIG;CDC42EP2;RIT1;BRK1;USP8;ARHGAP1
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.4418496512390994,-1.2589492208524415,0.22916666666666666,0.3151325812249163,1.0,9/20,26.37%,CLK2;GCK;SOGA1;C1QTNF3;GSK3A;INS;CRY1;MST1;DKKL1
prerank,negative regulation of DNA metabolic process (GO:0051053),0.37819027861607074,1.2589329408825591,0.1282051282051282,0.3081840121897126,1.0,8/26,13.35%,DACH1;BLM;XRCC5;ZRANB3;RPS3;MSH3;SUB1;MSH6
prerank,natural killer cell activation (GO:0030101),0.3382665673590802,1.258658052416021,0.06521739130434782,0.30820238173879366,1.0,15/41,29.21%,ULBP3;ULBP2;ULBP1;PRDX1;IL21R;ELF4;IL12B;CD2;RABL3;CASP8;CD244;IFNE;PIK3CD;NCR3;RASGRP1
prerank,regulation of JUN kinase activity (GO:0043506),-0.3797260117568545,-1.2584767694422563,0.13559322033898305,0.3154838292871475,1.0,13/33,21.13%,SASH1;DVL3;NPPA;TLR9;MAP3K4;HIPK3;PPEF2;DAB2IP;DVL2;DUSP19;MAPK8IP1;MAP3K10;MAP3K7
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.3170529072684784,-1.2577446156945222,0.1111111111111111,0.3162628887989198,1.0,26/81,20.36%,FNTB;RGS11;CNGB1;GNG7;RGS2;CAMK2A;USP20;GPER1;CALM1;GIT2;RIC8B;ZDHHC7;SYP;KCTD8;GRK5;TULP3;GRK4;RGS5;PLCE1;ROCK1;NMT2;RAMP3;PLCB1;RGS6;RGS12;CRY1
prerank,microvillus assembly (GO:0030033),0.43677512572113164,1.2577236619326266,0.19607843137254902,0.30901465879535434,1.0,6/15,19.26%,FXYD5;RAP2B;STK26;EZR;RAP2A;SLC9A3R1
prerank,dendritic spine morphogenesis (GO:0060997),-0.44635291454768333,-1.257486597196733,0.17307692307692307,0.316213426637127,1.0,5/16,9.43%,CTNND2;SHANK3;DLG4;DIP2A;PTEN
prerank,protein targeting (GO:0006605),0.30495743179558576,1.257465497916254,0.058823529411764705,0.3088135139524575,1.0,33/121,16.01%,AP1S3;TOMM34;SRPRB;ZDHHC9;TIMM23;ATG3;BCAP31;TOMM40;TIMM10;TIMM13;SPCS1;TOMM22;SEC61A1;TOMM20;LAMP2;SEC61G;ZDHHC12;TIMM17B;RAB3IP;TIMM8B;ZDHHC3;RABGEF1;ZDHHC24;YIF1B;TSPO;KATNB1;SORL1;ZDHHC6;PRKCI;PEX16;NACA2;FUT10;AP1M2
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.4505076582758665,-1.25744872548561,0.15873015873015872,0.3157976494030977,1.0,6/18,12.45%,RIC3;SLC5A7;COLQ;RAPSN;CHRNA3;CHRNB4
prerank,phospholipid biosynthetic process (GO:0008654),0.3691586890488775,1.2571202969578479,0.23255813953488372,0.308731760872256,1.0,14/36,20.93%,CPNE7;SRD5A3;AGPAT5;DOLK;CPNE3;IDI2;DPAGT1;FDPS;FITM2;PCYT2;CPNE1;AGPAT3;NUS1;IDI1
prerank,negative regulation of translation (GO:0017148),0.3094073805283483,1.2569996741627012,0.13043478260869565,0.3083344259033255,1.0,27/84,16.82%,ENC1;CALR;CAPRIN1;PUS7;GZMB;DHFR;MRPL13;GAPDH;EIF4EBP1;IGF2BP1;NCL;EIF4A3;YTHDF1;NANOS3;IGF2BP3;RPS3;CNOT10;GRB7;IGF2BP2;EIF4E2;MEX3D;TRIM71;MALSU1;YTHDF2;CNOT1;EIF3E;SYNCRIP
prerank,regulation of epidermal cell differentiation (GO:0045604),0.3881966047149694,1.2567478468043016,0.19148936170212766,0.3081947060814803,1.0,9/24,19.58%,SULT2B1;CBFB;CTSV;RUNX1;AQP3;BMP4;SFRP4;KDF1;SFN
prerank,cilium-dependent cell motility (GO:0060285),-0.41842566939071196,-1.2565128609140908,0.15873015873015872,0.3168772291907846,1.0,8/22,15.77%,EFHC1;CCDC39;CFAP44;CFAP54;TEKT2;EFHC2;TEKT3;DNAH1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.38557018919368147,1.2563673089836236,0.12244897959183673,0.3083308878660881,1.0,11/27,20.78%,TRIB3;CEBPB;ERO1A;BBC3;CHAC1;AIFM1;TNFRSF10B;TRAF2;BAX;BAK1;DNAJC10
prerank,regulation of cellular component organization (GO:0051128),-0.30668123700530137,-1.2560580943798123,0.1111111111111111,0.31719227047070525,1.0,51/136,24.55%,FAM107A;RASGRP2;STON1;RAP1A;EGLN2;SOCS2;PTCH2;AGTR1;SLITRK2;LTBP4;ANGPTL7;WFDC1;PACSIN1;KIAA1109;SETD5;RAB5B;NRG3;ARHGEF11;TAOK2;OPHN1;PLCE1;DAB2IP;TJP1;GFAP;RAB4B;RIT2;RAPGEF1;MARK4;PACSIN2;PAPPA2;ROCK1;CAMK2D;SGK3;PIFO;TSC2;CAMSAP2;PACSIN3;SPOCK1;CD36;RAPGEF2;RUFY1;RUFY2;SETD1A;RPTOR;MTOR;LATS1;BAP1;CDK11B;PINK1;ZFYVE16;CDK11A
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.41274088131226677,-1.2558035332057003,0.15789473684210525,0.3171416051295955,1.0,13/27,19.91%,TNS2;PRKCB;NCK1;PIP4K2B;GRB10;PID1;INPP5K;GRB14;PIP4K2A;KANK1;TSC2;RPS6KB1;GSK3A
prerank,negative regulation of DNA binding (GO:0043392),0.4266225742718081,1.255453150170714,0.1891891891891892,0.30901639872036457,1.0,14/30,20.67%,E2F1;TFAP4;MSX2;MDFI;LEF1;HMGA2;KDM1A;SUMO1;GZMA;CPNE1;ZNF675;SUMO3;NFKBIA;IFI16
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4118529085563375,-1.2549171523406202,0.16666666666666666,0.318061963508387,1.0,11/25,14.50%,DCTN1;MAPT;NUMA1;CLIP1;STMN2;CLASP1;FES;NAV3;ARL2;RAC1;SLAIN2
prerank,regulation of ion transmembrane transport (GO:0034765),-0.37001524270104524,-1.2546224189829593,0.14285714285714285,0.3179948937793293,1.0,19/35,29.86%,AKAP6;WNK3;KCNH2;P2RX7;CASQ2;KCNE2;KCNJ8;KCNJ1;AHCYL1;KCNJ9;CHRM3;ANO6;WNK1;KCNJ5;AKAP9;NEDD4L;KCNE5;CALHM1;KCNJ12
prerank,positive regulation of apoptotic process (GO:0043065),-0.27866612244451305,-1.254244461935797,0.06451612903225806,0.3181094834790302,1.0,87/296,20.65%,ARHGEF26;FLCN;CLIP3;TRIM39;APBB1;RBM5;ADAMTSL4;ARHGEF17;EPHA7;MLLT11;KCNMA1;CLU;ARHGEF9;PRDM11;PNMA1;GPER1;MOAP1;JMY;PLEKHG2;SNCA;ITSN1;ARHGEF6;DLC1;ATF4;OBSCN;PRNP;NGF;RPS6KA2;ING4;NGFR;PTGIS;RHOB;OLFM1;DAPK1;PSEN1;SLIT2;PHLDA3;SIRT2;QRICH1;ARHGEF18;ARHGEF11;CALHM2;APH1B;FGD1;LATS2;BACE1;PNMA3;TNFSF10;DAB2IP;ERCC3;TIAM1;DAPK3;KLF11;GADD45B;PRMT2;SFRP1;CSRNP3;SOS2;BCL10;ARHGEF7;PSEN2;PIDD1;PIP5KL1;MAPK8;RNF122;APC;MCF2;FAS;TRIO;SOS1;HOXA5;NUPR1;CASP3;ING3;CASP9;DCUN1D3;UBB;RASSF2;MAP3K10;APAF1;FGD2;ANKRD1;CRADD;SIRT1;BNIP3;ING5;AKAP13
prerank,positive regulation of axon extension (GO:0045773),-0.4273651875343125,-1.2542188434947614,0.11666666666666667,0.3176500778804879,1.0,8/22,17.55%,NTN1;MAPT;MACF1;RUFY3;L1CAM;MEGF8;DBN1;DSCAM
prerank,regulation of interleukin-10 production (GO:0032653),0.34551748065060245,1.2539321083563848,0.0975609756097561,0.3112871610916566,1.0,28/46,36.08%,HSPD1;IL23A;FOXP3;SYK;CD46;JAK3;PRKCZ;ISG15;IL23R;LILRB4;NOD2;TNFSF4;MMP8;HMGB1;IL12B;CD47;TYROBP;TIGIT;CLEC7A;PIBF1;XCL1;CD274;LILRA5;CD28;TLR4;PDCD1LG2;IL13;LILRB1
prerank,long-term synaptic potentiation (GO:0060291),-0.41540568149042284,-1.2538010887773967,0.17857142857142858,0.31803612809204734,1.0,7/21,12.32%,VAMP2;NFATC4;MPP2;TSHZ3;SLC8A2;NPTN;SLC8A3
prerank,positive regulation of DNA repair (GO:0045739),0.3446739890100393,1.253781090332388,0.08333333333333333,0.31110404156314886,1.0,24/43,30.19%,BRCC3;TIMELESS;UBE2N;HDAC10;ERCC8;RPS3;DHX9;CEBPG;WRAP53;BRCA1;FOXM1;EYA1;PRKCG;TMEM161A;TRIM28;SPIRE2;HMGB1;MGMT;RNF8;TIGAR;NPAS2;OOEP;PARP1;PCNA
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.375859075747591,-1.251656478529872,0.18,0.3213850053642804,1.0,13/32,28.62%,PTPRS;NR1D1;TLR9;TLR3;DAB2IP;TICAM2;GPS2;LRRC14;SARM1;NFKBIL1;OTUD4;F2RL1;CACTIN
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.43064413100765,1.251593151630073,0.11363636363636363,0.31437864503830093,1.0,12/19,31.53%,IL1B;CCL3;IRAK1;TGFB1;LYN;MTDH;TICAM1;IL18;HCK;CD6;TNF;CCL5
prerank,regulation of cell cycle process (GO:0010564),0.3018830460281556,1.2514800592172015,0.08333333333333333,0.3140347106553767,1.0,30/104,13.90%,CHEK1;SND1;KIF20B;DBF4;FBXO5;TIPIN;KNSTRN;RACGAP1;RCC1;KIF20A;CEP250;RMI2;NEK2;CDC25C;AURKB;SPAG5;ECT2;RAB11A;SOX9;BCL2L1;PDXP;CSNK2A1;PRPF40A;HMGA2;RAB11FIP4;AURKA;PKMYT1;BUB1;PLK1;YTHDF2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.26311656138497846,-1.2513157540430149,0.014705882352941176,0.32149333738856045,1.0,118/367,23.54%,CALCOCO1;PDE2A;TNRC6A;MYOM1;BVES;HAND2;ANK2;RBMS3;ACTA1;GSN;FGF2;OSR1;CLU;ACTA2;MAPK7;MAGI2;AGO4;MITF;CITED2;ANK3;GPER1;HOXD3;CUX2;CLDN5;GH1;ZNF580;NTRK3;CELF1;SNCA;P2RX7;FGF22;CD34;INPP5F;TNRC6C;ATF4;WNT6;TLR9;NGF;AR;OLFM1;RHOXF1;PSEN1;MPHOSPH8;RBPJ;SLC24A3;PPM1F;CNTF;EMILIN1;RNF207;TLR3;ECE1;HEY1;PID1;RDX;MEF2C;AGO3;MAPK1;MAPK3;FGF17;MAPK11;PIK3R3;AVPR2;MAP2K5;ACTC1;HINFP;GATA2;SEC16B;MUSK;PDGFB;FGF7;BRAF;ROCK1;MAPK8;HEY2;SLC38A2;TLE1;NTF3;FGF5;FGF10;AZU1;CD63;MAPK14;AHI1;HOXA5;SMO;FGF1;WNT16;SOX11;INSR;FGF16;RAMP3;CD36;TNRC6B;POU3F3;AGO1;MED23;VSTM2A;ANGPT1;GSK3A;INS;RIMS1;SETDB1;FGF9;IFNGR1;ADAM19;CDH5;KLF2;OSR2;UBR5;WFS1;MTOR;TTN;ID2;RAMP2;PLCG2;MYLK2;ATF2;SETDB2
prerank,regulation of humoral immune response (GO:0002920),0.34149018949097104,1.2510824857294318,0.12195121951219512,0.31437317345447097,1.0,14/41,20.77%,ZP3;C1QBP;CD46;CD55;C4BPA;CD81;CPN1;SERPING1;C4BPB;GATA6;C3;C2;C8G;CXCL13
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.3211109366993037,-1.2494541930411953,0.08196721311475409,0.3247807375394959,1.0,30/89,20.62%,VAMP2;STON1;USP6;HAP1;CHMP3;RAB12;PACSIN1;INPP5F;DNAJC13;FES;LGI3;STXBP5L;RAB5B;LRRK2;OPHN1;SLC30A8;MAPK1;MAPK3;RAB3A;RAB4B;RIT2;PACSIN2;TSC2;RAB13;GAS1;PACSIN3;RAB3C;RUFY1;RAB8B;RUFY2
prerank,cholesterol metabolic process (GO:0008203),0.3222421510407348,1.248417829671815,0.14893617021276595,0.31853770874696136,1.0,27/66,22.35%,SULT2B1;CYP51A1;SQLE;NSDHL;DHCR7;NR0B2;CEL;IDI2;FDPS;ACAT2;FDX1;MSMO1;DHCR24;TM7SF2;GBA;CLN6;ACLY;HMGCS1;G6PD;INSIG1;FDFT1;MVK;CETP;EBP;IDI1;TSKU;HMGCR
prerank,neuromuscular process (GO:0050905),-0.43517428866821734,-1.247752714136316,0.19148936170212766,0.32721899603614074,1.0,5/19,10.64%,PRRT2;DCTN1;NRXN1;PAFAH1B1;KCNA1
prerank,neuron differentiation (GO:0030182),-0.2846717361399603,-1.247298434676802,0.03125,0.32758643917777563,1.0,48/170,18.15%,RNF112;NRBP2;WNT9A;HAND2;BRSK1;TENM1;PBX3;FZD4;NLGN4X;CTF1;SRF;PHOX2B;SNPH;PHOX2A;WNT6;NGRN;WNT5B;SMARCA1;PBX2;FZD7;ATOH8;ALK;EPHA5;MYEF2;FOXN4;ATP8A2;GLI2;OPHN1;MEF2C;MYT1L;WNT2B;ERCC3;ISL2;VSX1;TENM3;LHX6;FUT9;IL1RAPL1;LMX1B;RORB;SPINK5;FZD8;IRX6;WNT16;SOX11;SPOCK1;CASP3;LHX4
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.34874422357980006,1.2469449859201935,0.17391304347826086,0.3204184953230504,1.0,20/50,21.53%,E2F1;TP73;CHEK2;PRKDC;PML;IKBKE;EPHA2;BCL2L1;BCL2A1;CASP2;AEN;BRCA1;MSH6;TNFRSF1B;BAX;SFN;BAK1;IFI16;MCL1;MSH2
prerank,negative regulation of DNA replication (GO:0008156),0.4104752807034645,1.246381142329562,0.1590909090909091,0.3208213453990556,1.0,6/15,19.71%,S100A11;GTPBP4;MCIDAS;GMNN;CDC6;PDS5A
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.4946186613501223,-1.2460475109665456,0.19607843137254902,0.3294003792501308,1.0,9/15,27.02%,CSPG4;UST;DCN;DSEL;CSGALNACT2;CHST12;NCAN;CHST14;CSPG5
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2899897997017137,1.245908518028711,0.037037037037037035,0.32126142730496354,1.0,43/160,14.56%,NOTUM;PSMD14;PSMB2;DKK4;PSMB9;PSMA5;PSMB3;UBAC2;PSME3;PSMA3;RUVBL2;PSMA7;KREMEN2;PSMD13;WNT5A;AXIN2;PSME2;PSMC2;PSMC4;PSMD10;PTPRO;PSMD12;SOX9;LRP4;PSMB5;MDK;STK4;ZNRF3;HDAC1;PSMD8;IGFBP2;PSMB4;GSK3B;PSMD3;PSMB1;PSMA4;MLLT3;WNT11;PSME1;PSMF1;PSMD11;PSMD1;IGFBP1
prerank,regulation of protein kinase B signaling (GO:0051896),-0.2828391403386816,-1.2452732487635716,0.1232876712328767,0.3302846364736203,1.0,59/200,20.16%,FLCN;FGFR1;SFRP5;NRG2;FGF2;GAB1;FERMT2;TSPYL5;GCNT2;PPP2R5B;MYOC;BTC;MAGI2;PDGFRA;RASD2;GPER1;PIK3R1;FGFR2;NTRK3;FGF22;KIT;KITLG;TNFAIP8L3;PTEN;PHLDA3;MSTN;FLT3LG;KL;OTUD3;RRAS;MC1R;NTRK1;THPO;INPP5K;P2RY12;FGF17;RICTOR;RAC1;ESR1;PDGFB;AKR1C2;FGF7;PHLPP2;FGF5;FGF10;TSC2;AKT2;FGF1;RTN4;INSR;FGF16;EGFR;ERBB4;RAMP3;ANGPT1;RET;SIRT1;INS;CCL21
prerank,amide biosynthetic process (GO:0043604),0.35414551854970183,1.2446170336492997,0.10869565217391304,0.3228574340303614,1.0,14/49,14.67%,SLC25A15;SPTLC1;RHCE;CERS6;ASS1;NANP;SMPD2;PCSK1;SPTLC2;PNPLA1;NMRAL1;CERS2;DEGS2;GBA
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.305866477809243,1.2438004615788218,0.1,0.3238316055170955,1.0,41/100,24.58%,SOX4;PERP;INHBA;HDAC2;EIF3C;NAT10;EIF4A3;VPS35;PRKDC;YTHDF1;RPS4X;EIF6;UHRF1;FGFR4;ASPH;EIF3D;ELAVL1;EZR;AGT;PLK1;NPM1;CLN6;LARP4B;RBM3;NSUN5;ASPSCR1;EIF3E;TGFB1;NFKBIA;VGLL4;MSN;PASK;WNT7A;BAK1;HSP90AA1;EEF2;METTL5;AURKAIP1;THBS1;LARP4;HNRNPD
prerank,hexose metabolic process (GO:0019318),0.37200691938788827,1.2431356491837766,0.08888888888888889,0.3245716813467477,1.0,18/41,23.31%,SORD;PMM2;SLC35A2;FUCA2;GALK2;FUOM;AKR1A1;GALK1;KHK;KCNJ11;DCXR;SLC37A4;ALDOC;GALM;BRAT1;ADPGK;ALDOB;FBP1
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.3341732345699683,-1.2421025625057756,0.11864406779661017,0.33585214730061547,1.0,19/69,14.02%,FLCN;GPR17;KANK2;RAF1;LPAR1;STARD13;MYOC;DLC1;ABCA1;STARD8;MYO9B;KCTD10;ARHGEF18;OPHN1;RASIP1;GPR20;RIT2;SCAI;RAC1
prerank,sensory perception (GO:0007600),-0.35978352739372615,-1.2420234507063375,0.15,0.335490423223787,1.0,15/48,21.51%,ASIC3;SCN9A;BBS4;P2RX7;KCNA2;CDH23;KCNK4;PENK;ADORA2A;GNAL;OPRL1;MRGPRX2;PCDH15;CCL2;TMEM150C
prerank,regulation of ruffle assembly (GO:1900027),-0.3975400667770499,-1.2411799253506433,0.1320754716981132,0.33644961956463204,1.0,8/23,15.56%,NLGN1;EVL;RDX;ARHGAP24;NDEL1;P2RY12;DEF8;KANK1
prerank,detection of chemical stimulus involved in sensory perception (GO:0050907),0.4120009029539104,1.240944234664504,0.13333333333333333,0.3282452421115393,1.0,18/22,51.78%,OR2A4;PKD2L1;OR2A7;OR6K3;OR4E2;GPR148;OR5AN1;OR12D2;OR10Z1;OR10K1;OR10J1;OR6N2;OR12D3;OR10J3;OR10K2;OR6K2;OR10T2;OR6K6
prerank,positive regulation of developmental growth (GO:0048639),-0.35068909869069986,-1.2408847359631305,0.171875,0.3364434171527334,1.0,21/50,24.94%,NTN1;MAPT;MACF1;ACTN3;GH1;ITSN2;RUFY3;L1CAM;NGF;GHR;SYT2;DBN1;INSR;PLCB1;DLL1;RIMS1;SYT1;CPNE6;SYT3;CDKL5;ISLR2
prerank,regulation of cellular component movement (GO:0051270),-0.36598779890090827,-1.2401920179632873,0.1568627450980392,0.33696936149181667,1.0,16/49,18.29%,ZSWIM8;RAF1;NRG2;TGFBR3;BTC;HDAC6;ZSWIM6;ACTN1;INPP5F;FES;CADM4;DAPK3;RHOA;ROCK1;EGFR;ERBB4
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.3994340117893586,-1.2401614995430352,0.16,0.33653437561091826,1.0,8/25,15.17%,RYR3;PKD2;FGF2;ITPR1;RYR1;RYR2;ANXA6;HTR2B
prerank,regulation of intracellular transport (GO:0032386),-0.37145418653335094,-1.2400604883920445,0.10344827586206896,0.3362333846269845,1.0,15/35,23.43%,CRYAB;HAP1;NUMA1;RBM4;NEFH;INPP5F;MAP2;LRRK2;NDEL1;TTC21B;GAS1;GRIPAP1;MYBPC3;MYLK2;AAAS
prerank,autonomic nervous system development (GO:0048483),-0.41096607166347565,-1.2397772388501915,0.14545454545454545,0.33610988051165114,1.0,8/20,17.74%,GDNF;PHOX2B;PHOX2A;RHOXF1;NTRK1;EDNRB;SEMA3A;SOX11
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.35538519649607486,1.2396666161786483,0.13333333333333333,0.33004779759001257,1.0,21/39,35.01%,NDUFS6;NDUFB3;NDUFB11;NDUFA12;NDUFAB1;NDUFA3;NDUFA1;NDUFB9;NDUFB6;NDUFB5;NDUFB4;NDUFS3;NDUFA4;NDUFS1;NDUFB7;NDUFA2;NDUFC1;NDUFS5;NDUFB2;NDUFA6;NDUFS8
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.43976761398355735,1.2391393733415044,0.1836734693877551,0.33031422015485196,1.0,8/19,21.99%,RGPD4;NUP35;KPNA7;KPNB1;KPNA2;RGPD1;RGPD3;IPO5
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.31739561694159185,1.2386830829339266,0.0,0.33046517666101344,1.0,22/72,21.40%,RFC3;RPA3;FEN1;RFC5;RFC2;POLD2;GTF2H3;ERCC5;DNA2;PDE12;DDB1;UBA52;RPA2;POLD1;CUL4A;DNASE1L1;REXO4;XRN2;RFC4;ERCC2;DDX1;ZC3H12A
prerank,RNA metabolic process (GO:0016070),0.2937012389699368,1.2379257253565856,0.13513513513513514,0.33132070887623216,1.0,52/128,22.09%,POLR2F;DKC1;POLR2D;RNASEH1;SND1;HNRNPF;TP53RK;PRPF4;PABPC3;MRPL44;LAGE3;LSM8;TBRG4;FASTKD2;PNPT1;NCBP1;NUFIP1;PTBP1;EXOSC7;SNRNP40;HNRNPK;DHX9;WDR74;DDX54;CLP1;DUSP11;NCBP2;HNRNPC;POLR2C;GTF2F2;DHX8;POLR2K;HNRNPA0;POLR2J;APOBEC1;RBM3;POLR2G;DEDD2;PPP1R8;SYNCRIP;RNASEH2A;XRN2;HNRNPR;RNASEH2B;HNRNPA2B1;POLR2H;TFIP11;HNRNPA1;POLR2I;ZC3H12A;POLR2L;RNGTT
prerank,granulocyte differentiation (GO:0030851),0.41830860898331834,1.2377975072513128,0.16981132075471697,0.3311269707245701,1.0,11/20,26.85%,E2F1;LEF1;PML;CDK4;CEBPA;JAGN1;DEK;SRP54;CDK2;SPI1;CEBPE
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.3069342279660271,1.2376842817488112,0.08888888888888889,0.3307439948196549,1.0,34/82,21.69%,CEP72;CDK1;CEP250;GTSE1;KIF14;YWHAE;NEK2;TUBB4B;HAUS2;YWHAG;TUBA4A;ATAD5;HAUS8;CEP76;AURKA;TPX2;CKAP5;HAUS1;HAUS6;PLK1;NPM1;TUBG1;CEP78;CENPF;PLK4;DYNLL1;HAUS7;DYRK3;MAPRE1;SSNA1;CEP41;HSP90AA1;TUBB;CDK2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.30667707303919967,1.2368365309636795,0.030303030303030304,0.331916898902331,1.0,14/74,10.97%,EPHB2;IL23A;SLC7A1;ZP3;CD276;IL1B;PNP;CD46;CHRNB2;IL21;CD80;CD81;JAK3;CD70
prerank,regulation of developmental growth (GO:0048638),-0.3819322561534151,-1.2364358115553815,0.24561403508771928,0.34149450814197957,1.0,13/30,23.11%,OLFM1;GHR;MBD5;LATS2;PRL;MUSK;SIN3A;INSR;PLCB1;DLL1;SOD1;NIPBL;LATS1
prerank,hexose transmembrane transport (GO:0008645),-0.4159523770639103,-1.2350356458792453,0.1836734693877551,0.3436799556821607,1.0,4/21,5.73%,SLC2A4;SLC45A1;SLC2A11;PPARD
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.4510793421472797,-1.2348598583590045,0.25862068965517243,0.3434720337694058,1.0,8/16,25.33%,FAM107A;GPER1;ZFP36L1;NR3C1;ZFP36;SSTR2;BCL2L11;ZFP36L2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.2979414952648388,1.2345578979165461,0.08888888888888889,0.33586778158463404,1.0,22/73,17.36%,CBFB;ABCE1;IRAK2;VRK2;SYK;TNFAIP3;USP18;IFNGR2;SOCS1;SPATA2;IRAK1;RUNX1;AGPAT2;STAT1;TRAF2;SOCS3;ELF1;SUMO1;PALM3;PTPN2;HSP90AB1;OTULIN
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4366345635454136,1.2343412196127568,0.18867924528301888,0.33570533647847106,1.0,9/16,28.70%,VHL;ADIPOR1;SOCS1;SOCS3;PTPN2;CAV1;PPP2CA;PPP2R1A;PIBF1
prerank,regulation of viral entry into host cell (GO:0046596),0.3551356354729506,1.2341333413172415,0.11320754716981132,0.3356566113531027,1.0,13/37,22.27%,IFITM3;LY6E;IFITM1;P4HB;IFITM2;TRIM27;TRIM14;TRIM26;TRIM11;LGALS1;TMPRSS4;TRIM31;TRIM22
prerank,regulation of oxidative phosphorylation (GO:0002082),0.4335077538505381,1.2341043629499484,0.17391304347826086,0.3351373548487321,1.0,9/16,19.85%,SHMT2;UQCC2;PDE12;PPIF;COX7A2L;COX7A2;VCP;SLC25A33;MLXIPL
prerank,nucleosome organization (GO:0034728),0.33217307656068734,1.2327012741226182,0.1111111111111111,0.33689415652069776,1.0,17/56,15.44%,CHAF1B;HMGA1;CHAF1A;SET;SMARCB1;GRWD1;SMARCA4;POLE3;SOX9;SPTY2D1;HMGB2;ZNHIT1;SMARCD2;SMARCC1;NPM1;LIN54;VPS72
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.39946354662610406,-1.2325134316919744,0.16071428571428573,0.34775236871061826,1.0,12/25,21.82%,BMPR1A;NUMA1;SMAD4;RBPJ;RNF165;GDF5;ZNF423;SOX11;ACVR2A;SMAD2;BMPR1B;CDH5
prerank,ventricular septum development (GO:0003281),-0.3623861458600931,-1.2318226722630523,0.125,0.34860406824204915,1.0,14/37,17.92%,PDE2A;TGFBR3;BMPR1A;DAND5;SMAD4;CITED2;ZFPM2;SLIT2;MDM4;SLIT3;HEY1;HEY2;SOX11;HECTD1
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.36452312682317356,-1.2315486805821576,0.16326530612244897,0.3486225070262387,1.0,14/37,23.85%,PLIN5;DLG4;ITGB3;PTX3;RIN3;SIRT2;ATXN2;OPTN;ANKRD13A;EDNRB;INS;ANKRD13D;BTN2A2;PINK1
prerank,generation of neurons (GO:0048699),-0.28179419136862965,-1.231156848098393,0.04411764705882353,0.34878637299997056,1.0,53/195,18.15%,RNF112;NRBP2;WNT9A;EML1;FGFR1;BRSK1;ARNTL;FZD4;MAPT;NLGN4X;MAP1B;DNER;CTF1;PAFAH1B1;PHOX2B;SNPH;CEP85L;WNT6;NGRN;GPM6A;MDGA1;WNT5B;SMARCA1;ADGRL3;FZD7;ATOH8;NAV1;MYEF2;ASTN1;HEY1;OPHN1;MEF2C;MYT1L;WNT2B;ASTN2;MARK1;LHX6;RAC1;FUT9;FGF13;RELN;DISC1;IL1RAPL1;HEY2;LMX1B;FZD8;IRX6;SEMA3A;WNT16;SOX11;SPOCK1;CASP3;LHX4
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.4202574224672475,-1.2299506829932696,0.17543859649122806,0.35044586576648273,1.0,11/27,24.09%,CACNA1C;ANK2;PDE4D;CTNNA3;PLN;RYR2;FGF13;CAMK2D;SCN5A;CAV3;ATP2A2
prerank,cellular response to organonitrogen compound (GO:0071417),-0.30900185531226254,-1.229947344505004,0.07272727272727272,0.3499247209671406,1.0,36/100,22.81%,PDE2A;RYR3;AKAP6;TRPV1;RAPGEF3;PKD2;RAP1A;DEFB124;RRAGC;P2RY1;CPEB1;P2RX7;SLIT2;ZFP36L1;PDE3A;CPEB3;MEF2C;AQP1;INPP5K;P2RY12;RRAGB;RAPGEF1;KCNE1;SSH1;SFRP1;IGFBP5;CRHBP;GABRG2;P2RY11;RRAGD;RAPGEF2;HCN3;RPTOR;ACTB;CPEB4;MTOR
prerank,positive regulation of transferase activity (GO:0051347),0.2797204059245282,1.229852945145982,0.06666666666666667,0.3415908328769174,1.0,37/144,14.30%,DKC1;RFC3;MYC;TRIB3;DSCC1;RFC5;DCUN1D5;CCT2;RFC2;UBE2N;PDGFRB;EPHB2;EPHB3;MET;XRCC5;EPHA1;NEK2;SERINC5;RPS2;EPHB4;AURKB;EPHA2;NAF1;ZNF622;DBI;DDR1;PTGES3;FGFR4;DTX3L;IGF1R;WRAP53;SORL1;MAPK15;PLK1;GRHL2;KDR;CCT4
prerank,organic acid transport (GO:0015849),0.30561329737482507,1.2292527211021083,0.1111111111111111,0.34228165893727847,1.0,34/95,24.46%,SLC6A20;SLC1A5;SLC1A4;SLC5A6;FOLR1;SLC6A14;SLC7A1;SLC7A11;AKR1C4;SLC38A5;ABCC11;GOT2;SLC6A6;SLC19A1;LRRC8D;SLCO1B3;SLC25A17;SLC7A4;SLC3A2;SLC16A10;SLCO1C1;SLC27A5;SLC13A3;SLC43A2;SLC25A48;SLC7A7;ABCC2;SLC7A8;SLC6A18;SLC27A4;SLCO1A2;SLC7A6;SLC26A8;SLC46A1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.37381879025085274,1.2289725537236365,0.22916666666666666,0.3423717427068248,1.0,9/28,28.01%,AZGP1;IL23A;CD1A;CD1B;IL23R;HLA-F;IL12B;IL12RB1;CD1E
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.33905339031743353,1.2287050105748083,0.2,0.34178691061413463,1.0,29/55,35.01%,COA1;NDUFS6;FOXRED1;NDUFB3;NDUFB11;NDUFA12;NDUFAB1;NDUFA3;NDUFAF2;NUBPL;NDUFAF3;NDUFA1;NDUFB9;TMEM126A;NDUFB6;NDUFB5;NDUFB4;NDUFS3;NDUFAF6;NDUFAF4;NDUFS1;NDUFB7;NDUFA2;NDUFC1;NDUFS5;NDUFB2;NDUFA6;TMEM126B;NDUFS8
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.33905339031743353,1.2287050105748083,0.2,0.34178691061413463,1.0,29/55,35.01%,COA1;NDUFS6;FOXRED1;NDUFB3;NDUFB11;NDUFA12;NDUFAB1;NDUFA3;NDUFAF2;NUBPL;NDUFAF3;NDUFA1;NDUFB9;TMEM126A;NDUFB6;NDUFB5;NDUFB4;NDUFS3;NDUFAF6;NDUFAF4;NDUFS1;NDUFB7;NDUFA2;NDUFC1;NDUFS5;NDUFB2;NDUFA6;TMEM126B;NDUFS8
prerank,membrane repolarization (GO:0086009),-0.47151157234387564,-1.2286075493906257,0.14285714285714285,0.35234467348916515,1.0,7/15,13.82%,ATP1B2;ATP1A2;KCNIP2;KCNH2;KCNE2;KCND3;KCNE1
prerank,regulation of cell morphogenesis (GO:0022604),-0.40289313259695486,-1.2278690065372364,0.22448979591836735,0.3531378167688818,1.0,18/32,28.81%,ZNF135;ZMYM6;FERMT2;MACF1;WTIP;MYO9A;NTNG1;EFNA5;ZMYM3;CAPZB;ZRANB1;PHIP;STRIP1;FMNL2;ARC;CAMSAP1;ZMYM4;SH3D19
prerank,cognition (GO:0050890),-0.3559999494378158,-1.2269167373159888,0.140625,0.35436152745832306,1.0,9/43,8.99%,FAM107A;GTF2A1L;SOBP;PTCHD1;SLC8A2;CUX2;BBS4;SETD5;GPR155
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.3405424556424697,1.2257130483881886,0.125,0.3470308377105458,1.0,19/48,25.41%,NME6;CHEK1;MAD2L1;TOM1L1;ZWINT;NABP2;ZW10;PTPN3;BUB1;BMP7;BMP4;TGFB1;SLC9A3R1;BUB1B;RFPL1;SCRIB;AURKAIP1;CTNNB1;CDKN1B
prerank,mitotic cytokinesis (GO:0000281),0.3446855317842636,1.2255606643873482,0.175,0.3468151066744319,1.0,16/48,13.76%,INCENP;CEP55;RACGAP1;CENPA;KIF23;KIF20A;STMN1;RTKN;ECT2;SPAST;MYH10;KIF4B;STAMBP;CKAP2;ANLN;PLK1
prerank,endoderm formation (GO:0001706),0.3734234109987653,1.2249576338899553,0.14893617021276595,0.34752718974387575,1.0,15/35,19.78%,DUSP4;COL11A1;INHBA;TBX20;HMGA2;FN1;DUSP1;MMP2;ITGA5;LAMB3;LAMA3;MMP9;DUSP2;MMP15;MMP8
prerank,negative regulation of binding (GO:0051100),0.3120387208516506,1.2247375718269142,0.1,0.34734837015729914,1.0,27/78,20.67%,GNL3L;E2F1;TFAP4;GTPBP4;MDFI;PPP1CA;LEF1;AURKB;TMBIM6;SLPI;HMGA2;AURKA;CTNNBIP1;ZFPM1;GSK3B;SORL1;KDM1A;SUMO1;CTSZ;GZMA;CPNE1;SUMO3;NFKBIA;BAX;CAV1;TFIP11;IFI16
prerank,regulation of response to cytokine stimulus (GO:0060759),0.44029659318151115,1.224488687215299,0.24390243902439024,0.3472071112082812,1.0,8/20,15.84%,CBFB;IRAK2;WNT5A;DHX9;IRAK1;RUNX1;TAF9;ELF1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.44073847733126115,-1.224183304740186,0.16,0.3589394968198979,1.0,9/18,25.33%,FAM107A;KLF9;ZFP36L1;NR3C1;AQP1;ZFP36;SSTR2;BCL2L11;ZFP36L2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.29982008258057685,-1.2240533611347297,0.07017543859649122,0.35861063939289556,1.0,37/132,23.74%,GLP2R;ADCY5;PTH1R;ADCYAP1R1;ADCY2;ADRB3;ADCY4;POMC;VIPR2;ADRB2;ADCY9;PRKACA;GNG2;RAMP1;ADORA2A;PRKAR2B;VIP;MC1R;GPR20;AVPR2;ADRB1;ADCY6;TSHB;MAPK14;HTR4;CRHR1;GPR27;RAMP3;P2RY11;GPBAR1;LHCGR;HTR7;CRHR2;PLCG1;RAMP2;PLCG2;ADCYAP1
prerank,regulation of cytokinesis (GO:0032465),0.3203747465226226,1.2239064035065073,0.14285714285714285,0.3478042558031833,1.0,34/83,23.30%,KIF20B;RACGAP1;SSTR5;KIF23;KIF20A;KIF14;CXCR5;AURKB;ECT2;RAB11A;CHMP4C;BCL2L1;PDXP;PRPF40A;OR2A4;RAB11FIP4;AURKA;SPAST;DRD2;PLK1;E2F8;PLK4;CENPV;CDC6;PKP4;CDC42;RXFP3;GIT1;E2F7;CUL3;GIPC1;CDC14C;MYO19;CSPP1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.3189680644793527,1.2236949756014808,0.14893617021276595,0.34758903690983434,1.0,33/77,32.06%,USP50;RIPK2;WNT5A;SERPINB1;TNFAIP3;CARD17;CCL3;MYD88;IL17A;GBP5;F2R;EGR1;LILRB4;NOD2;MNDA;IFI16;GIT1;ZC3H12A;TYROBP;CARD16;GSTP1;FFAR4;IFNG;CLEC7A;CASP8;NLRP2;PYDC1;PANX1;NLRP3;TLR8;AIM2;TNF;LILRA5
prerank,detection of chemical stimulus involved in sensory perception of smell (GO:0050911),0.40095989952453565,1.2236657716939126,0.24444444444444444,0.34704358354740034,1.0,20/20,59.94%,OR2A4;OR2A7;OR6K3;OR4E2;GPR148;OR12D2;OR10Z1;OR10K1;OR10J1;OR6N2;OR12D3;OR10J3;OR10K2;OR6K2;OR10T2;OR6K6;OR10R2;OR13G1;OR1K1;OR2A25
prerank,negative regulation of interferon-gamma production (GO:0032689),0.35954631827814004,1.2236017182796504,0.17647058823529413,0.3465550214492305,1.0,18/28,37.42%,INHBA;FOXP3;C1QBP;LILRB4;TNFSF4;HMGB1;ZC3H12A;IL36RN;XCL1;CD274;AXL;HAVCR2;TLR4;PDCD1LG2;LILRB1;LGALS7;LAPTM5;LGALS9B
prerank,positive regulation of protein catabolic process (GO:0045732),0.3002110561452343,1.2234974440759476,0.07317073170731707,0.346104740659463,1.0,30/83,23.96%,ASB9;CSNK2A3;IL1B;WNT5A;VPS35;TNFAIP3;C4BPA;CSNK2A1;C4BPB;GSK3B;SORL1;OAZ3;DDB1;EZR;VCP;ADAM8;NSF;RAB7A;IDE;TNFRSF1B;ADAM9;AXIN1;VGLL4;MSN;HSP90AA1;HECW1;HECW2;DTL;WWP2;BARD1
prerank,negative regulation of innate immune response (GO:0045824),0.33795853168546613,1.223490617801009,0.125,0.3455278994250306,1.0,14/37,20.67%,LYAR;TNFAIP3;USP18;NMI;TTLL12;SERPING1;NLRC5;YTHDF2;GRN;RPS19;ISG15;PTPN2;OAS3;IFI16
prerank,positive regulation of cell population proliferation (GO:0008284),0.2448792062347877,1.2229754503557453,0.0,0.3459392361106652,1.0,139/454,21.98%,CIAO1;SOX4;MYC;MCTS1;CALR;E2F1;TDGF1;OSM;KIF20B;FBXO5;IRS1;LAMC2;TIPIN;ESM1;RASSF10;CXCL5;IL11;WNT2;EREG;SAPCD2;CDC123;WDR77;CSF2;SSR1;PDGFRB;CSNK2A3;AREG;ROMO1;PHB;HDAC2;KIF14;FGF19;EPHA1;SAAL1;GDF9;IL1B;WNT5A;TBRG4;TIMP1;TBX20;CEACAM6;GID8;SHH;LEF1;REG1A;CDK4;CTSH;PROX1;S100A6;SOX9;NACC1;TGFB2;RPS4X;RTKN2;MDK;DHX9;CSNK2A1;MAZ;BAMBI;IL21;FAM98A;HMGA2;CD81;XBP1;PRAME;NOX1;FN1;HDAC1;FGFR4;RELA;ADAM10;CDCA7L;IGF1R;FGF20;PRMT1;STAT1;STAMBP;CAPN1;KDM1A;PRLR;RPS9;NME1;STX3;AGT;MAPK15;ZNF703;FGF3;CIB1;PRKCI;NPM1;KDR;BMP4;FAM98B;GRN;CXCR2;PAK1;FOXM1;PDCD10;BST2;ACER2;RAB25;SLC35F6;SLC25A33;RNF187;HPSE;F2R;UBE2A;IL7R;TGFB1;LRP5;SLC25A5;LYN;INSL4;NOD2;EGR4;BIRC5;STOX1;FXN;CDC7;PROK2;RPRD1B;TGFBR2;TNFSF4;MLXIPL;HES1;TGFA;PAX2;CD86;TSPAN31;SPDYA;RPL23;CDK6;CUL3;DDRGK1;PRDX3;CDK2;NOTCH1;LGMN;TTK
prerank,mRNA metabolic process (GO:0016071),0.28647645898627927,1.2227629555521342,0.11428571428571428,0.3457839614072792,1.0,32/91,19.45%,CPSF3;SNRPF;LSM5;EREG;SNRPG;U2AF1;SLBP;PABPC3;SNRPB;TBRG4;PNPT1;NCBP1;SNRPE;SRSF9;PTBP1;NONO;CNOT10;NUDT21;LSM2;NCBP2;HNRNPA0;SSB;YTHDF2;LSM6;ZNF473;USP39;LSM3;SF3A3;HNRNPR;NUDT16L1;HNRNPA2B1;SNRPD3
prerank,organelle disassembly (GO:1903008),0.3655854587107006,1.2227018942849617,0.17391304347826086,0.3453743531925328,1.0,14/32,21.34%,MCTS1;CDK1;VRK1;KIF9;DENR;MTIF2;TEX264;GFM2;VCP;UFC1;DYRK3;ZFAND1;UFM1;DDRGK1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.3764790353758883,1.2221466790783824,0.16326530612244897,0.34602015428737987,1.0,17/30,31.64%,ABCE1;WNT5A;USP18;TTLL12;NLRC5;YTHDF2;ISG15;PTPN2;HSP90AB1;UBE2K;OAS3;ZBP1;PTPN11;STAT2;YTHDF3;SAMHD1;CNOT7
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.3858901813081776,-1.2220426910194515,0.15254237288135594,0.36203272713738344,1.0,7/30,10.66%,SORBS1;PRKAB2;GPER1;ASXL3;PRKAG2;PRKAA2;SIRT4
prerank,regulation of DNA repair (GO:0006282),0.3397086342023805,1.2215889795839565,0.0851063829787234,0.346300954725108,1.0,17/41,20.61%,BRCC3;POLH;UBE2N;AXIN2;ERCC8;PML;RPS3;WRNIP1;DHX9;CEBPG;WRAP53;BRCA1;USP1;EYA1;DEK;TMEM161A;TRIM28
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.37999396644269073,-1.2213634468166645,0.17647058823529413,0.3628763949534619,1.0,9/36,12.69%,DYNC1I1;MYO15A;HAP1;PAFAH1B1;TRAK2;KIF1A;MYO5A;MYO1C;NDEL1
prerank,ephrin receptor signaling pathway (GO:0048013),0.30092570027000864,1.2212669322264142,0.14634146341463414,0.34629101483747443,1.0,31/82,20.98%,GRIN2B;ACTR3;ACTR2;EFNA3;EPHB2;EPHB3;EPHA1;EPHB4;EFNA4;ARPC5;ACTG1;EPHA2;EFNB1;APH1A;EFNA1;ARHGEF28;AP2S1;MMP2;EFNA2;ARPC3;MMP9;PAK1;AP2B1;NCSTN;LYN;VAV3;FYN;CDC42;VAV2;YES1;GIT1
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.3225685002699924,-1.2205661811502655,0.1206896551724138,0.3641614587500735,1.0,26/78,20.98%,LMOD1;CCL27;CFL2;TENM1;SYNPO2;NUMA1;SORBS3;NTRK3;CDC42EP3;P2RX7;FES;EVL;NCK1;FER;NCKAP1L;SYNPO;FCHSD1;LMOD2;CDC42EP4;NTF3;BAIAP2;CCL11;FCHSD2;CCL21;MYLK3;BCAS3
prerank,regulation of dephosphorylation (GO:0035303),-0.4453574205199301,-1.2198913513732095,0.2028985507246377,0.365070723321909,1.0,7/15,33.30%,MTMR9;INPP5K;CDK5RAP3;SMG6;SMG5;PPP1R16B;MTMR4
prerank,cellular response to amyloid-beta (GO:1904646),-0.39029198214625915,-1.21933242383664,0.15384615384615385,0.3655488163977214,1.0,12/35,18.84%,CACNA2D1;ADRB2;CACNB1;PRNP;NGFR;PSEN1;ATP1A3;NTRK1;EPHA4;GRIN2A;CACNA1A;CD36
prerank,negative regulation of ossification (GO:0030279),0.3967161704656316,1.2192795658984634,0.17647058823529413,0.34926488663279753,1.0,5/22,9.42%,KREMEN2;SOX9;LRP4;MDK;CCL3
prerank,fat cell differentiation (GO:0045444),-0.33850118925628825,-1.2192710670923141,0.1320754716981132,0.3652270610375045,1.0,22/58,23.74%,CLIP3;ZNF516;BBS4;WNT5B;FAM120B;BSCL2;C1QTNF3;PID1;STEAP4;BBS2;GDF6;BBS7;BBS9;AKT2;CBY1;SIRT1;NR4A3;PRDM16;SENP2;SOX8;NR4A1;OSBPL11
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.4492106593231779,1.2192362672252084,0.24,0.34878070663643074,1.0,7/15,28.63%,GET4;EMC8;EMC10;EMC1;EMC7;UBL4A;EMC3
prerank,positive regulation of nervous system process (GO:0031646),-0.42870041593644426,-1.2191003440685009,0.19672131147540983,0.36499170536369296,1.0,6/16,14.93%,NLGN2;PARD3;RNF10;TPPP;DICER1;CARTPT
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.3339775779007576,-1.218870343343692,0.04838709677419355,0.3647997122348444,1.0,26/71,21.63%,PKD1;FAM107A;KANK2;FHL1;PKD2;JADE1;ZNF655;LSM11;ADAMTS1;PTEN;RDX;UBE2E2;CDKN1A;PRMT2;APC;CDKN2C;FGF10;RBL2;EGFR;MYO16;KMT2E;DCUN1D3;PLCB1;INO80;CCL2;RPTOR
prerank,organelle transport along microtubule (GO:0072384),-0.38161491157564353,-1.2185702042343944,0.2033898305084746,0.3649488919620394,1.0,10/28,18.78%,DYNC1I1;MAPT;HAP1;PAFAH1B1;TRAK2;BICD2;ARHGAP21;NDEL1;RHOT2;UBB
prerank,regulation of secretion by cell (GO:1903530),-0.344188869057113,-1.2183845752701237,0.15789473684210525,0.3647292150464942,1.0,22/52,24.33%,VAMP2;CPLX3;HAP1;CAMK2A;RAB12;DISP1;LGI3;STXBP5L;RIC1;MEF2C;CHRNB4;KCNMB4;RAB3A;RAB13;RAB3C;SYN1;INS;RAB8B;RIMS1;SYT1;CCKAR;RHBDF1
prerank,spermatid development (GO:0007286),-0.34430703140926855,-1.21764967146247,0.19642857142857142,0.3656278630665697,1.0,8/39,8.95%,RFX2;JAM2;DPY19L2;BBS4;TTC21A;DDX25;PLD6;PRM2
prerank,regulation of BMP signaling pathway (GO:0030510),-0.3300760908767364,-1.2173253956748276,0.10606060606060606,0.365732714608915,1.0,33/73,28.14%,RBPMS2;BMPR1A;DAND5;CHRD;NUMA1;SMAD4;SKOR1;FSTL3;RBPJ;RNF165;SKI;FSTL1;FST;GDF5;SMAD9;ZNF423;SOX11;ACVR2A;SMAD2;TRIM33;BMPR1B;SMAD7;CDH5;DLX1;VWC2;TWSG1;NBL1;BMPER;CRIM1;NOG;SMURF1;FBXL15;BMPR2
prerank,retinoid metabolic process (GO:0001523),-0.3185745643861995,-1.2165798478510184,0.06153846153846154,0.36672581668158116,1.0,23/81,18.12%,RDH5;BCO2;LRAT;ADH1B;CYP27C1;ALDH8A1;SCPEP1;GPIHBP1;AKR1C1;SDC3;SDC2;PNLIP;RARRES2;CLPS;CYP26B1;ALDH1A1;HSPG2;CYP1A1;CYP4V2;OPN1SW;AKR1B1;RLBP1;GPC1
prerank,histone deubiquitination (GO:0016578),-0.4475361600929767,-1.2160822272017249,0.2857142857142857,0.3671666619530833,1.0,10/17,27.76%,UIMC1;USP49;USP51;KAT2A;ATXN7;USP15;USP21;SUPT3H;USP3;USP16
prerank,cellular lipid catabolic process (GO:0044242),0.39786544005502117,1.2158662764010346,0.19148936170212766,0.3541018837261144,1.0,8/24,9.85%,NUDT19;PLBD1;ACBD5;MGST2;ABHD12;AOAH;CEL;LIPG
prerank,sulfur amino acid metabolic process (GO:0000096),0.4122455735621208,1.2158306377763088,0.1702127659574468,0.35361136170171387,1.0,8/21,15.08%,AHCY;DPEP1;MTHFD1;MAT1A;SMS;ADO;CTH;MPST
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.29721632153621114,-1.2153613458395023,0.08064516129032258,0.36804206742631,1.0,59/154,24.11%,PKD1;MKNK1;DMPK;CSNK2A2;BRSK1;ULK1;PNCK;TTBK2;HIPK4;CSNK1E;CAMK2A;ULK2;RPS6KA5;PRKCB;PRKCA;RPS6KA2;CSNK1A1;CAMK1;PRKACA;PRKD1;HIPK3;DYRK1A;LRRK2;MAST2;MAST4;STK32B;LATS2;MAST1;MAPK1;RICTOR;MARK1;MORC3;PDGFB;ROCK1;MAPK8;CAMK2D;SGK3;MAPK14;AKT2;MARK3;STK32A;CSNK1D;MAP3K10;MAP3K12;RPS6KB1;PIKFYVE;MKNK2;MAPK12;PKN1;SMG1;TNKS;MTOR;LATS1;HIPK1;WNK1;PRKCD;RIPK1;PINK1;PRKCH
prerank,dendritic cell migration (GO:0036336),0.4384844958941265,1.2149542372742923,0.17391304347826086,0.3544518643694696,1.0,6/18,22.26%,TRPM2;CXCR4;CXCR2;PIK3CG;HMGB1;CXCR1
prerank,negative regulation of double-strand break repair (GO:2000780),0.40798149664632855,1.2145881267643244,0.1702127659574468,0.35469773996583415,1.0,5/25,9.31%,FANCB;PARPBP;OTUB2;RMI2;HMGA2
prerank,phosphatidic acid metabolic process (GO:0046473),-0.3588181733924262,-1.2141031763888146,0.10909090909090909,0.37003801139873965,1.0,17/48,18.97%,AGPAT1;PLA2G5;PLA2G4B;ABHD8;DGKE;PLD6;AGPAT4;PLA2G6;ABHD4;LIPI;SLC27A1;DDHD2;DGKG;DDHD1;PLA2G1B;PLD2;DGKB
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.2861025887236629,-1.2134684466868593,0.09836065573770492,0.3705839731858875,1.0,54/145,27.04%,GPR17;ADCY5;CACNA1C;JPH2;LPAR1;JPH4;AGTR1;CACNA2D1;PDGFRA;GPER1;P2RY1;DLG4;P2RX7;SLC8A1;ADRA1A;PTGER3;P2RX2;CCR10;ADRA1D;JPH3;NPTN;RYR2;PLCE1;TACR1;GPR20;S1PR3;ACKR3;OPRL1;ESR1;PLA2G1B;TBXA2R;CACNA1A;ACKR2;FFAR1;CD36;C5AR2;PTGFR;LPAR6;CAV3;TRPC3;ADRA1B;LPAR4;ADCYAP1;CHRNA10;CACNB3;C1QTNF1;F2RL3;GPR4;BDKRB1;P2RY4;TAC1;F2RL1;CCKBR;AVPR1B
prerank,regulation of protein ubiquitination (GO:0031396),0.2938951741142773,1.2131563182948857,0.075,0.35651858611427534,1.0,32/101,21.20%,GNL3L;SOX4;PRR7;PRMT3;RIPK2;GTPBP4;UBE2N;DERL1;NDFIP2;PSMD10;RPS3;TNFAIP3;FBXO4;XIAP;BRCA1;DNAJA1;HSPBP1;ISG15;TBC1D7;COMMD1;PRKCG;SPRTN;UBQLN1;HSP90AB1;PAXIP1;FANCI;AXIN1;UBE2D1;BIRC7;CAV1;HSP90AA1;CUL3
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.33025417307078603,1.2129234429959284,0.15789473684210525,0.3565278893329098,1.0,17/58,13.76%,INCENP;CEP55;RACGAP1;CENPA;KIF23;KIF20A;STMN1;RTKN;AURKB;ECT2;SPAST;MYH10;KIF4B;STAMBP;CKAP2;ANLN;PLK1
prerank,regulation of autophagosome assembly (GO:2000785),-0.3671378526071749,-1.2124464736415197,0.19298245614035087,0.3721081017562475,1.0,11/33,20.20%,PIP4K2B;LRRK2;FEZ2;PIP4K2A;LRSAM1;RAB3GAP1;NUPR1;CHMP4A;ADPRH;TBC1D12;PIKFYVE
prerank,antibacterial humoral response (GO:0019731),0.3380304862124352,1.2117745522514185,0.16666666666666666,0.35812565886527903,1.0,15/33,30.94%,DEFA6;SLPI;RPL39;WFDC10A;PI3;SEMG1;ANG;DMBT1;RNASE7;WFDC3;DEFA1;SEMG2;WFDC9;WFDC13;WFDC12
prerank,BMP signaling pathway (GO:0030509),-0.32960134935655727,-1.2115582431412582,0.11290322580645161,0.37320833065047426,1.0,29/62,28.48%,RGMA;TMEM100;TGFBR3;BMPR1A;CHRD;SMAD4;GDF7;MEGF8;MAPK3;USP9Y;GDF5;GDF6;SMAD9;ACVR2A;SMAD2;USP15;BMPR1B;SMAD7;PDCD4;ZFYVE16;TGFB3;AMHR2;SMAD3;RUNX2;BMP5;NOG;SMURF1;BMPR2;HIVEP1
prerank,vasculature development (GO:0001944),-0.438438051731216,-1.2104426955668601,0.19607843137254902,0.374905307364642,1.0,9/17,22.86%,FOXF1;PDGFRA;TCF21;FLT4;NOTCH4;FBXW7;SOX18;CDH5;ERRFI1
prerank,stem cell differentiation (GO:0048863),-0.35800721708114647,-1.209945215484747,0.17307692307692307,0.3754685021615502,1.0,12/38,16.23%,LMBR1L;OSR1;FGFR2;HOXB4;GPM6A;KIT;SETD2;FOXO4;MEF2C;SFRP1;HTR2B;MEOX1
prerank,negative regulation of phosphatase activity (GO:0010923),0.39290050750027755,1.2098038625684358,0.16,0.3616427254040088,1.0,20/27,36.66%,MASTL;SH2D4A;TGFB2;STYXL1;PPP1R1B;SEMA4D;GSK3B;PPP1R35;TIPRL;URI1;PPP1R11;FKBP1B;SH3RF2;CHP1;PPP1R36;FKBP1A;GPATCH2;PPP1R26;ZCCHC9;BOD1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.3016050551008968,-1.2097648166601105,0.11864406779661017,0.3751534737806893,1.0,33/98,25.77%,FLCN;TGFB1I1;TGFBR3;DAND5;WFIKKN2;SMAD4;CITED2;LTBP4;CDKN1C;EMILIN1;SPRY1;LATS2;SKI;PPM1A;ZEB2;IL17RD;SOX11;SMAD2;UBB;DKK3;TRIM33;SIRT1;PRDM16;VASN;SMAD7;PIN1;NREP;LATS1;CD109;PEG10;SMAD3;SNX25;ZNF451
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.4377021965096388,-1.2084173490245362,0.24561403508771928,0.3774928034249137,1.0,6/17,16.11%,CHMP3;DNAJC13;RDX;MAPK1;MAPK3;VPS11
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.45063104792007247,1.2084091728902067,0.2222222222222222,0.36347609182717405,1.0,5/15,15.66%,ARMC10;PSMD10;CD44;KDM1A;RNF34
prerank,protein deubiquitination (GO:0016579),0.25967430252560186,1.2078009903032472,0.09090909090909091,0.3639891641148944,1.0,80/257,23.96%,RUVBL1;PSMD14;MYC;OTUB2;SHMT2;PSMB2;BRCC3;CDK1;USP50;PSMB9;PSMA5;ACTL6A;SKP2;PSMB3;SMAD1;PSME3;PSMA3;POLB;KDM1B;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;TOMM20;TNFAIP3;USP18;PSMD12;ACTR8;PSMB5;USP37;USP10;UCHL5;RNF128;SPATA2;PSMD8;PSMB4;PSMD3;PSMB1;STAMBP;PSMA4;COPS5;RAD23B;ADRM1;BRCA1;PSME1;PSMF1;PSMD11;TRAF2;TNIP3;UBA52;PSMD1;VCP;USP1;CDC25A;CLSPN;USP38;OTULIN;USP26;PSMD6;NFKBIA;STAM;CDC20;CFTR;UBE2D1;PSMD5;VCPIP1;KEAP1;ZC3H12A;MCRS1;PSMC1;STAMBPL1;ACTR5;ENY2;USP5;RCE1;DESI2;TP53;BARD1
prerank,response to molecule of bacterial origin (GO:0002237),0.30010887604445863,1.2077754526131539,0.2,0.36347206814552213,1.0,23/65,23.78%,CXCL8;CXCL2;IL1B;CYP27B1;TNFAIP3;HMGB2;SLPI;MAPKAPK3;IRAK1;NOS2;MAPKAPK2;HNRNPA0;GCH1;TRIB1;NOCT;F2R;IL23R;PALM3;PRDX3;SRR;S100A14;GPR31;RPS6KA3
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.35825065388164445,-1.2076445966279372,0.16363636363636364,0.3784379737769971,1.0,16/46,18.97%,AGPAT1;PLA2G5;PLA2G4B;ABHD8;DGKE;PLD6;AGPAT4;ABHD4;LIPI;SLC27A1;DDHD2;DGKG;DDHD1;PLA2G1B;PLD2;DGKB
prerank,protein secretion (GO:0009306),0.32869588819919654,1.2071781364194452,0.11627906976744186,0.3641782395728524,1.0,19/61,16.85%,MIA2;PDIA4;PDX1;CANX;RAB15;CTAGE9;RAB10;RAB8A;MTTP;FAM3B;RAB3D;COPG1;COPG2;CTAGE8;CTAGE4;CTAGE6;CTAGE15;STEAP3;PREB
prerank,import into cell (GO:0098657),0.3481906135550447,1.2067974290166605,0.1875,0.36431651017016303,1.0,11/41,11.22%,LRRC8E;SLC6A20;SLC5A6;SLC6A14;SLC7A1;SLC7A5;SLC6A6;SLC19A1;LRRC8D;TSPO2;SLC11A2
prerank,mammary gland development (GO:0030879),0.39766220608469666,1.20633168386629,0.1590909090909091,0.36478963698034217,1.0,7/23,12.65%,TDGF1;WNT2;WNT7B;OXTR;APLN;PRLR;WNT3
prerank,regulation of cartilage development (GO:0061035),-0.4203063042127745,-1.205707864042587,0.21739130434782608,0.3814163403214848,1.0,8/18,20.75%,TAPT1;SOX5;ZBTB16;TRPS1;BMP1;KAT2A;BMPR1B;SOX6
prerank,establishment of endothelial barrier (GO:0061028),-0.39903713681790554,-1.2054656688342538,0.24444444444444444,0.38131557137782146,1.0,12/28,20.23%,PDE2A;RAPGEF3;RAP1A;PDE4D;RDX;TJP1;RAPGEF1;MYADM;ROBO4;SOX18;RAPGEF6;RAPGEF2
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.3086439505940594,-1.2046024118597116,0.1724137931034483,0.38230602570324107,1.0,26/108,16.29%,TPCN2;DMPK;PTH1R;ATP2B4;ANK2;CCL14;STIM1;SLC8A2;SLC39A13;SLC24A4;SLC8A1;ELANE;SLC24A3;NPTN;CTRC;RYR2;ATP2B3;SLC30A8;SLC8A3;SLC41A1;CSRP3;TRDN;RGN;MT1X;HTR2B;SLC39A12
prerank,neuromuscular junction development (GO:0007528),-0.42612546052860656,-1.2044886731082047,0.23529411764705882,0.38187330498268063,1.0,10/24,16.32%,PDZRN3;CACNB2;DCTN1;ANK3;CACNB1;UNC13C;LRRK2;PPFIBP1;MUSK;ZC4H2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.3655454140038785,1.2039378719838367,0.1282051282051282,0.3691903008125502,1.0,8/27,14.95%,DTYMK;DCTD;CMPK1;CTPS2;AK2;GSR;NME1;GLRX
prerank,axoneme assembly (GO:0035082),0.3570284273960212,1.2037608612763726,0.1956521739130435,0.36905601176313485,1.0,9/28,11.76%,RP1;CCDC103;DNAAF2;SPAG1;TTC26;RSPH9;CFAP74;DNAAF3;SPAG17
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.448868489261479,-1.2034695193516012,0.2653061224489796,0.3836998226905199,1.0,5/15,7.43%,NLGN2;HAP1;NPAS4;NLGN1;ADRA1A
prerank,neuron maturation (GO:0042551),-0.4222850691740142,-1.203359205289445,0.23076923076923078,0.3832938107096014,1.0,7/18,24.38%,LGI4;ADGRB3;ANKS1A;ACTL6B;SCARF1;SRRM4;MTCH1
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.3956878733856765,-1.2031472080088894,0.2222222222222222,0.3831772736530664,1.0,10/20,25.82%,RHOQ;NCKAP1L;FHOD3;ROCK1;RAB13;STRIP1;FMNL3;FMNL2;FHOD1;NCKAP1
prerank,positive regulation of hormone secretion (GO:0046887),0.44132708834300777,1.2026672353815258,0.20512820512820512,0.370713548208874,1.0,7/17,19.10%,TFR2;SPP1;HCAR2;VAMP8;PLA2G3;NMB;SNX4
prerank,nucleosome assembly (GO:0006334),0.3788252545851288,1.2025575855352841,0.16279069767441862,0.3704194430616747,1.0,9/30,15.92%,CHAF1B;CHAF1A;GRWD1;SOX9;SPTY2D1;HMGB2;HAT1;NPM1;HIRA
prerank,cellular response to BMP stimulus (GO:0071773),-0.3175473788563678,-1.202446172387006,0.12698412698412698,0.38418503162044926,1.0,32/68,28.48%,RGMA;TMEM100;TGFBR3;BMPR1A;SMAD4;PHOX2B;GDF7;MEGF8;MAPK3;SFRP1;USP9Y;GDF5;GDF6;SMAD9;ACVR2A;SMAD2;USP15;VSTM2A;BMPR1B;SMAD7;DLX1;ADAMTS7;PDCD4;ZFYVE16;TGFB3;AMHR2;SMAD3;RUNX2;BMP5;SMURF1;BMPR2;HIVEP1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.38426108586839797,1.2020399396006265,0.23076923076923078,0.37073900992753284,1.0,5/27,5.36%,CDH3;DHFR;SCARB1;IL1B;CYP27B1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.3086747043199098,-1.2019013557268075,0.15873015873015872,0.3848339574581329,1.0,35/95,24.45%,TRIM39;FOXF2;ZER1;CLU;MAP1A;CSNK1E;RNF19A;RNF180;CSNK1A1;RNF217;DET1;BAG2;LRRK2;SIRT2;ZYG11B;WAC;KLHL40;GNA12;OGT;TRIB2;BBS7;ARIH2;RNF144B;HECTD1;CSNK1D;DNAJB2;ARIH1;RNF14;GSK3A;PRICKLE1;SMAD7;CAMLG;PIAS1;RNF144A;GABARAP
prerank,negative regulation of secretion by cell (GO:1903531),0.34884189825139134,1.2018249418336855,0.17391304347826086,0.37046327968215537,1.0,14/38,22.77%,OSM;CYP51A1;IL11;RHBDF2;PNKD;ERP29;VAMP8;DRD2;TNFRSF1B;SLC30A1;NOTCH1;IL12B;HMGCR;LIF
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.250769644423147,-1.2015184308445033,0.01282051282051282,0.3850299805985727,1.0,151/498,22.04%,CALCOCO1;CAND2;HDAC4;APBB1;SMARCD3;TGFB1I1;FOXF1;HAND2;FOXF2;ZNF516;MYOCD;ARNTL;MLLT11;FZD4;FGF2;TRIM45;CAPN3;ACTA2;PRDM11;PPP3CB;ELF2;GLI3;MITF;SMAD4;CITED2;TFE3;DVL3;ILK;PPARD;TAL1;NCOA1;NPAS3;KCNH2;RORA;CASZ1;NR1D1;KAT6B;TEAD1;ATF4;TBX1;CDKN1C;AR;KMT2A;SMARCA1;ZKSCAN3;NR2F2;EPC1;TP53INP2;PSEN1;GDF7;NFATC1;FZD7;NOS1;DYRK1A;ATOH8;EDRF1;ZBTB16;MSTN;QRICH1;RXRB;ZMIZ1;NFIB;RNF10;ARHGEF11;JMJD6;ZNF496;GLI2;WAC;HEY1;KDM3A;CXXC1;WBP2;SOX17;MAPRE3;NOTCH4;MEF2C;NFIL3;NR1H2;MED17;INPP5K;PPM1A;RXRA;ARNT2;EBF3;SETD3;MAP2K7;KMT2B;UBE2V1;PRMT2;SFRP1;BCL10;ZFHX3;HINFP;TFEB;ESR1;PDGFB;FGF7;GDF6;RLF;GLIS2;TEAD2;TP53INP1;TCF4;BTRC;HEY2;KAT2A;SMARCC2;CEP290;ZNF423;RORB;IRX6;SPIN1;TRERF1;SOX11;TP53BP1;ZFP90;EGFR;NAT14;ERBB4;SMAD2;KMT2E;SMARCA2;AFAP1L2;POU3F3;PLCB1;ZBTB48;HHEX;RET;RNF14;MDFIC;CDK5RAP2;SOX18;MAP3K12;RAI1;SOX2;CAMKK2;ING5;PHIP;PRDM16;FLI1;USP21;FZD1;NR1D2;PSMD9;KAT5;SERTAD3;TRIM56;KLF2;OSR2;LRP6;TRIM44
prerank,negative regulation of interleukin-10 production (GO:0032693),0.4571458906460601,1.2012056349920806,0.20588235294117646,0.3712005851554673,1.0,8/16,24.25%,IL23A;FOXP3;JAK3;IL23R;LILRB4;MMP8;IL12B;TYROBP
prerank,regulation of catecholamine secretion (GO:0050433),-0.41010565741954874,-1.2011137445009354,0.22641509433962265,0.38544375999071623,1.0,9/26,12.21%,KCNB1;SYT10;SNCA;KCNA2;SYT11;SYT2;SYT9;SYT6;SYT5
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.2854563714456517,-1.2006115844039968,0.11864406779661017,0.385951699620714,1.0,45/129,25.70%,TGFB1I1;RGMA;TMEM100;DUSP22;TGFBR3;BMPR1A;FERMT2;GCNT2;PXN;WFIKKN2;SMAD4;CLDN5;PARD3;GDF7;ZMIZ1;MEGF8;ARHGEF18;SKI;MAPK3;RHOA;USP9Y;GDF5;GDF6;SMAD9;CBL;ZFYVE9;ACVR2A;SMAD2;USP15;LRRC32;HPGD;UBB;BMPR1B;SIRT1;MAP3K7;SMAD7;CDH5;PDCD4;ZFYVE16;TWSG1;TGFB3;AMHR2;SMAD3;FNTA;RUNX2
prerank,ceramide metabolic process (GO:0006672),0.3485354971092176,1.200599959846508,0.18181818181818182,0.37163935358590827,1.0,26/51,27.11%,SPTLC1;CERS6;SMPD2;SPTLC2;PNPLA1;ASAH2B;CERS2;ORMDL3;DEGS2;FUT7;SGPL1;GBA;CLN6;ACER2;FA2H;SPTSSB;ORMDL2;PLA2G15;ALOXE3;FUT6;ASAH2;ABCA12;PPP2CA;FUT3;ALOX12B;PPP2R1A
prerank,activation of protein kinase B activity (GO:0032148),-0.3719794829139704,-1.2001276147732467,0.17307692307692307,0.38632208546251184,1.0,14/31,27.85%,ADRA2B;NTRK3;RICTOR;PDGFB;MAPKAP1;NTF3;CCDC88A;FGF1;INSR;INS;MTOR;PINK1;ITGB1BP1;MT3
prerank,stress-activated MAPK cascade (GO:0051403),-0.3313854397052415,-1.2000214225357524,0.14545454545454545,0.3859713368496029,1.0,27/61,24.86%,MAPK10;ARHGEF6;TAB2;SKP1;ZFP36L1;TAOK2;MAPK1;MAPK3;MAPK11;MAP2K7;TAB1;UBE2V1;MAP2K4;MAPK8;BTRC;MAP4K2;GPS2;ZFP36;MAPK14;UBB;MAP3K10;MAP3K12;MAP3K7;SH2D3C;MAP3K8;FBXW11;MAP4K3
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.3633264225126935,-1.200010902818917,0.15873015873015872,0.3854181312364504,1.0,11/31,20.36%,PER1;KANK2;CRY2;ARNTL;TCF21;STRN3;PIAS2;SFRP1;VPS11;SIRT1;CRY1
prerank,mammary gland epithelium development (GO:0061180),0.4400071670669389,1.1999234793457438,0.20754716981132076,0.3728073509124034,1.0,6/15,17.12%,WNT2;WNT7B;EPHA2;WNT3;ZNF703;IRF6
prerank,ganglioside biosynthetic process (GO:0001574),-0.42378825850904395,-1.199738339346429,0.23529411764705882,0.3854354763733314,1.0,8/15,28.94%,ST6GALNAC3;ST8SIA3;ST3GAL5;B4GALNT1;ST6GALNAC6;ST6GALNAC5;B3GALT4;ST8SIA2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.3685479656584224,1.199520346435016,0.24324324324324326,0.3728600885239809,1.0,10/28,19.35%,TRIB3;DCUN1D5;FBXO5;UBE2N;LIMK1;RPS2;DTX3L;PLK1;FEM1A;AXIN1
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.3612792406740207,-1.1993003713583774,0.21311475409836064,0.38570976628515974,1.0,17/32,26.02%,MPP2;NLGN3;NPAS4;CHRNA3;LRRK2;MEF2C;NPFF;RAB3GAP1;GRIN2A;GABRG1;GABRG2;GSK3A;DRD4;GRID2;GRIN2C;GABRA1;GABRA5
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.39318915339571126,-1.199292541583311,0.28,0.38515936942552176,1.0,11/29,21.46%,FAM107A;CYP46A1;SCGN;PTN;SHANK3;SHISA7;EPHA4;RELN;INS;NSG1;CALB2
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.2569494270130152,-1.1987600681272363,0.03896103896103896,0.38572996655131375,1.0,137/418,24.86%,TCF7L1;PHF1;APBB3;APBB1;ZSCAN26;NR2C2;SSBP2;HCFC2;ZNF516;ZNF280D;DMTF1;ARNTL;ATF7;SOX15;ZNF219;ZBTB4;CHD3;HP1BP3;ZNF536;PHF12;ZNF273;PRDM2;SAP30L;ZNF676;MITF;WWTR1;BNC2;PPARGC1B;WTIP;YY1AP1;RPS6KA5;ZNF519;RORA;PRDM8;SKOR1;ZNF284;CASZ1;ZNF626;KAT6B;ATF4;NAB2;FOXN3;NFYB;ZNF732;TERF2IP;RHOXF1;SOX13;AKAP17A;GON4L;FZD7;ZNF331;ZMIZ1;TULP3;NR3C1;FOXN4;ZNF117;ZNF37A;FOXO4;GLI4;CXXC1;SOX17;MEF2C;NFIL3;WWC2;ZNF274;ZFAT;KAT7;VSX1;ARNT2;SOX7;DAPK3;IRF2;DVL2;UBE2V1;ERC1;ZFHX3;HINFP;TFEB;ESR1;TEAD2;DENND4A;WWC3;LMX1B;ZNF423;RORB;ZFPL1;MZF1;ATXN1L;ZFP37;SPIN1;APBB2;ZNF98;SOX11;INSR;SAP30;HIC1;BAZ2A;SUFU;SMARCA2;PFDN5;MED23;ZNF431;RNF14;SOX18;EFEMP1;ZNF653;ZNF2;INS;SOX2;SOX6;MLLT6;NR1D2;SERTAD3;NFIA;HOXB1;SCRT1;IGSF1;ZNF682;RFX3;ZNF350;CREM;NFYC;LIMD1;ATF2;JMJD1C;CDK11B;ESRRB;CELSR2;SUPT3H;ZNF395;NFX1;NKX3-1;SNAI2;CDK11A;HOXD13;BNC1;ZNF502
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.45061905210624553,1.198643597770902,0.2982456140350877,0.3738664003251896,1.0,5/15,12.50%,TRIAP1;ARMC10;CD44;KDM1A;TAF9
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3886360226504237,1.197695973550597,0.2,0.37530237241126685,1.0,17/27,31.06%,RIPK2;UBE2N;IRAK2;TNFAIP3;RELA;IRAK1;AAMP;UBA52;OTULIN;NOD2;CASP8;TRAF6;NOD1;ITCH;UBC;LACC1;IKBKG
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.2797304743943902,1.1974029618827358,0.09302325581395349,0.3753336455754396,1.0,35/123,15.19%,PSMD14;CELSR1;PSMB2;PSMB9;PSMA5;PSMB3;PSME3;PSMA3;CELSR3;PSMA7;PSMD13;WNT5A;PSME2;PSMC2;PSMC4;LEF1;PSMD10;PSMD12;PSMB5;PSMD8;AP2S1;ARHGEF19;PSMB4;PSMD3;PSMB1;PSMA4;FZD10;CLTC;WNT11;PSME1;PSMF1;PSMD11;PSMD1;AP2B1;PLCB3
prerank,response to hydrogen peroxide (GO:0042542),0.327782973655299,1.1970450438531262,0.1951219512195122,0.37527852566544545,1.0,19/47,21.53%,GLRX2;TRPM2;STK26;RPS3;TNFAIP3;ECT2;PPIF;STK24;RELA;GPX1;APTX;PDCD10;MAPK13;FXN;ADAM9;FYN;NET1;PAX2;PRDX3
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.4363889583577909,1.1970014055827825,0.19148936170212766,0.3747927825146522,1.0,10/17,19.61%,DNMT1;DNMT3B;KDM1A;BRCA1;WDR5;MYB;PAXIP1;PIH1D1;CTR9;AUTS2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.4717905434137731,1.1968951289286764,0.23684210526315788,0.3745150201844263,1.0,6/15,11.36%,TRIAP1;PSMD10;BCL2L1;PPIF;GPX1;PRELID1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.3640144859461686,1.1967933018315078,0.20930232558139536,0.37406634803726263,1.0,7/27,12.39%,RNASEH1;CPSF3;POP1;LACTB2;POP7;PDE12;NHP2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.44382477353859184,1.1960811483542861,0.23728813559322035,0.3751798260669976,1.0,4/15,4.65%,ENTPD7;NUDT1;NUDT15;NUDT5
prerank,mesenchyme development (GO:0060485),-0.4560085848699929,-1.1954223427026884,0.2777777777777778,0.3918607424069373,1.0,4/15,6.32%,FOXF1;PKD2;FGFR2;CRELD1
prerank,mRNA 3'-end processing (GO:0031124),0.30802882043052204,1.1952672000120974,0.11428571428571428,0.37605008941215146,1.0,24/77,15.43%,POLR2D;CSTF2;CPSF3;ALYREF;THOC3;PABPC1;U2AF1;CSTF1;MAGOH;SLBP;MAGOHB;EIF4A3;CPSF4L;NCBP1;DDX39A;SRSF9;NUDT21;CLP1;GRSF1;NCBP2;CPSF2;THOC6;ZNF473;LEO1
prerank,peptidyl-serine modification (GO:0018209),-0.28325492162970883,-1.1952203709099793,0.11594202898550725,0.3917744521189212,1.0,60/164,24.11%,PKD1;MKNK1;DMPK;CSNK2A2;BRSK1;ULK1;PNCK;TTBK2;GALNT16;HIPK4;CSNK1E;CAMK2A;ULK2;RPS6KA5;PRKCB;PRKCA;RPS6KA2;CSNK1A1;CAMK1;PRKACA;PRKD1;HIPK3;DYRK1A;LRRK2;MAST2;MAST4;STK32B;LATS2;MAST1;MAPK1;RICTOR;MARK1;MGAT5B;MORC3;PDGFB;ROCK1;MAPK8;CAMK2D;SGK3;MAPK14;AKT2;MARK3;STK32A;CSNK1D;MAP3K10;MAP3K12;RPS6KB1;PARP2;MKNK2;MAPK12;PKN1;SMG1;TNKS;MTOR;LATS1;HIPK1;WNK1;PRKCD;PINK1;PRKCH
prerank,extracellular structure organization (GO:0043062),-0.27575488718457986,-1.1951899619898614,0.08695652173913043,0.3913258625499038,1.0,65/206,21.56%,ITGA7;JAM3;ITGA10;ADAMTSL4;FBLN5;ADAMTS10;FGF2;COL6A1;COL28A1;VIT;ADAMTSL3;LAMA2;DDR2;LAMA5;JAM2;ADAMTS8;LAMB2;NID1;RECK;COL24A1;COLQ;COL6A2;COL16A1;ITGB3;ADAMTS1;PAPLN;LAMC1;LAMA4;ADAMTSL1;SH3PXD2A;DCN;LAMB1;MFAP5;COL4A5;COL5A3;MIA;COL23A1;TNC;MMP27;APLP1;ADAMTS13;HSPG2;PDGFB;ADAMTS9;COL13A1;COL27A1;SPINK5;ADAMTS5;COL4A6;COL4A2;ELN;MMP17;COL4A3;TEX14;MMP16;PXDN;ITGA2B;MMP28;ITGA8;MADCAM1;ITGA9;COL22A1;NCAN;ADAMTS3;ADAM19
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.4071427559750435,-1.1950149608041525,0.22033898305084745,0.39124059905496916,1.0,8/20,15.71%,CAPRIN2;CUX2;OBSL1;BHLHB9;RELN;CAMK2B;IL1RAPL1;DBN1
prerank,negative regulation of JNK cascade (GO:0046329),-0.38396633850394046,-1.1943856236291246,0.2692307692307692,0.3919053589330565,1.0,10/30,23.99%,PER1;DUSP3;ZMYND11;NPPA;HIPK3;DUSP19;GPS2;MAPK8IP1;PINK1;PDCD4
prerank,endodermal cell differentiation (GO:0035987),0.35987661014122835,1.1943334020724605,0.1956521739130435,0.37744766873258395,1.0,13/31,19.78%,COL11A1;INHBA;HMGA2;FN1;MMP2;ITGA5;LAMB3;LAMA3;MMP9;LEO1;MMP15;CTR9;MMP8
prerank,regulation of ossification (GO:0030278),0.3599817590919605,1.19422345275259,0.1891891891891892,0.37703136893312983,1.0,9/34,8.43%,NOTUM;KREMEN2;WNT5A;CYP27B1;ANKH;SOX9;TGFB2;LRP4;MDK
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.27813839774939547,-1.1940403165183362,0.0625,0.3920467848354936,1.0,42/190,18.86%,TRIM39;POGZ;HNRNPDL;GDNF;NOVA1;AFF3;PEG3;PRDM6;NKAPL;STX1B;TARDBP;AFF1;PRDM2;PRDM11;MTMR9;SLC8A2;TRIM6;PHOX2B;PCBP3;RSPO1;SLC8A1;GNB3;ZNF445;PSEN1;NOVA2;ZFP36L1;MEGF8;YBX3;CGGBP1;PCBP4;PRDM5;ZNF335;HINFP;TFEB;ZNF407;TRIM34;PCBP2;AFF4;ZNF827;TOB2;ZNF462;ZNF513
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.25684264066150786,-1.194015172945516,0.09230769230769231,0.3915469940647253,1.0,148/451,23.27%,PER1;ZNF540;CIPC;MBD1;CRYAB;HDAC4;CRY2;BEND5;SCMH1;CIART;TSHZ3;ARNTL;BTAF1;NACC2;EID2B;ZNF219;USP47;TWIST2;ZBTB4;RCOR3;ZHX3;CAPN3;PHF12;MECP2;TCEAL7;PRDM11;PBXIP1;RUNX1T1;GLI3;FOXP2;UIMC1;SMAD4;CITED2;CREBZF;L3MBTL1;IKZF4;ZMYND11;PPARD;RPS6KA5;DMAP1;HDAC6;CIC;NR1D1;KAT6B;ZNF568;ING4;FOXN3;CDKN1C;RBFOX2;ZNF174;ZKSCAN3;NR2F2;EPC1;SOX13;ZFPM2;MPHOSPH8;EID1;RBPJ;RING1;ATOH8;ZBTB16;HAND1;ZNF425;PPM1F;SIRT2;NR3C1;HEY1;ARID4A;NFIL3;NR1H2;HDAC5;INPP5K;DAB2IP;KAT7;MTA3;SOX7;PRDM5;HDAC9;PRMT2;SFRP1;SFMBT2;HINFP;PHC2;TBX2;PDGFB;ARID5A;ZGPAT;GLIS2;BTRC;HEY2;THRA;TLE1;SMARCC2;ZNF423;SPEN;RORB;ZNF658;SIN3A;TNP1;TRERF1;SMAD2;SMARCA2;PFDN5;ZNF224;DPF2;HEXIM1;ZNF24;POU3F3;DKK3;PLCB1;KLF10;HHEX;MAP3K10;SMARCE1;PIAS4;MDFIC;ZBTB14;TRIM33;SOX18;HMX1;CBY1;ZNF653;SIRT1;PRICKLE1;ID3;CRY1;DPF3;PRDM16;EHMT1;TLE2;EIF4A2;LOXL3;NR1D2;KAT5;PHC1;PCGF6;ARID5B;CBFA2T2;SUMO4;ZNF639;RFX3;NIPBL;ID2;SOX8;ZNF350;BAP1;LIMD1;CHD8
prerank,defense response to symbiont (GO:0140546),0.2833071277806658,1.1938824720761847,0.11904761904761904,0.37697429752612055,1.0,28/118,15.93%,EXOSC5;IFITM3;IFITM1;SKP2;ABCE1;IFITM2;G3BP1;EXOSC4;IFI6;PMAIP1;SERINC5;BCL2L1;NT5C3A;PDE12;IFI44L;IL21;OAS2;MYD88;RELA;STAT1;APOBEC3F;NLRC5;BST2;IFIT3;OASL;ISG15;MX1;PRF1
prerank,regulation of neuroblast proliferation (GO:1902692),-0.4377917947125074,-1.1912311136605604,0.21568627450980393,0.39666095495167675,1.0,5/15,14.55%,SMARCD3;PTN;LRRK2;ZNF335;DISC1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.35546850809404884,1.1904116550366362,0.1875,0.38333323570901173,1.0,10/31,16.49%,COPZ1;COPB2;COG6;COG5;COPA;COPG1;COPG2;COPB1;VTI1A;NSF
prerank,telomere maintenance via telomerase (GO:0007004),0.37272232168040803,1.1901147180424583,0.14634146341463414,0.3833175611214192,1.0,10/28,21.69%,DKC1;GAR1;SHQ1;NOP10;PTGES3;WRAP53;NHP2;HSP90AB1;HSP90AA1;CDK2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.3505073367365447,-1.1896136308827472,0.22641509433962265,0.39945725547202304,1.0,16/52,20.09%,ATP2B4;FGFR1;FGF2;MECP2;PRKCA;PRKD1;ANGPT4;HSPB1;MEF2C;GATA2;PDGFB;MAPK14;CSNK2B;ANGPT1;AGTR2;SIRT1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.3043436246038058,1.189518088716209,0.07317073170731707,0.38396359016619336,1.0,21/81,12.17%,ENC1;CALR;CAPRIN1;PUS7;GZMB;DHFR;MRPL13;GAPDH;IGF2BP1;NCL;EIF4A3;NANOS3;IGF2BP3;RPS3;CNOT10;GRB7;IGF2BP2;EIF4E2;ORMDL3;SORL1;TRIM71
prerank,cellular response to copper ion (GO:0071280),-0.4403080279846309,-1.1891760856458935,0.25,0.3996667566055506,1.0,7/18,27.85%,SNCA;PRNP;AQP1;MT1X;MT1M;MT1A;MT3
prerank,positive regulation of T cell cytokine production (GO:0002726),0.3794500757124356,1.1888618014283763,0.20930232558139536,0.3846415039662872,1.0,11/21,30.93%,IL1B;CD55;CD81;PRKCZ;TRAF2;TNFSF4;IL18;TRAF6;NLRP3;RSAD2;XCL1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.41131740400387046,1.1888300026358873,0.21568627450980393,0.38416722865721514,1.0,10/15,29.87%,MAD2L1;FBXO5;LIMK1;DTX3L;RPL11;RPL23;RPS7;PARK7;BAG5;MAD2L2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.452924839027557,-1.187457657132871,0.32142857142857145,0.40260998437994683,1.0,9/20,19.23%,SYNGAP1;LZTR1;MFN2;SLIT2;SPRY1;DAB2IP;SPRY3;MAPKAP1;CGNL1
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.43138902858058,-1.1874041505962885,0.1935483870967742,0.40220465884397283,1.0,11/17,22.99%,SETD1B;SETD4;KMT2A;SETD2;SETD3;ASH1L;KMT2B;SETD7;EHMT1;SETD1A;SETMAR
prerank,mitotic spindle assembly (GO:0090307),0.3451942206359547,1.1870099977131547,0.1951219512195122,0.3875953593283113,1.0,17/40,22.34%,KIF2A;MZT1;RACGAP1;KIF23;CHEK2;AURKB;RAB11A;KIF3B;TPX2;KIF4B;KPNB1;SMC1A;BCCIP;WRAP73;KIF4A;MISP;KIFC1
prerank,protein localization to centrosome (GO:0071539),-0.4311812159545541,-1.1868798073269005,0.23255813953488372,0.40252844210051253,1.0,9/18,20.19%,BBS4;KIAA0753;DCTN2;PCM1;GOLGB1;CCDC14;CSNK1D;HOOK3;CEP192
prerank,protein dephosphorylation (GO:0006470),-0.2842145315666037,-1.1866293541357187,0.07017543859649122,0.402547320070576,1.0,51/138,26.12%,TNS2;PTPN21;DUSP22;PPP1R12A;PPP2R2B;PPP2R3A;PPP2R5B;PTPRS;PTPRM;PPP3CB;PPP2R5D;DUSP3;PTPRZ1;PPM1M;DUSP26;CTDSP2;NCK1;PTPN14;PPEF2;PTEN;PPM1L;PPM1F;PPP3CC;PPP2R2D;PTPN5;PPM1A;PPTC7;TAB1;PPM1B;PPP4R1;SSH1;PPP2CB;BTRC;RPRD1A;PPP1CB;CTDNEP1;EYA2;EYA4;PTPRT;PTPN12;PTPRB;LHPP;CTDSP1;SDHAF2;SBF1;ILKAP;FBXW11;MTMR7;CDC14B;RPAP2;PTPRG
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3239241389274703,1.1859653329435464,0.1388888888888889,0.38917507917591526,1.0,15/37,27.58%,CHEK1;E2F1;TFDP1;CBX3;RNF2;UXT;RBBP8;BRCA1;CDC7;SUZ12;EZH2;RBBP7;RRM2;EED;CBX5
prerank,cellular amino acid catabolic process (GO:0009063),0.2919626958097646,1.1856022092765033,0.17391304347826086,0.3896556513630305,1.0,30/84,24.57%,SHMT2;IL4I1;HSD17B10;DDAH1;GAD1;GOT2;GLS2;MCCC2;MAT1A;ALDH5A1;KMO;NOS2;SDSL;IDO1;ACMSD;ALDH4A1;KYNU;ALDH7A1;TDO2;HNMT;QDPR;HAAO;SDS;GSTZ1;ECHS1;CRYM;GLDC;GCDH;SHMT1;GLUD2
prerank,cellular response to pH (GO:0071467),-0.4048357639670221,-1.1854027711228097,0.17307692307692307,0.4048493274930821,1.0,5/18,21.47%,TRPV1;KCNK4;MCOLN1;INSRR;RAB11FIP5
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.39355796332851134,-1.183461159315341,0.22448979591836735,0.40789595674132745,1.0,10/27,17.26%,CSPG4;CHST3;B3GAT1;CHST15;DCN;XYLT1;CHST7;CHST9;CSGALNACT2;CHST12
prerank,negative regulation of calcium ion transport (GO:0051926),-0.39952181283605165,-1.1823722803146517,0.1724137931034483,0.40956526697967954,1.0,9/18,25.52%,ATP1A2;PLN;NOS1;INPP5K;PACSIN3;SLN;CAV3;CD33;EPO
prerank,intracellular pH reduction (GO:0051452),0.3538613476914445,1.1816995339324725,0.18181818181818182,0.3974469416280362,1.0,12/35,19.13%,ATP6V1C2;RAB20;ATP6V1G1;CLCN3;ATP6V0B;ATP6V1A;GPR89A;TMEM9;ATP6V1F;RAB7A;GPR89B;ATP6V0A4
prerank,chromatin assembly (GO:0031497),0.350950903544806,1.1810880115059663,0.23076923076923078,0.3984672657349213,1.0,11/36,14.44%,CHAF1B;CHAF1A;GRWD1;POLE3;SOX9;SPTY2D1;HMGB2;NOC2L;HMGA2;NPM1;LIN54
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.2548418737543688,1.1809043844179712,0.08108108108108109,0.3982276014741106,1.0,62/248,14.98%,CDH3;SOX4;NOTUM;RUVBL1;PSMD14;COL1A1;PSMB2;DKK4;PSMB9;PSMA5;LGR5;PSMB3;UBAC2;PSME3;PSMA3;RUVBL2;FOLR1;PTK7;PSMA7;KREMEN2;PSMD13;WNT5A;AXIN2;LGR6;PPP1CA;GID8;PSME2;PSMC2;PSMC4;PSMD10;PTPRO;PSMD12;SOX9;LRP4;JUP;PSMB5;MDK;BAMBI;STK4;ZNRF3;XIAP;HDAC1;PSMD8;IGFBP2;NRARP;PSMB4;GSK3B;PSMD3;PSMB1;PSMA4;MLLT3;WNT11;ZNF703;PSME1;SEMA5A;PSMF1;PSMD11;PSMD1;IGFBP1;GSKIP;VCP;TMEM9
prerank,inflammatory response (GO:0006954),0.25788735339298724,1.1807940706454791,0.07894736842105263,0.39782134030908956,1.0,94/217,31.73%,CEBPB;IL1A;CXCL5;CCL24;CXCL8;CXCL3;RIPK2;CXCL1;IL1RN;CXCL11;CXCL2;IL1B;CCL20;PRDX5;OLR1;CD44;CCL22;ADCY1;PF4;HYAL3;CXCR4;PARP4;CYBA;CCL4;CCL3;NOX1;RELA;CCRL2;NOS2;MAPKAPK2;CXCL9;VNN1;HNRNPA0;CCL26;FOS;FUT7;CXCL10;CXCL6;CXCR2;FPR3;ABCF1;FPR2;ADAM8;CCR3;F2R;CCL17;PIK3CG;TGFB1;PF4V1;IL36B;PLA2G2D;PROK2;TNFSF4;CHI3L1;F11R;LY75;CXCL13;HMGB1;ELF3;CYBB;ADGRE5;IL36RN;NFAM1;NAIP;THBS1;IL2RA;TRAF3IP2;CCL1;IL36G;ANXA1;TNFRSF4;ITGB2;IL37;IFNG;XCR1;IL18;CCL7;PIK3CD;MMP25;NCR3;PTGIR;NOD1;NLRP3;TAC4;ITCH;XCL1;IKBKG;IL22;IL17D;XCL2;TNF;CCL5;IKBKB;FPR1
prerank,positive regulation of filopodium assembly (GO:0051491),-0.41427073559376604,-1.1804895023099355,0.23404255319148937,0.41284620458294563,1.0,11/24,20.98%,PALM;TENM1;PIK3R1;NLGN1;GPM6A;RHOQ;DPYSL3;DOCK11;CCL21;TENM2;BCAS3
prerank,histone ubiquitination (GO:0016574),0.3894057550008432,1.1803388380617827,0.175,0.3983018022491723,1.0,8/21,18.64%,UBE2N;RNF40;UHRF1;DTX3L;LEO1;UBE2A;RAG1;CTR9
prerank,regulation of gluconeogenesis (GO:0006111),-0.3993632850572174,-1.1802900217654533,0.21428571428571427,0.4126272082698984,1.0,12/25,25.07%,CLK2;GCK;ZNF692;SOGA1;C1QTNF3;OGT;PDK2;SIRT1;INS;CRY1;NNMT;MST1
prerank,regulation of TOR signaling (GO:0032006),-0.3245578325404507,-1.1798894811486014,0.15789473684210525,0.4129329928991733,1.0,22/67,21.63%,FLCN;EPM2A;TSC1;FBXO9;ARNTL;RRAGC;TNFAIP8L1;PRKAA2;UBR2;GNA12;RRAGB;RICTOR;WDR59;UBR1;FAM83D;TSC2;DEPDC5;RRAGD;GSK3A;SIRT1;TBCK;RPTOR
prerank,protein mannosylation (GO:0035268),-0.42163958629641907,-1.1791698495850436,0.21818181818181817,0.41381367024746163,1.0,7/18,9.64%,TMTC1;POMT2;DPY19L2;FKRP;POMT1;TMTC2;B4GAT1
prerank,positive regulation of JNK cascade (GO:0046330),-0.32592328832075895,-1.1787258956038844,0.23728813559322035,0.4141430455377683,1.0,25/72,23.62%,DUSP22;MTURN;TRAF1;PJA2;TLR9;ANKRD6;FZD7;FLT4;TAOK2;DAB2IP;GADD45B;MAP4K2;SH3RF3;DUSP19;SEMA3A;WNT16;MAPK8IP1;PLCB1;RASSF2;EDA2R;MAP3K10;CCL21;TIRAP;GADD45G;RIPK1
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.38942362218686183,-1.1786275877502974,0.22641509433962265,0.4137016308650038,1.0,7/27,13.19%,MEIS2;DUSP3;TAL1;PRKCA;USP2;CCDC57;ASNS
prerank,carboxylic acid transport (GO:0046942),0.32112507165850035,1.177244982675844,0.21052631578947367,0.40428583060214046,1.0,10/55,7.30%,SLC6A20;SLC1A5;SLC1A4;SLC6A14;SLC7A1;SLC38A5;SLC7A5;SLC16A13;SLC6A6;SLC16A3
prerank,miRNA metabolic process (GO:0010586),0.4196575162590621,1.1762908750872536,0.2558139534883721,0.40577107655086775,1.0,6/17,12.17%,RAN;SND1;XPO5;KHSRP;TARBP2;TRIM71
prerank,negative regulation of protein secretion (GO:0050709),0.3428060226742459,1.1753087249250285,0.16666666666666666,0.40736824119123294,1.0,10/37,16.16%,BMP8A;CYP51A1;IRS1;IL1B;RAB11FIP1;RHBDF2;ERP29;DRD2;KCNJ11;F2R
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3738844088383817,1.1745749305624527,0.17777777777777778,0.4081966886475962,1.0,11/24,23.68%,NUDT19;CYP2W1;ACBD5;CEL;ACOT8;CYP4F3;CYP4F11;PLA2G15;FAAH;CYP26A1;CYP4F2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.3307156093885901,-1.1745730306628184,0.19642857142857142,0.4218482725367867,1.0,9/45,8.40%,RBPMS2;IL6R;BMPR1A;FGF2;MEF2D;FOXJ2;ADAMTS1;ELANE;MFN2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.295865465757346,1.1739528558086094,0.15555555555555556,0.4087573356036475,1.0,23/81,15.70%,CCND1;CDKN3;TFAP4;CDK7;GTPBP4;BLM;CCNO;CCNE1;CCNI2;CDC25C;PSMD10;CCNK;PROX1;PSRC1;CDKN2A;CEBPA;CCNF;CCNJ;PKMYT1;CDK5RAP1;PLK1;CDC25A;BCCIP
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.29958877890120367,-1.1739165088568213,0.19672131147540983,0.4226333613290364,1.0,34/76,27.53%,FGFR1;FGF2;GAB1;MYOC;PDGFRA;ROR2;GPER1;PIK3R1;GH1;NTRK3;KIT;DCN;NTRK1;ROR1;EPOR;PDGFB;NTF3;CBL;WNT16;INSR;PLXNB1;SIRT1;INS;PDGFD;HGF;FLT1;NKX3-1;PDGFA;EPO;HCLS1;SELP;F2RL1;PIK3R5;FSHR
prerank,endomembrane system organization (GO:0010256),-0.2830546054337493,-1.173515012674759,0.15517241379310345,0.4229224921456042,1.0,59/190,19.74%,RNF112;SEC31B;DMPK;SYNGR1;TJAP1;TBC1D20;SYNE1;ANK3;SUN1;ATP8B2;SNX33;GOLGA8A;DYNC2H1;SUN2;LMAN1L;PLEKHM2;CLASP1;A4GALT;CSNK1A1;DNAJC13;SYP;PRKD1;OBSL1;CAV2;CLASP2;LRRK2;HACE1;ARHGAP21;GOLGA8B;OPTN;VPS33B;GOLGA8N;DYSF;AKTIP;RAB30;ATL3;GORASP1;ATL2;PI4K2A;ATL1;SEC16B;GBF1;ARHGEF7;TICAM2;COG1;DYM;VPS11;GOLGB1;VPS4A;VAPA;CSNK1D;TRAPPC8;ALS2;HOOK3;PLEKHF1;GOLGA8R;CTDNEP1;ATP8B3;DNM1
prerank,regulation of anoikis (GO:2000209),0.40097640252632505,1.1731555921744026,0.275,0.4098295302051092,1.0,8/19,21.78%,PTRH2;CEACAM6;BRMS1;CEACAM5;ITGA5;CAV1;MCL1;NOTCH1
prerank,glycoprotein biosynthetic process (GO:0009101),0.29473550600937265,1.17186549496502,0.20512820512820512,0.4118242402249824,1.0,22/81,15.71%,ALG1;PMM2;ALG5;B3GNT4;SERP1;DDOST;FUT1;ALG3;B3GNT2;GCNT1;ALG1L2;B3GALNT2;CANT1;DAD1;B3GALT6;B4GALT7;ST8SIA6;FUT7;FUT2;B3GNT3;B3GNT5;FUT10
prerank,gene silencing by miRNA (GO:0035195),-0.3819443332115443,-1.171760301168326,0.22413793103448276,0.42601344547004577,1.0,13/31,18.93%,TNRC6A;ZC3H7A;AGO4;WTIP;RBM4;TNRC6C;DICER1;NOTCH4;AGO3;PRKRA;ZFP36;TNRC6B;AGO1
prerank,positive regulation of response to stimulus (GO:0048584),0.3310747767210652,1.171034731787506,0.20833333333333334,0.41295462349599166,1.0,11/44,16.94%,MYC;HMGA1;WNT5A;CDKN2A;TGFB2;DHX9;HMGA2;CD80;TAF9;NSMCE1;HOMER1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.34864048545431936,-1.1706170266405327,0.18032786885245902,0.4278259461895213,1.0,18/41,20.10%,TNS2;SORBS1;GKAP1;PRKCB;NCK1;PIP4K2B;GRB10;PID1;INPP5K;GRB14;OGT;PIP4K2A;KANK1;TSC2;RPS6KB1;GSK3A;SIRT1;INS
prerank,apoptotic mitochondrial changes (GO:0008637),0.3617894986318087,1.1701052408194488,0.2608695652173913,0.4143782795136804,1.0,13/33,20.48%,HSPD1;ATG3;IFI6;VPS35;BBC3;TIMM50;BCL2L1;GGCT;BIK;BAX;BID;SFN;BAK1
prerank,peptidyl-tyrosine modification (GO:0018212),-0.3086613559427897,-1.1701030135992572,0.17857142857142858,0.42839124358470365,1.0,20/56,19.84%,FGFR1;DDR2;PDGFRA;FGFR2;FES;KIT;DYRK1A;FLT4;FER;NTRK1;ABI2;EPHA4;RELN;EPHA3;PDGFB;TPST1;INSR;EGFR;ERBB4;EFEMP1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.40834625524115864,1.1700697292429234,0.22916666666666666,0.41382284994780294,1.0,8/16,27.29%,COX6B1;COX7A2L;CYCS;COX4I1;COX5B;COX7B;COX5A;NDUFA4
prerank,potassium ion import across plasma membrane (GO:1990573),-0.3351764326020228,-1.169867667127935,0.15254237288135594,0.42833476520248237,1.0,10/42,12.33%,ATP1B2;ATP1A2;SLC12A4;FXYD2;KCNH2;ATP1A4;KCNE2;ATP1A3;ABCC9;KCNJ8
prerank,regulation of G0 to G1 transition (GO:0070316),0.3187451440454385,1.1696437411210174,0.18421052631578946,0.414172852711853,1.0,9/40,13.13%,CHEK1;E2F1;TFDP1;CBX3;RHNO1;RNF2;UXT;RBBP8;BRCA1
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.449697896556964,-1.1692128715880048,0.25,0.429349366489346,1.0,4/15,19.50%,PYGM;CALM1;AGL;PHKA2
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.4310143560767775,1.1691015571958687,0.17777777777777778,0.4145054015217977,1.0,6/17,24.05%,RAN;ERLIN1;KPNB1;ERLIN2;MBTPS2;ABCG1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.4122197251893365,-1.1687172830011145,0.25862068965517243,0.4297555577701649,1.0,9/20,18.29%,TGFBR3;BMPR1A;FGF2;FGFR2;ZFPM2;RBPJ;MEF2C;TBX2;ERBB4
prerank,regulation of cilium assembly (GO:1902017),-0.31733871268883024,-1.1685220525057776,0.15254237288135594,0.4294658140170401,1.0,23/61,24.51%,TBC1D1;TBC1D17;RABGAP1;TAPT1;TBC1D10A;TBC1D20;BBS4;CROCC;EVI5L;TBC1D2B;TBC1D13;TCHP;MARK4;CCDC88A;SGSM3;FUZ;ODF2L;TESK1;CEP97;CEP120;TBC1D24;CDKL5;ARHGAP35
prerank,organic anion transport (GO:0015711),0.280810727606435,1.1683362546280287,0.13636363636363635,0.41537760057761713,1.0,25/92,19.32%,LRRC8E;CA9;SLC22A11;SLC35A2;SLC4A11;SLC35B2;SLC52A2;ABCC11;SLC19A1;LRRC8D;SLCO1B3;SLC39A8;SLC52A3;AQP9;SLC25A19;SLCO4A1;SLC25A17;CYB5R2;SLC25A24;SLC35C2;SLCO1C1;CA6;CYB5R4;SLC9A3R1;CFTR
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4150595097856371,1.1681639574535045,0.19607843137254902,0.4149875797969605,1.0,3/15,12.25%,USP50;MYD88;GBP5
prerank,histone lysine demethylation (GO:0070076),-0.3820231348145708,-1.1675665259853425,0.24528301886792453,0.431129899554608,1.0,15/24,35.41%,PHF2;KDM2A;KDM3A;KDM4B;KDM5D;KDM6B;JMJD1C;KDM4E;UTY;KDM4A;PHF8;KDM4C;KDM3B;KDM5B;KDM6A
prerank,lytic vacuole organization (GO:0080171),-0.38299096319033954,-1.1671274700922174,0.24,0.4315190944170928,1.0,13/31,26.17%,TPCN2;ABCA1;ZKSCAN3;LRRK2;AKTIP;CLVS2;TFEB;HOOK3;SNAPIN;MTOR;TPP1;CLN3;HPS1
prerank,natural killer cell activation involved in immune response (GO:0002323),-0.4104785376051465,-1.1670626566488096,0.22033898305084745,0.43104872555233636,1.0,1/20,0.20%,VAMP2
prerank,protein localization to microtubule organizing center (GO:1905508),-0.4093102737732865,-1.166650162881837,0.2916666666666667,0.43127061390300847,1.0,8/16,20.19%,BBS4;KIAA0753;DCTN2;PCM1;CCDC14;CSNK1D;HOOK3;CEP192
prerank,maintenance of blood-brain barrier (GO:0035633),-0.37071125230320173,-1.166605909943971,0.21052631578947367,0.43075077887099417,1.0,8/29,7.91%,JAM3;VCL;DMD;LAMA2;JAM2;WNK3;CLDN5;LAMC1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2618477283616193,1.1665677970525627,0.11363636363636363,0.4176205763506908,1.0,36/125,18.63%,SOX4;MYC;IRS1;EREG;PDGFRB;EIF3C;IL1B;NAT10;EIF4A3;PRKDC;YTHDF1;TGFB2;DNA2;RPS4X;EIF6;DHX9;ATAD5;XBP1;NOX1;FGFR4;NMD3;PRMT1;EIF3D;NLRC5;ELAVL1;NPM1;CDT1;KDR;LARP4B;RBM3;NSUN5;HSPH1;EIF3E;NPM2;NOD2;MTPN
prerank,external encapsulating structure organization (GO:0045229),-0.27140621704711826,-1.1658171001553592,0.1044776119402985,0.4315849507244745,1.0,67/207,22.64%,ITGA7;JAM3;ITGA10;ADAMTSL4;FBLN5;ADAMTS10;FGF2;COL6A1;COL28A1;VIT;ADAMTSL3;LAMA2;DDR2;LAMA5;JAM2;ADAMTS8;LAMB2;NID1;RECK;COL24A1;COLQ;COL6A2;COL16A1;ITGB3;ADAMTS1;PAPLN;LAMC1;LAMA4;ADAMTSL1;SH3PXD2A;DCN;LAMB1;MFAP5;COL4A5;COL5A3;MIA;COL23A1;TNC;MMP27;APLP1;ADAMTS13;HSPG2;PDGFB;ADAMTS9;COL13A1;COL27A1;SPINK5;ADAMTS5;COL4A6;COL4A2;ELN;MMP17;COL4A3;MMP16;PXDN;ITGA2B;MMP28;ITGA8;MADCAM1;ITGA9;COL22A1;NCAN;ADAMTS3;ADAM19;TGM1;ECM2;MMP19
prerank,epidermis development (GO:0008544),0.2837798808140385,1.1655690682260533,0.17777777777777778,0.4192182126540284,1.0,23/69,22.70%,GRHL3;LAMC2;KLK7;GJB5;HDAC2;CDSN;ATP2C1;RBP2;EDAR;HDAC1;LAMB3;EVPL;LAMA3;GRHL2;GATA6;DSP;OVOL3;SCEL;OVOL1;KRT15;OVOL2;KRT83;KRT32
prerank,muscle cell development (GO:0055001),-0.3582068312303168,-1.164823466470759,0.1694915254237288,0.4332323415724799,1.0,13/33,23.07%,ANK2;MYH6;DMD;TCAP;MEGF10;SLC8A1;EFEMP2;DYSF;HEY2;ALPK3;TTN;CAV3;RAMP2
prerank,regulation of filopodium assembly (GO:0051489),-0.34674750618619093,-1.164339540357563,0.23214285714285715,0.4335517992687709,1.0,15/38,20.98%,PALM;TENM1;PIK3R1;NLGN1;FXR2;GAP43;GPM6A;RHOQ;DPYSL3;SRGAP2C;DOCK11;CAPZB;CCL21;TENM2;BCAS3
prerank,positive regulation of cell motility (GO:2000147),0.25174658836086816,1.1641422310453928,0.07894736842105263,0.42193483459744063,1.0,49/209,15.41%,CLDN1;MMP7;CEMIP;TDGF1;COL1A1;LAMC2;MGAT5;CCL24;PDGFRB;EPHB2;PLAU;GTSE1;CFAP20;DUOXA2;EPHA1;IL1B;LGR6;CEACAM6;LEF1;CTSH;ACTG1;FAM83H;GRB7;MDK;DUOX2;MAZ;CCL3;XBP1;F7;CPNE3;ADAM10;IGF1R;SEMA4D;PECAM1;CXCL16;ACTN4;WNT11;CCL26;ZNF703;SEMA5A;CIB1;MMP9;KDR;MIEN1;GRN;PAK1;PDCD10;SMIM22;RHOD
prerank,Wnt signaling pathway (GO:0016055),-0.29839576985306493,-1.1640374101062665,0.2037037037037037,0.43360352173048033,1.0,26/91,18.88%,TCF7L1;WNT9A;DIXDC1;SFRP5;FZD4;FERMT2;CSNK1E;NXN;DVL3;WNT6;CSNK1A1;WNT5B;FZD7;SKP1;PTEN;LRRK2;WLS;WNT2B;DVL2;SFRP1;BTRC;APC;FZD8;WNT16;UBB;ZRANB1
prerank,actin filament bundle organization (GO:0061572),-0.36258307501190834,-1.1639941664914162,0.20754716981132076,0.4330967424424569,1.0,9/31,19.40%,FAM107A;ADD1;CALD1;LIMA1;DPYSL3;ADD2;BAIAP2;FSCN3;AIF1L
prerank,extracellular matrix organization (GO:0030198),-0.2560226732481402,-1.1636700297866913,0.13043478260869565,0.4331109294707295,1.0,86/284,21.56%,ITGA7;JAM3;GPM6B;ITGA10;ADAMTSL4;DPT;FBLN5;COL21A1;ADAMTS10;GSN;FGF2;LOXL4;COL6A1;COL28A1;VIT;ADAMTSL3;LAMA2;DDR2;LAMA5;JAM2;ADAMTS8;LAMB2;NID1;RECK;COL24A1;COLQ;COL6A2;COL16A1;ITGB3;ADAMTS1;PAPLN;ELANE;LAMC1;CRTAP;LAMA4;ADAMTSL1;SH3PXD2A;DCN;LAMB1;P3H2;CTRB2;TIMP2;DST;MFAP5;CTRB1;BMP1;TLL1;SCUBE1;COL4A5;COL5A3;MIA;COL23A1;OPTC;TNC;MMP27;APLP1;ADAMTS13;HSPG2;PDGFB;ADAMTS9;COL13A1;COL27A1;SPINK5;ADAMTS5;COL4A6;COL4A2;ELN;MMP17;FLRT2;COL4A3;MMP16;COL25A1;SCUBE3;HTRA1;COLGALT2;PXDN;ITGA2B;MMP28;ITGA8;MADCAM1;ITGA9;LOXL3;COL22A1;NCAN;ADAMTS3;ADAM19
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.44967608941225157,-1.1636470097220557,0.24193548387096775,0.43254293727773613,1.0,7/15,13.82%,KCNA5;KCNIP2;KCNH2;KCNE2;KCNJ8;KCND3;KCNE1
prerank,cellular transition metal ion homeostasis (GO:0046916),0.267351932523976,1.163387895288725,0.13636363636363635,0.42293592221557186,1.0,26/90,19.51%,MYC;TFR2;SLC31A1;SLC39A10;LCN2;GLRX3;ATP6V1G1;FRRS1;HMOX2;ATP13A2;SLC40A1;HEPHL1;SLC39A8;ATP6V1A;SLC11A2;ATP7B;SLC30A5;ATP6AP1;SLC30A9;FTL;ATOX1;SLC39A7;SLC30A1;FXN;COX19;LCK
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.2968071848327821,-1.1633785150247429,0.21568627450980393,0.4324188260486731,1.0,25/79,22.24%,CLIP3;SORBS1;ATP2B4;WNK3;GPER1;PIK3R1;ZDHHC7;RHOQ;CNPY4;AR;STAC2;STAC;NUMB;VTI1B;PID1;LGALS3;TMBIM1;EPHA3;VPS4A;EGFR;RAMP3;AP2M1;INS;ACTB;STX7
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.3806681403624603,-1.1623383503116922,0.203125,0.43393573815365216,1.0,9/22,21.13%,SASH1;DVL3;TLR9;MAP3K4;DAB2IP;DVL2;DUSP19;MAP3K10;MAP3K7
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.39196588382875097,1.1623281428096044,0.27906976744186046,0.42427503987793286,1.0,11/24,29.67%,SERPINB1;TNFAIP3;CARD17;LILRB4;GIT1;ZC3H12A;CARD16;GSTP1;FFAR4;PYDC1;NLRP3
prerank,bile acid biosynthetic process (GO:0006699),0.35889565590812855,1.1620728572017671,0.21818181818181817,0.4242644625829842,1.0,12/25,24.07%,HSD17B10;AKR1C4;OSBPL3;BAAT;CYP39A1;CYP7B1;HSD3B7;ACOT8;SLC27A5;HSD17B4;OSBPL2;OSBP
prerank,glutathione metabolic process (GO:0006749),0.33685444215254,1.1620648064067032,0.20833333333333334,0.42365489359653186,1.0,13/40,17.15%,DPEP1;MMACHC;GLRX2;MGST2;GSS;CHAC2;CHAC1;GGCT;GPX1;GCLM;GSR;CNDP2;G6PD
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.32283267762452555,-1.1619131319372902,0.15789473684210525,0.43437721978237503,1.0,14/51,18.80%,CLIP3;SORBS1;ATP2B4;WNK3;CNST;GPER1;PIK3R1;CNPY4;STAC2;STAC;LGALS3;EPHA3;EGFR;RAMP3
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.288804574241627,-1.1618049343532038,0.1320754716981132,0.43402456413084967,1.0,37/133,23.74%,GLP2R;ADCY5;PTH1R;ADCYAP1R1;ADCY2;ADRB3;ADCY4;POMC;VIPR2;ADRB2;ADCY9;PRKACA;GNG2;RAMP1;ADORA2A;PRKAR2B;VIP;MC1R;GPR20;AVPR2;ADRB1;ADCY6;TSHB;MAPK14;HTR4;CRHR1;GPR27;RAMP3;P2RY11;GPBAR1;LHCGR;HTR7;CRHR2;PLCG1;RAMP2;PLCG2;ADCYAP1
prerank,peptidyl-lysine modification (GO:0018205),0.28066989964845557,1.1615878084743092,0.10416666666666667,0.4240170779592321,1.0,31/99,18.40%,NUP37;LIPT2;NUP155;LOXL2;RAE1;RNF113A;NUP93;NUP35;PLOD3;HDAC10;SEH1L;NUP210;NUP43;P3H4;NUP50;NUP88;RANGAP1;NUP107;RNF212B;METTL21A;UBA2;NUP205;NSMCE2;CTH;NUP62;NUP160;NDUFAB1;EYA1;SUMO1;NDC1;SUMO3
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.2923433655297792,-1.1613946828152333,0.19298245614035087,0.4345150001377174,1.0,33/88,25.48%,DUSP22;TGFBR3;BMPR1A;FERMT2;GCNT2;PXN;WFIKKN2;SMAD4;CLDN5;PARD3;ZMIZ1;ARHGEF18;SKI;RHOA;USP9Y;GDF5;SMAD9;CBL;ZFYVE9;SMAD2;USP15;LRRC32;HPGD;UBB;SIRT1;MAP3K7;SMAD7;CDH5;TWSG1;TGFB3;AMHR2;SMAD3;FNTA
prerank,receptor signaling pathway via STAT (GO:0097696),-0.37526419937628835,-1.1613262441136643,0.18181818181818182,0.43407525118578205,1.0,12/25,27.44%,PKD1;PKD2;SOCS2;GHR;THPO;IFNAR1;CLCF1;CCL2;PIAS1;STAT4;IL31RA;STAT6
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.4227952609601794,-1.1603610534360114,0.25,0.43562976474464044,1.0,4/18,9.34%,IL6R;PTN;ZNF580;SLIT2
prerank,regulation of cellular protein localization (GO:1903827),-0.33076102161287646,-1.1597672389935085,0.24,0.43632883873842254,1.0,18/46,22.67%,MAPT;MAP1A;CSNK1E;DVL3;CCDC66;MAP2;PRKAA2;PPM1F;SETD2;NDEL1;GBF1;GPC1;TRIM67;TRIM46;RAB11FIP5;GPC6;SUMO4;PIN1
prerank,response to peptide hormone (GO:0043434),-0.337164297844417,-1.1596442322820393,0.22641509433962265,0.4360259326355746,1.0,16/50,20.36%,TSC1;TGFBR3;GPER1;GNAI1;EPM2AIP1;CYP11B1;ZFP36L1;SLC27A1;CYP11A1;CELA2A;OGT;IGFBP5;ROCK1;EIF2B4;SIRT1;CRY1
prerank,regulation of defense response to virus by host (GO:0050691),0.3510205196317897,1.1588851412331544,0.21153846153846154,0.4293177074695688,1.0,14/33,25.70%,IL23A;TNFAIP3;DHX9;TARBP2;DTX3L;STAT1;APOBEC3F;MICB;IL23R;HSP90AA1;ZC3H12A;IL12B;IL12RB1;TRAF3IP2
prerank,negative regulation of MAPK cascade (GO:0043409),-0.30473539264157956,-1.15882989010168,0.16363636363636364,0.43707213971627457,1.0,23/90,13.93%,FLCN;LMO3;RGS2;SMAD4;DUSP3;GPER1;DUSP26;P2RX7;UCHL1;CNKSR3;PPEF2;PTEN;EMILIN1;SPRY1;PRDM15;FBLN1;SYNJ2BP;INPP5K;TIMP3;DAB2IP;RANBP9;SPRY3;SEMA6A
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.35768266139314825,-1.158794880899766,0.2765957446808511,0.43653216821486407,1.0,12/30,24.33%,CLIP3;SORBS1;PIK3R1;GH1;RHOQ;BRAF;AKT2;INSR;INS;NR4A3;CLTCL1;OCLN
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.4121389920295258,-1.1587728501111612,0.22916666666666666,0.4360061027205904,1.0,6/18,14.52%,MAPKBP1;TLR9;ELANE;SSC5D;OTUD7B;MAP2K5
prerank,signal transduction by p53 class mediator (GO:0072331),0.3489568237081742,1.158720894413142,0.25,0.429074128683917,1.0,15/33,26.58%,TRIAP1;PMAIP1;USP10;BATF;POU4F1;MYO6;ACER2;HINT1;PAXIP1;IFI16;E2F7;TP53;MAGEA2;FHIT;MYBBP1A
prerank,regulation of histone acetylation (GO:0035065),-0.35665180851275835,-1.1580600899461062,0.24528301886792453,0.4368491714163489,1.0,12/33,14.59%,FLCN;MYOCD;RAPGEF3;RPS6KA5;SNCA;SETD5;KMT2A;CAMK1;NOS1;HDAC5;MAPK3;TADA2B
prerank,glycolytic process (GO:0006096),0.37556694179326844,1.157881767534222,0.28205128205128205,0.43024761127243955,1.0,13/28,25.23%,PGAM4;GAPDH;LDHA;HKDC1;TPI1;ENO4;GAPDHS;PKLR;PKM;ALDOC;ALDOB;PFKL;PGAM1
prerank,regulation of mitochondrion organization (GO:0010821),-0.3456286702329558,-1.1578577013281093,0.2765957446808511,0.43672144084836007,1.0,18/43,26.85%,PDE2A;FLCN;CSNK2A2;MAPT;HDAC6;LRRK2;PID1;MGARP;RHOT2;PISD;FBXW7;PARL;GSK3A;MUL1;PINK1;MFF;DNM1L;GOLPH3
prerank,regulation of interleukin-12 production (GO:0032655),0.3267975698816442,1.1577747673062584,0.25,0.4297944575040347,1.0,23/51,30.41%,HSPD1;RIPK2;IL23A;C1QBP;SYK;MDK;IL17A;JAK3;IL23R;TNFSF4;HMGB1;IL12B;LTB;CD47;THBS1;TIGIT;IFNG;CLEC7A;IRAK3;IL10;PIBF1;TLR8;SCIMP
prerank,regulation of calcium ion import (GO:0090279),-0.3979177330539081,-1.157509506660831,0.22388059701492538,0.4368792628842233,1.0,11/24,22.87%,PKD2;WNK3;GRM6;PLN;PRNP;LGALS3;PSEN2;PDGFB;CCL2;SLN;CAV3
prerank,"phagocytosis, engulfment (GO:0006911)",-0.33847250865324663,-1.157378620597603,0.21311475409836064,0.43670229922306697,1.0,10/36,21.18%,GSN;XKR4;ADGRB1;MEGF10;DOCK1;RAC1;GULP1;ELMO1;CD36;RHOBTB1
prerank,regulation of intracellular signal transduction (GO:1902531),-0.2453954120972415,-1.157353174957475,0.09722222222222222,0.436154792721936,1.0,135/424,23.29%,ARHGEF26;PDE2A;INPP5B;FLCN;ARHGAP10;PRKAB2;PIP5K1C;FBXO9;CSNK2A2;ARHGEF17;AKAP6;TRIP10;ARHGAP33;MAPT;STARD13;CHD3;CAPN3;PPP2R5B;ARHGEF9;PRDM11;MYOC;RRAGC;SYDE1;AKAP12;RASD2;L3MBTL1;TRIM6;GNAI1;TRAF1;JMY;PLEKHG2;NTRK3;MYO9A;FAM13B;NLGN1;ARHGAP6;ARHGAP20;ITSN1;ARHGEF6;DLC1;PJA2;STARD8;OBSCN;RHOQ;RHOJ;MYO9B;RHOB;PIP4K2B;SRGAP2;PTEN;CARD8;PRKAG2;LRRK2;PRKAA2;ARHGAP21;MDM4;ARHGAP19;USP2;ARHGEF18;OPTN;RRAS;ARHGEF11;SYDE2;PRKAR2B;NTRK1;TAOK2;OPHN1;ARHGAP23;FGD1;ARHGAP24;HSPB1;WWC2;FBXL2;DAB2IP;MAPK1;TIAM1;MAPK3;GNA12;MAPK11;RRAGB;RIT2;RICTOR;RGN;RAC1;RHOA;SOS2;FAM83D;ARHGAP29;ARHGEF7;PIP4K2A;PIDD1;TP53INP1;MAPKAP1;WWC3;TAF3;ARHGAP31;MCF2;RAD50;TRIO;SOS1;RHOT2;MAPK14;FGF1;NRK;PEX5L;EGFR;CSNK2B;RASSF2;ANKRD54;FGD2;ARHGAP5;SRGAP1;ING5;AKAP13;MAP2K6;EHMT1;ZNF385A;TBCK;KAT5;GRM2;PIK3R2;PAK3;SUMO4;ARHGEF3;MBD3;PIN1;TMBIM4;SLC15A2;MTOR;ARHGDIG;NUAK1;ARHGAP28;RHOU;HIPK1;PLCG2
prerank,'de novo' posttranslational protein folding (GO:0051084),0.35089616213771274,1.15726001117911,0.29411764705882354,0.4303696874384251,1.0,11/30,20.26%,CCT2;ERO1A;UGGT1;HSPA14;HSPA9;PTGES3;DNAJC7;SDF2L1;HSPA5;HSPA13;SDF2
prerank,protein modification process (GO:0036211),0.308548919913292,1.1571816404913462,0.21428571428571427,0.42986960543945935,1.0,26/76,25.51%,RPN1;RPN2;ERO1A;SERP1;UBE2S;LOXL2;ATG3;PRKDC;PARP4;ABL2;SEPHS1;B4GALT7;LCMT1;UBL5;UBA52;MANBA;MMP15;UBE2L6;YES1;MCRS1;UBE2D2;WWP2;UBL4A;CSNK1G3;ICMT;PPP4R2
prerank,cellular response to glucose starvation (GO:0042149),-0.3327025505401187,-1.1569057649721861,0.22807017543859648,0.43679441614742104,1.0,10/42,13.19%,NIM1K;SZT2;BRSK1;ATG14;ATF4;PRKAG2;PRKAA2;RRP8;PIK3C3;ASNS
prerank,mitochondrion disassembly (GO:0061726),-0.35301075850130925,-1.156716375985409,0.2631578947368421,0.4367046139519118,1.0,7/35,6.17%,GABARAPL1;ULK1;ATG2B;ATG9A;WDR45;ULK2;MAP1LC3C
prerank,calcium-mediated signaling (GO:0019722),-0.2858152944349438,-1.1559251536559705,0.23728813559322035,0.4375635181629821,1.0,34/101,23.29%,TPCN2;DMPK;CACNA1C;ANK2;PPP3CB;PLA2G4B;AGTR1;RCAN2;P2RX7;SLC8A1;PRNP;PRKACA;CCR10;LRRK2;PPP3CC;RYR2;PPP1R9A;PLCE1;P2RY12;ACKR3;HTR2B;EDNRB;AZU1;ACKR2;EGFR;P2RY11;ADGRL1;CAMKK2;CHRM3;PTGFR;PTGDR2;RCAN1;PLCG1;PLCG2
prerank,positive regulation of cell communication (GO:0010647),-0.38144942316378233,-1.1554304223271685,0.2413793103448276,0.43812490259848824,1.0,12/27,23.91%,LGI1;ANK3;ILK;DLG4;GRIK2;RIMS3;WLS;CARTPT;SOX11;RIMS1;SYT1;CLSTN2
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.38413684629450945,-1.1553039427873797,0.2413793103448276,0.437873984491183,1.0,9/23,19.49%,APOD;GDI1;LRRK2;RAB23;INPP5K;KCNE1;SUFU;CABP1;MDFIC
prerank,positive regulation of cell adhesion (GO:0045785),-0.3054792115883197,-1.154891392767229,0.15,0.43815128597325864,1.0,27/78,22.82%,FLCN;TPM1;VIT;CHRD;CITED2;TFE3;DUSP26;MEGF10;PRKCA;FSTL3;PPM1F;NCKAP1L;MAGI1;EPHA4;P2RY12;ARL2;RAC1;ZFHX3;PDGFB;AZU1;RET;CCL21;SMAD7;FBLN2;ECM2;IL12A;RSU1
prerank,negative regulation of hydrolase activity (GO:0051346),-0.3223061273944015,-1.1545481479906692,0.27450980392156865,0.43835433747029356,1.0,15/53,13.84%,PLXNB3;MAPK7;CAMK2A;GPSM1;PLIN5;PTX3;CPEB2;NOS1;SERPINA5;MAP2;EGLN1;LRRK2;RDX;DAB2IP;ARL2
prerank,wound healing (GO:0042060),-0.3046965232984144,-1.1545153136966428,0.22807017543859648,0.43783491658816587,1.0,17/65,13.20%,CFLAR;RAF1;TPM1;FGF2;MACF1;PDGFRA;SRF;ITGB3;SYT11;AHNAK2;FZD7;ANXA6;DST;DYSF;SYTL4;MYOZ1;RAB3A
prerank,glycerophospholipid metabolic process (GO:0006650),0.28842960279041746,1.1542388384734903,0.20754716981132076,0.435659376564347,1.0,27/73,21.47%,CPNE7;PIGM;DPM2;PDGFRB;SERINC5;ABHD12;GDPD1;PIGW;PDXP;CPNE3;PLA2G7;PNPLA3;ACP6;PLA2G4E;PLA2G3;PIGF;PLA2G4D;PLCB3;PIGA;CPNE1;PLEK;PLA2G2D;CETP;PIGN;PIGX;PGP;PLA2G15
prerank,regulation of fibroblast proliferation (GO:0048145),0.3164500744347978,1.154147052332984,0.21428571428571427,0.4352489170013087,1.0,11/46,13.23%,MYC;E2F1;WNT2;EREG;WNT5A;CDK4;S100A6;DHX9;FN1;B4GALT7;AGT
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3253314175418245,-1.1541170737538533,0.17857142857142858,0.43818448929936,1.0,20/49,22.90%,PDE2A;MAP3K14;KCNK4;PIEZO2;TLR3;HABP4;AQP1;MAPK3;MAP2K4;BCL10;MAPK8;FAS;PIEZO1;TNFSF14;ANKRD1;CRADD;BNIP3;TMEM150C;CASP8AP2;BAD
prerank,cellular response to radiation (GO:0071478),0.3168356340357034,1.1536352303012345,0.18181818181818182,0.4356692841636786,1.0,7/42,7.04%,INTS7;RAD51AP1;RHNO1;BLM;FIGNL1;RAD9B;ECT2
prerank,calcium ion transport into cytosol (GO:0060402),-0.42717588698991266,-1.1520377567520421,0.25925925925925924,0.4419990317776949,1.0,9/21,11.05%,ATP2B4;CACNA1C;JPH2;JPH4;CACNA2D1;SLC8A1;ADRA1A;JPH3;RYR2
prerank,epithelial tube morphogenesis (GO:0060562),-0.3736877350153023,-1.15177562498341,0.2545454545454545,0.4418546785887268,1.0,12/34,18.69%,PKD1;PKD2;RHOB;SLIT2;MEGF8;RYR2;GLI2;SOX17;MEF2C;RASIP1;FGF10;CSNK2B
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.29408572482566797,-1.1514942261388834,0.22413793103448276,0.44212454330796985,1.0,38/107,19.88%,TCF7L1;DAAM2;DACT3;SFRP5;CTNND2;MACF1;NXN;TRABD2B;AMER2;FGFR2;RSPO1;PSEN1;NFATC1;FZD7;LRRK2;RSPO2;GRB10;WLS;SKI;TIAM1;SOX7;DISC1;SFRP1;ESR1;KANK1;GNAQ;BTRC;TLE1;TSC2;SPIN1;HIC1;CDK14;RSPO3;ZRANB1;TAX1BP3;HHEX;MDFIC;CBY1
prerank,protein K11-linked ubiquitination (GO:0070979),0.3656824124612531,1.1514540573455623,0.29411764705882354,0.4396570501269017,1.0,7/27,16.22%,UBE2T;UBE2S;ANAPC1;UBE2C;CDC26;ANAPC11;UBE2A
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.3903776082138682,1.1509671167872757,0.2926829268292683,0.4400379937429135,1.0,11/17,31.53%,WNT5A;STK39;CCL4;CCL3;ADAM10;CXCL13;CCL7;ADAM17;XCL1;XCL2;CCL5
prerank,L-amino acid transport (GO:0015807),0.3477856159891923,1.15082538906527,0.28205128205128205,0.4396235735736142,1.0,8/28,15.09%,SLC6A20;SLC1A4;SLC7A1;SLC38A5;SLC7A5;SLC25A22;SFXN1;SLC3A2
prerank,cellular response to peptide (GO:1901653),-0.3291357842988808,-1.1505413859363307,0.24074074074074073,0.44351202011339297,1.0,18/57,18.84%,CACNA2D1;GPER1;LDOC1;ADRB2;CACNB1;PRNP;NGFR;PSEN1;CYP11B1;ZFP36L1;ATP1A3;NTRK1;CYP11A1;EPHA4;VIM;GRIN2A;CACNA1A;CD36
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3249038898471538,1.1502856276896263,0.18181818181818182,0.44013036272064937,1.0,23/44,29.96%,WDR43;IL1B;PNPT1;ZPR1;GRSF1;RELA;TRMT112;UTP15;HEATR1;NMD3;RBM22;BMP4;MYCN;TGFB1;RIOK1;U2AF2;TP53;RIOK2;WDR75;LIN28A;LIN28B;SUPV3L1;SIRT7
prerank,cellular response to inorganic substance (GO:0071241),0.3981344506412635,1.149730733288115,0.3111111111111111,0.44074656492696934,1.0,3/17,3.75%,DPEP1;TIMELESS;BLM
prerank,regulation of cell junction assembly (GO:1901888),-0.37778533656278623,-1.1494585544317475,0.2542372881355932,0.445393578301724,1.0,13/27,24.33%,RAP1A;CLDN5;SETD5;PRKACA;MYO1C;MEF2C;TJP1;RAPGEF1;ROCK1;RAPGEF2;PRKCH;SNAI2;OCLN
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.3895738737974018,-1.1492674785024624,0.23214285714285715,0.44520915677070017,1.0,9/16,32.08%,GPER1;ECSCR;CCL2;PLCG1;ANO6;PDCD4;RGCC;CD40;CD160
prerank,regulation of lamellipodium assembly (GO:0010591),-0.3440628927619439,-1.1488639109981524,0.2037037037037037,0.44565482853756133,1.0,15/32,25.82%,PLXNB3;PIK3R1;SLIT2;MSTN;FER;PLCE1;ABI2;ARPC2;RAC1;CAPZB;WASF2;BRK1;OCLN;AKIRIN1;NCKAP1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.29743357307007495,-1.1487768900200885,0.18518518518518517,0.4453979956283563,1.0,29/91,26.62%,ATP2B4;RAF1;CAPRIN2;TENM1;RAPGEF3;TRIM6;NTRK3;SNCA;HDAC6;NGF;CAMK1;TERF2IP;PRKD1;NOS1;MTCP1;BRAF;NTF3;EGFR;RAMP3;RPTOR;SH2D3C;BCAR3;LATS1;PINK1;HCLS1;FNIP1;DOCK7;AKAP9;IFNA5
prerank,outflow tract septum morphogenesis (GO:0003148),-0.3856509813515684,-1.1486490074425098,0.25,0.4451539104055712,1.0,7/25,9.09%,BMPR1A;NRP2;SMAD4;FGFR2;TBX1;ZFPM2;PARVA
prerank,response to cytokine (GO:0034097),0.2587129132534192,1.1486024208295411,0.1702127659574468,0.44254723302408827,1.0,44/145,19.81%,SHMT2;IFITM3;IFITM1;DDOST;IFITM2;LAMP3;IRAK2;IL1B;KHSRP;TIMP1;CYP27B1;LEF1;PML;MME;IKBKE;CXCR4;BCL2L1;MAPKAPK3;MYD88;RELA;ADAM10;IRAK1;JAK3;FOXA2;MAPKAPK2;STAT1;FOXH1;CXCL16;POU4F1;TAF9;COL3A1;GCH1;KYNU;BST2;ISG15;MX1;XAF1;IL23R;PTPN2;IL1RL2;PLSCR1;ADAM9;TMEM102;CHI3L1
prerank,B cell activation involved in immune response (GO:0002312),0.402882074035317,1.1485454463478662,0.23404255319148937,0.4420210310030155,1.0,5/15,25.64%,EXOSC3;BATF;MSH6;MSH2;RNF8
prerank,lipid biosynthetic process (GO:0008610),0.2988985013675865,1.1479484779609146,0.21951219512195122,0.4427422584298488,1.0,24/75,18.43%,CYP51A1;SRD5A1;AGPAT5;SCD;PDSS1;ACSL6;XBP1;LIPG;PDSS2;FDXR;IDI2;MCAT;PRLR;AGPS;ACSL5;ACLY;FITM2;NDUFAB1;ACSF3;PCYT2;OXSM;FDFT1;MVK;AGPAT3
prerank,sphingolipid metabolic process (GO:0006665),0.28250580406052334,1.1478088404094844,0.21212121212121213,0.4422960289015711,1.0,39/112,22.52%,SPTLC1;HACD3;CERS6;NEU1;HEXB;GLA;GLB1;ALDH3B2;SGPP2;TECR;SMPD2;SPTLC2;CERS2;HACD2;ORMDL3;SUMF2;UGT8;DEGS2;GM2A;SPNS2;FUT7;ELOVL1;SGPL1;GBA;ACER2;ELOVL7;SUMF1;PPT1;CTSA;FA2H;SPTSSB;ORMDL2;PDXDC1;PLA2G15;ALOXE3;ALDH3B1;ELOVL6;FUT6;ASAH2
prerank,regulation of intracellular protein transport (GO:0033157),-0.35653993351106483,-1.147726748435974,0.1875,0.44651450399660403,1.0,9/31,16.55%,VAMP2;TENM1;RUFY3;PTPN14;OAZ2;NDEL1;PCM1;CEP290;PCNT
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.39274393055338586,-1.1472020478928924,0.1724137931034483,0.44716091019460463,1.0,9/22,16.90%,HDAC7;CD34;PRNP;SFTPD;NAV3;HOMER2;HOMER3;VSIG4;ZFP36
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.31103929442759615,1.1470410581071309,0.2682926829268293,0.44320350679325843,1.0,22/51,24.79%,DPEP1;TRIAP1;ARL6IP1;LAMP3;IFI6;YWHAE;CD44;CSNK2A1;XIAP;GPX1;LAMTOR5;DHCR24;SFN;CST7;PAX2;IFI16;RPS6KA1;SH3RF1;RPS6KA3;NAIP;THBS1;CARD16
prerank,carboxylic acid metabolic process (GO:0019752),0.35948457113237087,1.146765764881118,0.3018867924528302,0.4430719625383146,1.0,13/33,24.42%,LIPT2;CYP2S1;TBXAS1;GSTO2;ST6GAL1;CYP4F8;GSTO1;ACOT4;CYP4F3;SLC2A1;CYP2J2;CYP4F2;PON3
prerank,negative regulation of growth (GO:0045926),-0.2835602587586098,-1.1455899678019084,0.21052631578947367,0.4502956474423555,1.0,37/121,21.52%,TSPYL2;FLCN;FHL1;APBB1;MYL2;CAPRIN2;DACT3;NPR1;RERG;JADE1;PRDM11;SMAD4;WFDC1;ING4;SLIT2;SLIT3;CGRRF1;SOX17;TCHP;CDKN1A;SFRP1;MT1X;NOTCH2;SIPA1;CDKN2C;NPPB;APBB2;RTN4;SMARCA2;DCUN1D3;DNAJB2;AGTR2;TP53TG5;SIRT1;ING5;SERTAD3;MT1M
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.36855635844066975,-1.1445750168302113,0.29310344827586204,0.45205270289053334,1.0,13/33,23.93%,GAB1;PRKD1;VEGFB;FLT4;HSPB1;DAB2IP;SEMA6A;MAPK14;GAS1;VEGFC;RAMP2;NR4A1;FLT1
prerank,ERBB2 signaling pathway (GO:0038128),-0.36058219592884594,-1.143997076869294,0.3076923076923077,0.4527493872105806,1.0,6/31,7.04%,NRG2;GAB1;MYOC;BTC;PIK3R1;PRKCA
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.33955178762537785,-1.1436581452448744,0.27450980392156865,0.4529889388305428,1.0,13/35,19.19%,MTURN;ARNT;TAL1;FAXDC2;FES;NCKAP1L;BRD1;THPO;MAPK11;MAPK14;HOXA5;ACVR2A;ANKRD54
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.3133004094417778,-1.1435115289357671,0.1875,0.4526055999758105,1.0,25/60,23.51%,CSNK2A2;ULK1;WNK3;HIPK4;CAMK2A;CDC42BPA;PRKCA;PRKD1;HIPK3;CDC42BPB;DYRK1A;LRRK2;MAPK1;ROCK1;MAPK8;CAMK2D;CSNK2B;MAP3K10;MAP3K12;GSK3A;TNKS;HIPK1;MYLK2;WNK1;PRKCD
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.423364451314855,-1.143276543996638,0.2833333333333333,0.45252203412887737,1.0,11/22,25.01%,CALM1;TAOK2;NEK10;PDGFB;RAD50;RASSF2;INS;PDGFD;CALM2;PDGFA;GPNMB
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.2900416659644265,-1.1429799462126689,0.24193548387096775,0.4526177213130625,1.0,30/76,24.87%,MYOCD;RGS2;UCHL1;SLC8A1;PKIG;CDKN1C;NR2F2;PTEN;SPRY1;PRKAR2B;LATS2;SLC8A3;RASIP1;INPP5K;DAB2IP;SPRY3;APC;INCA1;HEXIM1;CDK5RAP3;HHEX;SIRT1;HEG1;TESK1;LRP6;CAV3;LATS1;PRKCD;PRKAR1A;SMPD1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3690734587848369,-1.1428555717633002,0.17543859649122806,0.45229594736871154,1.0,12/29,25.52%,NGF;NTRK1;RAPGEF1;RELN;MMD2;EPOR;NOTCH2;FGF10;LRRD1;STK19;RASGRP4;EPO
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.33616960459377715,1.142849816821339,0.2826086956521739,0.4504676671081176,1.0,17/39,22.14%,CHEK1;BRCC3;CDK1;BLM;TICRR;NABP2;TOPBP1;NAE1;HMGA2;BRCA1;HUS1;PLK1;CLSPN;CDC6;ORC1;DTL;CDC14C
prerank,positive regulation of cell migration (GO:0030335),0.23783426724901016,1.1425451701988978,0.1875,0.4505610148285238,1.0,58/256,14.95%,CLDN1;MMP7;CEMIP;S100A11;TDGF1;COL1A1;KIF20B;FBXO5;LAMC2;MGAT5;CCL24;PDGFRB;EPHB2;PLAU;FERMT1;GTSE1;EPHA1;ZP3;IL1B;C1QBP;LGR6;CEACAM6;LEF1;CTSH;ACTG1;RAB11A;SOX9;FAM83H;TGFB2;GRB7;PLAA;MDK;MAZ;CCL3;XBP1;F7;CPNE3;APELA;FN1;ADAM10;IGF1R;SEMA4D;PECAM1;CXCL16;ACTN4;WNT11;CCL26;ZNF703;SEMA5A;CIB1;MMP9;KDR;MIEN1;GRN;PAK1;PDCD10;RAB25;SMIM22
prerank,regulation of cell growth (GO:0001558),-0.25878728155069314,-1.1421942884518632,0.1206896551724138,0.4529750264507546,1.0,56/203,20.45%,TSPYL2;FLCN;FAM107A;FHL1;APBB1;RASGRP2;MYL2;CAPRIN2;LGI1;DACT3;NPR1;AKAP6;USP47;RERG;EGLN2;SOCS2;JADE1;PTCH2;PRDM11;AGTR1;SMAD4;LTBP4;WFDC1;KIAA1109;BCL2;KLHL22;SLIT2;SLIT3;NRG3;ARHGEF11;TAOK2;CGRRF1;SOX17;PLCE1;TCHP;N6AMT1;CDKN1A;SFRP1;PAPPA2;CAMK2D;SGK3;SIPA1;CDKN2C;NPPB;APBB2;RTN4;SPOCK1;EGFR;SMARCA2;DCUN1D3;DNAJB2;AGTR2;TP53TG5;SIRT1;INS;INO80
prerank,ureteric bud development (GO:0001657),-0.4145351880735014,-1.141615023381225,0.29310344827586204,0.45361668841433894,1.0,5/19,9.34%,PKD2;OSR1;FGFR2;TCF21;SLIT2
prerank,cellular response to cytokine stimulus (GO:0071345),0.23029901096722477,1.1410608828860334,0.0,0.45321845147566836,1.0,160/463,26.94%,MYC;SLC12A2;CCND1;TDGF1;OSM;IL1A;IL20RA;IL11;CCL24;CXCL8;TCF7;EREG;CSF2;CXCL1;IFITM2;IL1RN;COL1A2;TNFSF11;MMP1;IL23A;IRAK2;PHB;CXCL2;GAPDH;IL1B;KHSRP;LRP8;WNT5A;CCL20;PNPT1;TIMP1;LCN2;SYK;LEF1;RPS3;CCL22;PF4;MME;CEBPA;SOX9;HYAL3;CXCR4;BCL2L1;IL27RA;DHX9;PDE12;DUOX2;STK39;USP10;DCSTAMP;CD80;CCL4;CCL3;XBP1;IFNGR2;SOCS1;ICAM1;FN1;JUNB;ABL2;RELA;IRAK1;IL17A;JAK3;NOS2;DUSP1;BATF;ADAMTS12;MMP2;GSK3B;STAT1;FOXH1;IL19;MMP3;GBP5;POU4F1;PRLR;STX3;IL17F;CCL26;BRCA1;IL13RA2;FOS;INPP5D;CIB1;SDC1;CXCL10;MMP9;IRF8;UBA52;GBA;SOCS3;MAPK13;IL22RA2;CCL17;SYNCRIP;IL23R;PTPN2;UBE2K;TGFB1;IL1RL2;BAG4;IL36B;TNFRSF1B;EGR1;ZNF675;BIRC5;STAT5A;FYN;LCK;CHI3L1;MNDA;CD86;FSCN1;HSP90AA1;PTAFR;IFI16;STAT5B;GBP1;ZC3H12A;MCL1;IL12B;HYAL2;ASAH2;CD47;LIF;GBP3;FASLG;TYK2;PTPN7;IL12RB2;CD58;TP53;IL36RN;OCSTAMP;SHMT1;IL2RA;SELPLG;NPNT;IL12RB1;PTPN11;CSF2RA;PTPRJ;CDKN1B;IL2RB;GBP4;ZEB1;CCL1;IL36G;RPL13A;HIF1A;HTRA2;ITGAX;ANXA1;IL20RB;HNRNPU;ITGB2;HAS2;IL5;IL37
prerank,detection of mechanical stimulus (GO:0050982),-0.4318629954394618,-1.1403631973745159,0.3125,0.4557172569770031,1.0,10/19,22.87%,PKD1;PKD1L2;PKD2;TCAP;PIEZO2;CSRP3;CDH2;PIEZO1;TTN;CAV3
prerank,microtubule polymerization or depolymerization (GO:0031109),0.3464591839542202,1.1393110007272216,0.2916666666666667,0.4570393829440544,1.0,10/26,17.51%,KIF24;KIF2A;KIF18A;STMN1;KIF14;KATNB1;KIF2C;CKAP5;KIF18B;TRPV4
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.28090389857988407,-1.1390607758548825,0.21666666666666667,0.4578835877330323,1.0,29/104,18.06%,PKD1;ATP2B4;FGFR1;TENM1;PKD2;FGF2;FERMT2;SLC8A2;CALM1;GH1;SNCA;ADRB2;ELANE;KIT;CAMK1;LRRK2;SLC27A1;DIRAS2;MTCP1;MAPRE3;DAB2IP;PARP16;NEK10;RHOA;HTR2B;PDGFB;DIRAS1;FGF1;EGFR
prerank,positive regulation of catabolic process (GO:0009896),0.2998739465197952,1.1385862449218476,0.2571428571428571,0.45812087894028153,1.0,23/62,23.96%,ASB9;CSNK2A3;IL1B;WNT5A;TNFAIP3;C4BPA;CSNK2A1;C4BPB;GSK3B;SORL1;OAZ3;DDB1;VCP;SCT;NSF;RAB7A;IDE;AXIN1;HECW1;HECW2;DTL;WWP2;BARD1
prerank,selective autophagy (GO:0061912),-0.3141805864928907,-1.138542681969145,0.22033898305084745,0.4584572687752873,1.0,15/54,18.78%,ULK1;ATG2B;DYNC1I1;ULK2;ATG14;MAP1LC3C;CALCOCO2;HDAC6;WDFY3;UBE2V1;VIM;DYNC1LI2;PCNT;KLHL3;UBB
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.2567615915834151,-1.1385228269707424,0.1746031746031746,0.4578820844545671,1.0,69/218,23.92%,PER1;TRIM39;CFLAR;S100B;MAP3K3;FLNA;MAPKBP1;LPAR1;TRIM52;MAP3K14;CAPN3;ZDHHC17;LURAP1;TRIM6;TRAF1;ZMYND11;RORA;PRKCB;TAB2;NR1D1;TLR9;TERF2IP;PRKD1;CARD8;OTUD7A;LITAF;OPTN;OTUD7B;WLS;PELI2;ROR1;HSPB1;TNFSF10;DAB2IP;S100A13;PPM1A;PPM1B;UBE2V1;RHOA;BCL10;HTR2B;ESR1;TICAM2;PIDD1;GPRC5B;TRIM34;TLE1;NLRX1;APOL3;VAPA;MIB2;RNF31;EDA2R;SIRT1;CCL21;TRIM62;AKAP13;TRIM8;MAP3K7;TRIM38;TIRAP;SUMO4;PLCG2;ALPK1;MUL1;RIPK1;HMOX1;PINK1;RHOC
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.40460215116184534,-1.1379554494544386,0.28,0.45850155500879786,1.0,8/16,27.54%,WASF1;WASF3;ABI2;WASF2;FCHSD2;BRK1;NCKAP1;CORO1B
prerank,carbohydrate catabolic process (GO:0016052),0.32767932789399856,1.1375692869846747,0.26666666666666666,0.45982209777160366,1.0,17/40,26.15%,PGAM4;NEU1;GAPDH;LDHA;HKDC1;TPI1;ENO4;GAPDHS;PKLR;MANBA;PKM;ALDOC;DERA;ALDOB;PFKL;PGAM1;NAGA
prerank,regulation of autophagy (GO:0010506),-0.2544383493452504,-1.1374807085972924,0.1076923076923077,0.4592728252369718,1.0,72/222,24.06%,TPCN2;FLCN;ATP6V1G2;PRKAB2;CSNK2A2;ULK1;MAPT;RRAGC;ITPR1;MTMR9;TRIM6;WDR6;HDAC6;UCHL1;TAB2;EXOC7;PRKACA;ZKSCAN3;DAPK1;BCL2;KLHL22;PRKD1;PIP4K2B;PRKAG2;LRRK2;PRKAA2;SIRT2;DCN;SOGA1;OPTN;HSPB1;RASIP1;FBXL2;GFAP;DAPK3;RRAGB;LEPR;RNF152;TPCN1;TFEB;HTR2B;PIP4K2A;TP53INP1;ROCK1;MAPK8;TRIM34;DEPDC5;NUPR1;CASP3;ATP6V0A1;ATP6V1B1;EIF4G3;PLEKHF1;EEF1A2;FBXW7;RRAGD;ATP6V1E1;GSK3A;BNIP3;TRIM8;KAT5;TRIM38;BOK;RPTOR;PIK3R2;GOLGA2;MTOR;BAD;HGF;OSBPL7;PINK1;KAT8
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.36819437148196227,1.1370498677757706,0.16216216216216217,0.46032132290628786,1.0,10/29,21.69%,DKC1;GAR1;SHQ1;NOP10;PTGES3;WRAP53;NHP2;HSP90AB1;HSP90AA1;CDK2
prerank,neuropeptide signaling pathway (GO:0007218),-0.31814152577651633,-1.1365953536227351,0.2033898305084746,0.46081984317288416,1.0,28/62,31.40%,SORCS1;GALR2;NPPA;GALR1;QRFP;SORCS3;PENK;NTSR1;GLRB;NXPH3;SORCS2;NPY;LTB4R2;OPRL1;NPPB;RAPGEF2;SSTR2;PTGDR2;ADCYAP1;PYY;CYSLTR2;NMUR1;CPE;SSTR4;LTB4R;GPR149;MCHR2;OPRK1
prerank,regulation of immunoglobulin production (GO:0002637),0.3514329655382309,1.1362003324322036,0.1951219512195122,0.4617351537638347,1.0,11/28,29.16%,EPHB2;PHB;IL21;XBP1;TNFSF4;CD86;RBP4;TNFRSF4;GPI;IL10;PHB2
prerank,regulation of steroid metabolic process (GO:0019218),-0.3923833201558215,-1.1361714148487319,0.288135593220339,0.46116252723142726,1.0,8/23,28.28%,RORA;GNB3;ACADVL;ACADL;FMO5;ABCB11;NR1H4;STAR
prerank,mitochondrial membrane organization (GO:0007006),0.36431613879456703,1.1359089167829213,0.17777777777777778,0.4617496488291957,1.0,13/28,20.85%,MTX1;APOO;PMAIP1;TIMM50;BCL2L1;HSPA9;PPIF;CHCHD6;CHCHD3;SLC25A5;MTX2;BAK1;SAMM50
prerank,regulation of dendrite extension (GO:1903859),-0.4345130071144408,-1.1352430037431425,0.2545454545454545,0.4627737260170729,1.0,10/16,29.28%,ITSN2;SYT2;OSTN;RIMS1;SYT1;CPNE6;SYT3;NEDD4L;SMURF1;CPNE5
prerank,cellular response to reactive oxygen species (GO:0034614),-0.2990598126424109,-1.1351050741233204,0.14545454545454545,0.46249090828593575,1.0,20/62,20.28%,TPM1;PKD2;MAPT;MAPK7;PXN;PDGFRA;ZNF580;HDAC6;RHOB;FER;AQP1;MAPK1;MAPK3;MAPK8;ANKZF1;EGFR;PDK2;SETX;SIRT1;CAMKK2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.36357922784717334,1.1338498583472507,0.26666666666666666,0.465851333046484,1.0,8/28,7.77%,IL1A;INHBA;CSF2;IFI6;IL1B;PPP2R1B;PF4;BCL2L1
prerank,cardiac myofibril assembly (GO:0055003),-0.43661124757528164,-1.132984981506994,0.2553191489361702,0.46680451801448136,1.0,8/15,15.01%,MYL2;TCAP;PDGFRA;MEF2A;OBSL1;CSRP3;ACTC1;FHOD3
prerank,filopodium assembly (GO:0046847),-0.43623610063384644,-1.1329774131878192,0.2608695652173913,0.46622458619734347,1.0,8/16,27.38%,SRGAP2;FGD1;S1PR2;FGD2;FGD5;SPEF1;DNM3;FGD6
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.29459146876813425,-1.1326276354647686,0.25,0.4665816480600237,1.0,28/97,20.16%,DUSP22;HAND2;SASH1;MTURN;TRAF1;PJA2;TLR9;SEMA4C;ANKRD6;MAP3K4;FZD7;FLT4;TAOK2;DAB2IP;GADD45B;MID1;GDF6;MAP4K2;SH3RF3;DUSP19;SEMA3A;WNT16;MAPK8IP1;PLCB1;RASSF2;EDA2R;MAP3K10;CCL21
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.41574624839033747,-1.1320753591577268,0.23214285714285715,0.4668910899721396,1.0,9/17,20.11%,CLIP3;GH1;PRKCB;PRKAG2;INPP5K;PLA2G1B;BRAF;RTN2;NR4A3
prerank,regulation of osteoblast differentiation (GO:0045667),-0.2851874956304047,-1.1317210365518555,0.20588235294117646,0.4671647568505401,1.0,29/78,26.72%,IL6R;BMPR1A;TWIST2;CHRD;ZHX3;DDR2;FERMT2;HDAC7;WWTR1;FGFR2;ATF4;PRKACA;PRKD1;MEF2C;SKI;RANBP3L;RORB;SOX11;ACVR2A;SUFU;BMPR1B;HGF;LIMD1;SNAI2;TMEM64;TNN;RUNX2;CRIM1;NOG
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.4605011916147331,1.1315455923782205,0.29545454545454547,0.47079177017761065,1.0,10/15,31.51%,FOXP3;TGFB2;JAK3;TGFB1;LILRB4;HLA-F;IRAK3;IL10;XCL1;TNF
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3630326996310427,-1.1315264553926085,0.32142857142857145,0.4669833901965636,1.0,8/28,15.25%,FGF2;PDGFRA;ATG14;KIT;PRKD1;TNFAIP8L3;P2RY12;PDGFB
prerank,glycolipid biosynthetic process (GO:0009247),0.3362334245469091,1.1312923212145631,0.2962962962962963,0.4707162743140665,1.0,15/37,22.59%,PIGM;PIGU;DPM2;DPM1;PIGW;ST8SIA6;PGAP2;PIGF;B3GNT5;PIGO;PIGA;PIGN;DPM3;B4GALT6;PGAP3
prerank,negative regulation of immune response (GO:0050777),-0.26386074264259796,-1.1312315535318205,0.19298245614035087,0.46708172414250454,1.0,50/172,24.64%,GLP2R;ADCY5;PTH1R;MAPKBP1;ADCYAP1R1;ADCY2;ADRB3;ADCY4;POMC;VIPR2;ADRB2;ADCY9;PRKACA;GNG2;SIRT2;RAMP1;FER;ADORA2A;PRKAR2B;VIP;MC1R;LGALS3;GPR20;AVPR2;ADRB1;PPM1B;ADCY6;TRAFD1;SPINK5;TSHB;PCBP2;MAPK14;HTR4;CRHR1;GPR27;RAMP3;P2RY11;GPBAR1;LHCGR;RC3H1;HTR7;DHX58;CRHR2;PLCG1;RAMP2;PLCG2;MUL1;ADCYAP1;PRKAR1A;TRAF3IP1
prerank,regulation of defense response (GO:0031347),0.2857682705802981,1.1309194758194299,0.1794871794871795,0.47085682430513476,1.0,36/81,31.20%,LRP8;WNT5A;PIK3AP1;TKFC;USP18;XIAP;SPATA2;MYD88;RELA;ADAMTS12;SETD6;GRN;TMSB4X;IL1RL2;NOD2;ZMPSTE24;ERAP1;TNFSF4;SEMA7A;CASP4;ELMOD2;ZBP1;ACE2;ANXA1;IL37;CASP8;PARK7;BCL6;HCK;NLRP6;SAMHD1;DAGLB;LACC1;XCL1;AREL1;CASP5
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.37213998406856263,1.130828018927154,0.2564102564102564,0.46978387386771675,1.0,7/21,19.55%,RPA3;GTF2H3;ERCC5;DDB1;RPA2;CUL4A;ERCC2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.37213998406856263,1.130828018927154,0.2564102564102564,0.46978387386771675,1.0,7/21,19.55%,RPA3;GTF2H3;ERCC5;DDB1;RPA2;CUL4A;ERCC2
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.38050190934276606,-1.1298775573951647,0.2641509433962264,0.46962012014327675,1.0,8/16,25.96%,PDGFRA;FER;PDGFB;PLAT;NR4A3;PDGFD;PDGFA;PIK3C2A
prerank,regulation of regulated secretory pathway (GO:1903305),-0.36669524372614515,-1.1295664965559564,0.2916666666666667,0.46970328862171595,1.0,18/32,26.75%,SYT10;SYT11;RIMS3;LRRK2;SYT2;SYT9;SYT6;SYT5;RAB3A;RIMS4;SYN1;SNAPIN;PREPL;RIMS1;SYT1;SYT3;RAB27A;SYT15
prerank,regulation of nuclear division (GO:0051783),0.3837369403959219,1.1293322847647973,0.25,0.472765260722589,1.0,7/20,12.42%,KIF20B;FBXO5;RCC1;NEK2;CDC25C;PDXP;PKMYT1
prerank,regulation of phagocytosis (GO:0050764),0.3114657256171791,1.1289042932423365,0.24444444444444444,0.47302480838373284,1.0,10/53,9.05%,CALR;LYAR;LMAN2;SYT7;SCARB1;IL1B;SYK;IL15RA;SPACA3;CYBA
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.353089411031772,-1.1282570720391973,0.19230769230769232,0.47303182932728205,1.0,10/31,14.70%,DLG2;LRRC7;MTCL1;PARD3B;MYO9A;PARD3;OPHN1;SYNJ2BP;CRB1;RHOA
prerank,cellular protein catabolic process (GO:0044257),0.3080620428192344,1.1280543731468404,0.25,0.47414094674460594,1.0,20/57,18.51%,FAP;GZMB;CTSV;CHEK2;CTSH;CTSC;CLTA;PCSK9;AP2S1;ADAMTS12;LONP1;CLTC;CLPP;YME1L1;AP2B1;RAB7A;CTSZ;GZMA;IDE;RSPRY1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2826216877960421,1.1279178594145747,0.18181818181818182,0.47387806789674075,1.0,25/75,21.20%,TRIB3;DCUN1D5;RIPK2;UBE2N;DERL1;RPS2;NDFIP2;PSMD10;FBXO4;XIAP;KDM1A;BRCA1;PLK1;HSPBP1;TBC1D7;COMMD1;SPRTN;UBQLN1;PAXIP1;FANCI;AXIN1;UBE2D1;BIRC7;CAV1;CUL3
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.31495414390435716,1.1275203398725302,0.1702127659574468,0.474196051314374,1.0,19/46,22.00%,RAN;KHDRBS1;GTSE1;IL1B;YWHAE;ECT2;ZPR1;JUP;DHX9;NCBP2;GSK3B;RBM22;TGFB1;XPO4;TRIM28;ANP32B;ZC3H12A;IPO5;HYAL2
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.3919974326831063,-1.1274029736068825,0.2982456140350877,0.4744302732233096,1.0,13/24,25.44%,TGFBR3;SMAD4;LTBP4;LATS2;SOX11;SMAD2;DKK3;TRIM33;SMAD7;DLX1;NREP;LATS1;SMAD3
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3552085192333213,-1.1272170271059925,0.3114754098360656,0.4742296129138365,1.0,16/31,25.44%,TGFBR3;SMAD4;LTBP4;FSTL3;LATS2;FSTL1;FST;SOX11;SMAD2;DKK3;TRIM33;SMAD7;NREP;LATS1;TWSG1;SMAD3
prerank,regulation of cell cycle (GO:0051726),0.23310120008735613,1.1270766460963546,0.09375,0.47440643362754353,1.0,64/287,15.03%,FAP;CHEK1;MYC;DDIAS;CALR;CCND1;WDR12;CDKN3;SND1;CKS2;CKS1B;KIF20B;TP73;TFAP4;FBXO5;CDK7;SKP2;LIN9;CDK5;CXCL8;INHBA;CDC123;MCIDAS;CSNK2A3;NEK6;PES1;BOP1;FIGNL1;MASTL;TBRG4;PNPT1;RNF40;DLGAP5;NANOS3;PML;CDK4;PROX1;CDKN2A;SOX9;TGFB2;MYBL2;CSNK2A1;TTLL12;HMGA2;XIAP;JUNB;ADAM10;PRR11;DUSP1;CDC26;POU4F1;PTPRK;BMP7;BRCA1;ZNF703;ZBED6;PLK1;DHCR24;BMP4;GATA6;LIN54;FOXM1;SMIM22;CENPF
prerank,negative regulation of lyase activity (GO:0051350),-0.39813000714527935,-1.1268833330612238,0.21666666666666667,0.4743527952553843,1.0,7/16,25.62%,PALM;RD3;LTB4R2;EDNRB;GNAI2;GRM2;GRM3
prerank,protein insertion into ER membrane (GO:0045048),0.33747528127894355,1.126690616734825,0.2127659574468085,0.4745401110676645,1.0,7/35,7.72%,SERP1;GET4;SEC61B;EMC8;EMC10;TRAM1;SEC61G
prerank,regulation of protein localization to cell surface (GO:2000008),-0.3604744180945567,-1.1260629957706851,0.2641509433962264,0.4755828837235529,1.0,12/32,22.87%,GPM6B;RIC3;MAP1A;ACTN2;SNX33;GBF1;LEPROT;TAX1BP3;GOPC;RAB11FIP5;GPD1L;CAV3
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.27072055536201156,1.1259237524043113,0.2,0.47547918629565655,1.0,27/87,20.48%,GNL3L;MMP1;AJUBA;LIMK1;SYK;RPS3;ATP13A2;BIK;GSK3B;MMP3;BMP7;SDC1;CDT1;CRB3;VCP;HAS3;RAB7A;SUMO1;TGFB1;PLEK;PIH1D1;STX18;STAM;BAX;BID;VIL1;BAK1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.37389595695171507,1.1257540046339494,0.3,0.4751099994620509,1.0,15/24,31.06%,RIPK2;UBE2N;IRAK2;TNFAIP3;IRAK1;AAMP;UBA52;RNF34;NOD2;CASP8;TRAF6;NOD1;ITCH;UBC;IKBKG
prerank,regulation of interleukin-2 production (GO:0032663),0.31607317546953634,1.125652141179694,0.1956521739130435,0.474681187786724,1.0,14/48,14.13%,IL1A;FOXP3;IL1B;PNP;RPS3;TNFAIP3;STOML2;CARD11;CD80;TRIM27;RUNX1;IL17F;EZR;TRAF2
prerank,regulation of exocytosis (GO:0017157),-0.33750540477383023,-1.125588833228393,0.2727272727272727,0.47624546897815245,1.0,15/43,18.31%,VAMP2;HAP1;CHMP3;SNCA;RAB12;RAB2B;CLASP1;LGI3;STXBP5L;CLASP2;SYTL4;RAB3A;IL1RAPL1;RAB13;RAB3C
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.4004930095861612,-1.1254150752302543,0.30612244897959184,0.47607806195431,1.0,5/16,8.10%,PTN;RBM24;LTBP3;HOXB4;SOX5
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.3979612323653803,-1.124782005711562,0.2692307692307692,0.4771520389574169,1.0,8/17,23.22%,CHRM2;RGS10;RGS8;GNAQ;PLCB1;CHRM5;CHRM3;GNA11
prerank,negative regulation of anoikis (GO:2000811),0.4103984372160638,1.124463106894109,0.325,0.47669114118182015,1.0,7/15,21.78%,PTRH2;CEACAM6;CEACAM5;ITGA5;CAV1;MCL1;NOTCH1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.3540948505951579,1.1238849978445402,0.34782608695652173,0.4772138555905671,1.0,12/28,29.67%,SERPINB1;TNFAIP3;CARD17;LILRB4;GIT1;ZC3H12A;CARD16;GSTP1;FFAR4;IL10;PYDC1;NLRP3
prerank,organelle organization (GO:0006996),-0.23970314251663016,-1.1229788987181824,0.12162162162162163,0.4803234862233458,1.0,137/400,24.20%,RNF112;SEC31B;ZNF135;MICAL3;ARHGAP10;ZMYM6;PALLD;TPM1;GABPB1;PKD2;TJAP1;CENPT;TBC1D20;NUMA1;RAB34;SYNE1;SYNE3;CNTNAP1;DES;PLIN5;KIF5C;ATP8B2;WTIP;CHMP3;GOLGA8A;DYNC2H1;VPS13D;PACSIN1;LMAN1L;PEX19;PLEKHM2;GEM;CLASP1;CSNK1A1;PRKD1;CDC42BPB;PRM2;OBSL1;WASF3;CAV2;CLASP2;LRRK2;HACE1;MTX3;KLHL20;ARHGAP21;BSCL2;MAST2;GOLGA8B;PYROXD2;SIRT4;OPTN;MAST4;GOLGA8N;DST;FGD1;RAB30;MAST1;KRT25;PLCE1;ATL3;ABI2;RANBP9;GORASP1;SLC25A36;MARK1;ATL2;SEMA6A;MARK4;PI4K2A;ATL1;MCOLN1;PACSIN2;SEC16B;GBF1;ARHGEF7;TICAM2;COG1;ZMYM3;DYM;RANBP10;VPS11;SIPA1;GOLGB1;VPS4A;RHOT2;RAB3GAP1;ABCA3;ATXN7;PACSIN3;CAPZB;VAPA;EPS15;CHMP4A;CSNK1D;TRAPPC8;FITM1;CCL11;DPYSL2;PLEKHF1;PLD2;GOLGA8R;ZRANB1;ATP8B3;FGD2;CECR2;PIKFYVE;ABCD4;FAM161B;PHIP;CCL2;BCAS3;SIRT3;STRIP1;NRF1;TRAPPC11;ABCD1;LIG4;STX7;PITPNB;DNAJC28;BRWD1;FMNL3;FMNL2;RAB31;GOLGA2;WDR81;RHOU;LIMD1;FGD5;PINK1;ZNF501;KIF3A;CHMP7;ABCD2;RAB18;ZFYVE16
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.36997041019348453,-1.12273906994999,0.3018867924528302,0.480323571653868,1.0,10/23,20.52%,PDE2A;PDE9A;PDE4D;NUDT10;NUDT11;ENTPD4;NUDT16;NT5E;ACAT1;MLYCD
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.2905555106665947,-1.1227263414959376,0.2692307692307692,0.4797398228839039,1.0,28/87,20.87%,PLXNB3;FGF2;PTPRM;NRP2;ARNT;ZNF580;ITGB3;PRKCA;NR2F2;PRKD1;ATOH8;CAV2;VEGFB;FLT4;VIP;THBS4;SYNJ2BP;PRL;EGFL7;KRIT1;HTR2B;PDGFB;TIE1;FGF16;CCL11;ANGPT1;SIRT1;VEGFC
prerank,retinol metabolic process (GO:0042572),-0.3928844755499642,-1.122372551488199,0.30357142857142855,0.4798892667033921,1.0,4/17,14.82%,LRAT;ADH1B;CYP27C1;CYP1A1
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.37317273375867954,-1.121776914676759,0.30612244897959184,0.4804951180433648,1.0,7/21,22.16%,ABCA8;NR1H2;RXRA;GPS2;ABCA3;SIRT1;CES1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.3560715920364662,1.1214047664130338,0.3,0.48282336370374307,1.0,8/27,14.27%,RIPK2;UBE2N;IRAK2;TNFAIP3;IRAK1;TIFA;AAMP;UBA52
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.4290533403413231,1.1212939299612628,0.3333333333333333,0.48243154646765335,1.0,8/16,20.34%,CARD14;TNFSF15;IRAK1;TNFRSF10B;TRAF2;CARD10;CHI3L1;TNFRSF10A
prerank,negative regulation of developmental process (GO:0051093),-0.2972866035346493,-1.1202659464251663,0.20689655172413793,0.48333491740642875,1.0,28/73,24.07%,SFRP5;RAPGEF3;MAPT;PTPRS;TBX1;NFIB;ARHGEF15;HEY1;NOTCH4;VAT1;SPRY3;SRGAP2C;KLF7;SFRP1;TBX2;KANK1;ROCK1;HEY2;DCC;DLL1;ARPIN;FUZ;BNIP3;RC3H1;PARP3;MUL1;PINK1;NKX3-1
prerank,leukocyte cell-cell adhesion (GO:0007159),0.3765857043274981,1.1200683076313958,0.3148148148148148,0.48469086919549176,1.0,8/26,19.87%,SYK;OLR1;ICAM1;SEMA4D;PECAM1;EZR;MSN;F11R
prerank,triglyceride metabolic process (GO:0006641),0.30107704505784566,1.119891011233705,0.16666666666666666,0.484417859695193,1.0,12/44,20.05%,FABP6;DGAT2;PNPLA4;LIPG;PNPLA1;GK;PNPLA3;LPGAT1;APOC1;SLC27A5;CETP;CAV1
prerank,cell-cell junction organization (GO:0045216),-0.30050760313341346,-1.1196986397876985,0.25,0.4840375473841968,1.0,16/77,9.89%,LIMS2;FLCN;NLGN2;TLN1;GJC1;CDH19;CADM2;CTNND2;CDHR3;NLGN4X;CADM3;CLDN5;DCHS1;CTNND1;SDK1;CDH10
prerank,positive regulation of interleukin-10 production (GO:0032733),0.34238877582985755,1.1192512011645346,0.3191489361702128,0.48503154063994725,1.0,18/31,34.62%,HSPD1;IL23A;SYK;CD46;PRKCZ;ISG15;NOD2;TNFSF4;HMGB1;IL12B;TIGIT;CLEC7A;PIBF1;XCL1;CD274;LILRA5;CD28;TLR4
prerank,Notch signaling pathway (GO:0007219),0.27763429141271717,1.118963056869548,0.17073170731707318,0.48496874835865555,1.0,14/60,11.66%,MYC;NOTCH3;NLE1;POFUT1;WWC1;DLGAP5;DTX2;GMDS;APH1A;MDK;ADAM10;DTX3L;NRARP;STAT1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.33283816551607615,-1.1177518019930108,0.34,0.48768515044308947,1.0,13/37,20.98%,CCL27;RAPGEF3;PDGFRA;NTRK3;FES;SEMA3E;TJP1;DAPK3;NOTCH2;NTF3;BAIAP2;ESAM;BCAS3
prerank,collagen fibril organization (GO:0030199),-0.276856159235882,-1.1176947971159659,0.22413793103448276,0.48723301383221984,1.0,29/88,21.43%,DPT;COL21A1;LOXL4;COL6A1;COL28A1;DDR2;COL24A1;COL6A2;COL16A1;CRTAP;P3H2;DST;BMP1;TLL1;COL4A5;COL5A3;COL23A1;OPTC;COL13A1;COL27A1;COL4A6;COL4A2;COL4A3;COL25A1;COLGALT2;PXDN;LOXL3;COL22A1;ADAMTS3
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.3042376750223244,-1.1175516678017572,0.2222222222222222,0.48689548092669344,1.0,24/64,21.03%,MEIS1;TNRC6A;MYL9;MEIS2;KAT2B;AGO4;L3MBTL1;PRKCB;TNRC6C;FES;KMT2A;ZBTB16;MEF2C;LGALS3;AGO3;KMT2B;SIN3A;HOXA5;KMT2E;TNRC6B;AGO1;ITGA2B;NR4A3;SETD1A
prerank,T cell mediated immunity (GO:0002456),0.38603222394949444,1.1160681922808533,0.19148936170212766,0.4911507108085628,1.0,4/16,10.97%,CTSH;CD46;CD55;CD70
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.39124109733910306,-1.1157029091226134,0.2711864406779661,0.490458138429174,1.0,6/23,10.64%,JPH2;ANK3;SNCA;SLC8A1;TMTC2;KCNA1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.2769562651006695,1.1155077848139978,0.2777777777777778,0.4915732552803363,1.0,35/75,28.06%,PSME3;TRIAP1;PSMD10;TMBIM6;BCL2L1;RTKN2;NOC2L;CSNK2A1;MAZ;PPIF;RELA;GPX1;PRELID1;CAAP1;MMP9;BMP4;SLC35F6;PLAUR;SLC25A5;PIH1D1;FXN;TMEM14A;URI1;MCL1;ASAH2;ITGA6;SH3RF1;THBS1;NDUFS3;GSTP1;BCL2L10;TGFBR1;GHITM;PARK7;FZD9
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.32032266624123124,1.1150052303389564,0.32432432432432434,0.49200958424302776,1.0,10/38,13.77%,IL1A;DHFR;LYPLA1;GLA;SCARB1;IL1B;DDAH1;GCH1;SPR;NOSIP
prerank,positive regulation of nuclear division (GO:0051785),0.3505901580677322,1.1142386105557927,0.34782608695652173,0.4933544803496658,1.0,10/26,20.04%,IL1A;EREG;PDGFRB;IL1B;AURKA;NUP62;DMRT1;LRP5;NPM2;TGFA
prerank,regulation of translational initiation (GO:0006446),0.2832193634746185,1.113939366943139,0.30952380952380953,0.4936084834504646,1.0,17/67,16.42%,POLR2D;CEBPB;CDC123;KHDRBS1;EIF4EBP1;NCBP1;YTHDF1;MTIF2;GLE1;DNAJC3;NCBP2;EIF3B;EIF3H;NPM1;YTHDF2;POLR2G;EIF3E
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.3694318734490108,1.1139104222293168,0.30952380952380953,0.4929693843936709,1.0,8/19,18.76%,PDP1;ABL2;RFK;PDP2;AGT;POR;NOD2;FXN
prerank,positive regulation of binding (GO:0051099),0.2868343861583959,1.1138701693622413,0.25806451612903225,0.4923320149689659,1.0,34/86,24.74%,TRIB3;RAN;RIPK2;STMN1;MET;DERL1;NCBP1;HMGB2;DHX9;BAMBI;STK4;DTX3L;CEBPG;NMD3;GSK3B;NME1;CDT1;MMP9;BMP4;PPARG;PLAUR;EDF1;GMNN;IDE;MMP8;HES1;CAV1;RPL11;EPB41;HMGB1;MEN1;WNT3A;EGF;TERT
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.27645619276740174,-1.1133527517565096,0.17543859649122806,0.4957442478578673,1.0,23/86,19.62%,RBPMS;FLCN;TGFB1I1;SH2B1;BMPR1A;NUMA1;SMAD4;CITED2;BMP3;CDKN1C;GDF7;RBPJ;MSTN;RNF165;GDF5;GDF6;ZNF423;ZEB2;SOX11;ACVR2A;SMAD2;CSNK2B;BMPR1B
prerank,regulation of cholesterol efflux (GO:0010874),-0.334270846000121,-1.1120692981732236,0.23728813559322035,0.4983827447417944,1.0,9/30,22.16%,YJEFN3;ABCA8;NR1H2;RXRA;ABCA5;GPS2;ABCA3;SIRT1;CES1
prerank,cellular response to lipid (GO:0071396),0.24085426914727615,1.111944167644514,0.13513513513513514,0.49622054435263835,1.0,64/210,21.40%,TESC;IL1A;IRS1;CXCL5;CXCL8;WNT2;CXCL3;CXCL1;CXCL11;RUVBL2;WNT7B;CXCL2;PTK7;IL1B;WNT5A;SPP1;DEFA6;ADCY1;PF4;TNFAIP3;CARD17;SOX9;HMGB2;PLAA;CD80;XBP1;ABL2;MYD88;RELA;FFAR2;IRAK1;FZD10;POU4F1;CXCL9;WNT3;WNT11;ZNF703;CXCL10;CXCL6;TNIP3;MED1;ADAM15;INSIG1;PF4V1;LYN;IL36B;TNFRSF1B;CHMP5;NOD2;CTR9;ADAM9;SERPINE1;CFTR;MSN;WNT8B;TNFSF4;URI1;PAX2;CD86;CXCL13;GIT1;NFKBIB;HMGB1;ZC3H12A
prerank,cellular response to ionizing radiation (GO:0071479),0.3086493408306234,1.1117435581209207,0.2553191489361702,0.49609897482102794,1.0,8/47,7.04%,INTS7;RAD51AP1;RHNO1;BLM;XRCC5;FIGNL1;RAD9B;ECT2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.3866581612186041,-1.111584981456737,0.3018867924528302,0.4991061412476693,1.0,13/22,23.83%,MPP2;NLGN3;NPAS4;CHRNA3;LRRK2;MEF2C;NPFF;RAB3GAP1;GRIN2A;GSK3A;DRD4;GRID2;GRIN2C
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.2987797484854251,-1.1107661246005245,0.2909090909090909,0.5006963306809334,1.0,27/67,24.07%,TSC1;HP1BP3;EGLN2;CPEB1;RORA;FMN2;CPEB2;PTGIS;ZFP36L1;EGLN1;SIRT2;MDM4;ANGPT4;NPEPPS;SLC8A3;AQP1;SFRP1;MGARP;SIRT1;BNIP3;EPAS1;CPEB4;MTOR;BAD;HMOX1;PINK1;NKX3-1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.34501923146470836,1.1105102909515845,0.3,0.4987145087209673,1.0,15/34,25.42%,THY1;RPS3;KCNN4;CARD11;CD81;RELA;EZR;PTPN2;LILRB4;LCK;GBP1;DGKZ;CD300A;PTPRJ;SH2D1A
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.28948641959888216,-1.1104224851055131,0.24561403508771928,0.5008067645639294,1.0,22/69,18.29%,FGFR1;DDR2;PDGFRA;FGFR2;FES;KIT;GHR;DYRK1A;FLT4;FER;NTRK1;ABI2;EPHA4;MAPK3;RELN;BMX;EPHA3;PDGFB;AATK;INSR;EGFR;ERBB4
prerank,regulation of protein catabolic process (GO:0042176),0.27129428907644454,1.1099753754558617,0.24324324324324326,0.4995058650848255,1.0,32/100,22.35%,MAD2L1;CYP51A1;ASB9;SF3B3;ODC1;CSNK2A3;CHEK2;PHB;AZIN1;WNT5A;TNFAIP3;C4BPA;CSNK2A1;ATP13A2;C4BPB;GSK3B;SORL1;OAZ3;DDB1;VCP;TMEM9;PRKCG;NSF;RAB7A;IDE;SNX12;CTSA;AXIN1;HECW1;HECW2;DTL;HMGCR
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.32633417290699906,1.1098926684007047,0.225,0.49895251515614547,1.0,8/34,12.39%,DKC1;GAR1;DCLRE1B;SHQ1;NOP10;PTGES3;WRAP53;NHP2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.3454891807808984,1.109664083340734,0.25,0.4989752693896445,1.0,16/36,23.68%,EIF5A;RNF183;BCAP31;PMAIP1;RPS3;BBC3;STYXL1;BCL2L1;MSX1;SLC9A3R1;LCK;BAX;BID;CAV1;RPS7;TP53
prerank,pyruvate metabolic process (GO:0006090),0.2936768671605925,1.1095043376011158,0.2,0.4986301110860444,1.0,19/54,22.81%,VDAC1;PGAM4;GLO1;GAPDH;LDHA;HKDC1;SLC16A3;TPI1;ENO4;GAPDHS;PKLR;PKM;ALDOC;SDS;PCK2;ALDOB;ME1;SRR;PFKL
prerank,regulation of p38MAPK cascade (GO:1900744),-0.32509073272308286,-1.109503332694245,0.25862068965517243,0.5025485440068356,1.0,8/37,15.44%,PER1;HAND2;SASH1;PJA2;MAP3K4;DAB2IP;GADD45B;GDF6
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3590514025798472,-1.1093101906924925,0.26785714285714285,0.5024316793898955,1.0,10/30,17.26%,CSPG4;CHST3;CHST15;IDS;DCN;DSEL;CHST7;CHST9;CSGALNACT2;CHST12
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.32410720949670985,-1.1086873431821571,0.3125,0.5033702646790972,1.0,15/44,20.89%,NPR2;ADCY5;ADCY2;NPR1;ADCY4;NPPA;ADCY9;AK5;PANK4;ADCY6;NPPC;NPPB;ACAT1;AMPD1;ADSL
prerank,cardiac atrium morphogenesis (GO:0003209),0.37769532551556184,1.1086104380482353,0.3469387755102041,0.5000492005586294,1.0,5/17,11.08%,TBX20;PROX1;TGFB2;ENG;ZFPM1
prerank,membrane lipid biosynthetic process (GO:0046467),0.2995308718542877,1.108373643847768,0.2777777777777778,0.4998209271528703,1.0,16/54,15.24%,SPTLC1;HACD3;CERS6;ALDH3B2;SGPP2;SPTLC2;CERS2;HACD2;DEGS2;ST8SIA6;SPNS2;ELOVL1;SGPL1;ACER2;B3GNT5;ELOVL7
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.2375779515471649,-1.1081195635688394,0.21518987341772153,0.5038581099897923,1.0,151/454,26.04%,TCF7L1;PHF1;APBB3;TSC1;APBB1;ZSCAN26;NR2C2;SSBP2;HCFC2;ZNF516;ZNF280D;DMTF1;ARNTL;ATF7;SOX15;ZNF219;ZBTB4;CHD3;HP1BP3;ZNF536;PHF12;ZNF273;PRDM2;SAP30L;ZNF676;MITF;WWTR1;BNC2;PPARGC1B;WTIP;YY1AP1;RPS6KA5;ZNF519;RORA;PRDM8;SKOR1;DDX25;ZNF284;CASZ1;ZNF626;KAT6B;RBBP6;ATF4;NAB2;FOXN3;NFYB;ZNF732;TERF2IP;RHOXF1;SOX13;AKAP17A;GON4L;FZD7;ZNF331;TULP3;ATXN2;NR3C1;FOXN4;ZNF117;ZNF37A;FOXO4;GLI4;CXXC1;SOX17;MEF2C;NFIL3;WWC2;ZNF274;ZFAT;KAT7;VSX1;ARNT2;SOX7;DAPK3;IRF2;DVL2;RBM4B;UBE2V1;ERC1;ZFHX3;HINFP;TFEB;ESR1;TEAD2;DENND4A;WWC3;LMX1B;ZNF423;CCDC88A;RORB;ZFPL1;MZF1;EIF2B4;ATXN1L;ZFP37;SPIN1;APBB2;ZNF98;SOX11;INSR;SAP30;HIC1;BAZ2A;SUFU;SMARCA2;PFDN5;MED23;ZNF431;RNF14;SOX18;EFEMP1;ZNF2;INS;SOX2;SOX6;MLLT6;NR1D2;SERTAD3;NFIA;HOXB1;SCRT1;IGSF1;ZNF682;RFX3;ZNF350;CREM;NFYC;LIMD1;ATF2;JMJD1C;CDK11B;ESRRB;CELSR2;SUPT3H;ZNF395;NFX1;NKX3-1;SNAI2;CDK11A;PDGFA;HOXD13;BNC1;ZNF502;FOXO3;ZNF33A;ZNF143;GATA1;HCLS1;SPIN3;ZNF221;ESR2
prerank,positive regulation of mRNA processing (GO:0050685),0.3422391779742962,1.1080885810315868,0.32,0.49972515942765433,1.0,7/23,16.83%,NCL;NCBP1;NCBP2;DAZAP1;RBM3;LEO1;TRA2B
prerank,histone H3 deacetylation (GO:0070932),-0.40818213545023924,-1.1080762685868555,0.3,0.5033145606270856,1.0,4/15,14.29%,PER1;HDAC4;SIRT2;HDAC9
prerank,steroid metabolic process (GO:0008202),0.25859976297013176,1.1080212797224267,0.19047619047619047,0.4992637574240934,1.0,28/90,23.98%,SULT2B1;CYP51A1;DHRS2;SRD5A1;HSD17B10;AKR1C4;CYP27B1;SHH;BAAT;FDXR;UGT1A3;CYP39A1;TSPO;PRLR;FDX1;CYP7B1;MSMO1;DHCR24;CYP2B6;FDFT1;LIPA;HSD17B4;CYP24A1;UGT2B7;LGMN;HSD3B1;CYP26A1;UGT1A7
prerank,glycolipid metabolic process (GO:0006664),0.30685293449720813,1.1076065478554542,0.28205128205128205,0.4995782373935422,1.0,14/52,16.71%,NEU1;HEXB;GLA;GLB1;PIGW;SMPD2;SUMF2;UGT8;ST8SIA6;GM2A;FUT2;GBA;B3GNT5;SUMF1
prerank,lipid homeostasis (GO:0055088),0.3113375309748178,1.1070175544960252,0.32432432432432434,0.5003443774998,1.0,19/57,20.68%,DGAT2;ACOXL;TLCD1;CEBPA;PNPLA4;ATP13A2;XBP1;LIPG;ABHD5;PNPLA1;PNPLA3;ORMDL3;POLD1;PPARG;FITM2;ORMDL2;CETP;MLXIPL;HNF4A
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.3494038971157289,1.106723583047107,0.3111111111111111,0.5002192687931991,1.0,6/27,9.19%,SLC6A20;SLC1A4;SLC7A1;SLC38A5;SLC7A5;SLC25A22
prerank,peptide metabolic process (GO:0006518),0.27981282815410213,1.1065743073962455,0.2777777777777778,0.4999634704440224,1.0,17/79,10.66%,DPEP1;NLN;RHCE;HM13;MMACHC;MIPEP;BACE2;GLRX2;CPZ;CPD;SPCS1;DNPEP;MME;APEH;PCSK1;CPN1;GPX1
prerank,response to organophosphorus (GO:0046683),0.40104109925966425,1.1065376466402375,0.30952380952380953,0.4993739604816354,1.0,5/16,15.01%,RFC3;DUOX2;VGF;STAT1;KCNJ11
prerank,dendritic spine organization (GO:0097061),-0.35073446175198364,-1.106149852277988,0.30357142857142855,0.5074250377105285,1.0,6/27,9.43%,CTNND2;SHANK3;DLG4;PRNP;DIP2A;PTEN
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.40729853532755844,1.1060452977431905,0.32727272727272727,0.49990400624952414,1.0,4/15,12.55%,NAA20;NAA15;NAA50;NAA35
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.41957702278010955,-1.1058670797138181,0.373134328358209,0.5075710840638515,1.0,9/17,30.25%,BMPR1A;RBPJ;HEY1;HEY2;NOTCH2;SNAI2;NOG;ACVR1;HEYL
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.3095061300021857,-1.1050743856244118,0.29508196721311475,0.5087878865517153,1.0,20/49,21.03%,TNRC6A;MYL9;MTURN;KAT2B;AGO4;L3MBTL1;FAXDC2;TNRC6C;KMT2A;MEF2C;THPO;AGO3;KMT2B;SIN3A;KMT2E;TNRC6B;AGO1;ITGA2B;NR4A3;SETD1A
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.25709529669526693,1.1047471641944298,0.22580645161290322,0.5024191859761046,1.0,37/147,15.30%,SLC25A15;SPTLC1;HACD3;RHCE;CERS6;MOCS3;INHBA;PAH;ALDH3B2;MOCOS;SGPP2;ASS1;MGST2;NANP;STARD7;GCNT1;PCSK1;GSTO2;CSNK2A1;AKR1A1;SLC44A1;SPTLC2;NMRAL1;LPCAT2;CERS2;HACD2;GSTO1;DEGS2;GCH1;SPNS2;ELOVL1;SLC44A3;SGPL1;ACER2;TYW1;ELOVL7;GPHN
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.29787511831834845,-1.1044416680625604,0.2692307692307692,0.5095114207237073,1.0,21/62,20.16%,TSC1;GPM6B;VCL;MYOC;MACF1;DUSP3;CLASP1;SEMA3E;CORO1C;AJAP1;DAPK3;EFNA5;SFRP1;RHOA;PEAK1;EPHA3;ROCK1;CD36;LIMCH1;SLK;CCL21
prerank,RNA interference (GO:0016246),0.40327067978700626,1.104305390066638,0.3469387755102041,0.5027555611846015,1.0,6/17,10.37%,TSN;HENMT1;MRPL44;DHX9;CLP1;TARBP2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.3629466845839181,-1.1040194025258632,0.3103448275862069,0.5100217319560524,1.0,11/26,26.76%,MAPK7;ATF4;LRRK2;HSPB1;PDE8A;SIRT1;INS;NME5;NOL3;PINK1;GPR37L1
prerank,negative regulation of catabolic process (GO:0009895),-0.30965862853448056,-1.1034274677851605,0.25396825396825395,0.5104641123722469,1.0,11/47,10.13%,HDAC4;FLNA;PDE3B;ACTN3;ADGRB1;FMN2;ZDHHC7;ALK;BSCL2;SIRT2;MDM4
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.30165594691381253,-1.103176946674654,0.22413793103448276,0.5103391384738211,1.0,25/73,21.18%,ZER1;CLU;CSNK1E;RNF19A;RNF180;CSNK1A1;RNF217;DET1;BAG2;LRRK2;SIRT2;ZYG11B;KLHL40;TRIB2;BBS7;ARIH2;RNF144B;HECTD1;CSNK1D;DNAJB2;ARIH1;RNF14;GSK3A;PRICKLE1;SMAD7
prerank,peptidyl-proline modification (GO:0018208),0.3281691213715032,1.1029604516981413,0.29545454545454547,0.5051157358886894,1.0,14/30,26.70%,NTMT1;PPIH;PPIL1;PPIB;PPIF;FKBP4;OGFOD1;PPIAL4A;PPIL3;PPIAL4C;PPID;PPIL6;FKBP1B;PPIAL4G
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.374591877407581,1.1029435031585046,0.3090909090909091,0.504479995946121,1.0,7/22,20.53%,ACTR2;PRKDC;HMGA2;DTX3L;WRAP53;NUDT16L1;TFIP11
prerank,regulation of dendrite development (GO:0050773),-0.3344898074600869,-1.1027563339958046,0.3137254901960784,0.5107468044719742,1.0,13/39,18.60%,ADGRB3;PTN;ZDHHC15;PACSIN1;CHRNA3;ALK;SDC2;DAB2IP;MARK1;VLDLR;DBN1;CAMSAP2;DCC
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.391313328957881,-1.1026804671686843,0.24074074074074073,0.5102784007325666,1.0,5/17,17.67%,FLCN;HDAC4;ACTN3;PID1;NUPR1
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.28548940532429906,-1.1024013865509674,0.24193548387096775,0.5105523968315958,1.0,18/66,18.69%,LCAT;CSNK2A2;PLA2G5;PLA2G4B;PCYT1B;CHKB;TMEM86B;PLA2G6;ABHD4;SLC27A1;NR1H2;PLA2G4C;LPIN1;ENPP2;PLA2G1B;PCYT1A;ABCA3;CSNK2B
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.390303885950872,-1.1020546227970316,0.3617021276595745,0.5107925855920169,1.0,9/21,21.29%,CSPG4;CHST3;CHST15;DCN;CHST7;CHST9;CSGALNACT2;CHST12;NCAN
prerank,positive regulation of response to external stimulus (GO:0032103),0.2559646420564793,1.101626472448269,0.24390243902439024,0.5066586134079093,1.0,37/131,19.77%,OSM;EREG;PDGFRB;IL23A;ZP3;POLR3C;IL1B;WNT5A;MGST2;AKIRIN2;CEBPA;NMI;MDK;DHX9;IL21;POLR3B;CYBA;CCL3;THBD;PLA2G7;GBP5;STX3;CCL26;AGT;GRN;MAPK13;FPR2;ADAM8;OASL;FEM1A;TGFB1;POLR3G;PLSCR1;NFKBIA;SLC15A4;SERPINE1;TNFSF4
prerank,regulation of MAP kinase activity (GO:0043405),-0.27223266018523173,-1.101369715734035,0.20967741935483872,0.5118600063649079,1.0,27/96,18.89%,FGFR1;TENM1;FGF2;RGS2;GH1;UCHL1;ELANE;KIT;KSR1;PPEF2;LRRK2;SPRY1;DIRAS2;INPP5K;DAB2IP;SPRY3;TSG101;NEK10;TRIB2;HTR2B;PDGFB;DUSP19;DIRAS1;FGF1;FGF16;EGFR;CDK5RAP3
prerank,cellular response to starvation (GO:0009267),-0.27120744647708606,-1.1012243964558786,0.22033898305084745,0.5115248009364526,1.0,51/147,25.23%,FLCN;ATP6V1G2;NIM1K;SZT2;BRSK1;GABARAPL1;ZFYVE1;WDR45;RRAGC;ATG14;MAP1LC3C;ATF4;PRKD1;PRKAG2;GAS2L1;LRRK2;PRKAA2;RRP8;PIK3C3;MAPK1;MAPK3;ASNS;RRAGB;RNF152;WDR59;CDKN1A;SFRP1;CARTPT;TFEB;MAPK8;FAS;DEPDC5;GABARAPL2;ATP6V1B1;KPTN;KLF10;RRAGD;ATP6V1E1;TCIRG1;SIRT1;RPTOR;MAP1LC3A;CPEB4;MTOR;NUAK1;ATF2;SIK2;GABARAP;RRAGA;PDK4;FOXO3
prerank,regulation of cell adhesion (GO:0030155),0.2579236972339195,1.1009157051047829,0.2564102564102564,0.5076935094436816,1.0,32/129,15.41%,C2CD4A;TESC;P4HB;CXCL8;TGFBI;EPHB2;EPHB3;PLAU;ADGRG1;KIF14;FUT1;C1QBP;IBSP;CXCR4;EPHA2;MDK;EFNA1;ABL2;CD164;ADAM10;CXCR3;DUSP1;ARHGDIB;SEMA4D;ARHGDIA;STX3;SEMA5A;FUT7;YTHDF2;FUT2;ADAM8;RHOD
prerank,RNA polyadenylation (GO:0043631),0.3622853378432155,1.1008640712148952,0.3111111111111111,0.5064937753979066,1.0,7/24,15.43%,CPSF3;PABPC1;PNPT1;CLP1;GRSF1;CPSF2;LEO1
prerank,mRNA polyadenylation (GO:0006378),0.3622853378432155,1.1008640712148952,0.3111111111111111,0.5064937753979066,1.0,7/24,15.43%,CPSF3;PABPC1;PNPT1;CLP1;GRSF1;CPSF2;LEO1
prerank,oligodendrocyte development (GO:0014003),-0.40151211083169064,-1.1003104153448158,0.3469387755102041,0.5129962152396683,1.0,5/15,16.63%,PLP1;CNTNAP1;PRDM8;TPPP;EIF2B4
prerank,regulation of peptide hormone secretion (GO:0090276),-0.30063237173295226,-1.0998416728821174,0.3448275862068966,0.5137272606307145,1.0,12/66,10.32%,KCNB1;CACNA1C;ARNTL;KCNA5;RAPGEF3;RAP1A;PPP3CB;ITPR1;ABCC8;PRKCA;GCK;SNAP25
prerank,platelet degranulation (GO:0002576),-0.27105739939122075,-1.099244152025618,0.3114754098360656,0.5146982356575027,1.0,48/105,27.51%,FLNA;TLN1;VCL;CLU;ACTN2;ITIH4;CALM1;F8;ITGB3;ACTN1;CFD;PCDH7;CYB5R1;VEGFB;MMRN1;HABP4;VTI1B;RARRES2;ALDOA;SYTL4;TIMP3;CDC37L1;NHLRC2;PDGFB;TMX3;CD63;CLEC3B;SCG3;CD36;F13A1;ITGA2B;VEGFC;A1BG;SOD1;TPH1;ENDOD1;TTN;HGF;CD109;STXBP1;PDGFA;TGFB3;SELP;ABCC4;ISLR;LHFPL2;BRPF3;BLK
prerank,metal ion transport (GO:0030001),-0.2951849067536299,-1.0985956208009588,0.2903225806451613,0.5156669043303079,1.0,22/85,15.23%,RYR3;CACNA1C;PKD2;TRPC1;ITPR1;CAMK2A;CACNA2D1;SLC8A2;RYR1;NIPAL4;SLC8A1;CDH23;PSEN1;TRPC4;RAMP1;RYR2;SLC30A8;SLC8A3;SLC41A1;CACNG7;PSEN2;TUSC3
prerank,RNA processing (GO:0006396),-0.25463277700012793,-1.0982339499364224,0.23214285714285715,0.5158990316093274,1.0,33/170,10.90%,SRSF5;DDX17;RBPMS;SRSF11;RNPC3;ADARB1;RBM5;LUC7L3;RBM6;NOVA1;DDX39B;ADARB2;SF3B1;SRSF4;TARDBP;PABPN1;SRRM1;AKAP8L;RRAGC;CELF1;PRPF3;MBNL1;RBM4;PRPF4B;ELAVL4;METTL3;PRKACA;HNRNPH3;RBMS1;SNRPN;SON;ALKBH5;CELF2
prerank,regulation of chemotaxis (GO:0050920),-0.3578543776564153,-1.0981345455058082,0.3541666666666667,0.5155176401028569,1.0,12/31,22.82%,ZSWIM8;PDGFRA;DUSP3;ZSWIM6;ELANE;PPM1F;RARRES2;P2RY12;PDGFB;CCL21;ADGRA2;MYCBP2
prerank,regulation of embryonic development (GO:0045995),-0.33875721589022467,-1.0978412439046445,0.3103448275862069,0.5157712604449,1.0,8/34,12.08%,NPHP3;NR2C2;PHLDB1;PHLDB2;CLASP1;RBM19;CLASP2;SOX17
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.2938438119000694,-1.0976523395177278,0.22807017543859648,0.5157512813803196,1.0,19/70,15.89%,PHF1;HDAC4;SF3B1;MECP2;KAT2B;CREBZF;PHF2;TAF1C;HDAC6;EPC1;DIRAS3;MPHOSPH8;MYO1C;WBP2;HDAC5;CGGBP1;ZNF335;DNMT3A;KAT2A
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.36135471668166474,1.097580672407367,0.2830188679245283,0.5142973743363832,1.0,12/24,35.75%,FPR3;FPR2;MICB;LYN;SPG21;SLA2;NCR3;FPR1;FCER1G;LAX1;BCAR1;SH2B2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.39195596274770295,1.0970431864989785,0.38461538461538464,0.5150302962984759,1.0,5/19,9.45%,RNF183;PMAIP1;TMBIM6;BCL2L1;XBP1
prerank,regulation of receptor recycling (GO:0001919),-0.41972340316974904,-1.0963812961220578,0.34782608695652173,0.5180218406387754,1.0,5/17,10.96%,BVES;SNCA;INPP5F;OPTN;ECE1
prerank,DNA double-strand break processing (GO:0000729),0.3657492291778498,1.0961610835428286,0.2909090909090909,0.5165484230758691,1.0,5/18,13.13%,UBE2N;BLM;DNA2;RBBP8;BRCA1
prerank,erythrocyte differentiation (GO:0030218),0.29042976318182534,1.0961320479811647,0.2826086956521739,0.5159615893721377,1.0,16/43,21.98%,LYAR;INHBA;HSPA9;TSPO2;JAK3;RPS14;ZFPM1;CEBPG;RPS19;MED1;PTPN2;DYRK3;SLC25A5;LYN;ALAS1;KLF1
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.27253846127286285,-1.0960042314864367,0.2962962962962963,0.5182716106723727,1.0,36/91,25.50%,TGFBR3;FGF2;OSR1;FGFR2;NR1D1;TBX1;LAMC1;CDKN1C;PRKD1;ZFP36L1;LAMB1;MCC;TINF2;DAB2IP;SFRP1;GDF5;FGF7;TIE1;FGF10;ZFP36;FGF1;NUPR1;FGF16;EGFR;ANGPT1;SCN5A;NR4A3;SOX2;FGF9;OSR2;B2M;BAD;NR4A1;NKX3-1;NME2;MTSS1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3032913998683295,1.0956357687431388,0.2857142857142857,0.5165752961208767,1.0,27/61,30.39%,MYC;PERP;GRIN2B;USP50;RIPK2;BCAP31;PMAIP1;SYK;ASPH;CYCS;F2R;FYN;BAK1;IFI16;HMGB1;LGMN;PDCD5;TTBK1;HTRA2;CLEC7A;CASP8;CYFIP2;NLRP2;FOXL2;NOD1;NLRP3;AIM2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.2894522937036236,-1.0954920857864312,0.2982456140350877,0.5189342857743542,1.0,21/63,29.00%,CNR1;ADRB3;CHRM2;MC1R;NPY;HTR2B;HTR4;AGTR2;CHRM5;LHCGR;HTR1E;CHRM3;CCL2;HTR7;SSTR2;DRD4;HTR2A;HTR5A;HRH2;NPY1R;SSTR4
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.4086500333082987,-1.095283108695675,0.2807017543859649,0.5187585190519266,1.0,7/17,15.08%,ZDHHC17;FSTL3;SLIT2;TMEM204;FSTL1;FST;LRIT3
prerank,protein modification by small protein removal (GO:0070646),0.23165635469779342,1.0945331772848823,0.13513513513513514,0.518555931186843,1.0,55/268,15.47%,RUVBL1;PSMD14;MYC;OTUB2;PSMB2;BRCC3;CDK1;USP50;PSMB9;PSMA5;ACTL6A;SKP2;PSMB3;SMAD1;PSME3;PSMA3;POLB;KDM1B;PSMA7;PSMD13;PSME2;PSMC2;PSMC4;PSMD10;TOMM20;TNFAIP3;USP18;PSMD12;ACTR8;PSMB5;USP37;USP10;UCHL5;RNF128;PSMD8;PSMB4;TOR1A;PSMD3;PSMB1;STAMBP;PSMA4;COPS5;RAD23B;ADRM1;BRCA1;PSME1;PSMF1;PSMD11;TRAF2;TNIP3;UBA52;PSMD1;VCP;USP1;CDC25A
prerank,positive regulation of cell development (GO:0010720),-0.3312589491875907,-1.0941738845712703,0.3333333333333333,0.5206240621068041,1.0,14/36,25.54%,NUMBL;GPER1;BHLHB9;PDE3A;NUMB;ZNF335;SPEN;SERPINF1;SOX11;LIG4;RFX3;BAD;HOXA11;MYF6
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3526484561211922,-1.0935384576832687,0.3333333333333333,0.5213250151200893,1.0,7/27,15.17%,RYR3;PKD2;FGF2;ITPR1;RYR1;RYR2;HTR2B
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.275178104958939,1.0932105023349838,0.3191489361702128,0.5212148021007333,1.0,20/64,21.17%,CCND1;CEBPB;CDK1;CBFB;LEF1;CDK4;CDKN2A;SOX9;CCNC;RELA;HNF1A;MED14;SUB1;MED1;MED30;PAXIP1;BAX;TRIM28;MED31;MED20
prerank,ruffle organization (GO:0031529),-0.4051682552824578,-1.0928158216515833,0.38333333333333336,0.5224358790795629,1.0,8/16,27.54%,TPM1;LIMA1;INPP5K;RAC1;AIF1L;CCL21;PIP5K1A;CORO1B
prerank,positive regulation of insulin secretion (GO:0032024),-0.32603965194880785,-1.092369110541224,0.2692307692307692,0.5226787256252886,1.0,7/36,12.14%,NLGN2;NNAT;PPP3CB;GPER1;PLA2G6;GCK;SLC30A8
prerank,mitotic recombination (GO:0006312),0.40506334047175035,1.0919678606856504,0.3617021276595745,0.5233406998756897,1.0,4/15,14.19%,RAD54B;MSH3;NSMCE2;TPRKB
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.4128752066329922,-1.0918240119965958,0.35555555555555557,0.5233315958552643,1.0,6/15,24.98%,RORA;GNB3;PDK2;SIRT1;MLYCD;PDK4
prerank,histone monoubiquitination (GO:0010390),0.34670743099952556,1.0917855305008934,0.23809523809523808,0.5232032788036611,1.0,10/24,21.22%,RNF40;UHRF1;RNF2;DTX3L;DDB1;LEO1;RAG1;CTR9;TRIM37;PCGF1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.3048716896542289,-1.0914241414811956,0.3,0.5235512437579377,1.0,13/37,17.76%,CORO2B;FZD4;GCNT2;MYOC;FZD7;SEMA3E;CORO1C;FBLN1;AJAP1;EFNA5;RHOA;KANK1;SPOCK1
prerank,aminoglycan biosynthetic process (GO:0006023),0.3120260929827675,1.0906374993639614,0.21739130434782608,0.5257182037637094,1.0,13/49,14.43%,B3GNT4;HS6ST2;HS3ST1;AGRN;B3GNT2;HS2ST1;GALNT5;B3GALT6;B4GALT7;EXT2;SDC1;B3GNT3;PXYLP1
prerank,protein ADP-ribosylation (GO:0006471),-0.3621937080922288,-1.0905162589531194,0.3333333333333333,0.5251717569607924,1.0,11/28,22.56%,PARP6;SIRT2;SIRT4;PARP16;PARP15;SIRT1;ART4;PARP2;SIRT3;PARP3;TNKS
prerank,sensory organ development (GO:0007423),-0.3105450563839749,-1.0901449298521293,0.35294117647058826,0.5255287226127608,1.0,16/56,20.21%,MEIS1;MAB21L2;MAB21L1;SALL2;MEIS2;PBX3;CPAMD8;CHRDL1;PBX2;ECE1;MEIS3;SMCHD1;ABCB5;AHI1;BMPR1B;SOX2
prerank,negative regulation of protein kinase activity (GO:0006469),-0.27888544380833113,-1.0897334532374114,0.29310344827586204,0.5259924044598677,1.0,30/84,22.87%,ADARB1;WWTR1;DUSP3;DUSP26;SNCA;SLC8A1;PRKRIP1;DBNDD2;CDKN1C;PRKAG2;PPM1F;CORO1C;HSPB1;SLC8A3;INPP5K;DAB2IP;TAB1;CDKN1A;PTPRQ;TRIB2;GNAQ;SH3BP5L;DUSP19;TSC2;CDK5RAP3;TESK1;PTPRT;LRP6;PTPRB;CAV3
prerank,negative regulation of protein catabolic process (GO:0042177),-0.3332641203922923,-1.089546503033277,0.3269230769230769,0.5257889899699438,1.0,17/42,20.10%,FLNA;SNRNP70;ADGRB1;SNCA;FMN2;TIMP4;RIC1;SIRT2;MDM4;TIMP2;TIMP3;DAB2IP;ROCK1;AZIN2;EGFR;CDK5RAP3;INS
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.31520658102770543,-1.0893508927164468,0.2878787878787879,0.5255431289896701,1.0,11/44,13.88%,PER1;TSC1;ZC3H7A;GCNT2;ATG14;ZC3H10;DDX25;NANOS1;ATXN2;YTHDC1;RBM4B
prerank,regulation of catabolic process (GO:0009894),0.40809010101219884,1.088658864880734,0.34,0.52981294730974,1.0,3/17,3.51%,FAP;ODC1;CHEK2
prerank,base conversion or substitution editing (GO:0016553),-0.41907772593528864,-1.088595860432484,0.3137254901960784,0.5266267838960145,1.0,5/17,18.96%,ADARB1;ADARB2;METTL3;NUDT16;APOBEC2
prerank,cellular iron ion homeostasis (GO:0006879),0.28861313809027445,1.088573097632098,0.2608695652173913,0.5293565221666782,1.0,12/53,11.22%,MYC;TFR2;LCN2;GLRX3;ATP6V1G1;FRRS1;HMOX2;ATP13A2;SLC40A1;HEPHL1;ATP6V1A;SLC11A2
prerank,cellular response to osmotic stress (GO:0071470),-0.36606261480957764,-1.088270884584216,0.32075471698113206,0.526990700253774,1.0,7/22,12.44%,MYLK;PKD2;CAPN3;WNK3;ZFP36L1;YBX3;AQP1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.2877480460475968,1.0875875045457455,0.2765957446808511,0.5311615940805322,1.0,17/51,20.61%,MYC;BRCC3;UBE2N;PMAIP1;ERCC8;RPS3;DHX9;HMGA2;CEBPG;WRAP53;BRCA1;MSX1;EYA1;NSMCE1;SPRED2;TMEM161A;TRIM28
prerank,actin filament bundle assembly (GO:0051017),-0.32593506235609626,-1.0871196136452428,0.3620689655172414,0.5291928830763967,1.0,9/33,19.40%,FAM107A;ADD1;CALD1;LIMA1;DPYSL3;ADD2;BAIAP2;FSCN3;AIF1L
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.4012815304514693,1.0871111362985637,0.3170731707317073,0.5315088135651207,1.0,7/15,20.06%,TACSTD2;SOX9;SIX1;AGT;BMP4;PAX8;PAX2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.27791852528220523,1.0870401455124286,0.3023255813953488,0.5310801506668734,1.0,11/41,13.36%,COL1A1;LOXL2;IL1B;AXIN2;CRB2;LEF1;TGFB2;MDK;BAMBI;BCL9L;ZNF703
prerank,release of cytochrome c from mitochondria (GO:0001836),0.3971668726097576,1.0867076168861887,0.34782608695652173,0.5313140028262023,1.0,9/18,20.48%,IFI6;BBC3;TIMM50;BCL2L1;GGCT;BAX;BID;SFN;BAK1
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.3420837059965467,-1.0853612146782623,0.35294117647058826,0.5328104317201683,1.0,7/28,14.00%,MAPT;ITPR1;SLC8A2;P2RX2;LRRK2;RIT2;RGN
prerank,water transport (GO:0006833),0.36085704116295275,1.08505739898143,0.3,0.5344987348152841,1.0,6/17,20.66%,UPK3A;AQP5;AQP9;AQP3;CFTR;SLC5A1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2527203936715391,1.0848885683295952,0.2857142857142857,0.5342784432903999,1.0,27/109,18.20%,TRIB3;INCENP;CCND1;THY1;CDKN3;SYAP1;CDK7;GTPBP4;BLM;CCNO;CCNE1;CCNI2;CDC25C;CCNK;CCNF;HMGA2;CCNJ;PKMYT1;CIB1;TRIB1;PDCD10;CDC25A;BCCIP;CDK12;CDC6;LRP5;PIH1D1
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.3329222203759718,-1.0844075263955428,0.29310344827586204,0.5346594388447765,1.0,15/30,27.54%,PIK3R1;MSTN;CORO1C;PLCE1;ABI2;ARPC2;RAC1;ENPP2;ARHGEF7;WASF2;BRK1;OCLN;AKIRIN1;NCKAP1;CORO1B
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.3139548128762826,-1.0835691132249186,0.35185185185185186,0.5362058268062396,1.0,15/42,20.68%,TNRC6A;EIF4ENIF1;RBM24;CELF1;NANOS1;METTL3;TNRC6C;ZFP36L1;CPEB3;ROCK1;ZFP36;FTO;BTG2;TNRC6B;RC3H1
prerank,myeloid cell differentiation (GO:0030099),0.3007394016025526,1.0833753616294775,0.25,0.5376895735190982,1.0,18/49,21.98%,IL11;INHBA;CSF2;CEBPA;HSPA9;RUNX1;JAK3;RPS14;ZFPM1;RPS19;PRKX;PTPN2;DYRK3;SLC25A5;LYN;IFI16;PRDX3;KLF1
prerank,plasma membrane invagination (GO:0099024),-0.33776488819171174,-1.0828271869835282,0.3137254901960784,0.5373016364540858,1.0,8/29,18.84%,GSN;SNX33;DOCK1;GULP1;RHOA;SNX18;ELMO1;CD36
prerank,glutathione derivative metabolic process (GO:1901685),-0.3576422110436065,-1.0816981329427855,0.3684210526315789,0.5386468170290699,1.0,7/21,19.35%,GSTM2;GSTM5;GSTA4;GSTM3;HPGDS;GSTT2B;GSTM4
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.3576422110436065,-1.0816981329427855,0.3684210526315789,0.5386468170290699,1.0,7/21,19.35%,GSTM2;GSTM5;GSTA4;GSTM3;HPGDS;GSTT2B;GSTM4
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.3495711924058084,1.0815610771440654,0.2608695652173913,0.5412416953680467,1.0,6/23,7.77%,IL1A;CSF2;IFI6;IL1B;PF4;BCL2L1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.3495711924058084,1.0815610771440654,0.2608695652173913,0.5412416953680467,1.0,6/23,7.77%,IL1A;CSF2;IFI6;IL1B;PF4;BCL2L1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.4005905964853759,1.0813667293375584,0.3877551020408163,0.5410279113435635,1.0,11/16,31.64%,USP18;TTLL12;NLRC5;YTHDF2;ISG15;PTPN2;OAS3;STAT2;YTHDF3;SAMHD1;CNOT7
prerank,negative regulation of gene expression (GO:0010629),-0.24012721529108366,-1.0808875983440436,0.23076923076923078,0.5402027385135586,1.0,76/307,19.25%,ZNF540;FLCN;PHF1;TSC1;TNRC6A;PTBP2;ATP2B4;ASB1;HAND2;SAMD4A;PGR;RBMS3;EIF4ENIF1;BMPR1A;FGF2;MAPT;TARDBP;MECP2;KAT2B;AGO4;TCEAL1;CITED2;CREBZF;GPER1;TRIM6;ZC3H10;RPS6KA5;CLDN5;CELF1;RBM4;CD34;NANOS1;METTL3;FXR2;TNRC6C;SYT11;CILP;DIP2A;OLFM1;EPC1;DAPK1;PSEN1;MPHOSPH8;ATOH8;PRKAA2;SLC24A3;EMILIN1;NPTN;CPEB3;DICER1;MEF2C;AGO3;DAPK3;DXO;HDAC9;SFRP1;SFMBT2;NUDT16;HINFP;GATA2;IGFBP5;ESR1;PDGFB;DNMT3A;HEY2;NOTCH2;MYADM;ZFP36;RBL2;SMO;SOX11;BTG2;TNRC6B;AGO1;FBXW7;PARP15
prerank,positive regulation of exosomal secretion (GO:1903543),0.3970779884953491,1.0791810419420935,0.3469387755102041,0.5457799838954275,1.0,8/15,29.65%,ATP13A2;SDC1;RAB7A;STAM;CHMP2A;SDC4;IFNG;SNF8
prerank,heart trabecula morphogenesis (GO:0061384),-0.38257802091015913,-1.0790778260792195,0.30357142857142855,0.5439693203698605,1.0,5/18,11.75%,TGFBR3;BMPR1A;RBPJ;S1PR1;HEY1
prerank,neural crest cell differentiation (GO:0014033),-0.39618808299936115,-1.0790227649068982,0.328125,0.5434308750021312,1.0,9/19,24.27%,TAPT1;MEF2C;CDH2;HTR2B;SOX11;LRP6;SOX8;FAM172A;SNAI2
prerank,positive regulation of protein metabolic process (GO:0051247),0.2620418399245775,1.0789200189103592,0.3235294117647059,0.5457281409327995,1.0,37/113,21.83%,ASB9;INHBA;CSNK2A3;IL23A;TFR2;IL1B;WNT5A;TNFAIP3;C4BPA;CSNK2A1;UHRF1;CD80;C4BPB;GSK3B;PRMT1;SORL1;OAZ3;DDB1;IL17F;AGT;GBA;VCP;RAB1A;NSF;RAB7A;IL23R;TGFB1;IDE;MTPN;NFKBIA;AXIN1;CD86;WNT7A;HECW1;HECW2;IL12B;DTL
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.34443175115949204,-1.0788796750865617,0.36507936507936506,0.5430416439259743,1.0,10/31,16.33%,LIMS2;FLNA;FERMT2;MYOC;ILK;TRIOBP;DOCK1;RAC1;ARHGEF7;MYADM
prerank,RNA transport (GO:0050658),0.2758683709920525,1.0783926787442615,0.2727272727272727,0.5462885641751564,1.0,15/75,6.05%,ALYREF;THOC3;NUP155;U2AF1;XPO5;MAGOH;RAE1;SLBP;NUP62CL;MAGOHB;PNPT1;EIF4A3;NCBP1;DDX39A;SRSF9
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.33273279029794545,1.0783470902942303,0.32558139534883723,0.5456526378395845,1.0,9/28,13.76%,CHEK1;BRCC3;CDK1;BLM;TICRR;TOPBP1;HMGA2;BRCA1;PLK1
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.32511881137415843,-1.0776756755656485,0.2692307692307692,0.5450816594206638,1.0,15/39,24.84%,GPM6B;BMPR1A;OSR1;PTN;P2RX7;SLC8A1;WNT6;KL;MEF2C;ACVR2A;BMPR1B;OSR2;ANO6;PKDCC;TGFB3
prerank,alpha-amino acid metabolic process (GO:1901605),0.30807326077498826,1.077283783938411,0.25,0.547904730877578,1.0,8/40,6.74%,DPEP1;MTHFD1;GPT2;DDAH1;ASS1;GOT2;ALDH18A1;GLS2
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.3305079818964871,1.0764925708105493,0.35714285714285715,0.5489315046154556,1.0,10/32,18.77%,CYP51A1;MOCS3;SRD5A1;MOCOS;FDXR;PRLR;GCH1;GPHN;FDFT1;PYCR1
prerank,protein-containing complex disassembly (GO:0032984),-0.29779587856526446,-1.0759576520861205,0.36363636363636365,0.5484141779142366,1.0,24/54,25.92%,GABARAPL1;LIX1L;CHMP3;DVL3;MAP1LC3C;CSNK1A1;UVRAG;LIX1;EPG5;VTI1B;VPS33B;VIPAS39;DVL2;TSG101;APC;VPS4A;GABARAPL2;FZD1;MAP1LC3A;LRP6;TECPR1;GABARAP;CLN3;VPS33A
prerank,determination of left/right symmetry (GO:0007368),-0.3210345051101433,-1.0752048020658884,0.38461538461538464,0.5494321515194346,1.0,8/38,10.33%,NPHP3;PKD2;DAND5;CITED2;CCDC39;CCDC40;TBX1;MEGF8
prerank,positive regulation of macrophage migration (GO:1905523),-0.376841659276059,-1.0750819129838747,0.3508771929824561,0.5491746445134297,1.0,5/18,13.04%,MSTN;RARRES2;MAPK1;MAPK3;P2RY12
prerank,heterochromatin assembly (GO:0031507),0.37458873382055685,1.0748774612476977,0.3617021276595745,0.5528625044616307,1.0,7/20,9.92%,HMGA1;SUV39H1;BEND3;CDKN2A;POLE3;HMGA2;HDAC1
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.3395709303519306,-1.0747872945776769,0.31746031746031744,0.5493381245218992,1.0,12/31,21.82%,EPN2;FGF2;RHOJ;SYNJ2BP;TJP1;SEMA6A;ADAMTS9;GLUL;FGF1;FGF16;DLL1;KLF2
prerank,limb development (GO:0060173),-0.3481381703856035,-1.0746713136532495,0.328125,0.5489763287637146,1.0,10/26,19.62%,INTU;KAT2B;GLI3;RSPO2;MEGF8;KAT2A;FGF10;PCSK5;IFT122;BMPR1B
prerank,RNA stabilization (GO:0043489),0.34223299337034613,1.0743360258322197,0.3695652173913043,0.553465711431107,1.0,9/26,15.95%,DKC1;E2F1;PABPC1;AXIN2;NAF1;FUS;ELAVL1;NSUN2;NOCT
prerank,negative regulation of T cell proliferation (GO:0042130),0.3013095891035718,1.0742257322325257,0.35,0.5530870927559387,1.0,14/33,28.41%,CEBPB;IL4I1;FOXP3;CD80;PLA2G2F;VTCN1;LILRB4;PLA2G2D;CD86;CRTAM;SCRIB;SDC4;IL10;GLMN
prerank,RNA 3'-end processing (GO:0031123),0.28693715771521117,1.0740219712149843,0.3409090909090909,0.5529438521755096,1.0,18/64,13.22%,CSTF2;CPSF3;ALYREF;THOC3;U2AF1;CSTF1;MAGOH;MAGOHB;PNPT1;EIF4A3;NCBP1;DDX39A;SRSF9;NUDT21;CLP1;NCBP2;CPSF2;THOC6
prerank,histone H3 acetylation (GO:0043966),-0.31824066487711566,-1.0733662657141538,0.3492063492063492,0.5514151612775924,1.0,13/40,24.44%,PER1;SUPT7L;JADE1;KAT2B;KAT6B;ING4;BRD1;KAT7;KAT2A;ING5;MAP3K7;SUPT3H;JADE2
prerank,nitrogen compound transport (GO:0071705),0.25040007655018076,1.0733092588920266,0.34146341463414637,0.5540955869017138,1.0,42/136,22.98%,SLC12A2;CMTM6;SLC6A20;SLC1A5;SLC1A4;TCN1;SLC6A14;SLC7A1;SLC7A11;SLC38A5;SLC7A5;SLC52A2;SLC6A6;LRRC8D;SLC44A1;SLC52A3;AQP9;CD320;SLC6A4;SLC7A4;CENPF;SLC3A2;SLC16A10;SCAMP3;RAB7A;PPT1;RHBG;ARRDC5;NDC1;SLC43A2;SLC15A4;SNX4;CHMP2B;SLC25A48;CHMP1A;SLC7A7;ABCC2;SLC7A8;SLC18A1;SLC18A2;SLC6A18;TMEM30B
prerank,positive regulation of cartilage development (GO:0061036),-0.3805382409332378,-1.0729981265720165,0.40384615384615385,0.55190024761972,1.0,10/18,25.23%,TAPT1;SOX5;ZBTB16;BMP1;GDF5;GDF6;BMPR1B;SOX6;PKDCC;HOXA11
prerank,hyaluronan catabolic process (GO:0030214),0.37789733935413766,1.0723917574966486,0.40384615384615385,0.5556433373344719,1.0,4/17,7.29%,CEMIP;HEXB;CD44;HYAL3
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.3445387774397958,-1.0719430201925064,0.4339622641509434,0.5536188004554639,1.0,10/29,20.16%,FGF2;PDGFRA;ATG14;KIT;PRKD1;TNFAIP8L3;P2RY12;PDGFB;EEF1A2;CCL21
prerank,phospholipid translocation (GO:0045332),-0.3417873040687722,-1.0719156397363805,0.3275862068965517,0.5530865900801013,1.0,13/29,26.79%,PLSCR4;ATP8B2;P2RX7;ABCA1;ATP10D;ATP8A2;ATP9B;ATP10A;ATP8B3;ANO6;ATP8B4;ATP11C;PLSCR5
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.38703720731106284,-1.071445056213051,0.3148148148148148,0.5535263883487826,1.0,8/17,21.87%,FGFR1;RAI2;CELF1;CELF4;STOX2;RICTOR;UBR3;OSR2
prerank,establishment of mitotic spindle orientation (GO:0000132),0.37569979722782915,1.0712808907478604,0.3181818181818182,0.5578878533208231,1.0,8/24,13.76%,MAD2L1;SAPCD2;CENPA;SPDL1;NDC80;GPSM2;ZW10;PLK1
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.29805892677179,-1.0711969919470736,0.30357142857142855,0.5536106761406109,1.0,19/50,24.39%,LMO3;WDFY2;TFE3;PPARD;SOX13;ZBTB16;ZFP36L1;FNDC5;RARRES2;SFRP1;ZFP36;MEDAG;VSTM2A;INS;ZNF385A;ID2;PIM1;TMEM64;LPL
prerank,organophosphate biosynthetic process (GO:0090407),0.30596978285955406,1.070746027093429,0.3404255319148936,0.5588781595560575,1.0,14/38,18.43%,PNPO;MOCS3;MOCOS;AGPAT5;TPI1;TKT;GK;IPPK;GPHN;IPMK;FITM2;PCYT2;G6PD;AGPAT3
prerank,negative regulation of inflammatory response (GO:0050728),-0.25164101137673917,-1.0706280712252962,0.38181818181818183,0.5544342556339086,1.0,51/202,23.74%,GLP2R;ADCY5;PTH1R;ADCYAP1R1;ADCY2;ADRB3;ADCY4;MAPK7;POMC;VIPR2;GPER1;PPARD;RORA;LRFN5;ADRB2;NR1D1;ELANE;ADCY9;PTGIS;PRKACA;GNG2;RAMP1;ADORA2A;C1QTNF3;PRKAR2B;VIP;MC1R;GPR20;AVPR2;ADRB1;ADCY6;TSHB;GPS2;MAPK14;HTR4;CRHR1;GPR27;RAMP3;P2RY11;FNDC4;GPBAR1;INS;LHCGR;HTR7;CRHR2;CDH5;PLCG1;RAMP2;PLCG2;PRKCD;ADCYAP1
prerank,regulation of immune effector process (GO:0002697),0.30649618636240705,1.0704714322897506,0.3170731707317073,0.5587422870478761,1.0,12/40,19.14%,C1QBP;CD46;CD55;C4BPA;CD81;CPN1;SERPING1;C4BPB;C3;ZNF683;C2;C8G
prerank,cartilage development (GO:0051216),-0.29808762441073827,-1.070452653268798,0.2708333333333333,0.5542260330168783,1.0,20/49,26.68%,PKD1;FGF2;OSR1;HOXD3;SOX5;WNT5B;ZBTB16;NFIB;MEF2C;WNT2B;SNX19;GDF5;SOX6;OSR2;CREB3L2;COL11A2;HOXA11;WNT10B;RUNX2;TRIP11
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.33910569864460705,1.070112551912314,0.3333333333333333,0.559003666096177,1.0,5/18,12.88%,WDR43;LYAR;UTP15;HEATR1;POLR2K
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.4069550982152265,-1.0694415622567899,0.3492063492063492,0.5561797741997706,1.0,7/17,15.56%,FLCN;MYOC;DLC1;KCTD10;RASIP1;SCAI;KANK1
prerank,cellular response to heat (GO:0034605),0.3216947097843816,1.0691654369813084,0.3018867924528302,0.5604536494430468,1.0,14/34,26.15%,CLPB;POLR2D;IL1A;YWHAE;HSBP1;VCP;SUMO1;HSP90AB1;TRPV4;ZFAND1;HSP90AA1;RBBP7;THBS1;HTRA2
prerank,negative regulation of cell population proliferation (GO:0008285),-0.2352224167493849,-1.0688064740417325,0.3230769230769231,0.5569457903132898,1.0,100/361,20.42%,TNS2;FLCN;KANK2;SPEG;TSC1;GNRH1;ADARB1;RBM5;TGFB1I1;WNT9A;RAF1;SFRP5;MYOCD;TENM1;NACC2;TGFBR3;IGFBP6;PKD2;RERG;ADAMTS8;MAGI2;KAT2B;CHD5;ROR2;ADGRB1;GPER1;LDOC1;PODN;CELF1;WDR6;ZBTB49;DLC1;ADAMTS1;ADRA1A;NDRG4;NGF;RPS6KA2;ING4;CDKN1C;AR;MFN2;MN1;APOD;PTPN14;PTEN;MSTN;SIRT2;MDM4;OGN;P3H2;ZBTB17;ATP8A2;VIP;NTRK1;FOXO4;MCC;FBLN1;CGRRF1;SKI;TINF2;DAB2IP;ADORA3;TES;SLC16A2;SOX7;KLF11;AVPR2;CDKN1A;MORC3;SFRP1;PRKRA;GATA2;IGFBP5;GDF5;TP53INP1;APC;CDKN2C;INCA1;MNT;TSC2;NUPR1;SOX11;SST;DLG5;COL4A3;PLXNB1;CCL23;BTG2;ERBB4;MYO16;SMARCA2;CSNK2B;DNAJB2;KLF10;BMPR1B;DLL1;FUZ;SOX2;RAPGEF2;ING5
prerank,copper ion homeostasis (GO:0055070),0.382047985329678,1.0687977850580195,0.37209302325581395,0.5605757237423733,1.0,8/17,25.17%,SLC31A1;XIAP;ATP7B;COMMD1;ATOX1;COX19;ABCB6;CCDC22
prerank,MAPK cascade (GO:0000165),-0.23548432345729903,-1.0662748992613604,0.30303030303030304,0.562904694674231,1.0,90/297,21.85%,NCAM1;FNTB;GFRA1;GDNF;SYNGAP1;MAP3K3;FGFR1;RAF1;NRG2;FGF2;DLG2;PABPN1;BTC;GFRA3;ACTN2;CAMK2A;GFRA2;LRRC7;PDGFRA;MEF2A;SPTBN4;CALM1;SHANK3;PIK3R1;FGFR2;DLG4;FGF22;FRS3;SHC2;KIT;RGL2;RALGDS;KSR1;KITLG;SKP1;RGL1;ZFP36L1;LRRK2;FLT3LG;NRTN;KL;PRKG2;TAOK2;MEF2C;DAB2IP;MAPK1;MAPK3;RANBP9;FGF17;MAPK11;RIT2;ARL2;MAP2K7;FGF13;CAMK2B;HTR2B;PDGFB;FGF7;BRAF;MAPK8;PEA15;BTRC;NEFL;FGF5;FGF10;ZFP36;SOS1;PPP1CB;RASA3;IL17RD;FGF1;NRK;MARK3;FGF16;EGFR;ERBB4;UBB;ANGPT1;RET;SETX;RAPGEF2;CAMKK2;CCL2;FGF9;MAP3K7;PSMD9;GOLGA7;MAPK12;SHC3;PIK3R2
prerank,regulation of chromosome segregation (GO:0051983),0.3972846155006716,1.0661184372455565,0.37777777777777777,0.5663699207684566,1.0,8/17,20.86%,RMI2;RAD18;AURKB;CSNK2A1;KIF2C;BUB1;CDC6;MKI67
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.32114531125398266,-1.0645291478817955,0.3770491803278688,0.566312808888926,1.0,11/30,24.73%,LCAT;CSNK2A2;PCYT1B;CHKB;SLC27A1;LPIN1;PCYT1A;CSNK2B;CHAT;CHKA;LPIN3
prerank,response to glucose (GO:0009749),-0.30174724220278315,-1.064140687422227,0.32142857142857145,0.5667855824840413,1.0,9/44,12.14%,VAMP2;KCNB1;GPER1;PRKACA;GYS2;PRKAA2;ZNF236;GCK;SLC30A8
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.3731847600411093,1.0641157161648256,0.25,0.5703248314136312,1.0,4/17,13.79%,IL4I1;ASS1;JAK3;VTCN1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.37900992110792253,1.063695352919854,0.38636363636363635,0.5707742661086709,1.0,6/22,11.12%,ULBP3;GZMB;ULBP2;TUBB4B;ULBP1;CEBPG
prerank,sympathetic nervous system development (GO:0048485),-0.3951251735162303,-1.061359900223488,0.36538461538461536,0.5727134840426855,1.0,6/16,17.74%,GDNF;NRP2;PHOX2B;NTRK1;SEMA3A;SOX11
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.28580669675002907,-1.0612553947877867,0.3559322033898305,0.5723419563192995,1.0,26/59,27.01%,GPR17;LPAR1;NGF;NTRK1;GPR20;RAPGEF1;RAC1;MMD2;EPOR;NOTCH2;FGF10;MAPRE2;ALS2;LRRD1;STK19;AKAP13;ABRA;LPAR6;ARHGEF3;LPAR4;RASGRP4;EPO;SYNPO2L;F2RL3;GPR4;F2RL1
prerank,sprouting angiogenesis (GO:0002040),-0.310607225169137,-1.0609380752277158,0.38181818181818183,0.5725074100676444,1.0,19/50,23.39%,YJEFN3;CCBE1;FGF2;RECK;SRF;PARVA;SLIT2;VEGFB;SEMA3E;FLT4;JMJD6;PIK3R3;RSPO3;ANGPT1;DLL1;VEGFC;ADGRA2;RAMP2;NR4A1
prerank,iron ion homeostasis (GO:0055072),0.27492024405942017,1.0608547548184062,0.3191489361702128,0.5770369735159234,1.0,12/56,11.22%,MYC;TFR2;LCN2;GLRX3;ATP6V1G1;FRRS1;HMOX2;ATP13A2;SLC40A1;HEPHL1;ATP6V1A;SLC11A2
prerank,transition metal ion transport (GO:0000041),0.32288970382115795,1.0607060388979292,0.2916666666666667,0.5767036117606678,1.0,12/33,18.44%,TFR2;SLC31A1;ATP2C1;HEPHL1;SLC39A8;SLC11A2;ATP7B;SLC30A5;SLC39A2;SLC30A9;ATOX1;SLC30A1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.27058742932477564,-1.0606730291249133,0.3508771929824561,0.5725489054224443,1.0,12/80,6.53%,SNX1;SGSM2;TBC1D17;RAB9B;DCTN1;TBC1D10A;RBSN;ANKFY1;RAB6B;STX16;DENND5A;DENND2A
prerank,transition metal ion homeostasis (GO:0055076),0.35635735648591393,1.0605892379583153,0.425,0.5763575216520073,1.0,8/25,16.21%,TFR2;HMOX2;ATP13A2;SLC40A1;XIAP;HEPHL1;COMMD1;FTL
prerank,negative regulation of biosynthetic process (GO:0009890),-0.3715886008730296,-1.0605791393069413,0.35185185185185186,0.5720141996735638,1.0,8/17,29.65%,GPER1;ASXL3;EMILIN1;INS;ABCD1;ABCD2;CEACAM1;SLC30A10
prerank,epithelium development (GO:0060429),0.23858306931558954,1.060234467920857,0.2631578947368421,0.5767431620337399,1.0,37/118,20.26%,ANXA4;CDK1;VDAC1;MTHFD1;WNT2;TIMELESS;WNT7B;ACTL8;TAGLN2;UPK3A;SHH;DNPH1;PTER;PROX1;SOX9;CASP6;EHF;RIPK4;APELA;SIX1;STAT1;TRIM71;WNT3;UPK2;GRHL2;KDR;GATA6;PPARG;DLX3;TGFB1;PIH1D1;IHH;SLC9A3R1;PAX8;PAX2;ALDOC;VIL1
prerank,anion transmembrane transport (GO:0098656),0.29039488565291605,1.0600695429249474,0.375,0.5764113937473857,1.0,20/66,17.99%,LRRC8E;SLC6A20;SLC35A2;SLC5A6;SLC7A1;SLC38A5;SLC7A5;MFSD12;SLC19A1;LRRC8D;SLC25A22;SFXN2;SLC39A8;SLC25A19;SFXN1;LRRC8B;SLC3A2;SLC35C2;SLC25A5;SLC13A3
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.3742682306192219,1.0598001380574031,0.36585365853658536,0.5764449811317798,1.0,7/20,13.13%,SOX4;RUVBL2;FOXP3;IL1B;RPS6KA4;DIP2B;BRCA1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.2560025938752064,-1.0593148590932284,0.2909090909090909,0.5745121659245347,1.0,34/139,16.37%,TEAD3;NR2C2;RXRG;PGR;HDAC7;KAT2B;WWTR1;THRB;PPARD;RORA;CDK9;NPPA;NR1D1;TEAD1;RARB;AR;RBPJ;MAML1;RXRB;NR3C1;NOTCH4;NR1H2;HDAC5;MED17;NR2C1;ERCC3;RXRA;HDAC9;ESR1;TEAD2;THRA;NOTCH2;TAF3;RORB
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.39344659548667027,1.0579474439794354,0.3076923076923077,0.5807666768350557,1.0,6/16,16.46%,TRIB3;SOX9;ERLIN1;BRCA1;APOC1;ERLIN2
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.34599095614759146,1.0576180366995718,0.3695652173913043,0.5808756478768163,1.0,15/25,29.18%,SF3B3;PRPF4;KHSRP;SNRNP40;PRPF6;TRA2B;SF3A3;DBR1;WDR83;TXNL4A;GEMIN2;LSM1;DDX23;MPHOSPH10;BCAS2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.2633368306621372,1.0574034401979115,0.28888888888888886,0.580796026272939,1.0,20/74,13.72%,POLR2F;POLR2D;HNRNPF;FGF19;NCBP1;ANOS1;PTBP1;FGFRL1;FIBP;GALNT3;FGFR4;SHCBP1;NCBP2;FGF20;TRIM71;POLR2C;GTF2F2;POLR2K;FGF3;POLR2J
prerank,retina homeostasis (GO:0001895),0.31808668388225003,1.0573752698838093,0.3617021276595745,0.5801657497886517,1.0,8/32,9.51%,CDH3;AZGP1;CST4;POC1B;CRB2;ACTG1;ZG16B;PRDX1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.3152328716718378,-1.0572612628337796,0.34,0.5788727735852643,1.0,13/35,23.03%,TSC1;CRY2;PPP1R12A;MAGI2;CALM1;PPP6R2;BOD1L1;CSNK2B;AGTR2;BOD1L2;MTOR;CALM2;NUAK1
prerank,midbody abscission (GO:0061952),0.3491540071948212,1.056690177128088,0.3953488372093023,0.5813351517663801,1.0,6/17,20.37%,CEP55;KIF20A;CHMP4C;CHMP5;CHMP2B;CHMP1A
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.35385551177333613,-1.0564229209219131,0.3333333333333333,0.5804040164892409,1.0,9/24,14.46%,SETD1B;SETD5;SETD4;VCPKMT;KMT2A;SETD2;OGT;SETD3;ZNF335
prerank,regulation of response to biotic stimulus (GO:0002831),0.32763428720107696,1.0563450743657772,0.35135135135135137,0.5816037271037717,1.0,7/29,19.27%,LRP8;TKFC;CD55;XIAP;GATA6;ZMPSTE24;ERAP1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.33902856358028854,1.0563194326933045,0.32558139534883723,0.5809479990939788,1.0,16/32,25.57%,TESC;PLAU;SYK;TGFB2;EPHA2;EFNA1;CIB1;ACER2;PIK3CG;LYN;ADAM9;SERPINE1;LIF;EPHA8;PTPN11;RAC3
prerank,cholesterol transport (GO:0030301),-0.31180902225577944,-1.0561413892771134,0.3389830508474576,0.5805184635415426,1.0,12/43,18.84%,LCAT;ABCA8;CLU;LIMA1;ABCG4;ABCA1;OSBPL5;AKR1C1;ABCA5;STX12;VPS4A;CD36
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.21083629734936182,1.0560852185038188,0.3103448275862069,0.5807350752478586,1.0,98/346,21.83%,PSMD14;MAD2L1;PSMB2;PTTG1;PSMB9;PSMA5;SKP2;RNF114;PSMB3;UBE2S;FBXO45;PSME3;PSMA3;TOM1L1;KIF14;BUB3;PSMA7;PSMD13;RNF6;RNF40;NDFIP2;GID8;PSME2;PSMC2;PSMC4;PSMD10;TRIM72;ERCC8;PML;AURKB;TNFAIP3;PSMD12;ANAPC1;RNF43;BFAR;PSMB5;KCTD5;PLAA;UBE2C;UHRF1;ZNRF3;UBE3D;TRIM2;XBP1;PRAME;RNF128;PSMD8;AURKA;DTX3L;CDC26;KLHL8;PSMB4;PSMD3;PSMB1;PSMA4;TRIM71;RAD23B;ADRM1;DDB1;SPSB2;RNF149;PSME1;PSMF1;ANAPC11;PLK1;PSMD11;NHLRC1;PSMD1;VCP;UBA1;CUL4A;RNF34;RNF187;FBXL14;UBE2A;UBQLN1;FEM1A;OS9;UBE2K;VPS37B;PSMD6;UBE3C;UBE2L6;CDC20;BUB1B;UBE2D1;PSMD5;RBCK1;KBTBD7;HECW1;MVB12A;KEAP1;CUL3;HECW2;CBLC;RNF19B;PSMC1;DTL
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.32628500986452946,-1.0560306317560753,0.36666666666666664,0.5801313532356488,1.0,14/45,16.33%,LIMS2;FLNA;CAPRIN2;FERMT2;MYOC;CUX2;ILK;TRIOBP;OBSL1;DOCK1;RAC1;ARHGEF7;IL1RAPL1;MYADM
prerank,cellular glucose homeostasis (GO:0001678),-0.31684841150475235,-1.0559622105225155,0.2692307692307692,0.5796735637489611,1.0,9/42,9.95%,KCNB1;GPER1;PIK3R1;NR1D1;NGFR;PRKACA;PRKAA2;ZNF236;GCK
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.33065532905657175,-1.05575949942307,0.4126984126984127,0.5795638607428565,1.0,14/33,23.29%,PKD1;TRIM39;ATP2B4;MN1;PTEN;CDKN1A;STXBP4;FAM83D;PAGR1;FBXW7;INO80;SUSD2;ID2;PLCG2
prerank,cellular response to estradiol stimulus (GO:0071392),-0.366296394234794,-1.0549777749822267,0.39622641509433965,0.580963528510861,1.0,8/20,21.61%,GPER1;SFRP1;ESR1;CRHBP;EGFR;RAMP3;KAT5;SSTR2
prerank,hydrogen peroxide metabolic process (GO:0042743),0.34091422425357826,1.0534006182151276,0.3877551020408163,0.5867454643941327,1.0,8/27,12.39%,PRDX4;PRDX5;DUOX2;CYBA;PRDX1;NOX1;GPX1;PRDX2
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.3320617650029614,-1.0530448749121049,0.3559322033898305,0.585466709535492,1.0,5/30,9.09%,ITGA7;JAM3;CTNNA3;ITGB3;PARVA
prerank,negative regulation of immune system process (GO:0002683),0.36234236622212307,1.052825820669031,0.3191489361702128,0.5877263807199985,1.0,6/18,18.67%,FOXP3;SOX9;COL3A1;LYN;LILRB4;HOXA7
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.3365450709322427,-1.0527524971956854,0.43636363636363634,0.5856053477414481,1.0,9/24,24.73%,CHKB;PLA2G6;ABHD4;SLC27A1;LPIN1;ETNK2;PISD;CHKA;LPIN3
prerank,protein localization to Golgi apparatus (GO:0034067),-0.35189826786833434,-1.0526402508425594,0.3684210526315789,0.5852761754590879,1.0,8/27,18.43%,ZDHHC15;VPS13D;OBSL1;BICD2;OPTN;VPS13A;GBF1;CSNK1D
prerank,regulation of neuron migration (GO:2001222),-0.3339183834172414,-1.0523094554198908,0.36666666666666664,0.5854654783124379,1.0,13/27,24.67%,CAMK2A;SRGAP2;NTNG1;ZNF609;DAB2IP;SEMA6A;SRGAP2C;CAMK2B;IGSF10;SEMA3A;RAPGEF2;NIPBL;TNN
prerank,inner ear morphogenesis (GO:0042472),0.33752481840176374,1.0517011319475151,0.3829787234042553,0.5896107595113944,1.0,14/24,28.02%,EPHB2;SOX9;SIX1;MYO6;CHD7;USH1C;MYO3B;PAX8;PAX2;DCANP1;HPN;TIFAB;HOXA1;TFAP2A
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.30247618213204414,1.05157949065825,0.36363636363636365,0.5891887915300521,1.0,19/44,31.53%,OCIAD2;PIGU;VHL;ADIPOR1;SOCS1;JAK3;SOCS3;F2R;HES1;CAV1;CRLF3;NOTCH1;EGF;IL10;IL10RA;IFNL1;IL26;TNF;CCL5
prerank,regulation of mononuclear cell migration (GO:0071675),-0.37448916125823767,-1.0508575380205791,0.40384615384615385,0.58852422610448,1.0,6/22,13.02%,SLIT2;MSTN;RARRES2;LGALS3;MAPK1;MAPK3
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.3395684316457769,1.0506120272347566,0.43137254901960786,0.5913857724837335,1.0,12/23,30.18%,PSMC2;PSMC4;HNF1A;MED14;SUB1;MED1;MED30;PAXIP1;TP53;MED13;MED4;HNF1B
prerank,amyloid fibril formation (GO:1990000),-0.28366700929138194,-1.0501822842243376,0.36363636363636365,0.5896516173052816,1.0,17/52,23.62%,GSN;MAPT;SNCA;NPPA;GGA3;APH1B;BACE1;PRL;HSPG2;MFGE8;GGA2;UBB;CD36;INS;B2M;GGA1;RIPK1
prerank,RNA destabilization (GO:0050779),-0.36604978319263237,-1.049860968658373,0.40425531914893614,0.5896736075856954,1.0,6/17,16.96%,RBM24;CELF1;METTL3;DXO;ROCK1;FTO
prerank,regulation of protein localization to membrane (GO:1905475),-0.3343180502796242,-1.0497369899312294,0.4222222222222222,0.5892407093281052,1.0,12/29,24.88%,GSN;ZDHHC7;NECAB2;AR;VTI1B;VPS4A;GPC1;INS;GPC6;ACTB;STX7;CLN3
prerank,positive regulation of interleukin-6 production (GO:0032755),0.2746948685371993,1.0481422774212443,0.4,0.5969487573542904,1.0,20/73,22.00%,IL1A;HSPD1;EREG;IL1B;WNT5A;SYK;DHX9;CYBA;XBP1;MYD88;IL17A;NOS2;IL17F;MAPK13;F2R;NOD2;TNFSF4;MMP8;HMGB1;HYAL2
prerank,cardiac conduction system development (GO:0003161),-0.38336111274127005,-1.0481088369890192,0.41379310344827586,0.5924838899766192,1.0,10/23,20.08%,BMPR1A;SMAD4;NPPA;MAML1;CACNA1G;HEY1;HEY2;NOTCH2;NPPB;SCN5A
prerank,positive regulation of gene expression (GO:0010628),-0.2201774748660623,-1.0477971339718974,0.3333333333333333,0.5926237421871648,1.0,118/460,20.10%,CALCOCO1;PDE2A;CIRBP;RBM20;TNRC6A;MYOM1;HAND2;SAMD4A;ANK2;AGPAT1;RBMS3;ACTA1;SF3B1;GSN;FGF2;OSR1;CLU;ACTA2;KAT2B;RBM24;AGO4;MITF;CITED2;LURAP1;ANK3;GPER1;HOXD3;CUX2;PHF2;PIK3R1;TAF1C;CLDN5;ZNF580;NTRK3;CELF1;P2RX7;FGF22;CD34;ELAVL4;METTL3;FXR2;TNRC6C;ATF4;WNT6;TLR9;NGF;LARP6;AR;OLFM1;RHOXF1;PSEN1;RBPJ;DYRK1A;SLC24A3;PPM1F;CNTF;EMILIN1;RNF207;TLR3;HABP4;MYO1C;C1QTNF3;CPEB3;HEY1;PID1;WBP2;RDX;CADM1;MEF2C;AGO3;MAPK1;S100A13;MAPK3;FGF17;MAPK11;PIK3R3;AVPR2;ACTC1;HINFP;GATA2;SEC16B;MUSK;HTR2B;PDGFB;FGF7;VIM;BRAF;ROCK1;MAPK8;HEY2;KAT2A;SLC38A2;TLE1;FGF5;FGF10;AZU1;MAPK14;HOXA5;SMO;FGF1;WNT16;SOX11;FGF16;EGFR;POLDIP3;RAMP3;CD36;TNRC6B;POU3F3;AGO1;MED23;VSTM2A;ANGPT1;PLA2R1;RPS6KB1;GSK3A;SETX;INS
prerank,histone modification (GO:0016570),0.24724716190597695,1.0476201998854189,0.3488372093023256,0.5975137213037791,1.0,22/109,12.30%,RUVBL1;INCENP;NTMT1;UBE2N;RUVBL2;PHB;HDAC2;MRGBP;HLCS;HDAC10;AURKB;PADI3;PADI1;BRMS1;UHRF1;HDAC1;NAA50;MTA2;PRMT1;PRMT6;RPS6KA4;CARM1
prerank,vasculogenesis (GO:0001570),0.3119491890620153,1.047561896542142,0.36363636363636365,0.5970180518282162,1.0,16/33,28.41%,PDGFRB;WNT7B;TBX20;SHH;APELA;ENG;KDR;TGFB1;TGFBR2;CAV1;TNNI3;NOTCH1;SPRED1;HAS2;APLNR;GLMN
prerank,regulation of bone mineralization (GO:0030500),-0.2921663068549541,-1.0474274259665657,0.39344262295081966,0.5930050773187632,1.0,10/55,12.28%,GPM6B;BMPR1A;DDR2;OSR1;PTN;P2RX7;SLC8A1;S1PR1;KL;MEF2C
prerank,positive regulation of dendrite extension (GO:1903861),-0.4083252783344787,-1.0470404696213154,0.32727272727272727,0.5934057087012575,1.0,13/15,37.42%,ITSN2;SYT2;RIMS1;SYT1;CPNE6;SYT3;NEDD4L;SMURF1;CPNE5;UNC13A;RNF157;SYT17;CPNE9
prerank,protein localization to lysosome (GO:0061462),0.3115036213627555,1.046876778932061,0.375,0.5981237929561746,1.0,8/28,16.52%,SH3BP4;ATP13A2;CD81;RNF128;SORL1;LAMTOR5;GLMP;RAB7A
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.27297549571352203,1.0468640760038128,0.38636363636363635,0.5974304470916506,1.0,27/78,27.35%,IL1A;EPHB2;IL23A;WNT5A;SYK;PF4;DHX9;CYBA;OAS2;CCL3;IL17A;IL17F;ADAM8;NOD2;ARFGEF2;OAS3;MMP8;CD86;HMGB1;IL12B;CD2;TYROBP;THBS1;PTPN11;PTPRJ;IFNG;CLEC7A
prerank,triglyceride biosynthetic process (GO:0019432),0.38951363727498645,1.0464714283679326,0.3469387755102041,0.5977546394529591,1.0,9/16,33.38%,DGAT2;GK;PNPLA3;LPGAT1;PCK2;AGMO;MOGAT1;DGAT1;MOGAT3
prerank,neutrophil activation (GO:0042119),0.3834785994593958,1.0456378230737626,0.4,0.5991585919298537,1.0,4/16,14.43%,CXCL8;SYK;CXCL6;CXCR2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3556704417414097,1.044952093845106,0.35294117647058826,0.6000590406703553,1.0,3/21,1.72%,GRIN2B;USP50;PSMB9
prerank,membrane fusion (GO:0061025),-0.3286751940811279,-1.044389192041386,0.35294117647058826,0.5993645408902148,1.0,13/34,28.78%,VAMP2;RABEP1;HACE1;VTI1B;VPS33B;DYSF;VAPA;DNM1;RIMS1;DNM1L;DNM3;OTOF;MYOF
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.27157482680900685,-1.0436359985212171,0.32727272727272727,0.6006410537199133,1.0,27/67,26.42%,KLF9;TGFBR3;PTPRM;FGFR2;CDKN1C;NR2F2;ATOH8;CAV2;NFIB;MCC;SYNJ2BP;PRL;TINF2;DAB2IP;KRIT1;SFRP1;GDF5;NUPR1;FBXW7;SOX2;B2M;SCG2;NKX3-1;SNAI2;MTSS1;RGCC;CEACAM1
prerank,cellular response to sterol (GO:0036315),-0.37786278445849275,-1.0434899337732642,0.40384615384615385,0.600420213829435,1.0,5/16,23.76%,RORA;SMO;LRP6;CES1;OSBPL7
prerank,superoxide metabolic process (GO:0006801),0.3193976979953086,1.0427101695028795,0.425531914893617,0.6050325108847621,1.0,10/29,25.52%,DUOX2;CYBA;PRDX1;NOX1;NOS2;PRDX2;CYB5R4;NCF2;CYBB;ALOX12
prerank,regulation of macroautophagy (GO:0016241),-0.2633448586317572,-1.042705609495823,0.41379310344827586,0.6016627530783556,1.0,36/109,25.38%,NRBP2;EPM2A;TSC1;ATP6V1G2;PRKAB2;ULK1;RRAGC;GPSM1;HDAC6;UCHL1;EXOC7;PRKACA;PRKAG2;LRRK2;PRKAA2;DCN;WAC;RRAGB;TBC1D25;MAPK8;TSC2;CASP3;ATP6V0A1;ATP6V1B1;RRAGD;ATP6V1E1;SIRT1;BNIP3;MAP3K7;RPTOR;SMG1;MTOR;PINK1;RRAGA;CLN3;EXOC1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3177482576607281,-1.0426906317322946,0.375,0.6010709514886248,1.0,16/33,28.75%,LSM11;ADAMTS1;RDX;UBE2E2;STXBP4;FAM83D;FGF10;PAGR1;EGFR;KMT2E;PLCB1;RPTOR;PLCG2;RGCC;LSM10;PAF1
prerank,Golgi organization (GO:0007030),-0.261950894876619,-1.0416851784365588,0.31666666666666665,0.6030599601702307,1.0,38/129,19.55%,TJAP1;TBC1D20;SYNE1;ATP8B2;STX16;VAMP4;GOLGA8A;DYNC2H1;LMAN1L;PLEKHM2;CLASP1;CSNK1A1;PRKD1;OBSL1;CLASP2;LRRK2;HACE1;ARHGAP21;GOLGA8B;OPTN;VTI1B;GOLGA8N;RAB30;ATL3;GORASP1;ATL2;PI4K2A;SEC16B;GBF1;ARHGEF7;TICAM2;COG1;DYM;GOLGB1;CSNK1D;TRAPPC8;GOLGA8R;ATP8B3
prerank,tube closure (GO:0060606),0.30132829868862815,1.0414456256659936,0.2692307692307692,0.6079064109872093,1.0,6/31,7.44%,GRHL3;CELSR1;MTHFD1;MTHFD1L;FOLR1;TGFB2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2730886861438538,1.0414198241328787,0.37209302325581395,0.6072456906023284,1.0,23/58,24.39%,HSD17B10;AKR1C4;OSBPL3;BAAT;XBP1;LIPG;MCAT;CYP39A1;ACMSD;CYP7B1;HSD3B7;ACOT8;ACLY;NDUFAB1;ACSF3;OXSM;SLC27A5;HSD17B4;SDS;SRR;OSBPL2;OSBP;HSD17B8
prerank,response to purine-containing compound (GO:0014074),-0.3710655467730254,-1.0412224468880948,0.391304347826087,0.6036564243069081,1.0,5/17,11.05%,P2RY1;RYR1;P2RX7;ABCC9;RYR2
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.36473785664444947,-1.0411974826499257,0.4186046511627907,0.6030643870082577,1.0,6/18,18.89%,WDR91;RIC1;RDX;DAB2IP;VPS11;CDK5RAP3
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.3354857616617276,-1.0407737203516942,0.3409090909090909,0.60344031147983,1.0,8/33,8.43%,AKAP6;TRPC1;CASQ1;CAPN3;GPER1;SNCA;P2RX7;P2RX2
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.22556867253281962,-1.0400751109197588,0.2857142857142857,0.6044326407328774,1.0,83/309,20.61%,PDE2A;RYR3;ATP2B4;WNT9A;TPM1;AKAP6;TRPV1;RAPGEF3;PKD2;RAP1A;FZD4;DEFB124;MAPT;PABPN1;OR51E2;RRAGC;PXN;PDGFRA;GPER1;LDOC1;P2RY1;MTR;CPEB1;RORA;P2RX7;NR1D1;WNT6;TBX1;FES;KCNK4;WNT5B;DAPK1;PRKD1;FZD7;GNG2;SLIT2;ZFP36L1;FER;PDE3A;CPEB3;PID1;MEF2C;AQP1;CERS1;INPP5K;DAB2IP;MAPK1;MAPK3;P2RY12;RRAGB;RAPGEF1;KCNE1;SSH1;SFRP1;RHOA;BCL10;IGFBP5;EPHA3;ESR1;PDGFB;TICAM2;VIM;ADCY6;MAPK8;RORB;CRHBP;ZFP36;MAPK14;SHPK;EGFR;RAMP3;P2RY11;RET;PDK2;RRAGD;ANKRD1;GPBAR1;SETX;NR4A3;RAPGEF2;CAMKK2;HCN3;CCL2
prerank,phagosome acidification (GO:0090383),0.3170216459154687,1.0399686434395656,0.3409090909090909,0.6107650244857965,1.0,8/28,19.13%,ATP6V1C2;RAB20;ATP6V1G1;ATP6V0B;ATP6V1A;ATP6V1F;RAB7A;ATP6V0A4
prerank,apical junction assembly (GO:0043297),0.2904132064880864,1.0395928530351077,0.38636363636363635,0.6112930306756377,1.0,16/54,19.87%,CLDN1;CLDN2;CLDN16;CLDN14;PARD6B;ECT2;PAK2;POF1B;PECAM1;MARVELD2;PRKCI;GRHL2;CRB3;CLDN4;STRN;F11R
prerank,cellular protein-containing complex assembly (GO:0034622),0.23204969683092044,1.038655123835876,0.28125,0.6128259762699838,1.0,42/158,15.57%,CENPW;CCT2;HSPD1;PSMG1;SMAD1;POMP;CENPE;CENPA;SHQ1;NUP93;PSMD13;PSMG3;FCHO1;DLGAP5;PFDN6;CCDC103;DHX9;DNAAF2;CYBA;SPAG1;AIFM1;PTGES3;CLTA;HSPA4;NUP107;VBP1;AP2S1;DNAAF3;COX7A2L;VAMP8;ADRM1;LONP1;PRLR;ANLN;CLTC;NUP205;PSMD11;TRAF2;USH1C;COX7A2;CENPF;TCP1
prerank,Rho protein signal transduction (GO:0007266),-0.2854918580983076,-1.0384102671439706,0.3888888888888889,0.6079685908690726,1.0,21/54,23.08%,NTN1;AGTR1;CDC42EP3;ARHGAP6;RHOJ;MYO9B;NGFR;RHOB;ARHGEF11;GNA12;CDC42EP4;RHOA;ARHGAP29;ROCK1;TAX1BP3;ARHGAP5;CTNNAL1;ARHGEF3;ARHGDIG;RHOU;CDC42EP2
prerank,positive regulation of chemotaxis (GO:0050921),-0.3259929168082678,-1.038379057782205,0.45614035087719296,0.6073943305717319,1.0,13/44,17.55%,IL6R;FGF2;PTN;ZNF580;NTRK3;PRKD1;PPM1F;MEGF8;RARRES2;HSPB1;P2RY12;PDGFB;DSCAM
prerank,clathrin-dependent endocytosis (GO:0072583),-0.34893846511746157,-1.0380523440603149,0.36538461538461536,0.6076945280384716,1.0,13/26,26.29%,PIP5K1C;ITSN2;ITSN1;INPP5F;SNAP91;SIGLEC1;AP2A2;FCHSD2;DLL1;AP2M1;SGIP1;DNAJC6;FCHO2
prerank,aortic valve morphogenesis (GO:0003180),-0.3449935096356612,-1.0376235557250908,0.41935483870967744,0.6078156589255937,1.0,10/31,16.93%,NPPA;NFATC1;SLIT2;EMILIN1;SLIT3;HEY1;ROCK1;HEY2;TIE1;ELN
prerank,ncRNA metabolic process (GO:0034660),0.30702621312933454,1.0375175534564194,0.3333333333333333,0.6152167050195297,1.0,6/34,4.71%,RAN;NIFK;HENMT1;XPO5;PIWIL1;KHSRP
prerank,cardiac ventricle development (GO:0003231),-0.3593721610002264,-1.0372409527418247,0.3442622950819672,0.6081741716790101,1.0,7/19,20.08%,PDE2A;DAND5;MDM4;HEY1;HEY2;HECTD1;SCN5A
prerank,retinoic acid metabolic process (GO:0042573),-0.36208317043018806,-1.0371328126540165,0.4482758620689655,0.6078791022388184,1.0,6/23,12.97%,BCO2;ADH1B;CYP27C1;ALDH8A1;SCPEP1;CYP26B1
prerank,chromatin remodeling (GO:0006338),0.25006781914572884,1.036906121588903,0.3673469387755102,0.616180782174954,1.0,21/103,11.39%,RUVBL1;MYC;SUV39H2;NPM3;CBX3;ACTL6A;RUVBL2;HDAC2;SMARCB1;FOXP3;NUDT5;TOP1;SMARCA4;POLE3;SOX9;ACTR8;HMGA2;HDAC1;MTA2;SMARCD2;HNRNPC
prerank,glucose homeostasis (GO:0042593),-0.2732483229309419,-1.0365168067411947,0.42857142857142855,0.6088790160191976,1.0,27/79,22.90%,SLC2A4;KCNB1;CRY2;HECTD4;PIK3R1;NR1D1;NGFR;CYP11B1;PRKAA2;GCK;MBD5;SLC30A8;INPP5K;LEPR;CRTC2;KLF7;CARTPT;INSR;PDK2;SIRT1;INS;CRY1;PIK3R2;OAS1;WFS1;CAV3;BAD
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.31252356472348425,1.0361560309953362,0.3333333333333333,0.6175201806221596,1.0,9/28,20.96%,MYC;INHBA;CCL3;ZFPM1;PTPN2;ZNF675;LILRB4;HOXA7;CDK6
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.3292190917985947,1.0355015453963785,0.375,0.618687332903627,1.0,12/25,26.70%,PPIH;PPIL1;PPIB;PPIF;FKBP4;PPIAL4A;PPIL3;PPIAL4C;PPID;PPIL6;FKBP1B;PPIAL4G
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.3364256478955621,-1.0353448577336255,0.390625,0.6112289823963176,1.0,14/38,20.82%,TENM1;CADM3;NLGN1;AMIGO1;DCHS1;FAT4;CADM1;CRB1;TENM3;IL1RAPL1;HMCN1;AMIGO2;ADGRL1;TENM2
prerank,macrophage differentiation (GO:0030225),0.37930839628667057,1.0351766736605084,0.38095238095238093,0.6190333422738876,1.0,8/15,33.22%,CSF2;MMP9;BMP4;CDC42;IFNG;CASP8;PARP1;VEGFA
prerank,lysosome organization (GO:0007040),-0.3286398595219887,-1.0347875676359826,0.38,0.6119076840474683,1.0,14/35,26.17%,TPCN2;ABCA1;ZKSCAN3;LRRK2;AKTIP;CLVS2;TFEB;HOOK3;SNAPIN;MTOR;TPP1;CLN3;VPS33A;HPS1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.28795197072012363,1.0346007187346264,0.391304347826087,0.6199883497533354,1.0,7/53,6.98%,GNL3L;SOX4;PRR7;PRMT3;GTPBP4;RPS3;TNFAIP3
prerank,carbohydrate derivative transport (GO:1901264),0.3634914450132619,1.0344840929676695,0.4782608695652174,0.6196192340080707,1.0,8/17,26.08%,SCARB1;SLC25A19;SLC29A2;SLC10A7;SLC15A4;ABCG1;PLA2G10;MFSD2A
prerank,mRNA catabolic process (GO:0006402),0.3078188210902474,1.0331748190689138,0.5,0.6219822170512666,1.0,11/39,18.28%,MRTO4;LSM5;EXOSC4;PNPT1;CNOT10;PDE12;LSM2;YTHDF2;LSM6;XRN2;NUDT16L1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.28486881049180673,-1.0319502127269358,0.41935483870967744,0.6183465738201233,1.0,12/47,18.50%,PER1;TGFBR3;SEMA4C;MAPK8IP3;TAOK2;DAB2IP;MAPK1;MAPK3;MID1;FAS;EGFR;MAPK8IP1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.2565237018598568,1.0318705257999188,0.4,0.6245464969969445,1.0,23/91,13.72%,POLR2F;POLR2D;TDGF1;CXCL8;HNRNPF;FGF19;NCBP1;ANOS1;CD44;PTBP1;FGFRL1;FIBP;GALNT3;FGFR4;SHCBP1;NCBP2;FGF20;TRIM71;POLR2C;GTF2F2;POLR2K;FGF3;POLR2J
prerank,negative regulation of dephosphorylation (GO:0035305),0.3660340357677272,1.0316877004259406,0.5,0.6241087527236213,1.0,11/19,36.43%,YWHAB;SH2D4A;PPP1R8;PPP1R35;URI1;SH3RF2;CHP1;PPP1R36;GPATCH2;PPP1R26;ZCCHC9
prerank,regulation of protein export from nucleus (GO:0046825),0.3421036491153534,1.0312900016147903,0.35714285714285715,0.6244330533208974,1.0,11/23,23.96%,GTSE1;IL1B;YWHAE;RANGAP1;GSK3B;RBM22;XPO4;UHMK1;ANP32B;TP53;BARD1
prerank,cholesterol homeostasis (GO:0042632),0.2635238216788964,1.0308109421969471,0.39473684210526316,0.6250529117391567,1.0,24/62,24.05%,TMEM97;DGAT2;SCARB1;MTTP;RALY;XBP1;LIPG;FGFR4;PCSK9;CYP39A1;CYP7B1;INSIG1;LRP5;MALL;ABCG5;APOM;CETP;CAV1;HNF4A;LDLR;TSKU;PLA2G12B;ABCG8;ABCG1
prerank,cellular response to misfolded protein (GO:0071218),-0.35070572336546124,-1.0302225178584412,0.43859649122807015,0.6221153649361281,1.0,4/19,6.84%,DNAJC18;POMT2;ATXN3;RNF185
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.350339841420682,-1.0282084767624737,0.4528301886792453,0.6262496011169131,1.0,9/21,21.60%,BCL2L2;MOAP1;BCL2;FAS;CASP3;CASP9;DCC;GSK3A;BOK
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.36210605723791855,-1.0281717358514442,0.46551724137931033,0.6257215318278397,1.0,7/17,24.37%,PPP1R12A;MAGI2;CALM1;AGTR2;MTOR;CALM2;CD33
prerank,regulation of protein sumoylation (GO:0033233),-0.3626606235522637,-1.0280082551872263,0.3888888888888889,0.6255182189190633,1.0,6/18,10.26%,HDAC4;PIAS3;CAPN3;RASD2;RWDD3;ZMIZ1
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.2379950047629806,-1.0277336832158392,0.36065573770491804,0.6255014750425033,1.0,61/203,21.73%,FLCN;ATP2B4;NOVA1;ASB1;MYOCD;ARNTL;RGS2;ACTN3;SRF;TFE3;PLCL1;RPS6KA5;NR1D1;ATF4;SYT11;EVL;LAMA4;RBPJ;PTEN;NOVA2;NFIB;NPTN;SPX;SPRY1;CORO1C;NPR3;MCC;HEY1;MEF2C;WWC2;NR1H2;DAB2IP;BBS2;ALDH1A1;KLF7;IP6K1;TRPV3;HDAC9;SFRP1;ROCK1;HEY2;RAB11FIP3;WWC3;ZNF423;ADAMTS5;CRHBP;IL17RD;EGFR;IL18R1;ABHD6;GSK3A;INS;HS3ST5;TLE3;LNPEP;VASN;MAP2K6;SMAD7;IFNGR1;RAB11FIP5;PARP3
prerank,multivesicular body assembly (GO:0036258),0.3126208674689551,1.0275670230775218,0.3783783783783784,0.6330191360904723,1.0,10/30,21.09%,VPS25;VTA1;RAB11A;CHMP4C;CHMP5;VPS37B;STAM;CHMP2B;CHMP1A;MVB12A
prerank,long-chain fatty acid metabolic process (GO:0001676),0.2585095081225441,1.026813369838966,0.30952380952380953,0.6344243914244603,1.0,30/75,26.90%,FAAH2;ACSL6;ASAH2B;GPX1;AIG1;PNPLA3;ACSL3;ELOVL1;ACSL5;ACOT4;ACOT8;CYP4F3;HSD17B4;CYP4F11;ALOXE3;LTA4H;ELOVL6;ASAH2;CYP2J2;FAAH;HACL1;SLC27A4;CYP4F2;DAGLA;GPX4;CPT2;ALOX12;GSTP1;PLA2G10;ALOX12B
prerank,hyaluronan metabolic process (GO:0030212),0.3380762659302652,1.026500762627294,0.3333333333333333,0.6345553744803948,1.0,5/22,7.29%,CEMIP;HEXB;IL1B;CD44;HYAL3
prerank,negative regulation of neurogenesis (GO:0050768),-0.3227688801216506,-1.0264623171856189,0.4393939393939394,0.6278628496626568,1.0,15/35,22.13%,PTN;RUFY3;NGFR;GDI1;PTEN;GORASP1;MAG;RHOA;PCM1;MCF2;RTN4;CCL11;HOOK3;RAPGEF2;B2M
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.2943178381278255,1.0264025966663584,0.4090909090909091,0.6339935967727741,1.0,10/30,19.35%,TRIB3;DCUN1D5;UBE2S;UBE2N;RPS2;UBE2C;PLK1;RAB1A;CDC20;AXIN1
prerank,protein heterooligomerization (GO:0051291),-0.35967806478928066,-1.0261877081371156,0.44642857142857145,0.6278143321502571,1.0,4/16,8.47%,PKD1;CPSF7;PKD2;MAT2A
prerank,regulation of mitotic spindle organization (GO:0060236),0.3021381064602589,1.0261706360256475,0.41025641025641024,0.6339454610093186,1.0,13/35,20.37%,TACC3;RAE1;PSRC1;CHMP4C;GPSM2;DRG1;TPX2;CLTC;PLK1;NUP62;CHMP5;CHMP2B;CHMP1A
prerank,cellular response to amino acid starvation (GO:0034198),-0.278140398698157,-1.0257754933144878,0.41818181818181815,0.6284006851072602,1.0,21/70,19.69%,FLCN;ATP6V1G2;SZT2;RRAGC;ATF4;PRKD1;MAPK1;MAPK3;RRAGB;RNF152;WDR59;CDKN1A;TFEB;MAPK8;FAS;DEPDC5;ATP6V1B1;KPTN;RRAGD;ATP6V1E1;TCIRG1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.2910128976633491,-1.0257732378590432,0.423728813559322,0.6277468705657454,1.0,14/44,16.33%,LIMS2;FLNA;FERMT2;MYOC;ILK;TRIOBP;DOCK1;CORO1C;FBLN1;RAC1;EFNA5;ARHGEF7;KANK1;MYADM
prerank,positive regulation of interferon-beta production (GO:0032728),0.332500058287877,1.0253637097708328,0.525,0.6354070521272074,1.0,15/34,30.16%,RIPK2;POLR3C;DHX9;POLR3B;OAS2;ISG15;POLR3G;OAS3;HSP90AA1;POLR3A;PTPN11;TLR7;IRF3;IRF7;TLR8
prerank,sensory perception of mechanical stimulus (GO:0050954),0.25954353036644834,1.0253410000217709,0.425,0.6347440173035555,1.0,23/82,19.13%,CEMIP;COL1A1;COL11A1;LHFPL5;KCNQ1;TIMM10;TIMM13;CHRNB2;TIMM8B;DCDC2;CACNA1D;SLC52A3;MARVELD2;EML2;ALDH7A1;USH1C;MYH14;TPRN;GRAP;EYA1;BIRC5;MYO3B;ATP6V0A4
prerank,nuclear envelope organization (GO:0006998),-0.3519163756151401,-1.0248392789167362,0.39655172413793105,0.6293845238384553,1.0,5/21,8.07%,DMPK;SUN1;TOR1AIP1;SUN2;TMEM43
prerank,protein-containing complex subunit organization (GO:0043933),-0.24345149625278611,-1.0242850516606072,0.38461538461538464,0.630347025380136,1.0,25/108,17.28%,VAMP2;SH3BGR;WDR19;CAPN3;TCAP;MITF;TRAF1;DLG4;PARD3;TEAD1;LAMC1;KMT2A;DET1;WASF1;WASF3;MDM4;NCKAP1L;TSPAN4;MAGI1;RANBP9;ADD2;TEAD2;APC;FAS;WIPF1
prerank,ureteric bud morphogenesis (GO:0060675),-0.33861995617344043,-1.0242701316150202,0.4426229508196721,0.629751573985051,1.0,4/19,7.34%,GDNF;PKD2;FGF2;TCF21
prerank,negative regulation of response to wounding (GO:1903035),0.3326416212876421,1.0239432055879154,0.425,0.6378222570982487,1.0,6/20,11.12%,CASK;KLK8;RTN4R;EPPK1;MDK;CERS2
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.347347434011524,-1.0238239436985879,0.4107142857142857,0.6301190921144402,1.0,12/29,24.14%,CLU;BAG2;KCNE2;PTEN;DAB2IP;ECSCR;NUPR1;CDK5RAP3;FBXW7;CAV3;OSBPL7;PSMC5
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.31510221803103405,-1.0232199878923003,0.38596491228070173,0.6310195642877829,1.0,15/39,22.97%,WNK3;CALM1;TRIM6;PARD3;CADM4;PPEF2;PRKAG2;SIRT2;INPP5K;MAPK1;S1PR2;AZU1;SMAD7;RPTOR;CALM2
prerank,fatty acid metabolic process (GO:0006631),0.2394698843009102,1.0231876668825173,0.36363636363636365,0.6389427849136753,1.0,53/115,32.36%,NUDT19;ADIPOR1;ACBD5;AOAH;ACSL6;BAAT;ACOT7;CEL;XBP1;LIPG;GPX1;MCAT;PNPLA3;ACSL3;MSMO1;ACSL5;SGPL1;ACOT4;ACOT8;ACLY;PPARG;NDUFAB1;ACSF3;FASN;OXSM;SLC27A5;FA2H;CYP4F11;PLA2G15;ALOXE3;CYP2J2;FAAH;HACL1;SLC27A4;CYP4F2;HSD17B8;PON3;GPX4;CPT2;ALOX12;ALOX12B;PEX2;ALOX5AP;ACOT6;LIPH;ACSM4;ACSBG1;ACSM3;ACSL4;CBR4;ACOX1;MECR;ADIPOR2
prerank,regulation of interleukin-6 production (GO:0032675),0.24365525985945957,1.0230475151297427,0.48717948717948717,0.6385581033923301,1.0,35/104,28.40%,IL1A;HSPD1;EREG;IL1B;WNT5A;SYK;TNFAIP3;DHX9;CYBA;XBP1;MYD88;IL17A;NOS2;MAPKAPK2;IL17F;GBA;MAPK13;F2R;LILRB4;NOD2;TNFSF4;MMP8;HMGB1;ZC3H12A;HYAL2;CD47;TYROBP;PTPN11;FOXJ1;IL37;IFNG;CLEC7A;IRAK3;IL10;TLR7
prerank,histone acetylation (GO:0016573),-0.27840676893956695,-1.0224390142728463,0.359375,0.6322089645665155,1.0,25/69,24.44%,PER1;APBB1;SUPT7L;JADE1;KAT2B;CHD5;DMAP1;KAT6B;ING4;BRD8;MORF4L1;EPC1;BRD1;ACTL6B;KAT7;KAT2A;ING3;EP400;ING5;MAP3K7;KAT5;ATF2;SUPT3H;KAT8;JADE2
prerank,response to amino acid starvation (GO:1990928),-0.2728856566038531,-1.022356280126292,0.4067796610169492,0.6317786821539998,1.0,21/71,19.69%,FLCN;ATP6V1G2;SZT2;RRAGC;ATF4;PRKD1;MAPK1;MAPK3;RRAGB;RNF152;WDR59;CDKN1A;TFEB;MAPK8;FAS;DEPDC5;ATP6V1B1;KPTN;RRAGD;ATP6V1E1;TCIRG1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3602882045682455,-1.0214566930083964,0.38596491228070173,0.633496846168522,1.0,11/25,26.55%,CACNA1C;ANK2;CALM1;CTNNA3;RYR2;FGF13;CAMK2D;CAV3;ATP2A2;AKAP9;NOS1AP
prerank,positive regulation of DNA metabolic process (GO:0051054),0.26958480967988135,1.0212048008661097,0.3333333333333333,0.6425624454319663,1.0,13/58,13.13%,MYC;BRCC3;UBE2N;PDGFRB;GNL3;ERCC8;PML;RPS3;DHX9;FGFR4;CEBPG;WRAP53;BRCA1
prerank,protein transport (GO:0015031),-0.22757448719914777,-1.0210491878744663,0.4166666666666667,0.6341097757087707,1.0,90/354,20.63%,SEC31B;VAMP2;SNX1;ATP6V1G2;DNAJC27;TBC1D1;SGSM2;TBC1D17;ARL4D;STX1B;RABGAP1;ARRDC4;RABL2B;ZDHHC17;CLU;TBC1D10A;USP6;TBC1D26;MACF1;RAB34;RABL2A;ANK3;VPS45;SNX33;CHMP3;RAB6B;STX16;VAMP4;SNX15;WDR11;RAB12;TRIM23;HDAC6;PRKCB;SNX27;NEURL1B;STX2;ABCA1;COPZ2;RAB28;NGFR;BBS1;EVI5L;RAB5B;LRP1B;TBC1D2B;GPIHBP1;RIC1;NAPB;SGSM1;RAMP1;ARRDC2;GGA3;OPTN;RD3;RAB23;WLS;VPS33B;HERC2;TBC1D13;RAB3A;BBS2;VIPAS39;KIF13A;MCOLN1;VLDLR;TICAM2;LRSAM1;TBC1D25;CEP290;SGSM3;STX12;RAB13;GGA2;ATP6V0A1;RAB3C;ATP6V1B1;VAMP5;RAMP3;CD36;RAB24;ADPRH;SNX31;ATP6V1E1;TCIRG1;TBC1D12;RPGR;RUFY1;RAB8B;PREPL
prerank,negative regulation of wound healing (GO:0061045),-0.3497789072065029,-1.020422167843614,0.38095238095238093,0.6352040948577532,1.0,9/26,15.40%,FGF2;PHLDB2;CD34;CLASP1;PTEN;CLASP2;AJAP1;MYOZ1;TFPI
prerank,"base-excision repair, AP site formation (GO:0006285)",0.3926465038992722,1.020247797041096,0.45454545454545453,0.6443723438092909,1.0,5/18,12.71%,UNG;NTHL1;NEIL3;ERCC5;MPG
prerank,peptidyl-threonine modification (GO:0018210),-0.2771082753488619,-1.0200731095070408,0.3898305084745763,0.6353125093134568,1.0,25/67,23.51%,CSNK2A2;ULK1;GALNT16;WNK3;HIPK4;CDC42BPA;PRKCA;PRKD1;HIPK3;CDC42BPB;DYRK1A;LRRK2;MAPK1;ROCK1;MAPK8;CAMK2D;CSNK2B;MAP3K10;MAP3K12;GSK3A;TNKS;HIPK1;MYLK2;WNK1;PRKCD
prerank,regulation of protein kinase activity (GO:0045859),-0.2570728975720538,-1.0197205005466439,0.4375,0.6354977638999539,1.0,36/104,22.87%,TSPYL2;RAP1A;DDR2;WWTR1;SNCA;TAB2;PRKRIP1;DBNDD2;PRKAG2;PPM1F;UVRAG;MAPRE3;HSPB1;PLCE1;INPP5K;TAB1;RELN;CDKN1A;MMD2;TRIB2;GNAQ;DUSP19;AZU1;TSC2;ALS2;RASSF2;ANKRD54;CAMKK1;SIRT1;CCL21;RAPGEF2;CAMKK2;SOD1;LRP6;TTN;CAV3
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3723138953853344,-1.0188672704625206,0.38461538461538464,0.637106872659532,1.0,7/16,27.15%,PPM1F;NOTCH4;TJP1;DENND6A;ADAM19;RGCC;FLOT1
prerank,membrane organization (GO:0061024),-0.23048669185472265,-1.0188654541147415,0.4307692307692308,0.6364535234832919,1.0,67/238,22.87%,VAMP2;FNBP1;DMPK;PIP5K1C;SYNGR1;ANK2;EPN2;TRIP10;FZD4;CNTN2;RABEP1;BTC;SYNJ1;ANK3;SUN1;CHMP3;VAMP4;REEP1;TOR1AIP1;AMPH;SUN2;ADRB2;ITSN1;A4GALT;TMEM43;MFN2;CHRM2;SYP;HACE1;SYT2;SLC18A3;SYT9;CORO1C;VTI1B;VPS33B;DYSF;ARPC2;DVL2;AP2A2;TRDN;AVPR2;PACSIN2;EPS15L1;RTP5;CCDC88A;MYADM;VPS4A;CBL;AZIN2;VAPA;EPS15;EGFR;CHMP4A;UBB;CTDNEP1;DNM1;AP2M1;PLEKHA3;RIMS1;GLTP;GAPVD1;ACTB;CLTCL1;SYT1;RTP1;SGIP1;CAV3
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.3515040795155287,1.0180421434685278,0.4339622641509434,0.649667756509788,1.0,7/17,18.34%,PLBD1;LCLAT1;PLA2G2F;PLA2G4E;PLA2G4D;LPGAT1;PLA2G2D
prerank,regulation of centrosome cycle (GO:0046605),0.33278370539401475,1.0173803182162544,0.4146341463414634,0.6508315121662692,1.0,13/22,33.74%,NAT10;CHMP4C;AURKA;NPM1;CHMP5;CHMP2B;CHMP1A;CHMP2A;RAB6C;ATF5;CHMP1B;GEN1;PKHD1
prerank,sterol homeostasis (GO:0055092),0.2564128101043256,1.0170983166258487,0.4358974358974359,0.6508151528749181,1.0,23/63,22.83%,TMEM97;DGAT2;SCARB1;MTTP;RALY;XBP1;LIPG;FGFR4;PCSK9;CYP39A1;CYP7B1;INSIG1;LRP5;MALL;ABCG5;APOM;CETP;CAV1;HNF4A;LDLR;TSKU;PLA2G12B;ABCG8
prerank,iron ion transport (GO:0006826),0.2822005848839825,1.016449001278579,0.3953488372093023,0.651835799666042,1.0,12/47,16.34%,ATP6V1C2;TFR2;ATP6V1G1;SLC40A1;ATP6V0B;HEPHL1;ATP6V1A;SLC11A2;CLTC;ATP6AP1;ATP6V1F;STEAP3
prerank,vascular transport (GO:0010232),-0.26512517774205335,-1.0164265233568237,0.3559322033898305,0.6419476045001166,1.0,22/83,18.29%,SLC2A4;ATP1B2;ATP2B4;SLC16A12;ATP1A2;ABCC5;SLC8A2;ATP1A4;SLC24A3;ABCC9;SLC27A1;SLC7A2;SLC1A2;KCNJ8;SLC16A2;LEPR;SLC38A2;SLC6A1;SLC6A17;SLC4A3;INSR;SLC29A1
prerank,protein autophosphorylation (GO:0046777),-0.23781499136009498,-1.0160569456591388,0.3384615384615385,0.642317064873034,1.0,54/156,23.93%,MKNK1;MAP3K3;FGFR1;ULK1;DDR2;WNK3;CAMK2A;ULK2;PDGFRA;EEF2K;FGFR2;CLK2;FES;KIT;DAPK1;GRK5;PRKD1;DYRK1A;ALK;LRRK2;FLT4;FER;NTRK1;TAOK2;MEX3B;EPHA4;MAPK3;DAPK3;STK33;BMX;CAMK2B;PEAK1;MUSK;CAMK2D;INSRR;AATK;MARK3;INSR;EGFR;ERBB4;MAP3K10;SLK;MAP3K12;PIKFYVE;CAMKK2;MKNK2;SMG1;MTOR;MYLK2;RIPK1;PIM1;CDKL5;PINK1;FLT1
prerank,cation transmembrane transport (GO:0098655),0.2939577643322461,1.0157721256570167,0.42857142857142855,0.6528288346353948,1.0,13/44,15.09%,SLC6A20;SLC7A1;SLC38A5;SLC7A5;TRPM2;MFSD12;ATP1B1;ATP13A2;SFXN2;SLC25A19;SFXN1;KCNJ11;SLC3A2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.3667221753245174,-1.0157147330624732,0.3389830508474576,0.6424365925775304,1.0,7/20,18.12%,FGF2;DSTYK;NPTN;SPRY1;SPRY3;LRIT3;GPC1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.28678854964039974,-1.0156750378311978,0.39622641509433965,0.6418953091508242,1.0,14/51,14.08%,TSPYL2;ADD1;TLN1;DCTN1;EXTL1;PPP2R5B;PLA2G4B;CTDSP2;TATDN2;ZBTB17;CXXC1;ACADVL;PARP16;EXTL2
prerank,positive regulation of interleukin-12 production (GO:0032735),0.3191559691875156,1.0155949074580526,0.4318181818181818,0.6525705151714071,1.0,11/34,22.41%,HSPD1;RIPK2;IL23A;SYK;MDK;IL17A;IL23R;TNFSF4;HMGB1;IL12B;LTB
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.3387627935791471,1.0155906858110244,0.44680851063829785,0.6518338976910362,1.0,8/20,26.17%,HS6ST2;GLCE;HS2ST1;EXT2;HPSE;SULF2;NDST3;EXT1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.39448476878371336,1.0144333348383836,0.4318181818181818,0.6540949010820305,1.0,10/15,27.49%,DNMT1;DNMT3B;BRCA1;WDR5;MYB;PAXIP1;CTR9;AUTS2;CTNNB1;WDR61
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.37643485865689685,-1.0139246340789894,0.4909090909090909,0.6460412478465953,1.0,6/20,9.98%,ATP1B2;ATP1A2;KCNMA1;SLC8A1;ATP1A4;ATP1A3
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.3792269729370809,1.0129346739364424,0.3829787234042553,0.6577589597390893,1.0,10/15,28.02%,MTHFD1;MTHFD1L;IRX5;EIF4A3;SIX1;TGFBR2;LHX1;TGFBR1;HOXA1;TFAP2A
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.35786513716111457,-1.0127663372325275,0.40625,0.6483061095219161,1.0,6/20,15.80%,TGFBR3;OLFM1;RBPJ;SPRY1;HEY1;HEY2
prerank,transferrin transport (GO:0033572),0.30099563432204735,1.0121678716142355,0.4358974358974359,0.6591163109076768,1.0,10/35,19.13%,ATP6V1C2;TFR2;ATP6V1G1;ATP6V0B;ATP6V1A;CLTC;ATP6AP1;ATP6V1F;STEAP3;ATP6V0A4
prerank,cellular macromolecule catabolic process (GO:0044265),0.2789925306033019,1.0119823597831525,0.42857142857142855,0.6588021027145167,1.0,16/49,18.84%,RNASEH1;SND1;STT3B;CHEK2;PNPT1;NCBP1;EXOSC7;MANBA;DNASE1L1;PPP1R8;FBXO6;RNASEH2A;XRN2;IDE;RNASEH2B;NGLY1
prerank,transport across blood-brain barrier (GO:0150104),-0.2631758315555977,-1.0117107292093146,0.3559322033898305,0.6507476222801006,1.0,23/85,18.84%,SLC2A4;ATP1B2;ATP2B4;SLC16A12;ATP1A2;ABCC5;SLC8A2;ATP1A4;SLC24A3;ABCC9;SLC27A1;SLC7A2;SLC1A2;KCNJ8;SLC16A2;LEPR;SLC38A2;SLC6A1;SLC6A17;SLC4A3;INSR;SLC29A1;CD36
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.3043402854865134,1.0114441729665926,0.5227272727272727,0.6594033360390239,1.0,6/29,7.77%,DDIAS;FBXO5;PSMD10;CD44;RPS3;BCL2L1
prerank,phospholipid metabolic process (GO:0006644),0.27321358530347883,1.0111886732220354,0.425,0.6594650025143995,1.0,21/63,18.43%,CYP2W1;AGPAT5;PLBD1;ABHD12;SMPD2;PLAA;PDXP;LIPG;IDI2;PNPLA3;ACP6;AGPAT2;PLA2G2F;PLA2G4E;PLA2G3;PLA2G4D;FITM2;PCYT2;FDFT1;PLA2G2D;AGPAT3
prerank,protein catabolic process (GO:0030163),-0.2692725330018967,-1.0105517571944054,0.43333333333333335,0.6531936296603454,1.0,14/60,15.54%,DENND3;FBXO17;CAPN3;UBE2G2;RAB12;NR1D1;ELANE;FBXO44;FBXO27;UBE2G1;DAB2IP;CELA2A;ADAMTS9;LRSAM1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.24880699414889065,1.0102724156800797,0.425531914893617,0.661151778712937,1.0,32/93,20.50%,CEP72;KIF24;CDK1;CEP250;YWHAE;NEK2;TUBB4B;HAUS2;RAB11A;YWHAG;TUBA4A;RAB3IP;HAUS8;B9D1;CEP76;TMEM216;RPGRIP1L;CKAP5;HAUS1;HAUS6;PLK1;TUBG1;CEP78;PLK4;TCTN3;DYNLL1;HAUS7;SCLT1;MAPRE1;SSNA1;CEP41;HSP90AA1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.26234555038251,-1.0102028189037497,0.4,0.6534726377011879,1.0,27/72,23.85%,FAM107A;HDAC4;DCUN1D4;PIAS3;TSPYL5;RASD2;RWDD3;LRRK2;KLHL40;BCL10;WDR48;DCUN1D3;UBB;CDK5RAP3;FBXW7;ANGPT1;PIAS4;GSK3A;PRICKLE1;CRY1;SMAD7;SENP2;WFS1;MYCBP2;PIAS1;MUL1;PINK1
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.38697868053540413,-1.009856367609904,0.47368421052631576,0.6536654430183262,1.0,3/16,5.32%,MYOCD;CLU;SRF
prerank,negative regulation of T cell activation (GO:0050868),0.2664583709924277,1.0097029571157148,0.5,0.6616858484142205,1.0,20/41,34.95%,CEBPB;IL4I1;FOXP3;CD80;JAK3;PLA2G2F;VTCN1;LILRB4;PLA2G2D;CD86;SDC4;TIGIT;IL10;GLMN;IFNL1;CD274;HAVCR2;LAX1;TNFAIP8L2;PDCD1LG2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2547809185660317,1.009446007594376,0.36585365853658536,0.6616449228101093,1.0,34/75,30.65%,ANXA4;IRAK2;FOXP3;PSMD10;DAP;TNFAIP3;CDKN2A;BRMS1;IRAK1;SETD6;NLRC5;BMP7;TMSB4X;COMMD1;NWD1;OTULIN;ZNF675;NFKBIA;RBCK1;TRIM37;G3BP2;NFKBIB;ZC3H12A;SPI1;CCDC22;FOXJ1;IRAK3;NLRP2;IL10;PYDC1;NLRP3;ITCH;AIM2;CHP1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.30210499096666155,-1.0083618952527587,0.4406779661016949,0.6571368829243257,1.0,12/45,15.25%,NFATC4;FGF2;SRF;PPARD;TEAD1;NGFR;ATOH8;NFIB;NR3C1;PRL;GATA2;PDGFB
prerank,integrin-mediated signaling pathway (GO:0007229),-0.2752430827667858,-1.007875807721912,0.48,0.6579806582623725,1.0,13/67,11.89%,ITGA10;ADAM11;FERMT2;LAMA5;PTN;ILK;COL16A1;ITGB3;ADAMTS1;PRKD1;DOCK1;DST;FBLN1
prerank,regulation of phosphorylation (GO:0042325),0.23597171645586204,1.0076295267194488,0.375,0.6658153513409745,1.0,30/121,17.92%,NUP37;EREG;NUP155;INHBA;RAE1;NUP93;NUP35;SEH1L;SEC13;NUP210;PML;CDKN2A;NUP43;MCM7;EIF6;NUP50;SOCS1;PTGES3;NUP88;FN1;NUP107;NLRC5;BMP7;NUP205;BMP4;NUP62;NUP160;DYNLL1;NDC1;LYN
prerank,regulation of spindle organization (GO:0090224),0.3331093962145122,1.007568127008924,0.45098039215686275,0.6652595822762951,1.0,7/18,15.21%,TACC3;RAE1;PSRC1;GPSM2;TPX2;CLTC;NUP62
prerank,eye morphogenesis (GO:0048592),-0.356786605342328,-1.007365283889068,0.35714285714285715,0.6585855779453933,1.0,10/19,34.36%,MFAP5;SKI;TENM3;IFT122;EFEMP1;NIPBL;ALDH1A3;RARG;COL5A1;FBN1
prerank,regulation of inflammatory response (GO:0050727),0.22349134603505727,1.0073219833809637,0.4186046511627907,0.6650904371311498,1.0,82/197,31.53%,OSM;IL23A;ZP3;IL1B;WNT5A;VPS35;PIK3AP1;MGST2;TNFAIP3;AOAH;USP18;CEBPA;NMI;MDK;DHX9;IL21;XIAP;CCL3;SPATA2;MYD88;RELA;FFAR2;PLA2G7;ADAMTS12;SETD6;PROC;MMP3;AGT;MMP9;GRN;TMSB4X;GBA;MAPK13;FPR2;PPARG;PTPN2;FEM1A;OTULIN;IL1RL2;MVK;TNFRSF1B;NOD2;NFKBIA;SERPINE1;TNFSF4;MMP8;SEMA7A;IL12B;HYAL2;CD47;ENPP3;GPR31;CASP4;DAGLA;ZBP1;SMPDL3B;ACE2;CCL1;FFAR4;ANXA1;ETS1;IL37;IFNG;IFI35;PARK7;IL10;IL18;TLR7;BCL6;TEK;HCK;LPCAT3;SNX6;NLRP3;NLRP6;DAGLB;LACC1;XCL1;AREL1;CASP5;TNF;CCL5
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.28260334488750943,1.007296639383614,0.42857142857142855,0.6643753235928849,1.0,23/52,32.06%,USP50;RIPK2;WNT5A;CCL3;MYD88;IL17A;GBP5;EGR1;NOD2;MNDA;IFI16;TYROBP;IFNG;CLEC7A;CASP8;NLRP2;PYDC1;PANX1;NLRP3;TLR8;AIM2;TNF;LILRA5
prerank,negative regulation of cell aging (GO:0090344),0.34146396112562094,1.00715380586682,0.4222222222222222,0.6640215142697151,1.0,7/16,24.74%,FBXO5;RBL1;HMGA2;FOXM1;CDK6;AKT3;TERT
prerank,regulation of establishment of protein localization (GO:0070201),-0.3854768240424107,-1.007028173685355,0.5319148936170213,0.6588386745841077,1.0,4/15,23.14%,CORO2B;CEP290;GAPVD1;CEP120
prerank,hepaticobiliary system development (GO:0061008),0.3505652819865751,1.0068876560171958,0.4489795918367347,0.6639658405820835,1.0,8/20,13.09%,MET;PROX1;CEBPA;LSR;XBP1;PCSK9;CEBPG;PRKCSH
prerank,regulation of cell-cell adhesion (GO:0022407),-0.29865315306146245,-1.006081654112791,0.43636363636363634,0.6607193161665514,1.0,9/41,14.25%,EPHA7;CITED2;MEGF10;MDGA1;FSTL3;MAGI1;TENM3;FUT9;EFNA5
prerank,regulation of macrophage activation (GO:0043030),0.3017140815412427,1.0060450236527114,0.4418604651162791,0.6653458008972762,1.0,4/28,7.48%,HSPD1;WNT5A;CEBPA;SPACA3
prerank,positive regulation of RNA splicing (GO:0033120),-0.3248063174497106,-1.0056131623659346,0.3404255319148936,0.6613384868338427,1.0,6/31,11.09%,CIRBP;RBM20;PIK3R1;CELF4;DYRK1A;HABP4
prerank,response to estradiol (GO:0032355),-0.31112573251424336,-1.0055930492969771,0.48,0.6607189483869335,1.0,11/35,21.61%,SOCS2;GPER1;GH1;STRN3;SFRP1;ESR1;CRHBP;EGFR;RAMP3;KAT5;SSTR2
prerank,regulation of telomere maintenance (GO:0032204),0.32337731209096304,1.0055365164426642,0.3958333333333333,0.6657337622236184,1.0,4/25,6.35%,MYC;GNL3;XRCC5;PML
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.338652995465118,-1.0054745391695503,0.4230769230769231,0.660393206487491,1.0,10/22,19.29%,MYOCD;CDKN1C;NR2F2;PTEN;LATS2;CDKN1A;APC;INCA1;HEXIM1;HHEX
prerank,protein targeting to membrane (GO:0006612),0.2531616101568041,1.0053326127582292,0.45652173913043476,0.6655528780471515,1.0,22/83,18.91%,ZDHHC9;SSR1;ARL6IP1;ATG3;PEX13;ACBD5;SEC61A1;TRAM1;ZDHHC12;RAB3IP;ZDHHC3;RABGEF1;ZDHHC24;YIF1B;ZDHHC6;SLC25A17;PRKCI;PEX16;NACA2;SIL1;VPS37B;SSR2
prerank,glucose metabolic process (GO:0006006),0.2768136755834852,1.005281080021274,0.44680851063829785,0.66495306613611,1.0,22/60,23.31%,SORD;GAPDH;GOT2;TPI1;AKR1A1;MDH2;GAPDHS;G6PC3;KCNJ11;DCXR;LRP5;SLC37A4;ALDOC;GALM;BRAT1;RBP4;SLC25A13;ADPGK;PCK2;ALDOB;SLC25A1;FBP1
prerank,ventricular septum morphogenesis (GO:0060412),-0.3177379482959188,-1.0050712536574093,0.4426229508196721,0.6608128506216484,1.0,10/28,17.74%,TGFBR3;BMPR1A;SMAD4;CITED2;ZFPM2;SLIT2;SLIT3;HEY1;HEY2;SOX11
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3072166353228887,1.0043229243061855,0.4782608695652174,0.6668431430657318,1.0,14/42,16.02%,ACTL6A;HDAC2;SMARCB1;SMARCA4;ACTR8;SPTY2D1;HDAC1;ZNHIT1;MTA2;SMARCD2;HNRNPC;SMARCC1;VPS72;CHD4
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.34624178836181224,-1.0042072622457823,0.47368421052631576,0.6622581185780732,1.0,8/20,28.88%,MSTN;RARRES2;MAPK1;MAPK3;AKIRIN1;MST1;MTUS1;DDT
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.239573284006602,-1.004124618202588,0.453125,0.6617718743492315,1.0,37/134,21.56%,FLCN;ZSWIM8;ULK1;PLIN5;SNX33;TRIM6;ARNT;SNCA;P2RX7;DAPK1;PSEN1;PRKD1;LRRK2;PRKAA2;DCN;OPTN;RDX;RNF152;TPCN1;DXO;TFEB;TP53INP1;ROCK1;TRIM34;VPS11;PACSIN3;AKT2;INSR;PLEKHF1;GSK3A;INS;BNIP3;RC3H1;TRIM8;KAT5;TRIM38;ABCD1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.2910049846864893,-1.0041150396390437,0.41379310344827586,0.6611080558751151,1.0,12/43,16.71%,PKD1;GDNF;PKD2;FGF2;TCF21;SLIT2;SEMA3E;GLI2;NOTCH4;RASIP1;TIE1;FGF10
prerank,liver development (GO:0001889),-0.3128081567004096,-1.0034735128631376,0.4666666666666667,0.6622294074747541,1.0,7/32,7.79%,NPHP3;TGFBR3;PKD2;CITED2;PHF2;CCDC39;CCDC40
prerank,regulation of multicellular organism growth (GO:0040014),-0.3558242889465183,-1.0028201272546755,0.4074074074074074,0.6631890392305593,1.0,5/18,13.42%,GH1;GHR;MBD5;PRL;BBS2
prerank,negative regulation of chemokine production (GO:0032682),-0.3771715064403818,-1.0028110717972023,0.48148148148148145,0.6625445421754353,1.0,7/17,27.01%,ELANE;APOD;C1QTNF3;MAP2K5;OAS1;MUL1;F2RL1
prerank,response to unfolded protein (GO:0006986),0.28735934031586513,1.0026077317452868,0.4230769230769231,0.6708332578838404,1.0,18/48,20.50%,STT3B;HSPD1;DERL1;ERP44;TMBIM6;HSPA14;HSPA9;HSPA4;TM7SF3;TOR1B;DNAJA1;HSPH1;HSPA5;HSP90AB1;HSPA13;BAX;BAK1;HSP90AA1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.34031643739304274,1.0022382808204475,0.43902439024390244,0.6710408150440289,1.0,3/18,11.39%,GNL3L;NAT10;HNRNPC
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.3386183228032347,-1.0022204531759287,0.4642857142857143,0.6636423100165285,1.0,5/24,11.15%,KCNB1;ANK3;MTCL1;PRNP;MYO1C
prerank,COPII vesicle coating (GO:0048208),0.2599720870147668,1.001963222635613,0.38636363636363635,0.6695658251001388,1.0,25/63,26.95%,TMED2;AREG;FOLR1;SEC13;CTSC;F5;TMED10;TRAPPC6A;RAB1A;TFG;NSF;TRAPPC9;PREB;CTSZ;CNIH1;KLHL12;TRAPPC2L;TGFA;CUL3;LMAN1;CNIH3;SERPINA1;SEC24A;TRAPPC4;BET1
prerank,vesicle coating (GO:0006901),0.2599720870147668,1.001963222635613,0.38636363636363635,0.6695658251001388,1.0,25/63,26.95%,TMED2;AREG;FOLR1;SEC13;CTSC;F5;TMED10;TRAPPC6A;RAB1A;TFG;NSF;TRAPPC9;PREB;CTSZ;CNIH1;KLHL12;TRAPPC2L;TGFA;CUL3;LMAN1;CNIH3;SERPINA1;SEC24A;TRAPPC4;BET1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.2599720870147668,1.001963222635613,0.38636363636363635,0.6695658251001388,1.0,25/63,26.95%,TMED2;AREG;FOLR1;SEC13;CTSC;F5;TMED10;TRAPPC6A;RAB1A;TFG;NSF;TRAPPC9;PREB;CTSZ;CNIH1;KLHL12;TRAPPC2L;TGFA;CUL3;LMAN1;CNIH3;SERPINA1;SEC24A;TRAPPC4;BET1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.31440674326392665,-1.0011968657291241,0.4918032786885246,0.6659253717639985,1.0,7/25,14.68%,RHOQ;GDI1;NUMB;PID1;INPP5K;KCNE1;TMBIM1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.30126247641497556,1.0009844880094834,0.40476190476190477,0.6717195705293487,1.0,15/31,29.18%,THY1;SOCS1;SEMA4D;PRKCZ;SOCS3;PTPN2;LILRB4;CAV1;HYAL2;CD300A;PPP2CA;PTK6;PPP2R1A;PIBF1;MVP
prerank,regulation of hippo signaling (GO:0035330),-0.359400972680778,-1.0007336253847172,0.42,0.6661954874078874,1.0,8/20,17.85%,WTIP;WWC2;WWC3;IQCJ-SCHIP1;MAPK14;SOX11;DLG5;MARK3
prerank,DNA methylation or demethylation (GO:0044728),0.3337752882963239,1.0007066246258323,0.4375,0.671055472379393,1.0,6/19,15.68%,DNMT1;BEND3;GATAD2A;DNMT3B;FOS;SPOCD1
prerank,DNA alkylation (GO:0006305),0.3337752882963239,1.0007066246258323,0.4375,0.671055472379393,1.0,6/19,15.68%,DNMT1;BEND3;GATAD2A;DNMT3B;FOS;SPOCD1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.27806125442079277,1.0002423901284552,0.4523809523809524,0.6717246285357824,1.0,11/39,22.00%,THY1;LRP8;RAP2B;DOK7;EFNA1;AGT;DLG3;FCGR1A;LILRB4;CAV1;HYAL2
prerank,sensory perception of sound (GO:0007605),0.24996467037105036,0.9999785900433651,0.4883720930232558,0.671965901835118,1.0,23/85,19.13%,CEMIP;COL1A1;COL11A1;LHFPL5;KCNQ1;TIMM10;TIMM13;CHRNB2;TIMM8B;DCDC2;CACNA1D;SLC52A3;MARVELD2;EML2;ALDH7A1;USH1C;MYH14;TPRN;GRAP;EYA1;BIRC5;MYO3B;ATP6V0A4
prerank,chondrocyte differentiation (GO:0002062),-0.2911303600898433,-0.9999607623724156,0.3620689655172414,0.667603516296656,1.0,13/31,25.70%,OSR1;SOX5;WNT5B;NFIB;MEF2C;WNT2B;SNX19;BMPR1B;SOX6;OSR2;CREB3L2;WNT10B;RUNX2
prerank,glycoprotein catabolic process (GO:0006516),0.34098386274175146,0.9996636646824417,0.46153846153846156,0.6723405022307433,1.0,7/17,18.84%,STT3B;ADAMTS12;EDEM2;MMP12;MANBA;FBXO6;NGLY1
prerank,acyl-CoA metabolic process (GO:0006637),0.3091767795161917,0.9993630587084555,0.4418604651162791,0.6724346894863202,1.0,10/32,17.38%,ACSL6;BAAT;THEM5;DBI;ACOT7;ACOT13;ACOT4;ACOT8;HMGCS1;OXSM
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.2767399925694979,0.9988107084105534,0.5128205128205128,0.6733057791430743,1.0,9/54,8.32%,E2F1;TFDP1;TP73;GZMB;YWHAB;YWHAE;PMAIP1;BBC3;YWHAG
prerank,positive regulation of phosphatase activity (GO:0010922),-0.33020670397437474,-0.998722869827651,0.3684210526315789,0.6700434693314593,1.0,7/20,22.97%,MAGI2;MTMR9;CALM1;MEF2C;AGTR2;MTOR;CALM2
prerank,positive regulation of interleukin-1 production (GO:0032732),0.2737658089294917,0.9986735335322924,0.4,0.672962049842757,1.0,25/58,32.06%,USP50;RIPK2;WNT5A;TMED10;CCL3;MYD88;IL17A;GBP5;EGR1;NOD2;MNDA;IFI16;HMGB1;TYROBP;IFNG;CLEC7A;CASP8;NLRP2;PYDC1;PANX1;NLRP3;TLR8;AIM2;TNF;LILRA5
prerank,positive regulation of reproductive process (GO:2000243),-0.3083074180137532,-0.9975859145899468,0.46774193548387094,0.6721153032498435,1.0,8/35,12.81%,CACNA1H;TACR2;SYDE1;SIRT2;PDE3A;VIP;TACR1;CFAP69
prerank,microglial cell activation (GO:0001774),-0.341322453398873,-0.9974768273246784,0.4727272727272727,0.6716617324943317,1.0,3/22,6.26%,MAPT;CLU;SNCA
prerank,chromatin organization (GO:0006325),0.23697824279128338,0.997346945311164,0.4594594594594595,0.6760235493321857,1.0,26/138,10.81%,RUVBL1;MYC;SUV39H2;NPM3;CBX3;ACTL6A;LOXL2;SUV39H1;RUVBL2;HDAC2;HMGN4;SMARCB1;FOXP3;NUDT5;HDAC10;TOP1;PADI3;HMGN1;SMARCA4;PADI1;SOX9;HMGB2;HMGA2;HDAC1;MTA2;SMARCD2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.35334496569859747,-0.9972082507798699,0.46938775510204084,0.6716551901367717,1.0,11/21,25.54%,TENM1;ZNF345;NAB2;AR;ZNF76;MAF1;RPTOR;MTOR;CHD8;ELL;ZNF143
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.32158581594888325,0.9971395191875324,0.5454545454545454,0.6758833188350365,1.0,9/25,26.50%,PMAIP1;SMYD2;PSMD10;CD44;KDM1A;MSX1;SPRED2;SPRED1;ATR
prerank,positive regulation of interleukin-8 production (GO:0032757),0.2556043418119601,0.9968233087175932,0.46511627906976744,0.6759609967925404,1.0,24/59,31.51%,IL1B;SYK;MYD88;RELA;FFAR2;NOS2;LAMTOR5;RAB1A;F2R;NOD2;SERPINE1;CHI3L1;HMGB1;HYAL2;CD2;CD58;CLEC7A;CD244;PARK7;TLR7;NOD1;TLR8;IL17D;TNF
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.231190168090157,-0.9967872199734532,0.4696969696969697,0.6721871757326752,1.0,43/157,20.16%,FGFR1;NRG2;FGF2;GAB1;FERMT2;TSPYL5;GCNT2;MYOC;BTC;PDGFRA;RASD2;PIK3R1;FGFR2;FGF22;KIT;KITLG;TNFAIP8L3;FLT3LG;KL;MC1R;THPO;P2RY12;FGF17;RICTOR;RAC1;ESR1;PDGFB;AKR1C2;FGF7;FGF5;FGF10;AKT2;FGF1;RTN4;INSR;FGF16;EGFR;ERBB4;RAMP3;ANGPT1;RET;INS;CCL21
prerank,positive regulation of proteolysis (GO:0045862),0.25657172899242703,0.9964022007631363,0.4888888888888889,0.676304166300087,1.0,18/54,21.96%,PERP;PRSS22;HDAC2;IL1B;CTSH;CTSC;FGFR4;ASPH;PLK1;GBA;CLN6;ADAM8;NKD2;TNFRSF1B;ADAM9;BAK1;ZC3H12A;ASTL
prerank,ERK1 and ERK2 cascade (GO:0070371),0.35160807027633884,0.9962503378389259,0.4583333333333333,0.6759710929878059,1.0,6/21,15.33%,MYC;CDK1;CTSH;SOX9;KDR;SULT1A3
prerank,glycerolipid catabolic process (GO:0046503),0.33612496511152706,0.9951459063177076,0.4528301886792453,0.6781570035484246,1.0,6/19,13.61%,ABHD12;GDPD1;LYPLA2;ABHD2;PLA2G4E;PLA2G4D
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2231228686743691,0.9950384149104547,0.47368421052631576,0.6777022705998416,1.0,40/131,23.98%,CYP2S1;VDAC1;MTHFD1L;SLC5A6;GLO1;PDZD11;HLCS;LDHA;GOT2;AOAH;PCCB;MCCC2;SLC16A3;BAAT;ACOT7;UGT1A3;CKMT2;AASDHPPT;ALDH4A1;ACSL3;VNN1;MSMO1;KYNU;SGPL1;ACOT4;PPARG;ACSF3;FASN;FA2H;CKMT1A;CYP4F11;BTD;PCCA;ME1;VNN3;CYP2J2;HACL1;SLC27A4;CYP26A1;UGT1A7
prerank,sodium ion homeostasis (GO:0055078),-0.3335476824466003,-0.9947507112032887,0.42,0.6769291319287071,1.0,8/24,18.50%,ATP1B2;ATP1A2;SLC8A1;ATP1A4;ATP1A3;SCNN1B;SCNN1G;ATP4A
prerank,primary alcohol metabolic process (GO:0034308),-0.3202853587748624,-0.9944374628768301,0.40384615384615385,0.6769821887965111,1.0,6/29,14.82%,LRAT;ADH1B;CYP27C1;CYP11B1;CYP11A1;CYP1A1
prerank,protein depolymerization (GO:0051261),-0.32699942753849626,-0.9939788697440504,0.4074074074074074,0.6774331829397194,1.0,7/28,8.75%,MICAL3;CFL2;STMN4;GSN;DSTN;STMN2;NCKAP5L
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.26609264722162856,-0.9939606350748642,0.40350877192982454,0.676792061892904,1.0,18/74,15.25%,FGFR1;PLXNB3;FGF2;NRP2;AGTR1;ARNT;ZNF580;ITGB3;PRKCA;PRKD1;VEGFB;FLT4;VIP;THBS4;EGFL7;GATA2;HTR2B;PDGFB
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.34550199501092993,0.9936741629669033,0.46938775510204084,0.6806870149126475,1.0,2/16,1.50%,BMP8A;IRS1
prerank,mucosal immune response (GO:0002385),0.3361865574127284,0.9935455493950553,0.39473684210526316,0.6804106515494674,1.0,4/20,10.94%,DEFA6;RPL39;FFAR2;NOS2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3007657779306821,-0.9934781750313891,0.4,0.6776303533750261,1.0,14/41,26.38%,CLU;MAGI2;GH1;NTF3;CD63;CBL;AHI1;INSR;ANGPT1;CCL21;B2M;SGIP1;DGKD;HIP1
prerank,positive regulation of cell cycle (GO:0045787),-0.27109346696984593,-0.9926625798236139,0.4918032786885246,0.6789007369538478,1.0,18/65,18.06%,PKD1;MEIS2;PKD2;CITED2;DUSP3;FGFR2;TAL1;CCPG1;PRKCA;USP2;CCDC57;MAPRE3;USP19;ASNS;NUDT16;PDGFB;NUPR1;EGFR
prerank,carbohydrate homeostasis (GO:0033500),-0.27079331722978595,-0.9925980535734849,0.5172413793103449,0.6783522695517968,1.0,22/62,22.90%,SLC2A4;KCNB1;CRY2;HECTD4;NGFR;CYP11B1;PRKAA2;GCK;MBD5;SLC30A8;INPP5K;LEPR;CRTC2;KLF7;INSR;PDK2;INS;CRY1;OAS1;WFS1;CAV3;BAD
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.32268657177388427,0.9921558148337998,0.4897959183673469,0.6832779444114639,1.0,8/25,20.10%,DDIAS;TRIAP1;CD44;BCL2L1;KDM1A;TAF9;TPT1;TMEM161A
prerank,regulation of mitotic spindle assembly (GO:1901673),0.33230138303895906,0.9916625057266701,0.4090909090909091,0.6838861190833125,1.0,10/19,30.45%,CHMP4C;DRG1;PLK1;CHMP5;CHMP2B;CHMP1A;CHMP2A;HNRNPU;CCSAP;CHMP1B
prerank,establishment of spindle orientation (GO:0051294),0.315338639873934,0.9904550297658531,0.4375,0.686527904345431,1.0,7/30,9.97%,MAD2L1;SAPCD2;CENPA;SPDL1;NDC80;GPSM2;ZW10
prerank,regulation of chromosome organization (GO:0033044),0.3215137068414217,0.9901795208237892,0.4117647058823529,0.686425740231211,1.0,6/21,15.66%,MYC;RMI2;XRCC5;BUB1;CDT1;CENPV
prerank,multivesicular body organization (GO:0036257),0.29954368485709537,0.9898835060699926,0.425,0.6864432401277766,1.0,10/31,21.09%,VPS25;VTA1;RAB11A;CHMP4C;CHMP5;VPS37B;STAM;CHMP2B;CHMP1A;MVB12A
prerank,phospholipid catabolic process (GO:0009395),0.31540337752943925,0.9892630120180704,0.4090909090909091,0.6871765730529384,1.0,6/22,13.61%,PLBD1;ABHD12;GDPD1;LIPG;PLA2G4E;PLA2G4D
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.37219861755145445,-0.9888869303971074,0.5344827586206896,0.6871997916945459,1.0,8/16,24.26%,ROGDI;WNT6;TBX1;GLI2;ANKRD11;SCN5A;LRP6;EDA
prerank,establishment of mitotic spindle localization (GO:0040001),0.3239117188913445,0.9886324620792298,0.45652173913043476,0.6878963952771028,1.0,9/29,13.76%,MAD2L1;SAPCD2;CENPA;SPDL1;NDC80;GPSM2;ZW10;KPNB1;PLK1
prerank,T cell proliferation (GO:0042098),-0.364640991487025,-0.9882625277757608,0.5,0.6879231605143665,1.0,5/15,21.35%,LMBR1L;PPP3CB;CADM1;TNFSF14;CTPS1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.33677749810798463,0.9882529762336486,0.5416666666666666,0.6883289287822986,1.0,5/16,16.38%,KLK6;PHB;MRAP;C3;MRAP2
prerank,cellular response to alcohol (GO:0097306),-0.2736070426863287,-0.9877149047256366,0.5081967213114754,0.6888289368448498,1.0,13/48,23.76%,ADCY5;KLF9;ADCY2;GNAI1;GNG2;SFRP1;AKR1C2;ADCY6;SMO;PTGFR;LRP6;CES1;OSBPL7
prerank,T cell activation involved in immune response (GO:0002286),0.30030202608032147,0.9874150447899648,0.4878048780487805,0.6898784111187137,1.0,9/27,36.08%,MDK;ICAM1;TNFSF18;IFNE;LCP1;CD74;FCER1G;EIF2AK4;LILRB1
prerank,positive regulation of metabolic process (GO:0009893),-0.2486980868909964,-0.9874029380239617,0.5079365079365079,0.688979888796935,1.0,31/112,22.14%,ACACB;PRKAB2;ZNF516;AGPAT1;ADRB3;PPARGC1B;PHOX2B;ADRB2;MFN2;BSCL2;GRB10;KDM3A;ACADL;OGT;LEPR;LPIN1;ADRB1;THRA;APC;INSR;EBF2;CD36;KDM6B;INS;GATM;PRDM16;EPAS1;EHMT1;CNOT3;SLN;FABP4
prerank,response to dsRNA (GO:0043331),0.317535406578857,0.9871874292662334,0.5476190476190477,0.6899158387308275,1.0,6/24,28.47%,PMAIP1;PDE12;SLC3A2;TICAM1;IRAK3;IFNE
prerank,regulation of protein secretion (GO:0050708),-0.24209499357437858,-0.9868442969813567,0.5084745762711864,0.6896718125855341,1.0,41/117,26.90%,APBB3;APBB1;KCNB1;MYOM1;CACNA1C;ARNTL;KCNA5;RAPGEF3;RAP1A;PPP3CB;ITPR1;ABCC8;FRMD4A;PRKCA;DISP1;STXBP5L;GCK;SNAP25;SYTL4;CELA2A;SERGEF;PLA2G1B;CACNA1A;FFAR1;ANKRD1;INS;KCNS3;DRD4;IL12A;RFX3;TTN;RHBDF1;CD33;TGFB3;RAPGEF4;DPP4;EXOC1;DNM1L;G6PC2;GOLPH3;GIPR
prerank,sulfur compound catabolic process (GO:0044273),0.2920558438210288,0.9865605045333993,0.47368421052631576,0.6909737208995409,1.0,11/39,16.01%,DPEP1;ACAN;HEXB;GLB1;CHAC2;CHAC1;BCAN;ADO;CTH;MPST;FITM2
prerank,organophosphate ester transport (GO:0015748),0.33089514204634174,0.9864272062888394,0.4186046511627907,0.690512022015676,1.0,6/23,11.36%,TRIAP1;SCARB1;MTTP;PRELID2;SLC25A19;PRELID1
prerank,defense response to bacterium (GO:0042742),0.21919524591684145,0.9860962059081555,0.525,0.6905841682637894,1.0,43/155,24.83%,CEBPB;IL23A;ROMO1;ANXA3;LPO;LCN2;SYK;GSDMA;DEFA6;HMGB2;SLPI;OAS2;RPL39;MYD88;WFDC10A;NOS2;PRB3;PI3;SEMG1;RPS19;FPR2;ISG15;RAB1A;GNLY;IL23R;PGLYRP4;NOD2;SERPINE1;OAS3;ANG;PGLYRP3;CXCL13;DMBT1;RNASE7;GSDMC;IL12B;S100A14;GSDMB;NAIP;RPL30;WFDC3;PPP1R11;DEFB4A
prerank,regulation of centrosome duplication (GO:0010824),0.2764749920363509,0.9859975904957009,0.48936170212765956,0.6900765708792026,1.0,14/30,33.74%,NAT10;CHMP4C;CCNF;CEP76;NPM1;CHMP5;CHMP2B;CHMP1A;CHMP2A;RAB6C;STIL;CHMP1B;GEN1;PKHD1
prerank,positive regulation of cellular protein localization (GO:1903829),0.2423251098522069,0.9855609363267616,0.4358974358974359,0.6903971580786356,1.0,20/66,19.38%,GNL3L;CDK1;CEP250;GNL3;NDC80;GTSE1;TM9SF4;CENPQ;DTX3L;GSK3B;ORMDL3;LAMTOR5;STX3;PLK1;CDT1;NUP62;HSP90AB1;TGFB1;CARD10;FYN
prerank,estrogen metabolic process (GO:0008210),0.31083931739083737,0.9852324562267235,0.48936170212765956,0.6903629690765097,1.0,9/24,29.29%,HSD17B10;UGT1A3;HSD17B4;UGT2B7;HSD3B1;UGT1A7;HSD17B8;SULT1E1;CYP3A7
prerank,macroautophagy (GO:0016236),-0.24482629073801632,-0.985223865201541,0.49230769230769234,0.6930568718448659,1.0,32/115,18.69%,PRKAB2;VPS39;CSNK2A2;GABARAPL1;ULK1;ZFYVE1;LIX1L;ATG14;CHMP3;MAP1LC3C;MFN2;PIP4K2B;PRKAG2;PRKAA2;UVRAG;LIX1;EPG5;VTI1B;VPS33B;PIK3C3;TMEM74;VIPAS39;TSG101;VPS37A;PIP4K2A;VPS4A;KLHL3;GABARAPL2;ATG12;CHMP4A;ATG4B;CSNK2B
prerank,transepithelial transport (GO:0070633),0.3459668889316168,0.9846363675920469,0.5121951219512195,0.6912367000423408,1.0,6/16,23.71%,SLC12A2;BEST1;CXADR;RHBG;ABCC2;ABCB1
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.37183417327386026,-0.9842368033220293,0.5227272727272727,0.6947963132876214,1.0,4/18,9.87%,PRKAB2;PPARD;PRKAG2;PRKAA2
prerank,positive regulation of embryonic development (GO:0040019),-0.3623090330747923,-0.984088904093028,0.4642857142857143,0.6945474447458052,1.0,3/18,8.62%,NR2C2;OSR1;RBM19
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.2170494375725232,0.9838886897461767,0.5227272727272727,0.6925914361783129,1.0,49/172,22.08%,CDH3;SOX4;MYC;IRS1;CXCL8;EREG;PDGFRB;EIF3C;DUOXA2;SCARB1;IL1B;NAT10;DDAH1;EIF4A3;PRKDC;YTHDF1;ASS1;DNA2;RPS4X;EIF6;DHX9;ATAD5;FGFR4;NMD3;PRMT1;EIF3D;DDB1;ELAVL1;ZNF205;NPM1;CDT1;LPGAT1;LARP4B;RBM3;NSUN5;EIF3E;DUOXA1;PTPN2;HSP90AB1;NPM2;EGR1;PASK;MMP8;MLXIPL;HSP90AA1;EEF2;OPN3;GIPC1;LDLR
prerank,positive regulation of angiogenesis (GO:0045766),0.23731865802697566,0.983814520736116,0.5555555555555556,0.6920726426835867,1.0,26/112,14.41%,IL1A;CXCL8;SMAD1;ADAM12;EPHA1;MYDGF;IL1B;FUT1;ANXA3;WNT5A;EMC10;CTSH;JUP;RLN2;MDK;HMGA2;XBP1;APELA;RUNX1;ADM2;ITGA5;BRCA1;SEMA5A;KDR;GATA6;GRN
prerank,cellular response to drug (GO:0035690),0.31697572097098115,0.9836404650441315,0.4897959183673469,0.691848768708345,1.0,7/26,14.82%,MYC;DPEP1;KCNQ1;IL1B;RBM22;RAP2A;ACER2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.2893456253183358,0.9835037385709782,0.4418604651162791,0.6915079758563834,1.0,14/38,19.53%,TRIAP1;PMAIP1;PSMD10;BBC3;BCL2L1;PPIF;BIK;GPX1;PRELID1;MMP9;PLAUR;FXN;BAX;BID
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.33440975011314017,0.9834480799063825,0.45454545454545453,0.6909450937737648,1.0,4/20,5.33%,GPR143;BCAP31;CCL20;TRPM2
prerank,establishment of epithelial cell polarity (GO:0090162),-0.34303212019959395,-0.9833658315000263,0.4230769230769231,0.6956514627048933,1.0,7/20,14.70%,MYO9A;PARD3;CYTH3;CLASP1;FBF1;OPHN1;RHOA
prerank,anterior/posterior pattern specification (GO:0009952),-0.27096743362217823,-0.9823731433622664,0.42857142857142855,0.6974653427972998,1.0,17/62,21.91%,HOXD3;HOXA4;HOXB4;TBX1;WLS;HEY1;HOXB3;SKI;HOXD4;HOXD9;HEY2;PCSK5;HOXA5;SMAD2;HHEX;HOXC5;HOXC4
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.318197696651457,-0.982201833408068,0.41935483870967744,0.6973148938342952,1.0,10/21,27.23%,OSR1;ACTN2;PLN;CASQ2;CAMK2D;GOPC;SLN;CAV3;EPO;NEDD4L
prerank,epithelial cell morphogenesis (GO:0003382),0.3549722397310657,0.9821986141006879,0.49019607843137253,0.6937806810582643,1.0,7/16,27.15%,MET;POF1B;GRHL2;RAB25;SIPA1L3;CCDC88C;TNMD
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.33182380682614876,0.9820161382687952,0.5555555555555556,0.6934506207819683,1.0,5/18,17.25%,UGGT1;EDEM2;UBA52;MAN1B1;OS9
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.23303420841251848,0.9817473565520194,0.39473684210526316,0.6934719564733011,1.0,33/128,15.47%,CEP72;CDK1;CDK7;SKP2;KHDRBS1;CEP250;CHEK2;PHLDA1;YWHAE;MASTL;AJUBA;NEK2;CDC25C;TUBB4B;HAUS2;YWHAG;TUBA4A;HAUS8;CEP76;AURKA;PPME1;PKMYT1;CKAP5;LCMT1;HAUS1;HAUS6;PLK1;TUBG1;FOXM1;USH1C;CEP78;PLK4;CDC25A
prerank,activation of phospholipase C activity (GO:0007202),-0.3278382661612454,-0.9813857524214756,0.5185185185185185,0.698832011354036,1.0,14/32,27.43%,LPAR1;ARHGAP6;ADRA1A;P2RY12;HTR2B;GNAQ;EGFR;AVPR1A;PLCB2;PLCG1;RASGRP4;HTR2A;AVPR1B;NMUR1
prerank,neurogenesis (GO:0022008),-0.29089254160441236,-0.9813583804156291,0.5098039215686274,0.6982163212091969,1.0,8/42,9.01%,ROGDI;LPAR1;MAPT;HAP1;TRAK2;DCHS1;METTL3;FAT4
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3284148835519768,0.9813385028188765,0.5740740740740741,0.6939253079625559,1.0,8/21,18.08%,CXCL8;STMN1;YWHAB;MET;RPGRIP1L;MRAP;MRAP2;PLEK
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.25746507819190617,0.9813176889609334,0.4375,0.6932345337341933,1.0,18/56,20.05%,BCAP31;PMAIP1;PML;RPS3;BBC3;STYXL1;BCL2L1;PAK2;AGT;TRAF2;TNFRSF12A;DEDD2;TRAF7;SLC9A3R1;LCK;BAX;BID;CAV1
prerank,positive regulation of protein export from nucleus (GO:0046827),0.37148195951185026,0.9809430937738781,0.4878048780487805,0.6934774290705076,1.0,8/15,23.68%,GTSE1;IL1B;YWHAE;GSK3B;RBM22;XPO4;ANP32B;TP53
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.36555451585768944,-0.9791180691383197,0.4782608695652174,0.7035121819212407,1.0,6/15,23.81%,FGF2;AGTR1;NGFR;GATA2;IL12A;HMOX1
prerank,canonical Wnt signaling pathway (GO:0060070),-0.2666561607788332,-0.9790289576085662,0.5,0.7030202750702277,1.0,19/67,17.74%,TCF7L1;WNT9A;DIXDC1;SFRP5;FZD4;CSNK1E;DVL3;WNT6;CSNK1A1;WNT5B;FZD7;PTEN;LRRK2;WNT2B;DVL2;SFRP1;APC;FZD8;WNT16
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.32520616822826853,-0.978526533330199,0.5094339622641509,0.703654630287983,1.0,5/19,13.19%,ASPA;SLC25A12;NAALAD2;MTHFR;ASNS
prerank,protein tetramerization (GO:0051262),0.24410658710979374,0.9780809309721115,0.4222222222222222,0.70092508069096,1.0,16/70,14.36%,HPRT1;SHMT2;GRIN2B;SSBP1;FARSB;TK1;FARSA;HSD17B10;TRPM2;MAT1A;NUDT21;AQP5;ACOT13;GBP5;TDO2;CTH
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.2909052015943945,0.9776349338864398,0.35135135135135137,0.7016244286259026,1.0,3/29,4.81%,GNL3L;DACH1;NAT10
prerank,regulation of Golgi organization (GO:1903358),-0.3500428050103662,-0.9773138501068664,0.4230769230769231,0.7063638680009394,1.0,10/16,31.43%,RBSN;MYO5A;MAPK1;MAPK3;CAMSAP2;PDE4DIP;MAP2K2;AKAP9;RAB33B;EHD3
prerank,RNA biosynthetic process (GO:0032774),0.296643472602694,0.9772465545371248,0.5,0.701544054962591,1.0,14/32,29.28%,PRIM2;PRIM1;TTF2;POLA1;BRF2;SMN1;TAF4;TERT;GTF2B;TAF5;PRMT5;TBPL1;NCOA6;TAF7
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.3490758306196728,-0.976984226566234,0.5344827586206896,0.7063415850496298,1.0,7/18,15.80%,BMPR1A;SMAD4;OLFM1;MDM4;SLIT3;HEY1;HEY2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.25869176679368355,0.9769016799695653,0.5,0.7018003459405153,1.0,24/74,27.35%,IL1A;EPHB2;IL23A;WNT5A;SYK;PF4;DHX9;CYBA;OAS2;CCL3;IL17A;NOD2;ARFGEF2;OAS3;MMP8;HMGB1;IL12B;CD2;TYROBP;THBS1;PTPN11;PTPRJ;IFNG;CLEC7A
prerank,regulation of neuroinflammatory response (GO:0150077),0.3663104544931439,0.9762741310333358,0.59375,0.7031572419300958,1.0,8/19,31.51%,IL1B;MMP3;MMP9;TNFRSF1B;MMP8;DAGLA;IL18;TNF
prerank,regulation of necroptotic process (GO:0060544),-0.3385960830592204,-0.9761023422491649,0.5,0.7083009234460387,1.0,4/23,13.69%,CFLAR;SLC25A4;YBX3;OGT
prerank,regulation of protein-containing complex assembly (GO:0043254),0.23320033333423953,0.9757671845626612,0.46511627906976744,0.7036776026292743,1.0,31/107,20.53%,GNL3L;KIF9;MMP1;AJUBA;SYK;HJURP;RPS3;SVIP;BIK;NCLN;GSK3B;SORL1;MMP3;LCMT1;MAPK15;CDT1;PRKCZ;TRAF2;GBA;VCP;HSPA5;SUMO1;PREB;TGFB1;PIH1D1;BAX;BID;CDC42;BAK1;HSP90AA1;TFIP11
prerank,negative regulation of neuron differentiation (GO:0045665),0.33954418088552163,0.9753829764727036,0.5128205128205128,0.7039308352082517,1.0,7/22,19.90%,CALR;SOX9;GSK3B;BMP7;SIX3;MED1;HES1
prerank,icosanoid metabolic process (GO:0006690),0.26340663477806053,0.9753127350102606,0.4772727272727273,0.7033747259462365,1.0,20/51,26.90%,DPEP1;CYP2S1;FAAH2;TBXAS1;CYP4F8;GPX1;MAPKAPK2;CYP4F3;CYP4F11;ALOXE3;LTA4H;CYP2J2;FAAH;CYP4F2;PON3;DAGLA;GPX4;ALOX12;PLA2G10;ALOX12B
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.2578608062757298,-0.9743290185840077,0.5423728813559322,0.7124258946736345,1.0,28/92,19.12%,SASH1;FGF2;GLIPR2;NRP2;ZNF580;ITGB3;HDAC6;PRKCA;CLASP1;RHOB;PRKD1;ATOH8;CLASP2;PPM1F;FLT4;DOCK1;RRAS;ANGPT4;CAPN7;RAC1;ENPP2;FGF7;FGF10;FGF1;IQSEC1;RTN4;MAPRE2;ANGPT1
prerank,regulation of cell communication (GO:0010646),-0.2908449905232563,-0.9730945235515632,0.5,0.7150437201387124,1.0,10/36,15.78%,TSPYL2;ANK2;SOCS2;CASQ2;SLC8A1;GRK5;GRK4;RYR2;TRDN;CAMK2D
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.2621725375298568,-0.972388050042693,0.5,0.7160866409769613,1.0,22/67,27.41%,TGFB1I1;DAND5;WFIKKN2;EMILIN1;SPRY1;SKI;PPM1A;IL17RD;SMAD2;UBB;SIRT1;PRDM16;VASN;SMAD7;PIN1;CD109;PEG10;SMAD3;SNX25;ZNF451;SMURF1;LDLRAD4
prerank,proton transmembrane transport (GO:1902600),-0.2995163871914164,-0.9718294815095926,0.47368421052631576,0.7167670072655637,1.0,8/33,18.93%,SLC25A27;UCP3;ATP1A2;ATP1A4;ATP1A3;ATP6V1B1;ATP4A;OTOP2
prerank,positive regulation of protein secretion (GO:0050714),-0.25204802816213884,-0.9715395959406895,0.559322033898305,0.7168877865963404,1.0,13/69,12.67%,APBB3;APBB1;MYOM1;NLGN2;NNAT;OR51E2;GPER1;FRMD4A;GCK;WLS;C1QTNF3;SLC30A8;SYTL4
prerank,regulation of multicellular organismal development (GO:2000026),0.3057873088297123,0.9712594934164315,0.4883720930232558,0.7136925956330323,1.0,6/27,9.27%,CDK1;RACGAP1;GBX2;DUSP9;DUSP6;OAS2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.30272924522478456,0.9712581267244433,0.4418604651162791,0.7129429185367792,1.0,12/30,22.91%,TNFAIP3;BCL2L1;ICAM1;GPX1;TNFRSF10B;GSK3B;BRCA1;TRAF2;RNF34;SERPINE1;TNFRSF10A;FASLG
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.31326465091510075,-0.971132085795064,0.5,0.717008330719073,1.0,11/23,25.82%,PIK3R1;MSTN;PLCE1;ABI2;ARPC2;RAC1;WASF2;BRK1;OCLN;AKIRIN1;NCKAP1
prerank,cellular response to interferon-gamma (GO:0071346),0.23018760588507517,0.9710842572370876,0.5957446808510638,0.7126440182035464,1.0,47/112,31.53%,TDGF1;CCL24;GAPDH;WNT5A;CCL20;CD44;PML;CCL22;PDE12;OAS2;CCL4;CCL3;IFNGR2;ICAM1;TRIM26;STAT1;GBP5;CCL26;IRF8;OASL;FCGR1A;CCL17;SYNCRIP;IRF6;OAS3;PTAFR;GBP1;TRIM31;HLA-F;TRIM22;CD47;GBP3;CD58;IL12RB1;GBP4;CCL1;RPL13A;IFNG;CCL7;IRF3;HCK;IRF7;IRF9;XCL1;XCL2;GBP7;CCL5
prerank,intermediate filament organization (GO:0045109),-0.3510221730488554,-0.9704793910742401,0.5094339622641509,0.7181800827056275,1.0,7/17,20.15%,DES;GFAP;VIM;NEFL;DNAJB6;KRT20;KLHL24
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.34169669337717284,0.970317340954097,0.5142857142857142,0.7142327226110659,1.0,10/21,31.51%,WNT5A;SLC7A5;FFAR2;CLC;TNFRSF1B;NOD2;IL10;SCIMP;LACC1;TNF
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.3298164446166433,-0.9694400945983843,0.44680851063829785,0.7199600580818182,1.0,6/24,10.64%,ZER1;POMT2;ATXN3;HDAC6;RNF185;ZYG11B
prerank,gland development (GO:0048732),0.2531807215890143,0.968977153288373,0.6041666666666666,0.7169445036557418,1.0,24/70,20.71%,TDGF1;STRA6;EPHB3;MET;SHH;PROX1;CEBPA;SOX9;MDK;LSR;XBP1;PCSK9;CEBPG;SIX1;EZR;WNT11;PRKCSH;SIX3;SLC9A3R1;MSN;HES1;PAX8;CAV1;SRP54
prerank,response to UV (GO:0009411),0.23739895265461303,0.9688757296672322,0.5957446808510638,0.7164241995675739,1.0,32/95,21.83%,MYC;FEN1;CCND1;POLH;RHNO1;TRIAP1;RUVBL2;ZRANB3;ERCC8;AURKB;ERCC5;NOC2L;RELA;GPX1;KDM1A;PTPRK;MSH6;NPM1;USP1;MAPK13;CDC25A;POLD1;UBE2A;SPRTN;SDE2;ERCC2;TMEM161A;EIF2S1;BAK1;MSH2;IL12B;DTL
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.2767277180652109,-0.9687430359446272,0.4807692307692308,0.7209652227978816,1.0,21/41,37.17%,POMC;CD34;SYT11;MC1R;DICER1;C5AR2;NFKBIL1;CD33;BPI;NLRC3;NR1H4;CACTIN;CX3CL1;RARA;GAS6;ARG2;SIRPA;CIDEA;LGALS9;ADIPOQ;CLEC4A
prerank,sterol transport (GO:0015918),-0.3379611028980276,-0.9686219575873666,0.5,0.7206243569869341,1.0,3/18,10.11%,LCAT;ABCA8;OSBPL5
prerank,protein destabilization (GO:0031648),-0.3183700402075324,-0.9679106411203726,0.5892857142857143,0.7217164485582209,1.0,12/33,24.67%,GSN;CAPN3;SNCA;NR1D1;PRNP;GGA3;SOX17;BTRC;SIRT1;SENP2;MUL1;FBXW11
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.3228122978267115,-0.9678067697864698,0.5185185185185185,0.7212681972045322,1.0,3/22,8.37%,TTLL3;TTLL7;TTLL11
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.2380278137700514,-0.9673936871657945,0.4909090909090909,0.721598117849082,1.0,43/119,23.39%,PLXNB3;FGF2;OSR1;NRP2;PTN;ARNT;FGFR2;ZNF580;ITGB3;PRKCA;TBX1;LAMC1;PRKD1;FZD7;VEGFB;FLT4;LAMB1;VIP;THBS4;EGFL7;SFRP1;STXBP4;PTPRN;HTR2B;PDGFB;FGF7;NOTCH2;FGF10;FGF1;SOX11;RTN4;EGFR;CCL11;SCN5A;SIRT1;NR4A3;VEGFC;FGF9;OSR2;TGM1;BAD;SCG2;NR4A1
prerank,regulation of transport (GO:0051049),-0.28591761517005004,-0.9673444342375065,0.5294117647058824,0.7210705138430081,1.0,9/34,13.72%,VAMP2;ICA1L;POFUT2;USP6;SNCA;FES;LRRK2;SLC30A8;LEPR
prerank,protein homotetramerization (GO:0051289),0.26549984909043983,0.9671088107929344,0.4489795918367347,0.7203553022069921,1.0,12/51,14.36%,HPRT1;SHMT2;SSBP1;TK1;HSD17B10;TRPM2;MAT1A;AQP5;ACOT13;GBP5;TDO2;CTH
prerank,bone development (GO:0060348),-0.2743030858644643,-0.9664755104964109,0.5901639344262295,0.7227821686163732,1.0,15/40,24.44%,BGLAP;MYOC;FGFR2;GH1;SKI;CYP26B1;RANBP3L;DYM;VKORC1;AKAP13;SBDS;OSR2;LRP6;SH3PXD2B;LRRC17
prerank,organic substance transport (GO:0071702),-0.23348748405160535,-0.9659837090440422,0.5714285714285714,0.7234214791036441,1.0,36/125,24.29%,VAMP2;ABCA9;ABCA10;ABCA6;ARRDC4;ABCA8;CUBN;CHMP3;ABCG4;PEX19;DISP1;ABCA1;LRP1B;RAMP1;ARRDC2;SLC48A1;RD3;SLC35F3;VPS33B;SLC47A1;ABCA5;CEP290;ABCA3;SLCO2A1;RAMP3;NME4;RUFY1;ABCD1;ABCG2;RAMP2;CHKA;ABCB9;TXNIP;KIF3A;ABCD2;SLC19A2
prerank,cellular response to hexose stimulus (GO:0071331),-0.31907763774972675,-0.965925202492588,0.4909090909090909,0.7228758431343507,1.0,5/24,9.93%,KCNB1;GPER1;PRKACA;PRKAA2;ZNF236
prerank,establishment of vesicle localization (GO:0051650),-0.35146055280455846,-0.9658675620512902,0.5370370370370371,0.722313474386764,1.0,4/18,7.82%,KIF5A;SYNJ1;KIF5C;SYT11
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.2584067600873003,-0.9655791853509694,0.5652173913043478,0.7222762837937624,1.0,22/64,22.82%,LIMS2;FLNA;VIT;FERMT2;MYOC;ILK;TRIOBP;PPM1F;DOCK1;ARL2;RAC1;SFRP1;ARHGEF7;PDGFB;MYADM;CD36;CCL21;TESK1;FBLN2;CCL28;ECM2;RSU1
prerank,mesoderm development (GO:0007498),-0.33943321964721374,-0.9650284587522961,0.49019607843137253,0.7228603769487727,1.0,10/18,33.37%,TBX1;BMX;TCF15;TIE1;GDF11;TBX6;JAK2;HES7;SECTM1;BTK
prerank,odontogenesis (GO:0042476),0.28418428712695154,0.9643107787907517,0.5208333333333334,0.726672903756962,1.0,13/37,17.39%,INHBA;COL1A2;HDAC2;AXIN2;AMELX;TGFB2;AQP5;HDAC1;TUFT1;AQP3;BMP4;MSX1;PITX2
prerank,response to amyloid-beta (GO:1904645),-0.287806447980965,-0.9639796142771249,0.5166666666666667,0.7245249942471694,1.0,14/44,19.15%,CACNA2D1;ADRB2;CACNB1;PRNP;NGFR;PSEN1;ATP1A3;NTRK1;EPHA4;GRIN2A;CACNA1A;RAMP3;CD36;CACNA1B
prerank,protein acetylation (GO:0006473),0.30366401418730926,0.962836850958812,0.5106382978723404,0.7299555925833168,1.0,7/30,13.73%,DSCC1;NAT10;ESCO2;NAA15;NAA50;NAA35;HAT1
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.2440578268216648,-0.9624421788501003,0.48214285714285715,0.7279756232929714,1.0,32/88,25.27%,FAM107A;GPM6B;RND2;CORO2B;RAPGEF3;PDGFRA;DLC1;RHOQ;RHOB;EPHA5;SEMA3E;TAOK2;DAPK3;RICTOR;RAC1;EFNA5;RHOA;EPHA3;ROCK1;NOTCH2;CCDC88A;BAIAP2;ESAM;TESK1;RHOBTB1;PAK3;MTOR;PRKCD;RHOC;ARHGAP35;PDGFA;ARHGAP17
prerank,stress granule assembly (GO:0034063),-0.3171270226549158,-0.9623601414814007,0.5652173913043478,0.7275172505560096,1.0,5/20,15.05%,CIRBP;MAPT;ATXN2;CSDE1;ATXN2L
prerank,keratinocyte differentiation (GO:0030216),0.31080748575834105,0.962068652397974,0.5714285714285714,0.7313219558169956,1.0,14/32,27.17%,EREG;WNT5A;CDSN;EPHA2;EVPL;DSP;MED1;SCEL;ST14;ADAM9;OPN3;CSTA;ANXA1;EXPH5
prerank,negative regulation of response to external stimulus (GO:0032102),-0.2376166390328287,-0.9619228624047005,0.5454545454545454,0.7281117736528413,1.0,33/110,24.78%,MAPKBP1;FGF2;PTPRS;MAPK7;DUSP3;GPER1;PPARD;RORA;LRFN5;NR1D1;INPP5F;ELANE;PTGIS;PTEN;CARD8;SIRT2;C1QTNF3;EPHA4;AJAP1;PPM1B;TRAFD1;PCBP2;GPS2;FNDC4;DHX58;CDH5;NFKBIL1;GRID2;PRKCD;MUL1;CD109;TRAF3IP1;TNFRSF1A
prerank,melanosome organization (GO:0032438),0.2877553289481182,0.9609454592591512,0.4782608695652174,0.7339761787981847,1.0,8/27,18.84%,GPR143;BLOC1S4;TRAPPC6A;AP3B1;PMEL;BLOC1S3;BLOC1S2;SHROOM2
prerank,protein targeting to peroxisome (GO:0006625),0.32506853380119594,0.9605499408669281,0.48717948717948717,0.7342971864376815,1.0,6/29,13.96%,PEX7;PEX13;ACBD5;PEX10;SLC25A17;PEX16
prerank,protein modification by small protein conjugation (GO:0032446),0.19384413450868476,0.9602910454253306,0.6451612903225806,0.7343553634645603,1.0,99/381,21.40%,RFWD3;NUP37;UBE2T;ENC1;DCUN1D5;RNF39;MOCS3;ASB9;NUP155;UBE2S;VHL;FBXO45;UBE2N;TRAIP;ATG3;RAE1;TRIM24;RNF113A;DERL1;NUP93;RAD18;NUP35;RNF6;RNF40;SEH1L;PEX13;PRKDC;TRIM72;NUP210;DTX2;NUP43;FBXO4;RNF43;NAE1;LMO7;UBE2C;UHRF1;ZNRF3;CCNF;NUP50;TRIM27;NUP88;RANGAP1;PEX10;NUP107;BSPRY;DTX3L;RNF212B;TRIM14;TRIM26;KLHL8;UBA2;DDB1;TSPAN17;SPSB2;NUP205;BRCA1;ANAPC11;PLK1;NSMCE2;UBA52;VCP;TRIM11;NUP62;LEO1;UBA1;ISG15;CUL4A;RNF34;RNF187;COMMD1;NUP160;EYA1;UBE2A;TRIM54;SUMO1;UFC1;TRAF7;OS9;OTULIN;UBE2K;NDC1;RNF181;SUMO3;CTR9;SDE2;URM1;UBE2D1;BIRC7;VCPIP1;TRIM28;UFM1;HECW1;KEAP1;CUL3;HECW2;DDRGK1;CBLC;UBE2Z
prerank,negative regulation of platelet activation (GO:0010544),-0.3566936036031008,-0.9584499390675612,0.5084745762711864,0.7359209370278789,1.0,8/15,29.16%,PDGFRA;PRKG1;PDGFB;PRKCD;C1QTNF1;PDGFA;CEACAM1;SH2B3
prerank,regulation of smooth muscle cell migration (GO:0014910),0.3305174165390152,0.958425267236671,0.43478260869565216,0.7386947842661793,1.0,7/18,19.32%,S100A11;PDGFRB;PLAU;SORL1;TRIB1;IGFBP3;SERPINE1
prerank,Rac protein signal transduction (GO:0016601),-0.332273455807517,-0.9583598325899775,0.48,0.7353857001936237,1.0,9/18,27.00%,WASF1;HACE1;ABI2;TIAM1;RAC1;ELMO1;BRK1;NCKAP1;CDH13
prerank,cellular senescence (GO:0090398),0.3283504568098206,0.9578738054072464,0.5217391304347826,0.739669643074773,1.0,5/25,9.31%,CALR;HMGA1;PML;CDKN2A;HMGA2
prerank,cellular sodium ion homeostasis (GO:0006883),-0.37937925384037163,-0.9577193690099223,0.5,0.7362266537251523,1.0,5/15,9.98%,ATP1B2;ATP1A2;SLC8A1;ATP1A4;ATP1A3
prerank,histone lysine methylation (GO:0034968),0.28894943714603316,0.9576553246187441,0.6111111111111112,0.7396311736152497,1.0,11/34,17.90%,SUV39H2;SUV39H1;SMYD3;SMYD2;RBBP5;DPY30;TRMT112;SETD6;WDR5;WDR5B;PAXIP1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.3447791123355926,-0.9573110958954502,0.5172413793103449,0.7364054952652402,1.0,9/19,24.33%,CLDN5;PRKACA;MYO1C;NPHP1;TJP1;ROCK1;PRKCH;SNAI2;OCLN
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.30762996769769896,-0.957133196270142,0.5217391304347826,0.7361528748211129,1.0,8/25,25.48%,FNTB;CNGB1;CALM1;GRK4;NMT2;PDE6B;RHO;FNTA
prerank,peptidyl-arginine modification (GO:0018195),0.36072596989735856,0.9571308054955013,0.5208333333333334,0.7404214273118888,1.0,3/15,11.58%,PADI3;PADI1;PRMT1
prerank,response to peptide (GO:1901652),0.29631116085310777,0.9570662307791538,0.5,0.7398039433652738,1.0,17/36,27.27%,MMP13;IRS1;REG1A;MMP2;STAT1;MMP3;MMP9;MMP12;NOD2;STAT5A;FYN;STAT5B;CHRNA7;CALCR;REG3A;ANXA1;STAT2
prerank,regulation of keratinocyte proliferation (GO:0010837),0.311424625891702,0.9570001483254217,0.5833333333333334,0.739278356721074,1.0,5/23,8.43%,CDH3;CASK;AREG;EPPK1;MDK
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.3367191376378035,-0.9567099082553813,0.5636363636363636,0.7366039369500684,1.0,3/19,5.77%,DAAM2;PTN;PTPRZ1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.3607473590119526,0.9566368313460025,0.5490196078431373,0.7395573021870204,1.0,8/15,32.58%,IL23A;IL23R;HLA-F;IL12B;TYROBP;TICAM1;IL18;AXL
prerank,regulation of cell development (GO:0060284),0.29068167460043143,0.9558165025759426,0.5384615384615384,0.7413165653344533,1.0,9/40,14.93%,ASCL2;SIGLEC15;IL1B;HES6;HMGB2;WNT3;YTHDF2;GRN;RPS19
prerank,endocardial cushion development (GO:0003197),-0.34382691180183056,-0.9554505201429011,0.5892857142857143,0.7389773267461912,1.0,6/20,15.12%,FOXF1;BMPR1A;CRELD1;MDM4;HEY1;TBX2
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.25581859996026,-0.9552891787972198,0.5573770491803278,0.7386791169937899,1.0,17/72,15.13%,TGFB1I1;GLIPR2;FERMT2;GCNT2;PHLDB1;SMAD4;PHLDB2;WWTR1;CLASP1;OLFM1;PTEN;CLASP2;SPRY1;DAB2IP;TIAM1;SFRP1;EPHA3
prerank,protein localization to organelle (GO:0033365),-0.2334986132202376,-0.9552832136018222,0.546875,0.7380045779291643,1.0,41/137,20.76%,VAMP2;TUB;ANK2;MICALL1;XPA;BBS4;TTC21A;TOR1AIP1;CROCC;OBSCN;PRNP;BBS1;OBSL1;BICD2;LRRK2;TULP3;GBP2;OPTN;TIA1;CEP68;CNTLN;BBS2;CSRP3;PACSIN2;GBF1;ZNF423;TTC21B;TULP1;BBS9;IFT122;GABARAPL2;VAPA;CSNK1D;SCG3;ARL3;CTDNEP1;HHEX;TRAM1L1;TULP2;PIKFYVE;WDR35
prerank,negative regulation of protein transport (GO:0051224),0.3075927025615208,0.9552775234917188,0.5434782608695652,0.7421461915607952,1.0,9/25,23.88%,CYP51A1;NDFIP2;RHBDF2;ERP29;DRD2;SNX12;IL12B;HMGCR;WWP2
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3034965607472403,0.9530838427274391,0.55,0.7476445642533739,1.0,9/24,21.09%,VTA1;LAPTM4B;CHMP4C;VCP;CHMP5;LEPROTL1;CHMP2B;CHMP1A;MVB12A
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.21074670948259464,-0.9525850254638895,0.6060606060606061,0.7442315940691222,1.0,94/329,23.74%,TGFB1I1;GDNF;PRKAB2;NR2C2;ZNF516;AGPAT1;NPR1;BMPR1A;FGF2;TAPT1;GLIPR2;ADRB3;FERMT2;GCNT2;PTN;HAP1;NUMA1;SYDE1;SMAD4;LURAP1;WWTR1;PPARGC1B;PHOX2B;GH1;NLGN1;ADRB2;ABCA1;ADRA1A;SOX5;MFN2;OLFM1;GHR;RBM19;ADRA1D;ZBTB16;BSCL2;SLC27A1;GRB10;C1QTNF3;VIP;BMP1;KDM3A;CADM1;PRL;INPP5K;ACADL;S100A13;TIAM1;OGT;LEPR;LPIN1;AVPR2;ADRB1;FST;HTR2B;PDGFB;ROCK1;KAT2A;THRA;APC;TBXA2R;NPPB;SMO;SOX11;RTN4;TP53BP1;SMAD2;EBF2;CD36;PLCB1;BMPR1B;PLA2R1;KDM6B;SIRT1;INS;GATM;AVPR1A;PRDM16;EPAS1;SOX6;EHMT1;SOD1;HHLA2;CNOT3;SLN;FABP4;RFX3;MTOR;BAD;SOX8;GADD45G;ADRA1B;ESRRB;ADCYAP1
prerank,monocyte chemotaxis (GO:0002548),0.27759101242338596,0.9525170884755751,0.5384615384615384,0.7485110688243789,1.0,10/37,16.66%,CCL24;TNFSF11;CCL20;CCL22;PTPRO;CCL4;CCL3;CCL26;RPS19;CCL17
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.300157323113525,-0.9522623368878725,0.46551724137931033,0.744445411689077,1.0,13/32,27.72%,NYAP1;PIK3R1;PTEN;ZFP36L1;SIRT2;HTR2B;MYO16;PIK3R2;HTR2A;PIK3C2A;PIK3R5;TPTE2;LTK
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.3306127874399717,-0.9520668138703274,0.5636363636363636,0.7441868578737907,1.0,7/18,22.02%,TARDBP;ELAVL4;YBX3;ZFP36;MAPK14;ANGEL2;TIRAP
prerank,pore complex assembly (GO:0046931),0.33270727938144273,0.9520643272552831,0.45454545454545453,0.7490605679362494,1.0,6/18,17.76%,PDZD11;NUP93;NUP107;ADAM10;NUP205;NDC1
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.3411923052307137,-0.9520358207201661,0.5333333333333333,0.7435795181756308,1.0,4/16,10.00%,PDE3B;PLIN5;ALK;BSCL2
prerank,aortic valve development (GO:0003176),-0.30647153371909613,-0.9519835210782871,0.5384615384615384,0.743008219966203,1.0,10/35,16.93%,NPPA;NFATC1;SLIT2;EMILIN1;SLIT3;HEY1;ROCK1;HEY2;TIE1;ELN
prerank,mRNA stabilization (GO:0048255),0.2685447472963983,0.9517961682684845,0.5111111111111111,0.7489903775650425,1.0,13/38,16.82%,E2F1;PABPC1;IGF2BP1;AXIN2;DHX9;MYD88;MAPKAPK2;HNRNPC;FUS;ELAVL1;HNRNPA0;NOCT;SYNCRIP
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.28885018822644565,-0.9517067374931908,0.5666666666666667,0.7431265155544622,1.0,8/31,22.81%,SORBS1;PLIN5;SLC27A1;SIRT4;NR1H2;CTDNEP1;INS;MTOR
prerank,regulation of protein localization to nucleus (GO:1900180),0.2578925945178859,0.9511487627135876,0.6585365853658537,0.7499202545122864,1.0,15/45,19.19%,CDK1;BYSL;GTSE1;SHH;ATP13A2;DTX3L;GSK3B;ORMDL3;LAMTOR5;PLK1;BMP4;TGFB1;LILRB4;SUMO3;CARD10
prerank,regulation of cell death (GO:0010941),-0.2492612841699589,-0.9509199215869822,0.6101694915254238,0.7445071287499556,1.0,32/89,24.73%,TSC1;CRYAB;FGF2;FERMT2;CLU;CELF1;SNCA;SNCB;NCK1;PRKD1;SRGAP2;LRRK2;SNCG;PARP16;RILPL1;HTR2B;APC;PDE8A;WNT16;SOX11;DCC;UBB;RAMP3;CD36;HBB;BNIP3;GPR75;SARM1;ACOX2;TMEM109;NKX3-1;PACRG
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.2876216982615327,-0.9501593117706869,0.5892857142857143,0.7458938408982757,1.0,5/34,5.77%,TNS2;DUSP22;PTPRS;DUSP3;PTPRZ1
prerank,regulation of protein modification process (GO:0031399),-0.2732937908916935,-0.9498666867728222,0.5,0.7458178905579009,1.0,8/46,12.18%,FLCN;KAT2B;ATG14;CDK9;CADM4;FER;CORO1C;HSPB1
prerank,apoptotic process (GO:0006915),-0.21207400674252144,-0.9496329693550978,0.5423728813559322,0.7457073524764637,1.0,68/220,23.62%,MAL;DMPK;CFLAR;ATN1;RAF1;SFRP5;CASP12;NLRP1;PDE1B;PRUNE2;CAPN3;JADE1;RRAGC;ATCAY;PPARD;ARHGEF6;DLC1;ADRA1A;ING4;TBX1;NGFR;RHOB;DAPK1;BCL2;BNIP2;CDIP1;ZBTB16;ADORA2A;FEM1B;TAOK2;MAGEH1;ERCC3;DAPK3;TCHP;PLAGL1;OGT;RNF152;SEMA6A;EFNA5;THOC1;PIDD1;GDF6;NOTCH2;ELMO1;FAS;TSC2;RTN4;CASP3;TNFSF14;CASP9;DCC;DPF2;MAP3K10;APAF1;AHCYL1;BNIP3;NSG1;ZNF385A;MAP3K7;BOK;LIG4;BCL2L11;MTOR;BAD;CSRNP1;PRKCD;CDK11B;RIPK1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.3355212596060925,-0.9491563214715968,0.5,0.7462129095977963,1.0,7/17,23.93%,FGFR1;FGF2;MEF2C;COL4A3;CCL2;PLCG1;FLT1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.24114806014446566,-0.9488569562165174,0.5671641791044776,0.746223537048462,1.0,29/97,23.74%,PRKAB2;ZNF516;ADRB3;PPARGC1B;PHOX2B;ADRB2;MFN2;BSCL2;GRB10;KDM3A;ACADL;OGT;LEPR;LPIN1;ADRB1;THRA;APC;EBF2;CD36;KDM6B;GATM;PRDM16;EPAS1;EHMT1;CNOT3;SLN;FABP4;GADD45G;ADCYAP1
prerank,acidic amino acid transport (GO:0015800),0.3514180667632392,0.9488425003912726,0.5,0.7557641706871862,1.0,7/18,21.78%,LRRC8E;SLC6A6;LRRC8D;SLC25A22;SLC9A3R1;SLC25A13;GIPC1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.31542211610876136,-0.948315870365128,0.55,0.7469268016954921,1.0,9/27,16.11%,DDX39B;TCEA2;ZMYND11;SETD5;CCNT2;THOC5;KAT7;THOC1;SCAF8
prerank,response to reactive oxygen species (GO:0000302),-0.2542036557980974,-0.9482468924342531,0.6,0.7463917840642816,1.0,17/54,21.16%,TPM1;PKD2;MAPT;PXN;PDGFRA;APOD;FER;MAPK1;MAPK3;PTPRN;MAPK8;EGFR;PDK2;HBB;SIRT1;CAMKK2;SOD1
prerank,negative regulation of protein metabolic process (GO:0051248),-0.271831996751668,-0.9482272705414893,0.5555555555555556,0.7457194951576531,1.0,16/51,20.10%,CRYAB;FLNA;CLU;ADGRB1;FMN2;ITGB3;PTX3;PRNP;SIRT2;MDM4;ROCK1;EDNRB;AZIN2;EGFR;PFDN5;INS
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.33247205100755645,0.9480003111286418,0.5609756097560976,0.7574925033201351,1.0,7/20,15.90%,RASSF10;PROX1;MDK;SHCBP1;TRIM71;KDM1A;SIX3
prerank,cell cycle G2/M phase transition (GO:0044839),0.22379245582569643,0.9477901666154589,0.5,0.7573243897937793,1.0,33/129,15.47%,CEP72;CDK1;CDK7;SKP2;KHDRBS1;CEP250;CHEK2;PHLDA1;YWHAE;MASTL;AJUBA;NEK2;CDC25C;TUBB4B;HAUS2;YWHAG;TUBA4A;HAUS8;CEP76;AURKA;PPME1;PKMYT1;CKAP5;LCMT1;HAUS1;HAUS6;PLK1;TUBG1;FOXM1;USH1C;CEP78;PLK4;CDC25A
prerank,regulation of response to external stimulus (GO:0032101),0.22443439563620673,0.9476690311862872,0.5833333333333334,0.7567761832755056,1.0,50/124,31.20%,EPHB2;CAMKMT;LRP8;WNT5A;PIK3AP1;TKFC;USP18;CXCR4;CD55;XIAP;STK24;SPATA2;MYD88;RELA;FOXA2;ADAMTS12;SETD6;METAP1;GRK1;GATA6;GRN;TMSB4X;F2R;IL1RL2;NOD2;ZMPSTE24;ERAP1;GUCY2D;TNFSF4;CAV1;SEMA7A;CASP4;ELMOD2;PPEF1;ZBP1;METAP2;ACE2;ANXA1;IL37;CASP8;PARK7;BCL6;HCK;NLRP6;SAMHD1;DAGLB;LACC1;XCL1;AREL1;CASP5
prerank,N-glycan processing (GO:0006491),-0.3382357854241943,-0.9474734737236499,0.5192307692307693,0.7469306614787238,1.0,6/19,10.76%,ST8SIA1;MAN2A2;MAN1C1;ST8SIA3;GANC;ST8SIA5
prerank,cellular response to gamma radiation (GO:0071480),-0.3348669664944995,-0.9472840232480113,0.5178571428571429,0.7466731669572042,1.0,2/16,3.68%,CRYAB;TSPYL5
prerank,negative regulation of macrophage activation (GO:0043031),-0.37979064379986016,-0.9472387816815214,0.5178571428571429,0.7461317644295109,1.0,3/15,7.82%,LRFN5;NR1D1;SYT11
prerank,protein ubiquitination (GO:0016567),-0.19825692750391474,-0.9469980303834161,0.6533333333333333,0.7460821295809821,1.0,144/492,24.80%,HIF3A;RNF112;DTX3;WSB1;ZSWIM8;TRIM39;CAND2;ASB2;FBXO32;FBXO10;FBXO9;ASB1;PDZRN3;FBXL22;FBXL7;SASH1;TRIM52;LZTR1;HECTD2;UBE2QL1;KLHL42;ARRDC4;KLHL21;FBXW4;KLHL41;FBXO17;TRIM3;UBE2G2;PELI3;FBXO31;TRIM6;FBXO30;UBE2D4;UBE2E1;TRIM23;RNF185;PJA2;RBBP6;RNF146;RNF19A;RNF217;RNF38;DET1;ASB5;BCL2;KLHL22;CUL9;SKP1;FBXO24;KCTD10;RNF11;UBE3B;FBXW2;HACE1;KLHL20;LONRF1;RNF10;TRIM63;RNF115;PELI2;UNKL;NPEPPS;FBXO44;WAC;FBXO27;AKTIP;UBE2G1;FBXL5;HERC2;DZIP3;UBE2E2;UBR2;UHRF2;FBXL2;UBE4B;TRIM50;RNF152;NEDD8;UBE2V1;ANAPC16;RNF166;BCL10;UBE2Q2;UBR1;LRSAM1;CHFR;BTRC;RNF122;TRIM34;ARIH2;VPS11;SH3RF3;HLTF;CBL;RNF144B;SPSB1;KLHL3;MYLIP;RTF1;MIB2;RNF31;UBB;UBR3;RNF220;FBXW7;UBOX5;ARIH1;RNF14;TRIM33;FBXL8;SIRT1;KLHL24;TRIM62;HERC5;LNPEP;RC3H1;EPAS1;FBXL12;PSMD9;UBE2H;TRIM38;PHC1;TRIM44;UBR5;FBXO15;TRIM47;TNKS;MYCBP2;CNOT4;ZNRF1;MUL1;SPSB4;RNF167;PINK1;NFX1;FBXO25;PSMC5;TRIM41;DDB2;RNF144A;TRIM73;FBXW11;TMEM129;RRAGA
prerank,peptide hormone secretion (GO:0030072),-0.3136838954610325,-0.9467480033112622,0.5588235294117647,0.746204622810249,1.0,7/25,18.03%,CAMK2G;LTBP4;VIP;SLC30A8;SNX19;PTPRN;CRHR1
prerank,regulation of monooxygenase activity (GO:0032768),0.30771304945788613,0.9464920917131002,0.5384615384615384,0.7593365471937294,1.0,7/24,13.77%,IL1A;LYPLA1;IL1B;DDAH1;SPR;POR;NOSIP
prerank,gliogenesis (GO:0042063),-0.35800891929524203,-0.9461247638424373,0.5416666666666666,0.7471604848766701,1.0,6/17,16.74%,PHOX2B;METTL3;NFIB;RELN;CDH2;AZU1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.31317134907147004,0.9461149848706111,0.56,0.7596807307437216,1.0,12/23,29.67%,ADIPOR1;NMI;TSPAN6;RELA;BMP7;TMSB4X;CPNE1;ZC3H12A;SPI1;IFI35;ADGRG3;NLRP3
prerank,regulation of organelle organization (GO:0033043),-0.2464864064962601,-0.9454352288425496,0.5660377358490566,0.7482347713631335,1.0,32/76,26.85%,PDE2A;MAPT;NEXN;RBSN;SYDE1;SYT11;SPATA4;CLIC4;MYO5A;RDX;MAPK1;MAPK3;TJP1;TBC1D25;VPS11;RHOT2;ZEB2;CAMSAP2;PLXNB1;PISD;PARL;PDE4DIP;MUL1;PINK1;CLN3;MFF;SPEF1;TAOK1;DNM1L;AKAP9;CAPN2;GOLPH3
prerank,connective tissue development (GO:0061448),-0.28178477948546304,-0.945262743132791,0.574468085106383,0.7479517670127994,1.0,14/36,26.68%,PKD1;ZNF516;HOXD3;SLC39A13;SOX5;ZBTB16;PGRMC2;SOX6;ARID5B;SOX8;SH3PXD2B;CREB3L2;COL11A2;TRIP11
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.22944913109354617,0.9451887069696188,0.5714285714285714,0.7613405250920537,1.0,17/86,13.99%,MYC;DPEP1;TRIAP1;ARL6IP1;LAMP3;BCAP31;IFI6;YWHAE;PMAIP1;SYK;CD44;CSNK2A1;XIAP;GPX1;LAMTOR5;DHCR24;CYCS
prerank,engulfment of apoptotic cell (GO:0043652),-0.35972732644977357,-0.9444022003746513,0.6065573770491803,0.7495717977104213,1.0,4/15,14.02%,XKR4;ADGRB1;MEGF10;RAC1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.2808036620670512,0.9443770472511466,0.5555555555555556,0.7626514900276794,1.0,6/41,6.85%,SLC5A6;SLC6A14;SLC7A11;SLC38A5;SLC7A5;SLC19A1
prerank,negative regulation of cytokine production (GO:0001818),-0.21583310674491063,-0.9442521556008668,0.65625,0.7493137645604871,1.0,65/171,30.99%,ASB1;MAPKBP1;HDAC7;RPS6KA5;CD34;PRNP;TLR9;ELANE;SYT11;APOD;SSC5D;NCKAP1L;NPTN;RNF216;OTUD7B;C1QTNF3;SFTPD;NAV3;RAC1;HDAC9;HOMER2;MAP2K5;UBA7;HOMER3;TRIB2;VSIG4;NLRX1;PCBP2;ZFP36;C5AR2;DLL1;HERC5;KAT5;TAX1BP1;DHX58;ABCD1;PIN1;INHA;IL12A;CUEDC2;BTN2A2;OTUD5;PDCD4;ABCD2;TWSG1;CD33;TRAF3IP1;BPI;GPNMB;RGCC;CEACAM1;F2RL1;NLRC3;N4BP1;NR1H4;CACTIN;PTGER4;ARRB1;MAVS;TNFRSF21;DDIT3;CX3CL1;KLF4;RARA;GAS6
prerank,positive regulation of cell death (GO:0010942),0.2525765897433508,0.9441332527625722,0.5238095238095238,0.7624123719940624,1.0,23/61,27.18%,PRR7;GRIN2B;RIPK2;PHB;WNT5A;AXIN2;SLC6A6;GSK3B;MMP3;FOS;BMP4;HTATIP2;ACER2;EGR1;FYN;EIF2S1;ZC3H12A;TYROBP;CALCR;CDKN1B;ITGB2;DDIT4;IFNG
prerank,negative regulation of insulin secretion (GO:0046676),0.3475131081770839,0.9437113741100307,0.4883720930232558,0.7629855909302097,1.0,2/15,1.50%,BMP8A;IRS1
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.2764951246665228,-0.9436163998799304,0.6333333333333333,0.7505274963407912,1.0,11/40,19.62%,IL6R;BMPR1A;ZHX3;DDR2;FERMT2;WWTR1;PRKD1;MEF2C;SOX11;ACVR2A;BMPR1B
prerank,transcription by RNA polymerase II (GO:0006366),0.1996204455384235,0.9427571971399612,0.6875,0.7647130905323868,1.0,103/312,26.50%,NFE2L3;POLR2F;POLR2D;CSTF2;CPSF3;INTS7;TFDP1;NOTCH3;SNRPF;EAF1;CDK7;CBFB;SNRPG;ETV7;ABT1;CSTF1;SLBP;TRIM24;NR2C2AP;SNRPB;NELFCD;E2F3;GTF2H3;NABP2;DDX21;NCBP1;HDAC10;SNRPE;NR0B2;CCNK;NFYA;SSRP1;TEAD4;TAF1A;NUDT21;TTF2;MAZ;XBP1;TRIP13;HDAC1;CLP1;NCBP2;ADRM1;POLR2C;TAF9;CPSF2;GTF2F2;POLR2K;MLLT3;GTF2E1;POLR2J;MED18;HSF2BP;ZNF473;LEO1;POLR2G;PPARG;NOCT;MED1;CDK12;TAF4;DEK;BTF3;NELFE;CTR9;CPSF4;INTS5;RPRD1B;SNRPD3;ERCC2;NR1I3;POLR2H;ELP4;HNF4A;POLR2I;MED20;TAF15;POLR2L;NOTCH1;CSTF3;RNGTT;GTF2A1;TAF4B;NRBF2;HNF4G;NELFA;ESRRA;GTF2E2;VDR;CREBBP;GTF2B;TCFL5;GTF2A2;NKX2-8;GTF2I;INTS2;POLR2B;TAF5;CSTF2T;LHX1;NELFB;FOXE3;TAF2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.3109666435226992,-0.9424940812301146,0.5660377358490566,0.752713235860055,1.0,6/23,15.31%,PLA2G5;PLA2G4B;PLA2G6;ABHD4;PLA2G4C;PLA2G1B
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.31287797421835484,-0.942439819658226,0.5263157894736842,0.7521456401840214,1.0,6/24,15.44%,HAND2;SASH1;PJA2;MAP3K4;GADD45B;GDF6
prerank,actin filament capping (GO:0051693),-0.34483224559074294,-0.9424170865023331,0.5510204081632653,0.7508260970419312,1.0,6/19,17.73%,ADD1;GSN;TRIOBP;FLII;ADD2;CAPZB
prerank,barbed-end actin filament capping (GO:0051016),-0.34483224559074294,-0.9424170865023331,0.5510204081632653,0.7508260970419312,1.0,6/19,17.73%,ADD1;GSN;TRIOBP;FLII;ADD2;CAPZB
prerank,positive regulation of interferon-alpha production (GO:0032727),0.333678726742323,0.9422810537265963,0.4782608695652174,0.7651718362085805,1.0,4/20,11.66%,HSPD1;RIPK2;DHX9;STAT1
prerank,positive regulation of protein processing (GO:0010954),-0.3459696677068102,-0.9413368489470814,0.5531914893617021,0.7532248822873093,1.0,5/17,17.22%,CCBE1;GSN;BAG2;TNP1;CLEC3B
prerank,excitatory postsynaptic potential (GO:0060079),-0.3444974505442292,-0.941124352318949,0.5714285714285714,0.7531352832380456,1.0,11/19,23.83%,MPP2;NPAS4;CHRNA3;LRRK2;MEF2C;NPFF;RAB3GAP1;GRIN2A;GSK3A;GRID2;GRIN2C
prerank,meiosis I (GO:0007127),-0.3219143265727567,-0.9410797059416879,0.5555555555555556,0.7525699101296313,1.0,9/22,23.16%,FOXJ2;PTTG2;CCNA1;MOV10L1;FOXJ3;TDRD9;ZCWPW1;BCL2L11;DDX4
prerank,prostaglandin metabolic process (GO:0006693),0.29060442001839126,0.9410566197697944,0.5102040816326531,0.7676586795981657,1.0,6/30,10.18%,CYP2S1;AKR1C4;TBXAS1;PLAA;PTGES3;CYP4F8
prerank,histone H2A monoubiquitination (GO:0035518),-0.3283320860262463,-0.9410453466835355,0.574468085106383,0.7519206653330635,1.0,6/17,24.55%,PCGF3;SKP1;RING1;PCGF6;DDB2;PCGF2
prerank,intracellular protein transport (GO:0006886),-0.20929581609723152,-0.9409728538943921,0.5671641791044776,0.7514422789161547,1.0,63/321,15.56%,SEC31B;PKD1;CLIP3;SNX1;DNAJC27;TBC1D1;SGSM2;AKAP6;TBC1D17;EIF4ENIF1;ARL4D;STX1B;RABGAP1;RABL2B;TBC1D10A;USP6;HAP1;STRADA;TBC1D26;RABL2A;VPS45;RAB6B;STX16;SNX15;TRAK2;WDR11;MAP1LC3C;TRIM23;HDAC6;NLGN1;SNX27;STX2;COPZ2;RAB28;TECPR2;NGFR;EVI5L;RAB5B;NPAP1;TBC1D2B;GPIHBP1;RIC1;NAPB;SGSM1;GGA3;IPO13;RAB23;MYO1C;WLS;VPS33B;SPRN;FAM53C;HERC2;AP4E1;TBC1D13;BAG3;VIPAS39;KIF13A;RANBP3L;HOMER3;TICAM2;AP4S1;TBC1D25
prerank,peroxisomal membrane transport (GO:0015919),0.325043176531152,0.9397101575548131,0.4444444444444444,0.7704727954461479,1.0,6/27,13.96%,PEX7;PEX13;ACBD5;PEX10;SLC25A17;PEX16
prerank,zymogen activation (GO:0031638),0.2921937284404367,0.9385869377352782,0.5555555555555556,0.7726505206202468,1.0,10/33,21.84%,PERP;F12;RIPK2;PLAU;CTSH;ASPH;PRSS3;BAK1;IFI16;LGMN
prerank,neural tube closure (GO:0001843),0.27472673113445806,0.9384080858118945,0.6,0.7724472349680156,1.0,6/34,7.44%,GRHL3;CELSR1;MTHFD1;MTHFD1L;FOLR1;TGFB2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.2645708766879904,-0.9383631136383516,0.66,0.7575078699367284,1.0,23/54,28.14%,RBPMS;BMPR1A;SMAD4;BMP3;GDF7;MSTN;EMILIN1;GDF5;GDF6;ACVR2A;CSNK2B;SMAD7;PIN1;INHA;GDF11;TWSG1;TGFB3;SNX25;BMPER;BMP5;NOG;LDLRAD4;BMPR2
prerank,bile acid metabolic process (GO:0008206),0.277969830704185,0.9382589963170643,0.5510204081632653,0.7720787141294456,1.0,10/31,18.77%,HSD17B10;AKR1C4;OSBPL3;BAAT;CYP39A1;CYP7B1;HSD3B7;ACOT8;SLC27A5;HSD17B4
prerank,response to hexose (GO:0009746),-0.338360589421532,-0.9372333427743306,0.509090909090909,0.7597941932741434,1.0,7/20,26.77%,VAMP2;GYS2;SLC30A8;EIF2B4;EIF2B1;LPL;SLC2A5
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.27947508669297016,-0.9369502137220047,0.5384615384615384,0.7598513505807212,1.0,12/33,24.87%,MAGI2;CALM1;DUSP26;DLC1;AGTR2;CDH5;PIN1;MTOR;CALM2;PRKCD;CAMTA1;SMPD1
prerank,positive regulation of protein kinase activity (GO:0045860),-0.2250256347714617,-0.9368551859524411,0.6507936507936508,0.7594350770409964,1.0,40/150,20.23%,RAP1A;IL6R;DDR2;CLU;STRADA;SLC8A2;CALM1;DLG4;GH1;SNCA;ITGB3;ADRB2;TAB2;NAB2;PRNP;CAMK1;PRKAG2;SLC27A1;MTCP1;TAOK2;MAPRE3;DAB2IP;EPHA4;PARP16;RELN;CDKN1A;MMD2;RHOA;PDGFB;GPRC5B;CCDC88A;DUSP19;AZU1;NRK;INSR;ALS2;RASSF2;CAMKK1;CCL21;RAPGEF2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.23251380042929326,-0.9368022261581856,0.6617647058823529,0.7589013411127713,1.0,25/86,21.39%,VAMP2;SORCS1;RABEP1;EXOC6B;AP1S2;MON2;CORO7;KLHL20;OSBPL5;MYO5A;AP4E1;VPS13A;CLVS2;CCDC93;GBF1;AP4S1;BLOC1S1;GOLGB1;STEAP2;EPS15;AP1M1;ARL3;TXNDC5;GOPC;GOLGA7
prerank,protein homooligomerization (GO:0051260),0.22358186207321668,0.9367049688360873,0.5625,0.7752962849656434,1.0,27/118,15.93%,HPRT1;SHMT2;SSBP1;SLC1A5;TK1;SIGMAR1;BLM;HSD17B10;PNPT1;TRPM2;TRIM72;BEND3;ECT2;CARD11;MAT1A;AQP5;SPAST;ACOT13;PRMT1;FUS;GBP5;ELAVL1;TIFA;TDO2;CTH;TRMT61B;PRF1
prerank,positive regulation of immune system process (GO:0002684),0.3307618069199718,0.9366679532701594,0.5319148936170213,0.7746060412238576,1.0,10/20,33.22%,ZP3;TGFB2;HCAR2;AQP3;TNFSF18;ANXA1;PIK3CD;IFNL1;RSAD2;VEGFA
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.32120607944320867,-0.9363336651085251,0.55,0.75959191846702,1.0,4/19,7.34%,GDNF;PKD2;FGF2;TCF21
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.34852067618546995,-0.9359721782746924,0.4915254237288136,0.7600367911960871,1.0,9/16,35.49%,AGTR1;ECE1;AVPR2;AVPR1A;AVPR1B;EDN3;NOS3;CYP11B2;RASL10B
prerank,integrated stress response signaling (GO:0140467),0.3474414917931404,0.9351496259832514,0.44680851063829785,0.7781228947528813,1.0,5/15,20.12%,EIF2AK1;CXCL8;IGFBP1;HSPA5;EIF2S1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.23209940834039477,0.9350257439500682,0.6388888888888888,0.7776071809850332,1.0,31/76,27.92%,IL1A;PSME3;CSF2;IFI6;IL1B;PF4;TNFAIP3;BCL2L1;ICAM1;RELA;GPX1;TNFRSF10B;GSK3B;BRCA1;BMP4;TRAF2;RNF34;EYA1;SERPINE1;TNFRSF10A;MCL1;FASLG;ITGA6;SH3RF1;THBS1;TERT;UNC5B;GSTP1;TGFBR1;CASP8;PARK7
prerank,primary neural tube formation (GO:0014020),0.2730251443018178,0.9350102589692089,0.5098039215686274,0.7768397830959276,1.0,4/30,2.16%,GRHL3;CELSR1;MTHFD1;MTHFD1L
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.3170116177548641,-0.9348073356702219,0.5178571428571429,0.7624177829241333,1.0,9/20,19.29%,MYOCD;CDKN1C;NR2F2;PTEN;LATS2;APC;INCA1;HEXIM1;HHEX
prerank,regulation of neuron apoptotic process (GO:0043523),-0.23687500646905316,-0.9341367664548827,0.5818181818181818,0.7637006482027107,1.0,32/96,25.23%,NFATC4;NRBP2;KCNB1;GDNF;EPHA7;EGLN2;PTPRZ1;ATF4;PRNP;NGF;CRLF1;BCL2;CNTF;BHLHB9;NTRK1;BACE1;MEF2C;MAG;NTF3;NUPR1;CLCF1;CCL2;SOD1;LIG4;CPEB4;WFS1;GRID2;LANCL1;PINK1;TGFB3;CLN3;FOXO3
prerank,ethanol metabolic process (GO:0006067),-0.32473744978201713,-0.9341116902654794,0.559322033898305,0.7630393675921269,1.0,9/16,37.08%,ADH1B;ALDH1A1;ADH5;SULT1A2;ADH7;ALDH2;ADH1C;ACSS1;SULT1A1
prerank,metal ion homeostasis (GO:0055065),-0.2738927226876019,-0.9334914341751227,0.5636363636363636,0.7637902318564589,1.0,9/41,12.96%,JPH2;SLC12A4;ANK3;KCNH2;SNCA;SLC8A1;TMTC2;KCNA1;SCNN1B
prerank,lymphocyte migration (GO:0072676),0.27707826443413774,0.9327082325925864,0.58,0.7821879362035765,1.0,18/35,33.23%,CCL24;CCL20;CCL22;CCL4;CCL3;CCL26;ADAM8;CCL17;MSN;CRTAM;ZAP70;CCL1;CCL7;XCL1;XCL2;CCL5;GATA3;CCL18
prerank,axonemal dynein complex assembly (GO:0070286),0.30971732892731085,0.9323528127381081,0.5,0.7823934448378912,1.0,5/22,11.71%,DNAAF5;CCDC103;DNAAF2;SPAG1;DNAAF3
prerank,response to retinoic acid (GO:0032526),0.25038448344738395,0.9323432927348456,0.6341463414634146,0.7816454773972396,1.0,20/60,20.97%,TESC;WNT2;WNT7B;PTK7;WNT5A;CTSH;SOX9;ABL2;FZD10;WNT3;WNT11;AQP3;GATA6;ACER2;MICB;LYN;WNT8B;PAX2;TMEM161A;RBP4
prerank,negative regulation of RNA splicing (GO:0033119),0.3159497081287453,0.932081539063755,0.5581395348837209,0.7815228013341332,1.0,10/19,24.51%,PTBP3;C1QBP;SRSF9;PTBP1;TMBIM6;SAP18;RPS13;U2AF2;RNPS1;RPS26
prerank,determination of bilateral symmetry (GO:0009855),-0.29821918971978534,-0.9317715206420254,0.6274509803921569,0.7677282511641385,1.0,4/26,7.91%,NPHP3;PKD2;CITED2;TBX1
prerank,dephosphorylation (GO:0016311),-0.21965268867832832,-0.9315699315205529,0.7017543859649122,0.7675010436770523,1.0,29/138,15.79%,PTPN21;PPP1R12A;PPP2R3A;PPP2R5B;PTPRS;PTPRM;PPP3CB;PPP2R5D;DUSP3;PTPRZ1;PPM1M;DUSP26;CTDSP2;FRA10AC1;PTPN14;PPEF2;PTEN;PPM1L;PPM1F;PPP3CC;PTPN5;INPP5K;PPM1A;TAB1;PPM1B;PPP4R1;SSH1;PPP2CB;BTRC
prerank,mononuclear cell differentiation (GO:1903131),0.3028536172464495,0.9311674760421718,0.5217391304347826,0.7832917713686888,1.0,7/25,20.67%,CSF2;TRPM2;BMP4;IRF8;PPARG;LYN;IFI16
prerank,negative regulation of cell adhesion (GO:0007162),-0.2464198338700161,-0.9309962215561176,0.5967741935483871,0.7681201862883748,1.0,16/68,19.12%,JAM3;PLXNB3;CORO2B;FZD4;GCNT2;PDE3B;FZD7;FBLN1;SEMA6A;RHOA;SIPA1;DSCAM;PLXNA4;SPOCK1;PLXNB1;ANGPT1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.2910406602081037,-0.9309698040785955,0.5806451612903226,0.7675332097480828,1.0,11/32,22.09%,HDAC6;TCF21;SAFB2;AR;KDM5D;PIAS2;PRMT2;SFRP1;RNF14;SIRT1;PKN1
prerank,cellular response to dsRNA (GO:0071359),0.33262996999688427,0.9302812768898505,0.5652173913043478,0.7848060132393226,1.0,6/16,26.72%,DHX9;PDE12;NPM1;CAV1;ZCCHC3;RALB
prerank,macrophage activation (GO:0042116),-0.29428863000406463,-0.930165265623894,0.543859649122807,0.7687364352093604,1.0,8/35,23.29%,MAPT;CRTC3;CLU;SNCA;DYSF;AZU1;IFNGR1;PLCG2
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.2191857474171821,-0.9296028885316876,0.7142857142857143,0.7694279575758987,1.0,38/193,15.36%,INPP5B;IP6K3;PLCD4;LCAT;ITPKB;INPP5A;AGPAT1;EPHA7;INPP4A;INPPL1;PLA2G5;PPP3CB;PLA2G4B;SYNJ1;DUSP3;CALM1;PI4KA;NUDT10;PLA2G2C;GK5;FRA10AC1;PIP4K2B;TNFAIP8L3;NUDT11;PTEN;ALK;LRRK2;GCK;PLCE1;ALDOA;INPP5K;GFPT2;PPM1A;MAPK3;PLA2G4C;IP6K1;HTR2B;PIP4K2A
prerank,cellular response to amino acid stimulus (GO:0071230),-0.2961505911591321,-0.9295600961760337,0.6379310344827587,0.7688497357534261,1.0,13/30,26.70%,RRAGC;CPEB1;KLHL22;CPEB3;UBR2;RRAGB;UBR1;RRAGD;RPTOR;CPEB4;MTOR;RRAGA;CAPN2
prerank,regulation of protein processing (GO:0070613),-0.32405267911344815,-0.9292577682863199,0.43478260869565216,0.7689479217841664,1.0,6/22,17.52%,CCBE1;PRNP;BAG2;LRRK2;TNP1;GAS1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.32150351982190367,0.928766629217485,0.5862068965517241,0.7881066851678786,1.0,6/17,27.39%,SYK;NMI;ENPP3;TYROBP;IFNG;IFI35
prerank,sterol metabolic process (GO:0016125),0.24519825368305712,0.9284623119572705,0.6744186046511628,0.7880761835877882,1.0,23/60,24.05%,SULT2B1;CYP51A1;SQLE;NSDHL;DHCR7;SC5D;NR0B2;FDXR;CYP39A1;FDX1;CYP7B1;MSMO1;TM7SF2;GBA;CLN6;INSIG1;LIPA;CETP;EBP;TSKU;HMGCR;CYP26A1;ABCG1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.315270553472924,0.9282157435634396,0.5,0.7878823989289625,1.0,11/22,26.50%,EIF5A;PMAIP1;RPL37;MSX1;SPRED2;RPS15;RPL23;RPS7;SPRED1;RPS20;ATR
prerank,pulmonary valve morphogenesis (GO:0003184),0.32215715001459017,0.9271844907085389,0.5476190476190477,0.7895819062314968,1.0,5/17,14.09%,STRA6;TBX20;TGFB2;ROBO2;BMP4
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.31502137397643953,-0.926955138879992,0.6041666666666666,0.7742107232246982,1.0,3/21,9.46%,SASH1;PRKCA;CARD8
prerank,positive regulation of DNA binding (GO:0043388),0.2781901603761465,0.9261825551718293,0.6216216216216216,0.7916258244825286,1.0,12/30,21.39%,HMGB2;CEBPG;POU4F1;NME1;MMP9;PPARG;PLAUR;EDF1;TGFB1;MMP8;HES1;HMGB1
prerank,regulation of B cell differentiation (GO:0045577),0.3017435646624016,0.9259783087886511,0.46153846153846156,0.791461675612414,1.0,4/18,9.45%,IL4I1;INHBA;SYK;XBP1
prerank,cellular response to glucose stimulus (GO:0071333),-0.28744649528648747,-0.92580022931376,0.6071428571428571,0.7763013759858287,1.0,7/29,14.84%,KCNB1;GPER1;PRKACA;PRKAA2;ZNF236;RAB11FIP2;PTPRN
prerank,positive regulation of protein transport (GO:0051222),-0.2485649886079137,-0.9254362905320865,0.6122448979591837,0.7763759591120593,1.0,24/64,26.85%,VAMP2;APBB3;APBB1;MYOM1;TENM1;CNST;FRMD4A;RUFY3;OAZ2;SYTL4;PCM1;PLA2G1B;CEP290;PCNT;ANKRD1;BCAS3;TTN;CD33;TGFB3;CLN3;EXOC1;TPR;DNM1L;GOLPH3
prerank,positive regulation of biosynthetic process (GO:0009891),0.27011299999351346,0.9251538597681253,0.6428571428571429,0.7931851476093298,1.0,13/39,19.85%,CXCL8;HDAC2;AMELX;CYBA;RUNX1;SUCO;BMP4;F2R;TGFB1;CREB3L1;MTPN;MMP8;MLXIPL
prerank,regulation of cellular protein metabolic process (GO:0032268),0.24812952198005847,0.9250119005669758,0.5208333333333334,0.7928355745028393,1.0,18/48,22.49%,INHBA;NOLC1;VPS35;NANOS3;UHRF1;EIF4E;AGT;METAP1;PKP3;GBA;RBM3;TGFB1;MTPN;NFKBIA;WNT7A;MAPKAPK5;GEMIN5;CYFIP1
prerank,chemical homeostasis (GO:0048878),0.25205827837496,0.9238951048039608,0.627906976744186,0.7950738988330854,1.0,11/58,11.13%,SLC4A11;ACOXL;TLCD1;CEBPA;PNPLA4;ATP13A2;VGF;ABHD5;PNPLA1;AQP9;PNPLA3
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.2990635380572856,-0.9238949886205428,0.631578947368421,0.7794329214333021,1.0,7/23,20.10%,ARNT;P2RX7;PSEN1;PRKAA2;PDGFB;INSR;INS
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.31489974210994154,0.923854754834788,0.56,0.7944203484669644,1.0,10/21,23.36%,MAD2L1;FBXO5;UBE2S;UBE2C;PLK1;RAB1A;CDC20;RPL11;RPL23;RPS7
prerank,positive regulation of receptor internalization (GO:0002092),-0.32361674518841094,-0.9233905830455377,0.5714285714285714,0.7802183889418136,1.0,7/23,19.12%,MAGI2;GH1;NTF3;CD63;AHI1;INSR;ANGPT1
prerank,negative regulation of transposition (GO:0010529),0.3036266319749741,0.9233008212824451,0.5714285714285714,0.7948700751255531,1.0,14/24,38.04%,PIWIL1;APOBEC3F;SMYD5;SPOCD1;TEX19;ZNF93;APOBEC3B;SIRT7;PIWIL2;BTBD18;APOBEC3A;ZNF91;PIWIL4;APOBEC3G
prerank,epithelial cell migration (GO:0010631),-0.2770431265836388,-0.9231561661550648,0.5517241379310345,0.7800238815656175,1.0,17/40,25.22%,KANK2;STARD13;PXN;NANOS1;KRT2;KIT;FSTL1;RHOA;KANK1;ROCK1;ZEB2;TESK1;ADGRA2;PKN1;SCG2;FAT2;DPP4
prerank,regulation of viral release from host cell (GO:1902186),0.30734408642759115,0.9230258555945845,0.5434782608695652,0.7947144978703312,1.0,10/22,25.50%,PML;TRIM26;DDB1;TRIM11;VPS37B;CHMP2B;TRIM28;TRIM31;TRIM15;CHMP2A
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.3080922641810656,-0.9226567575605712,0.5882352941176471,0.7804842762915573,1.0,4/23,9.03%,PHF1;CREBZF;EPC1;MPHOSPH8
prerank,protein polyubiquitination (GO:0000209),-0.19787487587926972,-0.9224604171499929,0.7096774193548387,0.78023193282876,1.0,84/306,22.21%,WSB1;FBXO32;FBXO10;FBXO9;FBXL22;FBXL7;SASH1;HECTD2;UBE2QL1;KLHL42;FBXW4;FBXO17;TRIM3;UBE2G2;PELI3;FBXO31;TRIM6;FBXO30;TRAF1;UBE2D4;UBE2E1;RBBP6;RNF146;RNF19A;RNF217;BCL2;SKP1;UBE3B;FBXW2;HACE1;KLHL20;LONRF1;RNF216;RNF115;PELI2;UNKL;NPEPPS;FBXO44;FBXO27;AKTIP;UBE2G1;FBXL5;DZIP3;UBE2E2;UBR2;ANAPC4;UBE4B;RNF152;NHLRC4;ZFP91;UBE2V1;RNF166;UBE2Q2;LRSAM1;CHFR;BTRC;TRIM34;ARIH2;RNF144B;SPSB1;FBXO38;KLHL3;MYLIP;HECTD1;MIB2;RNF31;UBB;FBXW7;UBOX5;ARIH1;RNF14;FBXL8;TRIM62;TTC3;HERC5;LNPEP;RC3H1;FBXL12;PSMD9;UBE2H;TRIM38;TRIM56;UBR5;FBXO15
prerank,sulfur compound transport (GO:0072348),0.28841194840419093,0.921395393422886,0.5217391304347826,0.7984517459205007,1.0,6/28,11.24%,RACGAP1;SLC5A6;SLC35B2;SLC6A6;LRRC8D;SLC25A19
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.2535176425579009,0.920618077240233,0.6666666666666666,0.7997256379713705,1.0,15/50,18.05%,PSMD14;PSME3;NUDT15;LAMP3;PSME2;PSMC2;UCHL5;GPX1;RAD23B;PSME1;PSMF1;COMMD1;PRKCG;HSP90AB1;DESI1
prerank,positive regulation of B cell activation (GO:0050871),0.25913621849036905,0.919094338479605,0.6666666666666666,0.8031923701483616,1.0,12/47,19.77%,EPHB2;SYK;CHRNB2;IL21;CD81;XBP1;SH3KBP1;CD320;PAXIP1;NOD2;VAV3;TNFSF4
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.2779771167439126,-0.9181691972423403,0.6226415094339622,0.790698801550709,1.0,12/30,26.72%,TWIST2;CHRD;HDAC7;SKI;RANBP3L;RORB;SUFU;LIMD1;TMEM64;TNN;CRIM1;NOG
prerank,artery development (GO:0060840),-0.3143707955968104,-0.9178037190162746,0.5087719298245614,0.7907930928609492,1.0,4/22,10.27%,PDE2A;PKD2;TBX1;EFEMP2
prerank,negative regulation of cell cycle (GO:0045786),-0.23980595549587083,-0.9177789853019565,0.625,0.7901772111490275,1.0,28/78,24.07%,TSPYL2;MYOCD;GPER1;RPS6KA2;CDKN1C;RHOB;NR2F2;PTEN;ZBTB17;LATS2;APC;SIPA1;INCA1;NPPC;GAS1;NUPR1;BTG2;HEXIM1;HPGD;HHEX;HECA;ANGEL2;INHA;LATS1;NR4A1;RNF167;PDCD4;NKX3-1
prerank,response to glucocorticoid (GO:0051384),-0.3226580380841469,-0.9169576924976849,0.6,0.7915833104774216,1.0,11/27,25.33%,FAM107A;SLIT2;ZFP36L1;SLIT3;NR3C1;ZFP36;PDCD7;SSTR2;BCL2L11;HSD3B2;ZFP36L2
prerank,positive regulation of leukocyte migration (GO:0002687),-0.3072156350876707,-0.9167428599829557,0.6197183098591549,0.7914375674456922,1.0,6/28,12.48%,JAM3;IL6R;PTN;ZNF580;NCKAP1L;LGALS3
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.3549857148829478,-0.9161794813967213,0.5882352941176471,0.7920907620008275,1.0,5/15,17.98%,FGFR1;FGF2;PRKD1;HSPB1;FGF16
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.29627102634316105,0.915942695329578,0.6,0.8110924416103464,1.0,8/23,25.17%,CBFB;SLC39A10;CD81;RUNX1;ELF1;LYN;NFAM1;CD300A
prerank,positive regulation of viral life cycle (GO:1903902),0.30349624126715985,0.9155857857336145,0.65,0.8113513683771655,1.0,8/23,19.25%,P4HB;DDB1;KPNA2;TRIM11;LGALS1;VPS37B;TMPRSS4;CHMP2B
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.20820366693293324,0.9155748792813109,0.7209302325581395,0.8105797183391983,1.0,41/138,21.40%,ANXA4;NFKBIE;MDFI;IRAK2;HDAC2;FOXP3;NR0B2;PSMD10;DAP;HES6;TNFAIP3;PROX1;CDKN2A;BRMS1;RNF2;IRAK1;CTNNBIP1;FOXA2;CEBPG;SETD6;FOXH1;KDM1A;NLRC5;BMP7;TRIB1;TMSB4X;COMMD1;NWD1;SUMO1;OTULIN;SFRP4;PAXIP1;ZNF675;NFKBIA;ID1;TNFSF4;HES1;RBCK1;TRIM37;KEAP1;ZC3H12A
prerank,negative regulation of nervous system development (GO:0051961),0.3279999963969942,0.9148577200698331,0.5714285714285714,0.8116211580189351,1.0,8/18,24.73%,IL1B;SORL1;ROBO2;PAX6;WNT7A;NOTCH1;WNT3A;DYNLT1
prerank,fatty acid catabolic process (GO:0009062),0.24419127756263137,0.9147312782121225,0.5813953488372093,0.8110542207770975,1.0,23/66,25.28%,NUDT19;HSD17B10;PEX13;ACBD5;PCCB;CEL;MCAT;AIG1;ABHD2;ACAT2;SLC25A17;ACOT8;MMAA;HSD17B4;PCCA;PLA2G15;ECHS1;FAAH;HACL1;DECR1;SLC27A4;EHHADH;CPT2
prerank,cellular response to nitrogen compound (GO:1901699),0.3543657090983433,0.9146131365505433,0.6086956521739131,0.8106167710125545,1.0,3/17,8.52%,TIMELESS;BLM;PDE12
prerank,secondary alcohol metabolic process (GO:1902652),-0.2715257104530408,-0.9146091413752402,0.6111111111111112,0.7953423545322825,1.0,10/40,15.94%,LCAT;GBA2;OSBPL1A;PPARD;ABCA1;CYP11B1;OSBPL5;CYP11A1;RXRA;ABCA5
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.29861704873806544,0.9136059165299201,0.5609756097560976,0.8124460526310897,1.0,14/23,28.62%,SOX9;MDK;LBX2;SIX1;AGT;BMP4;PAX8;PAX2;SIRT6;LIF;EGF;ITGAX;LHX1;PIK3CD
prerank,mRNA destabilization (GO:0061157),0.2873783081377419,0.9134607795272525,0.4772727272727273,0.8119547114451783,1.0,10/34,15.78%,POLR2D;DCPS;KHSRP;PLEKHN1;YTHDF1;PDE12;MEX3D;TRIM71;YTHDF2;CNOT1
prerank,regulation of osteoclast differentiation (GO:0045670),0.2719503599788525,0.9130201100535746,0.625,0.8124030509025976,1.0,9/35,18.19%,CEBPB;TNFSF11;IL23A;CCL3;IL17A;POU4F1;IL23R;ZNF675;LILRB4
prerank,keratan sulfate metabolic process (GO:0042339),0.26699393819928885,0.9129943399443303,0.6415094339622641,0.8117208798800549,1.0,7/33,14.39%,B3GNT4;ACAN;HEXB;GLB1;B3GNT2;B4GALT1;B3GNT3
prerank,organic hydroxy compound transport (GO:0015850),0.26518854190362806,0.9127147826319393,0.6521739130434783,0.8115723643671758,1.0,13/37,24.07%,STRA6;AKR1C4;ABCC11;SLCO1B3;AQP9;SLCO1C1;SLC27A5;ABCG5;ABCC2;RBP4;ABCG8;SLCO1A2;OSBP
prerank,positive regulation of T cell migration (GO:2000406),0.2781636094439297,0.9125372559159924,0.6222222222222222,0.811285864420224,1.0,7/24,20.77%,WNT5A;CCL20;STK39;ADAM10;CXCL10;TMEM102;CXCL13
prerank,protein trimerization (GO:0070206),0.3402827873788764,0.9122769421487706,0.6530612244897959,0.8104597489027624,1.0,3/15,5.25%,SLC1A5;SIGMAR1;PNPT1
prerank,protein homotrimerization (GO:0070207),0.3402827873788764,0.9122769421487706,0.6530612244897959,0.8104597489027624,1.0,3/15,5.25%,SLC1A5;SIGMAR1;PNPT1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.3037715084507657,-0.9120667609061319,0.6101694915254238,0.8010210269975439,1.0,5/22,10.13%,CCBE1;ARNT;RORA;ATF4;FLT4
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.28748883189191676,-0.9116074818073283,0.6808510638297872,0.8012862166631817,1.0,13/31,28.60%,PKD1;PKD2;SOCS2;GHR;FER;IFNAR1;CLCF1;CCL2;PIAS1;STAT4;IL31RA;STAT6;IL15
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.23936504155865534,0.9110064870247376,0.6666666666666666,0.8130810606580675,1.0,21/61,25.66%,CCND1;CEBPB;CDK1;CBFB;LEF1;CDK4;CDKN2A;SOX9;CCNC;RELA;MED14;MED1;MED30;BAX;TRIM28;MED31;MED20;TP53;CTNNB1;MED13;FOSL1
prerank,neuron apoptotic process (GO:0051402),-0.3242088911997762,-0.9109729510950785,0.5272727272727272,0.8021416623232678,1.0,7/20,21.69%,ATN1;NLRP1;NGFR;BCL2;FAS;BNIP3;LIG4
prerank,activation of protein kinase activity (GO:0032147),-0.22497376500423105,-0.9107378811012429,0.7142857142857143,0.8019955239238693,1.0,34/113,23.85%,ADCY5;PILRB;ADRA2B;ADCY2;ADCY4;STRADA;NTRK3;ITGB3;ADRB2;ADCY9;PRKACA;GHR;CHRNA3;TLR3;PRKAR2B;TAOK2;RICTOR;ZFP91;PDGFB;ADCY6;MAPKAP1;NTF3;CCDC88A;FGF1;NRK;INSR;ANGPT1;INS;MAP3K7;PAK3;TIRAP;MTOR;PRKCD;PINK1
prerank,regulation of cell division (GO:0051302),-0.2460140620229921,-0.9105174644951957,0.68,0.8018905946098104,1.0,27/73,24.07%,FLCN;EFHC1;KLHL21;CALM1;BBS4;FGFR2;TAL1;INSC;AURKC;SIRT2;ZFYVE26;PRDM15;UVRAG;SETD2;PIK3C3;KIF13A;HTR2B;RAB11FIP3;FGF1;DLL1;SUSD2;AHCTF1;PIN1;CALM2;ESRRB;TXNIP;NKX3-1
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.2767021468771377,-0.9098068420050608,0.5862068965517241,0.802890521175426,1.0,9/32,20.10%,ACTN3;ARNT;P2RX7;PSEN1;PRKAA2;PID1;NUPR1;INSR;INS
prerank,oligodendrocyte differentiation (GO:0048709),-0.310389053961515,-0.9090977610677795,0.5882352941176471,0.8039459064551286,1.0,9/19,23.45%,PTPRZ1;PRDM8;SOX13;TPPP;SLC8A3;EIF2B4;SOX6;SOX8;EIF2B1
prerank,lipid transport (GO:0006869),-0.23014540354202076,-0.9089751059461777,0.7068965517241379,0.8035863145967151,1.0,40/99,28.86%,ABCA9;ABCA10;ABCA6;ABCA8;PPARD;NCOA1;ABCG4;PEX19;ABCA1;TNFAIP8L3;OSBPL5;AKR1C1;SLC27A1;RXRA;SLC10A4;ABCA5;SLC27A3;ABCA3;SLCO2A1;CD36;NME4;PLEKHA3;SLC51A;GLTP;ABCD1;PITPNB;CHKA;ABCD2;PITPNA;CLN3;ABCB11;CEACAM1;ABCC4;CLN8;SLC10A6;ACSL1;NR1H4;SLC51B;UGCG;APOL2
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.23137680039478573,-0.9088298750146308,0.6181818181818182,0.8033252907199536,1.0,30/97,22.00%,CSPG4;PRELP;ST3GAL3;ABCC5;GCNT2;UST;CHST3;ST3GAL6;CHST15;B4GAT1;DCN;SDC3;SDC2;OGN;DSEL;NDST2;NDST1;XYLT1;CHST7;HSPG2;OMD;CHST9;CSGALNACT2;CHST12;GPC1;ANGPT1;HS3ST5;NCAN;GPC6;KERA
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.26850355635074424,0.9083260410782672,0.5526315789473685,0.8193738673227458,1.0,13/32,30.93%,WNT5A;SLC7A5;CD55;FFAR2;TRAF2;NOD2;TNFSF4;HLA-F;CLEC7A;TRAF6;SCIMP;LACC1;XCL1
prerank,modification-dependent protein catabolic process (GO:0019941),0.19384782326293623,0.9083018290328991,0.6923076923076923,0.8186789939771261,1.0,55/195,21.83%,PSMD14;MAD2L1;PTTG1;RNF114;UBE2S;FBXO45;BUB3;PSMD13;RNF6;RNF40;NDFIP2;PSMC2;AURKB;ANAPC1;RNF43;BFAR;UBE2C;UHRF1;ZNRF3;XBP1;RNF128;AURKA;DTX3L;CDC26;KLHL8;PSMD3;ADRM1;LONP1;DDB1;SPSB2;RNF149;PSMF1;ANAPC11;PLK1;PSMD11;UBA52;UBA1;ISG15;RNF34;FBXL14;UBE2A;UBQLN1;FEM1A;OS9;UBE2K;UBE3C;UBE2L6;CDC20;BUB1B;UBE2D1;KEAP1;CUL3;CBLC;RNF19B;DTL
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.28594573529851647,0.908069407923499,0.6451612903225806,0.8184719024003271,1.0,14/27,33.62%,WDR43;EAF1;NELFCD;LEO1;CDK12;NELFE;NELFA;RNF8;NELFB;HNRNPU;EAF2;SUPT16H;BTBD18;LDB1
prerank,protein deacylation (GO:0035601),0.3112083575316124,0.9079557539373179,0.6666666666666666,0.8179799634312356,1.0,9/23,17.10%,NOTUM;LYPLA1;HDAC10;HDAC1;ABHD10;LYPLA2;ABHD17C;ABHD17B;PPT1
prerank,positive regulation of dephosphorylation (GO:0035306),-0.3042723554522283,-0.9079179491549225,0.575,0.8048748827485313,1.0,9/28,24.87%,MTMR9;CALM1;DLC1;CDH5;PIN1;CALM2;PRKCD;CAMTA1;SMPD1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.23841028114434634,0.9071448915282545,0.7045454545454546,0.8191038104356989,1.0,18/61,21.49%,DDIAS;HYOU1;ARMC10;TMBIM6;BCL2L1;RTKN2;NOC2L;PPIF;XBP1;VNN1;DNAJA1;MMP9;PLAUR;CREB3L1;TPT1;URI1;TMEM161A;MCL1
prerank,aggrephagy (GO:0035973),-0.3008181608130877,-0.9069603573453097,0.6530612244897959,0.8063728618407653,1.0,9/28,18.78%,DYNC1I1;MAP1LC3C;HDAC6;WDFY3;UBE2V1;VIM;DYNC1LI2;PCNT;UBB
prerank,regulation of organelle assembly (GO:1902115),-0.24178673064547274,-0.9062655452035834,0.7192982456140351,0.8074449481564279,1.0,19/73,20.70%,TBC1D1;TBC1D17;GSN;RABGAP1;TBC1D10A;TBC1D20;SENP6;TBC1D2B;ATXN2;RDX;TBC1D13;TSG101;ATXN2L;VPS11;SGSM3;ADPRH;TBC1D12;PIKFYVE;SPICE1
prerank,response to lipid (GO:0033993),0.21267459665727773,0.9059208449154805,0.7307692307692307,0.8215013671115962,1.0,37/106,24.05%,IL1B;SCD;CYP27B1;SPP1;CTSH;SOX9;HMGB2;SLPI;MAPKAPK3;FGFR4;IRAK1;NOS2;MAPKAPK2;HNRNPA0;GCH1;AQP3;GATA6;TRIB1;ACER2;PPARG;NOCT;F2R;MICB;IL23R;PALM3;TGFB1;WNT8B;CYP24A1;TMEM161A;STAT5B;RBP4;PRDX3;PCK2;SRR;S100A14;RPS6KA3;ABCG1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.27999559284348663,0.9056816042954479,0.5869565217391305,0.8213028961518232,1.0,4/27,7.21%,EREG;VPS25;AREG;GPRC5A
prerank,male meiosis I (GO:0007141),-0.3323815805628762,-0.9056170615327462,0.6078431372549019,0.8084012945313068,1.0,6/15,23.16%,FOXJ2;CCNA1;MOV10L1;FOXJ3;TDRD9;DDX4
prerank,programmed necrotic cell death (GO:0097300),0.2980725798607743,0.9053344811792459,0.6274509803921569,0.8215678684247707,1.0,6/18,24.76%,PGAM5;PPIF;IPMK;FASLG;MLKL;TICAM1
prerank,membrane lipid metabolic process (GO:0006643),0.29731802519667017,0.9052952596328415,0.6037735849056604,0.8208965807993177,1.0,8/22,26.90%,SPTLC1;MGST2;TECR;FUT2;ALOXE3;AGMO;SMPDL3B;ALOX12B
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.30449125161999513,-0.9047950818529579,0.6428571428571429,0.8096403395055677,1.0,4/23,4.41%,CIRBP;GDNF;EIF4ENIF1;RBM24
prerank,negative regulation of cell death (GO:0060548),0.22099137029912835,0.904062553795378,0.6666666666666666,0.8232517326270119,1.0,27/84,21.72%,SOX4;DCPS;CDK5;RAD18;VPS35;PDE12;ATP13A2;GSK3B;TM7SF3;SORL1;POU4F1;BMP7;WNT11;ZBED6;BMP4;TRAF2;GBA;NUP62;SULT1A3;DUS2;AGR2;TNFRSF1B;FYN;ATG5;PAX2;NENF;HLA-F
prerank,regulation of exosomal secretion (GO:1903541),0.31897788465725296,0.9034074541644821,0.6363636363636364,0.8242171776161985,1.0,9/18,29.65%,ATP13A2;ATP9A;SDC1;RAB7A;STAM;CHMP2A;SDC4;IFNG;SNF8
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.2545122420697685,0.9033263507351901,0.631578947368421,0.8236291546247779,1.0,10/42,13.45%,THY1;TNFSF11;SKAP1;IL1B;CEACAM6;CD44;MDK;FOXA2;BMP7;FUT7
prerank,negative regulation of response to stimulus (GO:0048585),0.2421991685700745,0.9027286876122592,0.6818181818181818,0.8241734394014544,1.0,7/57,5.01%,THY1;CASK;FBXO5;SRMS;RBL1;FOXP3;DDAH1
prerank,protein autoubiquitination (GO:0051865),0.2371367584088459,0.9023556273956808,0.631578947368421,0.8243295200875849,1.0,23/61,23.88%,UBE2T;RNF183;RAD18;ERCC8;BFAR;UHRF1;UBE3D;DTX3L;TRIM71;BRCA1;TRAF2;RNF187;UBE2A;RNF181;RAG1;TRIM37;CUL3;ASB4;RNF19B;RNF141;UBE2D2;SH3RF1;WWP2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.33798641516351074,0.9023041171620769,0.5777777777777777,0.8237326161787687,1.0,4/15,11.71%,PHB;SMARCA4;HDAC1;FOXH1
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3260665824962956,-0.9010481871998077,0.6140350877192983,0.8181347226940571,1.0,7/18,21.45%,CLU;EPHA4;GSAP;CASP3;GSK3A;LRRTM3;IFNGR1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.30296397041395484,-0.9007992254122321,0.609375,0.8180571916198122,1.0,9/21,28.41%,SMAD4;CARF;ATF4;RBPJ;SMAD9;CREB3;RUNX2;MT3;CHD6
prerank,cholesterol efflux (GO:0033344),-0.3202835369376507,-0.9003257924889587,0.6333333333333333,0.8184417122796347,1.0,5/19,16.69%,ABCA8;ABCG4;ABCA1;ABCA5;STX12
prerank,spindle assembly (GO:0051225),-0.23324014155361097,-0.8999996157899873,0.6507936507936508,0.8184854982842281,1.0,27/78,23.43%,STARD9;FLNA;TUBGCP6;NUMA1;GOLGA8A;CLASP1;ARHGEF10;CLASP2;GOLGA8B;GOLGA8N;MAPRE3;RHOA;HAUS4;TUBGCP5;CEP63;NEK7;HAUS3;MAP9;MAPRE2;CSNK1D;GOLGA8R;CEP192;INO80;SPICE1;GOLGA2;TNKS;AAAS
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.324048045898711,-0.8999097573773648,0.48936170212765956,0.818051921665982,1.0,6/19,20.98%,CCL27;NTRK3;FES;NTF3;BAIAP2;BCAS3
prerank,regulation of lipid metabolic process (GO:0019216),0.2139510599794329,0.8997376866874588,0.6521739130434783,0.8301552454118704,1.0,28/84,22.35%,CYP51A1;ADIPOR1;TGS1;SQLE;DHCR7;IL1B;SC5D;SCD;NFYA;HELZ2;FGFR4;CERS2;FDPS;CARM1;TM7SF2;APOC1;HMGCS1;PPARG;MED1;EDF1;FASN;FDFT1;MVK;CAV1;HNF4A;IDI1;ELOVL6;HMGCR
prerank,cellular response to retinoic acid (GO:0071300),0.2652225568507359,0.8981332382149372,0.717391304347826,0.8336754142606544,1.0,10/42,13.07%,TESC;WNT2;WNT7B;PTK7;WNT5A;SOX9;ABL2;FZD10;WNT3;WNT11
prerank,endothelial cell proliferation (GO:0001935),0.3126506835330576,0.8973608870114252,0.68,0.83474963273575,1.0,6/18,18.89%,LOXL2;NRARP;SEMA5A;BMP4;PRKX;PROK2
prerank,regulation of protein import into nucleus (GO:0042306),-0.2850350088187467,-0.8973133503518819,0.673469387755102,0.8235678345251799,1.0,17/36,26.14%,FLNA;PIK3R1;DMAP1;PSEN1;APOD;RAB23;BAG3;EFCAB7;SUFU;CABP1;MDFIC;PIK3R2;UBR5;PRKCD;SMAD3;HCLS1;TPR
prerank,COPII-coated vesicle budding (GO:0090114),0.2322363741103235,0.89720529436146,0.7692307692307693,0.834415880095401,1.0,26/70,26.95%,TMED2;SEC23B;AREG;FOLR1;SEC13;CTSC;F5;TMED10;TRAPPC6A;RAB1A;TFG;NSF;TRAPPC9;PREB;CTSZ;CNIH1;KLHL12;TRAPPC2L;TGFA;CUL3;LMAN1;CNIH3;SERPINA1;SEC24A;TRAPPC4;BET1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.3009550006329565,-0.8968869681276348,0.6896551724137931,0.8237604583718218,1.0,5/23,10.13%,CCBE1;ARNT;RORA;ATF4;FLT4
prerank,female gamete generation (GO:0007292),-0.2800438520143943,-0.8966252581277333,0.6428571428571429,0.8238155830126381,1.0,4/28,7.05%,PTN;FMN2;NANOS1;METTL3
prerank,positive regulation of defense response to virus by host (GO:0002230),0.3151733130421878,0.8965871530785791,0.6,0.8351336091345639,1.0,10/25,25.70%,IL23A;DTX3L;STAT1;APOBEC3F;IL23R;HSP90AA1;ZC3H12A;IL12B;IL12RB1;TRAF3IP2
prerank,cellular response to light stimulus (GO:0071482),0.2271128323008454,0.8964822499943629,0.68,0.8346234169135517,1.0,19/67,21.50%,MYC;RHNO1;TRIAP1;RUVBL2;AURKB;NOC2L;GNGT1;KDM1A;PTPRK;NPM1;GRK1;MAPK13;CDC25A;POLD1;SDE2;TMEM161A;EIF2S1;BAK1;OPN3
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.316853906922505,0.8964360837646179,0.5531914893617021,0.8339688034320712,1.0,9/18,28.17%,SKAP1;SYK;TGFB2;CIB1;ADAM9;CXCL13;LIF;RAC3;CD3E
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.21335719735503617,-0.8964019140027968,0.6607142857142857,0.8236045866927709,1.0,36/163,16.37%,TEAD3;NR2C2;RXRG;PGR;HDAC7;KAT2B;WWTR1;THRB;PPARD;TAF1C;RORA;CDK9;NPPA;NR1D1;TEAD1;RARB;AR;RBPJ;MAML1;RXRB;NR3C1;NOTCH4;NR1H2;HDAC5;MED17;NR2C1;ERCC3;MAPK3;RXRA;HDAC9;ESR1;TEAD2;THRA;NOTCH2;TAF3;RORB
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.2775029460863189,0.8959946222699331,0.6037735849056604,0.8343944214844966,1.0,5/26,7.26%,TDGF1;SYAP1;KNSTRN;ZPR1;SOX9
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.2712009567579361,0.8959667130277833,0.6206896551724138,0.8336894347957927,1.0,5/28,14.27%,HSPD1;IRAK2;MYD88;IRAK1;UBA52
prerank,positive regulation of secretion by cell (GO:1903532),-0.2439286052646205,-0.8957973438186235,0.6724137931034483,0.8243846406350231,1.0,13/68,13.20%,APBB3;APBB1;KCNB1;MYOM1;STX1B;GPER1;FRMD4A;SNCA;RAB2B;CLASP1;CLASP2;SYTL4;RAB3A
prerank,positive regulation of cellular component movement (GO:0051272),0.2798410716498914,0.8954792232510187,0.6521739130434783,0.834114513350606,1.0,10/26,29.77%,CFAP20;DUOXA2;DUOX2;ACTN4;RPS19;LYN;C1QTNF8;ETS1;TGFBR1;ADAM17
prerank,negative regulation of cation channel activity (GO:2001258),-0.3077684121745933,-0.89524049102154,0.6271186440677966,0.8250587205409594,1.0,10/26,22.97%,GSTM2;PKD2;CALM1;CASQ2;GNB5;TRDN;CLIC2;CRHR1;DRD4;CALM2
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.2285149248732432,-0.8952272733613327,0.6896551724137931,0.8243888956194761,1.0,24/99,18.80%,CLIP3;SORBS1;KCNB1;ATP2B4;WNK3;ANK3;MTCL1;GPER1;PIK3R1;PRNP;CNPY4;NECAB2;BCL2;STAC2;PPP3CC;STAC;MYO1C;LGALS3;EPHA3;MAPK8;EFCAB7;AKT2;EGFR;RAMP3
prerank,phosphatidylserine metabolic process (GO:0006658),0.2678935189046538,0.8951327275219811,0.5833333333333334,0.8340215102413974,1.0,17/32,30.57%,PTDSS1;SERINC5;ABHD12;PLA2G2F;PLA2G4E;PLA2G3;PLA2G4D;PLA2G2D;PLSCR1;ABHD12B;PLA2G15;PLA2G10;OSBPL8;PLA2G2E;LPCAT3;MBOAT1;PLA1A
prerank,positive regulation of growth (GO:0045927),0.22271762536143314,0.8947419667881229,0.8,0.8343111093239474,1.0,20/69,21.39%,CSNK2A3;EXOSC4;NCBP1;PSMD10;DNPH1;ZPR1;TGFB2;CSNK2A1;ADAM10;CXCL16;DDX49;EXOSC2;CIB1;SLC25A33;AGR2;MTPN;FXN;CDC42;BRAT1;RPS6KA1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.2196923554166297,0.8935900053200697,0.6153846153846154,0.836551804519437,1.0,21/89,17.42%,TDGF1;OSM;IL11;RIPK2;IL23A;LRP8;RAP2B;CD44;EFNA1;CD80;CD81;CLEC6A;PAK2;SEMA4D;PECAM1;ITGA5;AGT;PRKCZ;IL22RA2;IL23R;TGFB1
prerank,positive regulation of vasculature development (GO:1904018),0.21879694087220442,0.8934823085916618,0.717391304347826,0.8360028496887536,1.0,22/98,14.41%,IL1A;CXCL8;ADAM12;EPHA1;MYDGF;IL1B;ANXA3;WNT5A;EMC10;CTSH;JUP;RLN2;HMGA2;XBP1;APELA;RUNX1;ADM2;BRCA1;SEMA5A;KDR;GATA6;GRN
prerank,inorganic anion transport (GO:0015698),0.2385247302788908,0.8934231067536711,0.7346938775510204,0.8354033920043796,1.0,8/52,8.80%,CLIC1;TTYH3;RACGAP1;SLC4A11;BEST1;CLIC3;CLCN4;CLCN1
prerank,amyloid-beta metabolic process (GO:0050435),0.3214568065297692,0.89312870557043,0.6170212765957447,0.835299318958139,1.0,6/17,17.71%,BACE2;MME;APEH;APH1A;NCSTN;IDE
prerank,phagosome maturation (GO:0090382),0.2554020748744258,0.8928979631390614,0.7346938775510204,0.8351028541013801,1.0,10/37,19.85%,ATP6V1C2;MREG;RAB20;ATP6V1G1;ATP6V0B;ATP6V1A;ATP6V1F;RAB7A;ATP6V0A4;CORO1A
prerank,regulation of actin filament-based process (GO:0032970),0.22464391018042218,0.8927673294740217,0.7906976744186046,0.8346703677699409,1.0,22/71,20.27%,GRHL3;SIGLEC15;CELSR1;PDGFRB;CNN2;ARHGAP18;ABRACL;OR2A4;ARHGEF19;FZD10;MLST8;EZR;PAK1;BST2;SMIM22;RHOD;ARHGEF5;IQGAP3;CORO1A;F11R;FSCN1;RHOF
prerank,regulation of execution phase of apoptosis (GO:1900117),0.3092674876732813,0.8927247577950966,0.6078431372549019,0.8339717177702936,1.0,8/20,24.17%,FAP;BCL2L1;MTRNR2L3;MTRNR2L1;ZC3H12A;TP53;MTRNR2L9;DFFA
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.3293352702485477,-0.8924371551064958,0.5789473684210527,0.8305405215540006,1.0,6/15,24.78%,PLA2G6;ORMDL1;SAMD8;SIRT3;PRKCD;TNFRSF1A
prerank,glycoprotein metabolic process (GO:0009100),0.23967556133284887,0.8924336044810445,0.6486486486486487,0.8337975616754925,1.0,17/52,19.64%,MAN2A1;STT3B;FUT8;ERP44;GCNT1;GANAB;B4GALT7;ST8SIA6;PRKCSH;MANBA;HPSE;AGA;MAN1B1;FBXO6;PCSK6;NGLY1;B4GALT5
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.3127017103011112,0.8923408246954622,0.673469387755102,0.8332445174301409,1.0,4/17,11.66%,NOTCH3;WWC1;DLGAP5;STAT1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.23858571068499476,-0.891560384358272,0.6909090909090909,0.8322188147355692,1.0,26/71,25.44%,BCL2L2;MLLT11;IL6R;MOAP1;P2RX7;NGF;BCL2;TLR3;DAB2IP;DEDD;BAG3;FAS;CASP3;CASP9;DCC;GSK3A;CRADD;BOK;CASP8AP2;IL12A;BAD;HIPK1;RIPK1;GABARAP;TNFRSF1A;SMAD3
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.27426577745338404,-0.8913096708212445,0.639344262295082,0.8320337003630696,1.0,11/42,23.11%,TRIM39;FOXF2;CSNK2A2;CLU;PTEN;QRICH2;GNA12;CDK5RAP3;FBXW7;CAV3;LATS1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.31991841946882066,0.8910171289495832,0.5476190476190477,0.8357336214587573,1.0,8/17,26.00%,PLA2G7;CXCL10;FPR2;SERPINE1;HMGB1;LGMN;S100A14;CCL1
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.2783677135463125,-0.890205494551725,0.6666666666666666,0.8340763584121972,1.0,6/37,6.73%,ADRA2B;NLGN3;BTC;SHANK3;HDAC6;ADRB2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2579853413761303,-0.8898815213652762,0.6274509803921569,0.8340420591667608,1.0,15/43,30.99%,POMC;CD34;SYT11;MC1R;DICER1;C5AR2;NFKBIL1;CD33;BPI;NLRC3;NR1H4;CACTIN;CX3CL1;RARA;GAS6
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.28769701268153686,-0.8894662839935396,0.6,0.834207782826788,1.0,6/25,17.25%,PLA2G5;PLA2G4B;SLC27A1;PLA2G1B;CDS2;ABCA3
prerank,sphingolipid biosynthetic process (GO:0030148),0.22773230239764639,0.8894009714970001,0.7317073170731707,0.8391285476507724,1.0,24/68,22.52%,SPTLC1;HACD3;CERS6;ALDH3B2;SGPP2;SMPD2;SPTLC2;PNPLA1;CERS2;HACD2;DEGS2;SPNS2;ELOVL1;SGPL1;GBA;ACER2;ELOVL7;FA2H;SPTSSB;ALOXE3;ALDH3B1;B4GALT6;ELOVL6;ASAH2
prerank,mesenchymal cell differentiation (GO:0048762),-0.258764199983203,-0.8884925854732446,0.6538461538461539,0.836043468632031,1.0,13/51,15.80%,DDX17;FGFR1;FOXF2;TGFBR3;FGFR2;RBPJ;NOTCH4;MEF2C;RANBP3L;FAM83D;HTR2B;ROCK1;HEY2
prerank,hydrogen peroxide catabolic process (GO:0042744),0.3107312497108393,0.8884462169975545,0.6470588235294118,0.8405650589469394,1.0,5/19,12.39%,PRDX4;PRDX5;PRDX1;GPX1;PRDX2
prerank,glycosphingolipid metabolic process (GO:0006687),-0.2606693365463961,-0.8882465450764706,0.6666666666666666,0.8359197262839984,1.0,9/46,10.76%,GBA2;ST8SIA1;ST6GALNAC3;ESYT3;A4GALT;ST8SIA3;ST3GAL5;B4GALNT1;ST8SIA5
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.2902712514543907,0.8881021112802733,0.6739130434782609,0.8406612731433412,1.0,11/24,28.01%,GAPDH;TPI1;GAPDHS;PKLR;PKM;ALDOC;ADPGK;ALDOB;PFKL;PGAM1;GPI
prerank,cellular zinc ion homeostasis (GO:0006882),0.28536044519665876,0.8880120990989622,0.7894736842105263,0.8401758295839911,1.0,10/27,23.85%,SLC39A10;ATP13A2;SLC39A8;SLC30A5;SLC30A9;SLC39A7;SLC30A1;LCK;SLC39A4;MT1F
prerank,positive regulation of neuron death (GO:1901216),0.2502683379365344,0.8874509179536353,0.6829268292682927,0.8407206706613382,1.0,20/46,28.02%,GRIN2B;CDK5;WNT5A;TGFB2;CCL3;PCSK9;GSK3B;FOS;GRN;EGR1;FYN;BAX;EIF2S1;TYROBP;CTNNB1;ITGB2;DDIT4;CDK5R1;IFNG;TFAP2A
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.2870181185915772,0.8871526685802665,0.6808510638297872,0.8406128235871735,1.0,11/32,18.08%,INHBA;SHH;ARMC6;TMEM190;BATF;MLLT3;KDR;BMP4;PLD4;TGFB1;PLEK
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.26666874198050605,-0.8863821529153337,0.6862745098039216,0.8395377947200824,1.0,7/36,13.69%,TRIM39;CSNK2A2;MAP1A;WAC;KLHL40;QRICH2;OGT
prerank,negative regulation of neuron death (GO:1901215),-0.21914004250623603,-0.8861575203331045,0.6909090909090909,0.8394192218913773,1.0,16/96,12.28%,NFATC4;NRBP2;GDNF;INPP5A;PTPRZ1;SNCA;CD34;ATF4;NGF;CRLF1;BCL2;LRRK2;CNTF;BHLHB9;NTRK1;MEF2C
prerank,detection of visible light (GO:0009584),-0.33100542594242915,-0.8860625198999292,0.660377358490566,0.8390061831289004,1.0,8/16,25.25%,CNGB1;GRM6;GNAQ;TULP1;PDE6B;GNA11;RHO;CACNA1F
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.2783990210949449,-0.8858294684696149,0.58,0.8388564436335956,1.0,7/29,15.31%,PLA2G5;PLA2G4B;TMEM86B;PLA2G6;NR1H2;PLA2G4C;PLA2G1B
prerank,negative regulation of GTPase activity (GO:0034260),-0.2891573970661526,-0.8845112911512063,0.5660377358490566,0.8414657355828545,1.0,11/23,23.49%,PLXNB3;GPSM1;CPEB2;LRRK2;RDX;DAB2IP;ARL2;KLRK1;BCAS3;FICD;WNK1
prerank,glial cell differentiation (GO:0010001),0.2737889848035437,0.8843527736408147,0.6304347826086957,0.8468531415821515,1.0,5/28,7.26%,SOX4;CDK5;GPR157;SHH;SOX9
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.3382095835665753,-0.8843103627310952,0.6666666666666666,0.8412903081973159,1.0,10/16,29.30%,NPPA;SPX;NPPB;GSK3A;ADM;GPR37L1;SLC2A5;KLK2;BMPR2;KLK3
prerank,regulation of monocyte chemotaxis (GO:0090025),0.28159696052377314,0.8841761960754212,0.6097560975609756,0.8465670347831399,1.0,10/23,26.00%,PLA2G7;DUSP1;CXCL10;FPR2;LYN;SERPINE1;HMGB1;LGMN;S100A14;CCL1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.22317346902090784,-0.884043387579378,0.74,0.8411866124985523,1.0,26/72,24.32%,MYH2;PIK3R1;NCK1;PLA2G6;DOCK1;NCKAP1L;MYO1C;MAPK1;MAPK3;ARPC2;ELMO2;RAC1;ELMO1;BAIAP2;WIPF1;WASF2;PLD2;NR4A3;PIK3R2;ACTB;WIPF3;PLCG1;PLCG2;PRKCD;BRK1;ARPC1A
prerank,negative regulation of lipid storage (GO:0010888),-0.3226291670296296,-0.8836531547297478,0.5686274509803921,0.841392360275167,1.0,4/19,12.57%,PPARD;ITGB3;ABCA1;NR1H2
prerank,regulation of extracellular matrix organization (GO:1903053),0.32589847480885764,0.8832307755724226,0.6078431372549019,0.848322451441148,1.0,5/15,13.23%,FAP;DDR1;FGFR4;RUNX1;AGT
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.32011119558556095,-0.8828727395004002,0.6851851851851852,0.8426356789581283,1.0,5/20,19.05%,TMEM178A;FSTL3;TLR3;CARTPT;FBXW7
prerank,regulation of transposition (GO:0010528),0.2912905687593034,0.8827049799107853,0.6046511627906976,0.8486340596144769,1.0,6/21,21.67%,PIWIL1;APOBEC3F;SMYD5;SPOCD1;TEX19;APOBEC3B
prerank,positive regulation of TOR signaling (GO:0032008),-0.2769937567208076,-0.8820951125905084,0.6875,0.8437264572735416,1.0,8/39,13.99%,FLCN;SIK3;RRAGC;KLHL22;NCKAP1L;RRAGB;RICTOR;WDR59
prerank,fatty acid beta-oxidation (GO:0006635),-0.26886501493323456,-0.8819929727668755,0.6271186440677966,0.8432176456542191,1.0,17/51,26.16%,ETFDH;ACAD11;ECHDC2;PPARD;ACADVL;ACADL;ECI2;ACAT1;HADHB;ABCD4;CROT;ABCD1;BDH2;ACOX2;ABCD2;ACADM;CRAT
prerank,carbohydrate biosynthetic process (GO:0016051),0.2948744787250057,0.8819515166341956,0.6170212765957447,0.8497559281434125,1.0,10/24,25.67%,FUT8;FUT1;ST8SIA6;FUT7;B4GALT1;FUT2;MPDU1;FUT6;FUT4;FUT3
prerank,zinc ion homeostasis (GO:0055069),0.28402324995253225,0.8816768734749825,0.7297297297297297,0.849731477778545,1.0,10/28,23.85%,SLC39A10;ATP13A2;SLC39A8;SLC30A5;SLC30A9;SLC39A7;SLC30A1;LCK;SLC39A4;MT1F
prerank,acylglycerol biosynthetic process (GO:0046463),0.30112608959819237,0.8815599135949054,0.5853658536585366,0.8493327521872263,1.0,9/21,30.15%,DGAT2;GK;PNPLA3;LPGAT1;ANG;PLA2G15;AGMO;MOGAT1;DGAT1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.22226340308373949,-0.8813376856859019,0.7346938775510204,0.8441559077207961,1.0,25/69,24.32%,MYH2;PIK3R1;NCK1;PLA2G6;DOCK1;NCKAP1L;MYO1C;MAPK1;MAPK3;ARPC2;ELMO2;RAC1;ELMO1;BAIAP2;WIPF1;WASF2;PLD2;PIK3R2;ACTB;WIPF3;PLCG1;PLCG2;PRKCD;BRK1;ARPC1A
prerank,histone H3-K4 methylation (GO:0051568),-0.2652555378627677,-0.8807836755623805,0.6290322580645161,0.8447609341254673,1.0,13/30,28.42%,SETD1B;SETD4;KMT2A;CXXC1;OGT;KMT2B;ZNF335;PAGR1;SETD1A;SETMAR;TET2;KMT2C;KMT2D
prerank,positive regulation of mitochondrial fission (GO:0090141),0.3370728976591577,0.8807473401751832,0.6046511627906976,0.8508450687850443,1.0,5/17,14.32%,RALA;VPS35;AURKA;KDR;MCU
prerank,response to organic cyclic compound (GO:0014070),0.2399594339605503,0.8801165142357096,0.6382978723404256,0.8516174378333814,1.0,13/57,13.86%,DHFR;IL1B;PMAIP1;HLCS;TRPM2;CYP27B1;SPP1;CHRNB2;CCL3;FGFR4;DRD2;KYNU;AQP3
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.2928763229822917,0.8799358419325987,0.7115384615384616,0.8512887003349834,1.0,4/19,13.13%,HS6ST2;GLCE;HS2ST1;EXT2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.3466801662256356,-0.8798349431631033,0.5535714285714286,0.8462643019277193,1.0,6/16,17.74%,PSEN1;HAND1;HEY1;HEY2;SIN3A;SOX11
prerank,regulation of cellular metabolic process (GO:0031323),-0.2564586771296052,-0.8791653520957251,0.7169811320754716,0.8469847347038713,1.0,16/44,28.27%,ACACB;AGPAT1;BCO2;RSPO1;GNB3;PID1;SSH1;PARL;PDK2;BTN2A2;PINK1;PDK4;ABCB11;FLOT1;NCOR2;CYP1B1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.28905222975324263,-0.8788690799642641,0.7192982456140351,0.8462343106735104,1.0,6/20,20.10%,ARNT;P2RX7;PSEN1;PRKAA2;INSR;INS
prerank,positive regulation of glycolytic process (GO:0045821),-0.28905222975324263,-0.8788690799642641,0.7192982456140351,0.8462343106735104,1.0,6/20,20.10%,ARNT;P2RX7;PSEN1;PRKAA2;INSR;INS
prerank,response to organonitrogen compound (GO:0010243),0.2788642895465736,0.8786667498453041,0.7608695652173914,0.8536719803046162,1.0,11/36,18.79%,DHFR;DERL1;HLCS;TRPM2;DRD2;KYNU;VCP;GPRC6A;ERLEC1;GLRA2;CCDC47
prerank,proteoglycan biosynthetic process (GO:0030166),-0.27171918662648636,-0.8780011565911265,0.6896551724137931,0.8474639852555824,1.0,10/31,19.62%,B3GAT1;CHST10;FAM20B;XYLT1;CHST9;CSGALNACT2;CHST12;GAL3ST3;CHST8;BMPR1B
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.3036755274542273,-0.8778739580675295,0.5862068965517241,0.8470497252829317,1.0,9/26,18.93%,ZC3H7A;AGO4;METTL3;DICER1;AGO3;PRKRA;DGCR8;SMAD2;AGO1
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.2133838564423685,-0.8772668565675583,0.6909090909090909,0.8477585812523473,1.0,24/99,20.10%,ACACB;BVES;AGPAT1;MAGI2;AGTR1;PPARD;GH1;SNCA;INPP5F;AKR1C1;ECE1;PID1;NR1H2;IFNAR1;CDKN1A;PDGFB;NTF3;CD63;MAPK14;AHI1;INSR;RAMP3;ANGPT1;INS
prerank,cellular response to virus (GO:0098586),0.2718101685330015,0.8768129499668467,0.6785714285714286,0.8571183451875579,1.0,8/32,21.40%,EIF5A;IFI6;RRP1B;IL21;CXCL10;BAX;HSP90AA1;ZC3H12A
prerank,regulation of hormone secretion (GO:0046883),0.3084525885469409,0.8761414773436963,0.6521739130434783,0.8579928048269639,1.0,4/16,14.00%,OSM;IL11;FFAR2;NMB
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.24321604215182815,0.8760175846722966,0.7441860465116279,0.8575187064551619,1.0,17/49,21.50%,TRIB3;PRMT3;GLA;FGF19;KHSRP;PROX1;ERLIN1;ACMSD;BRCA1;APOC1;ERLIN2;PLEK;FYN;CAV1;PGP;ZC3H12A;OPN3
prerank,epithelial to mesenchymal transition (GO:0001837),-0.2475374472432562,-0.8754725748992072,0.6981132075471698,0.8510855860009205,1.0,12/46,17.84%,DDX17;FGFR1;FOXF2;TGFBR3;OLFM1;RBPJ;HEY1;NOTCH4;FAM83D;ROCK1;HEY2;DLG5
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.2765633615527672,-0.8752730357615611,0.6730769230769231,0.8506771440888848,1.0,8/32,15.62%,CAPRIN2;ADGRB3;CUX2;CHRNA3;OBSL1;SDC2;GORASP1;IL1RAPL1
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.31164042363823397,-0.8751090874026023,0.6122448979591837,0.8503790015700043,1.0,10/24,26.32%,JAM3;SLIT2;NCKAP1L;THBS4;RAC1;C5AR2;CCL21;TIRAP;DPP4;DNM1L
prerank,protein stabilization (GO:0050821),-0.20180413070529904,-0.8750712035098203,0.7666666666666667,0.8497528210195753,1.0,51/165,23.85%,TSC1;TRIM39;CRYAB;ATP1B2;FLNA;ANK2;CLU;MTMR9;PER3;TMEM88;DVL3;PIK3R1;PEX19;CTNND1;CRTAP;ZSWIM7;PARVA;BAG2;PTEN;GPIHBP1;MDM4;OTUD3;USP2;SOX17;USP19;EPHA4;BAG3;CDKN1A;CDC37L1;MORC3;STXBP4;PRKRA;GNAQ;STX12;WIZ;RTN4;RASSF2;FBXW7;SMAD7;GOLGA7;TRIM44;CAMLG;TBRG1;WFS1;PIN1;WDR81;TBL1X;PRKCD;MUL1;IFT46;PINK1
prerank,B cell activation (GO:0042113),0.2159873896106212,0.8749766155662341,0.825,0.8589837199973921,1.0,28/82,29.77%,HSPD1;IL11;EPHB2;PHB;CHRNB2;TCF3;JAK3;CD70;CEBPG;TPD52;PTPN2;SLC25A5;RAG1;CD86;MSH2;ZAP70;NFAM1;PTPRJ;CR2;RABL3;CASP8;IL10;IFNE;PIK3CD;ADGRG3;PHB2;RASGRP1;ADAM17
prerank,organic cation transport (GO:0015695),-0.29488727377374646,-0.8744446282208342,0.6595744680851063,0.8505345498886051,1.0,3/19,13.83%,SLC25A42;SLC5A7;SLC47A1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.27407788363946395,0.8744358359069357,0.627906976744186,0.8594326680060856,1.0,5/21,12.78%,RASSF10;PROX1;MDK;KDM1A;DRD2
prerank,negative regulation of type I interferon production (GO:0032480),-0.2608467217502986,-0.8743707933049271,0.6521739130434783,0.850034244098503,1.0,18/40,33.64%,PTPRS;RNF216;PPM1B;UBA7;NLRX1;PCBP2;HERC5;TAX1BP1;DHX58;PIN1;OTUD5;TRAF3IP1;NLRC3;CACTIN;MAVS;YY1;NPLOC4;SIRPA
prerank,cellular response to unfolded protein (GO:0034620),0.28834696585165726,0.874238732151,0.6538461538461539,0.859048772958349,1.0,9/26,20.48%,HSPD1;TMBIM6;HSPA14;HSPA9;TM7SF3;HSPA5;HSPA13;BAX;BAK1
prerank,regulation of amyloid fibril formation (GO:1905906),-0.33512894390848946,-0.8739647386672972,0.5892857142857143,0.8503930727541653,1.0,3/15,8.83%,CRYAB;CLU;PSEN1
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.2587597827549139,-0.8737545394966523,0.7868852459016393,0.8500262635308916,1.0,18/55,22.00%,CSPG4;PRELP;FGF2;LYVE1;STAB2;HPSE2;IDS;DCN;SDC3;SDC2;OGN;HSPG2;OMD;GPC1;HGSNAT;NCAN;GPC6;KERA
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.2800950492407527,0.8733475042299385,0.6,0.8605584565203893,1.0,2/24,4.81%,GNL3L;NAT10
prerank,positive regulation of exocytosis (GO:0045921),0.2591835269669902,0.8730118523731816,0.6923076923076923,0.8605644729608452,1.0,18/34,29.89%,RAB15;RAB3D;ATP13A2;CADPS;SDC1;ATP6AP1;RAB7A;STAM;CFTR;RAB27B;CADPS2;CHMP2A;SDC4;EXPH5;IFNG;RAB5A;SNF8;RAB9A
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.34476826838025243,-0.8727163161901248,0.6666666666666666,0.8514127041679223,1.0,6/15,20.68%,TARDBP;RBM24;ZFP36L1;CPEB3;ZFP36;RC3H1
prerank,regulation of proteolysis (GO:0030162),0.23968994634167606,0.8727141583718734,0.72,0.8605104965310905,1.0,20/50,28.03%,PERP;CST4;CDK5;HDAC2;CSTB;SHH;FGFR4;ASPH;PLK1;CLN6;PLAUR;TM4SF20;CAV1;BAK1;AURKAIP1;CSTA;KNG1;SERPINE2;CASP8;CYFIP2
prerank,dopaminergic neuron differentiation (GO:0071542),0.28247728752040263,0.8725824248762145,0.6140350877192983,0.8600670906672081,1.0,4/20,10.95%,WNT2;SHH;MANF;FOXA2
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.3350091803703524,-0.8720556736835086,0.6491228070175439,0.8522753537865114,1.0,2/17,1.71%,PAN2;SAMD4A
prerank,proteoglycan metabolic process (GO:0006029),-0.2972359106061255,-0.8719638481783645,0.6792452830188679,0.8518301228491888,1.0,9/24,19.62%,CHST10;FAM20B;XYLT1;CHST9;CSGALNACT2;CHST12;GAL3ST3;CHST8;BMPR1B
prerank,transcription by RNA polymerase III (GO:0006383),0.2678602726134336,0.8717084812016218,0.6363636363636364,0.8613707825498627,1.0,9/27,21.57%,POLR3K;GTF3A;POLR2K;GTF3C4;POLR3G;CRCP;GTF3C3;GTF3C2;POLR2L
prerank,positive regulation of telomere maintenance (GO:0032206),0.2783336603702111,0.8717067884198232,0.58,0.860588429432197,1.0,6/31,7.96%,GNL3;NABP2;NEK2;PML;AURKB;NAF1
prerank,arachidonic acid metabolic process (GO:0019369),0.23837682532423488,0.8716007986171335,0.7142857142857143,0.8600166708620548,1.0,19/50,26.90%,CYP2S1;FAAH2;CYP2F1;TBXAS1;PTGES3;GPX1;PTGES2;CYP2B6;CYP4F3;CYP4F11;ALOXE3;CYP2J2;FAAH;CYP4F2;DAGLA;GPX4;ALOX12;PLA2G10;ALOX12B
prerank,endoplasmic reticulum organization (GO:0007029),-0.2328053145338325,-0.8714432017981342,0.8305084745762712,0.8523646379696996,1.0,16/69,17.86%,RNF112;SEC31B;VAMP2;REEP2;REEP1;LMAN1L;PRNP;CAV2;LRRK2;ATL3;ATL2;TRDN;ATL1;SEC16B;RTN4;VAPA
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.23927599080770956,0.870628330197136,0.78,0.8613765726112256,1.0,20/51,28.96%,IL1RN;TRAIP;RNF113A;USP18;TTLL12;NLRC5;YTHDF2;ISG15;PPARG;PALM3;PTPN2;ZNF675;OAS3;IL36RN;CARD16;GSTP1;STAT2;IRAK3;YTHDF3;PYDC1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3097607974977068,0.8702762483944666,0.6666666666666666,0.8612426127039179,1.0,4/17,7.05%,CCND1;PSMD10;PROX1;PSRC1
prerank,regulation of tissue remodeling (GO:0034103),0.2845519323420901,0.8700147869612687,0.66,0.861009558698991,1.0,6/20,11.96%,IL23A;SYT7;MDK;IL21;RUNX1;SUCO
prerank,protein complex oligomerization (GO:0051259),0.2227011835642427,0.8699852528483247,0.6888888888888889,0.8602906170895075,1.0,21/85,16.94%,CLDN1;SHMT2;BLM;PNPT1;TRIM72;BEND3;ECT2;STOML2;CARD11;LRRC8D;NUDT21;SPAST;PRMT1;FUS;ELAVL1;TIFA;MCU;YME1L1;TRMT61B;PRF1;HOMER1
prerank,response to interleukin-1 (GO:0070555),0.22476359701887724,0.8690243251749991,0.7777777777777778,0.8618734188490199,1.0,33/80,28.61%,CCL24;CXCL8;IRAK2;IL1B;CCL20;CCL22;SOX9;HYAL3;USP10;CCL4;CCL3;MYD88;RELA;IRAK1;ADAMTS12;TAF9;CCL26;MAPK13;CCL17;CHI3L1;GBP1;ZC3H12A;HYAL2;CD47;GBP3;CCL1;HIF1A;ANXA1;TNFRSF11A;HAS2;IRAK3;TRAF6;CCL7
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.279675612475109,-0.868999511275741,0.6511627906976745,0.8571059575578097,1.0,8/24,20.11%,ADRB3;COQ10A;PID1;ACADVL;GFPT2;LEPR;COX4I2;NR4A3
prerank,positive chemotaxis (GO:0050918),-0.3029150011065258,-0.8686249354300166,0.6071428571428571,0.8572628203265131,1.0,8/18,25.01%,PLXNB3;LGALS3;FGF7;FGF10;TSC2;ANGPT1;SCG2;GPNMB
prerank,xenobiotic transport (GO:0042908),-0.30340813120566545,-0.8683227955491852,0.660377358490566,0.8570629077739036,1.0,6/19,22.81%,ABCC5;ABCA8;SLC47A1;ABCA3;ABCG2;SLC15A2
prerank,positive regulation of lipid catabolic process (GO:0050996),0.29038196880742706,0.8674604339789375,0.6410256410256411,0.8646520814916122,1.0,4/16,16.46%,IRS1;IL1B;ABHD5;SCT
prerank,visual perception (GO:0007601),0.211363121846366,0.8672474612475723,0.75,0.8643574067550549,1.0,13/90,10.45%,COL1A1;COL11A1;ZIC2;GRM8;GPR143;REEP6;CEP250;CRYBB3;RP2;BEST1;CHRNB2;TH;POU6F2
prerank,positive regulation of DNA replication (GO:0045740),0.30159584519569865,0.8671606195409595,0.6744186046511628,0.8638160402214384,1.0,6/16,17.87%,EREG;DNA2;DHX9;ATAD5;CDT1;NPM2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.21956642796515685,-0.8661933549175631,0.7708333333333334,0.8614321530233412,1.0,25/70,24.32%,MYH2;PIK3R1;NCK1;PLA2G6;DOCK1;NCKAP1L;MYO1C;MAPK1;MAPK3;ARPC2;ELMO2;RAC1;ELMO1;BAIAP2;WIPF1;WASF2;PLD2;PIK3R2;ACTB;WIPF3;PLCG1;PLCG2;PRKCD;BRK1;ARPC1A
prerank,regulation of secretion (GO:0051046),0.3328698925914385,0.8660850805370588,0.5581395348837209,0.8656863703903844,1.0,4/15,13.20%,KCNQ1;OAS2;ACSL3;MYO6
prerank,sulfur compound biosynthetic process (GO:0044272),-0.2136973060648753,-0.8651983659215131,0.8,0.8629235481110381,1.0,26/108,19.35%,GSTM2;GSTM5;CSPG4;PRELP;ST3GAL3;UST;CHST3;CDO1;MAT2A;ST3GAL6;CHST15;GSTA4;B4GAT1;DCN;OGN;GSTM3;DSEL;CHST7;OMD;CHST9;HPGDS;CSGALNACT2;CHST12;GSTT2B;ANGPT1;GSTM4
prerank,fatty acid transport (GO:0015908),-0.2976024695719813,-0.8631947981267241,0.6271186440677966,0.8666311887316649,1.0,7/19,22.14%,PPARD;SLC27A1;CPT1B;SLC27A6;SLC27A3;CD36;FABP4
prerank,fatty acid biosynthetic process (GO:0006633),0.22640959212066586,0.8628886328222592,0.7692307692307693,0.8717683065582081,1.0,16/62,17.38%,HACD3;SCD;TECR;ACOT7;XBP1;LIPG;ASAH2B;MCAT;HACD2;ABHD2;ELOVL1;ELOVL7;ACLY;NDUFAB1;ACSF3;OXSM
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.24670336650438957,-0.8628735309324514,0.7627118644067796,0.8666094959322591,1.0,9/50,13.02%,IL6R;DEFB124;PTN;ZNF580;MSTN;VEGFB;RARRES2;MAPK1;MAPK3
prerank,lipid catabolic process (GO:0016042),-0.2846886320547201,-0.8625576365698274,0.5967741935483871,0.8666032751580703,1.0,11/24,27.85%,SIRT2;LIPI;PNLIP;ACADL;HSD17B14;PLA2G1B;PNLIPRP3;CES1;LPL;CYP4F12;MT3
prerank,positive regulation of glucose import (GO:0046326),-0.280233859087956,-0.8621563777198727,0.6458333333333334,0.8667050250363415,1.0,10/24,28.39%,SORBS1;PIK3R1;RHOQ;AKT2;INSR;INS;CLTCL1;OCLN;CAPN10;ARPP19
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.20207084208916015,-0.8619947421516975,0.8225806451612904,0.8663211891763294,1.0,47/166,23.92%,CFLAR;S100B;MAP3K3;FLNA;LPAR1;TRIM52;MAP3K14;ZDHHC17;LURAP1;TRIM6;PRKCB;TAB2;TLR9;TERF2IP;PRKD1;LITAF;WLS;PELI2;ROR1;TNFSF10;S100A13;PPM1A;UBE2V1;RHOA;BCL10;HTR2B;TICAM2;GPRC5B;TRIM34;APOL3;VAPA;MIB2;RNF31;EDA2R;CCL21;TRIM62;AKAP13;TRIM8;MAP3K7;TRIM38;TIRAP;ALPK1;MUL1;RIPK1;HMOX1;PINK1;RHOC
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.3227068166500996,0.8616645309209456,0.660377358490566,0.8735295084033822,1.0,6/16,21.48%,ENTPD7;CMPK1;ENTPD2;CMPK2;ENTPD6;ENTPD1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.2822585482991952,-0.8611624868220538,0.6666666666666666,0.8672775486152032,1.0,10/24,26.38%,HAP1;GPER1;RBPJ;CCDC88A;CBL;RTN4;AFAP1L2;BCAR3;DGKD;HIP1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.29482916929721203,0.8606181931891432,0.74,0.8754846163452141,1.0,5/18,16.83%,NCL;NCBP1;DAZAP1;RBM3;TRA2B
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.22106996697210324,0.8600200651278459,0.8536585365853658,0.8761958022003221,1.0,18/78,16.42%,SOX4;EIF3C;NAT10;EIF4A3;PRKDC;YTHDF1;SMPD2;RPS4X;EIF6;EFNA1;RELA;EIF3D;ELAVL1;NPM1;LARP4B;RBM3;NSUN5;EIF3E
prerank,regulation of protein binding (GO:0043393),0.2092393204601747,0.8596378094586774,0.8048780487804879,0.8763745833787263,1.0,21/108,14.09%,GNL3L;TRIB3;RAN;RIPK2;DERL1;PPP1CA;AURKB;TMBIM6;BAMBI;STK4;SLPI;AURKA;DTX3L;CTNNBIP1;ZFPM1;NMD3;GSK3B;SORL1;KDM1A;PLK1;BMP4
prerank,negative regulation of kinase activity (GO:0033673),-0.23075664621313807,-0.859158617741282,0.7931034482758621,0.8708861193048094,1.0,15/58,17.16%,MAPT;WWTR1;SNCA;PRKRIP1;DBNDD2;CDKN1C;PRKAG2;PPM1F;HSPB1;INPP5K;TAB1;TRIB2;GNAQ;DUSP19;TSC2
prerank,establishment of protein localization to membrane (GO:0090150),-0.2287169885187998,-0.8588463659229588,0.8333333333333334,0.8708379375564395,1.0,21/66,22.60%,NACAD;SYNE3;MICALL1;ZDHHC15;REEP1;PARD3;ZDHHC7;MYO1C;TAOK2;GORASP1;VPS37A;BRAF;RTP5;RAB3GAP1;ZDHHC18;EGFR;ZDHHC11;PIKFYVE;GOLGA7;ZDHHC21;RTP1
prerank,regulation of nervous system development (GO:0051960),-0.2536164854776322,-0.8586025438289456,0.7301587301587301,0.8707053625464539,1.0,7/39,11.75%,LGI4;NPHP3;ARNTL;PTN;PTPRZ1;SIRT2;HEY1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.22726998049656105,-0.8583495014773987,0.7547169811320755,0.8705806807792528,1.0,27/79,26.38%,CFLAR;CASP12;NLRP1;MAPT;SNCA;DLC1;NGF;NGFR;CARD8;TNFSF10;PIDD1;FAS;COL4A3;CASP9;APAF1;KHDC1;CRADD;BOK;CASP8AP2;BAD;MUL1;RIPK1;NKX3-1;MTCH1;SMAD3;CASP10;HIP1
prerank,regulation of postsynapse organization (GO:0099175),-0.2659268330958786,-0.8562004229551622,0.7741935483870968,0.8742971980362961,1.0,12/28,25.78%,ZDHHC15;SHANK3;KIF1A;LRRK2;ABI2;EPHA4;IL1RAPL1;SIPA1L1;PPFIA2;CDKL5;ARC;TANC2
prerank,hexose biosynthetic process (GO:0019319),0.26042225905307254,0.8561805258301527,0.7346938775510204,0.883756190016263,1.0,15/42,23.31%,SORD;GAPDH;GOT2;TPI1;MDH2;GAPDHS;G6PC3;SLC37A4;ALDOC;RBP4;SLC25A13;PCK2;ALDOB;SLC25A1;FBP1
prerank,regulation of protein dephosphorylation (GO:0035304),-0.2581990238776009,-0.8549569649416809,0.7804878048780488,0.8759699137706264,1.0,16/38,32.10%,TSC1;CALM1;DLC1;PPP6R2;CDH5;PIN1;CALM2;PRKCD;CAMTA1;SMPD1;PPP6R3;HSP90B1;ARPP19;CNEP1R1;PPP1R15A;PPP1R16B
prerank,acute inflammatory response (GO:0002526),0.29099790449425417,0.8539032564796482,0.5957446808510638,0.8882086015961271,1.0,7/20,21.34%,C2CD4A;CEBPB;CTNNBIP1;VNN1;PLSCR1;TNFSF4;C2CD4B
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.32885390370281725,-0.8537566524674495,0.6981132075471698,0.8777699749163141,1.0,6/17,22.81%,SORBS1;PPARD;SIRT4;EEF1A2;INS;MTOR
prerank,second-messenger-mediated signaling (GO:0019932),-0.22634900384773368,-0.8534364503810413,0.7272727272727273,0.8777928100369893,1.0,25/86,23.29%,TPCN2;INPP5A;PLA2G4B;AGTR1;RCAN2;CCR10;NOS1;LRRK2;RYR2;PPP1R9A;PLCE1;P2RY12;ACKR3;HTR2B;EDNRB;ACKR2;P2RY11;CD36;AGTR2;CAMKK2;CHRM3;PTGDR2;RCAN1;PLCG1;PLCG2
prerank,regulation of synapse organization (GO:0050807),-0.2959697317105359,-0.8534129442733918,0.74,0.8771584568206753,1.0,12/26,26.88%,SLITRK2;SETD5;MDGA1;MEF2C;EPHA4;CAMK2B;IL1RAPL1;GRIPAP1;CDKL5;CLN3;SLITRK4;YWHAZ
prerank,T cell differentiation (GO:0030217),0.25103240930179643,0.8533181060889508,0.7708333333333334,0.888856827507077,1.0,18/41,29.77%,SOX4;TCF7;LFNG;SHH;GPR89A;CHD7;GPR89B;PTPN2;RAG1;LCK;JAG2;ZAP70;SPI1;RABL3;ANXA1;RHOH;PIK3CD;ADAM17
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.2560650054637026,0.8531062291604332,0.6818181818181818,0.8885434355170256,1.0,9/29,23.07%,CALR;C1QBP;PLA2G7;CXCL10;FPR2;SERPINE1;HMGB1;LGMN;S100A14
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.3257820590252136,0.8524501771033836,0.72,0.889062911871569,1.0,4/15,12.50%,WNT5A;DHX9;AGPAT2;TAF9
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.22736234210810352,-0.8522370660203474,0.7666666666666667,0.8790752322656994,1.0,18/61,24.78%,DEFB124;MAP3K14;TBKBP1;TAB2;TLR9;TLR3;DAB2IP;TAB1;ERC1;BCL10;TICAM2;ROCK1;RNF31;UBB;MAP3K7;NFKBIL1;RIPK1;TNFRSF1A
prerank,chloride transport (GO:0006821),0.21659470004640155,0.851852570937928,0.8571428571428571,0.889503197075617,1.0,11/74,8.80%,CLIC1;SLC12A2;TTYH3;GABRP;BEST1;CLIC3;SLC12A8;GABRD;CLCN3;CLCN4;CLCN1
prerank,kidney development (GO:0001822),-0.2158158605060448,-0.8515035423834448,0.7413793103448276,0.8800276302113185,1.0,15/68,16.72%,NPHP3;PKD1;KANK2;GDNF;OSR1;AGTR1;PYGO1;TCF21;ZBTB16;GLI2;SOX17;GDF6;CEP290;FGF10;PCSK5
prerank,glycerophospholipid catabolic process (GO:0046475),-0.2810721243674929,-0.8506993430298675,0.6779661016949152,0.8809708341716374,1.0,8/26,20.21%,PLA2G5;PLA2G4B;INPP5F;PLA2G6;PLA2G4C;ENPP2;ENPP6;ABHD16A
prerank,regulation of platelet activation (GO:0010543),-0.2835901831103705,-0.8506641697832971,0.6326530612244898,0.8803588010967982,1.0,9/20,27.51%,PDGFRA;PRKCA;CELA2A;PDGFB;C1QTNF1;PDGFA;SELP;PLA2G4A;BLK
prerank,positive regulation of cholesterol transport (GO:0032376),-0.2581640150031462,-0.8505808218838449,0.7547169811320755,0.8797706057559194,1.0,8/30,22.16%,ABCA8;NR1H2;RXRA;ABCA5;GPS2;ABCA3;SIRT1;CES1
prerank,negative regulation of cellular component movement (GO:0051271),-0.3134630172274593,-0.8500073990074198,0.7090909090909091,0.880430360978577,1.0,4/15,14.51%,TGFBR3;ACTN1;FBLN1;SPOCK3
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.22144559881216244,-0.8500033221495741,0.8,0.8797215174486486,1.0,22/69,24.88%,NFATC4;NRBP2;GDNF;PTPRZ1;NGF;CRLF1;BCL2;CNTF;BHLHB9;NTRK1;MEF2C;MAG;NTF3;CLCF1;CCL2;SOD1;LIG4;CPEB4;WFS1;PINK1;TGFB3;CLN3
prerank,regulation of chemokine production (GO:0032642),-0.26304458348958526,-0.8497886546204755,0.6964285714285714,0.8794844842500362,1.0,6/41,10.93%,IL6R;TLR9;ELANE;ACKR1;TLR3;TSLP
prerank,negative regulation of defense response (GO:0031348),-0.223756149618317,-0.849645281109513,0.7647058823529411,0.8790354652272858,1.0,22/78,24.78%,MAPKBP1;MAPK7;GPER1;PPARD;RORA;LRFN5;NR1D1;ELANE;PTGIS;SIRT2;C1QTNF3;PPM1B;TRAFD1;PCBP2;GPS2;FNDC4;DHX58;CDH5;PRKCD;MUL1;TRAF3IP1;TNFRSF1A
prerank,dopamine metabolic process (GO:0042417),0.27505791325909446,0.8489234601634635,0.675,0.8957193888537459,1.0,5/18,15.33%,TGFB2;TH;DRD2;GCH1;SULT1A3
prerank,regulation of telomere capping (GO:1904353),-0.2758928474912015,-0.8488150759993803,0.7241379310344828,0.880095324450891,1.0,9/23,22.56%,MAP3K4;RTEL1;MAPK1;MAPK3;MAP2K7;RAD50;NEK7;SMG6;TNKS
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.30106621965722713,0.8487170636195865,0.7142857142857143,0.8953131150120026,1.0,3/15,7.77%,DDIAS;RPS3;BCL2L1
prerank,insulin secretion (GO:0030073),-0.32156822874017443,-0.8480608851753856,0.6491228070175439,0.8810701499239489,1.0,5/16,14.84%,CAMK2G;RAB11FIP2;SLC30A8;SNX19;PTPRN
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.285574515107547,-0.847570527928083,0.7076923076923077,0.8815288779171913,1.0,8/18,31.69%,RTEL1;TINF2;SMG6;TNKS;SLX4;TNKS2;ERCC4;SMG5
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.2867746197788563,0.8468678158124273,0.75,0.8988201435211891,1.0,5/17,14.67%,GLE1;IGF1R;GSPT1;OGFOD1;GBA
prerank,protein K48-linked ubiquitination (GO:0070936),-0.24150221743477127,-0.8468114956571368,0.7719298245614035,0.8823648548946007,1.0,19/55,23.21%,UBE2G2;UBE2D4;UBE2E1;RNF146;HACE1;RNF216;RNF115;UBE2G1;UBE2E2;RNF152;NHLRC4;UBE2Q2;ARIH2;FBXO38;KLHL3;TTC3;UBE2H;UBR5;ZNRF1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.1913927819389834,-0.8466036417314756,0.8688524590163934,0.8821645922873292,1.0,74/241,26.12%,HDAC4;CFLAR;MYOCD;FZD4;TRIM52;CRTC3;DDR2;CAPN3;CLU;CAMK2A;SRF;PPARGC1B;TRIM6;TRAF1;JMY;RPS6KA5;PRKCB;TAB2;STK36;TLR9;KIT;AR;TERF2IP;BEX1;PRKD1;PTEN;ALK;EPHA5;FER;CRTC1;NTRK1;ROR1;HDAC5;DVL2;CRTC2;TAB1;RELN;UBE2V1;ERC1;BCL10;ESR1;PLA2G1B;PIDD1;TRIM34;SMO;TP53BP1;IL18R1;RNF31;UBB;CD36;EDA2R;INS;TRIM62;TRIM8;FZD1;MAP3K7;TRIM38;ABRA;LRP6;TIRAP;ARID5B;PLCG2;ATF2;RIPK1;PRKCH;TRIM41;EDA;SMAD3;TSSK4;IL18RAP;HCLS1;RGCC;ESR2;TRAF5
prerank,cilium movement (GO:0003341),-0.2531687830380085,-0.8463251634913813,0.7358490566037735,0.8819269186945597,1.0,14/38,27.30%,DNHD1;CCDC39;CCDC40;CFAP54;TEKT2;TEKT3;CFAP70;DNAH1;RSPH4A;SPEF2;ADCY10;SPEF1;DNAH17;CFAP61
prerank,renal system development (GO:0072001),-0.22277866312432937,-0.8461078491921034,0.7796610169491526,0.8817499649887518,1.0,9/55,12.08%,NPHP3;PKD1;FOXF1;MYOCD;AGTR1;PYGO1;TCF21;GLI2;SOX17
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.3014877666175162,-0.8460937381884512,0.7272727272727273,0.8810608975272366,1.0,10/18,31.10%,NPHP3;CCDC39;CCDC40;NEK10;RFX3;SPEF2;ADCY10;AQP4;CFAP53;CABYR
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.26282502266733526,-0.845863559818198,0.6538461538461539,0.8808999964352546,1.0,9/22,22.71%,PRKRIP1;CDKN1C;INPP5K;CDKN1A;ROCK1;CDKN2C;SIRT1;TESK1;INHA
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.24269398303569167,0.8458358799029092,0.8717948717948718,0.9001860449288754,1.0,14/38,24.48%,PMAIP1;TNFAIP3;BCL2L1;ICAM1;GPX1;TNFRSF10B;GSK3B;BRCA1;TRAF2;RNF34;SERPINE1;TNFRSF10A;FASLG;THBS1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.2711551632823845,0.845752216918632,0.68,0.8995626149119292,1.0,10/25,26.85%,B3GNT4;B3GNT2;HS2ST1;EXT2;B3GNT3;HAS3;B3GNT8;NDST3;EXT1;HAS2
prerank,activin receptor signaling pathway (GO:0032924),0.30940251763702664,0.8454301719555833,0.7333333333333333,0.8992614168297257,1.0,2/17,2.73%,TDGF1;INHBA
prerank,protein insertion into membrane (GO:0051205),0.2712333104342556,0.845228580487618,0.7380952380952381,0.8990482547121632,1.0,6/32,8.75%,SERP1;GET4;SEC61B;TRAM1;SEC61G;COX18
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.3325153472374347,-0.8448481162197371,0.6862745098039216,0.8822891071889529,1.0,6/16,23.29%,KIT;BCL10;GPRC5B;SIRT1;NR4A3;PLCG2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.27680119047225926,0.8443819421934845,0.7872340425531915,0.8997874305782594,1.0,9/26,20.26%,ERO1A;HSPA14;HSPA9;PTGES3;DNAJC7;SDF2L1;HSPA5;HSPA13;SDF2
prerank,regulation of Notch signaling pathway (GO:0008593),-0.23461417143924468,-0.8441527023832398,0.8035714285714286,0.8829543315361309,1.0,20/73,20.80%,YJEFN3;EPN2;KAT2B;METTL3;RBPJ;MAML1;ZMIZ1;HEY1;NOTCH4;SYNJ2BP;HIF1AN;EGFL7;GATA2;EGFR;BEND6;FBXW7;ENHO;DLL1;TM2D3;RFNG
prerank,protein-containing complex assembly (GO:0065003),0.18021494792689743,0.8441217500150405,0.9259259259259259,0.8995644750218978,1.0,81/257,25.84%,CLDN1;RUVBL1;MYC;TFAP4;CAPG;TMED2;NIFK;TCF7;PPIH;CDC123;AREG;BLM;FOLR1;PDZD11;CAPZA1;AXIN2;CLDN14;PARD6B;LEF1;SEC13;PML;RBBP5;CTSC;SMARCA4;SOX9;F5;STOML2;TMED10;DHX9;FN1;HDAC1;ZW10;TRAPPC6A;ADAM10;RSPH9;BCL9L;GSK3B;REPS2;TRAF2;MCU;USH1C;LEO1;RAB1A;TFG;CD2AP;NSF;FANCA;TRAPPC9;PREB;CTSZ;SLC2A1;CNIH1;FANCC;KNTC1;CARD10;SLC9A3R1;AXIN1;KLHL12;TRAPPC2L;HES1;TGFA;VIL1;SAMM50;CUL3;ZC3H12A;GEMIN5;PPID;LMAN1;GPAA1;MEN1;TP53;TSPAN33;ANKS4B;TERT;CTNNB1;CD3G;CREBBP;CNIH3;SERPINA1;IL2RB;SEC24A
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.29235087700697765,-0.8438026035558189,0.6166666666666667,0.8830100974228134,1.0,6/24,17.74%,HAND2;TRIM6;HEY1;HEY2;SIN3A;SOX11
prerank,adenine nucleotide transport (GO:0051503),0.3088242707190605,0.8435070079559298,0.6666666666666666,0.8999431101693798,1.0,7/18,17.61%,LRRC8E;SLC35B2;SLC19A1;LRRC8D;SLC25A17;SLC25A24;SLC25A5
prerank,JNK cascade (GO:0007254),-0.25735481905758045,-0.8434540381517901,0.7169811320754716,0.8830282490907818,1.0,15/41,21.71%,MAPK10;ARHGEF6;TAB2;MAP2K7;TAB1;UBE2V1;MAP2K4;MAPK8;MAP4K2;GPS2;UBB;MAP3K10;MAP3K12;MAP3K7;SH2D3C
prerank,lymphocyte differentiation (GO:0030098),0.20971372491130513,0.8433368581363695,0.8157894736842105,0.8994588303480366,1.0,26/81,28.77%,SOX4;IL11;LFNG;TCF3;JAK3;CEBPG;TPD52;GPR89A;CHD7;GPR89B;PTPN2;SLC25A5;RAG1;LCK;JAG2;MSH2;ZAP70;NFAM1;PTPRJ;CR2;RABL3;RHOH;IL10;IFNE;PIK3CD;ADGRG3
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.31622737532238054,-0.8426931762472436,0.7115384615384616,0.8842161578418161,1.0,5/17,16.68%,CPSF7;CPEB1;CDK9;CPEB3;ZC3H14
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.25160192841639856,-0.8416085044366203,0.7407407407407407,0.8857617821391204,1.0,14/36,23.85%,BCO2;MAPT;BCL2;LRRK2;PID1;SLC25A36;PIP5KL1;RNF122;AKT2;UBB;SOD1;ABCD1;BAD;PINK1
prerank,phospholipid transport (GO:0015914),0.2274811574247879,0.8404089023012038,0.7837837837837838,0.9050251675151131,1.0,21/51,28.92%,TRIAP1;SCARB1;MTTP;ATP11A;PRELID2;PRELID1;ATP9A;APOC1;ATP10B;PITPNM1;LDLR;OSBPL2;TMEM30B;ABCB1;ABCG1;ABCA12;PLA2G10;MFSD2A;ATP11B;OSBPL8;ATP8B1
prerank,body fluid secretion (GO:0007589),-0.3150528398409963,-0.8402535722481217,0.6666666666666666,0.887903819641309,1.0,4/15,18.29%,NPR1;VIP;NPPB;ERBB4
prerank,regulation of monocyte differentiation (GO:0045655),0.30921262269145267,0.8396150546986505,0.7692307692307693,0.9059299007589159,1.0,5/15,20.96%,MYC;DCSTAMP;CTNNBIP1;HOXA7;CDK6
prerank,chloride transmembrane transport (GO:1902476),0.22626075308381988,0.8387036946957482,0.76,0.906968317268801,1.0,18/50,28.46%,SLC12A2;GABRP;SLC12A8;GABRD;CLCN3;CLCN1;GABRB1;GLRA2;CFTR;SLC5A1;GABRR1;GABRB2;SLC12A9;ANO9;GABRA3;GABRA4;SLC12A7;APOL1
prerank,lipid translocation (GO:0034204),-0.27593329708935466,-0.8385629610258957,0.6896551724137931,0.8907829494835626,1.0,7/23,19.55%,ATP8B2;ABCA1;ATP10D;ATP8A2;ATP9B;ATP10A;ATP8B3
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.25792175602242184,-0.8384297589705669,0.6666666666666666,0.8903687002412651,1.0,9/34,15.25%,FGF2;SRF;TEAD1;NGFR;ATOH8;NR3C1;PRL;GATA2;PDGFB
prerank,vesicle organization (GO:0016050),-0.24751643754262026,-0.8383639541555828,0.6779661016949152,0.8897758810357161,1.0,13/40,19.74%,SNX33;CD34;DNAJC13;CAV2;VPS33B;AKTIP;PI4K2A;VPS11;EPS15;ALS2;HOOK3;PLEKHF1;DNM1
prerank,positive regulation of cellular component organization (GO:0051130),-0.20903734177427552,-0.8383079143115788,0.8387096774193549,0.8891840195348611,1.0,43/108,29.04%,CLIP3;ADD1;RAPGEF3;DCTN1;CLU;FRMPD4;NRXN1;TRABD2B;CALY;SHANK3;TAL1;SNCA;PLEKHM2;AR;CAMK1;TPPP;LGALS3;DAB2IP;RELN;CAMK2B;INSR;ATP10A;ADGRL1;DLL1;BNIP3;CDH5;TIRAP;BCL2L11;CDC42EP2;RHOC;BRK1;TGFB3;SMPD1;MPP7;FNIP1;FLOT1;NEDD4L;ASAP1;PTPN23;ANAPC2;ICE1;BMF;SH3GLB1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.21255478499641697,0.8382882506631828,0.8571428571428571,0.9070877695209781,1.0,30/77,29.67%,IL23A;ADIPOR1;PHB;IL1B;RPS3;NMI;RTKN2;TSPAN6;RELA;IRAK1;ACTN4;BMP7;EZR;TMSB4X;CPNE1;NOD2;NFKBIA;MMP8;CD86;ZC3H12A;IL12B;SPI1;IFI35;TLR7;TRAF6;ADGRG3;NOD1;PHB2;EIF2AK2;NLRP3
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.2858906633553852,-0.8378183904795128,0.703125,0.8894654966096771,1.0,7/25,16.11%,DDX39B;CCNT2;THOC5;KAT7;SUPT6H;THOC1;SCAF8
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.28647009967481707,-0.8378091740333785,0.6481481481481481,0.8880394751117507,1.0,7/20,25.32%,DLD;ACAD8;ACAT1;DBT;BCKDHA;ACADSB;ALDH6A1
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.28647009967481707,-0.8378091740333785,0.6481481481481481,0.8880394751117507,1.0,7/20,25.32%,DLD;ACAD8;ACAT1;DBT;BCKDHA;ACADSB;ALDH6A1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.22529574116364215,0.8365784488500324,0.75,0.9102839573896777,1.0,21/53,30.88%,IRAK2;MAPKAPK3;UNC93B1;CNPY3;MYD88;FFAR2;IRAK1;MAPKAPK2;TIFA;UBA52;NOD2;HMGB1;LGMN;CTSB;RPS6KA3;TLR7;TRAF6;NOD1;TLR8;UBC;LACC1
prerank,actin filament-based transport (GO:0099515),-0.2967010902543544,-0.8359146621588089,0.7037037037037037,0.8909692130572804,1.0,4/21,11.15%,MYO15A;SUN2;MYO5A;MYO1C
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.26821332204442405,0.835473936774149,0.825,0.911701301278469,1.0,7/24,19.32%,IL11;TNFAIP3;ICAM1;SEMA5A;KDR;PAK4;SERPINE1
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.25748589161079344,-0.835431674170468,0.7777777777777778,0.8911740254138747,1.0,9/39,19.98%,EPN2;KAT2B;RBPJ;MAML1;ZMIZ1;NOTCH4;ENHO;DLL1;TM2D3
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.24769122583830933,-0.8353860358215943,0.7592592592592593,0.8905838946402118,1.0,11/39,18.06%,BTC;DUSP3;SPRY1;RNF115;DAB2IP;TSG101;ARHGEF7;EPS15L1;CBL;EPS15;EGFR
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.25064972912689126,-0.8350680287900694,0.7884615384615384,0.8905215554941266,1.0,13/29,27.01%,GPR17;LPAR1;GPR20;RAC1;AKAP13;ABRA;LPAR6;ARHGEF3;LPAR4;SYNPO2L;F2RL3;GPR4;F2RL1
prerank,sodium ion import across plasma membrane (GO:0098719),0.28233758084788796,0.83478892867663,0.7105263157894737,0.912326607229731,1.0,6/18,22.56%,SLC12A2;SLC5A2;SLC9A7;SLC9C1;SLC5A1;SLC9A4
prerank,positive regulation of transport (GO:0051050),0.20169861612627682,0.8343416525081655,0.9047619047619048,0.912421704110737,1.0,11/87,9.05%,CDH3;CALR;LYAR;LMAN2;TFR2;IL1B;IL15RA;SPAG5;SPACA3;PLAA;CYBA
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.28801849097791465,-0.8341565750176635,0.7551020408163265,0.8914825004978769,1.0,7/21,16.92%,CYP46A1;CYP17A1;CYP11B1;AKR1C1;CYP11A1;AKR1C2;AKR1B1
prerank,gastrulation (GO:0007369),-0.3010577490563916,-0.8340085483199001,0.7037037037037037,0.8911306118850847,1.0,4/19,20.11%,NPHP3;MEGF8;SMAD2;NR4A3
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.28937714146843946,-0.8339556636041994,0.6981132075471698,0.8905201998564098,1.0,5/17,20.75%,HDAC4;FZD7;HDAC5;GSK3A;SOX6
prerank,cellular response to oxidative stress (GO:0034599),-0.2029118832991679,-0.8339114386843294,0.86,0.8898959721315555,1.0,30/124,20.28%,GPX3;TPM1;ARNTL;PKD2;MAPT;PXN;PDGFRA;ARNT;SNCA;STX2;ATF4;CPEB2;DAPK1;PRKD1;LRRK2;PRKAA2;SIRT2;FER;MAPK1;MAPK3;RAD52;CCS;MAPK8;ANKRD2;WNT16;EGFR;PDK2;PLA2R1;SETX;CAMKK2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.22069871774450894,0.8337432905771738,0.9166666666666666,0.9128242124443048,1.0,13/54,16.15%,HS6ST2;GLB1;HS3ST1;AGRN;HS2ST1;GALNT5;B3GALT6;B4GALT7;EXT2;SDC1;PXYLP1;CLN6;HPSE
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.2993269537113735,-0.8335694921622633,0.8301886792452831,0.8898122607257589,1.0,7/18,22.17%,MAPK7;HSPB1;SIRT1;INS;SOD1;NME5;NOL3
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.30696440635518346,-0.8332712426392181,0.7377049180327869,0.8895514493038033,1.0,7/18,22.71%,ATXN3;PIK3R1;RNF185;NCK1;TMEM259;BOK;BCL2L11
prerank,positive regulation of phagocytosis (GO:0050766),0.2245163418280889,0.833228050154109,0.8571428571428571,0.9129475177857905,1.0,7/50,9.05%,CALR;LYAR;LMAN2;IL1B;IL15RA;SPACA3;CYBA
prerank,inorganic anion transmembrane transport (GO:0098661),0.22085612331064536,0.8332235122705183,0.7608695652173914,0.9121590817473136,1.0,17/65,22.84%,SLC12A2;SLC5A6;GABRP;SLC12A8;GABRD;CLCN3;CLCN1;GABRB1;GLRA2;SLC37A4;CFTR;SLC5A1;SLC37A1;GABRR1;GABRB2;SLC12A9;ANO9
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.2667341616119386,-0.833156270303581,0.7719298245614035,0.889069689155059,1.0,4/21,15.31%,PLA2G5;PLA2G4B;OSBPL5;PLA2G1B
prerank,mitochondrial fission (GO:0000266),0.29594532771017046,0.8330368756830318,0.5652173913043478,0.9117842479202923,1.0,2/17,2.10%,MTFR2;MTFR1
prerank,cellular response to cadmium ion (GO:0071276),-0.2650564566679713,-0.8327898931074216,0.7192982456140351,0.8891859074404825,1.0,8/26,27.85%,MAPK1;MAPK3;MT1X;MAPK8;EGFR;MT1M;MT1A;MT3
prerank,regulation of neuron death (GO:1901214),0.2052955389644272,0.8324558476790654,0.8367346938775511,0.9119751857895949,1.0,33/84,28.48%,GRIN2B;CDK5;SIGMAR1;KIF14;WNT5A;VPS35;NAE1;ATP13A2;TRIM2;PCSK9;GSK3B;SORL1;FOS;DHCR24;TRAF2;GBA;SULT1A3;CTSZ;TNFRSF1B;EGR1;FYN;EIF2S1;NENF;HLA-F;TYROBP;CHRNA7;HTRA2;ITGB2;DDIT4;IFNG;GRM4;PARK7;EGLN3
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.24311267740705791,0.832362667184552,0.7,0.9112949286766313,1.0,9/39,16.46%,SOX4;TNFSF11;TFR2;TM7SF3;DRD2;AIMP1;MCU;AACS;SCT
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.2773717916339513,0.8319172573876189,0.7045454545454546,0.9114955217142906,1.0,3/26,2.65%,CCND1;TFDP1;MTBP
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.20346655030494365,-0.8315554176918725,0.8771929824561403,0.8909226972632583,1.0,56/145,28.67%,VAMP2;KCNB1;FLNA;CSNK2A2;TENM1;RAPGEF3;ANK3;MTCL1;PIK3R1;DMAP1;RUFY3;PRNP;CAMK1;BCL2;PSEN1;OAZ2;ABLIM3;PPP3CC;MYO1C;NPEPPS;BAG3;HSPA1L;PCM1;SEC16B;LEPROT;MAPK8;ARIH2;CEP290;VPS11;PCNT;EFCAB7;AKT2;RNF31;FBXW7;GSK3A;BCAS3;PIK3R2;UBR5;BAD;RHOU;BAP1;PRKCD;PINK1;MFF;SMAD3;HCLS1;TPR;UBL4B;YWHAZ;ITGB1BP1;TFDP2;RAB29;MICALL2;SLC51B;ICE1;MIEF2
prerank,cellular response to interferon-beta (GO:0035458),0.29049690427804964,0.831486808784311,0.6981132075471698,0.9114855939852142,1.0,6/18,20.67%,IFITM2;PNPT1;STAT1;UBE2K;MNDA;IFI16
prerank,gluconeogenesis (GO:0006094),0.2499907999194174,0.8313942886057138,0.75,0.9108934417166493,1.0,15/39,25.23%,GAPDH;GOT2;TPI1;MDH2;GAPDHS;G6PC3;SLC37A4;ALDOC;RBP4;SLC25A13;PCK2;ALDOB;SLC25A1;FBP1;PGAM1
prerank,response to steroid hormone (GO:0048545),-0.2536179473124101,-0.8312706785768827,0.7321428571428571,0.8907943340217173,1.0,7/34,15.40%,ATP1A2;AR;ATP1A3;NR3C1;WBP2;MGARP;TFPI
prerank,lymphocyte activation involved in immune response (GO:0002285),0.2663406756089902,0.8309623008189607,0.775,0.9110461774641306,1.0,23/23,73.39%,MDK;CD244;IFNE;LCP1;CD74;EIF2AK4;CD1C;IFNA1;IFNB1;IFNA8;IFNA14;IFNA7;IFNA4;IFNA10;IFNA17;IFNA16;IFNA2;IFNA6;IFNW1;IFNA21;GPR183;F2RL1;IFNA5
prerank,cellular response to interleukin-6 (GO:0071354),-0.2574358615080786,-0.8298328111634098,0.6923076923076923,0.8931007946316024,1.0,6/28,12.00%,IL6R;SMAD4;PTGIS;ST3GAL6;FER;PID1
prerank,sensory perception of pain (GO:0019233),-0.30370754752536444,-0.829440609824115,0.7413793103448276,0.8932575331295467,1.0,6/19,16.17%,SCN9A;P2RX7;KCNA2;KCNK4;OPRL1;MRGPRX2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.3238167067116002,-0.8285268241431379,0.6909090909090909,0.8940822947782433,1.0,6/15,18.06%,DYRK1A;NTRK1;MAPK3;BMX;AATK;EGFR
prerank,dicarboxylic acid transport (GO:0006835),0.2596145175165113,0.8284403751976834,0.75,0.9154006620973341,1.0,9/28,24.46%,FOLR1;SLC19A1;SLC25A22;SLC13A3;ABCC2;SLC25A13;GIPC1;SLC26A8;SLC46A1
prerank,sensory perception of light stimulus (GO:0050953),-0.21866881632851606,-0.827924221140901,0.8,0.89446547709345,1.0,25/91,22.61%,PRR4;SFRP5;CNGB1;PRPH2;ROM1;MYO9A;CDH23;CRYGN;RD3;GPR179;BBS2;CRYBG3;IMPG2;TULP1;ATXN7;CRYGS;PCDH15;CABP1;KIFC3;EFEMP1;TULP2;RPGR;PDE6C;EYA4;WFS1
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.3113518477076375,-0.827807732655853,0.6964285714285714,0.8939022237670707,1.0,8/16,27.01%,NTRK3;VEGFB;NTF3;AZU1;VEGFC;SCG2;CDH13;F2RL1
prerank,endocardial cushion morphogenesis (GO:0003203),0.2861678512023448,0.8276626054404023,0.6923076923076923,0.9162727523378941,1.0,7/19,21.78%,TBX20;SOX9;TGFB2;ENG;BMP4;TGFBR2;NOTCH1
prerank,positive regulation of response to wounding (GO:1903036),0.267136683722407,0.8262012411046686,0.6956521739130435,0.9183132902916493,1.0,11/27,28.22%,CLDN1;ACTG1;MDK;DUOX2;GRN;CLDN4;ARFGEF1;REG3A;ANXA1;CLEC7A;INSL3
prerank,regulation of cellular pH (GO:0030641),-0.26022013258931015,-0.8261764411001414,0.6727272727272727,0.896702580882433,1.0,13/30,30.52%,SLC9A9;ATP1A4;SLC4A7;CA7;SLC4A3;SLC9A5;SLC4A5;CLN3;SLC4A1;SLC4A4;SLC4A10;CA2;SLC9C2
prerank,receptor catabolic process (GO:0032801),0.25008600442460766,0.8246027661383908,0.7608695652173914,0.9206924254365328,1.0,13/25,28.72%,RNF43;ZNRF3;CLTA;PCSK9;AP2S1;CLTC;AP2B1;TGFB1;MVB12A;LGMN;BECN1;BECN2;KIF16B
prerank,positive regulation of cell growth (GO:0030307),-0.2107788012221659,-0.8241846174827804,0.8775510204081632,0.8997400724331607,1.0,26/93,23.82%,NTN1;LGI1;AKAP6;USP47;MAPT;MACF1;ITSN2;RUFY3;L1CAM;NGF;BCL2;KLHL22;SYT2;N6AMT1;SFRP1;DBN1;EGFR;INS;INO80;RIMS1;RPTOR;SYT1;ZNF639;CPNE6;SYT3;CDKL5
prerank,skeletal system development (GO:0001501),-0.20226561984670233,-0.8240204499125561,0.8775510204081632,0.8993275869332166,1.0,42/145,24.12%,PKD1;PTH1R;NKX3-2;FGFR1;PRELP;BGLAP;CHRD;EXTL1;MYOC;HOXD3;FGFR2;HAPLN2;BMP3;SOX5;ZBTB16;TRPS1;GLI2;NPR3;BMP1;TLL1;EVC;XYLT1;ANKRD11;DYM;COL13A1;PCSK5;SOX11;MMP16;SUFU;HAPLN4;VKORC1;BMPR1B;AKAP13;SOX6;NCAN;INHA;SPEF2;SH3PXD2B;CREB3L2;ADAMTS4;PKDCC;GDF11
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.2689784531105751,0.8238126418153748,0.7659574468085106,0.9213202896578282,1.0,6/21,16.46%,TRIB3;PRMT3;ERLIN1;BRCA1;APOC1;ERLIN2
prerank,DNA methylation (GO:0006306),0.2824192239090616,0.823665972906386,0.7804878048780488,0.9207706558154078,1.0,6/23,15.68%,DNMT1;BEND3;GATAD2A;DNMT3B;FOS;SPOCD1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.18715878087243643,0.8233205569215986,0.9047619047619048,0.9206106105292806,1.0,26/132,17.92%,TDGF1;OSM;IL11;RIPK2;CSF2;IL23A;LRP8;DOK7;CD44;ARL2BP;IL21;EFNA1;CD80;CD81;CLEC6A;PAK2;SEMA4D;PECAM1;ITGA5;AGT;DLG3;SOCS3;FCGR1A;IL23R;TGFB1;LYN
prerank,regulation of interleukin-13 production (GO:0032656),0.290338460226063,0.8224259132182465,0.8043478260869565,0.9215683991372334,1.0,7/16,32.81%,LEF1;PRKCZ;TNFSF4;IL18;IFNL1;LILRA5;GATA3
prerank,regulation of lipid catabolic process (GO:0050994),-0.28952162739929427,-0.8223898963502682,0.6981132075471698,0.9017442569730697,1.0,6/17,21.56%,PDE3B;ALK;BSCL2;RARRES2;INS;ABCD1
prerank,eosinophil migration (GO:0072677),0.3028112507136921,0.8220704106681612,0.75,0.9206143090564459,1.0,4/15,13.09%,CCL24;CCL4;CCL3;CCL26
prerank,eosinophil chemotaxis (GO:0048245),0.3028112507136921,0.8220704106681612,0.75,0.9206143090564459,1.0,4/15,13.09%,CCL24;CCL4;CCL3;CCL26
prerank,homologous chromosome segregation (GO:0045143),-0.31772917998332023,-0.8216685947062602,0.7333333333333333,0.9026015639422188,1.0,5/15,22.03%,PTTG2;FMN2;CENPC;RNF212;ZCWPW1
prerank,positive regulation of histone modification (GO:0031058),0.2462763930973247,0.8216522529214003,0.7777777777777778,0.920549413017812,1.0,8/33,13.13%,UBE2N;RUVBL2;FOXP3;IL1B;SDR16C5;RPS6KA4;KDM1A;BRCA1
prerank,regulation of cholesterol transport (GO:0032374),-0.2842007921555601,-0.8207780562112023,0.76,0.9035304890227338,1.0,4/20,15.94%,YJEFN3;ABCA8;NR1H2;ABCA5
prerank,glucose catabolic process to pyruvate (GO:0061718),0.27222717125969814,0.8207006013258744,0.7111111111111111,0.9209291833320588,1.0,10/23,28.01%,GAPDH;TPI1;GAPDHS;PKLR;PKM;ALDOC;ALDOB;PFKL;PGAM1;GPI
prerank,canonical glycolysis (GO:0061621),0.27222717125969814,0.8207006013258744,0.7111111111111111,0.9209291833320588,1.0,10/23,28.01%,GAPDH;TPI1;GAPDHS;PKLR;PKM;ALDOC;ALDOB;PFKL;PGAM1;GPI
prerank,blood vessel endothelial cell migration (GO:0043534),-0.2778427459075223,-0.8204716048671364,0.8367346938775511,0.9034079736073368,1.0,7/23,23.39%,FGF2;SRF;SLIT2;PIK3R3;SOX18;CDH5;NR4A1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.30708331995194893,-0.8203346649849402,0.7755102040816326,0.9029286503295462,1.0,4/18,14.13%,FGF2;SRF;SLIT2;PIK3R3
prerank,response to estrogen (GO:0043627),-0.24482050235747604,-0.8201919671048251,0.8,0.9025010424549116,1.0,10/34,22.52%,CITED2;AR;GSTM3;WBP2;SFRP1;ESR1;ARID5A;CRHBP;BCAS3;CITED4
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.30376523384107845,0.8201257112310755,0.6875,0.9211091574632253,1.0,3/15,8.43%,S100A11;PDGFRB;MDK
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.27902447374460637,-0.8199469585309213,0.7454545454545455,0.9023214329280751,1.0,4/18,17.06%,IL6R;SMAD4;FER;CBL
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.27866969253640833,0.8197218163361084,0.74,0.9210440596542205,1.0,8/25,16.46%,TRIB3;ADIPOR1;ERLIN1;EIF6;BRCA1;LPGAT1;APOC1;ERLIN2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.2660062700338404,-0.8193343047042655,0.7272727272727273,0.902701783605485,1.0,13/25,34.43%,PJA2;TLR9;TLR3;TICAM2;RTN4;TIRAP;F2RL1;FLOT1;NINJ1;TLR2;DDX3X;NR1H3;TLR1
prerank,endothelial cell migration (GO:0043542),0.25233563173455953,0.8181500383324267,0.8043478260869565,0.9232929257515008,1.0,4/38,4.27%,FAP;S100P;LOXL2;S100A2
prerank,regulation of cytokine production (GO:0001817),0.18602660891455572,0.8178191980817986,0.8888888888888888,0.923122693387597,1.0,55/146,30.09%,IL1A;EREG;GAPDH;IGF2BP1;FOXP3;CD276;IGF2BP3;BTN1A1;IGF2BP2;IL21;POLA1;CLEC6A;NOS2;MAPKAPK2;BATF;AGPAT2;RPS6KA4;IL17F;AGT;VTCN1;IRF8;ISG15;PLD4;PIK3CG;LYN;TNFRSF1B;TNFSF4;IFI16;SRGN;IL12B;BTNL10;ITK;CD47;CRTAM;NFAM1;PPP1R11;ZBP1;ACE2;FFAR4;ANXA1;IFNG;CASP8;RNF26;IL10;GLMN;HILPDA;PIK3CD;BCL6;IRF3;NLRP4;DTX4;EIF2AK2;BTN3A2;IRF7;CCDC88B
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.23924914945638712,-0.8177227909464572,0.7931034482758621,0.9050424991867428,1.0,15/46,24.87%,RGS2;NPPA;UCHL1;HIPK3;SPRY1;INPP5K;DAB2IP;SPRY3;DUSP19;MAPK8IP1;CDK5RAP3;CAV3;PRKCD;PDCD4;SMPD1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.2219472122813931,0.8173289110262244,0.8222222222222222,0.9232532262395318,1.0,20/44,29.18%,EREG;VPS25;AREG;GPRC5A;SH3KBP1;PTPN3;RAB7A;PTPN2;STAM;TGFA;CDC42;CBLC;EPN1;EGF;RNF126;PTPRJ;EPGN;ITGA1;SNX6;MVP
prerank,response to metal ion (GO:0010038),0.20885685291920048,0.817033518702429,0.9183673469387755,0.9229801191549336,1.0,27/65,26.58%,IL1A;LOXL2;SLC30A2;TFR2;PPP1CA;ALG2;AQP9;SLC11A2;ATP7B;SLC30A5;KHK;AQP3;GPHN;HOMER1;PLSCR1;FXN;ADAM9;SLC34A1;CAV1;SLC25A13;HAAO;ANXA11;THBS1;PPP2CA;TRPV6;HIF1A;PPP5C
prerank,positive regulation of mitochondrion organization (GO:0010822),0.2316300893453996,0.8166480518488562,0.7948717948717948,0.9228668326853923,1.0,17/55,20.48%,RALA;PMAIP1;VPS35;BBC3;PPIF;BIK;AURKA;GSK3B;ZDHHC6;ZNF205;MMP9;KDR;MCU;PLAUR;BAX;BID;BAK1
prerank,piRNA metabolic process (GO:0034587),0.2731159921355006,0.8165275969323456,0.7555555555555555,0.9222573533960693,1.0,2/19,3.85%,HENMT1;PIWIL1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.24750035282577468,-0.8161822962964405,0.8333333333333334,0.9071473094352973,1.0,13/38,23.85%,RAP1A;RDX;DAB2IP;TJP1;GFAP;RAPGEF1;ROCK1;VPS11;TIE1;CD36;RAPGEF2;LATS1;PINK1
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.2865352555571174,-0.8161356875737799,0.7166666666666667,0.9065150285465887,1.0,7/17,26.32%,CSNK2A2;HDAC6;FBXW7;GSK3A;CAMKK2;PINK1;DNM1L
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.22286658750709817,-0.8158590791990158,0.8636363636363636,0.9062750092528505,1.0,12/67,14.02%,TBC1D1;TBC1D17;RABGAP1;TBC1D10A;TBC1D20;FXR2;GAP43;TBC1D2B;FER;RDX;TBC1D13;RAC1
prerank,positive regulation of histone acetylation (GO:0035066),0.2754349076236563,0.8157544939356303,0.7647058823529411,0.9229683619293528,1.0,8/23,18.20%,RUVBL2;SMARCB1;FOXP3;IL1B;RPS6KA4;BRCA1;PAXIP1;PIH1D1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.22823032551635816,-0.8152198302448208,0.8363636363636363,0.9067738521036659,1.0,14/44,24.84%,RBPMS;BMPR1A;SMAD4;BMP3;GDF7;MSTN;GDF5;GDF6;ACVR2A;CSNK2B;INHA;GDF11;TWSG1;TGFB3
prerank,prostanoid metabolic process (GO:0006692),0.2936278914074201,0.815110007383048,0.7,0.9233602652929678,1.0,4/18,10.18%,CYP2S1;AKR1C4;PLAA;CYP4F8
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.2730638084374424,-0.8120466277467807,0.8333333333333334,0.911901922410765,1.0,4/20,9.41%,TMEM100;FGF2;VEZF1;ATOH8
prerank,stabilization of membrane potential (GO:0030322),-0.2873477784718183,-0.8115974164435817,0.7547169811320755,0.9119474005628234,1.0,5/17,23.42%,KCNK3;KCNK4;KCNK2;KCNK7;KCNK6
prerank,aerobic respiration (GO:0009060),0.2848669368111727,0.8114280819959346,0.813953488372093,0.9288428172668204,1.0,4/20,12.84%,MTFR2;MTFR1;MDH2;UQCRH
prerank,positive regulation of organelle assembly (GO:1902117),0.22197082138820776,0.8113390712960786,0.8431372549019608,0.9281929937372784,1.0,18/44,27.23%,CAPG;CSF2;G3BP1;SAXO1;SPAG5;GPSM2;SDC1;NUP62;PLK4;CNOT1;STX18;FSCN1;G3BP2;CNOT6;SDC4;RALB;IL5;PIP4K2C
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.24578075476247657,0.8105673480506416,0.7857142857142857,0.9285981112365246,1.0,4/37,6.14%,FXYD5;GTPBP4;IL1RN;ASS1
prerank,telomere capping (GO:0016233),0.3095742042456479,0.8104395492244986,0.660377358490566,0.9280241432852815,1.0,3/15,5.91%,DCLRE1C;DCLRE1B;PRKDC
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.24447390294587623,-0.810267934280811,0.8363636363636363,0.9137624612367158,1.0,13/41,21.67%,TSC1;FERMT2;MYOC;COL16A1;PPM1F;EFEMP2;RRAS;RAC1;SFRP1;ROCK1;CD36;CCL21;CCL28
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.267907026515145,0.8089957479597457,0.7636363636363637,0.929918343887489,1.0,11/19,37.30%,IL21;HLA-F;RAET1E;IL12B;CRTAM;SLAMF6;NCR3;RASGRP1;PVR;KLRC2;KLRD1
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.30275541112383264,-0.8074635540977675,0.7413793103448276,0.9180719177105708,1.0,6/15,25.27%,CADM4;ARHGAP24;OGT;ALS2;GABARAP;ARHGAP17
prerank,monosaccharide transmembrane transport (GO:0015749),0.289146622634088,0.8073635205796268,0.7358490566037735,0.9319209613337776,1.0,6/16,26.96%,SLC5A2;SLC5A10;SLC50A1;SLC5A1;SLC2A12;SLC45A3
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.22209635810063405,-0.8070738426036405,0.8983050847457628,0.9181629554022805,1.0,18/64,23.62%,CFLAR;FGFR1;PELI3;GPER1;TRAF1;ZMYND11;AR;FEM1B;LGALS3;TNFSF10;BCL10;MADD;FAS;AGTR2;PHIP;NOL3;SCG2;RIPK1
prerank,cellular response to fatty acid (GO:0071398),0.28956307216496624,0.8060623347609462,0.6862745098039216,0.93379006574734,1.0,4/17,10.28%,IRS1;DGAT2;AKR1C4;FFAR2
prerank,embryonic digit morphogenesis (GO:0042733),-0.3102002211747629,-0.8053625626514075,0.7818181818181819,0.9202715796201942,1.0,5/17,15.12%,OSR1;INTU;GLI3;ECE1;TBX2
prerank,negative regulation of RNA metabolic process (GO:0051253),0.26522831032742744,0.8052071580157907,0.7708333333333334,0.934643774734863,1.0,9/19,24.74%,PTBP3;SHQ1;PTBP1;TMBIM6;TGFB1;RPS13;ZC3H12A;RPS26;TERT
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.2820517848063643,-0.804926551387243,0.7608695652173914,0.9201879475688646,1.0,6/24,16.33%,GSN;SLIT2;KANK3;SSH1;KANK1;MYADM
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.2721294835685803,0.8042872954755373,0.7872340425531915,0.9355981060127302,1.0,7/20,20.76%,SAPCD2;BCL2L1;CLTC;MRAP;MRAP2;TGFB1;GBP1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.27747462533637257,0.804251536840033,0.7045454545454546,0.9348635300267484,1.0,9/19,28.16%,THY1;EZR;PTPN2;LILRB4;GBP1;DGKZ;PTPRJ;SH2D1A;SLA2
prerank,negative regulation of B cell activation (GO:0050869),0.2624803677665362,0.803895280888459,0.8108108108108109,0.9347878689146276,1.0,9/22,28.33%,INHBA;TNFAIP3;LYN;MNDA;TYROBP;CD300A;FOXJ1;CTLA4;IL10
prerank,positive regulation of ATPase activity (GO:0032781),-0.24164690620611862,-0.8019830992958346,0.8363636363636363,0.9245221443647829,1.0,14/42,23.36%,ATP1B2;TPM1;TNNT3;FXYD2;TOR1AIP1;RYR2;RGN;MYL3;FGF10;GABARAPL2;DNAJB2;MYBPC3;SETMAR;MYL4
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.25393434852616226,-0.8014970255744449,0.7450980392156863,0.9246078790390444,1.0,10/27,27.01%,GPR17;LPAR1;AGTR1;GPR20;OPRL1;LPAR6;LPAR4;F2RL3;GPR4;F2RL1
prerank,negative regulation of blood pressure (GO:0045776),-0.302213166027147,-0.8009656417736573,0.7592592592592593,0.9247150316553975,1.0,4/15,17.48%,NPPA;SCPEP1;NOS1;NPPB
prerank,metanephros development (GO:0001656),-0.29477398217113265,-0.8009606011772886,0.7692307692307693,0.9240037055346805,1.0,4/26,3.85%,PKD1;GDNF;PKD2;OSR1
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.28680250488106657,-0.8009580371161292,0.7833333333333333,0.9232934839576293,1.0,8/18,24.88%,TMCC2;PSEN1;APH1B;BACE1;PSEN2;NSG1;ADAM19;CLN3
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.2535807826530347,0.8003905634026541,0.8125,0.9402006802770952,1.0,5/22,11.57%,MGAT5;MASTL;STYXL1;PPP1R1B;GSK3B
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2554800830970759,0.7996101876287185,0.9,0.9406754956250215,1.0,13/31,31.62%,IKBKE;TNIP3;UBA52;UBE2D1;CD300LF;UBE2D2;TICAM1;CASP8;IRF3;IRF7;UBC;IKBKG;IKBKB
prerank,protein K48-linked deubiquitination (GO:0071108),-0.2763422846357872,-0.7987746515469509,0.75,0.926347060244706,1.0,11/22,25.75%,USP20;ATXN3;OTUD7A;OTUD3;OTUD7B;USP25;USP34;BAP1;OTUD5;USP8;OTUD4
prerank,response to tumor necrosis factor (GO:0034612),0.1966012800839667,0.7977579804420547,0.9024390243902439,0.9433208265157664,1.0,31/101,24.64%,TDGF1;CCL24;CXCL8;CCL20;RPS3;CCL22;HYAL3;DHX9;DCSTAMP;CCL4;CCL3;RELA;ADAM10;ADAMTS12;CXCL16;CCL26;GCH1;BRCA1;CIB1;GBA;CCL17;BAG4;ADAM9;CHI3L1;GBP1;ZC3H12A;HYAL2;GBP3;CD58;OCSTAMP;NPNT
prerank,regulation of interleukin-8 production (GO:0032677),0.18995683864009363,0.7976950327274736,0.8863636363636364,0.9426382356416741,1.0,29/78,31.51%,ANXA4;IL1B;SYK;MYD88;RELA;FFAR2;NOS2;LAMTOR5;IL17F;TMSB4X;RAB1A;F2R;NOD2;SERPINE1;CHI3L1;HMGB1;HYAL2;CD2;CD58;ANXA1;CLEC7A;CD244;PARK7;IL10;TLR7;NOD1;TLR8;IL17D;TNF
prerank,apoptotic cell clearance (GO:0043277),-0.25410285029148305,-0.7973338797157652,0.8148148148148148,0.9280996737104135,1.0,10/33,26.79%,XKR4;ADGRB1;ITGB3;MEGF10;RAC1;TXNDC5;RHOBTB1;FCN2;FCN3;XKR8
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.30161874757352836,-0.7972656744616593,0.7647058823529411,0.9275167366831883,1.0,5/15,19.11%,PLIN5;SLC27A1;NR1H2;FBXW7;CTDNEP1
prerank,regulation of vacuole organization (GO:0044088),0.25484188331510105,0.7965183434038647,0.6744186046511628,0.943847734334189,1.0,4/20,16.64%,LAPTM4B;ENO4;TBC1D14;NPRL3
prerank,response to ketone (GO:1901654),-0.260383743417635,-0.7963482096646258,0.7962962962962963,0.9284148344335629,1.0,16/28,35.25%,TGFBR3;SLIT2;SLIT3;WBP2;CCL21;HSD3B2;NKX3-1;TGFB3;CATSPERG;CATSPER2;YAP1;CSN1S1;CATSPERD;NR1H3;UBE3A;ABCB4
prerank,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.2839024628359154,0.7961192922289645,0.7551020408163265,0.9436819636959978,1.0,5/16,21.67%,CXCL8;HMGA2;APOBEC3F;TOP2A;APOBEC3B
prerank,regulation of transmembrane transport (GO:0034762),-0.23308621687884007,-0.7958724239055683,0.8431372549019608,0.9285899113493891,1.0,14/33,29.86%,SNCA;PRKCB;BCL2;KCNJ8;KCNJ1;KCNJ9;INS;ACTB;PIM1;KCNJ5;OCLN;NEDD4L;CALHM1;KCNJ12
prerank,regulation of cholesterol storage (GO:0010885),-0.30946400419642095,-0.7952131633409443,0.7551020408163265,0.9288860865566724,1.0,5/15,24.39%,PPARD;ABCA1;NR1H2;CES1;LPL
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.2755577582001891,0.7950001513943454,0.7692307692307693,0.9446583416086062,1.0,4/19,14.24%,PIK3AP1;NMI;IRAK1;TNIP3
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.3105457774967699,-0.7948293070241516,0.8214285714285714,0.9286824360103582,1.0,6/15,21.82%,RUFY3;KRIT1;KANK1;ROCK1;BCAS3;CDH5
prerank,TOR signaling (GO:0031929),0.2511395828866,0.7940375060606849,0.7727272727272727,0.9453570552723661,1.0,10/25,23.62%,SYAP1;EIF4EBP1;CARD11;RHEBL1;MLST8;NPRL3;TIPRL;RPS6KB2;PRR5;LARP1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.3000489977439396,0.7935107421246499,0.8125,0.9452823691305402,1.0,5/19,12.17%,TSN;HENMT1;MRPL44;TARBP2;TRIM71
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.2701252376420149,-0.7933125525894216,0.8035714285714286,0.9306674967209687,1.0,8/22,21.45%,CLU;EPHA4;RANBP9;GSAP;CASP3;GSK3A;LRRTM3;IFNGR1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.2852975725042615,-0.7931868174174438,0.7419354838709677,0.9301208907427925,1.0,6/21,17.53%,MEIS1;MEIS2;ZBTB16;ZFP36L1;ZFP36;HOXA5
prerank,modulation by symbiont of entry into host (GO:0052372),0.27720913969768013,0.7931247558000376,0.7636363636363637,0.9449506135818269,1.0,4/19,10.79%,CXCL8;FUCA2;TRIM27;TRIM14
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2518645998187318,-0.7930622881169296,0.803921568627451,0.9296463004463453,1.0,8/26,19.19%,ARNT;TAL1;NCKAP1L;BRD1;MAPK11;MAPK14;ACVR2A;ANKRD54
prerank,positive regulation of neutrophil migration (GO:1902624),0.2751972224353191,0.7922183372169433,0.7708333333333334,0.945601441073508,1.0,5/21,15.38%,CXCL8;C1QBP;MDK;MCU;ADAM8
prerank,pharyngeal system development (GO:0060037),0.2719738124439034,0.790842681911756,0.7608695652173914,0.9471865381569932,1.0,5/17,19.90%,FOLR1;TGFB2;BMP7;BMP4;HES1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.24691199149899878,0.7906311641137859,0.7727272727272727,0.9467074237279174,1.0,9/21,24.90%,PPP1CA;GSK3B;FRAT2;AXIN1;WNT8B;CAV1;WNT3A;FZD2;CTNNB1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.20611863198861627,-0.7900055928129494,0.9090909090909091,0.9340227336512572,1.0,8/59,10.93%,IL6R;CTF1;GH1;CRLF1;KIT;GHR;CNTF;TSLP
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.21183838301437152,-0.7898080344317222,0.8833333333333333,0.9336098296365942,1.0,26/66,27.00%,HAP1;BTC;DUSP3;GPER1;FER;SPRY1;RNF115;DAB2IP;TSG101;ARHGEF7;EPS15L1;CCDC88A;CBL;EPS15;EGFR;MVB12B;AFAP1L2;PTPN12;BCAR3;ERRFI1;RHBDF1;DGKD;ZFYVE28;HIP1;CEACAM1;CDH13
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.2567573468357842,0.7896223435219317,0.723404255319149,0.9474833257518221,1.0,9/25,19.81%,CEMIP;RIPK2;BMP7;PLK1;UBE2K;TGFB1;STOX1;AXIN1;CHI3L1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.26752719590864266,0.7895897574061084,0.8723404255319149,0.9467669342454846,1.0,9/23,25.67%,FUT8;FUT1;FUT7;B4GALT1;FUT2;MPDU1;FUT6;FUT4;FUT3
prerank,negative regulation of mitochondrion organization (GO:0010823),0.2468664557613558,0.7895560098401141,0.782608695652174,0.9460517357308312,1.0,10/33,19.86%,TRIAP1;PSMD10;BCL2L1;PPIF;GPX1;PRELID1;SLC35F6;SLC25A5;FXN;TMEM14A
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.24188579766561297,-0.7889320310391013,0.8679245283018868,0.934141984506611,1.0,12/33,27.15%,CLU;RSPO1;SNAP91;RAC1;CBL;TNK2;CCL21;B2M;SGIP1;HIP1;AAK1;FLOT1
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.27716783438114057,-0.7883458919587966,0.7272727272727273,0.934318547960054,1.0,6/28,14.57%,PRELP;ST3GAL3;ST3GAL6;B4GAT1;OGN;OMD
prerank,regulation of viral life cycle (GO:1903900),-0.25499717739901023,-0.7878711715953849,0.7083333333333334,0.9344381201308808,1.0,8/24,21.56%,TRIM6;TSG101;TRIM34;KPNA6;VPS4A;TRIM62;HS3ST5;TRIM38
prerank,myeloid cell development (GO:0061515),-0.27930532688496196,-0.7877674326278903,0.7796610169491526,0.9338632184174794,1.0,11/19,33.99%,KIT;NCKAP1L;THPO;ZNF385A;GATA1;ALAS2;SH2B3;NRROS;ANXA2;TLR2;APP
prerank,carbohydrate derivative catabolic process (GO:1901136),0.2564313837582951,0.7873978329844936,0.7916666666666666,0.9486343869694288,1.0,8/18,26.15%,STT3B;AOAH;MANBA;FBXO6;NGLY1;DERA;FUCA1;NAGA
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.26684208936817044,0.7871812825910326,0.7777777777777778,0.9480830648971161,1.0,4/20,9.45%,SYK;PRKDC;MDK;XBP1
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.20917914985768177,-0.7870578447630885,0.8448275862068966,0.934287360473203,1.0,22/81,20.98%,FGFR1;SASH1;FGF2;NRP2;ZNF580;ITGB3;PRKCA;RHOB;PRKD1;ATOH8;FLT4;RRAS;ANGPT4;HSPB1;RAC1;GATA2;PDGFB;MAPK14;FGF1;ANGPT1;SIRT1;BCAS3
prerank,early endosome to late endosome transport (GO:0045022),-0.27064870388870993,-0.7867117779928023,0.8245614035087719,0.9341095844592503,1.0,5/20,22.69%,WDR91;AKTIP;PIK3C3;HOOK3;WDR81
prerank,organelle fusion (GO:0048284),-0.2729931730600975,-0.7860973570335182,0.8360655737704918,0.9343703172732852,1.0,10/20,35.08%,MFN2;PLD6;VPS11;SPG7;MFF;MFN1;MIEF2;STX4;CYP26C1;USP30
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.28082883179960294,-0.7856152370653644,0.6545454545454545,0.9343693229508823,1.0,9/18,26.45%,IGFBP6;GH1;CILP;IGFBP4;IGFBP5;PHIP;ZFAND2B;NKX3-1;BMP5
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.2247224457818152,0.7849748103892609,0.8260869565217391,0.9507053231267422,1.0,16/41,31.51%,CHID1;MYD88;IL17A;NOS2;GBP5;PLD4;LILRB4;NOD2;ADCY7;ZC3H12A;TICAM1;HIF1A;CLEC7A;CD6;IL17D;TNF
prerank,artery morphogenesis (GO:0048844),-0.2512479791966938,-0.7845917620684577,0.8703703703703703,0.9352011193658302,1.0,9/29,21.18%,FOXF1;PKD2;BMPR1A;TBX1;TBX2;ADAMTS9;HEY2;HPGD;SMAD7
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.27823166415687445,0.7838775311362323,0.7872340425531915,0.9514649346931274,1.0,5/19,17.28%,PDZD8;BCAP31;MCUR1;MCU;MICU2
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.23519028978351408,-0.7838234475849161,0.8823529411764706,0.9355168390355855,1.0,11/36,19.19%,ARNT;TAL1;ZFP36L1;NCKAP1L;BRD1;MAPK11;ZFP36;MAPK14;HOXA5;ACVR2A;ANKRD54
prerank,positive regulation of lipid storage (GO:0010884),0.2692421340508857,0.7833345953132991,0.8409090909090909,0.9516680808374542,1.0,5/20,16.01%,SCARB1;IKBKE;PLIN3;C3;FITM2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.26949850939245873,0.7826760703671755,0.8421052631578947,0.9518163252163306,1.0,6/19,20.48%,BCAP31;PML;TMCO1;CCDC47;BAX;BAK1
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.27530215337417563,-0.7824457570566744,0.7037037037037037,0.9360764205542524,1.0,4/15,20.41%,AP3S2;AP3B2;BLOC1S1;SNAPIN
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.27530215337417563,-0.7824457570566744,0.7037037037037037,0.9360764205542524,1.0,4/15,20.41%,AP3S2;AP3B2;BLOC1S1;SNAPIN
prerank,regulation of spindle assembly (GO:0090169),0.25859742032201666,0.7819462982076718,0.7804878048780488,0.9522278374052437,1.0,12/25,30.45%,SPAG5;CHMP4C;GPSM2;DRG1;PLK1;CHMP5;CHMP2B;CHMP1A;CHMP2A;HNRNPU;CCSAP;CHMP1B
prerank,ceramide biosynthetic process (GO:0046513),0.23498200947443465,0.7816268461656636,0.8979591836734694,0.9520122076434584,1.0,14/41,22.52%,SPTLC1;CERS6;SMPD2;SPTLC2;PNPLA1;CERS2;DEGS2;ST8SIA6;GBA;FA2H;SPTSSB;ALOXE3;B4GALT6;ASAH2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.27360273848301825,-0.7811950262126571,0.75,0.9372913647245997,1.0,9/19,34.70%,NR1D1;DAB2IP;TICAM2;TIRAP;F2RL1;FLOT1;NINJ1;NR1H3;APPL1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.24832950774854118,0.7802716558195462,0.8372093023255814,0.9535568333152147,1.0,6/22,19.55%,GTF2H3;RAD23B;DDB1;UBA52;CUL4A;ERCC2
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.194351298938439,-0.7798708325913719,0.9298245614035088,0.9385677357901483,1.0,9/68,10.93%,IL6R;CTF1;GH1;INPP5F;CRLF1;KIT;GHR;CNTF;TSLP
prerank,dorsal/ventral pattern formation (GO:0009953),-0.276055336731464,-0.779507365573765,0.7924528301886793,0.9384581747965273,1.0,12/24,29.56%,BMPR1A;DSCAML1;GLI2;SFRP1;LMX1B;BMPR1B;NBL1;HOXA11;NOG;FBXL15;AIDA;ACVR1
prerank,actin nucleation (GO:0045010),-0.2763231656941192,-0.7795006788473623,0.7954545454545454,0.9377520806776035,1.0,5/20,13.30%,LMOD1;WHAMM;JMY;LMOD2;ARPC2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.23457043772106834,0.7792559748002783,0.8604651162790697,0.9543737757228815,1.0,18/33,32.12%,EREG;AREG;AGT;SHKBP1;MMP9;NUP62;PLAUR;AGR2;TGFA;EGF;DOK1;PTK6;EPGN;HIP1R;ADAM17;HBEGF;PDE6G;AKT1
prerank,regulation of integrin activation (GO:0033623),0.27399818941113824,0.7791646437377779,0.8297872340425532,0.953676905361463,1.0,3/15,4.47%,FERMT1;KIF14;SKAP1
prerank,negative regulation of blood coagulation (GO:0030195),0.24959563509479354,0.7788215394186131,0.7916666666666666,0.9533069555048951,1.0,6/29,11.75%,F12;PLAU;F7;THBD;SERPING1;PROC
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.24856158357538588,-0.7781085853276712,0.7222222222222222,0.9392917517537637,1.0,12/26,31.24%,ADGRB1;SNCA;CD36;INS;PIKFYVE;ABCD1;PLCG2;ABCD2;RAB27A;SLC30A10;SLC5A3;GRIN1
prerank,regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139),0.266280947255113,0.7779219986330249,0.9069767441860465,0.9538779575722337,1.0,18/18,73.39%,LIF;IFNG;IFNE;IFNA1;IFNB1;IFNA8;IFNA14;IFNA7;IFNA4;IFNA10;IFNA17;IFNA16;IFNA2;IFNA6;GADD45A;IFNW1;IFNA21;IFNA5
prerank,negative regulation of mRNA processing (GO:0050686),0.28211280061820354,0.7779037374651315,0.7674418604651163,0.9531109414586242,1.0,7/15,23.96%,C1QBP;SRSF9;PTBP1;SAP18;U2AF2;RNPS1;BARD1
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.2779742468284271,0.77733825601517,0.7804878048780488,0.953139552591596,1.0,6/16,22.24%,ATAD5;NPM1;DYRK3;CUL3;DDRGK1;EZH2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.2825509545577435,-0.7770694465964165,0.7647058823529411,0.9402332922858889,1.0,4/15,20.52%,PPARD;NR1H2;NR4A3;MLYCD
prerank,negative regulation of lymphocyte activation (GO:0051250),0.2433655994036403,0.7767451799441094,0.8484848484848485,0.9532132140339975,1.0,5/21,16.50%,IL4I1;TNFAIP3;JAK3;VTCN1;LST1
prerank,toll-like receptor signaling pathway (GO:0002224),0.1894849143996884,0.7759017303626122,0.9166666666666666,0.9538725384583848,1.0,31/84,31.62%,HSPD1;RIPK2;IRAK2;PIK3AP1;NMI;MAPKAPK3;UNC93B1;CNPY3;MYD88;IRAK1;MAPKAPK2;TNIP3;UBA52;UBE2D1;HMGB1;LGMN;UBE2D2;CTSB;S100A14;RPS6KA3;TICAM1;ITGB2;IRAK3;CASP8;TLR7;TRAF6;TLR8;SCIMP;UBC;IKBKG;IKBKB
prerank,regulation of phosphate metabolic process (GO:0019220),-0.2863770375076572,-0.7757237927084785,0.7454545454545455,0.9415376146695382,1.0,3/16,10.03%,GNB3;PSEN1;SIRT2
prerank,negative regulation of leukocyte activation (GO:0002695),-0.3085153459238052,-0.7754921146557361,0.7368421052631579,0.9411532685764252,1.0,2/15,6.27%,GPER1;LRFN5
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.2801559125310223,0.7736497997484746,0.813953488372093,0.9561426166314904,1.0,6/19,17.28%,PHB;STOML2;MCUR1;MCU;YME1L1;MICU2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.17578941199572518,0.7732345081555628,0.95,0.9558627412301761,1.0,42/153,22.88%,RIPK2;UBE2N;TNFSF11;IRAK2;IL1B;WNT5A;CARD14;RPS3;CARD11;RTKN2;DHX9;TRIM27;RIPK4;RHEBL1;MYD88;RELA;IRAK1;TRIM14;RPS6KA4;LAMTOR5;AGT;CIB1;PRKCI;NPM1;PRKCZ;TRAF2;UBA52;NFKB2;ADAM8;NOD2;MTPN;NFKBIA;CAV1;RBCK1;TRIM37;DDRGK1;NFKBIB;PRDX3;TRIM22;TNFSF18;MAP3K13;MTDH
prerank,cobalamin metabolic process (GO:0009235),-0.2835446911026054,-0.7722148534382023,0.7678571428571429,0.9452872568703817,1.0,5/19,11.90%,CUBN;MTR;CTRB2;CTRC;CTRB1
prerank,purine ribonucleotide transport (GO:0015868),0.2987765320581115,0.771863041794266,0.8125,0.9569408018696687,1.0,6/17,16.30%,LRRC8E;SLC35B2;SLC19A1;LRRC8D;SLC25A17;SLC25A24
prerank,endosome organization (GO:0007032),0.23931569895080962,0.7716635066795771,0.9069767441860465,0.9564990452488242,1.0,10/35,19.25%,USP50;PI4K2B;LAPTM4B;SNX10;CLCN3;RAB22A;TMEM9;HOOK1;ARFGEF2;CHMP2B
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.23947544275158256,0.7716300042689912,0.9024390243902439,0.9557528536820414,1.0,8/32,19.32%,IL11;TNFAIP3;MDK;ICAM1;SEMA5A;KDR;PAK4;SERPINE1
prerank,positive regulation of locomotion (GO:0040017),-0.24706877271240044,-0.771470715277504,0.7966101694915254,0.9455365761710869,1.0,8/30,20.16%,BVES;NTN1;PPM1F;RARRES2;P2RY12;PDGFB;AKT2;CCL21
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.2662976590139611,0.7711659834666696,0.8536585365853658,0.9557073763187436,1.0,4/20,7.05%,CCND1;PSMD10;PROX1;PSRC1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.23341801599247322,-0.7709319781745368,0.8235294117647058,0.9456668100737737,1.0,10/34,22.38%,TRIM39;MAP1A;WAC;KLHL40;OPHN1;OGT;GABARAPL2;USP25;ALAD;CAMLG
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.20500159295865678,-0.7707657414610699,0.8947368421052632,0.9450990893714132,1.0,16/66,23.51%,CAMK2G;NCAM1;CAMK2A;GBP2;IRF2;MID1;CAMK2B;CAMK2D;TRIM34;TRIM62;TRIM8;IFNGR1;TRIM38;B2M;OAS1;PRKCD
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.2283462712877041,-0.7705585477615564,0.8823529411764706,0.9446646995467638,1.0,12/29,28.62%,MAPKBP1;CARD8;SIRT2;PPM1B;TRAFD1;PCBP2;DHX58;NFKBIL1;MUL1;TRAF3IP1;NLRC3;CACTIN
prerank,sensory perception of chemical stimulus (GO:0007606),-0.19641706455551086,-0.7692743716757758,0.9508196721311475,0.9458751897769743,1.0,7/94,19.84%,BBS4;SLC24A4;SYT10;GNAL;CD36;UBR3;BEST2
prerank,cell chemotaxis (GO:0060326),-0.20481264345369044,-0.768968986866657,0.8181818181818182,0.9456288385093322,1.0,19/64,23.51%,PLXNB3;LPAR1;AGTR1;PDGFRA;KIT;CCR10;PARVA;ELMO2;ACKR3;PDGFB;DOCK4;AZU1;RAB13;ACKR2;CCL21;CCL28;HGF;NR4A1;PRKCD
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.21520782813239223,0.7686585709933734,0.8809523809523809,0.9580634041086271,1.0,9/51,12.97%,IL23A;PHB;IL1B;RPS3;NMI;RTKN2;RELA;IRAK1;ACTN4
prerank,peptide cross-linking (GO:0018149),0.23895679503775485,0.7683147622264744,0.8837209302325582,0.957693799153681,1.0,11/27,27.66%,FN1;COL3A1;EVPL;PI3;DSP;FCGR3A;THBS1;CSTA;CD3G;ANXA1;TGM6
prerank,triglyceride homeostasis (GO:0070328),0.27542649771710737,0.7673273230167672,0.8055555555555556,0.9582462302672359,1.0,8/21,22.72%,DGAT2;SCARB1;XBP1;FITM2;CETP;MLXIPL;HNF4A;PLA2G12B
prerank,development of primary male sexual characteristics (GO:0046546),-0.23422593294287153,-0.7654718014255564,0.8727272727272727,0.9498559275977062,1.0,14/40,27.53%,SOX15;MAMLD1;KIT;AR;KITLG;CSDE1;WNT2B;LHCGR;FGF9;SOX8;ADAM21;GATA1;LHFPL2;FSHR
prerank,protein hydroxylation (GO:0018126),-0.2970623083628092,-0.7653678526106786,0.6862745098039216,0.9492315800869525,1.0,5/15,13.53%,P3H2;VPS33B;HIF1AN;JMJD7;VIPAS39
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.27388591347851754,-0.7651506851827719,0.7833333333333333,0.9488721232815724,1.0,2/18,6.70%,DDX17;CELF4
prerank,regulation of lymphocyte activation (GO:0051249),0.27174795659079715,0.7649716836744326,0.8,0.9607374535774579,1.0,8/15,38.57%,LCK;SIT1;CRTAM;CLEC7A;CCL5;DCAF15;IKZF3;CD4
prerank,lipid droplet organization (GO:0034389),-0.258373127623432,-0.7646627519041771,0.8181818181818182,0.948874132484333,1.0,7/21,18.47%,ZFYVE1;PLIN5;BSCL2;PLA2G4C;CDS2;RAB3GAP1;FITM1
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.266536060462582,-0.7642899720747378,0.8409090909090909,0.9486195188288066,1.0,8/20,24.88%,ZDHHC7;AR;VTI1B;VPS4A;INS;ACTB;STX7;CLN3
prerank,vesicle transport along actin filament (GO:0030050),0.27529492290716406,0.764286037048215,0.7954545454545454,0.9608220764041083,1.0,8/19,23.56%,ACTN4;MYO6;FNBP1L;MYO5B;MYO1E;MYO19;MYO1D;MYO1H
prerank,ERAD pathway (GO:0036503),0.1947975545285634,0.7638893429863096,0.9782608695652174,0.9605674443877906,1.0,23/81,22.24%,STT3B;GET4;UGGT1;DERL1;SEC61B;ERLIN1;FOXRED2;TOR1A;UBE2J1;VCP;ERLIN2;HSPA5;MAN1B1;FBXO6;FAF2;UBQLN1;OS9;ERLEC1;CCDC47;AUP1;DNAJC10;UBXN8;RHBDD2
prerank,mitotic cytokinetic process (GO:1902410),-0.26644920307901465,-0.7638502173161213,0.8620689655172413,0.9485038965560008,1.0,6/20,18.28%,KLHDC8B;CHMP3;CNTROB;RHOA;VPS4A;CHMP4A
prerank,protein palmitoylation (GO:0018345),0.23617512538621566,0.7635737423051263,0.7906976744186046,0.9601527220775671,1.0,7/28,13.23%,ZDHHC9;ZDHHC5;ZDHHC12;ZDHHC3;ZDHHC24;ZDHHC13;ZDHHC6
prerank,regulation of cellular component size (GO:0032535),0.24622631675864945,0.7634765200725053,0.85,0.9595782993036992,1.0,11/30,20.92%,PPP1CA;ATP13A2;RAB22A;LAMTOR5;EZR;MTPN;VAV3;SLC9A3R1;MSN;VAV2;LAMTOR4
prerank,defense response to Gram-positive bacterium (GO:0050830),0.1930798625475989,0.7633448719145781,0.9555555555555556,0.9589335888797104,1.0,13/58,25.76%,ROMO1;DEFA6;HMGB2;RPL39;MYD88;PGLYRP4;ANG;PGLYRP3;DMBT1;RNASE7;PPP1R11;DEFB4A;GBP4
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.2592635806554926,0.7629547044414161,0.8888888888888888,0.9585656748930531,1.0,8/18,30.32%,DCUN1D5;UBQLN1;HSP90AB1;EGR1;HSP90AA1;HIF1A;TGFBR1;ITCH
prerank,regulation of tumor necrosis factor production (GO:0032680),0.17984879735654552,0.7624841534702956,0.926829268292683,0.9584472209399887,1.0,33/118,27.48%,IL1A;EPHB2;IL23A;WNT5A;SYK;PF4;TNFAIP3;DHX9;CYBA;OAS2;CCL3;TRIM27;IL17A;MAPKAPK2;NOD2;ARFGEF2;OAS3;MMP8;HMGB1;ZC3H12A;IL12B;CD47;CD2;TYROBP;THBS1;CHRNA7;PTPN11;PTPRJ;GSTP1;IL37;IFNG;CLEC7A;IRAK3
prerank,acylglycerol metabolic process (GO:0006639),0.22611473052638487,0.7623108895786154,0.8823529411764706,0.9578316329099649,1.0,9/35,20.05%,DGAT2;ABHD12;GK;PNPLA3;LYPLA2;ABHD2;APOC1;CETP;CAV1
prerank,regulation of leukocyte migration (GO:0002685),0.2728257781004042,0.762119593899382,0.8541666666666666,0.9573323974612253,1.0,7/17,27.97%,ZP3;CD81;HOXA7;TNFSF18;RAC2;ANXA1;RHOH
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.2829149659267188,0.7614366341149729,0.7435897435897436,0.9573925561371257,1.0,9/18,28.43%,POU4F1;LAMTOR5;TGFB1;PAX6;DDRGK1;GTF2B;IFNG;PARK7;TRAF6
prerank,positive regulation of protein binding (GO:0032092),0.212495424890709,0.7612468265291075,0.8611111111111112,0.9568236064265003,1.0,19/55,25.20%,TRIB3;RAN;RIPK2;DERL1;BAMBI;STK4;DTX3L;NMD3;GSK3B;MMP9;BMP4;IDE;CAV1;RPL11;EPB41;MEN1;WNT3A;TERT;PPP2CA
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.26030328165874717,0.7610385742921573,0.775,0.9563440960683789,1.0,4/16,13.66%,DCPS;SNRPC;NCBP2;RBM22
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.26208200229101103,-0.7609664999635612,0.8620689655172413,0.9511104067622052,1.0,7/21,21.95%,CLIP3;ZDHHC15;ZDHHC7;ZDHHC18;ZDHHC11;GOLGA7;ZDHHC21
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.26208200229101103,-0.7609664999635612,0.8620689655172413,0.9511104067622052,1.0,7/21,21.95%,CLIP3;ZDHHC15;ZDHHC7;ZDHHC18;ZDHHC11;GOLGA7;ZDHHC21
prerank,positive regulation of histone methylation (GO:0031062),-0.24008652299224445,-0.7605461879430767,0.875,0.95097934987136,1.0,5/25,13.69%,PHF1;SMAD4;KMT2A;FAM47E;OGT
prerank,organelle fission (GO:0048285),-0.2550102861863923,-0.760002430480115,0.8813559322033898,0.9510212323755045,1.0,9/24,27.16%,MTFR1L;PEX19;CORO1C;SEC16B;DNM1;MUL1;MFF;DNM1L;DNM3
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.2618147506561798,0.7598852383615806,0.8245614035087719,0.9569621429640792,1.0,4/17,13.23%,CSF2;PF4;PLA2G3;AGT
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.26593428734108165,-0.758720617097544,0.8103448275862069,0.9520780240246635,1.0,6/18,19.83%,OSR1;KIAA1109;AJAP1;KLF7;MAFG;DLL1
prerank,positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141),0.26626900479885174,0.7585490771660535,0.8863636363636364,0.9580741178253487,1.0,17/17,73.39%,LIF;IFNG;IFNE;IFNA1;IFNB1;IFNA8;IFNA14;IFNA7;IFNA4;IFNA10;IFNA17;IFNA16;IFNA2;IFNA6;IFNW1;IFNA21;IFNA5
prerank,negative regulation of biomineral tissue development (GO:0070168),0.23702744838152162,0.7576544375927343,0.8157894736842105,0.9585838088137532,1.0,5/21,21.78%,SOX9;CCL3;TGFB1;SRGN;NOTCH1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.28062735630731994,-0.7576389691502505,0.7719298245614035,0.9528572606663472,1.0,3/16,12.23%,OSR1;SPRY1;NOTCH4
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.22535719984120134,-0.7575004145935753,0.896551724137931,0.9523185297683272,1.0,11/39,21.82%,ATP2B4;PKD2;CLU;CD34;PTGIS;RAC1;INSR;CD36;AGTR2;HBB;KLF2
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.21803991247279814,-0.7568522908012789,0.8813559322033898,0.9525659623983997,1.0,8/42,15.86%,DOCK3;BTC;DLG4;PRNP;EPHA4;RELN;PDGFB;GPRC5B
prerank,acetyl-CoA metabolic process (GO:0006084),-0.27398210134187634,-0.7567324355404716,0.8431372549019608,0.951980063512313,1.0,4/15,20.52%,ACACB;DIP2A;ACAT1;MLYCD
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.23535546399875737,0.7561652318627905,0.8372093023255814,0.9597985768113957,1.0,10/24,29.18%,THY1;VPS25;GPRC5A;LILRB4;CAV1;CBLC;HYAL2;PTK6;SNX6;MVP
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.24794183562779218,-0.7547877503988708,0.8409090909090909,0.953747608621685,1.0,7/29,18.84%,PLA2G5;AGTR1;ITGB3;ABCA1;NR1H2;ABCA5;CD36
prerank,regulation of defense response to virus (GO:0050688),0.2741225709974163,0.7531540089505725,0.8,0.9629422327795408,1.0,3/15,8.44%,C1QBP;TNFAIP3;DHX9
prerank,heme biosynthetic process (GO:0006783),0.2602976295130685,0.7529618966128636,0.7647058823529411,0.9624072635909101,1.0,7/20,24.35%,HMBS;TSPO;CPOX;PGRMC1;FXN;ALAS1;ABCB6
prerank,receptor internalization (GO:0031623),-0.20770726053743171,-0.7528101979796806,0.9298245614035088,0.9556568721164211,1.0,15/47,27.16%,SNX1;SNCA;RAMP1;GRK4;ACKR3;RAMP3;CD36;DNM1;AP2M1;RAB31;CAV3;RAMP2;ADM;CEACAM1;DNM3
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.27759639993873064,0.7527975727273809,0.8163265306122449,0.9618115350678759,1.0,4/18,14.32%,CXCL8;C1QBP;MDK;MCU
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.2685566733307011,0.7524540349158724,0.803921568627451,0.9615333965197671,1.0,3/15,12.66%,XRCC5;NABP2;BRCA2
prerank,regulation of interferon-alpha production (GO:0032647),0.24731818204798273,0.7523138411466239,0.8627450980392157,0.9609568983439337,1.0,4/25,11.66%,HSPD1;RIPK2;DHX9;STAT1
prerank,mesenchyme morphogenesis (GO:0072132),0.2665118180792639,0.751501672477855,0.8372093023255814,0.9612067696357623,1.0,4/17,10.45%,TBX20;SOX9;TGFB2;ENG
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.27780101611474917,-0.7510056558783259,0.7777777777777778,0.9572267334346999,1.0,5/17,17.74%,FERMT2;LTBP3;THPO;KAT7;SOX11
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.2371083615838681,0.7502425170701437,0.8235294117647058,0.9620967677145668,1.0,11/22,37.30%,IL21;HLA-F;RAET1E;CRTAM;SLAMF6;NCR3;RASGRP1;PVR;RAET1G;KLRC2;KLRD1
prerank,female gonad development (GO:0008585),0.2602490721071788,0.7501089664598959,0.875,0.9615212009471461,1.0,3/21,10.08%,CEBPB;INHBA;NUP107
prerank,protein import into peroxisome membrane (GO:0045046),0.25277780675271616,0.7500003567674215,0.8604651162790697,0.960841428957311,1.0,4/22,13.96%,PEX13;ACBD5;SLC25A17;PEX16
prerank,neural tube development (GO:0021915),-0.27757250124940414,-0.7452287353650539,0.7678571428571429,0.9640105465656622,1.0,3/16,10.22%,PKD1;PKD2;ZNF358
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.22234781357648503,-0.7445662965626803,0.9661016949152542,0.9640150101545083,1.0,11/35,23.62%,RNF112;MAPK7;ZNF580;HDAC6;RHOB;AQP1;ANKZF1;SETX;SIRT1;PRKCD;RIPK1
prerank,nucleus organization (GO:0006997),0.21446627439959484,0.7441936911496384,0.96875,0.9669465805037267,1.0,18/46,25.97%,CEP55;NUP155;NUP93;NUP35;SEH1L;CHMP4C;TOR1A;WDR73;NUP205;RPS19;NDC1;CHMP5;CHMP2B;CHMP1A;SUN3;REEP4;CHMP2A;NUP98
prerank,positive regulation of telomere capping (GO:1904355),-0.2624942754750361,-0.7437916723959198,0.8545454545454545,0.9642936010760942,1.0,6/17,16.94%,MAP3K4;RTEL1;MAPK1;MAPK3;MAP2K7;NEK7
prerank,bicarbonate transport (GO:0015701),-0.23005320669003215,-0.7436091608538165,0.7931034482758621,0.9637294419310719,1.0,16/33,30.39%,CYB5R1;SLC4A7;AQP1;RHAG;CA7;SLC4A3;SLC26A7;HBB;CA5B;CA1;SLC4A5;SLC4A1;CA3;SLC4A4;SLC4A10;CA2
prerank,steroid hormone biosynthetic process (GO:0120178),0.2377605098501523,0.7435991944291929,0.875,0.9668320826169724,1.0,7/28,16.06%,SRD5A1;SRD5A3;DHCR7;FDXR;TSPO;FDX1;MED1
prerank,response to growth factor (GO:0070848),-0.2187923779577581,-0.743523653801346,0.8793103448275862,0.9630771570323341,1.0,11/40,20.21%,BMPR1A;MAPK7;HDAC6;NOS1;MAP2K5;SFRP1;PDGFB;ACVR2A;BMPR1B;RPS6KB1;SOX2
prerank,epithelial cell development (GO:0002064),0.26012813744240243,0.7424335900971754,0.8695652173913043,0.9674780950850117,1.0,11/21,30.89%,WNT7B;POF1B;GRHL2;RAB25;SIX3;SIPA1L3;WNT7A;PDZD7;EXPH5;BFSP1;ROS1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.23225664048666048,0.7423214196552277,0.9111111111111111,0.9668743393256751,1.0,5/23,15.64%,COPS5;RAD23B;DDB1;UBA52;CUL4A
prerank,gonad development (GO:0008406),-0.21911396561297708,-0.7422215977380987,0.8888888888888888,0.9638823595608046,1.0,8/48,12.64%,SOX15;MAMLD1;KIT;AR;NR2F2;KITLG;CSDE1;WNT2B
prerank,negative regulation of protein binding (GO:0032091),-0.2026178362650957,-0.7416922351557906,0.9365079365079365,0.9637980715100462,1.0,21/67,24.09%,ADRB3;TTBK2;CSNK1E;ADRB2;CAMK1;BAG2;MAP2;LRRK2;CDKN1A;DISC1;PDGFB;ROCK1;MAPK8;CCL23;DNAJB2;ACTB;B2M;GOLGA2;PIN1;PRKCD;ATP2A2
prerank,cellular respiration (GO:0045333),-0.21359234561204304,-0.7414707723365177,0.9090909090909091,0.9633725069341307,1.0,8/39,21.07%,MTFR1L;ETFDH;COQ10A;SDHA;BLOC1S1;COX4I2;NR4A3;SIRT3
prerank,oligosaccharide metabolic process (GO:0009311),0.2027095588338539,0.7408699131636877,0.9565217391304348,0.9675716442078361,1.0,17/49,26.15%,NEU1;GLA;FUT8;FUT1;ST8SIA6;FUT7;B4GALT1;FUT2;MANBA;MAN1B1;MPDU1;AMY1A;AMY1C;FUT6;FUT4;FUT3;NAGA
prerank,morphogenesis of an epithelium (GO:0002009),-0.23692760295095638,-0.740717419330924,0.8297872340425532,0.9636503378540112,1.0,4/27,7.25%,VCL;LAMA5;FGFR2;FLG2
prerank,regulation of macrophage differentiation (GO:0045649),0.2635649976838573,0.7406009297759655,0.8490566037735849,0.9671344262308623,1.0,2/15,6.75%,INHBA;PF4
prerank,male gonad development (GO:0008584),-0.22918265402866878,-0.7403334346975489,0.9230769230769231,0.9633277796081324,1.0,7/40,12.64%,SOX15;MAMLD1;KIT;AR;KITLG;CSDE1;WNT2B
prerank,tetrapyrrole metabolic process (GO:0033013),-0.2702051382979382,-0.7402469123786026,0.8727272727272727,0.9626514254723327,1.0,5/20,11.90%,CUBN;MTR;CTRB2;CTRC;CTRB1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.24394419211575166,-0.7400313919143984,0.8541666666666666,0.9622007287277883,1.0,5/29,13.69%,TRIM39;MAP1A;WAC;KLHL40;OGT
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.2491060442277724,0.7391571110753463,0.9130434782608695,0.9678565528373376,1.0,7/21,26.97%,TP73;PML;AEN;IFI16;MSH2;TP53;DDIT4
prerank,cellular response to acid chemical (GO:0071229),-0.25495605988552406,-0.738598622911076,0.84,0.9632745414052397,1.0,11/26,26.70%,RRAGC;CPEB1;CPEB3;RRAGB;RRAGD;RPTOR;KLF2;CPEB4;MTOR;RRAGA;CAPN2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.25568949231769145,0.7366423755998567,0.8076923076923077,0.969804903872144,1.0,4/20,14.32%,CXCL8;C1QBP;MDK;MCU
prerank,protein K63-linked ubiquitination (GO:0070534),-0.21345114948187335,-0.736169705594528,0.9454545454545454,0.9655092106821832,1.0,11/43,17.92%,PELI3;TRAF1;UBE2D4;RNF115;UBE2G1;UBE2E2;RNF152;ZFP91;UBE2V1;ARIH2;HECTD1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.22139467054878412,0.7361680216367916,0.8666666666666667,0.9694539341455269,1.0,10/29,21.34%,CBFB;RUNX1;FOXH1;CARM1;BRCA1;PAK1;CNOT1;AXIN1;UFM1;DDRGK1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.23423933080462406,0.7347801640420872,0.9512195121951219,0.9700855993225345,1.0,3/27,4.64%,RUVBL1;RUVBL2;MRGBP
prerank,pulmonary valve development (GO:0003177),0.23618482679868275,0.7344271686006467,0.8809523809523809,0.9697436469485843,1.0,6/18,21.78%,STRA6;TGFB2;ROBO2;BMP4;TNFRSF1B;NOTCH1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.23377542261192064,0.7341566323518112,0.9333333333333333,0.9692026590331921,1.0,9/32,18.02%,CXCL8;ADIPOR1;MFSD12;EIF6;FGFR4;C3;FITM2;MED1;TNFRSF1B
prerank,response to alcohol (GO:0097305),0.238357758862691,0.7340067495594667,0.8918918918918919,0.9685151294509503,1.0,5/30,9.42%,GRIN2B;GOT2;CHRNB2;TH;CCL3
prerank,protein acylation (GO:0043543),-0.22942932413470044,-0.7329289646154518,0.9038461538461539,0.9684334672527365,1.0,10/36,21.95%,ZDHHC17;KAT2B;ZDHHC15;ZDHHC7;ING4;KAT2A;GLUL;ZDHHC18;ING5;ZDHHC21
prerank,regulation of B cell activation (GO:0050864),0.21835953627508542,0.7321621546998736,0.8888888888888888,0.9697433248079133,1.0,13/27,37.57%,IL4I1;TNFAIP3;SH3KBP1;NOD2;TNFSF4;FOXJ1;IL10;AHR;SLAMF8;SAMSN1;BANK1;LAPTM5;IKZF3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.220621604422711,0.7320668403590421,0.8421052631578947,0.9690564532646224,1.0,6/32,12.44%,CALR;CBFB;RNF6;RUNX1;CARM1;KDM1A
prerank,regulation of glucose metabolic process (GO:0010906),0.23644687454220947,0.7314520518693719,0.8837209302325582,0.9688810068114969,1.0,4/29,7.76%,IRS1;ADIPOR1;PMAIP1;SDHAF3
prerank,regulation of transferase activity (GO:0051338),0.2540624299669748,0.7286448292381312,0.868421052631579,0.9709011746056707,1.0,5/17,19.54%,NABP2;PARP4;NLRC5;FEM1A;SPTSSB
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.2089454572399701,0.7285679780977963,0.9285714285714286,0.9702063770789525,1.0,16/45,26.29%,TDGF1;EREG;AREG;FAM83A;SOX9;GRB7;REPS2;AAMP;TGFB1;TGFA;VIL1;EGF;PTPN11;PIGR;EPGN;IQGAP1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.2498963471694658,0.7278483957913309,0.8723404255319149,0.9701512530097124,1.0,8/20,24.70%,IL4I1;PRKDC;PRELID1;ZNF683;PRDM1;CRTAM;CD2;XRCC6
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.2376324254741446,0.7245697702175482,0.8979591836734694,0.9725019472385955,1.0,10/24,23.36%,LAMP3;PML;CSNK2A1;EFNA1;PSMF1;PRKCG;HSP90AB1;RPL11;RPL23;RPS7
prerank,apoptotic nuclear changes (GO:0030262),-0.24113419924703927,-0.724104599447543,0.9482758620689655,0.9772928277858441,1.0,9/22,26.24%,GPER1;ACIN1;DICER1;CASP3;CDK5RAP3;CECR2;EXOG;DNASE1L3;KPNA1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.20816500651475228,-0.7235794789724643,0.953125,0.9772467927544191,1.0,13/41,23.99%,MAPK7;GPER1;KRIT1;GATA2;ECSCR;ANGPT1;CCL2;CDH5;PLCG1;SCG2;RAMP2;ANO6;PDCD4
prerank,response to fatty acid (GO:0070542),0.2556797529789471,0.7231100067777624,0.94,0.9733239323014995,1.0,4/19,10.28%,IRS1;SCD;SOX9;FFAR2
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.23792735717300373,-0.7228693255562235,0.9215686274509803,0.9771669356383269,1.0,12/28,26.14%,FLNA;PIK3R1;DMAP1;PSEN1;BAG3;EFCAB7;PIK3R2;UBR5;PRKCD;SMAD3;HCLS1;TPR
prerank,protein kinase B signaling (GO:0043491),-0.22763475155862772,-0.7225892550716401,0.8888888888888888,0.9767553206878403,1.0,8/24,24.07%,PTEN;ZFP36L1;SIRT2;PIK3R3;TSC2;SETX;CCL2;NKX3-1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.21727651593320196,0.7225732971933148,0.9361702127659575,0.9730598727519023,1.0,11/33,23.68%,HACD3;TECR;ACSL6;HACD2;ELOVL1;ACOT4;ELOVL7;SLC27A5;ELOVL6;SLC27A4;CYP4F2
prerank,endocytic recycling (GO:0032456),-0.2024564463999638,-0.722274987899927,0.9245283018867925,0.9763646128236392,1.0,10/45,19.22%,VPS39;EHD2;MICALL1;SNX27;KIAA1109;CCDC93;RAB11FIP3;RAB13;EPS15;SNX31
prerank,regulation of cell size (GO:0008361),0.2398606076505137,0.7219544368984973,0.8653846153846154,0.9728908537246804,1.0,9/23,20.92%,LAMTOR5;EZR;PLEK;MTPN;VAV3;SLC9A3R1;MSN;VAV2;LAMTOR4
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.1934204195407234,-0.7219322981243417,0.9538461538461539,0.9761029747890801,1.0,13/53,24.78%,CLIP3;CFLAR;PELI3;TRAF1;CARD8;MADD;GPS2;RNF31;TAX1BP1;HIPK1;SPPL2B;RIPK1;TNFRSF1A
prerank,necroptotic process (GO:0070266),0.2544943479795196,0.7219055179932997,0.8936170212765957,0.9721805712539564,1.0,5/16,24.76%,PGAM5;IPMK;FASLG;MLKL;TICAM1
prerank,establishment of melanosome localization (GO:0032401),0.23778114800355316,0.7211603176496131,0.875,0.9721155722711576,1.0,7/19,21.11%,GPR143;MREG;RAB11A;BLOC1S3;SHROOM2;RAB27B;RAB17
prerank,B cell differentiation (GO:0030183),0.19073978632880748,0.7205409369163795,0.975,0.9719391057598029,1.0,18/59,29.77%,IL11;TCF3;JAK3;CEBPG;TPD52;IRF2BP2;PTPN2;SLC25A5;RAG1;MSH2;NFAM1;PTPRJ;CR2;RABL3;IL10;IFNE;ADGRG3;ADAM17
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.2544169796510168,0.7204269876068843,0.9024390243902439,0.9712312315667173,1.0,2/16,4.88%,IRS1;PMAIP1
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.2290309043053052,-0.7201975842365316,0.8958333333333334,0.9770581764390628,1.0,4/29,11.28%,TLR9;SYT11;NCKAP1L;C1QTNF3
prerank,regulation of phosphatase activity (GO:0010921),-0.2472749420361814,-0.7194649755890792,0.8541666666666666,0.9770395274593235,1.0,3/25,11.64%,TSC1;MTMR9;PPP6R2
prerank,melanosome localization (GO:0032400),-0.25598422032223866,-0.7194055105843519,0.8846153846153846,0.9764135658511034,1.0,6/21,15.90%,BBS4;BBS5;MYO5A;VPS33B;BBS2;BBS7
prerank,ganglioside metabolic process (GO:0001573),0.25834392946654966,0.7192535237283083,0.8367346938775511,0.9715527239002432,1.0,5/20,14.77%,NEU1;HEXB;ST8SIA6;GM2A;CLN6
prerank,camera-type eye development (GO:0043010),-0.2376781157707057,-0.7189182728065734,0.9152542372881356,0.9761998590568073,1.0,7/25,19.84%,CACNA1C;SKI;TENM3;CEP290;IFT122;RAB3GAP1;EFEMP1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.20343785924586882,-0.7165659141705284,0.9607843137254902,0.9777114884204534,1.0,11/48,16.93%,RBPMS2;IL6R;NDRG4;ELANE;MFN2;APOD;OGN;VIP;IGFBP5;PDGFB;ELN
prerank,regulation of sequestering of triglyceride (GO:0010889),0.2639658297685491,0.7164489332267203,0.8636363636363636,0.9733292819716429,1.0,4/15,16.01%,ABHD5;PLIN3;PPARG;FITM2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.2650145161858919,-0.7164309994794547,0.8958333333333334,0.9771604738829943,1.0,8/19,24.30%,SLC25A4;CAMK2A;BCL2;BNIP3;SPG7;BAD;MUL1;ARHGAP11B
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.17827964637806307,-0.7161920808351493,0.9795918367346939,0.9767515617703155,1.0,31/117,24.38%,CFLAR;CASP12;GSN;NLRP1;MAPT;GPER1;SNCA;DLC1;NGF;NGFR;DAPK1;CARD8;PPM1F;TNFSF10;SOX7;BCL10;PIDD1;FAS;COL4A3;CASP9;APAF1;KHDC1;CRADD;SIRT1;BOK;CASP8AP2;BAD;MUL1;RIPK1;NKX3-1;MTCH1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.25001783981829356,-0.715994831193053,0.9090909090909091,0.9762894555600259,1.0,2/18,4.23%,PLA2G5;PLA2G4B
prerank,peptide catabolic process (GO:0043171),0.22697350529805463,0.715859430425997,0.8604651162790697,0.9731267531742709,1.0,8/24,21.95%,DPEP1;CTSH;CHAC2;CHAC1;XPNPEP1;IDE;ERAP1;LTA4H
prerank,mesoderm formation (GO:0001707),0.23732620185001535,0.715022810596293,0.8958333333333334,0.9730527721994224,1.0,4/19,14.13%,TBX20;CRB2;HMGA2;ITGA2
prerank,positive regulation of protein import (GO:1904591),0.22766229178225292,0.7149670144403624,0.8695652173913043,0.9723553278851649,1.0,11/30,22.00%,RAN;ECT2;ZPR1;JUP;RBM22;ARHGEF5;TGFB1;TRIM28;ZC3H12A;IPO5;HYAL2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.208455294852549,-0.7139165380105057,0.9615384615384616,0.9774942774639392,1.0,13/52,20.20%,BCO2;AGTR1;PLIN5;SNCA;SIRT2;AKR1C1;PID1;RAC1;CDKN1A;PDGFB;MAPK14;PARL;PIKFYVE
prerank,response to copper ion (GO:0046688),0.23994656294586383,0.7137771909256201,0.8947368421052632,0.9727088382599718,1.0,2/21,2.74%,IL1A;LOXL2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.25474115221058413,-0.7135599704188674,0.8596491228070176,0.9772068643265708,1.0,6/21,17.58%,SNX33;TIMP4;TIMP2;TIMP3;ROCK1;PACSIN3
prerank,regulation of neurogenesis (GO:0050767),-0.20701168689061322,-0.7130996991274415,0.9824561403508771,0.9769936678075721,1.0,17/60,22.13%,NUMBL;ARNTL;GPER1;BHLHB9;NUMB;HEY1;ZNF335;PCM1;HEY2;SPEN;SERPINF1;SOX11;CCL11;HOOK3;DLL1;LIG4;B2M
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.2355146214853957,0.7126360041599206,0.9761904761904762,0.9731470882438961,1.0,10/25,28.16%,THY1;EZR;PTPN2;LILRB4;GBP1;DGKZ;CD300A;PTPRJ;SH2D1A;SLA2
prerank,regulation of protein metabolic process (GO:0051246),0.20601016859865098,0.7124815865880681,0.9523809523809523,0.9725023288329836,1.0,10/44,18.63%,ODC1;CHEK2;VPS35;SHH;IL17F;GBA;TMEM9;PLAUR;HSP90AB1;MTPN
prerank,regulation of protein transport (GO:0051223),0.21320675359377028,0.7123658287278201,0.9607843137254902,0.9718585698245706,1.0,14/28,31.51%,NDFIP2;ATP13A2;RHBDF2;DNAJA1;SNX12;ARFIP1;WWP2;LLGL2;NDFIP1;DNAJC1;LCP1;CHP1;SCFD1;TNF
prerank,leukotriene metabolic process (GO:0006691),0.23747051491036014,0.7121809076782378,0.9,0.9712498451394834,1.0,7/22,25.52%,DPEP1;MGST2;MAPKAPK2;CYP4F3;LTA4H;CYP4F2;ALOX12
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.23795392762738454,0.7106246114770978,0.8837209302325582,0.9719599464524334,1.0,10/27,24.64%,NOTCH3;RITA1;LFNG;CHAC1;NRARP;YTHDF2;DLK2;WWP2;EGF;TSPAN15
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.1981152430439326,0.7099571300496997,0.9183673469387755,0.9717683842065041,1.0,18/46,27.35%,PDGFRB;ROMO1;SYK;CYBA;AGT;FPR2;DCXR;TGFB1;TGFBR2;MMP8;ZC3H12A;TP53;TYROBP;THBS1;GSTP1;ACE2;ITGB2;CLEC7A
prerank,linoleic acid metabolic process (GO:0043651),-0.2542128682421442,-0.7098551504786006,0.8775510204081632,0.9792479067405175,1.0,1/19,0.50%,GSTM2
prerank,histone H2A ubiquitination (GO:0033522),0.2509866969015049,0.7096668687765476,0.8958333333333334,0.971364885286393,1.0,7/17,25.64%,RNF2;DTX3L;DDB1;UBE2A;TRIM37;PCGF1;RNF8
prerank,establishment of spindle localization (GO:0051293),0.2587609406589403,0.7091638701100541,0.8260869565217391,0.9712334582908781,1.0,8/15,29.76%,KPNB1;ESPL1;CFL1;LLGL2;MAP4;KIF25;OOEP;ZBED3
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.24881404484744768,-0.7082536246639959,0.9152542372881356,0.9799580406950699,1.0,3/19,8.86%,ASPA;DLD;AASS
prerank,regulation of mitochondrial fission (GO:0090140),-0.2444183507996932,-0.707750441216472,0.8846153846153846,0.9798035639165229,1.0,12/22,29.85%,MAPT;LRRK2;DCN;DDHD1;BNIP3;MUL1;PINK1;MFF;DNM1L;MIEF2;SPIRE1;RALBP1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.257144206216639,-0.7074504644134783,0.9482758620689655,0.9794017962797026,1.0,5/18,25.91%,PTGS1;PTGIS;HPGDS;PTGDS;PLA2G4A
prerank,fatty acid oxidation (GO:0019395),-0.20803164506506586,-0.7065110545414763,0.8867924528301887,0.979508650510845,1.0,14/55,21.92%,ACAD11;ECHDC2;PPARD;ACADVL;ACADL;ECI2;ADH5;CYP4V2;ACAT1;HADHB;ABCD4;CROT;ABCD1;BDH2
prerank,ear morphogenesis (GO:0042471),-0.23541942138672212,-0.7054521352363347,0.9433962264150944,0.9797689881261318,1.0,4/23,9.35%,OSR1;FGFR2;TBX1;TMIE
prerank,contractile actin filament bundle assembly (GO:0030038),-0.26723404993102917,-0.7051271119280309,0.8367346938775511,0.9785942887313934,1.0,3/15,15.22%,SORBS1;RHOA;PDLIM1
prerank,stress fiber assembly (GO:0043149),-0.26723404993102917,-0.7051271119280309,0.8367346938775511,0.9785942887313934,1.0,3/15,15.22%,SORBS1;RHOA;PDLIM1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.25576754607087565,0.7044226482103991,0.8333333333333334,0.974628336930598,1.0,8/17,32.12%,DHFR;SCARB1;GCH1;NUS1;TERT;HIF1A;TNF;AKT1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.24146976481385407,0.7033197044562204,0.868421052631579,0.9746724576877703,1.0,4/15,18.67%,SMAD1;FUT1;ITGA5;PKM
prerank,vacuolar acidification (GO:0007035),0.23994080255480923,0.70325206275656,0.9107142857142857,0.9739548280049528,1.0,6/21,19.13%,GRN;CLN6;TMEM9;PPT1;ATP6AP2;ATP6V0A4
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.2765246714568601,-0.7031280205779663,0.8235294117647058,0.9794879403486624,1.0,5/16,20.52%,PPT2;DIP2A;SCD5;ACAT1;MLYCD
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.22348362619484666,0.7030732575873166,0.9347826086956522,0.9733820665697683,1.0,11/24,28.02%,CDK5;TGFB2;CCL3;PCSK9;GRN;BAX;MCL1;TYROBP;CTNNB1;CDK5R1;TFAP2A
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.24134824769619215,0.7027840842816413,0.875,0.9728186370919657,1.0,6/16,20.05%,STK39;PPIF;MMP9;COMMD1;SLC43A2;CAV1
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.21461335849478633,-0.7024281468669468,0.921875,0.9792746363236563,1.0,9/36,20.42%,TRIM39;CSNK2A2;TRAF1;BCL2;DAB2IP;MADD;FAS;CRADD;ING5
prerank,sensory perception of smell (GO:0007608),-0.1774244546892068,-0.7007719416259768,1.0,0.9799069320992501,1.0,3/103,5.96%,BBS4;SLC24A4;SYT10
prerank,negative regulation of proteolysis (GO:0045861),0.21236115280510598,0.6997990799546971,0.92,0.9746202845326984,1.0,10/38,19.76%,CST4;CDK5;CSTB;TIMP1;EFNA1;CHAC1;PTPN3;TM4SF20;SNX12;CST7
prerank,anterior/posterior axis specification (GO:0009948),0.2493500959115551,0.6986496674824697,0.8837209302325582,0.9746473676796289,1.0,6/19,26.44%,TDGF1;SHH;RIPPLY1;CDX2;CDX1;LHX1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.2258923904759926,0.6979302318191434,0.9387755102040817,0.9745142271154282,1.0,12/30,31.62%,IKBKE;UBA52;UBE2D1;CD300LF;UBE2D2;TICAM1;CASP8;IRF3;IRF7;UBC;IKBKG;IKBKB
prerank,glial cell development (GO:0021782),0.22502422104182687,0.6973340528526731,0.9024390243902439,0.9742296559029527,1.0,5/25,15.98%,SOX4;MDK;ZNF488;NSUN5;MYRF
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.2516860961610798,-0.6967020067558176,0.92,0.9826533526794161,1.0,7/18,23.85%,MAPK7;HSPB1;SIRT1;INS;NME5;NOL3;PINK1
prerank,response to progesterone (GO:0032570),0.24116528224703443,0.6966476279167955,0.9347826086956522,0.9739960273906574,1.0,6/20,24.48%,TGFB2;ABHD2;CATSPER1;TGFB1;CAV1;THBS1
prerank,blood vessel morphogenesis (GO:0048514),0.19637103013299803,0.6958576009373004,1.0,0.9738216357254144,1.0,15/55,21.62%,STRA6;TBX20;SYK;SHH;PROX1;APELA;ENG;KDR;TGFB1;LRP5;ID1;TGFBR2;HES1;CAV1;TNNI3
prerank,regulation of intracellular pH (GO:0051453),0.20208291314351542,0.695604617714933,1.0,0.9732608895838972,1.0,9/35,19.32%,TM9SF4;NOX1;TMEM165;GPR89A;SLC9B1;SLC9A7;GPR89B;SLC9C1;CFTR
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.1802038560608327,0.6954513276892056,0.9583333333333334,0.9726590095812027,1.0,19/68,22.24%,STT3B;DERL1;SEC61B;ERLIN1;FOXRED2;EDEM2;UBE2J1;VCP;ERLIN2;HSPA5;MAN1B1;FBXO6;FAF2;UBQLN1;OS9;AUP1;DNAJC10;UBXN8;RHBDD2
prerank,endocrine system development (GO:0035270),0.2346930286011244,0.6948894683435566,0.9183673469387755,0.9724860400817127,1.0,6/23,20.01%,STRA6;MDK;SIX1;WNT11;SIX3;PAX8
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.22113152902323732,0.6934329338541821,0.9285714285714286,0.9728667814024755,1.0,10/24,26.90%,ACOT7;ASAH2B;ALOXE3;LTA4H;ELOVL6;ASAH2;GPX4;ALOX12;GSTP1;ALOX12B
prerank,regulation of centriole replication (GO:0046599),-0.26750980102943844,-0.6933062200543738,0.94,0.9845716841851475,1.0,7/18,26.35%,MDM1;KAT2B;KAT2A;CDK5RAP2;SPICE1;CEP295NL;ALMS1
prerank,negative regulation of cell development (GO:0010721),0.2313053709897905,0.6919401136717506,0.972972972972973,0.9732888372012539,1.0,8/24,24.73%,IL1B;GSK3B;SORL1;PAX6;WNT7A;NOTCH1;WNT3A;DYNLT1
prerank,monocarboxylic acid transport (GO:0015718),-0.18863303234958606,-0.6905646133932662,0.9354838709677419,0.9859758626617235,1.0,22/54,30.02%,SLC16A12;NCOA1;AKR1C1;SLC27A1;RXRA;SLC16A2;SLC10A4;SLCO2A1;CD36;SLC51A;ABCG2;SLC16A7;SLC16A8;ABCB11;CEACAM1;ABCC4;SLC10A6;NR1H4;SLC6A8;SLC51B;SLC16A11;STARD5
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.22777163707127343,0.6883086425916205,0.9,0.9750163998591219,1.0,10/22,30.18%,HNF1A;MED14;SUB1;MED1;MED30;PAXIP1;MED13;FOSL1;MED4;HNF1B
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.2293351509076872,-0.6875973709527934,0.9411764705882353,0.9877032229223461,1.0,11/27,27.41%,PTEN;SPRY1;DAB2IP;SFRP1;IL17RD;FUZ;VASN;SMAD7;SDHAF2;BMP5;LDLRAD4
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.2110958437172668,-0.686776537511632,0.8888888888888888,0.9875910513957327,1.0,11/36,23.98%,JMY;ZNF385B;CDIP1;PHLDA3;RRP8;PDK2;SIRT1;BOK;USP28;HIPK1;TMEM109
prerank,protein localization to cell-cell junction (GO:0150105),0.2540163562198188,0.686475846952673,0.9375,0.975662066095165,1.0,6/15,23.94%,ACTG1;LSR;PAK2;DSP;F11R;SCRIB
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.22419393814644387,0.6857611378526626,0.9302325581395349,0.9753620679928253,1.0,5/23,17.25%,UGGT1;EDEM2;UBA52;MAN1B1;OS9
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.24103536798986136,-0.6857007996874149,0.9215686274509803,0.9876778567499199,1.0,6/20,30.09%,CFLAR;OGT;NUPR1;RIPK1;FLOT1;BIRC2
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.20860470884928897,-0.6853768053372093,0.9038461538461539,0.9871287826899032,1.0,5/31,12.29%,GH1;KIT;GHR;TSLP;PRL
prerank,organonitrogen compound catabolic process (GO:1901565),-0.19301899527593047,-0.6829735266892899,0.9841269841269841,0.9881687441444897,1.0,12/60,15.54%,PLA2G5;CAPN3;LVRN;ELANE;PLA2G6;NAALADL1;NPEPPS;CPQ;GNPDA2;ADAMTS13;ENPP2;LRSAM1
prerank,ERBB signaling pathway (GO:0038127),-0.1880897024948262,-0.6825275643307332,0.9411764705882353,0.98777220300463,1.0,17/64,22.77%,NRG2;GAB1;BTC;PIK3R1;RPS6KA5;PRKCA;PLCE1;MAPK1;BRAF;SOS1;CBL;EGFR;ERBB4;EFEMP1;SHC3;PTPN12;PLCG1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.21988507082772601,-0.679582728175327,0.9642857142857143,0.9892199270793366,1.0,3/34,5.64%,PER1;DUSP3;ZMYND11
prerank,embryonic axis specification (GO:0000578),0.23902208914244935,0.6792878546805731,0.8723404255319149,0.9790806298408555,1.0,1/16,0.87%,TDGF1
prerank,"wound healing, spreading of cells (GO:0044319)",0.23305418499552838,0.6784957372578576,0.9387755102040817,0.9788202248041437,1.0,6/21,14.93%,CD44;DDR1;TOR1A;ITGA5;PDCD10;MMP12
prerank,negative regulation of immune effector process (GO:0002698),0.24144633422115233,0.6779571656006654,0.9565217391304348,0.9783600327276392,1.0,10/16,36.08%,CD55;GRN;RPS19;CD47;ENPP3;CD300A;IFNL1;SLAMF8;HAVCR2;LILRB1
prerank,B cell receptor signaling pathway (GO:0050853),-0.20083652597237578,-0.677913910540906,0.9583333333333334,0.9898467459214103,1.0,5/33,14.37%,PRKCB;BCL2;NCKAP1L;MEF2C;BMX
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.2434186008151681,0.6763502007226916,0.8723404255319149,0.9786173165085622,1.0,4/17,24.63%,C1QBP;OASL;ZCCHC3;TRIM15
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.22559936619749793,-0.6758012381859232,1.0,0.9905914476346168,1.0,7/23,19.49%,LRAT;CUBN;CYP11A1;CYP1A1;RLBP1;VKORC1;PIAS4
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.23850224093609101,-0.6753913752970164,0.9649122807017544,0.9901415567065537,1.0,5/18,22.89%,PTN;PTPRZ1;DICER1;CLCF1;ID2
prerank,protein localization to chromosome (GO:0034502),-0.2154248967845739,-0.675288911790243,0.9285714285714286,0.9894748579398277,1.0,9/29,24.08%,IFFO1;TERF2IP;FAM47E;TINF2;ESR1;PARP3;TNKS;TPP1;CHMP7
prerank,regulation of cellular amide metabolic process (GO:0034248),0.2116661818962166,0.6728811718322365,0.9761904761904762,0.9797986503628738,1.0,13/31,26.48%,NOLC1;NANOS3;TMED10;EIF4E;METAP1;PKP3;RBM3;MTPN;MAPKAPK5;GEMIN5;CYFIP1;PGAM1;TIGAR
prerank,pigment granule transport (GO:0051904),-0.24605869487839466,-0.671274628524258,0.9444444444444444,0.9908750078594397,1.0,5/18,15.90%,BBS4;BBS5;MYO5A;BBS2;BBS7
prerank,melanosome transport (GO:0032402),-0.24605869487839466,-0.671274628524258,0.9444444444444444,0.9908750078594397,1.0,5/18,15.90%,BBS4;BBS5;MYO5A;BBS2;BBS7
prerank,apoptotic DNA fragmentation (GO:0006309),0.24620129467168347,0.6712694109263356,0.9387755102040817,0.9799961994860442,1.0,7/15,28.46%,HMGB2;KPNB1;ENDOG;DNASE2;HMGB1;DFFA;FOXL2
prerank,regulation of B cell proliferation (GO:0030888),0.1895568493421816,0.6690439289672054,0.975,0.9804179724921688,1.0,15/46,29.27%,EPHB2;CHRNB2;IL21;CD81;CD320;LYN;VAV3;MNDA;TYROBP;TNFSF13B;CD300A;TNFRSF4;CTLA4;IL10;AHR
prerank,global genome nucleotide-excision repair (GO:0070911),-0.19853095729271514,-0.66887469323025,0.9322033898305084,0.9915637250282714,1.0,11/26,30.04%,XPA;ERCC3;UBB;GTF2H4;XPC;DDB2;CHD1L;USP45;ERCC1;ERCC4;RNF111
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.2135002691773572,-0.6664466159384036,0.9310344827586207,0.9922580331501297,1.0,6/29,12.92%,MOAP1;NGF;BCL2;DAB2IP;DEDD;BAG3
prerank,response to gamma radiation (GO:0010332),0.2173041872024766,0.6656746315193216,0.9387755102040817,0.9816700448403249,1.0,9/23,29.19%,MYC;XRCC5;KDM1A;MEN1;TP53;XRCC6;FANCD2;ATR;WRN
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.228521739377886,0.6649369975051681,0.9183673469387755,0.981350938284611,1.0,8/21,24.17%,HMGB2;KPNB1;DNASE1L1;ENDOG;DNASE2;REXO4;HMGB1;DFFA
prerank,defense response to fungus (GO:0050832),0.21568281432128855,0.6626641015776598,0.9534883720930233,0.9819283704349393,1.0,10/23,38.42%,GAPDH;CLEC6A;RNASE7;IL36RN;CLEC7A;CLEC4D;CARD9;CX3CR1;LTF;FAM3A
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.24243272179148695,0.6610658017061818,0.8936170212765957,0.9820655311184826,1.0,3/16,9.21%,PAH;SMOX;TH
prerank,leukocyte tethering or rolling (GO:0050901),-0.24867236157894076,-0.6594268363175131,0.8846153846153846,0.9958403794188091,1.0,6/18,26.85%,JAM2;ADD2;ROCK1;MADCAM1;SELP;GOLPH3
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.2306726537046644,-0.6588656365180543,0.9482758620689655,0.995500539376889,1.0,4/16,19.11%,PLIN5;SLC27A1;NR1H2;CTDNEP1
prerank,regulation of vasculature development (GO:1901342),-0.2228186641328745,-0.6570114315057815,0.9629629629629629,0.9957840630950098,1.0,8/26,25.80%,FGF2;EGLN1;SFRP1;KRT1;ADGRA2;HMOX1;GPNMB;BMPER
prerank,response to amino acid (GO:0043200),-0.2096163305652141,-0.6568603618842181,0.9607843137254902,0.9951826651982645,1.0,11/29,26.70%,RRAGC;CPEB1;GLRB;CPEB3;RRAGB;RRAGD;RPTOR;CPEB4;MTOR;RRAGA;CAPN2
prerank,response to cadmium ion (GO:0046686),-0.20910028375914835,-0.6565460251027251,0.9622641509433962,0.9946279512106924,1.0,8/28,27.85%,MAPK1;MAPK3;MT1X;MAPK8;EGFR;MT1M;MT1A;MT3
prerank,synaptonemal complex organization (GO:0070193),0.23278385439470062,0.6564715879030903,0.9347826086956522,0.9831504804140745,1.0,5/15,26.25%,P3H4;TRIP13;SYCE3;HORMAD1;RAD21
prerank,synaptonemal complex assembly (GO:0007130),0.23278385439470062,0.6564715879030903,0.9347826086956522,0.9831504804140745,1.0,5/15,26.25%,P3H4;TRIP13;SYCE3;HORMAD1;RAD21
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.23502079407202117,-0.6561100378914807,0.9074074074074074,0.9941656209540508,1.0,6/20,22.61%,MAPK7;MAP2K5;PDGFB;MAPK8;KLF2;WFS1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.22116850860610912,0.6560716355554557,0.8974358974358975,0.9825998499575997,1.0,7/22,24.56%,VPS25;TOM1L1;PLAA;VPS37B;STAM;MVB12A;RNF126
prerank,regulation of platelet aggregation (GO:0090330),-0.23179678439880602,-0.6533765580485544,0.9387755102040817,0.9948808004165971,1.0,8/18,29.16%,PRKCA;PRKG1;CELA2A;PRKCD;C1QTNF1;CEACAM1;BLK;SH2B3
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.20481160394038106,0.6508411110643865,1.0,0.9842652241086806,1.0,6/27,17.42%,AJUBA;DHX9;EIF4E2;BMP4;MYCN;TGFB1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.2358351317837395,0.6501775903270539,0.9183673469387755,0.983797177109619,1.0,3/18,9.91%,CD46;TGFB2;FN1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.22428519633372201,-0.6483101514844111,0.9245283018867925,0.9967579244231244,1.0,10/24,26.32%,MLLT11;GPER1;MOAP1;TNFSF10;BNIP3;BCL2L11;BAD;PINK1;MFF;DNM1L
prerank,regulation of leukocyte activation (GO:0002694),-0.2558261130108902,-0.6481532470484921,0.9482758620689655,0.9961449056780187,1.0,2/16,7.17%,GPER1;PJA2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.24153950085299564,-0.6480251614008034,0.9795918367346939,0.9955327527785985,1.0,4/15,21.54%,TLR9;TLR3;USP15;DHX58
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.25630423288733384,-0.6475301206107126,0.9411764705882353,0.9950192583267367,1.0,8/16,27.00%,RBPJ;FER;EGFR;MVB12B;PTPN12;RHBDF1;CEACAM1;CDH13
prerank,snRNA metabolic process (GO:0016073),0.24130225837922673,0.6441427534027054,0.96,0.9858387916019707,1.0,1/15,1.03%,INTS7
prerank,lymphocyte proliferation (GO:0046651),-0.19537467754694107,-0.6439988427970353,1.0,0.9960766106544676,1.0,4/37,12.28%,LMBR1L;PPP3CB;BCL2;MEF2C
prerank,stem cell development (GO:0048864),0.2253206981439537,0.6437015852131064,0.9722222222222222,0.9853125370132219,1.0,5/17,20.24%,NOLC1;SHH;KBTBD8;KLHL12;WNT7A
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.2424531604407596,-0.6379054353956511,0.9629629629629629,0.9982587788158804,1.0,8/17,31.20%,SIRT1;CES1;BMP5;NR1H4;STAR;CYP7A1;CGA;NR0B1
prerank,bile acid and bile salt transport (GO:0015721),-0.21239279650672865,-0.6373260380338257,1.0,0.997855049012114,1.0,12/25,30.02%,NCOA1;AKR1C1;RXRA;SLC10A4;SLC51A;ABCB11;CEACAM1;ABCC4;SLC10A6;NR1H4;SLC51B;STARD5
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.23891671129723163,0.6370503588706723,0.9024390243902439,0.9872263369894972,1.0,5/15,26.50%,PMAIP1;MSX1;SPRED2;SPRED1;ATR
prerank,positive regulation of B cell proliferation (GO:0030890),0.20232535993607917,0.636741462887699,0.9473684210526315,0.9866092507250831,1.0,5/30,14.04%,EPHB2;CHRNB2;IL21;CD81;CD320
prerank,negative regulation of transferase activity (GO:0051348),-0.2126244619689867,-0.6353337031270369,0.9615384615384616,0.998063007458262,1.0,8/29,21.18%,MAPT;CDKN1C;CERS1;INPP5K;ZFP36;GSK3A;EIF4A2;SMAD7
prerank,mesenchymal cell development (GO:0014031),-0.23290182651784497,-0.6350903129472332,0.9705882352941176,0.9974780754257808,1.0,7/19,24.27%,TAPT1;CDH2;HEY2;SOX11;SOX8;FAM172A;SNAI2
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.17188902374927656,-0.6332202402984156,0.9824561403508771,0.9975172108818248,1.0,7/52,15.68%,GSTM2;PTGS1;PLA2G4B;FADS3;EPHX1;PLA2G4C;SCD5
prerank,regulation of lipid storage (GO:0010883),-0.2210173429551608,-0.633016266237402,0.94,0.9969075333461626,1.0,6/20,20.09%,PLIN5;ITGB3;FTO;FBXW7;VSTM2A;SIRT1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.19513836210914653,0.6323021858636836,0.9523809523809523,0.9876140850430495,1.0,14/32,33.13%,OCIAD2;PRLR;F2R;HES1;CRLF3;NOTCH1;IL10;PIBF1;IL10RA;IFNL1;IL26;TNF;CCL5;OCIAD1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.19340612561318504,-0.6322998653441395,1.0,0.9964867192979121,1.0,5/35,15.26%,AGPAT1;C1QTNF4;TRIM6;TSLP;TICAM2
prerank,"phototransduction, visible light (GO:0007603)",-0.23233253940703366,-0.6311257915771208,0.9411764705882353,0.9962219790022024,1.0,5/15,23.58%,CNGB1;GNAQ;PDE6B;GNA11;RHO
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.16738333997139276,-0.6292056003952264,1.0,0.9962036195219915,1.0,7/67,12.44%,IL6R;ADGRB1;TLR9;ELANE;OPTN;RARRES2;AQP1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.20656676972606375,0.6275804523058319,0.9047619047619048,0.9885598583145633,1.0,6/19,22.35%,TNFSF9;LST1;TNFRSF1B;IL12B;TNFSF8;TNFSF18
prerank,receptor metabolic process (GO:0043112),-0.17182139352296014,-0.6250092101959582,1.0,0.997039247580721,1.0,19/54,29.04%,SNX1;SNCA;RAMP1;UVRAG;GRK4;ACKR3;RAMP3;CD36;DNM1;AP2M1;NSG1;RAB31;RAMP2;ADM;SNX25;DNM3;SMURF1;RAB11B;SH3GLB1
prerank,aminoglycan catabolic process (GO:0006026),-0.20552708209676107,-0.6230247723994587,0.9818181818181818,0.9971043853266739,1.0,9/31,23.60%,HPSE2;IDS;SDC3;SDC2;HSPG2;GPC1;HGSNAT;GPC6;SGSH
prerank,diacylglycerol metabolic process (GO:0046339),-0.22002750282603942,-0.6216065937003166,0.9206349206349206,0.9969820815411705,1.0,8/22,26.40%,DGKE;DGKG;PLCE1;DGKB;DGKI;DGKD;PNPLA2;DGKA
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.21917492245423997,-0.620488783915653,0.96,0.9967437434791482,1.0,4/21,16.19%,GNB3;ACADVL;ACADL;FMO5
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.21202170309980245,-0.6196253089425776,0.9230769230769231,0.9963251008612083,1.0,7/21,24.10%,PLIN5;HDAC6;SIRT2;INS;ABCD1;PINK1;ABCD2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.2002637064878579,0.6184018155777695,0.9777777777777777,0.9910652719374582,1.0,7/18,26.49%,BMP4;MYCN;TGFB1;ZC3H12A;TP53;TERT;LIN28A
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.18607458042783245,-0.6171634570557825,0.98,0.9964421298214515,1.0,7/35,19.06%,PPT2;HMGCLL1;ACSS3;SCD5;PAM;HPGD;ACAT1
prerank,response to acidic pH (GO:0010447),-0.23012591446277259,-0.6152456453206077,0.9807692307692307,0.9964237064399452,1.0,5/15,28.31%,TRPV1;RAB11FIP5;CTSS;GPR4;RAB11B
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.20757597325153657,0.6105964073728845,0.9074074074074074,0.9928116232672082,1.0,6/22,20.16%,HMBS;TSPO;CPOX;PGRMC1;FXN;ALAS1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.20167381206063156,-0.6069048641361326,0.9821428571428571,0.9983946042871708,1.0,3/24,9.21%,MAPK7;ATF4;RBPJ
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.2089968300895753,-0.6050645501732206,0.9636363636363636,0.9982204461071064,1.0,6/21,24.37%,CLU;LRRK2;NR1H2;USP25;WFS1;CREB3
prerank,protein targeting to lysosome (GO:0006622),-0.2041025542709139,-0.5994894026387608,0.9454545454545454,0.9990944393161042,1.0,3/20,16.96%,CLU;GGA3;VPS4A
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.2014755338851076,-0.5950884560133316,0.9833333333333333,0.9996267227588052,1.0,9/26,26.55%,PKD2;CLU;INSR;CD36;AGTR2;HBB;KLF2;SMAD3;NOS1AP
prerank,positive regulation of chemokine production (GO:0032722),0.1593184801082238,0.5922848333393267,0.9787234042553191,0.9967621874856197,1.0,18/52,30.13%,IL1B;WNT5A;SYK;FFAR2;IL17A;IL17F;EGR1;OAS3;TNFSF4;HMGB1;HIF1A;IFNG;CLEC7A;IL18;TLR7;EIF2AK2;ADAM17;AIRE
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.19822234822510437,-0.5902297824514843,0.9830508474576272,1.0,1.0,9/27,26.55%,PKD2;CLU;INSR;CD36;AGTR2;HBB;KLF2;SMAD3;NOS1AP
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.1960800667787962,0.5862737568587102,1.0,0.9973376056075169,1.0,7/24,26.25%,P3H4;TRIP13;RNF212B;SYCE3;HORMAD1;FANCD2;RAD21
prerank,negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.2173191622942733,-0.586172125296311,0.9814814814814815,1.0,1.0,15/15,78.29%,MICA;CEACAM1;CLEC12B;LGALS9;KLRC1;KIR2DL4;HLA-A;HLA-G;HLA-E;HLA-B;KLRD1;LILRB1;ARRB2;SERPINB9;HLA-F
prerank,regulation of interferon-beta production (GO:0032648),0.16873201489409256,0.5861386539785646,1.0,0.9966097069313449,1.0,15/47,30.16%,RIPK2;POLR3C;DHX9;POLR3B;OAS2;ISG15;POLR3G;OAS3;HSP90AA1;POLR3A;PTPN11;TLR7;IRF3;IRF7;TLR8
prerank,negative regulation of phagocytosis (GO:0050765),-0.21938452696795024,-0.5857554776351646,0.9629629629629629,0.9997574224553567,1.0,9/15,36.65%,SYT11;DYSF;PRTN3;SNX3;TLR2;SIRPA;APPL1;FCGR2B;ADIPOQ
prerank,macromolecule catabolic process (GO:0009057),-0.1954947068334299,-0.584268281194272,1.0,0.9993524063116116,1.0,11/28,29.04%,CAPN3;ELANE;UVRAG;LRSAM1;MTOR;TPP1;SNX25;CLN8;SMURF1;CTRL;SH3GLB1
prerank,response to exogenous dsRNA (GO:0043330),0.17847210974283106,0.5841575163791497,0.972972972972973,0.9961611991943796,1.0,8/32,28.47%,DHX9;SLC3A2;CAV1;ZCCHC3;TICAM1;RALB;IRAK3;IFNE
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.2163235887804183,-0.5815550155333628,0.9821428571428571,0.9991528205834287,1.0,6/17,27.46%,APOD;ABCD1;CUEDC2;PDCD4;ABCD2;NLRC3
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.19595717255228057,0.5812236437976713,0.9636363636363636,0.996007816529795,1.0,5/21,21.48%,IL1B;C3;HSP90AB1;SUGT1;ENTPD1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.2193704628597744,0.5780793363687169,0.9574468085106383,0.9958219692384463,1.0,6/15,32.07%,ACOXL;ACOT8;HSD17B4;EHHADH;DECR2;ACOX1
prerank,response to zinc ion (GO:0010043),0.185945639217577,0.5748572739992409,1.0,0.9957099031245515,1.0,7/28,23.85%,SLC30A2;ATP13A2;SLC30A5;KHK;GLRA2;HAAO;MT1F
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.18570177848245228,-0.574722436691234,0.9615384615384616,0.9997468291376284,1.0,7/26,21.11%,SLC12A4;KCNH2;SCNN1B;SCNN1G;ATP6V1B1;PDK2;SLC26A4
prerank,peroxisome organization (GO:0007031),0.19494461646265215,0.5729416866155866,0.9487179487179487,0.9953286870997807,1.0,4/24,14.80%,PEX7;PEX10;PEX16;ACOT8
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.1906857974137877,-0.5639934150896023,0.9807692307692307,1.0,1.0,10/26,27.60%,CNRIP1;TSG101;ZGPAT;CRHBP;CBL;RAMP3;ERRFI1;ZFYVE28;CLEC12B;SLC6A9
prerank,acylglycerol homeostasis (GO:0055090),0.20835990611174554,0.5639619755669187,0.9545454545454546,0.9961223639120778,1.0,5/15,22.72%,SCARB1;CETP;MLXIPL;HNF4A;PLA2G12B
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.2083789149902887,-0.5638698121141043,0.98,1.0,1.0,4/18,14.61%,SKI;DAB2IP;MORC3;SFRP1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.2173191622942733,-0.5613868549495853,0.9811320754716981,0.9998831223358917,1.0,15/15,78.29%,MICA;CEACAM1;CLEC12B;LGALS9;FCGR2B;KLRC1;KIR2DL4;HLA-G;HLA-E;PTPRC;KLRD1;LILRB1;ARRB2;CX3CR1;HLA-F
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.19656500662438287,0.5602603747542809,0.9787234042553191,0.9958636425553006,1.0,9/17,33.93%,TGFB2;PDCD10;LYN;NOD2;EIF2AK2;SCIMP;IL26;TAOK3;CARD9
prerank,regulation of stem cell proliferation (GO:0072091),-0.20766306202617946,-0.5540309853836216,0.9791666666666666,1.0,1.0,4/17,17.74%,ZFP36L1;FBLN1;AGO3;SOX11
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.18985516869872676,-0.5496199908840962,1.0,1.0,1.0,6/20,23.96%,RHOQ;NUMB;PID1;TMBIM1;AP2M1;PKDCC
prerank,phosphate ion transport (GO:0006817),0.19696481414556838,0.5438179684393236,0.9795918367346939,0.9970058915864104,1.0,8/17,36.21%,SLC37A4;SLC34A1;SLC37A1;SLC34A3;SLC17A1;SLC25A10;SLC34A2;SLC37A3
prerank,lipid modification (GO:0030258),-0.1813250280158017,-0.543182929810952,1.0,1.0,1.0,8/28,26.47%,DGKE;DGKG;CYP1A1;DGKB;DGKI;DGKD;DGKA;PORCN
prerank,B cell proliferation (GO:0042100),0.1614443459954316,0.5410761943703314,1.0,0.9965760237729273,1.0,2/31,10.97%,HSPD1;CD70
prerank,mitochondrial fusion (GO:0008053),-0.1952394076809471,-0.5342315686756177,1.0,1.0,1.0,6/16,28.67%,MFN2;PLD6;SPG7;MFF;MFN1;MIEF2
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.19922042486033537,-0.5304759622673184,0.9787234042553191,1.0,1.0,3/15,16.84%,PELI3;CARD8;GPS2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.1997340390479036,-0.5263779815002346,1.0,0.99982339928934,1.0,6/19,26.85%,JAM2;ADD2;ROCK1;MADCAM1;SELP;GOLPH3
prerank,response to cholesterol (GO:0070723),0.17542049786947755,0.5221683438663721,1.0,0.9975046499794019,1.0,19/19,82.47%,CCL3;TGFB1;TGFBR2;TGFBR1;CCR5;PTCH1;GPLD1;GRAMD1A;GRAMD1C;GRAMD1B;MLC1;PMVK;ABCA2;CYP7A1;OSBPL7;CES1;LRP6;SMAD2;SMO
prerank,NAD biosynthetic process (GO:0009435),0.17735296265743236,0.5182994472339365,1.0,0.9969775510038268,1.0,7/18,31.11%,QPRT;KYNU;NAPRT;HAAO;NAMPT;NMNAT1;RNLS
prerank,regulation of mast cell degranulation (GO:0043304),-0.19971140060670994,-0.5128517459948667,0.9807692307692307,1.0,1.0,2/15,10.38%,FES;FER
prerank,regulation of T cell migration (GO:2000404),-0.18642440995049236,-0.5045719090556219,0.9795918367346939,0.9998776768957289,1.0,4/19,21.59%,APOD;RHOA;CCL21;TNFRSF14
prerank,cellular response to zinc ion (GO:0071294),-0.18381599799538992,-0.49671538079716837,0.9830508474576272,0.9995589574946884,1.0,5/17,27.85%,MT1X;ZNF658;MT1M;MT1A;MT3
prerank,leukotriene biosynthetic process (GO:0019370),-0.18669080076314376,-0.47508623865220545,1.0,0.999735245611588,1.0,5/15,27.53%,PLA2G5;PLA2G1B;PLA2G4A;GGT5;GGT7
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.12684328211972945,-0.41250264877573,1.0,0.9998732741523625,1.0,6/29,26.45%,MICA;CADM1;KLRK1;IL12A;PIK3R6;CLEC12B
